<HTML><HEAD><TITLE>Gene Ontology Results</TITLE></HEAD><BODY>
<H1>Gene Ontology Enrichment Results</H1>
<A HREF="homerResults.html">Homer <i>de novo</i> Motif Enrichment Results</A><BR/>
<A HREF="knownResults.html">Known Motif Enrichment Results</A><BR/>
<H4>Text file version of complete results (i.e. open with Excel)
<UL>
<LI><A HREF="biological_process.txt">biological process</A>: Functional groupings of proteins (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="molecular_function.txt">molecular function</A>: Mechanistic actions of proteins (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="cellular_component.txt">cellular component</A>: Protein localization (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="chromosome.txt">chromosome location</A>: Genes with similar chromosome localization (<A HREF="http://www.ncbi.nlm.nih.gov/gene">NCBI Gene</A>)</LI>
<LI><A HREF="kegg.txt">KEGG pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.genome.jp/kegg/pathway.html">KEGG</A>)</LI>
<LI><A HREF="interactions.txt">protein interactions</A>: "Proteins interacting with a common protein (BIND, EcoCyc, HPRD)" (<A HREF="http://www.ncbi.nlm.nih.gov/gene">NCBI Gene</A>)</LI>
<LI><A HREF="interpro.txt">interpro domains</A>: Proteins with similar domains and features (<A HREF="http://www.ebi.ac.uk/interpro/">Interpro</A>)</LI>
<LI><A HREF="pfam.txt">pfam domains</A>: Proteins with similar domains and features (<A HREF="http://www.sanger.ac.uk/Software/Pfam/">Pfam</A>)</LI>
<LI><A HREF="smart.txt">smart domains</A>: Proteins with similar domains and features (<A HREF="http://smart.embl-heidelberg.de/">SMART</A>)</LI>
<LI><A HREF="gene3d.txt">gene3d domains</A>: Proteins with similar domains and features (<A HREF="http://cathwww.biochem.ucl.ac.uk:8080/Gene3D">Gene3D</A>)</LI>
<LI><A HREF="prosite.txt">prosite domains</A>: Proteins with similar domains and features (<A HREF="http://ca.expasy.org/prosite/">Prosite</A>)</LI>
<LI><A HREF="prints.txt">prints domains</A>: Proteins with similar domains and features (<A HREF="http://www.bioinf.manchester.ac.uk/dbbrowser/PRINTS/">PRINTS</A>)</LI>
<LI><A HREF="msigdb.txt">MSigDB lists</A>: "Genes sets for pathways, factor/miRNA target predictions, expression patterns, etc." (<A HREF="http://www.broadinstitute.org/gsea/msigdb/index.jsp">MSigDB</A>)</LI>
<LI><A HREF="biocyc.txt">BIOCYC pathways</A>: Groups of proteins in the same pathways (<A HREF="http://biocyc.org/">BIOCYC</A>)</LI>
<LI><A HREF="cosmic.txt">COSMIC cancer mutations</A>: Genes mutated in similar cancers (<A HREF="http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/">COSMIC</A>)</LI>
<LI><A HREF="gwas.txt">GWAS genes</A>: Genes mutated in similar diseases (<A HREF="http://www.genome.gov/26525384">GWAS Catalog</A>)</LI>
<LI><A HREF="lipidmaps.txt">Lipid Maps pathways</A>: Groups of proteins in the same lipid pathways (<A HREF="http://www.ncbi.nlm.nih.gov/biosystems/">Lipid Maps/Biosystems</A>)</LI>
<LI><A HREF="pathwayInteractionDB.txt">Pathway Interaction DB</A>: Groups of proteins in the same pathways (<A HREF="http://pid.nci.nih.gov/">Pathway Interaction Database</A>)</LI>
<LI><A HREF="reactome.txt">REACTOME pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.reactome.org/PathwayBrowser/">REACTOME</A>)</LI>
<LI><A HREF="smpdb.txt">SMPDB pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.smpdb.ca/">SMPDB</A>)</LI>
<LI><A HREF="wikipathways.txt">WikiPathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.wikipathways.org/index.php/Special:BrowsePathwaysPage">Wikipathways</A>)</LI>
</UL>
<H2>Enriched Categories</H2>
<TABLE border="1" cellpading="0" cellspacing="0">
<TR><TH>P-value</TH><TD>ln(P)</TD><TD>Term</TD><TD>GO Tree</TD><TD>GO ID</TD><TD># of Genes in Term</TD><TD># of Target Genes in Term</TD><TD># of Total Genes</TD><TD># of Target Genes</TD><TD>Common Genes</TD></TR>
<TR><TD>1.056e-20</TD><TD>-46.00</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma</TD><TD>2125</TD><TD>75</TD><TD>16984</TD><TD>193</TD>
<TD>NAALADL2,PI15,ADAMTS12,CD96,ZPLD1,RYR2,PRKCE,SGCG,EPYC,LMX1A,CPXM2,SGCD,RBM20,NOL4,TMEFF2,DSCAM,NRG1,EFNA5,UTRN,SYT1,EPHA3,ZFPM2,PTPRD,PCDH9,GAP43,PWWP2A,ACVR2A,GMDS,ADAMTS5,SEMA3C,DAOA,CASK,FBN2,CRTC3,FGF14,ATG10,CNTN1,SLC7A8,PAX6,UBR4,FMNL2,SLIT2,MAP2,MEGF10,KCNK9,DNER,ACVR1C,IQGAP2,SPATA16,IL1RAPL2,KLF12,THSD7B,ZNF521,SERGEF,THSD7A,CNTNAP2,WRN,EPS8,VAV3,BCHE,UNC5C,NOVA1,CTSO,NBEA,FIGN,PHLPP1,MRPL13,ADAMTS3,EDIL3,NCKAP5,NTRK2,SKAP2,ROBO2,KAZN,STXBP6</TD></TR>
<TR><TD>1.056e-20</TD><TD>-46.00</TD><TD>Burkitt_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>Burkitt_lymphoma</TD><TD>2125</TD><TD>75</TD><TD>16984</TD><TD>193</TD>
<TD>FIGN,NBEA,MRPL13,ADAMTS3,PHLPP1,NCKAP5,EDIL3,STXBP6,SKAP2,NTRK2,ROBO2,KAZN,CNTNAP2,THSD7A,VAV3,WRN,EPS8,UNC5C,BCHE,NOVA1,CTSO,ACVR1C,IQGAP2,SPATA16,KCNK9,DNER,IL1RAPL2,KLF12,THSD7B,SERGEF,ZNF521,CASK,DAOA,CRTC3,FGF14,FBN2,SLC7A8,CNTN1,PAX6,UBR4,FMNL2,ATG10,MEGF10,MAP2,SLIT2,GAP43,PCDH9,PWWP2A,GMDS,ACVR2A,ADAMTS5,SEMA3C,DSCAM,SYT1,UTRN,NRG1,EFNA5,ZFPM2,EPHA3,PTPRD,CPXM2,SGCD,LMX1A,RBM20,TMEFF2,NOL4,ADAMTS12,CD96,NAALADL2,PI15,ZPLD1,PRKCE,RYR2,SGCG,EPYC</TD></TR>
<TR><TD>3.112e-13</TD><TD>-28.80</TD><TD>central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma</TD><TD>7233</TD><TD>132</TD><TD>16984</TD><TD>193</TD>
<TD>PHLPP1,CALN1,RASGEF1B,ROBO2,SKAP2,CXCL13,EDIL3,AOAH,VAV3,THSD7A,CTSO,WWOX,AGA,UNC5C,BCHE,KLF12,SPATA16,RPH3A,ACVR1C,DNER,KCNK9,DEPTOR,PHF14,PAQR3,FBN2,LRRN2,DAOA,MEGF10,GCNT1,MAP2,SLIT2,PAX6,CNTN1,ATG10,DCDC2C,ADAMTS5,CD226,GMDS,SYT1,EFNA5,DSCAM,ZFPM2,KIF6,EPHA3,RBM20,EFR3A,ARX,FAT4,CPXM2,PRLHR,TCF20,BANK1,RGS6,XPO4,PTPRZ1,CELF2,TMEFF2,MUC7,CD96,SGCG,PRKCE,LHCGR,EFR3B,RYR2,ADAMTS3,MRPL13,SS18,SLC25A46,SLC10A2,FIGN,AKAP9,STXBP6,KAZN,NTRK2,NCKAP5,EPHA4,WRN,FANCB,CNTNAP2,SEZ6L,NOVA1,PARP8,HNF4G,IL1RAPL2,LGI1,THSD7B,PLEK,IQGAP2,AFM,SERGEF,ZNF521,FGFR2,FGF20,FGF14,CRTC3,CDH5,FGD3,CASK,ADAM28,B3GAT2,LMBRD1,UBR4,FMNL2,SPHKAP,PTPRK,PWWP2A,NAV3,GAP43,RGS5,PCDH9,SEMA3C,ACVR2A,UTRN,DAAM1,NRG1,JMJD1C,PTPRD,GPR83,BACH2,SGCD,LMX1A,LRIG3,NOL4,ZPLD1,ADAMTS12,PI15,NAALADL2,SLC39A10,TRPS1,EPYC,PXDNL,IPO8</TD></TR>
<TR><TD>6.785e-13</TD><TD>-28.02</TD><TD>diffuse_large_B_cell_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>diffuse_large_B_cell_lymphoma</TD><TD>4162</TD><TD>93</TD><TD>16984</TD><TD>193</TD>
<TD>THSD7A,VAV3,BCHE,UNC5C,CTSO,NRSN1,PHLPP1,EDIL3,CXCL13,SKAP2,ROBO2,DAOA,FBN2,EFEMP1,ATG10,CNTN1,SLIT2,MAP2,MEGF10,DNER,RPH3A,SPATA16,KLF12,DEPTOR,CHRM3,DSCAM,EFNA5,SYT1,EPHA3,ZFPM2,KIF6,FGF5,CD226,GMDS,ADAMTS5,CD96,RYR2,LHCGR,PRKCE,SGCG,BANK1,CPXM2,FAT4,ARX,FZD6,TMEFF2,XPO4,SEZ6L,CNTNAP2,ASPN,EPS8,NOVA1,REXO2,AKAP9,FIGN,ADAMTS3,EPHA4,NCKAP5,NTRK2,KAZN,STXBP6,CASK,FGD3,CRTC3,MPEG1,FGF14,PTPRK,FMNL2,B3GAT2,IL1RAPL2,LGI1,THSD7B,FGF20,ZNF521,SERGEF,NRG1,DAAM1,UTRN,PTPRD,PCDH9,RGS5,NAV3,SEMA3C,NAALADL2,ADAMTS12,ZPLD1,EPYC,TRPS1,LMX1A,SGCD,NOL4,LINC01387,LRIG3</TD></TR>
<TR><TD>9.131e-13</TD><TD>-27.72</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma</TD><TD>3616</TD><TD>85</TD><TD>16984</TD><TD>193</TD>
<TD>UNC5C,BCHE,REXO2,NOVA1,CTSO,ASPN,CNTNAP2,THSD7A,SEZ6L,VAV3,EPS8,CXCL13,NCKAP5,EPHA4,EDIL3,STXBP6,KAZN,ROBO2,SKAP2,NRSN1,FIGN,AKAP9,ADAMTS3,PHLPP1,FMNL2,CNTN1,ATG10,B3GAT2,MEGF10,SLIT2,FGD3,CASK,DAOA,FGF14,EFEMP1,CRTC3,MPEG1,FBN2,SERGEF,DEPTOR,ZNF521,SPATA16,RPH3A,DNER,IL1RAPL2,LGI1,KLF12,THSD7B,ZFPM2,EPHA3,DSCAM,DAAM1,SYT1,UTRN,EFNA5,NRG1,ADAMTS5,CD226,GMDS,SEMA3C,NAV3,RGS5,PCDH9,FGF5,PRKCE,LHCGR,RYR2,SGCG,EPYC,CD96,ADAMTS12,NAALADL2,ZPLD1,TMEFF2,NOL4,XPO4,LRIG3,LINC01387,CPXM2,SGCD,BANK1,LMX1A,FZD6,ARX,FAT4</TD></TR>
<TR><TD>9.832e-13</TD><TD>-27.65</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm</TD><TD>7328</TD><TD>132</TD><TD>16984</TD><TD>193</TD>
<TD>UNC5C,BCHE,CTSO,THSD7A,VAV3,PRSS12,CXCL13,AOAH,EDIL3,SKAP2,ROBO2,NRSN1,PHLPP1,CALN1,PAX6,CNTN1,ATG10,MEGF10,MAP2,SLIT2,DAOA,EFEMP1,FBN2,PHF14,LRFN5,DEPTOR,RPH3A,ACVR1C,RUNX1T1,SPATA16,DNER,KCNK9,KLF12,KIF6,TGFBR2,ZFPM2,EPHA3,DSCAM,CHRM3,SYT1,EFNA5,CD226,GMDS,ADAMTS5,DCDC2C,FGF5,LHCGR,PRKCE,EFR3B,RYR2,MRPL3,SGCG,CD96,TMEFF2,MUC7,PTPRZ1,XPO4,CPXM2,BANK1,TCF20,EFR3A,FZD6,RBM20,FAT4,PARP8,NOVA1,REXO2,CNTNAP2,SEZ6L,FANCB,WRN,EPS8,NCKAP5,EPHA4,IRX1,STXBP6,PSKH2,NTRK2,DNAJC12,KAZN,FIGN,NBEA,AKAP9,SS18,MRPL13,ADAMTS3,SLC25A46,SLC7A8,SPHKAP,FMNL2,B3GAT2,LMBRD1,CASK,SLC7A14,ADAM28,LINC00583,CRTC3,FGF14,CDH5,FGF20,SERGEF,ZNF521,IQGAP2,LGI1,IL1RAPL2,THSD7B,PLEK,PTPRD,JMJD1C,DAAM1,UTRN,NRG1,ACVR2A,SEMA3C,RGS5,GAP43,NAV3,PCDH9,COQ2,IPO8,EPYC,PXDNL,ADAMTS12,SLC39A10,PI15,NAALADL2,ZPLD1,NOL4,LRIG3,LINC01387,SGCD,LMX1A</TD></TR>
<TR><TD>1.584e-12</TD><TD>-27.17</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma</TD><TD>3513</TD><TD>83</TD><TD>16984</TD><TD>193</TD>
<TD>FGFR2,ZNF521,LRFN5,IL1RAPL2,THSD7B,DNER,AFM,IQGAP2,SPATA16,SLIT2,MAP2,MEGF10,B3GAT2,PTPRK,SPHKAP,FMNL2,UBR4,NRCAM,CDH5,FBN2,RAI2,MPEG1,PAQR3,EFEMP1,FGD3,NTRK2,SKAP2,ROBO2,KAZN,AOAH,EDIL3,EPHA4,IRX1,NCKAP5,FUT9,PHLPP1,ADAMTS3,NBEA,FIGN,NRSN1,NOVA1,CTSO,HNF4G,UNC5C,FANCB,VAV3,SEZ6L,THSD7A,ZNF133,CNTNAP2,PTPRZ1,LRIG3,NOL4,TMEFF2,FAT4,BACH2,UHMK1,EFR3A,NOBOX,CPXM2,PXDNL,MRPL3,SGCG,RYR2,FNIP2,NAALADL2,ADAMTS12,SEMA3C,GMDS,ACVR2A,ADAMTS5,REG1B,PCDH9,PTPRD,EPHA3,ZFPM2,KIF6,NRG1,EFNA5,SYT1,UTRN,CHRM3,DSCAM</TD></TR>
<TR><TD>1.584e-12</TD><TD>-27.17</TD><TD>chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma</TD><TD>3513</TD><TD>83</TD><TD>16984</TD><TD>193</TD>
<TD>CNTNAP2,ZNF133,THSD7A,SEZ6L,VAV3,FANCB,UNC5C,HNF4G,CTSO,NOVA1,NRSN1,FIGN,NBEA,ADAMTS3,PHLPP1,FUT9,NCKAP5,IRX1,AOAH,EDIL3,EPHA4,ROBO2,KAZN,SKAP2,NTRK2,FGD3,MPEG1,PAQR3,EFEMP1,RAI2,FBN2,CDH5,UBR4,FMNL2,NRCAM,SPHKAP,PTPRK,B3GAT2,MEGF10,MAP2,SLIT2,IQGAP2,SPATA16,AFM,DNER,THSD7B,IL1RAPL2,LRFN5,ZNF521,FGFR2,DSCAM,CHRM3,UTRN,SYT1,EFNA5,NRG1,KIF6,ZFPM2,EPHA3,PTPRD,PCDH9,REG1B,ADAMTS5,GMDS,ACVR2A,SEMA3C,ADAMTS12,NAALADL2,FNIP2,RYR2,SGCG,MRPL3,PXDNL,CPXM2,UHMK1,NOBOX,EFR3A,BACH2,FAT4,TMEFF2,NOL4,LRIG3,PTPRZ1</TD></TR>
<TR><TD>1.925e-12</TD><TD>-26.98</TD><TD>central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV</TD><TD>2542</TD><TD>68</TD><TD>16984</TD><TD>193</TD>
<TD>FGF14,CDH5,CASK,SLIT2,FMNL2,UBR4,PTPRK,THSD7B,KLF12,IL1RAPL2,SPATA16,IQGAP2,DNER,AFM,SERGEF,ZNF521,LRFN5,VAV3,EPS8,CNTNAP2,SEZ6L,THSD7A,ACP6,UNC5C,PARP8,ADAMTS3,PHLPP1,FIGN,NBEA,STXBP6,KAZN,ROBO2,NCKAP5,PRSS12,EPHA4,EDIL3,CD96,ADAMTS12,SLC39A10,NAALADL2,PI15,LHCGR,PRKCE,RYR2,FZD6,EFR3A,RBM20,BACH2,SGCD,LMX1A,BANK1,PTPRZ1,TMEFF2,NOL4,UTRN,SYT1,NRG1,EFNA5,DSCAM,TGFBR2,KIF6,ZFPM2,EPHA3,PCDH9,SEMA3C,GMDS,CD226,ADAMTS5</TD></TR>
<TR><TD>7.763e-12</TD><TD>-25.58</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma</TD><TD>2746</TD><TD>70</TD><TD>16984</TD><TD>193</TD>
<TD>NOVA1,BCHE,UNC5C,THSD7A,SEZ6L,ZNF133,CNTNAP2,DNAJC12,ROBO2,KAZN,NTRK2,STXBP6,EDIL3,PRSS12,NCKAP5,FABP7,PHLPP1,ADAMTS3,NBEA,FIGN,SLIT2,LMBRD1,MAP2,MEGF10,ATG10,FMNL2,CNTN1,FBN2,FGF14,EFEMP1,DAOA,ZNF521,DEPTOR,PLEK,THSD7B,KLF12,IL1RAPL2,DNER,IQGAP2,RPH3A,GPR83,EPHA3,ZFPM2,EFNA5,NRG1,SYT1,UTRN,JMJD1C,DSCAM,SEMA3C,ADAMTS5,GMDS,PCDH9,NAV3,INSM1,TRPS1,SGCG,RYR2,PRKCE,LHCGR,NAALADL2,ADAMTS12,LRIG3,NOL4,TMEFF2,SHISA3,FAT4,RBM20,TCF20,CPXM2</TD></TR>
<TR><TD>1.738e-11</TD><TD>-24.78</TD><TD>mantle_cell_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>mantle_cell_lymphoma</TD><TD>2858</TD><TD>71</TD><TD>16984</TD><TD>193</TD>
<TD>ADAMTS12,NAALADL2,TRPS1,SGCG,INSM1,PRKCE,LHCGR,RYR2,RBM20,SHISA3,FAT4,CPXM2,TCF20,LRIG3,TMEFF2,NOL4,UTRN,SYT1,EFNA5,NRG1,DSCAM,JMJD1C,GPR83,ZFPM2,EPHA3,NAV3,PCDH9,SEMA3C,ADAMTS5,GMDS,FGF14,EFEMP1,FBN2,CASK,DAOA,MAP2,MEGF10,LMBRD1,SLIT2,FMNL2,CNTN1,ATG10,KLF12,THSD7B,IL1RAPL2,PLEK,IQGAP2,RPH3A,DNER,DEPTOR,ZNF521,ZNF133,CNTNAP2,THSD7A,SEZ6L,NOVA1,UNC5C,BCHE,ADAMTS3,PHLPP1,FIGN,NBEA,STXBP6,ROBO2,DNAJC12,KAZN,NTRK2,NCKAP5,PRSS12,FABP7,EDIL3</TD></TR>
<TR><TD>3.511e-11</TD><TD>-24.07</TD><TD>Ig_I-set</TD><TD>interpro domains</TD><TD>IPR013098</TD><TD>132</TD><TD>15</TD><TD>18605</TD><TD>215</TD>
<TD>NRG1,FGFR2,IL1RAPL2,ROBO2,PXDNL,PTPRD,DSCAM,UNC5C,CNTN1,LRIG3,LRRN2,NRCAM,PTPRK,SEMA3C,NTRK2</TD></TR>
<TR><TD>3.573e-11</TD><TD>-24.06</TD><TD>I-set</TD><TD>pfam domains</TD><TD>PF07679</TD><TD>132</TD><TD>15</TD><TD>17869</TD><TD>207</TD>
<TD>PXDNL,LRRN2,UNC5C,DSCAM,NTRK2,SEMA3C,ROBO2,PTPRD,NRCAM,PTPRK,CNTN1,NRG1,FGFR2,LRIG3,IL1RAPL2</TD></TR>
<TR><TD>7.415e-11</TD><TD>-23.32</TD><TD>acute_lymphoblastic_B_cell_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>acute_lymphoblastic_B_cell_leukaemia</TD><TD>3841</TD><TD>84</TD><TD>16984</TD><TD>193</TD>
<TD>BANK1,SGCD,CPXM2,BACH2,FAT4,RBM20,EFR3A,NOBOX,MUC7,NOL4,TMEFF2,LRIG3,PTPRZ1,NAALADL2,CD96,ADAMTS12,EFR3B,RYR2,PRKCE,LHCGR,MRPL3,SGCG,PCDH9,NAV3,ADAMTS5,ACVR2A,CD226,GMDS,CHRM3,JMJD1C,DSCAM,EFNA5,NRG1,UTRN,SYT1,EPHA3,KIF6,DNER,IQGAP2,SPATA16,RPH3A,ACVR1C,KLF12,IL1RAPL2,THSD7B,LGI1,ZNF521,FGFR2,SERGEF,LINC00583,FBN2,FGF14,CRTC3,PAQR3,ATG10,NRCAM,FMNL2,UBR4,CNTN1,SLC7A8,LMBRD1,SLIT2,MEGF10,MAP2,AKAP9,NBEA,NRSN1,FIGN,CALN1,PHLPP1,ADAMTS3,EPHA4,EDIL3,NCKAP5,ROBO2,SKAP2,NTRK2,PSKH2,STXBP6,THSD7A,CNTNAP2,BCHE,PARP8,UNC5C</TD></TR>
<TR><TD>7.415e-11</TD><TD>-23.32</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia</TD><TD>3841</TD><TD>84</TD><TD>16984</TD><TD>193</TD>
<TD>FGFR2,ZNF521,SERGEF,LGI1,KLF12,THSD7B,IL1RAPL2,DNER,RPH3A,ACVR1C,SPATA16,IQGAP2,SLIT2,LMBRD1,MEGF10,MAP2,ATG10,CNTN1,SLC7A8,FMNL2,NRCAM,UBR4,FBN2,CRTC3,PAQR3,FGF14,LINC00583,SKAP2,NTRK2,ROBO2,STXBP6,PSKH2,EDIL3,EPHA4,NCKAP5,CALN1,PHLPP1,ADAMTS3,AKAP9,NBEA,FIGN,NRSN1,BCHE,UNC5C,PARP8,THSD7A,CNTNAP2,PTPRZ1,LRIG3,MUC7,NOL4,TMEFF2,FAT4,BACH2,EFR3A,NOBOX,RBM20,BANK1,SGCD,CPXM2,MRPL3,SGCG,RYR2,EFR3B,LHCGR,PRKCE,NAALADL2,ADAMTS12,CD96,GMDS,ACVR2A,CD226,ADAMTS5,PCDH9,NAV3,EPHA3,KIF6,NRG1,EFNA5,SYT1,UTRN,JMJD1C,CHRM3,DSCAM</TD></TR>
<TR><TD>1.285e-10</TD><TD>-22.77</TD><TD>brainstem</TD><TD>COSMIC cancer mutations</TD><TD>brainstem</TD><TD>3116</TD><TD>73</TD><TD>16984</TD><TD>193</TD>
<TD>DNER,AFM,RPH3A,IQGAP2,SPATA16,IL1RAPL2,KLF12,THSD7B,LRFN5,FGFR2,ZNF521,SERGEF,CASK,CDH5,FGF14,PTPRK,UBR4,FMNL2,SLIT2,NBEA,FIGN,PHLPP1,ADAMTS3,EPHA4,EDIL3,NCKAP5,PRSS12,ROBO2,KAZN,STXBP6,SEZ6L,THSD7A,CNTNAP2,EPS8,VAV3,PARP8,UNC5C,WWOX,ACP6,BANK1,LMX1A,SGCD,BACH2,EFR3A,FZD6,RBM20,NOL4,TMEFF2,PTPRZ1,SLC39A10,NAALADL2,PI15,CD96,ADAMTS12,IGFL4,RYR2,LHCGR,PRKCE,PCDH9,CD226,GMDS,ADAMTS5,SEMA3C,DSCAM,NRG1,EFNA5,SYT1,UTRN,EPHA3,KIF6,TGFBR2,ZFPM2,PTPRD</TD></TR>
<TR><TD>1.638e-10</TD><TD>-22.53</TD><TD>acute_myeloid_leukaemia_therapy_related</TD><TD>COSMIC cancer mutations</TD><TD>acute_myeloid_leukaemia_therapy_related</TD><TD>1526</TD><TD>47</TD><TD>16984</TD><TD>193</TD>
<TD>FIGN,ADAMTS3,EDIL3,NCKAP5,NTRK2,ROBO2,THSD7A,CNTNAP2,VAV3,UNC5C,NOVA1,DNER,KCNK9,RPH3A,SPATA16,IL1RAPL2,THSD7B,ZNF521,DAOA,SLC7A14,CASK,CRTC3,FGF14,PAX6,SLC7A8,FMNL2,SLIT2,MAP2,MEGF10,B3GAT2,PCDH9,ACVR2A,DSCAM,NRG1,EFNA5,SYT1,UTRN,ZFPM2,LMX1A,BANK1,SGCD,RBM20,LRIG3,NAALADL2,CD96,RYR2,SGCG</TD></TR>
<TR><TD>1.638e-10</TD><TD>-22.53</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related</TD><TD>1526</TD><TD>47</TD><TD>16984</TD><TD>193</TD>
<TD>RBM20,LMX1A,BANK1,SGCD,LRIG3,NAALADL2,CD96,SGCG,RYR2,PCDH9,ACVR2A,EFNA5,NRG1,SYT1,UTRN,DSCAM,ZFPM2,IL1RAPL2,THSD7B,KCNK9,DNER,SPATA16,RPH3A,ZNF521,FGF14,CRTC3,DAOA,CASK,SLC7A14,SLIT2,B3GAT2,MAP2,MEGF10,FMNL2,SLC7A8,PAX6,ADAMTS3,FIGN,ROBO2,NTRK2,EDIL3,NCKAP5,VAV3,THSD7A,CNTNAP2,NOVA1,UNC5C</TD></TR>
<TR><TD>1.885e-10</TD><TD>-22.39</TD><TD>prostate-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>prostate-carcinoma</TD><TD>9014</TD><TD>145</TD><TD>16984</TD><TD>193</TD>
<TD>SKAP2,ROBO2,PRSS12,AOAH,EDIL3,RASGEF1B,CALN1,PHLPP1,CTSO,AGA,ACP6,UNC5C,VAV3,ZNF133,THSD7A,DEPTOR,PHF14,LRFN5,KLF12,ACVR1C,RPH3A,RUNX1T1,SPATA16,KCNK9,DNER,MEGF10,MAP2,GCNT1,SLIT2,PAX6,CNTN1,NRCAM,ATG10,EFEMP1,OR2AG1,RAI2,FBN2,LRRN2,CD226,GMDS,ADAMTS5,FGF5,PBX1,ZFPM2,KIF6,TGFBR2,ERCC6L2,EPHA3,SYT1,EFNA5,DSCAM,CHRM3,PTPRZ1,RGS6,XPO4,CELF2,TMEFF2,TWIST1,UHMK1,FZD6,RBM20,FAT4,CPXM2,BANK1,SGCG,LHCGR,PRKCE,RYR2,CD96,STXBP6,PSKH2,NTRK2,DNAJC12,KAZN,NCKAP5,EPHA4,IRX1,MRPL13,SS18,ADAMTS3,FUT9,SLC10A2,NBEA,AKAP9,NOVA1,PARP8,HNF4G,WRN,FANCB,EPS8,CNTNAP2,ASPN,SEZ6L,SERGEF,FGFR2,ZNF521,FGF20,IL1RAPL2,LGI1,THSD7B,UCHL1,IQGAP2,GHITM,LMBRD1,SPHKAP,FMNL2,UBR4,PTPRK,CRTC3,FGF14,CDH5,CASK,SLC7A14,SEMA3C,ACVR2A,COQ2,REG1B,NAT2,RGS5,GAP43,NAV3,PCDH9,PTPRD,GPR83,DAAM1,UTRN,NRG1,SPAG9,JMJD1C,CETN3,LRIG3,NOL4,NOBOX,FERD3L,BACH2,SGCD,LMX1A,EPYC,TRPS1,INSM1,PXDNL,FNIP2,ADAMTS12,SLC39A10,NAALADL2</TD></TR>
<TR><TD>1.893e-10</TD><TD>-22.39</TD><TD>oesophagus-lower_third-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus-lower_third-carcinoma-adenocarcinoma</TD><TD>6317</TD><TD>115</TD><TD>16984</TD><TD>193</TD>
<TD>SERGEF,ZNF521,IL1RAPL2,THSD7B,IQGAP2,UBR4,SLC7A8,SPHKAP,PTPRK,MPEG1,CRTC3,CDH5,FGD3,SLC7A14,ADAM28,PSKH2,KAZN,NTRK2,NCKAP5,IRX1,EPHA4,ADAMTS3,SS18,SLC25A46,SLC10A2,ZNF518B,AKAP9,NBEA,PARP8,EPS8,WRN,CNTNAP2,LRIG3,NOL4,FERD3L,BACH2,SGCD,LMX1A,TRPS1,PXDNL,IPO8,ZPLD1,ADAMTS12,NAALADL2,PI15,SLC39A10,ACVR2A,COQ2,REG1B,NAV3,NAT2,PCDH9,PTPRD,NUP35,UTRN,DAAM1,NRG1,SPAG9,JMJD1C,PHF14,LRFN5,KLF12,RUNX1T1,RPH3A,KCNK9,GCNT1,MAP2,MEGF10,SLIT2,CNTN1,PAX6,PAQR3,EFEMP1,FBN2,RAI2,ROBO2,SKAP2,PRSS12,CXCL13,AOAH,LRRC3B,PHLPP1,RASGEF1B,AGA,UNC5C,BCHE,VAV3,ZNF133,THSD7A,XPO4,RGS6,PTPRZ1,CELF2,TMEFF2,TWIST1,MUC7,EFR3A,FZD6,FAT4,SERINC5,CPXM2,PRLHR,PRKCE,LHCGR,RYR2,ADAMTS5,CD226,GMDS,TGFBR2,ZFPM2,EPHA3,PCGF5,EFNA5,DSCAM,CHRM3</TD></TR>
<TR><TD>4.021e-10</TD><TD>-21.63</TD><TD>blood_vessel</TD><TD>COSMIC cancer mutations</TD><TD>blood_vessel</TD><TD>2217</TD><TD>58</TD><TD>16984</TD><TD>193</TD>
<TD>FZD6,UHMK1,ARX,RBM20,CPXM2,SGCD,BANK1,LMX1A,PTPRZ1,NOL4,ZPLD1,NAALADL2,SGCG,PRKCE,RYR2,FGF5,RGS5,PCDH9,SEMA3C,UTRN,EFNA5,DSCAM,EPHA3,IL1RAPL2,THSD7B,PLEK,RPH3A,SPATA16,DNER,SERGEF,FGFR2,ZNF521,FGF14,FBN2,ADAM28,MAP2,B3GAT2,SLIT2,LMBRD1,FMNL2,PHLPP1,SPANXN1,SLC10A2,NBEA,SKAP2,NTRK2,ROBO2,KAZN,NCKAP5,EDIL3,AOAH,VAV3,EPS8,CNTNAP2,THSD7A,NOVA1,UNC5C,PARP8</TD></TR>
<TR><TD>4.958e-10</TD><TD>-21.42</TD><TD>system development</TD><TD>biological process</TD><TD>GO:0048731</TD><TD>3545</TD><TD>80</TD><TD>18905</TD><TD>220</TD>
<TD>BRINP3,UHMK1,SEMA3C,LMX1A,FBN2,PHF14,CNTN1,TGFBR2,ADAMTS12,PTPRD,MAP2,CNTNAP2,GCNT1,RBM20,FGFR2,ACVR2A,AMELX,CDH5,DAW1,AFG2A,LGI1,PCDH9,TRPS1,PBX1,IL1RAPL2,CHRM3,THSD7A,TWIST1,EPHA3,SERINC5,NRG1,ROBO2,RYR2,NRSN1,FZD6,FUT9,CYTL1,ARX,UCHL1,DSCAM,NTRK2,INSM1,ADAMTS5,FGF14,ZNF521,NOVA1,FGF20,UNC5C,ZFPM2,FAT4,FGF5,BCHE,FABP7,PAX6,LHCGR,PECAM1,GAP43,EFEMP1,VAV3,FERD3L,NAV3,ZFAND5,PPP1R17,SLC25A46,NRCAM,ADGRL3,SGCD,EFNA5,PLAAT1,WWOX,EPYC,SGCG,SLIT2,SEZ6L,DNER,ACVR1C,EPHA4,IRX1,SHTN1,PTPRZ1</TD></TR>
<TR><TD>8.486e-10</TD><TD>-20.89</TD><TD>angiosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>angiosarcoma</TD><TD>2198</TD><TD>57</TD><TD>16984</TD><TD>193</TD>
<TD>FGF5,PCDH9,RGS5,SEMA3C,EFNA5,UTRN,DSCAM,EPHA3,RBM20,UHMK1,FZD6,ARX,LMX1A,BANK1,SGCD,CPXM2,PTPRZ1,NOL4,ZPLD1,NAALADL2,SGCG,RYR2,PRKCE,PHLPP1,NBEA,SLC10A2,SPANXN1,KAZN,ROBO2,SKAP2,NTRK2,EDIL3,AOAH,NCKAP5,EPS8,VAV3,THSD7A,CNTNAP2,NOVA1,PARP8,UNC5C,PLEK,IL1RAPL2,THSD7B,DNER,SPATA16,RPH3A,ZNF521,SERGEF,FBN2,FGF14,ADAM28,SLIT2,LMBRD1,B3GAT2,MAP2,FMNL2</TD></TR>
<TR><TD>8.486e-10</TD><TD>-20.89</TD><TD>soft_tissue-blood_vessel-angiosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>soft_tissue-blood_vessel-angiosarcoma</TD><TD>2198</TD><TD>57</TD><TD>16984</TD><TD>193</TD>
<TD>VAV3,EPS8,CNTNAP2,THSD7A,NOVA1,UNC5C,PARP8,PHLPP1,SPANXN1,SLC10A2,NBEA,SKAP2,NTRK2,KAZN,ROBO2,NCKAP5,AOAH,EDIL3,FGF14,FBN2,ADAM28,MAP2,B3GAT2,LMBRD1,SLIT2,FMNL2,IL1RAPL2,THSD7B,PLEK,RPH3A,SPATA16,DNER,SERGEF,ZNF521,UTRN,EFNA5,DSCAM,EPHA3,FGF5,RGS5,PCDH9,SEMA3C,ZPLD1,NAALADL2,SGCG,PRKCE,RYR2,ARX,UHMK1,FZD6,RBM20,SGCD,CPXM2,LMX1A,BANK1,PTPRZ1,NOL4</TD></TR>
<TR><TD>1.525e-09</TD><TD>-20.30</TD><TD>multicellular organism development</TD><TD>biological process</TD><TD>GO:0007275</TD><TD>3972</TD><TD>85</TD><TD>18905</TD><TD>220</TD>
<TD>PECAM1,LHCGR,PAX6,FABP7,GAP43,EFEMP1,FERD3L,NAV3,VAV3,SLC25A46,PPP1R17,ZFAND5,EFNA5,ADGRL3,SGCD,NRCAM,WWOX,PLAAT1,EPYC,IRX1,EPHA4,ACVR1C,SEZ6L,DNER,SGCG,SLIT2,PTPRZ1,SHTN1,LMBRD1,ADAMTS3,ARX,CYTL1,FZD6,FUT9,NTRK2,DSCAM,UCHL1,ADAMTS5,INSM1,ZNF521,FGF14,NOVA1,FAT4,ZFPM2,UNC5C,FGF20,FGF5,BCHE,TMEFF2,PCDH9,TRPS1,RAI2,CHRM3,IL1RAPL2,PBX1,SERINC5,EPHA3,TWIST1,THSD7A,LRIG3,ROBO2,RYR2,NRSN1,NRG1,BRINP3,SEMA3C,UHMK1,FBN2,LMX1A,ADAMTS12,PTPRD,TGFBR2,CNTN1,PHF14,MAP2,GCNT1,CNTNAP2,AMELX,RBM20,ACVR2A,FGFR2,LGI1,AFG2A,DAW1,CDH5</TD></TR>
<TR><TD>1.030e-08</TD><TD>-18.39</TD><TD>chondroblastoma</TD><TD>COSMIC cancer mutations</TD><TD>chondroblastoma</TD><TD>536</TD><TD>24</TD><TD>16984</TD><TD>193</TD>
<TD>SGCD,IQGAP2,IL1RAPL2,EFR3A,TMEFF2,NOL4,ZNF521,NAALADL2,FGF14,FMNL2,ATG10,SLIT2,PCDH9,DCDC2C,GMDS,NCKAP5,EDIL3,CNTNAP2,DSCAM,SEZ6L,THSD7A,SYT1,VAV3,ZFPM2</TD></TR>
<TR><TD>1.145e-08</TD><TD>-18.29</TD><TD>axonogenesis</TD><TD>biological process</TD><TD>GO:0007409</TD><TD>366</TD><TD>20</TD><TD>18905</TD><TD>220</TD>
<TD>EPHA4,FGFR2,SLIT2,LGI1,ROBO2,PTPRZ1,SHTN1,EFNA5,EPHA3,NRCAM,UNC5C,LMX1A,SLC25A46,CNTN1,ARX,PAX6,SEMA3C,DSCAM,UCHL1,GAP43</TD></TR>
<TR><TD>1.187e-08</TD><TD>-18.25</TD><TD>anatomical structure development</TD><TD>biological process</TD><TD>GO:0048856</TD><TD>5236</TD><TD>100</TD><TD>18905</TD><TD>220</TD>
<TD>INSM1,ADAMTS5,ACP6,ZNF521,CYTL1,FUT9,FZD6,UCHL1,NTRK2,DSCAM,FGF5,ASPN,BCHE,NOVA1,UNC5C,VAV3,ZFAND5,PPP1R17,SLC25A46,FABP7,HNF4G,PAX6,LHCGR,PECAM1,SGCG,SLIT2,SEZ6L,ACVR1C,IRX1,EPHA4,LMBRD1,PTPRZ1,CXCL13,LRATD1,PLAAT1,LMX1A,PTPRD,ADAMTS12,UHMK1,FGFR2,AMELX,DAW1,AFG2A,CNTNAP2,SLC39A10,PBX1,CHRM3,CPQ,NRG1,ROBO2,RYR2,NRSN1,THSD7A,TWIST1,KAZN,LRIG3,FGF14,ARX,UTRN,FGF20,ZFPM2,FAT4,NOBOX,FERD3L,NAV3,SS18,GAP43,EFEMP1,DNER,ADAMTS3,SHTN1,NRCAM,ADGRL3,SGCD,EFNA5,EPYC,WWOX,FBN2,PHF14,TGFBR2,CNTN1,BRINP3,SEMA3C,RBM20,ACVR2A,CDH5,LGI1,PLEK,MAP2,SPATA16,GCNT1,IL1RAPL2,PCDH9,TMEFF2,RAI2,TRPS1,EPHA3,SERINC5,SPAG9,MEGF10</TD></TR>
<TR><TD>2.194e-08</TD><TD>-17.63</TD><TD>nervous system development</TD><TD>biological process</TD><TD>GO:0007399</TD><TD>2193</TD><TD>55</TD><TD>18905</TD><TD>220</TD>
<TD>PTPRZ1,SHTN1,IRX1,EPHA4,ACVR1C,SEZ6L,DNER,SLIT2,EFNA5,ADGRL3,NRCAM,SLC25A46,PPP1R17,NAV3,FERD3L,GAP43,PAX6,FABP7,BCHE,FGF5,FAT4,UNC5C,FGF20,NOVA1,ZNF521,FGF14,INSM1,NTRK2,DSCAM,UCHL1,ARX,FZD6,FUT9,ROBO2,NRSN1,NRG1,EPHA3,SERINC5,TWIST1,CHRM3,IL1RAPL2,PBX1,PCDH9,LGI1,AFG2A,FGFR2,CNTNAP2,MAP2,PTPRD,CNTN1,TGFBR2,LMX1A,SEMA3C,UHMK1,BRINP3</TD></TR>
<TR><TD>3.337e-08</TD><TD>-17.22</TD><TD>carcinoid-endocrine_tumour</TD><TD>COSMIC cancer mutations</TD><TD>carcinoid-endocrine_tumour</TD><TD>7779</TD><TD>126</TD><TD>16984</TD><TD>193</TD>
<TD>ZFPM2,KIF6,TGFBR2,EPHA3,DSCAM,SYT1,EFNA5,CD226,GMDS,DCDC2C,FGF5,LHCGR,PRKCE,EFR3B,RYR2,MRPL3,SGCG,CD96,TMEFF2,PTPRZ1,PRLHR,CPXM2,BANK1,EFR3A,UHMK1,RBM20,FAT4,UNC5C,BCHE,ACP6,ZNF133,THSD7A,VAV3,PRSS12,EDIL3,AOAH,SKAP2,ROBO2,RASGEF1B,PHLPP1,CNTN1,NRCAM,ATG10,MAP2,MEGF10,SLIT2,EFEMP1,PAQR3,PHF14,LRFN5,DEPTOR,RPH3A,ACVR1C,RUNX1T1,SPATA16,DNER,KCNK9,KLF12,ZFAND5,GPR83,JMJD1C,UTRN,DAAM1,NRG1,ACVR2A,SEMA3C,RGS5,GAP43,PCDH9,COQ2,REG1B,IPO8,EPYC,TRPS1,INSM1,ADAMTS12,SLC39A10,NAALADL2,PI15,NOL4,LRIG3,LINC01387,SGCD,LMX1A,BACH2,FERD3L,PARP8,HNF4G,NOVA1,CNTNAP2,SEZ6L,WRN,EPS8,NCKAP5,EPHA4,STXBP6,PSKH2,NTRK2,KAZN,FIGN,SPANXN1,MRPL13,SS18,ADAMTS3,SLC7A8,SPHKAP,UBR4,FMNL2,B3GAT2,LMBRD1,CASK,SLC7A14,ADAM28,LINC00583,CRTC3,FGF14,CDH5,SERGEF,FGFR2,ZNF521,UCHL1,IQGAP2,AFM,THSD7B,IL1RAPL2,PLEK</TD></TR>
<TR><TD>4.615e-08</TD><TD>-16.89</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm</TD><TD>767</TD><TD>28</TD><TD>16984</TD><TD>193</TD>
<TD>NCKAP5,GMDS,KAZN,NTRK2,RGS5,PCDH9,UNC5C,PARP8,ZFPM2,EPHA3,DSCAM,CNTNAP2,THSD7A,UTRN,SYT1,EFNA5,NOL4,SERGEF,DNER,IL1RAPL2,THSD7B,PRKCE,SLC7A8,RYR2,MEGF10,LMBRD1,SLIT2,SLC39A10</TD></TR>
<TR><TD>4.875e-08</TD><TD>-16.84</TD><TD>cerebellum</TD><TD>COSMIC cancer mutations</TD><TD>cerebellum</TD><TD>769</TD><TD>28</TD><TD>16984</TD><TD>193</TD>
<TD>SPATA16,TCF20,THSD7B,IL1RAPL2,NOL4,PTPRZ1,RGS6,CELF2,NAALADL2,FGF14,FBN2,NRCAM,RYR2,SLIT2,FIGN,PCDH9,SEMA3C,NTRK2,ROBO2,CNTNAP2,DSCAM,UTRN,DAAM1,NRG1,ZFPM2,EPHA3,BCHE,PTPRD</TD></TR>
<TR><TD>5.666e-08</TD><TD>-16.69</TD><TD>cell morphogenesis involved in neuron differentiation</TD><TD>biological process</TD><TD>GO:0048667</TD><TD>443</TD><TD>21</TD><TD>18905</TD><TD>220</TD>
<TD>SLC25A46,CNTN1,LMX1A,DSCAM,GAP43,UCHL1,SEMA3C,PAX6,ARX,PTPRZ1,LGI1,ROBO2,SHTN1,FGFR2,SLIT2,EPHA4,UNC5C,MAP2,NRCAM,EPHA3,EFNA5</TD></TR>
<TR><TD>6.004e-08</TD><TD>-16.63</TD><TD>neuron projection guidance</TD><TD>biological process</TD><TD>GO:0097485</TD><TD>224</TD><TD>15</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,LGI1,SLIT2,EPHA4,UNC5C,NRCAM,EPHA3,EFNA5,CNTN1,LMX1A,GAP43,DSCAM,SEMA3C,PAX6,ARX</TD></TR>
<TR><TD>6.004e-08</TD><TD>-16.63</TD><TD>axon guidance</TD><TD>biological process</TD><TD>GO:0007411</TD><TD>224</TD><TD>15</TD><TD>18905</TD><TD>220</TD>
<TD>UNC5C,NRCAM,EPHA3,EFNA5,LGI1,ROBO2,SLIT2,EPHA4,DSCAM,GAP43,SEMA3C,PAX6,ARX,CNTN1,LMX1A</TD></TR>
<TR><TD>6.069e-08</TD><TD>-16.62</TD><TD>neuron projection morphogenesis</TD><TD>biological process</TD><TD>GO:0048812</TD><TD>486</TD><TD>22</TD><TD>18905</TD><TD>220</TD>
<TD>CNTN1,LMX1A,DSCAM,UCHL1,SEMA3C,ARX,LGI1,FGFR2,CNTNAP2,UNC5C,MAP2,SLC25A46,GAP43,PAX6,PTPRZ1,ROBO2,SHTN1,SLIT2,EPHA4,NRCAM,EPHA3,EFNA5</TD></TR>
<TR><TD>6.334e-08</TD><TD>-16.57</TD><TD>generation of neurons</TD><TD>biological process</TD><TD>GO:0048699</TD><TD>1159</TD><TD>36</TD><TD>18905</TD><TD>220</TD>
<TD>PBX1,SLC25A46,PAX6,GAP43,DNER,SLIT2,EPHA4,IRX1,PTPRZ1,ROBO2,SHTN1,TWIST1,NRCAM,EFNA5,EPHA3,ADGRL3,INSM1,LMX1A,PTPRD,CNTN1,ZNF521,FUT9,BRINP3,ARX,NTRK2,DSCAM,UCHL1,SEMA3C,UHMK1,FGFR2,BCHE,LGI1,MAP2,FGF20,CNTNAP2,UNC5C</TD></TR>
<TR><TD>6.548e-08</TD><TD>-16.54</TD><TD>intestinal_adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>intestinal_adenocarcinoma</TD><TD>7235</TD><TD>119</TD><TD>16984</TD><TD>193</TD>
<TD>ADAM28,FGD3,CDH5,MPEG1,FGF14,PTPRK,SPHKAP,UBR4,FMNL2,B3GAT2,IQGAP2,PLEK,IL1RAPL2,THSD7B,FGFR2,ZNF521,SEZ6L,CNTNAP2,ASPN,WRN,PARP8,NBEA,AKAP9,ZNF518B,FIGN,SLC10A2,SS18,ADAMTS3,EPHA4,IRX1,NCKAP5,TSN,NTRK2,KAZN,SLC39A10,NAALADL2,PI15,ADAMTS12,FNIP2,IGFL4,IPO8,PXDNL,EPYC,TRPS1,LMX1A,FERD3L,BACH2,LRIG3,JMJD1C,CETN3,SPAG9,NRG1,UTRN,ZFAND5,GPR83,PTPRD,PCDH9,RGS5,NAT2,NAV3,ACVR2A,LRRN2,FBN2,PAQR3,PAX6,CNTN1,NRCAM,SLIT2,GCNT1,MAP2,MEGF10,KCNK9,DNER,RPH3A,SPATA16,RUNX1T1,KLF12,LRFN5,PHF14,THSD7A,ZNF133,BCHE,UNC5C,AGA,ACP6,CTSO,NRSN1,CALN1,LRRC3B,EDIL3,AOAH,ROBO2,RYR2,EFR3B,LHCGR,PRKCE,SGCG,TCF20,CPXM2,PRLHR,FAT4,UHMK1,FZD6,RBM20,MUC7,PTPRZ1,XPO4,CHRM3,OR52K2,DSCAM,SYT1,EPHA3,TGFBR2,ZFPM2,KIF6,ERCC6L2,FGF5,GMDS,ADAMTS5</TD></TR>
<TR><TD>6.548e-08</TD><TD>-16.54</TD><TD>stomach-carcinoma-intestinal_adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>stomach-carcinoma-intestinal_adenocarcinoma</TD><TD>7235</TD><TD>119</TD><TD>16984</TD><TD>193</TD>
<TD>ADAMTS5,GMDS,FGF5,ERCC6L2,ZFPM2,TGFBR2,KIF6,EPHA3,SYT1,DSCAM,CHRM3,OR52K2,XPO4,PTPRZ1,MUC7,RBM20,FZD6,UHMK1,FAT4,CPXM2,PRLHR,TCF20,SGCG,PRKCE,LHCGR,EFR3B,RYR2,ROBO2,AOAH,EDIL3,LRRC3B,CALN1,NRSN1,CTSO,ACP6,AGA,UNC5C,BCHE,ZNF133,THSD7A,PHF14,LRFN5,KLF12,RUNX1T1,SPATA16,RPH3A,KCNK9,DNER,MAP2,MEGF10,GCNT1,SLIT2,NRCAM,CNTN1,PAX6,PAQR3,FBN2,LRRN2,ACVR2A,NAV3,RGS5,NAT2,PCDH9,PTPRD,GPR83,ZFAND5,UTRN,NRG1,SPAG9,CETN3,JMJD1C,LRIG3,BACH2,FERD3L,LMX1A,TRPS1,EPYC,PXDNL,IPO8,IGFL4,FNIP2,ADAMTS12,PI15,NAALADL2,SLC39A10,KAZN,NTRK2,TSN,NCKAP5,IRX1,EPHA4,ADAMTS3,SS18,SLC10A2,FIGN,ZNF518B,NBEA,AKAP9,PARP8,WRN,ASPN,CNTNAP2,SEZ6L,ZNF521,FGFR2,IL1RAPL2,THSD7B,PLEK,IQGAP2,B3GAT2,UBR4,FMNL2,SPHKAP,PTPRK,FGF14,MPEG1,CDH5,FGD3,ADAM28</TD></TR>
<TR><TD>6.601e-08</TD><TD>-16.53</TD><TD>bone-humerus-other-chondroblastoma</TD><TD>COSMIC cancer mutations</TD><TD>bone-humerus-other-chondroblastoma</TD><TD>302</TD><TD>17</TD><TD>16984</TD><TD>193</TD>
<TD>SGCD,IQGAP2,IL1RAPL2,EFR3A,NCKAP5,GMDS,EDIL3,ZNF521,CNTNAP2,DSCAM,THSD7A,NAALADL2,FGF14,FMNL2,ZFPM2,ATG10,SLIT2</TD></TR>
<TR><TD>6.696e-08</TD><TD>-16.52</TD><TD>central_nervous_system-brain-glioma-astrocytoma_Grade_III</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-brain-glioma-astrocytoma_Grade_III</TD><TD>1424</TD><TD>40</TD><TD>16984</TD><TD>193</TD>
<TD>ADAM28,NAALADL2,FBN2,PAX6,SPHKAP,PRKCE,UBR4,RYR2,ATG10,GCNT1,IQGAP2,DNER,LMX1A,THSD7B,LGI1,IL1RAPL2,PLEK,FAT4,DEPTOR,DSCAM,CNTNAP2,UTRN,VAV3,EFNA5,UNC5C,PARP8,ZFPM2,EPHA3,AGA,RGS5,DCDC2C,ADAMTS3,FUT9,GMDS,PRSS12,NCKAP5,AOAH,EDIL3,SEMA3C,ROBO2</TD></TR>
<TR><TD>7.259e-08</TD><TD>-16.44</TD><TD>plasma membrane bounded cell projection morphogenesis</TD><TD>biological process</TD><TD>GO:0120039</TD><TD>491</TD><TD>22</TD><TD>18905</TD><TD>220</TD>
<TD>EPHA4,SLIT2,PTPRZ1,ROBO2,SHTN1,EPHA3,EFNA5,NRCAM,SLC25A46,PAX6,GAP43,FGFR2,LGI1,MAP2,UNC5C,CNTNAP2,LMX1A,CNTN1,ARX,SEMA3C,DSCAM,UCHL1</TD></TR>
<TR><TD>8.367e-08</TD><TD>-16.30</TD><TD>neurogenesis</TD><TD>biological process</TD><TD>GO:0022008</TD><TD>1335</TD><TD>39</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,FGF5,LGI1,BCHE,MAP2,FAT4,CNTNAP2,UNC5C,FGF20,LMX1A,INSM1,PTPRD,CNTN1,ZNF521,ARX,BRINP3,FUT9,SEMA3C,UHMK1,DSCAM,NTRK2,UCHL1,EPHA4,IRX1,DNER,SLIT2,PTPRZ1,ROBO2,SHTN1,EPHA3,EFNA5,ADGRL3,NRCAM,TWIST1,NAV3,PBX1,SLC25A46,PAX6,GAP43</TD></TR>
<TR><TD>8.663e-08</TD><TD>-16.26</TD><TD>cell projection morphogenesis</TD><TD>biological process</TD><TD>GO:0048858</TD><TD>496</TD><TD>22</TD><TD>18905</TD><TD>220</TD>
<TD>MAP2,CNTNAP2,UNC5C,FGFR2,LGI1,ARX,SEMA3C,DSCAM,UCHL1,LMX1A,CNTN1,EFNA5,EPHA3,NRCAM,EPHA4,SLIT2,PTPRZ1,ROBO2,SHTN1,PAX6,GAP43,SLC25A46</TD></TR>
<TR><TD>8.832e-08</TD><TD>-16.24</TD><TD>follicular_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>follicular_lymphoma</TD><TD>1212</TD><TD>36</TD><TD>16984</TD><TD>193</TD>
<TD>RYR2,MEGF10,MAP2,SLIT2,ADAMTS12,NAALADL2,FGF14,EFEMP1,FBN2,PHF14,NOL4,LRIG3,ZNF521,CPXM2,SPATA16,AMELX,AFM,DNER,IL1RAPL2,KIF6,UNC5C,ZFPM2,WWOX,DSCAM,CNTNAP2,SEZ6L,JMJD1C,SYT1,NRG1,ADAMTS5,NCKAP5,EDIL3,ROBO2,PCDH9,ADAMTS3,RASGEF1B</TD></TR>
<TR><TD>9.592e-08</TD><TD>-16.16</TD><TD>pancreas-carcinoid-endocrine_tumour</TD><TD>COSMIC cancer mutations</TD><TD>pancreas-carcinoid-endocrine_tumour</TD><TD>7277</TD><TD>119</TD><TD>16984</TD><TD>193</TD>
<TD>CD96,RYR2,EFR3B,LHCGR,PRKCE,SGCG,MRPL3,BANK1,CPXM2,FAT4,EFR3A,RBM20,TMEFF2,DSCAM,EFNA5,SYT1,EPHA3,ZFPM2,KIF6,DCDC2C,FGF5,CD226,GMDS,PAQR3,EFEMP1,ATG10,CNTN1,NRCAM,SLIT2,MEGF10,MAP2,DNER,KCNK9,ACVR1C,RPH3A,RUNX1T1,SPATA16,KLF12,LRFN5,PHF14,DEPTOR,THSD7A,ZNF133,VAV3,BCHE,UNC5C,ACP6,RASGEF1B,PHLPP1,AOAH,EDIL3,PRSS12,SKAP2,ROBO2,SLC39A10,PI15,NAALADL2,ADAMTS12,IPO8,INSM1,EPYC,LMX1A,SGCD,BACH2,FERD3L,NOL4,LINC01387,LRIG3,NRG1,UTRN,DAAM1,ZFAND5,GPR83,PCDH9,RGS5,GAP43,REG1B,COQ2,ACVR2A,SEMA3C,ADAM28,LINC00583,SLC7A14,CASK,CDH5,CRTC3,FGF14,SPHKAP,SLC7A8,UBR4,FMNL2,LMBRD1,B3GAT2,AFM,UCHL1,IQGAP2,PLEK,IL1RAPL2,THSD7B,FGFR2,ZNF521,SERGEF,SEZ6L,CNTNAP2,WRN,EPS8,HNF4G,PARP8,NOVA1,SPANXN1,FIGN,MRPL13,SS18,ADAMTS3,EPHA4,NCKAP5,NTRK2,KAZN,STXBP6</TD></TR>
<TR><TD>1.063e-07</TD><TD>-16.06</TD><TD>central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-cerebellum-primitive_neuroectodermal_tumour-medulloblastoma-SHH_subtype</TD><TD>653</TD><TD>25</TD><TD>16984</TD><TD>193</TD>
<TD>PCDH9,TCF20,FIGN,THSD7B,IL1RAPL2,NTRK2,CELF2,ROBO2,PTPRZ1,SEMA3C,RGS6,NAALADL2,CNTNAP2,DSCAM,NRG1,FBN2,DAAM1,UTRN,FGF14,RYR2,BCHE,EPHA3,NRCAM,SLIT2,PTPRD</TD></TR>
<TR><TD>1.095e-07</TD><TD>-16.03</TD><TD>SHH_subtype</TD><TD>COSMIC cancer mutations</TD><TD>SHH_subtype</TD><TD>654</TD><TD>25</TD><TD>16984</TD><TD>193</TD>
<TD>PCDH9,FIGN,ROBO2,NTRK2,SEMA3C,CNTNAP2,DSCAM,NRG1,DAAM1,UTRN,BCHE,EPHA3,PTPRD,TCF20,IL1RAPL2,THSD7B,CELF2,RGS6,PTPRZ1,NAALADL2,FBN2,FGF14,RYR2,NRCAM,SLIT2</TD></TR>
<TR><TD>1.151e-07</TD><TD>-15.98</TD><TD>axon development</TD><TD>biological process</TD><TD>GO:0061564</TD><TD>421</TD><TD>20</TD><TD>18905</TD><TD>220</TD>
<TD>SLC25A46,CNTN1,LMX1A,DSCAM,UCHL1,GAP43,SEMA3C,PAX6,ARX,ROBO2,PTPRZ1,LGI1,SHTN1,FGFR2,SLIT2,EPHA4,UNC5C,NRCAM,EFNA5,EPHA3</TD></TR>
<TR><TD>1.499e-07</TD><TD>-15.71</TD><TD>Ig_sub2</TD><TD>interpro domains</TD><TD>IPR003598</TD><TD>242</TD><TD>15</TD><TD>18605</TD><TD>215</TD>
<TD>LRFN5,NTRK2,LRRN2,NRCAM,PXDNL,PTPRD,DSCAM,CD226,UNC5C,CNTN1,LRIG3,NRG1,FGFR2,PECAM1,ROBO2</TD></TR>
<TR><TD>1.744e-07</TD><TD>-15.56</TD><TD>bone-femur-other-chondroblastoma</TD><TD>COSMIC cancer mutations</TD><TD>bone-femur-other-chondroblastoma</TD><TD>183</TD><TD>13</TD><TD>16984</TD><TD>193</TD>
<TD>DSCAM,CNTNAP2,SEZ6L,FGF14,SYT1,ATG10,SLIT2,IQGAP2,PCDH9,DCDC2C,TMEFF2,NCKAP5,NOL4</TD></TR>
<TR><TD>1.975e-07</TD><TD>-15.44</TD><TD>developmental process</TD><TD>biological process</TD><TD>GO:0032502</TD><TD>5746</TD><TD>103</TD><TD>18905</TD><TD>220</TD>
<TD>FGF14,UTRN,ARX,FGF20,FAT4,ZFPM2,SS18,SYT1,NOBOX,COX7B2,FERD3L,NAV3,EFEMP1,GAP43,ADAMTS3,SHTN1,DNER,ADAM28,WWOX,EPYC,NRCAM,EFNA5,ADGRL3,SGCD,PHF14,TGFBR2,CNTN1,FBN2,SEMA3C,BRINP3,CDH5,LGI1,ACVR2A,RBM20,SPATA16,GCNT1,PLEK,MAP2,IL1RAPL2,RAI2,TRPS1,TMEFF2,PCDH9,SPAG9,MEGF10,SERINC5,EPHA3,ACP6,ZNF521,INSM1,ADAMTS5,DSCAM,NTRK2,UCHL1,CYTL1,FUT9,FZD6,BCHE,FGF5,ASPN,UNC5C,NOVA1,ZFAND5,SLC25A46,PPP1R17,VAV3,PAX6,FABP7,HNF4G,LHCGR,PECAM1,PTPRZ1,LMBRD1,SEZ6L,SLIT2,SGCG,IRX1,EPHA4,ACVR1C,PLAAT1,LRATD1,CXCL13,PTPRD,ADAMTS12,LMX1A,UHMK1,DAW1,AFG2A,FGFR2,AMELX,CNTNAP2,CPQ,SLC39A10,CHRM3,PBX1,NRG1,NRSN1,ROBO2,RYR2,LRIG3,KAZN,TWIST1,THSD7A</TD></TR>
<TR><TD>2.076e-07</TD><TD>-15.39</TD><TD>Ig_sub</TD><TD>interpro domains</TD><TD>IPR003599</TD><TD>399</TD><TD>19</TD><TD>18605</TD><TD>215</TD>
<TD>CD96,ROBO2,NRG1,IL1RAPL2,PECAM1,FGFR2,CD226,UNC5C,CNTN1,LRIG3,PTPRD,PXDNL,DSCAM,SEMA3C,PTPRK,NRCAM,LRRN2,NTRK2,LRFN5</TD></TR>
<TR><TD>2.123e-07</TD><TD>-15.37</TD><TD>lymphoid_neoplasm</TD><TD>COSMIC cancer mutations</TD><TD>lymphoid_neoplasm</TD><TD>12270</TD><TD>169</TD><TD>16984</TD><TD>193</TD>
<TD>B3GAT2,LMBRD1,FMNL2,UBR4,SPHKAP,SLC7A8,PTPRK,FGF14,CRTC3,MPEG1,CDH5,FGD3,CASK,SLC7A14,ADAM28,LINC00583,SERGEF,ZNF521,FGFR2,FGF20,IL1RAPL2,LGI1,THSD7B,PLEK,IQGAP2,AFM,REXO2,NOVA1,PARP8,HNF4G,EPS8,WRN,FANCB,ASPN,CNTNAP2,SEZ6L,PSKH2,STXBP6,KAZN,DNAJC12,NTRK2,NCKAP5,FABP7,IRX1,EPHA4,ADAMTS3,SS18,MRPL13,SLC25A46,FUT9,SLC10A2,FIGN,AKAP9,NBEA,TRPS1,EPYC,INSM1,PXDNL,IPO8,ZPLD1,FNIP2,ADAMTS12,PI15,NAALADL2,SLC39A10,LRIG3,LINC01387,NOL4,NOBOX,BACH2,SGCD,LMX1A,PTPRD,GPR83,UTRN,DAAM1,NRG1,SPAG9,JMJD1C,SEMA3C,ACVR2A,PWWP2A,COQ2,REG1B,GAP43,NAV3,NAT2,RGS5,PCDH9,MEGF10,MAP2,SLIT2,NRCAM,PAX6,CNTN1,ATG10,EFEMP1,PAQR3,FBN2,RAI2,LRRN2,DAOA,DEPTOR,PHF14,LRFN5,KLF12,RUNX1T1,SPATA16,RPH3A,ACVR1C,AMELX,KCNK9,DNER,CTSO,WWOX,UNC5C,BCHE,VAV3,ZNF133,THSD7A,ROBO2,SKAP2,PRSS12,CXCL13,EDIL3,AOAH,LRRC3B,CALN1,PHLPP1,RASGEF1B,NRSN1,SGCG,MRPL3,PRKCE,LHCGR,EFR3B,RYR2,CD96,RGS6,XPO4,PTPRZ1,TMEFF2,DEFB115,MUC7,RBM20,FZD6,UHMK1,EFR3A,ARX,SHISA3,FAT4,CPXM2,PRLHR,BANK1,TCF20,ZFPM2,TGFBR2,KIF6,EPHA3,SYT1,PCGF5,EFNA5,DSCAM,CHRM3,ADAMTS5,CD226,GMDS,DCDC2C,FGF5</TD></TR>
<TR><TD>2.167e-07</TD><TD>-15.34</TD><TD>pharynx</TD><TD>COSMIC cancer mutations</TD><TD>pharynx</TD><TD>2697</TD><TD>59</TD><TD>16984</TD><TD>193</TD>
<TD>DSCAM,JMJD1C,DAAM1,UTRN,ZFPM2,TGFBR2,EPHA3,PBX1,GAP43,PCDH9,FGF5,REG1B,ADAMTS5,NAALADL2,PRKCE,RYR2,TCF20,FAT4,TMEFF2,TWIST1,MUC7,XPO4,PTPRZ1,CNTNAP2,THSD7A,EPS8,FANCB,UNC5C,BCHE,SLC10A2,NBEA,AKAP9,ADAMTS3,CALN1,FUT9,NCKAP5,STXBP6,ROBO2,DNAJC12,NTRK2,SLC7A14,PAQR3,EFEMP1,CRTC3,MPEG1,FBN2,UBR4,NRCAM,FMNL2,SPHKAP,B3GAT2,MAP2,LMBRD1,SLIT2,SPATA16,LRFN5,DEPTOR,ZNF521,FGFR2</TD></TR>
<TR><TD>2.246e-07</TD><TD>-15.31</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma</TD><TD>984</TD><TD>31</TD><TD>16984</TD><TD>193</TD>
<TD>MAP2,MEGF10,SLIT2,RYR2,FGF14,EFEMP1,ADAMTS12,NAALADL2,LRIG3,PHF14,NOL4,IL1RAPL2,SPATA16,CPXM2,AFM,DNER,WWOX,UNC5C,ZFPM2,SYT1,NRG1,CNTNAP2,DSCAM,SEZ6L,JMJD1C,ROBO2,NCKAP5,EDIL3,ADAMTS3,RASGEF1B,PCDH9</TD></TR>
<TR><TD>2.377e-07</TD><TD>-15.25</TD><TD>scalp</TD><TD>COSMIC cancer mutations</TD><TD>scalp</TD><TD>2110</TD><TD>50</TD><TD>16984</TD><TD>193</TD>
<TD>CPXM2,PRLHR,LMX1A,FERD3L,BACH2,FAT4,DEFB115,NOL4,PTPRZ1,LHCGR,IPO8,TRPS1,NAV3,GAP43,PWWP2A,ADAMTS5,SEMA3C,DSCAM,CHRM3,DAAM1,UTRN,SYT1,NRG1,PTPRD,AMELX,RPH3A,ACVR1C,LRFN5,FGFR2,ZNF521,SLC7A14,ADAM28,CNTN1,SPHKAP,UBR4,NRCAM,MAP2,MEGF10,SLIT2,NRSN1,LRRC3B,ADAMTS3,AOAH,EPHA4,ROBO2,ZNF133,SEZ6L,VAV3,WRN,UNC5C</TD></TR>
<TR><TD>3.522e-07</TD><TD>-14.86</TD><TD>mucosal</TD><TD>COSMIC cancer mutations</TD><TD>mucosal</TD><TD>2009</TD><TD>48</TD><TD>16984</TD><TD>193</TD>
<TD>BANK1,FAT4,BACH2,RGS6,LHCGR,IGFL4,MRPL3,SGCG,PCDH9,CETN3,OR52K2,CHRM3,SYT1,NRG1,KIF6,PTPRD,SPATA16,ACVR1C,DNER,IL1RAPL2,LRFN5,SERGEF,FGFR2,SLC7A14,LRRN2,ADAM28,EFEMP1,FBN2,CDH5,SPHKAP,SLC7A8,PTPRK,GCNT1,SLIT2,SLC10A2,LRRC3B,CALN1,EDIL3,EPHA4,SKAP2,ASPN,CNTNAP2,SEZ6L,VAV3,EPS8,WRN,UNC5C,PARP8</TD></TR>
<TR><TD>3.522e-07</TD><TD>-14.86</TD><TD>skin-mucosal-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-mucosal-malignant_melanoma</TD><TD>2009</TD><TD>48</TD><TD>16984</TD><TD>193</TD>
<TD>IGFL4,LHCGR,MRPL3,SGCG,BANK1,BACH2,FAT4,RGS6,CETN3,CHRM3,OR52K2,NRG1,SYT1,KIF6,PTPRD,PCDH9,LRRN2,ADAM28,SLC7A14,FBN2,CDH5,EFEMP1,PTPRK,SPHKAP,SLC7A8,SLIT2,GCNT1,DNER,SPATA16,ACVR1C,IL1RAPL2,LRFN5,FGFR2,SERGEF,SEZ6L,ASPN,CNTNAP2,EPS8,WRN,VAV3,UNC5C,PARP8,SLC10A2,CALN1,LRRC3B,EPHA4,EDIL3,SKAP2</TD></TR>
<TR><TD>4.271e-07</TD><TD>-14.67</TD><TD>lower_third</TD><TD>COSMIC cancer mutations</TD><TD>lower_third</TD><TD>7979</TD><TD>125</TD><TD>16984</TD><TD>193</TD>
<TD>ACP6,AGA,BCHE,UNC5C,VAV3,THSD7A,ZNF133,ROBO2,SKAP2,AOAH,PRSS12,CXCL13,PHLPP1,RASGEF1B,LRRC3B,SLIT2,MEGF10,MAP2,GCNT1,CNTN1,PAX6,FBN2,RAI2,EFEMP1,PAQR3,DEPTOR,LRFN5,PHF14,KLF12,DNER,KCNK9,RUNX1T1,RPH3A,EPHA3,TGFBR2,ZFPM2,EFNA5,PCGF5,CHRM3,DSCAM,ADAMTS5,CD226,GMDS,RYR2,EFR3B,PRKCE,LHCGR,CELF2,RGS6,XPO4,PTPRZ1,TWIST1,MUC7,TMEFF2,FAT4,SERINC5,FZD6,EFR3A,TCF20,CPXM2,PRLHR,NOVA1,PARP8,EPS8,WRN,SEZ6L,CNTNAP2,KAZN,NTRK2,PSKH2,IRX1,EPHA4,NCKAP5,SLC25A46,ADAMTS3,SS18,ZNF518B,NBEA,AKAP9,SLC10A2,ARL14,B3GAT2,PTPRK,UBR4,SPHKAP,SLC7A8,CDH5,CRTC3,MPEG1,ADAM28,FGD3,SLC7A14,CASK,ZNF521,SERGEF,IL1RAPL2,THSD7B,IQGAP2,PTPRD,NUP35,NRG1,DAAM1,UTRN,JMJD1C,SPAG9,ACVR2A,REG1B,COQ2,PCDH9,NAV3,NAT2,PXDNL,TRPS1,IPO8,ZPLD1,PI15,NAALADL2,SLC39A10,ADAMTS12,LRIG3,NOL4,BACH2,FERD3L,LMX1A,SGCD</TD></TR>
<TR><TD>4.889e-07</TD><TD>-14.53</TD><TD>cell morphogenesis</TD><TD>biological process</TD><TD>GO:0000902</TD><TD>688</TD><TD>25</TD><TD>18905</TD><TD>220</TD>
<TD>MAP2,CNTNAP2,UNC5C,FGFR2,LGI1,CDH5,ARX,SEMA3C,DSCAM,UCHL1,LMX1A,CNTN1,EFNA5,EPHA3,NRCAM,LRATD1,EPHA4,SLIT2,PTPRZ1,ROBO2,SHTN1,PAX6,GAP43,SLC25A46,SS18</TD></TR>
<TR><TD>6.370e-07</TD><TD>-14.27</TD><TD>astrocytoma_Grade_III</TD><TD>COSMIC cancer mutations</TD><TD>astrocytoma_Grade_III</TD><TD>1551</TD><TD>40</TD><TD>16984</TD><TD>193</TD>
<TD>LMX1A,DNER,IQGAP2,PLEK,FAT4,THSD7B,LGI1,IL1RAPL2,DEPTOR,NAALADL2,ADAM28,FBN2,ATG10,RYR2,UBR4,PRKCE,PAX6,SPHKAP,GCNT1,RGS5,FUT9,ADAMTS3,DCDC2C,EDIL3,AOAH,PRSS12,NCKAP5,GMDS,ROBO2,SEMA3C,CNTNAP2,DSCAM,EFNA5,VAV3,UTRN,EPHA3,UNC5C,ZFPM2,PARP8,AGA</TD></TR>
<TR><TD>6.734e-07</TD><TD>-14.21</TD><TD>anatomical structure morphogenesis</TD><TD>biological process</TD><TD>GO:0009653</TD><TD>2238</TD><TD>52</TD><TD>18905</TD><TD>220</TD>
<TD>TMEFF2,PBX1,EPHA3,THSD7A,TWIST1,LRIG3,RYR2,ROBO2,NRG1,SEMA3C,LMX1A,FBN2,TGFBR2,CNTN1,MAP2,CNTNAP2,GCNT1,AMELX,ACVR2A,RBM20,FGFR2,LGI1,CDH5,PAX6,GAP43,EFEMP1,VAV3,SLC25A46,ZFAND5,SS18,SGCD,EFNA5,NRCAM,CXCL13,LRATD1,WWOX,EPHA4,IRX1,SLIT2,SHTN1,LMBRD1,PTPRZ1,ARX,FZD6,UCHL1,NTRK2,DSCAM,ADAMTS5,ZFPM2,UNC5C,FGF20,FGF5</TD></TR>
<TR><TD>7.229e-07</TD><TD>-14.14</TD><TD>human chr20p11.23</TD><TD>chromosome location</TD><TD>human chr20p11.23</TD><TD>78</TD><TD>5</TD><TD>193383</TD><TD>404</TD>
<TD>ZNF133,KIZ-AS1,SCP2D1-AS1,INSM1,SLC24A3-AS1</TD></TR>
<TR><TD>8.261e-07</TD><TD>-14.01</TD><TD>Ig-like_dom</TD><TD>interpro domains</TD><TD>IPR007110</TD><TD>437</TD><TD>19</TD><TD>18605</TD><TD>215</TD>
<TD>NTRK2,LRFN5,PTPRK,SEMA3C,LRRN2,NRCAM,LRIG3,CNTN1,UNC5C,CD226,DSCAM,PXDNL,PTPRD,ROBO2,CD96,FGFR2,PECAM1,IL1RAPL2,NRG1</TD></TR>
<TR><TD>8.434e-07</TD><TD>-13.99</TD><TD>LRR_8</TD><TD>pfam domains</TD><TD>PF13855</TD><TD>173</TD><TD>12</TD><TD>17869</TD><TD>207</TD>
<TD>LGI1,LRIG3,NTRK2,PHLPP1,ASPN,EPYC,LRRN2,SLIT2,PXDNL,LRRC70,LRFN5,LRRC3B</TD></TR>
<TR><TD>9.563e-07</TD><TD>-13.86</TD><TD>neuron recognition</TD><TD>biological process</TD><TD>GO:0008038</TD><TD>46</TD><TD>7</TD><TD>18905</TD><TD>220</TD>
<TD>DSCAM,GAP43,CNTNAP2,NRCAM,EPHA3,ROBO2,EPHA4</TD></TR>
<TR><TD>1.027e-06</TD><TD>-13.79</TD><TD>soft_tissue</TD><TD>COSMIC cancer mutations</TD><TD>soft_tissue</TD><TD>5855</TD><TD>99</TD><TD>16984</TD><TD>193</TD>
<TD>SERGEF,FGFR2,ZNF521,UCHL1,IQGAP2,AFM,IL1RAPL2,THSD7B,PLEK,UBR4,FMNL2,B3GAT2,LMBRD1,FGD3,ADAM28,MPEG1,FGF14,NCKAP5,IRX1,NTRK2,KAZN,SPANXN1,SLC10A2,AKAP9,NBEA,ZNF518B,SS18,ADAMTS3,PARP8,NOVA1,CNTNAP2,ASPN,SEZ6L,WRN,FANCB,EPS8,NOL4,SGCD,LMX1A,NOBOX,TRPS1,INSM1,PXDNL,SLC39A10,NAALADL2,ZPLD1,SEMA3C,RGS5,GAP43,PCDH9,COQ2,SPAG9,JMJD1C,UTRN,NRG1,ACVR1C,RPH3A,SPATA16,DNER,KCNK9,MAP2,GCNT1,SLIT2,FBN2,PRSS12,AOAH,EDIL3,SKAP2,ROBO2,RASGEF1B,PHLPP1,UNC5C,BCHE,THSD7A,VAV3,PTPRZ1,RGS6,CPXM2,TCF20,BANK1,ARX,UHMK1,FZD6,RBM20,FAT4,SHISA3,LHCGR,PRKCE,RYR2,SGCG,MRPL3,CD226,ADAMTS5,FGF5,ZFPM2,KIF6,EPHA3,DSCAM,EFNA5</TD></TR>
<TR><TD>1.100e-06</TD><TD>-13.72</TD><TD>neuron differentiation</TD><TD>biological process</TD><TD>GO:0030182</TD><TD>1082</TD><TD>32</TD><TD>18905</TD><TD>220</TD>
<TD>FGF20,CNTNAP2,UNC5C,MAP2,LGI1,FGFR2,UCHL1,DSCAM,NTRK2,SEMA3C,UHMK1,BRINP3,FUT9,ARX,ZNF521,CNTN1,PTPRD,INSM1,LMX1A,NRCAM,EFNA5,EPHA3,SHTN1,PTPRZ1,ROBO2,SLIT2,IRX1,EPHA4,GAP43,PAX6,SLC25A46,PBX1</TD></TR>
<TR><TD>1.124e-06</TD><TD>-13.70</TD><TD>oesophagus</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus</TD><TD>15043</TD><TD>189</TD><TD>16984</TD><TD>193</TD>
<TD>PSKH2,KAZN,EPHA4,IRX1,MRPL13,FUT9,SLC25A46,SLC10A2,AKAP9,ZNF518B,NOVA1,REXO2,PARP8,HNF4G,WRN,CNTNAP2,ASPN,FGF20,THSD7B,IL1RAPL2,LGI1,PLEK,CYTL1,UCHL1,GHITM,IQGAP2,AFM,B3GAT2,ARL14,LMBRD1,SLC7A8,UBR4,PTPRK,CRTC3,FGF14,ADAM28,REG1B,GAP43,GPR83,DAAM1,UTRN,NRG1,SPAG9,CETN3,LRIG3,NOBOX,BACH2,EPYC,INSM1,IGFL4,ADAMTS12,NAALADL2,ROBO2,PRSS12,RASGEF1B,PHLPP1,ACP6,UNC5C,VAV3,ZNF133,THSD7A,ACVR1C,SPATA16,RUNX1T1,DNER,GCNT1,CNTN1,PAQR3,EFEMP1,FBN2,DAOA,LRRN2,CD226,GMDS,DCDC2C,TGFBR2,ZFPM2,ERCC6L2,SYT1,PTPRZ1,RGS6,DEFB115,FZD6,FAT4,SERINC5,SHISA3,BANK1,SGCG,LHCGR,RYR2,CD96,STXBP6,NTRK2,DNAJC12,FABP7,NCKAP5,TSN,SS18,ADAMTS3,SPANXN1,FIGN,NBEA,FANCB,EPS8,SEZ6L,SERGEF,FGFR2,ZNF521,SPHKAP,FMNL2,MPEG1,CDH5,CASK,SLC7A14,FGD3,LINC00583,SEMA3C,ACVR2A,COQ2,RGS5,NAT2,NAV3,PCDH9,PTPRD,NUP35,ZFAND5,JMJD1C,LINC01387,NOL4,FERD3L,SGCD,LMX1A,TRPS1,PXDNL,IPO8,ZPLD1,SLC39A10,PI15,SKAP2,CXCL13,EDIL3,AOAH,LRRC3B,CALN1,NRSN1,CTSO,WWOX,AGA,BCHE,DEPTOR,PHF14,LRFN5,KLF12,RPH3A,AMELX,KCNK9,MAP2,MEGF10,SLIT2,PAX6,NRCAM,ATG10,LRRC70,OR2AG1,RAI2,ADAMTS5,FGF5,KIF6,EPHA3,EFNA5,PCGF5,DSCAM,OR52K2,CHRM3,XPO4,CELF2,TMEFF2,MUC7,TWIST1,UHMK1,ARX,EFR3A,RBM20,PRLHR,CPXM2,TCF20,MRPL3,PRKCE,EFR3B</TD></TR>
<TR><TD>1.566e-06</TD><TD>-13.37</TD><TD>EGF-like_CS</TD><TD>interpro domains</TD><TD>IPR013032</TD><TD>32</TD><TD>6</TD><TD>18605</TD><TD>215</TD>
<TD>DNER,SLIT2,FAT4,EDIL3,FBN2,MEGF10</TD></TR>
<TR><TD>1.584e-06</TD><TD>-13.36</TD><TD>hEGF</TD><TD>pfam domains</TD><TD>PF12661</TD><TD>32</TD><TD>6</TD><TD>17869</TD><TD>207</TD>
<TD>SLIT2,FBN2,EDIL3,FAT4,MEGF10,DNER</TD></TR>
<TR><TD>1.834e-06</TD><TD>-13.21</TD><TD>cell adhesion</TD><TD>biological process</TD><TD>GO:0007155</TD><TD>946</TD><TD>29</TD><TD>18905</TD><TD>220</TD>
<TD>CASK,PCDH9,PECAM1,EDIL3,LRRN2,MEGF10,NRCAM,EPHA3,EFNA5,ADGRL3,PRKCE,ROBO2,PTPRK,CD226,EPHA4,DSCAM,CD96,PTPRD,ADAMTS12,CNTN1,TGFBR2,GCNT1,FAT4,CNTNAP2,LRFN5,PLEK,CDH5,STXBP6,AMELX</TD></TR>
<TR><TD>1.937e-06</TD><TD>-13.15</TD><TD>adenoma</TD><TD>COSMIC cancer mutations</TD><TD>adenoma</TD><TD>2876</TD><TD>59</TD><TD>16984</TD><TD>193</TD>
<TD>PTPRD,EPHA3,NRG1,SYT1,SPAG9,CD226,COQ2,PWWP2A,PCDH9,NAV3,PXDNL,LHCGR,ZPLD1,ADAMTS12,PTPRZ1,LRIG3,RGS6,FAT4,EFR3A,BCHE,HNF4G,UNC5C,SEZ6L,CNTNAP2,NTRK2,KAZN,ROBO2,AOAH,EDIL3,NCKAP5,CALN1,SLC25A46,ADAMTS3,AKAP9,ZNF518B,SLIT2,MEGF10,GCNT1,MAP2,PTPRK,SPHKAP,UBR4,FBN2,CRTC3,PAQR3,FGF14,CASK,FGD3,ZNF521,LGI1,KLF12,THSD7B,KCNK9,DNER,RPH3A,UCHL1,IQGAP2,SPATA16,RUNX1T1</TD></TR>
<TR><TD>2.093e-06</TD><TD>-13.08</TD><TD>lung-carcinoma-small_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma-small_cell_carcinoma</TD><TD>9947</TD><TD>144</TD><TD>16984</TD><TD>193</TD>
<TD>PCDH9,RGS5,NAT2,GAP43,NAV3,REG1B,ACVR2A,JMJD1C,SPAG9,NRG1,UTRN,DAAM1,NUP35,ZFAND5,PTPRD,LMX1A,FERD3L,BACH2,NOBOX,NOL4,LRIG3,SLC39A10,NAALADL2,ADAMTS12,ZPLD1,IPO8,PXDNL,INSM1,EPYC,TRPS1,AKAP9,ZNF518B,SPANXN1,FIGN,SLC10A2,SLC25A46,SS18,MRPL13,ADAMTS3,EPHA4,IRX1,FABP7,TSN,NTRK2,DNAJC12,PSKH2,SEZ6L,CNTNAP2,FANCB,WRN,EPS8,HNF4G,PARP8,NOVA1,AFM,UCHL1,LGI1,THSD7B,IL1RAPL2,FGF20,FGFR2,ZNF521,SERGEF,ADAM28,CASK,FGD3,CDH5,CRTC3,MPEG1,FGF14,PTPRK,SPHKAP,FMNL2,UBR4,LMBRD1,ARL14,PBX1,FGF5,CD226,GMDS,ADAMTS5,CHRM3,DSCAM,PCGF5,SYT1,EPHA3,TGFBR2,KIF6,ZFPM2,BANK1,TCF20,PRLHR,CPXM2,FAT4,UHMK1,FZD6,ARX,MUC7,TWIST1,TMEFF2,CELF2,PTPRZ1,RGS6,XPO4,CD96,RYR2,LHCGR,PRKCE,MRPL3,NRSN1,RASGEF1B,CALN1,AOAH,EDIL3,COX7B2,PRSS12,CXCL13,SKAP2,ROBO2,THSD7A,VAV3,BCHE,AGA,KCNK9,DNER,RPH3A,ACVR1C,AMELX,SPATA16,RUNX1T1,LRFN5,PHF14,DEPTOR,DAOA,LRRN2,FBN2,RAI2,OR2AG1,PAX6,CNTN1,NRCAM,SLIT2,MEGF10,MAP2</TD></TR>
<TR><TD>2.176e-06</TD><TD>-13.04</TD><TD>small_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>small_cell_carcinoma</TD><TD>9952</TD><TD>144</TD><TD>16984</TD><TD>193</TD>
<TD>DEPTOR,LRFN5,PHF14,DNER,KCNK9,AMELX,ACVR1C,RPH3A,RUNX1T1,SPATA16,SLIT2,MAP2,MEGF10,CNTN1,PAX6,NRCAM,RAI2,FBN2,OR2AG1,DAOA,LRRN2,SKAP2,ROBO2,AOAH,EDIL3,COX7B2,PRSS12,CXCL13,RASGEF1B,CALN1,NRSN1,AGA,BCHE,VAV3,THSD7A,CELF2,PTPRZ1,RGS6,XPO4,MUC7,TWIST1,TMEFF2,FAT4,ARX,FZD6,UHMK1,BANK1,TCF20,CPXM2,PRLHR,MRPL3,RYR2,LHCGR,PRKCE,CD96,CD226,GMDS,ADAMTS5,FGF5,PBX1,EPHA3,KIF6,ZFPM2,TGFBR2,PCGF5,SYT1,CHRM3,DSCAM,FGFR2,ZNF521,SERGEF,FGF20,LGI1,THSD7B,IL1RAPL2,AFM,UCHL1,LMBRD1,ARL14,PTPRK,SPHKAP,FMNL2,UBR4,CDH5,MPEG1,CRTC3,FGF14,ADAM28,CASK,FGD3,NTRK2,DNAJC12,PSKH2,EPHA4,IRX1,FABP7,TSN,SLC25A46,MRPL13,SS18,ADAMTS3,AKAP9,ZNF518B,SPANXN1,FIGN,SLC10A2,NOVA1,HNF4G,PARP8,FANCB,WRN,EPS8,SEZ6L,CNTNAP2,LRIG3,NOL4,BACH2,FERD3L,NOBOX,LMX1A,PXDNL,INSM1,EPYC,TRPS1,IPO8,ZPLD1,SLC39A10,NAALADL2,ADAMTS12,ACVR2A,REG1B,PCDH9,RGS5,NAT2,NAV3,GAP43,PTPRD,ZFAND5,NUP35,NRG1,UTRN,DAAM1,JMJD1C,SPAG9</TD></TR>
<TR><TD>2.208e-06</TD><TD>-13.02</TD><TD>lung-right_lower_lobe-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-right_lower_lobe-carcinoma-adenocarcinoma</TD><TD>5698</TD><TD>96</TD><TD>16984</TD><TD>193</TD>
<TD>PHLPP1,ROBO2,EDIL3,VAV3,ZNF133,THSD7A,AGA,UNC5C,BCHE,ACVR1C,AMELX,RUNX1T1,DNER,KCNK9,PHF14,LRFN5,OR2AG1,FBN2,RAI2,MEGF10,GCNT1,MAP2,SLIT2,CNTN1,PAX6,NRCAM,FGF5,GMDS,ADAMTS5,DSCAM,CHRM3,ZFPM2,EPHA3,EFR3A,SERINC5,FAT4,CPXM2,PRLHR,TCF20,PTPRZ1,RGS6,TMEFF2,MUC7,SGCG,RYR2,FUT9,SLC10A2,NBEA,AKAP9,ZNF518B,PSKH2,NTRK2,NCKAP5,EPHA4,FANCB,WRN,CNTNAP2,ASPN,SEZ6L,NOVA1,HNF4G,LGI1,THSD7B,IL1RAPL2,PLEK,IQGAP2,AFM,FGFR2,ZNF521,CRTC3,MPEG1,ADAM28,LMBRD1,SPHKAP,SLC7A8,UBR4,REG1B,NAV3,SEMA3C,UTRN,JMJD1C,PTPRD,GPR83,NOBOX,LMX1A,LRIG3,NOL4,FNIP2,ZPLD1,ADAMTS12,SLC39A10,PI15,TRPS1,PXDNL,INSM1,IPO8</TD></TR>
<TR><TD>2.208e-06</TD><TD>-13.02</TD><TD>right_lower_lobe</TD><TD>COSMIC cancer mutations</TD><TD>right_lower_lobe</TD><TD>5698</TD><TD>96</TD><TD>16984</TD><TD>193</TD>
<TD>CHRM3,DSCAM,EPHA3,ZFPM2,FGF5,ADAMTS5,GMDS,RYR2,SGCG,TCF20,PRLHR,CPXM2,FAT4,SERINC5,EFR3A,MUC7,TMEFF2,RGS6,PTPRZ1,THSD7A,ZNF133,VAV3,BCHE,UNC5C,AGA,PHLPP1,EDIL3,ROBO2,FBN2,RAI2,OR2AG1,NRCAM,CNTN1,PAX6,SLIT2,MEGF10,GCNT1,MAP2,KCNK9,DNER,RUNX1T1,ACVR1C,AMELX,LRFN5,PHF14,JMJD1C,UTRN,GPR83,PTPRD,NAV3,REG1B,SEMA3C,PI15,SLC39A10,ADAMTS12,FNIP2,ZPLD1,IPO8,INSM1,PXDNL,TRPS1,LMX1A,NOBOX,NOL4,LRIG3,SEZ6L,ASPN,CNTNAP2,WRN,FANCB,HNF4G,NOVA1,ZNF518B,AKAP9,NBEA,SLC10A2,FUT9,EPHA4,NCKAP5,NTRK2,PSKH2,ADAM28,MPEG1,CRTC3,UBR4,SLC7A8,SPHKAP,LMBRD1,AFM,IQGAP2,PLEK,LGI1,IL1RAPL2,THSD7B,ZNF521,FGFR2</TD></TR>
<TR><TD>2.239e-06</TD><TD>-13.01</TD><TD>upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma</TD><TD>1946</TD><TD>45</TD><TD>16984</TD><TD>193</TD>
<TD>MAP2,MEGF10,PXDNL,CNTN1,SPHKAP,UBR4,FMNL2,RYR2,PTPRK,FBN2,ADAMTS12,SLC7A14,ADAM28,LRRN2,NAALADL2,PHF14,NOL4,LRFN5,THSD7B,FAT4,SHISA3,IQGAP2,RUNX1T1,DNER,LMX1A,PTPRD,PARP8,EPHA3,HNF4G,WRN,DSCAM,CNTNAP2,JMJD1C,THSD7A,SEMA3C,ROBO2,ADAMTS5,NCKAP5,EPHA4,ADAMTS3,REG1B,NRSN1,NAV3,PCDH9,NBEA</TD></TR>
<TR><TD>2.287e-06</TD><TD>-12.99</TD><TD>mouth</TD><TD>COSMIC cancer mutations</TD><TD>mouth</TD><TD>9009</TD><TD>134</TD><TD>16984</TD><TD>193</TD>
<TD>LRRN2,FBN2,OR2AG1,EFEMP1,PAQR3,ATG10,NRCAM,CNTN1,SLIT2,MEGF10,MAP2,GCNT1,SPATA16,RUNX1T1,RPH3A,AMELX,ACVR1C,LRFN5,PHF14,DEPTOR,THSD7A,VAV3,UNC5C,WWOX,AGA,CTSO,NRSN1,PHLPP1,RASGEF1B,EDIL3,AOAH,PRSS12,ROBO2,CD96,RYR2,PRKCE,LHCGR,SGCG,TCF20,BANK1,PRLHR,CPXM2,SERINC5,FAT4,RBM20,UHMK1,MUC7,DEFB115,TMEFF2,CELF2,XPO4,RGS6,PTPRZ1,CHRM3,OR52K2,DSCAM,PCGF5,SYT1,EPHA3,KIF6,TGFBR2,ZFPM2,FGF5,ADAMTS5,ADAM28,SLC7A14,CASK,CDH5,CRTC3,MPEG1,PTPRK,UBR4,FMNL2,SLC7A8,SPHKAP,LMBRD1,B3GAT2,ARL14,AFM,CYTL1,PLEK,THSD7B,LGI1,IL1RAPL2,ZNF521,FGFR2,SEZ6L,CNTNAP2,EPS8,FANCB,WRN,HNF4G,PARP8,NOVA1,ZNF518B,AKAP9,NBEA,FIGN,SLC25A46,FUT9,SS18,IRX1,NCKAP5,KAZN,NTRK2,PSKH2,STXBP6,NAALADL2,PI15,ADAMTS12,IPO8,PXDNL,TRPS1,EPYC,LMX1A,FERD3L,BACH2,NOBOX,NOL4,LRIG3,JMJD1C,UTRN,DAAM1,GPR83,PTPRD,PCDH9,NAV3,RGS5,NAT2,REG1B,PWWP2A,COQ2,ACVR2A,SEMA3C</TD></TR>
<TR><TD>2.297e-06</TD><TD>-12.98</TD><TD>multicellular organismal process</TD><TD>biological process</TD><TD>GO:0032501</TD><TD>6260</TD><TD>106</TD><TD>18905</TD><TD>220</TD>
<TD>FGF14,UTRN,ARX,GPR83,FAT4,ZFPM2,FGF20,SS18,FERD3L,NAV3,SEPTIN5,EFEMP1,GAP43,SHTN1,ADAMTS3,CD226,DNER,EPYC,WWOX,EFNA5,ADGRL3,SGCD,NRCAM,TGFBR2,CNTN1,PHF14,FBN2,SEMA3C,BRINP3,LGI1,CDH5,ACVR2A,RBM20,GCNT1,SLC7A8,PLEK,MAP2,IL1RAPL2,TRPS1,RAI2,TMEFF2,PCDH9,PRKCE,MEGF10,EPHA3,SERINC5,ZNF521,ADAMTS5,INSM1,DSCAM,NTRK2,UCHL1,CYTL1,FUT9,FZD6,BCHE,ASPN,FGF5,UNC5C,NOVA1,SLC25A46,PPP1R17,ZFAND5,OR2AG1,VAV3,JMJD1C,LHCGR,PECAM1,PAX6,FABP7,PTPRZ1,LMBRD1,IRX1,EPHA4,ACVR1C,SEZ6L,WRN,SLIT2,SGCG,SKAP2,PLAAT1,CXCL13,PRLHR,PTPRD,ADAMTS12,LMX1A,UHMK1,OR52K2,AFG2A,DAW1,AMELX,FGFR2,CNTNAP2,CHRM3,PBX1,NRSN1,RYR2,ROBO2,NRG1,BANK1,LRIG3,KAZN,CRTC3,EPS8,TWIST1,THSD7A</TD></TR>
<TR><TD>2.303e-06</TD><TD>-12.98</TD><TD>larynx</TD><TD>COSMIC cancer mutations</TD><TD>larynx</TD><TD>1948</TD><TD>45</TD><TD>16984</TD><TD>193</TD>
<TD>JMJD1C,DSCAM,EPHA3,PTPRD,PCDH9,NAV3,REG1B,ADAMTS5,SEMA3C,NAALADL2,ADAMTS12,RYR2,PXDNL,LMX1A,FAT4,SHISA3,NOL4,THSD7A,CNTNAP2,WRN,HNF4G,PARP8,NBEA,NRSN1,ADAMTS3,EPHA4,NCKAP5,ROBO2,ADAM28,LRRN2,SLC7A14,FBN2,PTPRK,SPHKAP,CNTN1,FMNL2,UBR4,MEGF10,MAP2,DNER,RUNX1T1,IQGAP2,THSD7B,LRFN5,PHF14</TD></TR>
<TR><TD>2.744e-06</TD><TD>-12.81</TD><TD>lymph_node</TD><TD>COSMIC cancer mutations</TD><TD>lymph_node</TD><TD>1706</TD><TD>41</TD><TD>16984</TD><TD>193</TD>
<TD>FBN2,ADAMTS12,CASK,NAALADL2,B3GAT2,TRPS1,MEGF10,LMBRD1,SLIT2,PRKCE,ATG10,PTPRK,RYR2,UHMK1,IL1RAPL2,FAT4,AMELX,LRIG3,XPO4,ZNF521,FGFR2,FGF20,UTRN,EPS8,CNTNAP2,DSCAM,CHRM3,PTPRD,WWOX,TGFBR2,KIF6,ZFPM2,EPHA3,ADAMTS3,NAV3,PCDH9,AKAP9,SEMA3C,ROBO2,NTRK2,ACVR2A</TD></TR>
<TR><TD>3.388e-06</TD><TD>-12.60</TD><TD>transmembrane receptor protein kinase activity</TD><TD>molecular function</TD><TD>GO:0019199</TD><TD>81</TD><TD>8</TD><TD>18530</TD><TD>207</TD>
<TD>FGFR2,NTRK2,EFEMP1,TGFBR2,EPHA3,ACVR2A,ACVR1C,EPHA4</TD></TR>
<TR><TD>3.395e-06</TD><TD>-12.59</TD><TD>human chr4q28.1</TD><TD>chromosome location</TD><TD>human chr4q28.1</TD><TD>48</TD><TD>4</TD><TD>193383</TD><TD>404</TD>
<TD>MIR2054,AFG2A,FAT4,LINC02516</TD></TR>
<TR><TD>3.497e-06</TD><TD>-12.56</TD><TD>IGc2</TD><TD>smart domains</TD><TD>SM00408</TD><TD>242</TD><TD>15</TD><TD>9743</TD><TD>147</TD>
<TD>LRIG3,CNTN1,CD226,PTPRD,UNC5C,PXDNL,FGFR2,NRG1,LRRN2,NTRK2,ROBO2,NRCAM,LRFN5,PECAM1,DSCAM</TD></TR>
<TR><TD>3.533e-06</TD><TD>-12.55</TD><TD>myelodysplastic_syndrome</TD><TD>COSMIC cancer mutations</TD><TD>myelodysplastic_syndrome</TD><TD>1178</TD><TD>32</TD><TD>16984</TD><TD>193</TD>
<TD>EFNA5,CNTNAP2,DSCAM,PTPRD,ZFPM2,PARP8,UNC5C,TGFBR2,EPHA3,RGS5,PSKH2,SKAP2,NTRK2,NCKAP5,GMDS,ACVR2A,EPHA4,CASK,SLC39A10,MEGF10,SLIT2,UBR4,PRKCE,SLC7A8,IL1RAPL2,UHMK1,THSD7B,RUNX1T1,ACVR1C,DNER,FGFR2,NOL4</TD></TR>
<TR><TD>3.533e-06</TD><TD>-12.55</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome</TD><TD>1178</TD><TD>32</TD><TD>16984</TD><TD>193</TD>
<TD>GMDS,ACVR2A,NCKAP5,EPHA4,PSKH2,NTRK2,SKAP2,RGS5,TGFBR2,UNC5C,PARP8,ZFPM2,EPHA3,PTPRD,DSCAM,CNTNAP2,EFNA5,NOL4,FGFR2,ACVR1C,RUNX1T1,DNER,UHMK1,IL1RAPL2,THSD7B,SLC7A8,PRKCE,UBR4,MEGF10,SLIT2,CASK,SLC39A10</TD></TR>
<TR><TD>3.611e-06</TD><TD>-12.53</TD><TD>mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable</TD><TD>COSMIC cancer mutations</TD><TD>mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable</TD><TD>953</TD><TD>28</TD><TD>16984</TD><TD>193</TD>
<TD>ADAMTS5,NCKAP5,ACVR2A,PSKH2,ROBO2,DNAJC12,FIGN,SPANXN1,NBEA,ZFPM2,PTPRD,DSCAM,THSD7A,CHRM3,SEZ6L,UTRN,LRIG3,ZNF521,CELF2,RUNX1T1,TCF20,RBM20,BACH2,UBR4,CNTN1,IPO8,MAP2,FBN2</TD></TR>
<TR><TD>3.611e-06</TD><TD>-12.53</TD><TD>stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable</TD><TD>COSMIC cancer mutations</TD><TD>stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable</TD><TD>953</TD><TD>28</TD><TD>16984</TD><TD>193</TD>
<TD>PTPRD,ZFPM2,UTRN,DSCAM,CHRM3,SEZ6L,THSD7A,PSKH2,ROBO2,DNAJC12,ACVR2A,ADAMTS5,NCKAP5,FIGN,SPANXN1,NBEA,MAP2,CNTN1,UBR4,IPO8,FBN2,LRIG3,CELF2,ZNF521,RBM20,BACH2,RUNX1T1,TCF20</TD></TR>
<TR><TD>3.691e-06</TD><TD>-12.51</TD><TD>human chr4q21.21</TD><TD>chromosome location</TD><TD>human chr4q21.21</TD><TD>49</TD><TD>4</TD><TD>193383</TD><TD>404</TD>
<TD>RASGEF1B,PAQR3,PCAT4,FGF5</TD></TR>
<TR><TD>3.708e-06</TD><TD>-12.51</TD><TD>oesophagus-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus-carcinoma-adenocarcinoma</TD><TD>13175</TD><TD>174</TD><TD>16984</TD><TD>193</TD>
<TD>STXBP6,NTRK2,DNAJC12,NCKAP5,TSN,SS18,ADAMTS3,SPANXN1,FIGN,NBEA,EPS8,SEZ6L,SERGEF,FGFR2,ZNF521,SPHKAP,FMNL2,CDH5,SLC7A14,CASK,LINC00583,SEMA3C,ACVR2A,COQ2,RGS5,NAV3,PCDH9,PTPRD,NUP35,JMJD1C,LINC01387,NOL4,FERD3L,SGCD,LMX1A,TRPS1,PXDNL,IPO8,ZPLD1,SLC39A10,PI15,SKAP2,CXCL13,AOAH,EDIL3,LRRC3B,CALN1,NRSN1,CTSO,BCHE,DEPTOR,PHF14,LRFN5,KLF12,AMELX,RPH3A,KCNK9,MAP2,MEGF10,SLIT2,PAX6,NRCAM,ATG10,LRRC70,OR2AG1,RAI2,ADAMTS5,KIF6,EPHA3,PCGF5,EFNA5,DSCAM,OR52K2,XPO4,CELF2,TMEFF2,MUC7,TWIST1,EFR3A,ARX,UHMK1,RBM20,CPXM2,PRLHR,TCF20,MRPL3,PRKCE,EFR3B,PSKH2,KAZN,EPHA4,IRX1,MRPL13,FUT9,SLC25A46,SLC10A2,AKAP9,ZNF518B,NOVA1,REXO2,PARP8,WRN,CNTNAP2,ASPN,FGF20,LGI1,THSD7B,IL1RAPL2,PLEK,CYTL1,UCHL1,IQGAP2,GHITM,AFM,B3GAT2,LMBRD1,SLC7A8,UBR4,PTPRK,CRTC3,FGF14,ADAM28,REG1B,GAP43,GPR83,UTRN,DAAM1,NRG1,SPAG9,CETN3,LRIG3,NOBOX,BACH2,EPYC,ADAMTS12,NAALADL2,ROBO2,PRSS12,RASGEF1B,PHLPP1,ACP6,UNC5C,VAV3,ZNF133,THSD7A,ACVR1C,SPATA16,RUNX1T1,DNER,GCNT1,CNTN1,EFEMP1,PAQR3,FBN2,DAOA,LRRN2,GMDS,CD226,DCDC2C,TGFBR2,ZFPM2,ERCC6L2,SYT1,PTPRZ1,RGS6,DEFB115,FZD6,FAT4,SHISA3,BANK1,SGCG,LHCGR,RYR2,CD96</TD></TR>
<TR><TD>4.181e-06</TD><TD>-12.39</TD><TD>Ig-like_dom_sf</TD><TD>interpro domains</TD><TD>IPR036179</TD><TD>488</TD><TD>19</TD><TD>18605</TD><TD>215</TD>
<TD>SEMA3C,PTPRK,NRCAM,LRRN2,NTRK2,LRFN5,CD96,ROBO2,PECAM1,IL1RAPL2,FGFR2,NRG1,CNTN1,LRIG3,UNC5C,CD226,DSCAM,PTPRD,PXDNL</TD></TR>
<TR><TD>4.301e-06</TD><TD>-12.36</TD><TD>oesophagus-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus-carcinoma</TD><TD>4273</TD><TD>77</TD><TD>16984</TD><TD>193</TD>
<TD>REG1B,PCDH9,NAV3,ADAMTS5,CD226,UTRN,JMJD1C,SPAG9,DSCAM,PTPRD,EPHA3,NUP35,KIF6,TGFBR2,FAT4,RBM20,FZD6,NOBOX,EFR3A,BANK1,CPXM2,PRLHR,SGCD,RGS6,PTPRZ1,DEFB115,NOL4,MUC7,ZPLD1,PI15,ADAMTS12,CD96,TRPS1,RYR2,EFR3B,SS18,NBEA,AKAP9,SLC10A2,FIGN,ROBO2,NTRK2,CXCL13,NCKAP5,FABP7,FANCB,WRN,VAV3,THSD7A,CNTNAP2,CTSO,HNF4G,BCHE,UNC5C,DNER,KCNK9,GHITM,SPATA16,IQGAP2,RUNX1T1,ZNF521,FGFR2,LRFN5,RAI2,FBN2,ADAM28,FGD3,CASK,SLIT2,GCNT1,MEGF10,MAP2,PTPRK,NRCAM,UBR4,SPHKAP,CNTN1</TD></TR>
<TR><TD>4.386e-06</TD><TD>-12.34</TD><TD>humerus</TD><TD>COSMIC cancer mutations</TD><TD>humerus</TD><TD>547</TD><TD>20</TD><TD>16984</TD><TD>193</TD>
<TD>SLIT2,ZFPM2,FMNL2,UBR4,RYR2,ATG10,FGF14,CNTNAP2,DSCAM,NAALADL2,THSD7A,ZNF521,GMDS,NCKAP5,EDIL3,EFR3A,IL1RAPL2,ADAMTS3,IQGAP2,SGCD</TD></TR>
<TR><TD>4.700e-06</TD><TD>-12.27</TD><TD>cell recognition</TD><TD>biological process</TD><TD>GO:0008037</TD><TD>137</TD><TD>10</TD><TD>18905</TD><TD>220</TD>
<TD>EPHA3,PECAM1,NRCAM,CNTNAP2,MEGF10,GAP43,DSCAM,CD226,EPHA4,ROBO2</TD></TR>
<TR><TD>4.794e-06</TD><TD>-12.25</TD><TD>IG_LIKE</TD><TD>prosite domains</TD><TD>PS50835</TD><TD>435</TD><TD>19</TD><TD>12232</TD><TD>162</TD>
<TD>SEMA3C,DSCAM,NRG1,LRFN5,NRCAM,UNC5C,NTRK2,PXDNL,ROBO2,PTPRK,PTPRD,PECAM1,CD226,FGFR2,CD96,LRRN2,LRIG3,CNTN1,IL1RAPL2</TD></TR>
<TR><TD>5.527e-06</TD><TD>-12.11</TD><TD>ovary-other-neoplasm</TD><TD>COSMIC cancer mutations</TD><TD>ovary-other-neoplasm</TD><TD>12765</TD><TD>170</TD><TD>16984</TD><TD>193</TD>
<TD>PXDNL,INSM1,TRPS1,EPYC,IPO8,FNIP2,ZPLD1,NAALADL2,PI15,SLC39A10,ADAMTS12,LINC01387,LRIG3,NOL4,BACH2,FERD3L,LMX1A,SGCD,GPR83,PTPRD,NUP35,ZFAND5,NRG1,UTRN,DAAM1,CETN3,JMJD1C,SPAG9,SEMA3C,ACVR2A,REG1B,PWWP2A,COQ2,PCDH9,NAV3,GAP43,RGS5,LMBRD1,B3GAT2,PTPRK,UBR4,FMNL2,SLC7A8,SPHKAP,CDH5,FGF14,CRTC3,MPEG1,LINC00583,ADAM28,FGD3,SLC7A14,CASK,ZNF521,FGFR2,SERGEF,FGF20,CYTL1,PLEK,THSD7B,LGI1,IL1RAPL2,AFM,IQGAP2,GHITM,UCHL1,REXO2,NOVA1,HNF4G,PARP8,EPS8,WRN,FANCB,SEZ6L,ASPN,CNTNAP2,KAZN,DNAJC12,NTRK2,PSKH2,STXBP6,IRX1,EPHA4,NCKAP5,FABP7,SLC25A46,FUT9,ADAMTS3,MRPL13,SS18,NBEA,AKAP9,SLC10A2,SPANXN1,FIGN,MRPL3,SGCG,RYR2,EFR3B,PRKCE,LHCGR,CD96,TWIST1,MUC7,DEFB115,TMEFF2,SHISA3,FAT4,RBM20,FZD6,ARX,EFR3A,BANK1,TCF20,CPXM2,EPHA3,ZFPM2,KIF6,TGFBR2,PCGF5,EFNA5,SYT1,CHRM3,DSCAM,ADAMTS5,GMDS,CD226,FGF5,DCDC2C,PBX1,SLIT2,MAP2,MEGF10,ATG10,CNTN1,PAX6,FBN2,RAI2,LRRC70,PAQR3,EFEMP1,LRRN2,DAOA,DEPTOR,LRFN5,PHF14,KLF12,KCNK9,DNER,SPATA16,RUNX1T1,ACVR1C,RPH3A,ACP6,AGA,CTSO,BCHE,UNC5C,VAV3,THSD7A,ZNF133,ROBO2,SKAP2,AOAH,EDIL3,PRSS12,CXCL13,PHLPP1,RASGEF1B,NRSN1</TD></TR>
<TR><TD>5.789e-06</TD><TD>-12.06</TD><TD>Ig_3</TD><TD>pfam domains</TD><TD>PF13927</TD><TD>141</TD><TD>10</TD><TD>17869</TD><TD>207</TD>
<TD>DSCAM,NRCAM,PXDNL,PTPRD,LRFN5,ROBO2,LRIG3,PECAM1,FGFR2,CNTN1</TD></TR>
<TR><TD>6.221e-06</TD><TD>-11.99</TD><TD>Leu-rich_rpt_typical-subtyp</TD><TD>interpro domains</TD><TD>IPR003591</TD><TD>175</TD><TD>11</TD><TD>18605</TD><TD>215</TD>
<TD>PXDNL,LRIG3,SLIT2,LRFN5,LGI1,ASPN,PHLPP1,LRRC70,EPYC,LRRC3B,LRRN2</TD></TR>
<TR><TD>6.673e-06</TD><TD>-11.92</TD><TD>neuron projection development</TD><TD>biological process</TD><TD>GO:0031175</TD><TD>694</TD><TD>23</TD><TD>18905</TD><TD>220</TD>
<TD>EFNA5,EPHA3,NRCAM,EPHA4,SLIT2,ROBO2,PTPRZ1,SHTN1,PAX6,GAP43,SLC25A46,MAP2,CNTNAP2,UNC5C,FGFR2,LGI1,ARX,UHMK1,SEMA3C,DSCAM,UCHL1,LMX1A,CNTN1</TD></TR>
<TR><TD>7.799e-06</TD><TD>-11.76</TD><TD>human chr3q26.2</TD><TD>chromosome location</TD><TD>human chr3q26.2</TD><TD>59</TD><TD>4</TD><TD>193383</TD><TD>404</TD>
<TD>SLC7A14-AS1,MIR551B,MIR569,SLC7A14</TD></TR>
<TR><TD>8.264e-06</TD><TD>-11.70</TD><TD>IG</TD><TD>smart domains</TD><TD>SM00409</TD><TD>399</TD><TD>19</TD><TD>9743</TD><TD>147</TD>
<TD>LRRN2,NRG1,DSCAM,LRFN5,PECAM1,SEMA3C,NRCAM,NTRK2,PTPRK,CD96,ROBO2,PXDNL,PTPRD,UNC5C,CNTN1,LRIG3,CD226,FGFR2,IL1RAPL2</TD></TR>
<TR><TD>8.390e-06</TD><TD>-11.69</TD><TD>neuron development</TD><TD>biological process</TD><TD>GO:0048666</TD><TD>860</TD><TD>26</TD><TD>18905</TD><TD>220</TD>
<TD>LGI1,FGFR2,CNTNAP2,UNC5C,MAP2,CNTN1,LMX1A,INSM1,SEMA3C,UHMK1,UCHL1,DSCAM,NTRK2,ARX,SHTN1,ROBO2,PTPRZ1,EPHA4,SLIT2,EPHA3,EFNA5,NRCAM,SLC25A46,PBX1,GAP43,PAX6</TD></TR>
<TR><TD>8.765e-06</TD><TD>-11.64</TD><TD>upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma</TD><TD>6955</TD><TD>109</TD><TD>16984</TD><TD>193</TD>
<TD>SGCG,PRKCE,LHCGR,RYR2,CD96,RGS6,XPO4,PTPRZ1,CELF2,TMEFF2,DEFB115,MUC7,RBM20,FAT4,CPXM2,PRLHR,TCF20,ZFPM2,TGFBR2,KIF6,EPHA3,DSCAM,OR52K2,CHRM3,ADAMTS5,FGF5,GCNT1,MAP2,MEGF10,SLIT2,NRCAM,CNTN1,ATG10,OR2AG1,FBN2,DEPTOR,PHF14,LRFN5,SPATA16,RUNX1T1,AMELX,ACVR1C,CTSO,AGA,WWOX,VAV3,THSD7A,ROBO2,PHLPP1,TRPS1,EPYC,PXDNL,IPO8,ADAMTS12,NAALADL2,LRIG3,NOL4,NOBOX,FERD3L,LMX1A,PTPRD,GPR83,DAAM1,UTRN,JMJD1C,SEMA3C,ACVR2A,PWWP2A,NAV3,NAT2,RGS5,PCDH9,ARL14,B3GAT2,LMBRD1,UBR4,FMNL2,SPHKAP,PTPRK,CRTC3,MPEG1,CDH5,CASK,SLC7A14,ADAM28,ZNF521,FGFR2,LGI1,THSD7B,IL1RAPL2,CYTL1,AFM,NOVA1,PARP8,HNF4G,EPS8,FANCB,WRN,CNTNAP2,SEZ6L,PSKH2,KAZN,NCKAP5,IRX1,FUT9,FIGN,ZNF518B,AKAP9,NBEA</TD></TR>
<TR><TD>9.770e-06</TD><TD>-11.54</TD><TD>ovary-carcinoma-serous_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>ovary-carcinoma-serous_carcinoma</TD><TD>10739</TD><TD>150</TD><TD>16984</TD><TD>193</TD>
<TD>CD96,LHCGR,PRKCE,RYR2,MRPL3,PRLHR,CPXM2,TCF20,BANK1,EFR3A,UHMK1,RBM20,FAT4,SERINC5,SHISA3,TMEFF2,MUC7,DEFB115,PTPRZ1,RGS6,XPO4,DSCAM,CHRM3,OR52K2,SYT1,PCGF5,ZFPM2,KIF6,TGFBR2,EPHA3,FGF5,CD226,GMDS,ADAMTS5,LRRN2,PAQR3,EFEMP1,OR2AG1,FBN2,CNTN1,PAX6,NRCAM,MEGF10,MAP2,SLIT2,ACVR1C,RPH3A,RUNX1T1,SPATA16,KCNK9,DNER,KLF12,PHF14,LRFN5,DEPTOR,ZNF133,THSD7A,VAV3,UNC5C,BCHE,CTSO,AGA,ACP6,NRSN1,LRRC3B,CALN1,PHLPP1,CXCL13,EDIL3,SKAP2,ROBO2,ADAMTS12,PI15,FNIP2,ZPLD1,TRPS1,INSM1,PXDNL,SGCD,LMX1A,NOBOX,FERD3L,BACH2,NOL4,LRIG3,SPAG9,JMJD1C,UTRN,DAAM1,NRG1,NUP35,PTPRD,GPR83,NAT2,GAP43,NAV3,PCDH9,COQ2,ACVR2A,SEMA3C,CASK,SLC7A14,FGD3,ADAM28,CRTC3,MPEG1,FGF14,CDH5,SPHKAP,SLC7A8,UBR4,FMNL2,PTPRK,B3GAT2,LMBRD1,IQGAP2,AFM,LGI1,THSD7B,IL1RAPL2,PLEK,CYTL1,FGFR2,ZNF521,CNTNAP2,ASPN,SEZ6L,WRN,EPS8,PARP8,HNF4G,NOVA1,FIGN,SPANXN1,SLC10A2,NBEA,AKAP9,ZNF518B,MRPL13,SS18,ADAMTS3,FUT9,FABP7,NCKAP5,EPHA4,IRX1,PSKH2,NTRK2,DNAJC12,KAZN</TD></TR>
<TR><TD>9.971e-06</TD><TD>-11.52</TD><TD>central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell</TD><TD>1121</TD><TD>30</TD><TD>16984</TD><TD>193</TD>
<TD>CNTNAP2,DSCAM,UTRN,UNC5C,ZFPM2,KIF6,EPHA3,NBEA,SS18,COQ2,GMDS,NCKAP5,AOAH,EDIL3,KAZN,CASK,ADAMTS12,NAALADL2,FGF14,PTPRK,RYR2,B3GAT2,IQGAP2,SPATA16,BANK1,IL1RAPL2,THSD7B,RBM20,FAT4,RGS6</TD></TR>
<TR><TD>1.027e-05</TD><TD>-11.49</TD><TD>oesophagus-middle_third-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus-middle_third-carcinoma-squamous_cell_carcinoma</TD><TD>3538</TD><TD>66</TD><TD>16984</TD><TD>193</TD>
<TD>ZPLD1,ADAMTS12,SGCG,PXDNL,IPO8,RYR2,NOBOX,SHISA3,SGCD,LMX1A,PTPRZ1,RGS6,LRIG3,CELF2,NOL4,MUC7,DAAM1,UTRN,DSCAM,SPAG9,JMJD1C,GPR83,KIF6,EPHA3,FGF5,NAV3,PCDH9,SEMA3C,ADAMTS5,MPEG1,CDH5,FBN2,LRRN2,MEGF10,B3GAT2,SLIT2,LMBRD1,SPHKAP,FMNL2,UBR4,KLF12,THSD7B,CYTL1,RUNX1T1,IQGAP2,FGFR2,ZNF521,LRFN5,VAV3,EPS8,CNTNAP2,THSD7A,UNC5C,HNF4G,MRPL13,LRRC3B,SS18,ADAMTS3,RASGEF1B,FIGN,SLC10A2,NBEA,AKAP9,PRSS12,EPHA4,IRX1</TD></TR>
<TR><TD>1.047e-05</TD><TD>-11.47</TD><TD>middle_third</TD><TD>COSMIC cancer mutations</TD><TD>middle_third</TD><TD>3540</TD><TD>66</TD><TD>16984</TD><TD>193</TD>
<TD>NOL4,MUC7,PTPRZ1,LRIG3,RGS6,CELF2,SGCD,LMX1A,NOBOX,SHISA3,RYR2,IPO8,SGCG,PXDNL,ADAMTS12,ZPLD1,ADAMTS5,SEMA3C,NAV3,PCDH9,FGF5,KIF6,EPHA3,GPR83,DSCAM,SPAG9,JMJD1C,UTRN,DAAM1,LRFN5,FGFR2,ZNF521,IQGAP2,RUNX1T1,KLF12,THSD7B,CYTL1,SPHKAP,FMNL2,UBR4,MEGF10,B3GAT2,LMBRD1,SLIT2,LRRN2,MPEG1,CDH5,FBN2,PRSS12,EPHA4,IRX1,FIGN,SLC10A2,AKAP9,NBEA,LRRC3B,SS18,MRPL13,ADAMTS3,RASGEF1B,UNC5C,HNF4G,CNTNAP2,THSD7A,VAV3,EPS8</TD></TR>
<TR><TD>1.048e-05</TD><TD>-11.47</TD><TD>upper_aerodigestive_tract-pharynx-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>upper_aerodigestive_tract-pharynx-carcinoma-squamous_cell_carcinoma</TD><TD>1485</TD><TD>36</TD><TD>16984</TD><TD>193</TD>
<TD>EPHA3,ZFPM2,TGFBR2,THSD7A,JMJD1C,CNTNAP2,EPS8,FANCB,UTRN,DAAM1,DNAJC12,PCDH9,PBX1,GAP43,SLC10A2,REG1B,FUT9,RYR2,NRCAM,LMBRD1,SLIT2,MAP2,NAALADL2,SLC7A14,FBN2,EFEMP1,PAQR3,LRFN5,TWIST1,MUC7,FGFR2,XPO4,PTPRZ1,DEPTOR,SPATA16,FAT4</TD></TR>
<TR><TD>1.073e-05</TD><TD>-11.44</TD><TD>TSP1_ADAMTS</TD><TD>pfam domains</TD><TD>PF19030</TD><TD>26</TD><TD>5</TD><TD>17869</TD><TD>207</TD>
<TD>ADAMTS12,ADAMTS5,THSD7A,ADAMTS3,THSD7B</TD></TR>
<TR><TD>1.099e-05</TD><TD>-11.42</TD><TD>outflow tract septum morphogenesis</TD><TD>biological process</TD><TD>GO:0003148</TD><TD>26</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,ROBO2,SEMA3C,ZFPM2,TGFBR2</TD></TR>
<TR><TD>1.233e-05</TD><TD>-11.30</TD><TD>oesophagus-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus-carcinoma-squamous_cell_carcinoma</TD><TD>6490</TD><TD>103</TD><TD>16984</TD><TD>193</TD>
<TD>VAV3,THSD7A,CTSO,WWOX,UNC5C,BCHE,PHLPP1,EDIL3,PAQR3,FBN2,LRRN2,MAP2,SLIT2,CNTN1,RPH3A,AMELX,SPATA16,RUNX1T1,KCNK9,PHF14,LRFN5,PCGF5,DSCAM,CHRM3,ZFPM2,TGFBR2,EPHA3,ADAMTS5,CD96,LHCGR,PRKCE,EFR3B,RYR2,RBM20,FAT4,CPXM2,BANK1,PTPRZ1,XPO4,CELF2,TMEFF2,MUC7,DEFB115,WRN,FANCB,EPS8,CNTNAP2,ASPN,SEZ6L,NOVA1,PARP8,HNF4G,SS18,ADAMTS3,SLC25A46,SPANXN1,FIGN,AKAP9,NBEA,DNAJC12,KAZN,NCKAP5,IRX1,MPEG1,CRTC3,FGF14,CDH5,CASK,SLC7A14,FGD3,ADAM28,LMBRD1,SPHKAP,UBR4,THSD7B,IQGAP2,FGFR2,ZNF521,FGF20,UTRN,DAAM1,NRG1,SPAG9,JMJD1C,PTPRD,ZFAND5,NAV3,GAP43,PCDH9,SEMA3C,ZPLD1,ADAMTS12,PI15,NAALADL2,EPYC,TRPS1,INSM1,PXDNL,IPO8,BACH2,LMX1A,LRIG3,NOL4</TD></TR>
<TR><TD>1.245e-05</TD><TD>-11.29</TD><TD>lung-carcinoma-large_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma-large_cell_carcinoma</TD><TD>850</TD><TD>25</TD><TD>16984</TD><TD>193</TD>
<TD>TMEFF2,NOL4,PTPRZ1,FGFR2,ACVR1C,UHMK1,FAT4,PRKCE,UBR4,MRPL3,CASK,ZPLD1,ACVR2A,EPHA4,SEMA3C,PSKH2,ROBO2,NTRK2,FGF5,TGFBR2,EPHA3,CNTNAP2,SYT1,FANCB,NRG1</TD></TR>
<TR><TD>1.245e-05</TD><TD>-11.29</TD><TD>large_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>large_cell_carcinoma</TD><TD>850</TD><TD>25</TD><TD>16984</TD><TD>193</TD>
<TD>SYT1,NRG1,FANCB,CNTNAP2,TGFBR2,EPHA3,FGF5,PSKH2,SEMA3C,NTRK2,ROBO2,ACVR2A,EPHA4,ZPLD1,CASK,MRPL3,PRKCE,UBR4,UHMK1,FAT4,ACVR1C,PTPRZ1,FGFR2,TMEFF2,NOL4</TD></TR>
<TR><TD>1.258e-05</TD><TD>-11.28</TD><TD>diffuse_adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>diffuse_adenocarcinoma</TD><TD>4392</TD><TD>77</TD><TD>16984</TD><TD>193</TD>
<TD>XPO4,LRIG3,PTPRZ1,NOL4,DEFB115,RBM20,EFR3A,NOBOX,BACH2,FERD3L,FAT4,PRLHR,CPXM2,BANK1,LMX1A,TRPS1,IPO8,RYR2,EFR3B,ADAMTS12,ADAMTS5,CD226,ACVR2A,GMDS,FGF5,REG1B,GAP43,RGS5,PCDH9,PTPRD,GPR83,ZFPM2,TGFBR2,EPHA3,UTRN,NRG1,DSCAM,OR52K2,JMJD1C,DEPTOR,ZNF521,FGFR2,LRFN5,THSD7B,IL1RAPL2,LGI1,SPATA16,IQGAP2,DNER,B3GAT2,MAP2,SLIT2,UBR4,SPHKAP,CNTN1,SLC7A8,FGF14,CASK,SLC7A14,ADAM28,KAZN,ROBO2,NCKAP5,AOAH,ADAMTS3,MRPL13,LRRC3B,CALN1,SLC10A2,NBEA,AGA,BCHE,EPS8,CNTNAP2,ZNF133,THSD7A,SEZ6L</TD></TR>
<TR><TD>1.258e-05</TD><TD>-11.28</TD><TD>stomach-carcinoma-diffuse_adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>stomach-carcinoma-diffuse_adenocarcinoma</TD><TD>4392</TD><TD>77</TD><TD>16984</TD><TD>193</TD>
<TD>LMX1A,BANK1,CPXM2,PRLHR,BACH2,FERD3L,FAT4,RBM20,NOBOX,EFR3A,NOL4,DEFB115,XPO4,LRIG3,PTPRZ1,ADAMTS12,RYR2,EFR3B,IPO8,TRPS1,PCDH9,GAP43,RGS5,REG1B,FGF5,ADAMTS5,GMDS,ACVR2A,CD226,OR52K2,JMJD1C,DSCAM,NRG1,UTRN,EPHA3,TGFBR2,ZFPM2,GPR83,PTPRD,DNER,IQGAP2,SPATA16,IL1RAPL2,LGI1,THSD7B,LRFN5,ZNF521,FGFR2,DEPTOR,ADAM28,SLC7A14,CASK,FGF14,UBR4,CNTN1,SPHKAP,SLC7A8,SLIT2,B3GAT2,MAP2,NBEA,SLC10A2,CALN1,ADAMTS3,LRRC3B,MRPL13,AOAH,NCKAP5,ROBO2,KAZN,THSD7A,SEZ6L,ZNF133,CNTNAP2,EPS8,BCHE,AGA</TD></TR>
<TR><TD>1.304e-05</TD><TD>-11.25</TD><TD>LRRNT</TD><TD>pfam domains</TD><TD>PF01462</TD><TD>27</TD><TD>5</TD><TD>17869</TD><TD>207</TD>
<TD>LRRC3B,ASPN,NTRK2,SLIT2,EPYC</TD></TR>
<TR><TD>1.343e-05</TD><TD>-11.22</TD><TD>lung-right_upper_lobe-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-right_upper_lobe-carcinoma-adenocarcinoma</TD><TD>10389</TD><TD>146</TD><TD>16984</TD><TD>193</TD>
<TD>LMBRD1,B3GAT2,PTPRK,SLC7A8,SPHKAP,UBR4,CDH5,ADAM28,SLC7A14,CASK,FGFR2,ZNF521,SERGEF,PLEK,CYTL1,LGI1,THSD7B,AFM,UCHL1,GHITM,IQGAP2,NOVA1,HNF4G,PARP8,WRN,FANCB,EPS8,SEZ6L,CNTNAP2,NTRK2,DNAJC12,PSKH2,EPHA4,IRX1,NCKAP5,TSN,FUT9,SS18,ADAMTS3,NBEA,AKAP9,ZNF518B,SPANXN1,FIGN,SLC10A2,PXDNL,INSM1,EPYC,TRPS1,IPO8,ZPLD1,SLC39A10,NAALADL2,PI15,ADAMTS12,NOL4,FERD3L,BACH2,NOBOX,LMX1A,SGCD,GPR83,PTPRD,NUP35,NRG1,UTRN,DAAM1,JMJD1C,SPAG9,SEMA3C,ACVR2A,REG1B,COQ2,PCDH9,NAT2,NAV3,GAP43,SLIT2,MAP2,GCNT1,MEGF10,CNTN1,PAX6,NRCAM,FBN2,RAI2,PAQR3,EFEMP1,OR2AG1,DAOA,LRRN2,DEPTOR,LRFN5,PHF14,KLF12,DNER,KCNK9,ACVR1C,RPH3A,RUNX1T1,SPATA16,BCHE,UNC5C,VAV3,THSD7A,SKAP2,ROBO2,EDIL3,AOAH,COX7B2,PRSS12,RASGEF1B,CALN1,NRSN1,MRPL3,RYR2,LHCGR,PRKCE,CD96,PTPRZ1,RGS6,XPO4,MUC7,DEFB115,TMEFF2,SERINC5,FAT4,SHISA3,UHMK1,EFR3A,FZD6,ARX,TCF20,CPXM2,PRLHR,EPHA3,TGFBR2,ZFPM2,KIF6,EFNA5,OR52K2,CHRM3,DSCAM,GMDS,CD226,ADAMTS5</TD></TR>
<TR><TD>1.343e-05</TD><TD>-11.22</TD><TD>right_upper_lobe</TD><TD>COSMIC cancer mutations</TD><TD>right_upper_lobe</TD><TD>10389</TD><TD>146</TD><TD>16984</TD><TD>193</TD>
<TD>RASGEF1B,CALN1,NRSN1,SKAP2,ROBO2,EDIL3,AOAH,COX7B2,PRSS12,VAV3,THSD7A,BCHE,UNC5C,KLF12,KCNK9,DNER,ACVR1C,RPH3A,SPATA16,RUNX1T1,DEPTOR,LRFN5,PHF14,FBN2,RAI2,PAQR3,EFEMP1,OR2AG1,DAOA,LRRN2,SLIT2,GCNT1,MAP2,MEGF10,PAX6,CNTN1,NRCAM,CD226,GMDS,ADAMTS5,EFNA5,OR52K2,CHRM3,DSCAM,EPHA3,TGFBR2,ZFPM2,KIF6,FAT4,SERINC5,SHISA3,UHMK1,EFR3A,ARX,FZD6,TCF20,PRLHR,CPXM2,PTPRZ1,XPO4,RGS6,MUC7,DEFB115,TMEFF2,CD96,MRPL3,RYR2,LHCGR,PRKCE,FUT9,SS18,ADAMTS3,AKAP9,NBEA,ZNF518B,FIGN,SPANXN1,SLC10A2,NTRK2,DNAJC12,PSKH2,EPHA4,IRX1,TSN,NCKAP5,FANCB,WRN,EPS8,SEZ6L,CNTNAP2,NOVA1,HNF4G,PARP8,PLEK,CYTL1,THSD7B,LGI1,AFM,UCHL1,GHITM,IQGAP2,FGFR2,ZNF521,SERGEF,CDH5,ADAM28,SLC7A14,CASK,LMBRD1,B3GAT2,PTPRK,SLC7A8,SPHKAP,UBR4,REG1B,COQ2,PCDH9,NAT2,GAP43,NAV3,SEMA3C,ACVR2A,NRG1,DAAM1,UTRN,JMJD1C,SPAG9,GPR83,PTPRD,NUP35,FERD3L,BACH2,NOBOX,LMX1A,SGCD,NOL4,ZPLD1,SLC39A10,NAALADL2,PI15,ADAMTS12,INSM1,PXDNL,EPYC,TRPS1,IPO8</TD></TR>
<TR><TD>1.375e-05</TD><TD>-11.19</TD><TD>human chr7q21.11</TD><TD>chromosome location</TD><TD>human chr7q21.11</TD><TD>68</TD><TD>4</TD><TD>193383</TD><TD>404</TD>
<TD>LINC00972,MAGI2-AS2,LINC03017,SEMA3C</TD></TR>
<TR><TD>1.375e-05</TD><TD>-11.19</TD><TD>human chr2q36.3</TD><TD>chromosome location</TD><TD>human chr2q36.3</TD><TD>68</TD><TD>4</TD><TD>193383</TD><TD>404</TD>
<TD>LOC646736,SPHKAP,DNER,DAW1</TD></TR>
<TR><TD>1.432e-05</TD><TD>-11.15</TD><TD>NS-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>NS-malignant_melanoma</TD><TD>3425</TD><TD>64</TD><TD>16984</TD><TD>193</TD>
<TD>FGFR2,ZNF521,DEPTOR,LRFN5,PHF14,THSD7B,KCNK9,DNER,RUNX1T1,SPATA16,IQGAP2,MEGF10,PTPRK,SPHKAP,UBR4,RAI2,FBN2,EFEMP1,FGF14,ADAM28,LRRN2,SKAP2,PSKH2,EPHA4,EDIL3,NCKAP5,TSN,FUT9,SS18,NBEA,BCHE,PARP8,WRN,FANCB,EPS8,VAV3,THSD7A,CNTNAP2,PTPRZ1,NOL4,FAT4,NOBOX,LMX1A,TCF20,CPXM2,PXDNL,EPYC,SGCG,RYR2,LHCGR,ZPLD1,ADAMTS12,SEMA3C,PCDH9,GPR83,EPHA3,ZFPM2,SYT1,UTRN,JMJD1C,OR52K2,CHRM3,DSCAM,SPAG9</TD></TR>
<TR><TD>1.433e-05</TD><TD>-11.15</TD><TD>prostate</TD><TD>COSMIC cancer mutations</TD><TD>prostate</TD><TD>13932</TD><TD>179</TD><TD>16984</TD><TD>193</TD>
<TD>SEMA3C,ACVR2A,COQ2,NAT2,RGS5,NAV3,PCDH9,PTPRD,ZFAND5,NUP35,JMJD1C,LINC01387,NOL4,FERD3L,SGCD,LMX1A,TRPS1,PXDNL,IPO8,FNIP2,ZPLD1,SLC39A10,PI15,STXBP6,NTRK2,DNAJC12,NCKAP5,SS18,ADAMTS3,FIGN,SPANXN1,NBEA,FANCB,EPS8,SEZ6L,SERGEF,FGFR2,ZNF521,SPHKAP,FMNL2,MPEG1,CDH5,CASK,SLC7A14,FGD3,LINC00583,ADAMTS5,FGF5,PBX1,KIF6,EPHA3,PCGF5,EFNA5,DSCAM,CHRM3,XPO4,CELF2,TMEFF2,MUC7,TWIST1,UHMK1,ARX,EFR3A,RBM20,CPXM2,TCF20,MRPL3,PRKCE,EFR3B,SKAP2,EDIL3,AOAH,LRRC3B,CALN1,NRSN1,CTSO,AGA,BCHE,DEPTOR,PHF14,LRFN5,KLF12,AMELX,RPH3A,KCNK9,MAP2,MEGF10,SLIT2,PAX6,NRCAM,ATG10,OR2AG1,RAI2,REG1B,GAP43,GPR83,UTRN,DAAM1,NRG1,SPAG9,CETN3,LRIG3,NOBOX,BACH2,EPYC,INSM1,ADAMTS12,NAALADL2,PSKH2,KAZN,EPHA4,IRX1,MRPL13,FUT9,SLC25A46,SLC10A2,AKAP9,ZNF518B,NOVA1,REXO2,PARP8,HNF4G,WRN,CNTNAP2,ASPN,FGF20,THSD7B,IL1RAPL2,LGI1,PLEK,CYTL1,UCHL1,IQGAP2,GHITM,AFM,B3GAT2,LMBRD1,SLC7A8,UBR4,PTPRK,CRTC3,FGF14,ADAM28,CD226,GMDS,DCDC2C,TGFBR2,ZFPM2,ERCC6L2,SYT1,PTPRZ1,RGS6,FZD6,FAT4,BANK1,SGCG,LHCGR,RYR2,CD96,ROBO2,PRSS12,RASGEF1B,PHLPP1,ACP6,UNC5C,VAV3,ZNF133,THSD7A,ACVR1C,RUNX1T1,SPATA16,DNER,GCNT1,CNTN1,EFEMP1,PAQR3,FBN2,DAOA,LRRN2</TD></TR>
<TR><TD>1.471e-05</TD><TD>-11.13</TD><TD>upper_aerodigestive_tract-mouth-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>upper_aerodigestive_tract-mouth-carcinoma</TD><TD>6429</TD><TD>102</TD><TD>16984</TD><TD>193</TD>
<TD>ROBO2,PRSS12,EDIL3,AOAH,PHLPP1,RASGEF1B,NRSN1,CTSO,AGA,UNC5C,THSD7A,DEPTOR,PHF14,LRFN5,RUNX1T1,ACVR1C,RPH3A,GCNT1,MEGF10,SLIT2,NRCAM,CNTN1,EFEMP1,PAQR3,FBN2,LRRN2,ADAMTS5,ZFPM2,KIF6,TGFBR2,EPHA3,SYT1,PCGF5,DSCAM,OR52K2,CHRM3,XPO4,RGS6,MUC7,DEFB115,RBM20,SERINC5,FAT4,PRLHR,CPXM2,TCF20,BANK1,SGCG,LHCGR,RYR2,CD96,STXBP6,KAZN,NCKAP5,IRX1,SS18,SLC25A46,FUT9,FIGN,ZNF518B,NBEA,AKAP9,NOVA1,HNF4G,EPS8,FANCB,CNTNAP2,ZNF521,FGFR2,THSD7B,PLEK,AFM,ARL14,LMBRD1,UBR4,SPHKAP,SLC7A8,CRTC3,CDH5,CASK,SLC7A14,SEMA3C,ACVR2A,COQ2,REG1B,NAV3,NAT2,PTPRD,GPR83,UTRN,JMJD1C,LRIG3,NOL4,NOBOX,FERD3L,BACH2,TRPS1,PXDNL,IPO8,ADAMTS12,NAALADL2,PI15</TD></TR>
<TR><TD>1.722e-05</TD><TD>-10.97</TD><TD>serous_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>serous_carcinoma</TD><TD>11016</TD><TD>152</TD><TD>16984</TD><TD>193</TD>
<TD>FGF5,ADAMTS5,GMDS,CD226,SYT1,PCGF5,DSCAM,CHRM3,OR52K2,ZFPM2,KIF6,TGFBR2,EPHA3,RBM20,EFR3A,UHMK1,SHISA3,SERINC5,FAT4,CPXM2,PRLHR,TCF20,BANK1,XPO4,RGS6,PTPRZ1,TMEFF2,DEFB115,MUC7,CD96,MRPL3,PRKCE,LHCGR,RYR2,LRRC3B,CALN1,PHLPP1,RASGEF1B,NRSN1,ROBO2,SKAP2,CXCL13,EDIL3,VAV3,ZNF133,THSD7A,CTSO,ACP6,WWOX,AGA,UNC5C,BCHE,KLF12,RUNX1T1,SPATA16,RPH3A,ACVR1C,DNER,KCNK9,DEPTOR,PHF14,LRFN5,OR2AG1,EFEMP1,PAQR3,FBN2,LRRN2,MEGF10,MAP2,SLIT2,NRCAM,CNTN1,PAX6,COQ2,GAP43,NAV3,NAT2,PCDH9,SEMA3C,ACVR2A,UTRN,DAAM1,NRG1,SPAG9,JMJD1C,PTPRD,GPR83,NUP35,NOBOX,BACH2,FERD3L,SGCD,LMX1A,LRIG3,NOL4,FNIP2,ZPLD1,ADAMTS12,PI15,TRPS1,INSM1,PXDNL,ADAMTS3,MRPL13,SS18,FUT9,SLC10A2,FIGN,SPANXN1,ZNF518B,AKAP9,NBEA,PSKH2,KAZN,DNAJC12,NTRK2,NCKAP5,FABP7,IRX1,EPHA4,EPS8,WRN,ASPN,CNTNAP2,SEZ6L,NOVA1,PARP8,HNF4G,LGI1,IL1RAPL2,THSD7B,CYTL1,PLEK,IQGAP2,AFM,ZNF521,FGFR2,FGF14,MPEG1,CRTC3,CDH5,FGD3,CASK,SLC7A14,ADAM28,B3GAT2,LMBRD1,UBR4,FMNL2,SLC7A8,SPHKAP,PTPRK</TD></TR>
<TR><TD>1.823e-05</TD><TD>-10.91</TD><TD>human chr8q21.3</TD><TD>chromosome location</TD><TD>human chr8q21.3</TD><TD>73</TD><TD>4</TD><TD>193383</TD><TD>404</TD>
<TD>PSKH2,C8orf88,RUNX1T1,PARAIL</TD></TR>
<TR><TD>1.986e-05</TD><TD>-10.83</TD><TD>lung-left_upper_lobe-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-left_upper_lobe-carcinoma-adenocarcinoma</TD><TD>556</TD><TD>19</TD><TD>16984</TD><TD>193</TD>
<TD>LRIG3,RGS6,NTRK2,LRFN5,CALN1,FAT4,NAV3,ZNF518B,TRPS1,MEGF10,MAP2,PTPRD,ZFPM2,BCHE,RYR2,FBN2,CNTNAP2,DSCAM,DAOA</TD></TR>
<TR><TD>2.067e-05</TD><TD>-10.79</TD><TD>lung-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma-squamous_cell_carcinoma</TD><TD>14744</TD><TD>185</TD><TD>16984</TD><TD>193</TD>
<TD>KAZN,PSKH2,IRX1,EPHA4,SLC25A46,FUT9,MRPL13,ZNF518B,AKAP9,SLC10A2,REXO2,NOVA1,HNF4G,PARP8,WRN,ASPN,CNTNAP2,FGF20,CYTL1,PLEK,LGI1,IL1RAPL2,THSD7B,AFM,IQGAP2,GHITM,UCHL1,LMBRD1,ARL14,B3GAT2,PTPRK,UBR4,SLC7A8,FGF14,CRTC3,ADAM28,REG1B,GAP43,GPR83,NRG1,UTRN,DAAM1,CETN3,SPAG9,LRIG3,BACH2,NOBOX,EPYC,NAALADL2,ADAMTS12,ROBO2,PRSS12,PHLPP1,RASGEF1B,ACP6,UNC5C,VAV3,THSD7A,ZNF133,DNER,SPATA16,RUNX1T1,ACVR1C,GCNT1,CNTN1,FBN2,PAQR3,EFEMP1,LRRN2,DAOA,CD226,GMDS,DCDC2C,ERCC6L2,ZFPM2,TGFBR2,SYT1,RGS6,PTPRZ1,DEFB115,SHISA3,SERINC5,FAT4,FZD6,BANK1,SGCG,RYR2,LHCGR,CD96,DNAJC12,NTRK2,TSN,NCKAP5,FABP7,ADAMTS3,SS18,NBEA,FIGN,SPANXN1,EPS8,FANCB,SEZ6L,ZNF521,FGFR2,SERGEF,FMNL2,SPHKAP,CDH5,MPEG1,FGD3,CASK,SLC7A14,SEMA3C,ACVR2A,PWWP2A,PCDH9,NAV3,NAT2,RGS5,PTPRD,ZFAND5,NUP35,JMJD1C,NOL4,FERD3L,LMX1A,SGCD,PXDNL,TRPS1,IPO8,ZPLD1,FNIP2,PI15,SLC39A10,SKAP2,AOAH,EDIL3,CXCL13,COX7B2,CALN1,LRRC3B,NRSN1,WWOX,AGA,CTSO,BCHE,DEPTOR,LRFN5,PHF14,KLF12,KCNK9,AMELX,RPH3A,SLIT2,MEGF10,MAP2,ATG10,NRCAM,PAX6,RAI2,OR2AG1,ADAMTS5,FGF5,PBX1,EPHA3,KIF6,PCGF5,EFNA5,CHRM3,OR52K2,DSCAM,CELF2,XPO4,TWIST1,MUC7,TMEFF2,RBM20,EFR3A,UHMK1,TCF20,CPXM2,PRLHR,MRPL3,EFR3B,PRKCE</TD></TR>
<TR><TD>2.087e-05</TD><TD>-10.78</TD><TD>left_upper_lobe</TD><TD>COSMIC cancer mutations</TD><TD>left_upper_lobe</TD><TD>558</TD><TD>19</TD><TD>16984</TD><TD>193</TD>
<TD>MEGF10,MAP2,PTPRD,TRPS1,ZFPM2,RYR2,BCHE,FBN2,DSCAM,CNTNAP2,DAOA,RGS6,LRIG3,NTRK2,LRFN5,FAT4,CALN1,NAV3,ZNF518B</TD></TR>
<TR><TD>2.369e-05</TD><TD>-10.65</TD><TD>human chr5q23.2</TD><TD>chromosome location</TD><TD>human chr5q23.2</TD><TD>78</TD><TD>4</TD><TD>193383</TD><TD>404</TD>
<TD>MARCHF3,LINC01170,MEGF10,LINC02240</TD></TR>
<TR><TD>2.450e-05</TD><TD>-10.62</TD><TD>trunk</TD><TD>COSMIC cancer mutations</TD><TD>trunk</TD><TD>3556</TD><TD>65</TD><TD>16984</TD><TD>193</TD>
<TD>AGA,HNF4G,PARP8,EPS8,WRN,THSD7A,SEZ6L,ZNF133,ROBO2,NTRK2,SKAP2,EDIL3,CXCL13,NCKAP5,TSN,PRSS12,ADAMTS3,AKAP9,NBEA,SLIT2,PTPRK,UBR4,FMNL2,NRCAM,PAX6,SPHKAP,FBN2,DAOA,ADAM28,FGFR2,LRFN5,PLEK,THSD7B,AFM,KCNK9,IQGAP2,RPH3A,UCHL1,PTPRD,EPHA3,KIF6,ZFPM2,UTRN,JMJD1C,OR52K2,CHRM3,SPAG9,DSCAM,FGF5,PCDH9,TRPS1,RYR2,LHCGR,PI15,NAALADL2,CD96,ADAMTS12,RGS6,PTPRZ1,MUC7,FAT4,RBM20,LMX1A,BANK1,CPXM2</TD></TR>
<TR><TD>2.460e-05</TD><TD>-10.61</TD><TD>O-linked glycosylation</TD><TD>REACTOME pathways</TD><TD>R-HSA-5173105</TD><TD>116</TD><TD>8</TD><TD>10391</TD><TD>107</TD>
<TD>ADAMTS5,GCNT1,THSD7A,MUC7,THSD7B,ADAMTS3,ADAMTS12,GALNT15</TD></TR>
<TR><TD>2.586e-05</TD><TD>-10.56</TD><TD>Developmental Biology</TD><TD>REACTOME pathways</TD><TD>R-HSA-1266738</TD><TD>1078</TD><TD>26</TD><TD>10391</TD><TD>107</TD>
<TD>ROBO2,FGFR2,SPAG9,KAZN,NRG1,VAV3,CNTN1,FGF20,HNF4G,PAX6,PAQR3,SLIT2,EFNA5,GAP43,ACVR2A,EPHA4,UNC5C,AKAP9,FGF5,NRCAM,EPHA3,ACVR1C,SHTN1,LGI1,PBX1,INSM1</TD></TR>
<TR><TD>2.775e-05</TD><TD>-10.49</TD><TD>breast-carcinoma-basal_(triple-negative)_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>breast-carcinoma-basal_(triple-negative)_carcinoma</TD><TD>2983</TD><TD>57</TD><TD>16984</TD><TD>193</TD>
<TD>DNER,UCHL1,ACVR1C,RUNX1T1,SPATA16,CYTL1,THSD7B,FGF20,PHF14,FGFR2,ZNF521,CDH5,FGF14,PAX6,CNTN1,SPHKAP,NRCAM,AKAP9,SS18,EPHA4,NTRK2,ROBO2,DNAJC12,ZNF133,CNTNAP2,FANCB,WRN,EPS8,VAV3,BCHE,HNF4G,PARP8,CPXM2,FAT4,EFR3A,FZD6,TWIST1,TMEFF2,CELF2,ADAMTS12,IPO8,LHCGR,PRKCE,PBX1,FGF5,DCDC2C,ACVR2A,GMDS,JMJD1C,CHRM3,SPAG9,NRG1,UTRN,EPHA3,TGFBR2,GPR83,PTPRD</TD></TR>
<TR><TD>2.775e-05</TD><TD>-10.49</TD><TD>basal_(triple-negative)_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>basal_(triple-negative)_carcinoma</TD><TD>2983</TD><TD>57</TD><TD>16984</TD><TD>193</TD>
<TD>NTRK2,ROBO2,DNAJC12,EPHA4,SS18,AKAP9,HNF4G,BCHE,PARP8,WRN,FANCB,EPS8,VAV3,ZNF133,CNTNAP2,FGFR2,ZNF521,FGF20,PHF14,CYTL1,THSD7B,DNER,UCHL1,ACVR1C,RUNX1T1,SPATA16,PAX6,SPHKAP,CNTN1,NRCAM,CDH5,FGF14,ACVR2A,GMDS,DCDC2C,FGF5,PBX1,GPR83,PTPRD,EPHA3,TGFBR2,NRG1,UTRN,JMJD1C,CHRM3,SPAG9,CELF2,TWIST1,TMEFF2,FAT4,FZD6,EFR3A,CPXM2,IPO8,LHCGR,PRKCE,ADAMTS12</TD></TR>
<TR><TD>2.935e-05</TD><TD>-10.44</TD><TD>TSP_1</TD><TD>pfam domains</TD><TD>PF00090</TD><TD>52</TD><TD>6</TD><TD>17869</TD><TD>207</TD>
<TD>THSD7B,ADAMTS3,THSD7A,UNC5C,ADAMTS5,ADAMTS12</TD></TR>
<TR><TD>2.970e-05</TD><TD>-10.42</TD><TD>fn3</TD><TD>pfam domains</TD><TD>PF00041</TD><TD>136</TD><TD>9</TD><TD>17869</TD><TD>207</TD>
<TD>CNTN1,EPHA3,PTPRD,ROBO2,PTPRZ1,DSCAM,EPHA4,PTPRK,NRCAM</TD></TR>
<TR><TD>3.063e-05</TD><TD>-10.39</TD><TD>chondrosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>chondrosarcoma</TD><TD>1189</TD><TD>30</TD><TD>16984</TD><TD>193</TD>
<TD>LRIG3,NOBOX,THSD7B,RBM20,IQGAP2,SGCD,SPATA16,MEGF10,MAP2,LHCGR,CNTN1,SPHKAP,FMNL2,UBR4,RYR2,FGD3,PI15,ACVR2A,CXCL13,SS18,ADAMTS3,PHLPP1,FIGN,NAV3,AKAP9,UNC5C,EPHA3,DAAM1,UTRN,CNTNAP2</TD></TR>
<TR><TD>3.189e-05</TD><TD>-10.35</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-mantle_cell_lymphoma</TD><TD>476</TD><TD>17</TD><TD>16984</TD><TD>193</TD>
<TD>ROBO2,SEMA3C,PCDH9,FAT4,ADAMTS3,IL1RAPL2,EPHA3,ATG10,PRKCE,ZFPM2,SLIT2,LMBRD1,NAALADL2,DSCAM,CASK,CNTNAP2,UTRN</TD></TR>
<TR><TD>3.302e-05</TD><TD>-10.32</TD><TD>Diseases associated with O-glycosylation of proteins</TD><TD>REACTOME pathways</TD><TD>R-HSA-3906995</TD><TD>60</TD><TD>6</TD><TD>10391</TD><TD>107</TD>
<TD>ADAMTS5,THSD7B,MUC7,THSD7A,ADAMTS12,ADAMTS3</TD></TR>
<TR><TD>3.404e-05</TD><TD>-10.29</TD><TD>animal organ morphogenesis</TD><TD>biological process</TD><TD>GO:0009887</TD><TD>989</TD><TD>27</TD><TD>18905</TD><TD>220</TD>
<TD>DSCAM,NTRK2,SEMA3C,FZD6,TGFBR2,ADAMTS5,FBN2,FGF20,GCNT1,ZFPM2,ACVR2A,FGF5,FGFR2,RBM20,AMELX,EFEMP1,PAX6,ZFAND5,PBX1,WWOX,LRIG3,TWIST1,NRG1,ROBO2,RYR2,SLIT2,IRX1</TD></TR>
<TR><TD>3.535e-05</TD><TD>-10.25</TD><TD>Defective B3GALTL causes Peters-plus syndrome (PpS)</TD><TD>REACTOME pathways</TD><TD>R-HSA-5083635</TD><TD>37</TD><TD>5</TD><TD>10391</TD><TD>107</TD>
<TD>THSD7B,ADAMTS5,THSD7A,ADAMTS12,ADAMTS3</TD></TR>
<TR><TD>3.589e-05</TD><TD>-10.23</TD><TD>upper_aerodigestive_tract</TD><TD>COSMIC cancer mutations</TD><TD>upper_aerodigestive_tract</TD><TD>13226</TD><TD>172</TD><TD>16984</TD><TD>193</TD>
<TD>UHMK1,ARX,RBM20,TCF20,CPXM2,PRLHR,CELF2,XPO4,MUC7,TWIST1,TMEFF2,MRPL3,PRKCE,FGF5,PBX1,ADAMTS5,PCGF5,EFNA5,CHRM3,OR52K2,DSCAM,EPHA3,KIF6,KCNK9,AMELX,RPH3A,DEPTOR,LRFN5,PHF14,RAI2,OR2AG1,LRRC70,SLIT2,MEGF10,MAP2,ATG10,PAX6,NRCAM,CALN1,NRSN1,SKAP2,AOAH,EDIL3,COX7B2,CXCL13,WWOX,AGA,CTSO,BCHE,FERD3L,LMX1A,NOL4,ZPLD1,SLC39A10,PI15,PXDNL,TRPS1,IPO8,PWWP2A,COQ2,PCDH9,NAT2,RGS5,NAV3,SEMA3C,ACVR2A,JMJD1C,PTPRD,NUP35,ZFAND5,FGFR2,ZNF521,SERGEF,CDH5,MPEG1,SLC7A14,CASK,FGD3,SPHKAP,FMNL2,SS18,ADAMTS3,NBEA,SPANXN1,FIGN,NTRK2,DNAJC12,STXBP6,TSN,NCKAP5,FANCB,EPS8,SEZ6L,FAT4,SERINC5,SHISA3,FZD6,BANK1,PTPRZ1,RGS6,DEFB115,CD96,SGCG,RYR2,LHCGR,CD226,GMDS,SYT1,TGFBR2,ZFPM2,DNER,ACVR1C,SPATA16,RUNX1T1,FBN2,PAQR3,EFEMP1,DAOA,LRRN2,GCNT1,CNTN1,RASGEF1B,PHLPP1,ROBO2,PRSS12,VAV3,THSD7A,ACP6,UNC5C,BACH2,NOBOX,LRIG3,NAALADL2,ADAMTS12,EPYC,REG1B,GAP43,UTRN,DAAM1,SPAG9,GPR83,PLEK,CYTL1,THSD7B,IL1RAPL2,LGI1,AFM,IQGAP2,FGF20,CRTC3,ADAM28,LMBRD1,ARL14,B3GAT2,PTPRK,SLC7A8,UBR4,FUT9,SLC25A46,MRPL13,AKAP9,ZNF518B,SLC10A2,KAZN,PSKH2,EPHA4,IRX1,WRN,CNTNAP2,NOVA1,HNF4G,PARP8</TD></TR>
<TR><TD>3.732e-05</TD><TD>-10.20</TD><TD>Ig-like_fold</TD><TD>interpro domains</TD><TD>IPR013783</TD><TD>726</TD><TD>22</TD><TD>18605</TD><TD>215</TD>
<TD>CD96,ROBO2,NRG1,PECAM1,IL1RAPL2,FGFR2,UNC5C,CD226,CNTN1,LRIG3,PTPRD,PXDNL,DSCAM,EPHA4,PTPRZ1,SEMA3C,PTPRK,NRCAM,LRRN2,NTRK2,EPHA3,LRFN5</TD></TR>
<TR><TD>3.751e-05</TD><TD>-10.19</TD><TD>femur</TD><TD>COSMIC cancer mutations</TD><TD>femur</TD><TD>1202</TD><TD>30</TD><TD>16984</TD><TD>193</TD>
<TD>FGF20,TMEFF2,NOL4,PTPRZ1,LRIG3,ZNF521,IQGAP2,THSD7B,FAT4,LHCGR,SPHKAP,UBR4,FMNL2,ATG10,SLIT2,ADAMTS12,PI15,FGF14,NCKAP5,CXCL13,PCDH9,DCDC2C,PHLPP1,UNC5C,HNF4G,DSCAM,CNTNAP2,JMJD1C,SEZ6L,SYT1</TD></TR>
<TR><TD>3.895e-05</TD><TD>-10.15</TD><TD>human chr4q21.23</TD><TD>chromosome location</TD><TD>human chr4q21.23</TD><TD>31</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>MIR4451,COQ2,WDFY3-AS2</TD></TR>
<TR><TD>4.190e-05</TD><TD>-10.08</TD><TD>central nervous system neuron differentiation</TD><TD>biological process</TD><TD>GO:0021953</TD><TD>176</TD><TD>10</TD><TD>18905</TD><TD>220</TD>
<TD>SLC25A46,FGFR2,SLIT2,LMX1A,EPHA4,NTRK2,BRINP3,MAP2,PAX6,ARX</TD></TR>
<TR><TD>4.261e-05</TD><TD>-10.06</TD><TD>central nervous system development</TD><TD>biological process</TD><TD>GO:0007417</TD><TD>1002</TD><TD>27</TD><TD>18905</TD><TD>220</TD>
<TD>DSCAM,NTRK2,ARX,BRINP3,FZD6,TGFBR2,CNTN1,LMX1A,FAT4,CNTNAP2,UNC5C,MAP2,AFG2A,FGFR2,GAP43,PAX6,PCDH9,SLC25A46,PPP1R17,IL1RAPL2,PBX1,NRCAM,PTPRZ1,ROBO2,EPHA4,DNER,SLIT2</TD></TR>
<TR><TD>4.274e-05</TD><TD>-10.06</TD><TD>animal organ development</TD><TD>biological process</TD><TD>GO:0048513</TD><TD>2860</TD><TD>56</TD><TD>18905</TD><TD>220</TD>
<TD>NRCAM,SGCD,WWOX,PLAAT1,EPYC,DNER,SGCG,SLIT2,IRX1,EPHA4,PAX6,PECAM1,LHCGR,EFEMP1,ZFAND5,SLC25A46,FGF20,FAT4,UNC5C,ZFPM2,FGF5,ASPN,FZD6,CYTL1,ARX,NTRK2,DSCAM,UTRN,INSM1,ADAMTS5,TWIST1,LRIG3,MEGF10,KAZN,NRG1,RYR2,ROBO2,PCDH9,RAI2,SLC39A10,PBX1,GCNT1,CNTNAP2,ACVR2A,FGFR2,RBM20,AMELX,DAW1,AFG2A,SEMA3C,LMX1A,FBN2,PHF14,ADAMTS12,CNTN1,TGFBR2</TD></TR>
<TR><TD>4.334e-05</TD><TD>-10.05</TD><TD>Leu-rich_rpt</TD><TD>interpro domains</TD><TD>IPR001611</TD><TD>255</TD><TD>12</TD><TD>18605</TD><TD>215</TD>
<TD>EPYC,NTRK2,LRRC70,ASPN,PHLPP1,LRFN5,LGI1,LRRC3B,LRRN2,LRIG3,PXDNL,SLIT2</TD></TR>
<TR><TD>4.365e-05</TD><TD>-10.04</TD><TD>Axon guidance</TD><TD>REACTOME pathways</TD><TD>R-HSA-422475</TD><TD>551</TD><TD>17</TD><TD>10391</TD><TD>107</TD>
<TD>NRCAM,EPHA3,NRG1,VAV3,FGFR2,EPHA4,ROBO2,FGF5,AKAP9,UNC5C,EFNA5,SLIT2,PAQR3,GAP43,SHTN1,FGF20,CNTN1</TD></TR>
<TR><TD>4.434e-05</TD><TD>-10.02</TD><TD>axon</TD><TD>cellular component</TD><TD>GO:0030424</TD><TD>650</TD><TD>20</TD><TD>19868</TD><TD>222</TD>
<TD>GAP43,DSCAM,SHTN1,LGI1,CNTNAP2,EPHA4,CNTN1,PCDH9,PRSS12,UHMK1,ADGRL3,UNC5C,SYT1,NTRK2,UCHL1,MAP2,NRSN1,ROBO2,EPS8,NRCAM</TD></TR>
<TR><TD>4.593e-05</TD><TD>-9.99</TD><TD>O-glycosylation of TSR domain-containing proteins</TD><TD>REACTOME pathways</TD><TD>R-HSA-5173214</TD><TD>39</TD><TD>5</TD><TD>10391</TD><TD>107</TD>
<TD>ADAMTS3,ADAMTS12,THSD7A,ADAMTS5,THSD7B</TD></TR>
<TR><TD>4.925e-05</TD><TD>-9.92</TD><TD>Cys-rich_flank_reg_C</TD><TD>interpro domains</TD><TD>IPR000483</TD><TD>83</TD><TD>7</TD><TD>18605</TD><TD>215</TD>
<TD>PXDNL,LGI1,LRRC70,NTRK2,LRIG3,LRRN2,SLIT2</TD></TR>
<TR><TD>5.163e-05</TD><TD>-9.87</TD><TD>skin-neck-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-neck-malignant_melanoma</TD><TD>1223</TD><TD>30</TD><TD>16984</TD><TD>193</TD>
<TD>EPHA4,PRSS12,ROBO2,DNAJC12,AKAP9,ADAMTS3,EPHA3,KIF6,PTPRD,CHRM3,OR52K2,DSCAM,CNTNAP2,DAAM1,LRFN5,LRIG3,TCF20,DNER,SPATA16,FAT4,FERD3L,IL1RAPL2,UBR4,LHCGR,PAX6,CNTN1,SPHKAP,SLIT2,ADAM28,FBN2</TD></TR>
<TR><TD>5.441e-05</TD><TD>-9.82</TD><TD>large_intestine-adenoma</TD><TD>COSMIC cancer mutations</TD><TD>large_intestine-adenoma</TD><TD>266</TD><TD>12</TD><TD>16984</TD><TD>193</TD>
<TD>PWWP2A,COQ2,EFR3A,NAV3,RUNX1T1,SLIT2,MEGF10,EPHA3,ZPLD1,PAQR3,CNTNAP2,ADAMTS12</TD></TR>
<TR><TD>5.463e-05</TD><TD>-9.81</TD><TD>stomach-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>stomach-adenocarcinoma</TD><TD>4102</TD><TD>71</TD><TD>16984</TD><TD>193</TD>
<TD>GPR83,EPHA3,NUP35,KIF6,EFNA5,NRG1,UTRN,DAAM1,CHRM3,JMJD1C,SPAG9,DSCAM,ADAMTS5,ACVR2A,GMDS,FGF5,PCDH9,NAV3,NAT2,TRPS1,IPO8,ZPLD1,SLC39A10,ADAMTS12,LRIG3,TMEFF2,FAT4,BACH2,FERD3L,UHMK1,BANK1,TCF20,LMX1A,CPXM2,ACP6,NOVA1,HNF4G,PARP8,SEZ6L,CNTNAP2,ROBO2,IRX1,EPHA4,EDIL3,COX7B2,CALN1,ADAMTS3,MRPL13,SS18,AKAP9,FIGN,LMBRD1,SLIT2,MAP2,MEGF10,ATG10,PTPRK,NRCAM,CNTN1,SLC7A8,SPHKAP,FBN2,MPEG1,ADAM28,FGD3,LRFN5,PLEK,DNER,GHITM,SPATA16,IQGAP2</TD></TR>
<TR><TD>5.617e-05</TD><TD>-9.79</TD><TD>actin-based cell projection</TD><TD>cellular component</TD><TD>GO:0098858</TD><TD>229</TD><TD>11</TD><TD>19868</TD><TD>222</TD>
<TD>EPHA4,SLC10A2,GAP43,SHTN1,UTRN,SLC7A8,EPS8,WWOX,UNC5C,MAP2,IQGAP2</TD></TR>
<TR><TD>5.817e-05</TD><TD>-9.75</TD><TD>neck</TD><TD>COSMIC cancer mutations</TD><TD>neck</TD><TD>1231</TD><TD>30</TD><TD>16984</TD><TD>193</TD>
<TD>ADAMTS3,AKAP9,ROBO2,DNAJC12,EPHA4,PRSS12,DAAM1,CHRM3,OR52K2,DSCAM,CNTNAP2,PTPRD,EPHA3,KIF6,FERD3L,FAT4,IL1RAPL2,TCF20,DNER,SPATA16,LRIG3,LRFN5,FBN2,ADAM28,SLIT2,UBR4,SPHKAP,LHCGR,CNTN1,PAX6</TD></TR>
<TR><TD>5.875e-05</TD><TD>-9.74</TD><TD>EGF_3</TD><TD>prosite domains</TD><TD>PS50026</TD><TD>196</TD><TD>11</TD><TD>12232</TD><TD>162</TD>
<TD>EDIL3,SLIT2,MEGF10,FAT4,ADAM28,DNER,CNTNAP2,TMEFF2,NRG1,EFEMP1,FBN2</TD></TR>
<TR><TD>5.965e-05</TD><TD>-9.73</TD><TD>prostate-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>prostate-carcinoma-adenocarcinoma</TD><TD>12423</TD><TD>164</TD><TD>16984</TD><TD>193</TD>
<TD>EPS8,FANCB,WRN,SEZ6L,CNTNAP2,REXO2,NOVA1,HNF4G,PARP8,SLC25A46,FUT9,ADAMTS3,MRPL13,SS18,ZNF518B,AKAP9,NBEA,SLC10A2,SPANXN1,FIGN,KAZN,DNAJC12,NTRK2,PSKH2,STXBP6,IRX1,EPHA4,NCKAP5,CDH5,FGF14,MPEG1,CRTC3,LINC00583,ADAM28,FGD3,SLC7A14,CASK,LMBRD1,B3GAT2,PTPRK,FMNL2,UBR4,SPHKAP,SLC7A8,CYTL1,PLEK,THSD7B,LGI1,IL1RAPL2,AFM,GHITM,IQGAP2,UCHL1,ZNF521,FGFR2,SERGEF,FGF20,NRG1,UTRN,DAAM1,JMJD1C,SPAG9,GPR83,PTPRD,NUP35,ZFAND5,REG1B,COQ2,PCDH9,GAP43,NAV3,RGS5,SEMA3C,ACVR2A,ZPLD1,FNIP2,NAALADL2,PI15,SLC39A10,ADAMTS12,PXDNL,TRPS1,EPYC,IPO8,BACH2,LMX1A,SGCD,LINC01387,LRIG3,NOL4,VAV3,THSD7A,AGA,CTSO,BCHE,UNC5C,PHLPP1,RASGEF1B,LRRC3B,NRSN1,ROBO2,SKAP2,EDIL3,AOAH,PRSS12,FBN2,OR2AG1,PAQR3,EFEMP1,LRRN2,DAOA,SLIT2,MAP2,MEGF10,ATG10,NRCAM,CNTN1,PAX6,KLF12,DNER,KCNK9,SPATA16,RUNX1T1,AMELX,ACVR1C,RPH3A,DEPTOR,LRFN5,PHF14,PCGF5,EFNA5,SYT1,CHRM3,DSCAM,EPHA3,KIF6,ZFPM2,DCDC2C,FGF5,ADAMTS5,GMDS,CD226,CD96,MRPL3,SGCG,EFR3B,RYR2,PRKCE,LHCGR,FAT4,RBM20,ARX,FZD6,EFR3A,BANK1,TCF20,CPXM2,CELF2,XPO4,RGS6,PTPRZ1,TWIST1,MUC7,TMEFF2</TD></TR>
<TR><TD>6.289e-05</TD><TD>-9.67</TD><TD>upper_leg</TD><TD>COSMIC cancer mutations</TD><TD>upper_leg</TD><TD>880</TD><TD>24</TD><TD>16984</TD><TD>193</TD>
<TD>PTPRD,EPHA3,EPS8,VAV3,JMJD1C,OR52K2,CHRM3,SEZ6L,DSCAM,SEMA3C,FUT9,PWWP2A,ADAMTS3,LRRC3B,PCDH9,SLIT2,GCNT1,MEGF10,PTPRK,UBR4,SPHKAP,ADAM28,CD96,FGFR2</TD></TR>
<TR><TD>6.547e-05</TD><TD>-9.63</TD><TD>LRR_TYP</TD><TD>smart domains</TD><TD>SM00369</TD><TD>175</TD><TD>11</TD><TD>9743</TD><TD>147</TD>
<TD>LRFN5,ASPN,EPYC,PHLPP1,LGI1,PXDNL,SLIT2,LRRN2,LRRC3B,LRIG3,LRRC70</TD></TR>
<TR><TD>7.486e-05</TD><TD>-9.50</TD><TD>aortic valve morphogenesis</TD><TD>biological process</TD><TD>GO:0003180</TD><TD>38</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>ADAMTS5,TWIST1,SLIT2,ROBO2,TGFBR2</TD></TR>
<TR><TD>7.562e-05</TD><TD>-9.49</TD><TD>cell migration</TD><TD>biological process</TD><TD>GO:0016477</TD><TD>922</TD><TD>25</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6,TMEFF2,PECAM1,FMNL2,VAV3,ZFAND5,TWIST1,CXCL13,NRCAM,EPS8,ADGRL3,EPHA3,MEGF10,SLIT2,PTPRK,DNER,EPHA4,SHTN1,ARX,NTRK2,SEMA3C,INSM1,ADAMTS12,GCNT1,CDH5</TD></TR>
<TR><TD>7.821e-05</TD><TD>-9.46</TD><TD>human chr4p15.33</TD><TD>chromosome location</TD><TD>human chr4p15.33</TD><TD>39</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>LINC01085,LINC01182,LINC00504</TD></TR>
<TR><TD>7.966e-05</TD><TD>-9.44</TD><TD>Immunoglobulins</TD><TD>gene3d domains</TD><TD>2.60.40.10</TD><TD>726</TD><TD>22</TD><TD>14531</TD><TD>178</TD>
<TD>LRFN5,CNTN1,CD226,NRG1,LRIG3,IL1RAPL2,CD96,PXDNL,NTRK2,DSCAM,PTPRZ1,LRRN2,PECAM1,ROBO2,EPHA4,EPHA3,PTPRK,SEMA3C,UNC5C,PTPRD,FGFR2,NRCAM</TD></TR>
<TR><TD>8.339e-05</TD><TD>-9.39</TD><TD>olfactory bulb interneuron development</TD><TD>biological process</TD><TD>GO:0021891</TD><TD>8</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,ARX,ROBO2</TD></TR>
<TR><TD>8.453e-05</TD><TD>-9.38</TD><TD>EGF-like_dom</TD><TD>interpro domains</TD><TD>IPR000742</TD><TD>232</TD><TD>11</TD><TD>18605</TD><TD>215</TD>
<TD>CNTNAP2,ADAM28,MEGF10,EDIL3,FBN2,EFEMP1,TMEFF2,DNER,SLIT2,FAT4,NRG1</TD></TR>
<TR><TD>8.716e-05</TD><TD>-9.35</TD><TD>TSP1_rpt_sf</TD><TD>interpro domains</TD><TD>IPR036383</TD><TD>63</TD><TD>6</TD><TD>18605</TD><TD>215</TD>
<TD>ADAMTS12,ADAMTS5,THSD7B,UNC5C,ADAMTS3,THSD7A</TD></TR>
<TR><TD>9.112e-05</TD><TD>-9.30</TD><TD>LRR_dom_sf</TD><TD>interpro domains</TD><TD>IPR032675</TD><TD>319</TD><TD>13</TD><TD>18605</TD><TD>215</TD>
<TD>EPYC,NTRK2,LRRC70,LRFN5,LGI1,ASPN,PHLPP1,LRRC3B,LRRN2,LHCGR,LRIG3,PXDNL,SLIT2</TD></TR>
<TR><TD>9.142e-05</TD><TD>-9.30</TD><TD>retinal ganglion cell axon guidance</TD><TD>biological process</TD><TD>GO:0031290</TD><TD>21</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>NRCAM,SLIT2,EFNA5,ROBO2</TD></TR>
<TR><TD>9.153e-05</TD><TD>-9.30</TD><TD>cell differentiation</TD><TD>biological process</TD><TD>GO:0030154</TD><TD>3657</TD><TD>66</TD><TD>18905</TD><TD>220</TD>
<TD>WWOX,PLAAT1,NRCAM,EFNA5,ADGRL3,SGCD,PTPRZ1,SHTN1,DNER,SLIT2,IRX1,EPHA4,ACVR1C,GAP43,PAX6,HNF4G,PECAM1,SYT1,SLC25A46,NOBOX,NAV3,FERD3L,FGF20,FAT4,UNC5C,ZFPM2,BCHE,FGF5,NTRK2,DSCAM,UCHL1,FUT9,CYTL1,ARX,ACP6,ZNF521,INSM1,ADAMTS5,SPAG9,MEGF10,KAZN,TWIST1,THSD7A,EPHA3,NRG1,ROBO2,TMEFF2,SLC39A10,PBX1,SPATA16,CNTNAP2,PLEK,MAP2,LGI1,AFG2A,FGFR2,AMELX,UHMK1,SEMA3C,BRINP3,PHF14,PTPRD,ADAMTS12,TGFBR2,CNTN1,LMX1A</TD></TR>
<TR><TD>9.387e-05</TD><TD>-9.27</TD><TD>cellular developmental process</TD><TD>biological process</TD><TD>GO:0048869</TD><TD>3660</TD><TD>66</TD><TD>18905</TD><TD>220</TD>
<TD>BCHE,FGF5,FAT4,UNC5C,ZFPM2,FGF20,ZNF521,ACP6,ADAMTS5,INSM1,NTRK2,DSCAM,UCHL1,ARX,CYTL1,FUT9,PTPRZ1,SHTN1,EPHA4,IRX1,ACVR1C,DNER,SLIT2,WWOX,PLAAT1,EFNA5,SGCD,ADGRL3,NRCAM,SLC25A46,SYT1,NAV3,FERD3L,NOBOX,GAP43,PECAM1,PAX6,HNF4G,LGI1,AFG2A,AMELX,FGFR2,CNTNAP2,SPATA16,MAP2,PLEK,ADAMTS12,PTPRD,CNTN1,TGFBR2,PHF14,LMX1A,UHMK1,SEMA3C,BRINP3,ROBO2,NRG1,MEGF10,KAZN,SPAG9,EPHA3,TWIST1,THSD7A,PBX1,SLC39A10,TMEFF2</TD></TR>
<TR><TD>9.526e-05</TD><TD>-9.26</TD><TD>TSP1_rpt</TD><TD>interpro domains</TD><TD>IPR000884</TD><TD>64</TD><TD>6</TD><TD>18605</TD><TD>215</TD>
<TD>THSD7B,THSD7A,UNC5C,ADAMTS3,ADAMTS12,ADAMTS5</TD></TR>
<TR><TD>1.024e-04</TD><TD>-9.19</TD><TD>growth cone</TD><TD>cellular component</TD><TD>GO:0030426</TD><TD>165</TD><TD>9</TD><TD>19868</TD><TD>222</TD>
<TD>DSCAM,GAP43,UNC5C,NRSN1,MAP2,SHTN1,EPHA4,PCDH9,EPS8</TD></TR>
<TR><TD>1.078e-04</TD><TD>-9.14</TD><TD>kidney-other-neoplasm</TD><TD>COSMIC cancer mutations</TD><TD>kidney-other-neoplasm</TD><TD>10692</TD><TD>146</TD><TD>16984</TD><TD>193</TD>
<TD>CD96,LHCGR,PRKCE,RYR2,EFR3B,SGCG,MRPL3,CPXM2,BANK1,TCF20,FZD6,EFR3A,ARX,RBM20,FAT4,TMEFF2,MUC7,PTPRZ1,XPO4,DSCAM,CHRM3,SYT1,PCGF5,EFNA5,ZFPM2,TGFBR2,KIF6,EPHA3,FGF5,DCDC2C,CD226,GMDS,ADAMTS5,DAOA,EFEMP1,PAQR3,FBN2,CNTN1,PAX6,NRCAM,ATG10,MEGF10,MAP2,SLIT2,RPH3A,ACVR1C,SPATA16,KCNK9,DNER,KLF12,PHF14,LRFN5,DEPTOR,ZNF133,THSD7A,VAV3,UNC5C,BCHE,CTSO,AGA,ACP6,NRSN1,RASGEF1B,PHLPP1,PRSS12,EDIL3,AOAH,SKAP2,ROBO2,ADAMTS12,SLC39A10,PI15,NAALADL2,ZPLD1,IPO8,EPYC,TRPS1,SGCD,LMX1A,BACH2,NOL4,LRIG3,LINC01387,JMJD1C,CETN3,DAAM1,UTRN,NRG1,ZFAND5,NUP35,GPR83,RGS5,GAP43,NAV3,PCDH9,COQ2,ACVR2A,SEMA3C,SLC7A14,CASK,ADAM28,CRTC3,FGF14,CDH5,SLC7A8,SPHKAP,FMNL2,UBR4,PTPRK,B3GAT2,LMBRD1,UCHL1,IQGAP2,GHITM,AFM,IL1RAPL2,THSD7B,LGI1,PLEK,FGF20,SERGEF,ZNF521,CNTNAP2,SEZ6L,WRN,FANCB,EPS8,PARP8,NOVA1,REXO2,FIGN,SPANXN1,SLC10A2,AKAP9,MRPL13,SS18,ADAMTS3,SLC25A46,NCKAP5,TSN,EPHA4,STXBP6,PSKH2,NTRK2,DNAJC12,KAZN</TD></TR>
<TR><TD>1.098e-04</TD><TD>-9.12</TD><TD>activin receptor activity</TD><TD>molecular function</TD><TD>GO:0017002</TD><TD>9</TD><TD>3</TD><TD>18530</TD><TD>207</TD>
<TD>ACVR1C,TGFBR2,ACVR2A</TD></TR>
<TR><TD>1.107e-04</TD><TD>-9.11</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.40.1620.60</TD><TD>21</TD><TD>4</TD><TD>14531</TD><TD>178</TD>
<TD>ADAMTS12,ADAMTS5,ADAM28,ADAMTS3</TD></TR>
<TR><TD>1.154e-04</TD><TD>-9.07</TD><TD>skin-scalp-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-scalp-malignant_melanoma</TD><TD>634</TD><TD>19</TD><TD>16984</TD><TD>193</TD>
<TD>UBR4,IPO8,PTPRD,SLIT2,SLC7A14,ZNF133,SEZ6L,CHRM3,ADAM28,VAV3,UTRN,AOAH,EPHA4,PTPRZ1,GAP43,ACVR1C,AMELX,LMX1A,ADAMTS3</TD></TR>
<TR><TD>1.174e-04</TD><TD>-9.05</TD><TD>MARCHF1 (membrane associated ring-CH-type finger 1)</TD><TD>protein interactions</TD><TD>55016</TD><TD>69</TD><TD>6</TD><TD>20077</TD><TD>223</TD>
<TD>TGFBR2,FGFR2,ADGRL3,EPHA3,ACVR2A,SLC25A46</TD></TR>
<TR><TD>1.183e-04</TD><TD>-9.04</TD><TD>Thrombospondin type-1 (TSP1) repeat</TD><TD>gene3d domains</TD><TD>2.20.100.10</TD><TD>63</TD><TD>6</TD><TD>14531</TD><TD>178</TD>
<TD>ADAMTS12,ADAMTS5,THSD7B,ADAMTS3,THSD7A,UNC5C</TD></TR>
<TR><TD>1.212e-04</TD><TD>-9.02</TD><TD>cardiac chamber morphogenesis</TD><TD>biological process</TD><TD>GO:0003206</TD><TD>127</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,FGFR2,TGFBR2,ROBO2,RYR2,NRG1,ZFPM2,SEMA3C</TD></TR>
<TR><TD>1.212e-04</TD><TD>-9.02</TD><TD>cardiac ventricle development</TD><TD>biological process</TD><TD>GO:0003231</TD><TD>127</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C,ZFPM2,NRG1,ROBO2,RYR2,TGFBR2,FGFR2,SLIT2</TD></TR>
<TR><TD>1.217e-04</TD><TD>-9.01</TD><TD>lung-carcinoma-undifferentiated_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma-undifferentiated_carcinoma</TD><TD>1409</TD><TD>32</TD><TD>16984</TD><TD>193</TD>
<TD>DNER,ACVR1C,UCHL1,RUNX1T1,FZD6,TWIST1,TMEFF2,FGF20,FGFR2,CDH5,FGF14,LHCGR,CNTN1,PAX6,PRKCE,AKAP9,PBX1,FGF5,SS18,EPHA4,ACVR2A,NTRK2,DNAJC12,SPAG9,FANCB,NRG1,WRN,VAV3,EPHA3,PARP8,TGFBR2,PTPRD</TD></TR>
<TR><TD>1.238e-04</TD><TD>-9.00</TD><TD>EGF_2</TD><TD>prosite domains</TD><TD>PS01186</TD><TD>213</TD><TD>11</TD><TD>12232</TD><TD>162</TD>
<TD>ADAM28,FBN2,EFEMP1,EPHA3,FAT4,MEGF10,NRG1,TMEFF2,SLIT2,EDIL3,DNER</TD></TR>
<TR><TD>1.240e-04</TD><TD>-9.00</TD><TD>netrin-activated signaling pathway</TD><TD>biological process</TD><TD>GO:0038007</TD><TD>9</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>UNC5C,SHTN1,DSCAM</TD></TR>
<TR><TD>1.285e-04</TD><TD>-8.96</TD><TD>human chr4p13</TD><TD>chromosome location</TD><TD>human chr4p13</TD><TD>46</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>LINC00682,UCHL1,SHISA3</TD></TR>
<TR><TD>1.285e-04</TD><TD>-8.96</TD><TD>human chr14q31.1</TD><TD>chromosome location</TD><TD>human chr14q31.1</TD><TD>46</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>DIO2-AS1,LINC02311,LINC02301</TD></TR>
<TR><TD>1.286e-04</TD><TD>-8.96</TD><TD>site of polarized growth</TD><TD>cellular component</TD><TD>GO:0030427</TD><TD>170</TD><TD>9</TD><TD>19868</TD><TD>222</TD>
<TD>DSCAM,GAP43,UNC5C,MAP2,NRSN1,SHTN1,EPHA4,PCDH9,EPS8</TD></TR>
<TR><TD>1.299e-04</TD><TD>-8.95</TD><TD>FN3_sf</TD><TD>interpro domains</TD><TD>IPR036116</TD><TD>203</TD><TD>10</TD><TD>18605</TD><TD>215</TD>
<TD>LRFN5,DSCAM,PTPRD,EPHA3,CNTN1,NRCAM,ROBO2,PTPRK,EPHA4,PTPRZ1</TD></TR>
<TR><TD>1.322e-04</TD><TD>-8.93</TD><TD>MMP26 (matrix metallopeptidase 26)</TD><TD>protein interactions</TD><TD>56547</TD><TD>24</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>EPHA4,ADGRL3,PTPRK,EFR3A</TD></TR>
<TR><TD>1.329e-04</TD><TD>-8.93</TD><TD>EFR3-like_ARM</TD><TD>interpro domains</TD><TD>IPR049152</TD><TD>2</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>EFR3A,EFR3B</TD></TR>
<TR><TD>1.332e-04</TD><TD>-8.92</TD><TD>upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma</TD><TD>9307</TD><TD>131</TD><TD>16984</TD><TD>193</TD>
<TD>RASGEF1B,PHLPP1,SKAP2,ROBO2,COX7B2,CXCL13,AOAH,EDIL3,VAV3,THSD7A,CTSO,AGA,ACP6,UNC5C,ACVR1C,AMELX,RUNX1T1,DNER,KCNK9,DEPTOR,PHF14,LRFN5,EFEMP1,LRRC70,RAI2,FBN2,DAOA,LRRN2,MEGF10,MAP2,SLIT2,PAX6,CNTN1,FGF5,PBX1,CD226,GMDS,ADAMTS5,SYT1,PCGF5,EFNA5,DSCAM,CHRM3,KIF6,ZFPM2,TGFBR2,EPHA3,ARX,UHMK1,FZD6,RBM20,FAT4,CPXM2,TCF20,BANK1,PTPRZ1,XPO4,RGS6,DEFB115,MUC7,TWIST1,MRPL3,LHCGR,PRKCE,RYR2,SS18,MRPL13,ADAMTS3,FIGN,SPANXN1,NBEA,AKAP9,PSKH2,NTRK2,DNAJC12,KAZN,TSN,EPHA4,IRX1,FANCB,WRN,EPS8,CNTNAP2,SEZ6L,NOVA1,PARP8,IL1RAPL2,THSD7B,IQGAP2,AFM,SERGEF,FGFR2,ZNF521,FGF20,CDH5,SLC7A14,CASK,FGD3,ADAM28,LMBRD1,SPHKAP,SLC7A8,UBR4,FMNL2,PTPRK,COQ2,RGS5,GAP43,NAV3,PCDH9,SEMA3C,ACVR2A,UTRN,DAAM1,SPAG9,JMJD1C,PTPRD,GPR83,NUP35,BACH2,FERD3L,LMX1A,LRIG3,NOL4,ZPLD1,ADAMTS12,SLC39A10,NAALADL2,TRPS1,PXDNL,IPO8</TD></TR>
<TR><TD>1.336e-04</TD><TD>-8.92</TD><TD>EFR3_ARM</TD><TD>pfam domains</TD><TD>PF21052</TD><TD>2</TD><TD>2</TD><TD>17869</TD><TD>207</TD>
<TD>EFR3A,EFR3B</TD></TR>
<TR><TD>1.347e-04</TD><TD>-8.91</TD><TD>skin-head_neck-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-head_neck-carcinoma-squamous_cell_carcinoma</TD><TD>14205</TD><TD>179</TD><TD>16984</TD><TD>193</TD>
<TD>CNTNAP2,WRN,PARP8,HNF4G,NOVA1,SLC10A2,ZNF518B,AKAP9,SLC25A46,FUT9,IRX1,EPHA4,PSKH2,KAZN,ADAM28,FGF14,CRTC3,UBR4,SLC7A8,PTPRK,B3GAT2,ARL14,LMBRD1,IQGAP2,UCHL1,AFM,IL1RAPL2,LGI1,THSD7B,CYTL1,PLEK,FGF20,SPAG9,CETN3,UTRN,DAAM1,NRG1,GPR83,GAP43,REG1B,ADAMTS12,NAALADL2,IGFL4,EPYC,NOBOX,BACH2,LRIG3,ZNF133,THSD7A,VAV3,UNC5C,PHLPP1,RASGEF1B,PRSS12,ROBO2,LRRN2,DAOA,PAQR3,EFEMP1,FBN2,CNTN1,GCNT1,SPATA16,RUNX1T1,ACVR1C,DNER,SYT1,ERCC6L2,TGFBR2,ZFPM2,GMDS,CD226,CD96,LHCGR,RYR2,SGCG,BANK1,FZD6,SHISA3,SERINC5,FAT4,DEFB115,RGS6,PTPRZ1,SEZ6L,EPS8,FANCB,SPANXN1,FIGN,NBEA,ADAMTS3,SS18,TSN,NCKAP5,STXBP6,DNAJC12,NTRK2,FGD3,SLC7A14,CASK,MPEG1,CDH5,FMNL2,SPHKAP,SERGEF,ZNF521,FGFR2,JMJD1C,NUP35,PTPRD,NAV3,NAT2,RGS5,PCDH9,PWWP2A,COQ2,ACVR2A,SEMA3C,PI15,SLC39A10,ZPLD1,FNIP2,IPO8,TRPS1,PXDNL,SGCD,LMX1A,FERD3L,NOL4,BCHE,CTSO,WWOX,NRSN1,LRRC3B,CALN1,CXCL13,COX7B2,AOAH,EDIL3,SKAP2,LRRC70,OR2AG1,RAI2,NRCAM,PAX6,ATG10,MAP2,MEGF10,SLIT2,RPH3A,AMELX,KCNK9,KLF12,PHF14,LRFN5,DEPTOR,DSCAM,CHRM3,OR52K2,EFNA5,PCGF5,KIF6,EPHA3,FGF5,ADAMTS5,EFR3B,MRPL3,CPXM2,PRLHR,TCF20,RBM20,UHMK1,ARX,EFR3A,TMEFF2,TWIST1,MUC7,XPO4,CELF2</TD></TR>
<TR><TD>1.348e-04</TD><TD>-8.91</TD><TD>fasciculation of motor neuron axon</TD><TD>biological process</TD><TD>GO:0097156</TD><TD>2</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.369e-04</TD><TD>-8.90</TD><TD>aortic valve development</TD><TD>biological process</TD><TD>GO:0003176</TD><TD>43</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>ADAMTS5,TWIST1,SLIT2,ROBO2,TGFBR2</TD></TR>
<TR><TD>1.369e-04</TD><TD>-8.90</TD><TD>ventricular septum morphogenesis</TD><TD>biological process</TD><TD>GO:0060412</TD><TD>43</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,TGFBR2,ZFPM2,SLIT2,FGFR2</TD></TR>
<TR><TD>1.386e-04</TD><TD>-8.88</TD><TD>undifferentiated_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>undifferentiated_carcinoma</TD><TD>1419</TD><TD>32</TD><TD>16984</TD><TD>193</TD>
<TD>CNTN1,PAX6,LHCGR,PRKCE,CDH5,FGF14,TWIST1,FGF20,TMEFF2,FGFR2,DNER,ACVR1C,UCHL1,RUNX1T1,FZD6,EPHA3,TGFBR2,PARP8,PTPRD,SPAG9,WRN,FANCB,NRG1,VAV3,EPHA4,ACVR2A,NTRK2,DNAJC12,AKAP9,PBX1,SS18,FGF5</TD></TR>
<TR><TD>1.428e-04</TD><TD>-8.85</TD><TD>skin-trunk-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-trunk-malignant_melanoma</TD><TD>2649</TD><TD>50</TD><TD>16984</TD><TD>193</TD>
<TD>TRPS1,RYR2,CD96,ADAMTS12,PI15,NAALADL2,RGS6,PTPRZ1,MUC7,RBM20,FAT4,BANK1,PTPRD,ZFPM2,UTRN,SPAG9,DSCAM,CHRM3,JMJD1C,OR52K2,PCDH9,SLIT2,FMNL2,UBR4,NRCAM,SPHKAP,PAX6,FBN2,ADAM28,DAOA,LRFN5,THSD7B,RPH3A,UCHL1,AGA,HNF4G,EPS8,WRN,ZNF133,THSD7A,ROBO2,SKAP2,TSN,CXCL13,PRSS12,NCKAP5,EDIL3,ADAMTS3,NBEA,AKAP9</TD></TR>
<TR><TD>1.437e-04</TD><TD>-8.85</TD><TD>ovary</TD><TD>COSMIC cancer mutations</TD><TD>ovary</TD><TD>14830</TD><TD>184</TD><TD>16984</TD><TD>193</TD>
<TD>BCHE,CTSO,AGA,NRSN1,LRRC3B,CALN1,CXCL13,EDIL3,AOAH,SKAP2,OR2AG1,LRRC70,RAI2,NRCAM,PAX6,ATG10,MAP2,MEGF10,SLIT2,RPH3A,KCNK9,KLF12,PHF14,LRFN5,DEPTOR,DSCAM,CHRM3,OR52K2,EFNA5,PCGF5,KIF6,EPHA3,PBX1,FGF5,ADAMTS5,PRKCE,EFR3B,MRPL3,CPXM2,PRLHR,TCF20,RBM20,UHMK1,ARX,EFR3A,TMEFF2,TWIST1,MUC7,XPO4,SEZ6L,EPS8,FANCB,FIGN,SPANXN1,NBEA,ADAMTS3,SS18,NCKAP5,FABP7,STXBP6,DNAJC12,NTRK2,FGD3,CASK,SLC7A14,LINC00583,MPEG1,CDH5,FMNL2,SPHKAP,SERGEF,ZNF521,FGFR2,JMJD1C,ZFAND5,NUP35,PTPRD,NAV3,RGS5,NAT2,PCDH9,PWWP2A,COQ2,ACVR2A,SEMA3C,PI15,SLC39A10,FNIP2,ZPLD1,IPO8,TRPS1,PXDNL,SGCD,LMX1A,FERD3L,NOL4,LINC01387,ZNF133,THSD7A,VAV3,UNC5C,ACP6,PHLPP1,RASGEF1B,PRSS12,ROBO2,LRRN2,DAOA,EFEMP1,PAQR3,FBN2,CNTN1,RUNX1T1,SPATA16,ACVR1C,DNER,SYT1,TGFBR2,ZFPM2,DCDC2C,GMDS,CD226,CD96,LHCGR,RYR2,SGCG,BANK1,FZD6,SHISA3,SERINC5,FAT4,DEFB115,RGS6,PTPRZ1,ASPN,CNTNAP2,WRN,PARP8,HNF4G,REXO2,NOVA1,SLC10A2,ZNF518B,AKAP9,MRPL13,SLC25A46,FUT9,IRX1,EPHA4,PSKH2,KAZN,ADAM28,FGF14,CRTC3,UBR4,SLC7A8,PTPRK,B3GAT2,LMBRD1,IQGAP2,GHITM,UCHL1,AFM,IL1RAPL2,LGI1,THSD7B,CYTL1,PLEK,FGF20,SPAG9,CETN3,UTRN,DAAM1,NRG1,GPR83,GAP43,REG1B,ADAMTS12,NAALADL2,EPYC,INSM1,NOBOX,BACH2,LRIG3</TD></TR>
<TR><TD>1.550e-04</TD><TD>-8.77</TD><TD>Ribonuclease Inhibitor</TD><TD>gene3d domains</TD><TD>3.80.10.10</TD><TD>319</TD><TD>13</TD><TD>14531</TD><TD>178</TD>
<TD>LRRN2,NTRK2,PHLPP1,SLIT2,LRFN5,ASPN,EPYC,LRRC70,LRIG3,LHCGR,PXDNL,LGI1,LRRC3B</TD></TR>
<TR><TD>1.552e-04</TD><TD>-8.77</TD><TD>human chr4q13.1</TD><TD>chromosome location</TD><TD>human chr4q13.1</TD><TD>49</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>ADGRL3,MIR548AG1,LINC02494</TD></TR>
<TR><TD>1.554e-04</TD><TD>-8.77</TD><TD>breast-carcinoma-HER-positive_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>breast-carcinoma-HER-positive_carcinoma</TD><TD>2026</TD><TD>41</TD><TD>16984</TD><TD>193</TD>
<TD>TGFBR2,UNC5C,PARP8,EPHA3,PTPRD,SPAG9,SEZ6L,UTRN,VAV3,FANCB,WRN,NRG1,ACVR2A,EPHA4,NTRK2,DNAJC12,PBX1,AKAP9,SS18,FGF5,LHCGR,CNTN1,PAX6,PRKCE,NRCAM,MEGF10,FGF14,CDH5,TMEFF2,FGF20,TWIST1,LRFN5,XPO4,FGFR2,ACVR1C,UCHL1,RUNX1T1,GHITM,DNER,AFM,FZD6</TD></TR>
<TR><TD>1.554e-04</TD><TD>-8.77</TD><TD>HER-positive_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>HER-positive_carcinoma</TD><TD>2026</TD><TD>41</TD><TD>16984</TD><TD>193</TD>
<TD>PTPRD,TGFBR2,UNC5C,PARP8,EPHA3,UTRN,VAV3,WRN,FANCB,NRG1,SPAG9,SEZ6L,NTRK2,DNAJC12,ACVR2A,EPHA4,FGF5,SS18,PBX1,AKAP9,MEGF10,LHCGR,CNTN1,PAX6,NRCAM,PRKCE,FGF14,CDH5,XPO4,FGFR2,FGF20,TMEFF2,LRFN5,TWIST1,FZD6,UCHL1,ACVR1C,RUNX1T1,GHITM,DNER,AFM</TD></TR>
<TR><TD>1.606e-04</TD><TD>-8.74</TD><TD>signaling receptor binding</TD><TD>molecular function</TD><TD>GO:0005102</TD><TD>1516</TD><TD>33</TD><TD>18530</TD><TD>207</TD>
<TD>AMELX,SEMA3C,PTPRZ1,EFEMP1,IGFL4,SYT1,MEGF10,LMBRD1,UTRN,FGF14,BANK1,DNER,LGI1,PTPRD,DSCAM,FBN2,UCHL1,CYTL1,EPHA4,CXCL13,VAV3,CDH5,EFNA5,CD226,EDIL3,FGF5,SLIT2,CASK,ADAMTS5,FGF20,TGFBR2,NRG1,AKAP9</TD></TR>
<TR><TD>1.623e-04</TD><TD>-8.73</TD><TD>mesenchyme development</TD><TD>biological process</TD><TD>GO:0060485</TD><TD>248</TD><TD>11</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2,ADAMTS5,SLC39A10,SEMA3C,PAX6,ROBO2,NRG1,AMELX,FGFR2,ZFPM2,TWIST1</TD></TR>
<TR><TD>1.741e-04</TD><TD>-8.66</TD><TD>haematopoietic_neoplasm</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_neoplasm</TD><TD>11157</TD><TD>150</TD><TD>16984</TD><TD>193</TD>
<TD>CD96,SGCG,MRPL3,LHCGR,PRKCE,RYR2,EFR3B,EFR3A,UHMK1,FZD6,RBM20,FAT4,SHISA3,CPXM2,TCF20,BANK1,PTPRZ1,XPO4,CELF2,TMEFF2,MUC7,SYT1,EFNA5,DSCAM,KIF6,ZFPM2,TGFBR2,ERCC6L2,EPHA3,DCDC2C,CD226,GMDS,ADAMTS5,PAQR3,EFEMP1,OR2AG1,FBN2,RAI2,DAOA,LRRN2,MAP2,MEGF10,SLIT2,PAX6,CNTN1,ATG10,KLF12,ACVR1C,RPH3A,AMELX,RUNX1T1,SPATA16,DNER,KCNK9,DEPTOR,PHF14,LRFN5,VAV3,ZNF133,THSD7A,CTSO,WWOX,ACP6,UNC5C,BCHE,RASGEF1B,CALN1,PHLPP1,SKAP2,ROBO2,PRSS12,AOAH,EDIL3,ADAMTS12,SLC39A10,NAALADL2,PI15,EPYC,PXDNL,NOBOX,BACH2,SGCD,LMX1A,LRIG3,NOL4,UTRN,NRG1,JMJD1C,CETN3,PTPRD,GPR83,ZFAND5,NUP35,COQ2,REG1B,RGS5,NAV3,PCDH9,SEMA3C,ACVR2A,CRTC3,MPEG1,FGF14,CDH5,SLC7A14,CASK,FGD3,ADAM28,B3GAT2,LMBRD1,SLC7A8,SPHKAP,FMNL2,UBR4,PTPRK,IL1RAPL2,THSD7B,PLEK,UCHL1,IQGAP2,GHITM,AFM,SERGEF,FGFR2,ZNF521,WRN,FANCB,EPS8,CNTNAP2,ASPN,SEZ6L,NOVA1,PARP8,HNF4G,ADAMTS3,FUT9,FIGN,SPANXN1,SLC10A2,AKAP9,NBEA,ZNF518B,STXBP6,PSKH2,NTRK2,KAZN,DNAJC12,FABP7,NCKAP5,EPHA4</TD></TR>
<TR><TD>1.890e-04</TD><TD>-8.57</TD><TD>filopodium</TD><TD>cellular component</TD><TD>GO:0030175</TD><TD>106</TD><TD>7</TD><TD>19868</TD><TD>222</TD>
<TD>GAP43,UNC5C,IQGAP2,MAP2,SHTN1,EPHA4,UTRN</TD></TR>
<TR><TD>1.896e-04</TD><TD>-8.57</TD><TD>negative chemotaxis</TD><TD>biological process</TD><TD>GO:0050919</TD><TD>46</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C,UNC5C,NRG1,EFNA5,SLIT2</TD></TR>
<TR><TD>1.904e-04</TD><TD>-8.57</TD><TD>astrocytoma_Grade_I</TD><TD>COSMIC cancer mutations</TD><TD>astrocytoma_Grade_I</TD><TD>139</TD><TD>8</TD><TD>16984</TD><TD>193</TD>
<TD>FGF14,NRG1,CNTNAP2,SPATA16,NAALADL2,FGFR2,ZFPM2,NOL4</TD></TR>
<TR><TD>1.911e-04</TD><TD>-8.56</TD><TD>cardiac septum morphogenesis</TD><TD>biological process</TD><TD>GO:0060411</TD><TD>72</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2,ROBO2,SLIT2,FGFR2,ZFPM2,SEMA3C</TD></TR>
<TR><TD>1.911e-04</TD><TD>-8.56</TD><TD>cardiac ventricle morphogenesis</TD><TD>biological process</TD><TD>GO:0003208</TD><TD>72</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,NRG1,RYR2,SEMA3C,ZFPM2,TGFBR2</TD></TR>
<TR><TD>1.955e-04</TD><TD>-8.54</TD><TD>TSP1</TD><TD>prosite domains</TD><TD>PS50092</TD><TD>64</TD><TD>6</TD><TD>12232</TD><TD>162</TD>
<TD>ADAMTS12,THSD7B,ADAMTS5,ADAMTS3,UNC5C,THSD7A</TD></TR>
<TR><TD>1.979e-04</TD><TD>-8.53</TD><TD>large_intestine-colon-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>large_intestine-colon-carcinoma</TD><TD>2612</TD><TD>49</TD><TD>16984</TD><TD>193</TD>
<TD>LRFN5,FGFR2,DEPTOR,RUNX1T1,GHITM,KLF12,UBR4,PAX6,B3GAT2,MEGF10,MAP2,FBN2,CDH5,CRTC3,IRX1,PRSS12,ROBO2,SKAP2,AKAP9,FIGN,CALN1,RASGEF1B,LRRC3B,PARP8,SEZ6L,ASPN,CNTNAP2,WRN,VAV3,PTPRZ1,TCF20,FAT4,IGFL4,TRPS1,PI15,SLC39A10,ACVR2A,SEMA3C,PCDH9,GAP43,NAV3,FGF5,NUP35,TGFBR2,PTPRD,JMJD1C,SPAG9,DSCAM,UTRN</TD></TR>
<TR><TD>2.101e-04</TD><TD>-8.47</TD><TD>semi-lunar valve development</TD><TD>biological process</TD><TD>GO:1905314</TD><TD>47</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2,ROBO2,ADAMTS5,SLIT2,TWIST1</TD></TR>
<TR><TD>2.151e-04</TD><TD>-8.44</TD><TD>regulation of axonogenesis</TD><TD>biological process</TD><TD>GO:0050770</TD><TD>138</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>SHTN1,ROBO2,SLIT2,EPHA4,NTRK2,DSCAM,MAP2,EFNA5</TD></TR>
<TR><TD>2.220e-04</TD><TD>-8.41</TD><TD>EphrinA-EPHA pathway</TD><TD>Pathway Interaction DB</TD><TD>ephrina_ephapathway</TD><TD>8</TD><TD>3</TD><TD>2232</TD><TD>37</TD>
<TD>EPHA3,EPHA4,EFNA5</TD></TR>
<TR><TD>2.251e-04</TD><TD>-8.40</TD><TD>regulation of neuron projection development</TD><TD>biological process</TD><TD>GO:0010975</TD><TD>443</TD><TD>15</TD><TD>18905</TD><TD>220</TD>
<TD>FUT9,PAX6,DSCAM,PAQR3,NTRK2,CNTN1,PTPRD,MAP2,NRCAM,EFNA5,EPHA3,SLIT2,EPHA4,SHTN1,ROBO2</TD></TR>
<TR><TD>2.386e-04</TD><TD>-8.34</TD><TD>cell-cell adhesion</TD><TD>biological process</TD><TD>GO:0098609</TD><TD>547</TD><TD>17</TD><TD>18905</TD><TD>220</TD>
<TD>DSCAM,PECAM1,PCDH9,TGFBR2,CNTN1,PTPRD,MEGF10,LRFN5,GCNT1,FAT4,ADGRL3,EFNA5,PLEK,NRCAM,ROBO2,CDH5,STXBP6</TD></TR>
<TR><TD>2.458e-04</TD><TD>-8.31</TD><TD>LRRCT</TD><TD>smart domains</TD><TD>SM00082</TD><TD>83</TD><TD>7</TD><TD>9743</TD><TD>147</TD>
<TD>LRRC70,LRIG3,LRRN2,SLIT2,PXDNL,LGI1,NTRK2</TD></TR>
<TR><TD>2.498e-04</TD><TD>-8.29</TD><TD>Diseases of glycosylation</TD><TD>REACTOME pathways</TD><TD>R-HSA-3781865</TD><TD>86</TD><TD>6</TD><TD>10391</TD><TD>107</TD>
<TD>ADAMTS5,ADAMTS12,ADAMTS3,THSD7B,MUC7,THSD7A</TD></TR>
<TR><TD>2.526e-04</TD><TD>-8.28</TD><TD>cell-cell adhesion via plasma-membrane adhesion molecules</TD><TD>biological process</TD><TD>GO:0098742</TD><TD>261</TD><TD>11</TD><TD>18905</TD><TD>220</TD>
<TD>CDH5,PTPRD,ROBO2,TGFBR2,PCDH9,PECAM1,EFNA5,ADGRL3,DSCAM,FAT4,LRFN5</TD></TR>
<TR><TD>2.636e-04</TD><TD>-8.24</TD><TD>distal axon</TD><TD>cellular component</TD><TD>GO:0150034</TD><TD>273</TD><TD>11</TD><TD>19868</TD><TD>222</TD>
<TD>EPS8,UNC5C,NTRK2,MAP2,NRSN1,EPHA4,PRSS12,PCDH9,GAP43,DSCAM,SHTN1</TD></TR>
<TR><TD>2.696e-04</TD><TD>-8.22</TD><TD>heart morphogenesis</TD><TD>biological process</TD><TD>GO:0003007</TD><TD>263</TD><TD>11</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,RBM20,SLIT2,ROBO2,RYR2,NRG1,TWIST1,ZFPM2,ADAMTS5,TGFBR2,SEMA3C</TD></TR>
<TR><TD>2.709e-04</TD><TD>-8.21</TD><TD>skin-upper_leg-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-upper_leg-malignant_melanoma</TD><TD>850</TD><TD>22</TD><TD>16984</TD><TD>193</TD>
<TD>SEMA3C,PCDH9,ADAMTS3,LRRC3B,FUT9,EPHA3,PTPRD,DSCAM,SEZ6L,CHRM3,OR52K2,JMJD1C,VAV3,EPS8,UBR4,SPHKAP,PTPRK,MEGF10,GCNT1,SLIT2,CD96,ADAM28</TD></TR>
<TR><TD>2.764e-04</TD><TD>-8.19</TD><TD>positive regulation of axonogenesis</TD><TD>biological process</TD><TD>GO:0050772</TD><TD>77</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,ROBO2,SHTN1,EFNA5,DSCAM,NTRK2</TD></TR>
<TR><TD>2.783e-04</TD><TD>-8.19</TD><TD>LRR</TD><TD>prosite domains</TD><TD>PS51450</TD><TD>196</TD><TD>10</TD><TD>12232</TD><TD>162</TD>
<TD>EPYC,SLIT2,LRRC70,PXDNL,PHLPP1,LRRC3B,LRFN5,LRRN2,LRIG3,ASPN</TD></TR>
<TR><TD>2.817e-04</TD><TD>-8.17</TD><TD>FGFR2c ligand binding and activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-190375</TD><TD>13</TD><TD>3</TD><TD>10391</TD><TD>107</TD>
<TD>FGFR2,FGF20,FGF5</TD></TR>
<TR><TD>2.904e-04</TD><TD>-8.14</TD><TD>kidney-carcinoma-clear_cell_renal_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>kidney-carcinoma-clear_cell_renal_cell_carcinoma</TD><TD>13957</TD><TD>176</TD><TD>16984</TD><TD>193</TD>
<TD>SGCD,LMX1A,NOL4,ZPLD1,FNIP2,PI15,SLC39A10,TRPS1,PXDNL,IPO8,PWWP2A,NAV3,RGS5,NAT2,PCDH9,SEMA3C,ACVR2A,JMJD1C,PTPRD,ZFAND5,NUP35,SERGEF,ZNF521,FGFR2,MPEG1,CDH5,FGD3,CASK,SLC7A14,FMNL2,SPHKAP,ADAMTS3,SS18,SPANXN1,FIGN,NBEA,STXBP6,DNAJC12,NTRK2,TSN,NCKAP5,EPS8,FANCB,SEZ6L,RBM20,ARX,UHMK1,EFR3A,PRLHR,CPXM2,TCF20,XPO4,CELF2,TMEFF2,TWIST1,MUC7,MRPL3,PRKCE,EFR3B,FGF5,PBX1,ADAMTS5,EFNA5,PCGF5,DSCAM,OR52K2,CHRM3,KIF6,EPHA3,KLF12,RPH3A,AMELX,KCNK9,DEPTOR,PHF14,LRFN5,OR2AG1,LRRC70,RAI2,MAP2,MEGF10,SLIT2,NRCAM,PAX6,ATG10,LRRC3B,CALN1,SKAP2,CXCL13,COX7B2,EDIL3,AOAH,AGA,BCHE,NOBOX,BACH2,LRIG3,ADAMTS12,NAALADL2,EPYC,IGFL4,REG1B,GAP43,DAAM1,UTRN,NRG1,SPAG9,CETN3,GPR83,IL1RAPL2,LGI1,THSD7B,PLEK,IQGAP2,AFM,FGF20,FGF14,CRTC3,ADAM28,B3GAT2,LMBRD1,UBR4,SLC7A8,PTPRK,MRPL13,SLC25A46,FUT9,SLC10A2,ZNF518B,AKAP9,PSKH2,KAZN,IRX1,EPHA4,WRN,ASPN,CNTNAP2,REXO2,NOVA1,PARP8,HNF4G,FZD6,FAT4,SERINC5,BANK1,RGS6,PTPRZ1,DEFB115,CD96,SGCG,LHCGR,RYR2,CD226,GMDS,SYT1,ERCC6L2,ZFPM2,TGFBR2,RUNX1T1,SPATA16,ACVR1C,DNER,PAQR3,EFEMP1,FBN2,GCNT1,CNTN1,PHLPP1,RASGEF1B,ROBO2,PRSS12,VAV3,ZNF133,THSD7A,ACP6,UNC5C</TD></TR>
<TR><TD>2.904e-04</TD><TD>-8.14</TD><TD>clear_cell_renal_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>clear_cell_renal_cell_carcinoma</TD><TD>13957</TD><TD>176</TD><TD>16984</TD><TD>193</TD>
<TD>AGA,BCHE,LRRC3B,CALN1,SKAP2,COX7B2,CXCL13,AOAH,EDIL3,OR2AG1,LRRC70,RAI2,MAP2,MEGF10,SLIT2,PAX6,NRCAM,ATG10,KLF12,RPH3A,AMELX,KCNK9,DEPTOR,PHF14,LRFN5,PCGF5,EFNA5,DSCAM,OR52K2,CHRM3,KIF6,EPHA3,FGF5,PBX1,ADAMTS5,MRPL3,PRKCE,EFR3B,UHMK1,ARX,EFR3A,RBM20,PRLHR,CPXM2,TCF20,XPO4,CELF2,TMEFF2,MUC7,TWIST1,FANCB,EPS8,SEZ6L,SS18,ADAMTS3,SPANXN1,FIGN,NBEA,STXBP6,NTRK2,DNAJC12,NCKAP5,TSN,MPEG1,CDH5,SLC7A14,CASK,FGD3,SPHKAP,FMNL2,SERGEF,FGFR2,ZNF521,JMJD1C,PTPRD,NUP35,ZFAND5,PWWP2A,RGS5,NAT2,NAV3,PCDH9,SEMA3C,ACVR2A,ZPLD1,FNIP2,SLC39A10,PI15,TRPS1,PXDNL,IPO8,SGCD,LMX1A,NOL4,VAV3,ZNF133,THSD7A,ACP6,UNC5C,RASGEF1B,PHLPP1,ROBO2,PRSS12,PAQR3,EFEMP1,FBN2,GCNT1,CNTN1,ACVR1C,SPATA16,RUNX1T1,DNER,SYT1,ZFPM2,TGFBR2,ERCC6L2,GMDS,CD226,CD96,SGCG,LHCGR,RYR2,FZD6,FAT4,SERINC5,BANK1,PTPRZ1,RGS6,DEFB115,WRN,CNTNAP2,ASPN,NOVA1,REXO2,PARP8,HNF4G,MRPL13,FUT9,SLC25A46,SLC10A2,AKAP9,ZNF518B,PSKH2,KAZN,EPHA4,IRX1,CRTC3,FGF14,ADAM28,B3GAT2,LMBRD1,SLC7A8,UBR4,PTPRK,THSD7B,LGI1,IL1RAPL2,PLEK,IQGAP2,AFM,FGF20,UTRN,DAAM1,NRG1,SPAG9,CETN3,GPR83,REG1B,GAP43,ADAMTS12,NAALADL2,EPYC,IGFL4,NOBOX,BACH2,LRIG3</TD></TR>
<TR><TD>3.008e-04</TD><TD>-8.11</TD><TD>tissue development</TD><TD>biological process</TD><TD>GO:0009888</TD><TD>1762</TD><TD>37</TD><TD>18905</TD><TD>220</TD>
<TD>PECAM1,PAX6,TMEFF2,PBX1,FERD3L,SLC39A10,ZFAND5,SGCD,TWIST1,MEGF10,KAZN,PLAAT1,EPYC,EPHA4,IRX1,DNER,SLIT2,SGCG,RYR2,ROBO2,NRG1,ARX,FZD6,CYTL1,SEMA3C,ADAMTS5,INSM1,ADAMTS12,TGFBR2,GCNT1,UNC5C,ZFPM2,FGF20,ASPN,AMELX,FGFR2,ACVR2A</TD></TR>
<TR><TD>3.100e-04</TD><TD>-8.08</TD><TD>TGFB_receptor</TD><TD>interpro domains</TD><TD>IPR000333</TD><TD>12</TD><TD>3</TD><TD>18605</TD><TD>215</TD>
<TD>ACVR2A,ACVR1C,TGFBR2</TD></TR>
<TR><TD>3.430e-04</TD><TD>-7.98</TD><TD>human chr4q28.3</TD><TD>chromosome location</TD><TD>human chr4q28.3</TD><TD>64</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>LINC02511,LINC02172,LINC00499</TD></TR>
<TR><TD>3.567e-04</TD><TD>-7.94</TD><TD>cell periphery</TD><TD>cellular component</TD><TD>GO:0071944</TD><TD>6404</TD><TD>96</TD><TD>19868</TD><TD>222</TD>
<TD>IQGAP2,PHLPP1,GPR83,MEGF10,NUP35,SGCG,CASK,OR2AG1,UBR4,LRRC3B,KAZN,PLEK,ACVR1C,IL1RAPL2,EPHA3,THSD7B,MUC7,KCNK9,NRG1,GAREM1,CD96,SLC39A10,PRKCE,VAV3,NRCAM,RGS6,CHRM3,FZD6,AMELX,FGFR2,PCDH9,SEMA3C,LRIG3,FBN2,SLC7A14,RYR2,SGCD,PRLHR,DSCAM,CDH5,EFR3B,EDIL3,TEC,PRSS12,NTRK2,SERINC5,UCHL1,EFNA5,CD226,SKAP2,PECAM1,LRFN5,EPYC,LRRN2,OR52K2,AKAP9,ACVR2A,CNTNAP2,THSD7A,PTPRZ1,CALN1,RASGEF1B,UTRN,RGS5,PXDNL,SLC10A2,TGFBR2,SYT1,ADAMTS5,ASPN,DNER,EFEMP1,RPH3A,LRRC70,GAP43,CNTN1,EPHA4,LHCGR,PTPRK,BCHE,WWOX,DAAM1,UNC5C,ADAMTS12,EFR3A,ROBO2,ADAM28,EPS8,ADAMTS3,SLC7A8,FAT4,NBEA,PTPRD,SEPTIN5,ADGRL3,LMBRD1</TD></TR>
<TR><TD>3.579e-04</TD><TD>-7.94</TD><TD>GJB7 (gap junction protein beta 7)</TD><TD>protein interactions</TD><TD>375519</TD><TD>55</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>GAP43,EFNA5,CNTN1,EFR3B,EFR3A</TD></TR>
<TR><TD>3.619e-04</TD><TD>-7.92</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma</TD><TD>751</TD><TD>20</TD><TD>16984</TD><TD>193</TD>
<TD>FAT4,NAV3,ROBO2,ZNF521,NTRK2,XPO4,LRIG3,FGF20,FBN2,EPS8,CHRM3,CNTNAP2,ADAMTS12,TRPS1,B3GAT2,MEGF10,PTPRD,RYR2,PTPRK,KIF6</TD></TR>
<TR><TD>3.640e-04</TD><TD>-7.92</TD><TD>outflow tract morphogenesis</TD><TD>biological process</TD><TD>GO:0003151</TD><TD>81</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C,ZFPM2,TWIST1,ROBO2,TGFBR2,FGFR2</TD></TR>
<TR><TD>3.671e-04</TD><TD>-7.91</TD><TD>germ_cell_tumour</TD><TD>COSMIC cancer mutations</TD><TD>germ_cell_tumour</TD><TD>869</TD><TD>22</TD><TD>16984</TD><TD>193</TD>
<TD>EPHA4,LRFN5,ACVR2A,NTRK2,FGFR2,RGS6,PSKH2,ACVR1C,FAT4,UHMK1,IPO8,EPHA3,TGFBR2,KIF6,CNTN1,ERCC6L2,PRKCE,LMBRD1,TRPS1,JMJD1C,NAALADL2,CASK</TD></TR>
<TR><TD>3.684e-04</TD><TD>-7.91</TD><TD>IL32 (interleukin 32)</TD><TD>protein interactions</TD><TD>9235</TD><TD>31</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>ZFPM2,PRKCE,FGFR2,PTPRD</TD></TR>
<TR><TD>3.700e-04</TD><TD>-7.90</TD><TD>haematopoietic_and_lymphoid_tissue</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue</TD><TD>14454</TD><TD>180</TD><TD>16984</TD><TD>193</TD>
<TD>SLC7A14,CASK,FGD3,LINC00583,MPEG1,CDH5,SPHKAP,FMNL2,SERGEF,FGFR2,ZNF521,SEZ6L,FANCB,EPS8,FIGN,SPANXN1,NBEA,SS18,ADAMTS3,FABP7,NCKAP5,STXBP6,NTRK2,DNAJC12,SLC39A10,PI15,ZPLD1,FNIP2,IPO8,TRPS1,PXDNL,SGCD,LMX1A,NOL4,LINC01387,JMJD1C,ZFAND5,NUP35,PTPRD,RGS5,NAT2,NAV3,PCDH9,COQ2,PWWP2A,ACVR2A,SEMA3C,OR2AG1,RAI2,PAX6,NRCAM,ATG10,MAP2,MEGF10,SLIT2,RPH3A,AMELX,KCNK9,KLF12,PHF14,LRFN5,DEPTOR,BCHE,CTSO,WWOX,NRSN1,LRRC3B,CALN1,CXCL13,AOAH,EDIL3,SKAP2,PRKCE,EFR3B,MRPL3,CPXM2,PRLHR,TCF20,EFR3A,UHMK1,ARX,RBM20,TMEFF2,MUC7,XPO4,CELF2,DSCAM,CHRM3,PCGF5,EFNA5,KIF6,EPHA3,FGF5,ADAMTS5,ADAM28,CRTC3,FGF14,SLC7A8,UBR4,PTPRK,B3GAT2,LMBRD1,UCHL1,GHITM,IQGAP2,AFM,THSD7B,LGI1,IL1RAPL2,PLEK,FGF20,CNTNAP2,ASPN,WRN,PARP8,HNF4G,NOVA1,REXO2,SLC10A2,AKAP9,ZNF518B,MRPL13,FUT9,SLC25A46,EPHA4,IRX1,PSKH2,KAZN,ADAMTS12,NAALADL2,EPYC,INSM1,NOBOX,BACH2,LRIG3,SPAG9,CETN3,UTRN,DAAM1,NRG1,GPR83,GAP43,REG1B,DAOA,LRRN2,EFEMP1,PAQR3,FBN2,CNTN1,ACVR1C,SPATA16,RUNX1T1,DNER,ZNF133,THSD7A,VAV3,UNC5C,ACP6,RASGEF1B,PHLPP1,PRSS12,ROBO2,CD96,LHCGR,RYR2,SGCG,BANK1,FZD6,FAT4,SHISA3,DEFB115,PTPRZ1,RGS6,SYT1,ZFPM2,TGFBR2,ERCC6L2,DCDC2C,GMDS,CD226</TD></TR>
<TR><TD>3.701e-04</TD><TD>-7.90</TD><TD>dendritic branch</TD><TD>cellular component</TD><TD>GO:0044307</TD><TD>3</TD><TD>2</TD><TD>19868</TD><TD>222</TD>
<TD>MAP2,AKAP9</TD></TR>
<TR><TD>3.886e-04</TD><TD>-7.85</TD><TD>TSP1</TD><TD>smart domains</TD><TD>SM00209</TD><TD>64</TD><TD>6</TD><TD>9743</TD><TD>147</TD>
<TD>ADAMTS5,UNC5C,THSD7B,ADAMTS12,ADAMTS3,THSD7A</TD></TR>
<TR><TD>3.926e-04</TD><TD>-7.84</TD><TD>LRRNT</TD><TD>interpro domains</TD><TD>IPR000372</TD><TD>54</TD><TD>5</TD><TD>18605</TD><TD>215</TD>
<TD>SLIT2,NTRK2,EPYC,ASPN,LRRC3B</TD></TR>
<TR><TD>3.941e-04</TD><TD>-7.84</TD><TD>prostate-adenoma</TD><TD>COSMIC cancer mutations</TD><TD>prostate-adenoma</TD><TD>1637</TD><TD>34</TD><TD>16984</TD><TD>193</TD>
<TD>KAZN,CD226,AOAH,ZNF518B,AKAP9,PTPRD,HNF4G,EPHA3,SYT1,NRG1,SEZ6L,RGS6,LRIG3,PTPRZ1,ZNF521,KLF12,LGI1,SPATA16,RPH3A,UCHL1,KCNK9,DNER,GCNT1,MAP2,SLIT2,UBR4,SPHKAP,PTPRK,FGF14,PAQR3,CRTC3,FBN2,ZPLD1,ADAMTS12</TD></TR>
<TR><TD>3.957e-04</TD><TD>-7.83</TD><TD>Sarcoglycan_gamma/delta/zeta</TD><TD>interpro domains</TD><TD>IPR039972</TD><TD>3</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>SGCG,SGCD</TD></TR>
<TR><TD>3.999e-04</TD><TD>-7.82</TD><TD>human chr1q23.3</TD><TD>chromosome location</TD><TD>human chr1q23.3</TD><TD>162</TD><TD>4</TD><TD>193383</TD><TD>404</TD>
<TD>UHMK1,RGS5,LMX1A,PBX1</TD></TR>
<TR><TD>4.005e-04</TD><TD>-7.82</TD><TD>enzyme-linked receptor protein signaling pathway</TD><TD>biological process</TD><TD>GO:0007167</TD><TD>626</TD><TD>18</TD><TD>18905</TD><TD>220</TD>
<TD>EPHA3,EFNA5,FGF20,GAREM1,ACVR1C,EPHA4,FGFR2,FGF5,ACVR2A,PTPRK,NRG1,CDH5,EFEMP1,NTRK2,TGFBR2,PTPRD,ZFAND5,SS18</TD></TR>
<TR><TD>4.013e-04</TD><TD>-7.82</TD><TD>fasciculation of sensory neuron axon</TD><TD>biological process</TD><TD>GO:0097155</TD><TD>3</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>4.013e-04</TD><TD>-7.82</TD><TD>apoptotic process involved in luteolysis</TD><TD>biological process</TD><TD>GO:0061364</TD><TD>3</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,SLIT2</TD></TR>
<TR><TD>4.079e-04</TD><TD>-7.80</TD><TD>olfactory bulb interneuron differentiation</TD><TD>biological process</TD><TD>GO:0021889</TD><TD>13</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,ARX,SLIT2</TD></TR>
<TR><TD>4.119e-04</TD><TD>-7.79</TD><TD>FN3</TD><TD>smart domains</TD><TD>SM00060</TD><TD>149</TD><TD>9</TD><TD>9743</TD><TD>147</TD>
<TD>PTPRD,CNTN1,EPHA3,PTPRZ1,DSCAM,ROBO2,PTPRK,EPHA4,NRCAM</TD></TR>
<TR><TD>4.182e-04</TD><TD>-7.78</TD><TD>seminoma</TD><TD>COSMIC cancer mutations</TD><TD>seminoma</TD><TD>702</TD><TD>19</TD><TD>16984</TD><TD>193</TD>
<TD>EPHA4,ACVR2A,NTRK2,FGFR2,RGS6,PSKH2,ACVR1C,FAT4,UHMK1,EPHA3,IPO8,ERCC6L2,PRKCE,CNTN1,TGFBR2,KIF6,LMBRD1,TRPS1,CASK</TD></TR>
<TR><TD>4.287e-04</TD><TD>-7.75</TD><TD>skin-nipple-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-nipple-malignant_melanoma</TD><TD>197</TD><TD>9</TD><TD>16984</TD><TD>193</TD>
<TD>CD96,ACVR1C,DSCAM,CHRM3,EFEMP1,ADAMTS3,FAT4,TMEFF2,LRIG3</TD></TR>
<TR><TD>4.287e-04</TD><TD>-7.75</TD><TD>nipple</TD><TD>COSMIC cancer mutations</TD><TD>nipple</TD><TD>197</TD><TD>9</TD><TD>16984</TD><TD>193</TD>
<TD>CHRM3,DSCAM,CD96,ACVR1C,FAT4,EFEMP1,ADAMTS3,TMEFF2,LRIG3</TD></TR>
<TR><TD>4.326e-04</TD><TD>-7.75</TD><TD>plasma membrane bounded cell projection organization</TD><TD>biological process</TD><TD>GO:0120036</TD><TD>1155</TD><TD>27</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,EPHA4,PTPRZ1,ROBO2,SHTN1,NRCAM,EPHA3,EFNA5,VAV3,SLC25A46,PAX6,GAP43,FGFR2,DAW1,LGI1,PLEK,MAP2,FGD3,CNTNAP2,UNC5C,LMX1A,CNTN1,ARX,DSCAM,UCHL1,SEMA3C,UHMK1</TD></TR>
<TR><TD>4.516e-04</TD><TD>-7.70</TD><TD>neuron projection</TD><TD>cellular component</TD><TD>GO:0043005</TD><TD>1335</TD><TD>29</TD><TD>19868</TD><TD>222</TD>
<TD>EPHA4,AKAP9,CNTN1,CNTNAP2,PCDH9,CHRM3,GAP43,CETN3,LGI1,NRCAM,RPH3A,RGS6,NTRK2,SYT1,UCHL1,DNER,NRSN1,MAP2,UHMK1,ADGRL3,PRSS12,DSCAM,EPHA3,SHTN1,ROBO2,BRINP3,PRLHR,EPS8,UNC5C</TD></TR>
<TR><TD>4.886e-04</TD><TD>-7.62</TD><TD>face</TD><TD>COSMIC cancer mutations</TD><TD>face</TD><TD>2139</TD><TD>41</TD><TD>16984</TD><TD>193</TD>
<TD>LMX1A,IQGAP2,SPATA16,BACH2,FAT4,KLF12,LRFN5,CELF2,FGFR2,ZNF521,PTPRZ1,DEPTOR,ADAM28,SLC39A10,ADAMTS12,FBN2,OR2AG1,PTPRK,SLIT2,SGCG,MEGF10,EPYC,TRPS1,PCDH9,AKAP9,ZNF518B,GAP43,NAV3,CALN1,ADAMTS3,PWWP2A,ADAMTS5,JMJD1C,CHRM3,SEZ6L,DSCAM,CNTNAP2,EPHA3,HNF4G,KIF6,PTPRD</TD></TR>
<TR><TD>5.016e-04</TD><TD>-7.60</TD><TD>bone</TD><TD>COSMIC cancer mutations</TD><TD>bone</TD><TD>8169</TD><TD>116</TD><TD>16984</TD><TD>193</TD>
<TD>FAT4,RBM20,EFR3A,TCF20,BANK1,CPXM2,PRLHR,CELF2,RGS6,PTPRZ1,TMEFF2,RYR2,PRKCE,LHCGR,FGF5,DCDC2C,ADAMTS5,GMDS,SYT1,OR52K2,DSCAM,EPHA3,ZFPM2,KIF6,KLF12,DNER,KCNK9,SPATA16,RUNX1T1,ACVR1C,LRFN5,PHF14,FBN2,RAI2,OR2AG1,SLIT2,MAP2,MEGF10,ATG10,NRCAM,CNTN1,PAX6,PHLPP1,RASGEF1B,SKAP2,AOAH,EDIL3,PRSS12,CXCL13,COX7B2,VAV3,THSD7A,ZNF133,BCHE,UNC5C,BACH2,FERD3L,NOBOX,LMX1A,SGCD,LRIG3,NOL4,ZPLD1,NAALADL2,PI15,SLC39A10,ADAMTS12,PXDNL,TRPS1,EPYC,IPO8,COQ2,PCDH9,GAP43,NAV3,RGS5,ACVR2A,NRG1,UTRN,DAAM1,JMJD1C,SPAG9,GPR83,PTPRD,THSD7B,IL1RAPL2,AFM,IQGAP2,ZNF521,FGFR2,SERGEF,FGF20,CDH5,FGF14,MPEG1,ADAM28,FGD3,LMBRD1,B3GAT2,UBR4,FMNL2,SPHKAP,ADAMTS3,SS18,AKAP9,FIGN,NTRK2,PSKH2,EPHA4,NCKAP5,FANCB,WRN,SEZ6L,CNTNAP2,HNF4G,PARP8</TD></TR>
<TR><TD>5.026e-04</TD><TD>-7.60</TD><TD>central nervous system neuron development</TD><TD>biological process</TD><TD>GO:0021954</TD><TD>86</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>NTRK2,ARX,EPHA4,FGFR2,SLIT2,MAP2</TD></TR>
<TR><TD>5.039e-04</TD><TD>-7.59</TD><TD>cell motility</TD><TD>biological process</TD><TD>GO:0048870</TD><TD>1105</TD><TD>26</TD><TD>18905</TD><TD>220</TD>
<TD>GCNT1,CDH5,SEMA3C,NTRK2,ARX,ADAMTS12,INSM1,MEGF10,LRATD1,EPHA3,ADGRL3,EPS8,NRCAM,TWIST1,CXCL13,SHTN1,EPHA4,DNER,SLIT2,PTPRK,FMNL2,PECAM1,TMEFF2,PAX6,ZFAND5,VAV3</TD></TR>
<TR><TD>5.050e-04</TD><TD>-7.59</TD><TD>human chr7q31.1</TD><TD>chromosome location</TD><TD>human chr7q31.1</TD><TD>73</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>EIF3IP1,NRCAM,LINC02903</TD></TR>
<TR><TD>5.050e-04</TD><TD>-7.59</TD><TD>human chr9q22.31</TD><TD>chromosome location</TD><TD>human chr9q22.31</TD><TD>73</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>ASPN,MIR548AU,FGD3</TD></TR>
<TR><TD>5.259e-04</TD><TD>-7.55</TD><TD>skin-scalp-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-scalp-carcinoma-squamous_cell_carcinoma</TD><TD>1596</TD><TD>33</TD><TD>16984</TD><TD>193</TD>
<TD>NRCAM,SPHKAP,CNTN1,LHCGR,TRPS1,MAP2,MEGF10,LRFN5,NOL4,DEFB115,PTPRZ1,ZNF521,FGFR2,CPXM2,PRLHR,RPH3A,FAT4,FERD3L,BACH2,UNC5C,DSCAM,SEZ6L,CHRM3,SYT1,DAAM1,NRG1,WRN,ADAMTS5,SEMA3C,ROBO2,NRSN1,NAV3,LRRC3B</TD></TR>
<TR><TD>5.658e-04</TD><TD>-7.48</TD><TD>knee</TD><TD>COSMIC cancer mutations</TD><TD>knee</TD><TD>125</TD><TD>7</TD><TD>16984</TD><TD>193</TD>
<TD>PTPRD,RYR2,CNTN1,ADAMTS3,PWWP2A,CHRM3,ADAM28</TD></TR>
<TR><TD>5.810e-04</TD><TD>-7.45</TD><TD>regulation of cell differentiation</TD><TD>biological process</TD><TD>GO:0045595</TD><TD>1625</TD><TD>34</TD><TD>18905</TD><TD>220</TD>
<TD>PTPRD,ADAMTS12,TGFBR2,LMX1A,FBN2,INSM1,NTRK2,DSCAM,BRINP3,CDH5,FGFR2,ACVR2A,ZFPM2,FGF20,MAP2,RUNX1T1,SS18,FERD3L,PBX1,TRPS1,EFEMP1,PAX6,PTPRZ1,ROBO2,SHTN1,NRG1,EPHA4,SLIT2,MEGF10,SPAG9,EPHA3,EFNA5,TWIST1,NRCAM</TD></TR>
<TR><TD>5.959e-04</TD><TD>-7.43</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia</TD><TD>10490</TD><TD>141</TD><TD>16984</TD><TD>193</TD>
<TD>LRRN2,DAOA,OR2AG1,PAQR3,EFEMP1,RAI2,FBN2,CNTN1,PAX6,ATG10,MEGF10,MAP2,SLIT2,RUNX1T1,SPATA16,AMELX,RPH3A,DNER,KCNK9,KLF12,PHF14,LRFN5,DEPTOR,ZNF133,THSD7A,VAV3,UNC5C,BCHE,CTSO,ACP6,WWOX,PHLPP1,CALN1,RASGEF1B,PRSS12,EDIL3,AOAH,ROBO2,SKAP2,CD96,PRKCE,LHCGR,EFR3B,RYR2,MRPL3,SGCG,CPXM2,BANK1,TCF20,RBM20,FZD6,EFR3A,SHISA3,FAT4,TMEFF2,MUC7,XPO4,PTPRZ1,CELF2,DSCAM,SYT1,EFNA5,ERCC6L2,KIF6,ZFPM2,EPHA3,DCDC2C,ADAMTS5,CD226,GMDS,FGD3,SLC7A14,CASK,ADAM28,FGF14,MPEG1,CRTC3,CDH5,UBR4,FMNL2,SLC7A8,SPHKAP,PTPRK,B3GAT2,LMBRD1,GHITM,IQGAP2,AFM,IL1RAPL2,THSD7B,PLEK,ZNF521,FGFR2,ASPN,CNTNAP2,SEZ6L,EPS8,FANCB,WRN,PARP8,HNF4G,NOVA1,SLC10A2,SPANXN1,ZNF518B,AKAP9,NBEA,ADAMTS3,NCKAP5,FABP7,EPHA4,PSKH2,STXBP6,DNAJC12,KAZN,NTRK2,ADAMTS12,NAALADL2,PI15,PXDNL,SGCD,LMX1A,NOBOX,BACH2,NOL4,LRIG3,CETN3,JMJD1C,UTRN,NRG1,ZFAND5,NUP35,PTPRD,GPR83,NAV3,RGS5,PCDH9,COQ2,REG1B,ACVR2A,SEMA3C</TD></TR>
<TR><TD>5.959e-04</TD><TD>-7.43</TD><TD>acute_myeloid_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>acute_myeloid_leukaemia</TD><TD>10490</TD><TD>141</TD><TD>16984</TD><TD>193</TD>
<TD>FGFR2,ZNF521,AFM,IQGAP2,GHITM,PLEK,IL1RAPL2,THSD7B,PTPRK,SPHKAP,SLC7A8,UBR4,FMNL2,LMBRD1,B3GAT2,ADAM28,SLC7A14,CASK,FGD3,CDH5,MPEG1,CRTC3,FGF14,EPHA4,FABP7,NCKAP5,NTRK2,KAZN,DNAJC12,STXBP6,PSKH2,NBEA,AKAP9,ZNF518B,SPANXN1,SLC10A2,ADAMTS3,HNF4G,PARP8,NOVA1,SEZ6L,CNTNAP2,ASPN,FANCB,WRN,EPS8,NOL4,LRIG3,LMX1A,SGCD,BACH2,NOBOX,PXDNL,NAALADL2,PI15,ADAMTS12,ACVR2A,SEMA3C,PCDH9,RGS5,NAV3,REG1B,COQ2,NUP35,ZFAND5,GPR83,PTPRD,JMJD1C,CETN3,NRG1,UTRN,LRFN5,PHF14,DEPTOR,DNER,KCNK9,RPH3A,AMELX,SPATA16,RUNX1T1,KLF12,ATG10,PAX6,CNTN1,SLIT2,MAP2,MEGF10,DAOA,LRRN2,RAI2,FBN2,EFEMP1,PAQR3,OR2AG1,EDIL3,AOAH,PRSS12,SKAP2,ROBO2,RASGEF1B,CALN1,PHLPP1,BCHE,UNC5C,WWOX,ACP6,CTSO,THSD7A,ZNF133,VAV3,MUC7,TMEFF2,CELF2,PTPRZ1,XPO4,BANK1,TCF20,CPXM2,FAT4,SHISA3,FZD6,EFR3A,RBM20,EFR3B,RYR2,LHCGR,PRKCE,SGCG,MRPL3,CD96,CD226,GMDS,ADAMTS5,DCDC2C,EPHA3,KIF6,ZFPM2,ERCC6L2,DSCAM,EFNA5,SYT1</TD></TR>
<TR><TD>5.978e-04</TD><TD>-7.42</TD><TD>extracellular matrix</TD><TD>cellular component</TD><TD>GO:0031012</TD><TD>561</TD><TD>16</TD><TD>19868</TD><TD>222</TD>
<TD>EDIL3,LRRN2,EPYC,LRRC3B,PTPRZ1,FGFR2,CASK,AMELX,ADAMTS12,FBN2,ASPN,EFNA5,LRIG3,ADAMTS5,ADAMTS3,EFEMP1</TD></TR>
<TR><TD>6.061e-04</TD><TD>-7.41</TD><TD>ER-PR-positive_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>ER-PR-positive_carcinoma</TD><TD>1882</TD><TD>37</TD><TD>16984</TD><TD>193</TD>
<TD>PBX1,AKAP9,SS18,FGF5,ACVR2A,EPHA4,DNAJC12,NTRK2,SPAG9,VAV3,FANCB,NRG1,WRN,PARP8,TGFBR2,EPHA3,PTPRD,RUNX1T1,UCHL1,ACVR1C,RPH3A,DNER,FZD6,FAT4,FGF20,TMEFF2,TWIST1,FGFR2,FGF14,ZPLD1,CDH5,PRKCE,FMNL2,PAX6,LHCGR,CNTN1,RYR2</TD></TR>
<TR><TD>6.061e-04</TD><TD>-7.41</TD><TD>breast-carcinoma-ER-PR-positive_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>breast-carcinoma-ER-PR-positive_carcinoma</TD><TD>1882</TD><TD>37</TD><TD>16984</TD><TD>193</TD>
<TD>PTPRD,PARP8,TGFBR2,EPHA3,VAV3,NRG1,FANCB,WRN,SPAG9,NTRK2,DNAJC12,ACVR2A,EPHA4,SS18,FGF5,PBX1,AKAP9,PAX6,CNTN1,LHCGR,PRKCE,FMNL2,RYR2,FGF14,ZPLD1,CDH5,FGFR2,FGF20,TMEFF2,TWIST1,FZD6,FAT4,RPH3A,UCHL1,ACVR1C,RUNX1T1,DNER</TD></TR>
<TR><TD>6.069e-04</TD><TD>-7.41</TD><TD>FN3_dom</TD><TD>interpro domains</TD><TD>IPR003961</TD><TD>203</TD><TD>9</TD><TD>18605</TD><TD>215</TD>
<TD>PTPRD,DSCAM,EPHA3,CNTN1,NRCAM,EPHA4,PTPRZ1,ROBO2,PTPRK</TD></TR>
<TR><TD>6.093e-04</TD><TD>-7.40</TD><TD>external encapsulating structure</TD><TD>cellular component</TD><TD>GO:0030312</TD><TD>562</TD><TD>16</TD><TD>19868</TD><TD>222</TD>
<TD>ADAMTS5,LRIG3,FBN2,EFNA5,ASPN,ADAMTS12,EFEMP1,ADAMTS3,EPYC,LRRN2,EDIL3,AMELX,CASK,FGFR2,PTPRZ1,LRRC3B</TD></TR>
<TR><TD>6.122e-04</TD><TD>-7.40</TD><TD>lung-carcinoma-non_small_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma-non_small_cell_carcinoma</TD><TD>5226</TD><TD>81</TD><TD>16984</TD><TD>193</TD>
<TD>RUNX1T1,IQGAP2,AMELX,ACVR1C,IL1RAPL2,PHF14,ZNF521,FGFR2,DEPTOR,SERGEF,ADAM28,FGD3,CASK,FBN2,RAI2,PTPRK,UBR4,CNTN1,SPHKAP,PAX6,SLIT2,LMBRD1,MAP2,ZNF518B,AKAP9,SPANXN1,RASGEF1B,ADAMTS3,SS18,MRPL13,IRX1,EPHA4,EDIL3,TSN,CXCL13,COX7B2,DNAJC12,KAZN,NTRK2,PSKH2,THSD7A,SEZ6L,CNTNAP2,WRN,FANCB,VAV3,NOVA1,CTSO,FAT4,BACH2,FERD3L,NOBOX,FZD6,UHMK1,ARX,TWIST1,RGS6,XPO4,LRIG3,PTPRZ1,ADAMTS12,RYR2,IPO8,PRKCE,TRPS1,NAV3,PBX1,RGS5,ADAMTS5,ACVR2A,JMJD1C,SPAG9,DSCAM,PCGF5,DAAM1,SYT1,EPHA3,NUP35,KIF6,TGFBR2,PTPRD</TD></TR>
<TR><TD>6.122e-04</TD><TD>-7.40</TD><TD>non_small_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>non_small_cell_carcinoma</TD><TD>5226</TD><TD>81</TD><TD>16984</TD><TD>193</TD>
<TD>ADAMTS12,TRPS1,PRKCE,IPO8,RYR2,NOBOX,ARX,UHMK1,FZD6,FAT4,FERD3L,BACH2,RGS6,LRIG3,XPO4,PTPRZ1,TWIST1,SYT1,DAAM1,PCGF5,SPAG9,DSCAM,JMJD1C,PTPRD,NUP35,KIF6,TGFBR2,EPHA3,NAV3,PBX1,RGS5,ADAMTS5,ACVR2A,RAI2,FBN2,FGD3,CASK,ADAM28,MAP2,SLIT2,LMBRD1,UBR4,PAX6,CNTN1,SPHKAP,PTPRK,IL1RAPL2,RUNX1T1,IQGAP2,AMELX,ACVR1C,SERGEF,DEPTOR,ZNF521,FGFR2,PHF14,VAV3,WRN,FANCB,CNTNAP2,THSD7A,SEZ6L,NOVA1,CTSO,ADAMTS3,MRPL13,SS18,RASGEF1B,SPANXN1,ZNF518B,AKAP9,PSKH2,DNAJC12,KAZN,NTRK2,TSN,CXCL13,COX7B2,IRX1,EPHA4,EDIL3</TD></TR>
<TR><TD>6.219e-04</TD><TD>-7.38</TD><TD>Regulation of Commissural axon pathfinding by Slit and Robo</TD><TD>REACTOME pathways</TD><TD>R-HSA-428542</TD><TD>4</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>SLIT2,ROBO2</TD></TR>
<TR><TD>6.316e-04</TD><TD>-7.37</TD><TD>RSPH1 (radial spoke head component 1)</TD><TD>protein interactions</TD><TD>89765</TD><TD>130</TD><TD>7</TD><TD>20077</TD><TD>223</TD>
<TD>CASK,PAX6,PTPRD,NRCAM,SEZ6L,DNER,EDIL3</TD></TR>
<TR><TD>6.362e-04</TD><TD>-7.36</TD><TD>positive regulation of neurogenesis</TD><TD>biological process</TD><TD>GO:0050769</TD><TD>246</TD><TD>10</TD><TD>18905</TD><TD>220</TD>
<TD>DSCAM,NTRK2,EFNA5,PAX6,PTPRZ1,PTPRD,ROBO2,SHTN1,EPHA4,SLIT2</TD></TR>
<TR><TD>6.398e-04</TD><TD>-7.35</TD><TD>transmembrane receptor protein tyrosine kinase activity</TD><TD>molecular function</TD><TD>GO:0004714</TD><TD>62</TD><TD>5</TD><TD>18530</TD><TD>207</TD>
<TD>EPHA3,FGFR2,NTRK2,EPHA4,EFEMP1</TD></TR>
<TR><TD>6.404e-04</TD><TD>-7.35</TD><TD>cell projection</TD><TD>cellular component</TD><TD>GO:0042995</TD><TD>2406</TD><TD>44</TD><TD>19868</TD><TD>222</TD>
<TD>FGD3,GPR83,IQGAP2,NRSN1,UCHL1,NTRK2,THSD7A,AKAP9,CASK,CNTNAP2,MEGF10,BRINP3,UTRN,PLEK,UHMK1,SLC10A2,DCDC2C,SHTN1,EPHA3,NRCAM,RGS6,RPH3A,MAP2,ASPN,DNER,SYT1,PCDH9,CNTN1,EPHA4,CETN3,LGI1,CHRM3,GAP43,EPS8,PRLHR,SLC7A8,ROBO2,DAW1,WWOX,DAAM1,UNC5C,ADGRL3,PRSS12,DSCAM</TD></TR>
<TR><TD>6.499e-04</TD><TD>-7.34</TD><TD>Activated point mutants of FGFR2</TD><TD>REACTOME pathways</TD><TD>R-HSA-2033519</TD><TD>17</TD><TD>3</TD><TD>10391</TD><TD>107</TD>
<TD>FGF20,FGF5,FGFR2</TD></TR>
<TR><TD>6.974e-04</TD><TD>-7.27</TD><TD>breast-carcinoma-ductolobular_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>breast-carcinoma-ductolobular_carcinoma</TD><TD>1622</TD><TD>33</TD><TD>16984</TD><TD>193</TD>
<TD>MAP2,CNTN1,LHCGR,NRCAM,PRKCE,UBR4,RYR2,FGF14,FBN2,PTPRZ1,XPO4,FGFR2,ZNF521,IL1RAPL2,EFR3A,FERD3L,RUNX1T1,PTPRD,TGFBR2,PARP8,ZFPM2,KIF6,EPHA3,VAV3,WRN,JMJD1C,ROBO2,TSN,EPHA4,FIGN,NAV3,NBEA,AKAP9</TD></TR>
<TR><TD>6.974e-04</TD><TD>-7.27</TD><TD>ductolobular_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>ductolobular_carcinoma</TD><TD>1622</TD><TD>33</TD><TD>16984</TD><TD>193</TD>
<TD>FIGN,NAV3,AKAP9,NBEA,TSN,EPHA4,ROBO2,JMJD1C,VAV3,WRN,ZFPM2,TGFBR2,PARP8,KIF6,EPHA3,PTPRD,RUNX1T1,EFR3A,IL1RAPL2,FERD3L,PTPRZ1,XPO4,FGFR2,ZNF521,FGF14,FBN2,LHCGR,CNTN1,UBR4,PRKCE,NRCAM,RYR2,MAP2</TD></TR>
<TR><TD>7.033e-04</TD><TD>-7.26</TD><TD>cellular response to growth factor stimulus</TD><TD>biological process</TD><TD>GO:0071363</TD><TD>494</TD><TD>15</TD><TD>18905</TD><TD>220</TD>
<TD>ADAMTS12,TGFBR2,NTRK2,PAX6,CDH5,GAREM1,ACVR1C,FGF5,FGFR2,ACVR2A,PTPRK,WWOX,FGF20,CXCL13,TWIST1</TD></TR>
<TR><TD>7.041e-04</TD><TD>-7.26</TD><TD>embryonic eye morphogenesis</TD><TD>biological process</TD><TD>GO:0048048</TD><TD>35</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6,TWIST1,FBN2,EFEMP1</TD></TR>
<TR><TD>7.144e-04</TD><TD>-7.24</TD><TD>heart valve morphogenesis</TD><TD>biological process</TD><TD>GO:0003179</TD><TD>61</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,TWIST1,ADAMTS5,TGFBR2,ROBO2</TD></TR>
<TR><TD>7.271e-04</TD><TD>-7.23</TD><TD>human chr4p15.31</TD><TD>chromosome location</TD><TD>human chr4p15.31</TD><TD>19</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>SLIT2,SLIT2-IT1</TD></TR>
<TR><TD>7.340e-04</TD><TD>-7.22</TD><TD>Mta1 (metastasis associated 1)</TD><TD>protein interactions</TD><TD>116870</TD><TD>37</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>PWWP2A,TCF20,PHF14,TRPS1</TD></TR>
<TR><TD>7.741e-04</TD><TD>-7.16</TD><TD>Phospholipase C-mediated cascade; FGFR2</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654221</TD><TD>18</TD><TD>3</TD><TD>10391</TD><TD>107</TD>
<TD>FGFR2,FGF5,FGF20</TD></TR>
<TR><TD>7.793e-04</TD><TD>-7.16</TD><TD>urinary_tract-bladder-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>urinary_tract-bladder-carcinoma</TD><TD>14095</TD><TD>176</TD><TD>16984</TD><TD>193</TD>
<TD>CASK,SLC7A14,FGD3,CDH5,MPEG1,SPHKAP,FMNL2,FGFR2,ZNF521,SERGEF,SEZ6L,FANCB,EPS8,NBEA,SPANXN1,FIGN,SS18,ADAMTS3,TSN,NCKAP5,NTRK2,DNAJC12,STXBP6,SLC39A10,PI15,ZPLD1,IPO8,PXDNL,TRPS1,LMX1A,FERD3L,NOL4,JMJD1C,NUP35,ZFAND5,PTPRD,PCDH9,RGS5,NAV3,COQ2,PWWP2A,ACVR2A,SEMA3C,RAI2,OR2AG1,PAX6,NRCAM,MAP2,MEGF10,KCNK9,AMELX,RPH3A,KLF12,LRFN5,PHF14,DEPTOR,BCHE,AGA,WWOX,CTSO,NRSN1,CALN1,LRRC3B,AOAH,EDIL3,COX7B2,CXCL13,SKAP2,PRKCE,MRPL3,TCF20,CPXM2,PRLHR,ARX,EFR3A,UHMK1,MUC7,TWIST1,TMEFF2,CELF2,XPO4,OR52K2,CHRM3,DSCAM,PCGF5,EFNA5,EPHA3,KIF6,PBX1,FGF5,ADAMTS5,ADAM28,CRTC3,FGF14,PTPRK,SLC7A8,UBR4,LMBRD1,ARL14,B3GAT2,AFM,UCHL1,IQGAP2,GHITM,PLEK,CYTL1,IL1RAPL2,LGI1,THSD7B,FGF20,CNTNAP2,ASPN,WRN,HNF4G,PARP8,NOVA1,AKAP9,ZNF518B,SLC10A2,FUT9,SLC25A46,MRPL13,EPHA4,IRX1,KAZN,PSKH2,NAALADL2,ADAMTS12,IGFL4,INSM1,BACH2,NOBOX,LRIG3,CETN3,SPAG9,NRG1,DAAM1,UTRN,GPR83,GAP43,REG1B,DAOA,LRRN2,FBN2,EFEMP1,CNTN1,GCNT1,DNER,ACVR1C,RUNX1T1,SPATA16,THSD7A,ZNF133,VAV3,UNC5C,ACP6,RASGEF1B,PHLPP1,PRSS12,ROBO2,CD96,RYR2,LHCGR,BANK1,FAT4,SERINC5,SHISA3,FZD6,PTPRZ1,RGS6,SYT1,TGFBR2,ZFPM2,ERCC6L2,GMDS,CD226</TD></TR>
<TR><TD>7.854e-04</TD><TD>-7.15</TD><TD>Sarcoglycan</TD><TD>interpro domains</TD><TD>IPR006875</TD><TD>4</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>SGCD,SGCG</TD></TR>
<TR><TD>7.886e-04</TD><TD>-7.15</TD><TD>pleura</TD><TD>COSMIC cancer mutations</TD><TD>pleura</TD><TD>4941</TD><TD>77</TD><TD>16984</TD><TD>193</TD>
<TD>TWIST1,PTPRZ1,LRIG3,XPO4,RGS6,CPXM2,TCF20,FZD6,UHMK1,ARX,BACH2,FAT4,PRKCE,RYR2,IPO8,TRPS1,ADAMTS12,ACVR2A,ADAMTS5,RGS5,NAV3,PBX1,KIF6,TGFBR2,NUP35,EPHA3,PTPRD,SPAG9,JMJD1C,SYT1,DAAM1,PCGF5,PHF14,DEPTOR,SERGEF,FGFR2,ZNF521,ACVR1C,AMELX,RUNX1T1,AFM,IL1RAPL2,PAX6,SPHKAP,CNTN1,UBR4,PTPRK,MAP2,CASK,FGD3,ADAM28,RAI2,COX7B2,CXCL13,NCKAP5,PRSS12,TSN,EDIL3,EPHA4,AOAH,IRX1,PSKH2,NTRK2,DNAJC12,SPANXN1,AKAP9,SS18,MRPL13,ADAMTS3,RASGEF1B,CALN1,BCHE,NOVA1,CNTNAP2,VAV3,FANCB,WRN</TD></TR>
<TR><TD>7.891e-04</TD><TD>-7.14</TD><TD>Sarcoglycan_1</TD><TD>pfam domains</TD><TD>PF04790</TD><TD>4</TD><TD>2</TD><TD>17869</TD><TD>207</TD>
<TD>SGCG,SGCD</TD></TR>
<TR><TD>7.965e-04</TD><TD>-7.14</TD><TD>regulation of negative chemotaxis</TD><TD>biological process</TD><TD>GO:0050923</TD><TD>4</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,SLIT2</TD></TR>
<TR><TD>7.965e-04</TD><TD>-7.14</TD><TD>embryonic olfactory bulb interneuron precursor migration</TD><TD>biological process</TD><TD>GO:0021831</TD><TD>4</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>ARX,SLIT2</TD></TR>
<TR><TD>8.010e-04</TD><TD>-7.13</TD><TD>cardiac chamber development</TD><TD>biological process</TD><TD>GO:0003205</TD><TD>168</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>ZFPM2,SEMA3C,TGFBR2,RYR2,ROBO2,NRG1,FGFR2,SLIT2</TD></TR>
<TR><TD>8.032e-04</TD><TD>-7.13</TD><TD>PK_Tyr_Ser-Thr</TD><TD>pfam domains</TD><TD>PF07714</TD><TD>130</TD><TD>7</TD><TD>17869</TD><TD>207</TD>
<TD>TEC,EPHA4,ACVR1C,TGFBR2,EPHA3,FGFR2,NTRK2</TD></TR>
<TR><TD>8.037e-04</TD><TD>-7.13</TD><TD>cell projection organization</TD><TD>biological process</TD><TD>GO:0030030</TD><TD>1203</TD><TD>27</TD><TD>18905</TD><TD>220</TD>
<TD>NRCAM,EFNA5,EPHA3,SHTN1,ROBO2,PTPRZ1,SLIT2,EPHA4,GAP43,PAX6,SLC25A46,VAV3,UNC5C,CNTNAP2,FGD3,PLEK,MAP2,DAW1,LGI1,FGFR2,UCHL1,DSCAM,UHMK1,SEMA3C,ARX,CNTN1,LMX1A</TD></TR>
<TR><TD>8.068e-04</TD><TD>-7.12</TD><TD>human chr4q22.3</TD><TD>chromosome location</TD><TD>human chr4q22.3</TD><TD>20</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>STPG2-AS1,UNC5C</TD></TR>
<TR><TD>8.132e-04</TD><TD>-7.11</TD><TD>SYCE1L (synaptonemal complex central element protein 1 like)</TD><TD>protein interactions</TD><TD>100130958</TD><TD>38</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>NOL4,SPHKAP,CALN1,SLC7A8</TD></TR>
<TR><TD>8.194e-04</TD><TD>-7.11</TD><TD>CNTN2 (contactin 2)</TD><TD>protein interactions</TD><TD>6900</TD><TD>17</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>NRCAM,CNTN1,CNTNAP2</TD></TR>
<TR><TD>8.211e-04</TD><TD>-7.10</TD><TD>EGF-type_Asp/Asn_hydroxyl_site</TD><TD>interpro domains</TD><TD>IPR000152</TD><TD>95</TD><TD>6</TD><TD>18605</TD><TD>215</TD>
<TD>SLIT2,DNER,FAT4,EDIL3,FBN2,EFEMP1</TD></TR>
<TR><TD>8.253e-04</TD><TD>-7.10</TD><TD>FYN (FYN proto-oncogene, Src family tyrosine kinase)</TD><TD>protein interactions</TD><TD>2534</TD><TD>417</TD><TD>13</TD><TD>20077</TD><TD>223</TD>
<TD>EPHA3,AKAP9,SKAP2,PTPRZ1,EPHA4,NTRK2,PTPRD,PRKCE,CNTN1,MAP2,CD226,FGFR2,PECAM1</TD></TR>
<TR><TD>8.283e-04</TD><TD>-7.10</TD><TD>large_intestine-colon-adenoma</TD><TD>COSMIC cancer mutations</TD><TD>large_intestine-colon-adenoma</TD><TD>627</TD><TD>17</TD><TD>16984</TD><TD>193</TD>
<TD>MAP2,PXDNL,BCHE,ADAMTS12,CNTNAP2,CASK,SPAG9,LRIG3,ROBO2,NCKAP5,THSD7B,ADAMTS3,FAT4,CALN1,IQGAP2,RUNX1T1,ZNF518B</TD></TR>
<TR><TD>8.323e-04</TD><TD>-7.09</TD><TD>transmembrane receptor protein phosphatase activity</TD><TD>molecular function</TD><TD>GO:0019198</TD><TD>17</TD><TD>3</TD><TD>18530</TD><TD>207</TD>
<TD>PTPRK,PTPRZ1,PTPRD</TD></TR>
<TR><TD>8.323e-04</TD><TD>-7.09</TD><TD>transmembrane receptor protein tyrosine phosphatase activity</TD><TD>molecular function</TD><TD>GO:0005001</TD><TD>17</TD><TD>3</TD><TD>18530</TD><TD>207</TD>
<TD>PTPRD,PTPRK,PTPRZ1</TD></TR>
<TR><TD>8.608e-04</TD><TD>-7.06</TD><TD>hairy_cell_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>hairy_cell_leukaemia</TD><TD>1440</TD><TD>30</TD><TD>16984</TD><TD>193</TD>
<TD>WRN,CNTNAP2,DSCAM,SPAG9,BCHE,EPHA3,SLC10A2,NAV3,AOAH,EDIL3,NCKAP5,RAI2,PAQR3,LRRN2,ADAMTS12,MEGF10,RYR2,PTPRK,LHCGR,CNTN1,PRKCE,UBR4,FAT4,DNER,IQGAP2,SPATA16,FGFR2,DEPTOR,PTPRZ1,DEFB115</TD></TR>
<TR><TD>8.608e-04</TD><TD>-7.06</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-hairy_cell_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-hairy_cell_leukaemia</TD><TD>1440</TD><TD>30</TD><TD>16984</TD><TD>193</TD>
<TD>AOAH,EDIL3,NCKAP5,SLC10A2,NAV3,BCHE,EPHA3,WRN,SPAG9,CNTNAP2,DSCAM,FGFR2,DEPTOR,PTPRZ1,DEFB115,FAT4,DNER,IQGAP2,SPATA16,MEGF10,PTPRK,RYR2,PRKCE,UBR4,CNTN1,LHCGR,RAI2,PAQR3,LRRN2,ADAMTS12</TD></TR>
<TR><TD>8.664e-04</TD><TD>-7.05</TD><TD>KIDINS220 (kinase D interacting substrate 220)</TD><TD>protein interactions</TD><TD>57498</TD><TD>178</TD><TD>8</TD><TD>20077</TD><TD>223</TD>
<TD>SEPTIN5,PHLPP1,NTRK2,EPHA3,FGFR2,CDH5,UTRN,CD226</TD></TR>
<TR><TD>8.675e-04</TD><TD>-7.05</TD><TD>EGF_Ca-bd_CS</TD><TD>interpro domains</TD><TD>IPR018097</TD><TD>96</TD><TD>6</TD><TD>18605</TD><TD>215</TD>
<TD>EDIL3,EFEMP1,FBN2,SLIT2,DNER,FAT4</TD></TR>
<TR><TD>8.721e-04</TD><TD>-7.04</TD><TD>olfactory bulb development</TD><TD>biological process</TD><TD>GO:0021772</TD><TD>37</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>ARX,SLIT2,PAX6,ROBO2</TD></TR>
<TR><TD>8.921e-04</TD><TD>-7.02</TD><TD>ARMC1 (armadillo repeat containing 1)</TD><TD>protein interactions</TD><TD>55156</TD><TD>67</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>EPS8,SYT1,CNTN1,MAP2,SLC25A46</TD></TR>
<TR><TD>9.081e-04</TD><TD>-7.00</TD><TD>Ser-Thr/Tyr_kinase_cat_dom</TD><TD>interpro domains</TD><TD>IPR001245</TD><TD>133</TD><TD>7</TD><TD>18605</TD><TD>215</TD>
<TD>EPHA3,NTRK2,FGFR2,TEC,ACVR1C,TGFBR2,EPHA4</TD></TR>
<TR><TD>9.157e-04</TD><TD>-7.00</TD><TD>autonomic_ganglia</TD><TD>COSMIC cancer mutations</TD><TD>autonomic_ganglia</TD><TD>4009</TD><TD>65</TD><TD>16984</TD><TD>193</TD>
<TD>ADAM28,CDH5,FBN2,OR2AG1,PTPRK,SPHKAP,SLC7A8,PAX6,SLIT2,MAP2,AFM,RPH3A,AMELX,ACVR1C,IQGAP2,SPATA16,PLEK,LGI1,FGFR2,ZNF521,DEPTOR,SERGEF,THSD7A,CNTNAP2,ZNF133,FANCB,VAV3,AGA,AKAP9,FUT9,CALN1,SS18,AOAH,PRSS12,CXCL13,TSN,NCKAP5,NTRK2,SLC39A10,NAALADL2,ADAMTS12,RYR2,PXDNL,SGCG,TRPS1,TCF20,CPXM2,FAT4,FZD6,RBM20,DEFB115,PTPRZ1,LRIG3,OR52K2,SPAG9,UTRN,DAAM1,EPHA3,PTPRD,PCDH9,RGS5,NAT2,NAV3,GMDS,ADAMTS5</TD></TR>
<TR><TD>9.284e-04</TD><TD>-6.98</TD><TD>cervix-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>cervix-carcinoma-squamous_cell_carcinoma</TD><TD>11825</TD><TD>154</TD><TD>16984</TD><TD>193</TD>
<TD>TRPS1,EPYC,INSM1,PXDNL,IPO8,IGFL4,ZPLD1,FNIP2,ADAMTS12,NAALADL2,SLC39A10,LRIG3,FERD3L,BACH2,SGCD,LMX1A,PTPRD,GPR83,ZFAND5,UTRN,DAAM1,NRG1,SPAG9,JMJD1C,ACVR2A,PWWP2A,REG1B,NAV3,GAP43,RGS5,NAT2,PCDH9,ARL14,LMBRD1,UBR4,SLC7A8,SPHKAP,PTPRK,FGF14,CRTC3,MPEG1,CDH5,FGD3,SLC7A14,CASK,ADAM28,SERGEF,ZNF521,FGFR2,FGF20,LGI1,THSD7B,IL1RAPL2,IQGAP2,UCHL1,AFM,REXO2,NOVA1,EPS8,FANCB,WRN,ASPN,CNTNAP2,SEZ6L,PSKH2,KAZN,DNAJC12,NTRK2,NCKAP5,TSN,IRX1,EPHA4,ADAMTS3,SLC25A46,FUT9,SLC10A2,SPANXN1,FIGN,ZNF518B,AKAP9,NBEA,MRPL3,SGCG,PRKCE,LHCGR,RYR2,EFR3B,CD96,RGS6,XPO4,PTPRZ1,CELF2,TMEFF2,TWIST1,MUC7,RBM20,UHMK1,FZD6,EFR3A,FAT4,SERINC5,CPXM2,PRLHR,TCF20,BANK1,ERCC6L2,KIF6,ZFPM2,TGFBR2,EPHA3,SYT1,EFNA5,PCGF5,DSCAM,CHRM3,ADAMTS5,GMDS,CD226,MEGF10,MAP2,SLIT2,NRCAM,CNTN1,PAX6,ATG10,OR2AG1,RAI2,FBN2,LRRN2,DAOA,DEPTOR,LRFN5,SPATA16,RUNX1T1,AMELX,ACVR1C,RPH3A,DNER,KCNK9,CTSO,ACP6,BCHE,VAV3,ZNF133,THSD7A,ROBO2,SKAP2,PRSS12,AOAH,EDIL3,PHLPP1,CALN1,RASGEF1B,NRSN1</TD></TR>
<TR><TD>9.485e-04</TD><TD>-6.96</TD><TD>Reprolysin</TD><TD>pfam domains</TD><TD>PF01421</TD><TD>38</TD><TD>4</TD><TD>17869</TD><TD>207</TD>
<TD>ADAMTS12,ADAMTS5,ADAMTS3,ADAM28</TD></TR>
<TR><TD>9.503e-04</TD><TD>-6.96</TD><TD>cervix</TD><TD>COSMIC cancer mutations</TD><TD>cervix</TD><TD>11829</TD><TD>154</TD><TD>16984</TD><TD>193</TD>
<TD>FANCB,WRN,EPS8,CNTNAP2,ASPN,SEZ6L,NOVA1,REXO2,ADAMTS3,FUT9,SLC25A46,SPANXN1,FIGN,SLC10A2,AKAP9,NBEA,ZNF518B,PSKH2,NTRK2,DNAJC12,KAZN,NCKAP5,TSN,EPHA4,IRX1,MPEG1,CRTC3,FGF14,CDH5,SLC7A14,CASK,FGD3,ADAM28,ARL14,LMBRD1,SLC7A8,SPHKAP,UBR4,PTPRK,IL1RAPL2,THSD7B,LGI1,UCHL1,IQGAP2,AFM,SERGEF,FGFR2,ZNF521,FGF20,UTRN,DAAM1,NRG1,SPAG9,JMJD1C,PTPRD,GPR83,ZFAND5,PWWP2A,REG1B,RGS5,NAT2,GAP43,NAV3,PCDH9,ACVR2A,FNIP2,ZPLD1,ADAMTS12,SLC39A10,NAALADL2,EPYC,TRPS1,PXDNL,INSM1,IPO8,IGFL4,FERD3L,BACH2,SGCD,LMX1A,LRIG3,VAV3,ZNF133,THSD7A,CTSO,ACP6,BCHE,RASGEF1B,PHLPP1,CALN1,NRSN1,SKAP2,ROBO2,PRSS12,EDIL3,AOAH,OR2AG1,RAI2,FBN2,DAOA,LRRN2,MAP2,MEGF10,SLIT2,CNTN1,PAX6,NRCAM,ATG10,AMELX,RPH3A,ACVR1C,SPATA16,RUNX1T1,DNER,KCNK9,DEPTOR,LRFN5,SYT1,EFNA5,PCGF5,DSCAM,CHRM3,KIF6,TGFBR2,ZFPM2,ERCC6L2,EPHA3,GMDS,CD226,ADAMTS5,CD96,MRPL3,SGCG,LHCGR,PRKCE,EFR3B,RYR2,FZD6,EFR3A,UHMK1,RBM20,FAT4,SERINC5,CPXM2,PRLHR,BANK1,TCF20,PTPRZ1,XPO4,RGS6,CELF2,TMEFF2,MUC7,TWIST1</TD></TR>
<TR><TD>9.689e-04</TD><TD>-6.94</TD><TD>regulation of cell size</TD><TD>biological process</TD><TD>GO:0008361</TD><TD>173</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>SHTN1,VAV3,DSCAM,DEPTOR,MAP2,NRCAM,PLEK,EFNA5</TD></TR>
<TR><TD>9.741e-04</TD><TD>-6.93</TD><TD>TMPRSS13 (transmembrane serine protease 13)</TD><TD>protein interactions</TD><TD>84000</TD><TD>102</TD><TD>6</TD><TD>20077</TD><TD>223</TD>
<TD>SKAP2,CETN3,GCNT1,LRIG3,EFNA5,PTPRK</TD></TR>
<TR><TD>9.798e-04</TD><TD>-6.93</TD><TD>main axon</TD><TD>cellular component</TD><TD>GO:0044304</TD><TD>68</TD><TD>5</TD><TD>19868</TD><TD>222</TD>
<TD>LGI1,NRCAM,MAP2,CNTNAP2,ROBO2</TD></TR>
<TR><TD>9.801e-04</TD><TD>-6.93</TD><TD>behavior</TD><TD>biological process</TD><TD>GO:0007610</TD><TD>620</TD><TD>17</TD><TD>18905</TD><TD>220</TD>
<TD>LMX1A,SLC25A46,CNTN1,PAX6,DSCAM,NTRK2,UCHL1,SEPTIN5,ACVR2A,EPHA4,GPR83,BCHE,PRKCE,PTPRZ1,PRLHR,EPS8,CNTNAP2</TD></TR>
<TR><TD>9.921e-04</TD><TD>-6.92</TD><TD>dystrophin-associated glycoprotein complex</TD><TD>cellular component</TD><TD>GO:0016010</TD><TD>18</TD><TD>3</TD><TD>19868</TD><TD>222</TD>
<TD>UTRN,SGCD,SGCG</TD></TR>
<TR><TD>1.001e-03</TD><TD>-6.91</TD><TD>EGF</TD><TD>pfam domains</TD><TD>PF00008</TD><TD>66</TD><TD>5</TD><TD>17869</TD><TD>207</TD>
<TD>NRG1,FAT4,SLIT2,EDIL3,DNER</TD></TR>
<TR><TD>1.015e-03</TD><TD>-6.89</TD><TD>regulation of phosphate metabolic process</TD><TD>biological process</TD><TD>GO:0019220</TD><TD>1159</TD><TD>26</TD><TD>18905</TD><TD>220</TD>
<TD>FGF20,DEPTOR,PLEK,CDH5,FGFR2,ACVR2A,FGF5,AKAP9,UCHL1,DSCAM,NTRK2,PAQR3,TGFBR2,INSM1,SPAG9,EFNA5,PRKCE,NRG1,SLIT2,BANK1,EPHA4,PAX6,FNIP2,PECAM1,LHCGR,PPP1R17</TD></TR>
<TR><TD>1.028e-03</TD><TD>-6.88</TD><TD>regulation of phosphorus metabolic process</TD><TD>biological process</TD><TD>GO:0051174</TD><TD>1160</TD><TD>26</TD><TD>18905</TD><TD>220</TD>
<TD>PLEK,DEPTOR,FGF20,FGF5,FGFR2,ACVR2A,AKAP9,CDH5,PAQR3,NTRK2,DSCAM,UCHL1,INSM1,TGFBR2,EFNA5,SPAG9,BANK1,SLIT2,EPHA4,NRG1,PRKCE,PAX6,PECAM1,LHCGR,FNIP2,PPP1R17</TD></TR>
<TR><TD>1.030e-03</TD><TD>-6.88</TD><TD>FN3</TD><TD>prosite domains</TD><TD>PS50853</TD><TD>192</TD><TD>9</TD><TD>12232</TD><TD>162</TD>
<TD>PTPRK,DSCAM,EPHA4,PTPRD,ROBO2,PTPRZ1,CNTN1,EPHA3,NRCAM</TD></TR>
<TR><TD>1.052e-03</TD><TD>-6.86</TD><TD>mesothelioma</TD><TD>COSMIC cancer mutations</TD><TD>mesothelioma</TD><TD>4504</TD><TD>71</TD><TD>16984</TD><TD>193</TD>
<TD>LRIG3,RGS6,XPO4,PTPRZ1,TWIST1,UHMK1,ARX,FZD6,BACH2,CPXM2,TCF20,TRPS1,PRKCE,IPO8,RYR2,ADAMTS12,ADAMTS5,ACVR2A,NAV3,PBX1,RGS5,PTPRD,NUP35,TGFBR2,KIF6,EPHA3,DAAM1,SYT1,PCGF5,SPAG9,JMJD1C,DEPTOR,SERGEF,ZNF521,FGFR2,PHF14,IL1RAPL2,RUNX1T1,AMELX,ACVR1C,AFM,UBR4,SPHKAP,CNTN1,PAX6,PTPRK,RAI2,FGD3,CASK,ADAM28,PSKH2,DNAJC12,NTRK2,TSN,CXCL13,COX7B2,IRX1,EPHA4,EDIL3,AOAH,ADAMTS3,MRPL13,SS18,RASGEF1B,SPANXN1,AKAP9,NOVA1,VAV3,FANCB,WRN,CNTNAP2</TD></TR>
<TR><TD>1.065e-03</TD><TD>-6.84</TD><TD>FGFR2 ligand binding and activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-190241</TD><TD>20</TD><TD>3</TD><TD>10391</TD><TD>107</TD>
<TD>FGF20,FGF5,FGFR2</TD></TR>
<TR><TD>1.067e-03</TD><TD>-6.84</TD><TD>olfactory lobe development</TD><TD>biological process</TD><TD>GO:0021988</TD><TD>39</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,SLIT2,PAX6,ARX</TD></TR>
<TR><TD>1.103e-03</TD><TD>-6.81</TD><TD>central_nervous_system-brainstem-primitive_neuroectodermal_tumour-medulloblastoma-WNT_subtype</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-brainstem-primitive_neuroectodermal_tumour-medulloblastoma-WNT_subtype</TD><TD>181</TD><TD>8</TD><TD>16984</TD><TD>193</TD>
<TD>VAV3,BACH2,EPS8,CNTNAP2,NCKAP5,NBEA,THSD7A,BANK1</TD></TR>
<TR><TD>1.108e-03</TD><TD>-6.81</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-plasma_cell_myeloma</TD><TD>1264</TD><TD>27</TD><TD>16984</TD><TD>193</TD>
<TD>BANK1,ACVR1C,FAT4,NOBOX,THSD7B,LRFN5,TMEFF2,NAALADL2,SLC7A14,CD96,RYR2,PTPRK,SPHKAP,SLIT2,TRPS1,FIGN,NAV3,FUT9,ADAMTS5,NTRK2,THSD7A,CNTNAP2,DSCAM,PCGF5,HNF4G,EPHA3,TGFBR2</TD></TR>
<TR><TD>1.108e-03</TD><TD>-6.81</TD><TD>plasma_cell_myeloma</TD><TD>COSMIC cancer mutations</TD><TD>plasma_cell_myeloma</TD><TD>1264</TD><TD>27</TD><TD>16984</TD><TD>193</TD>
<TD>SPHKAP,RYR2,PTPRK,TRPS1,SLIT2,CD96,SLC7A14,NAALADL2,TMEFF2,LRFN5,ACVR1C,BANK1,THSD7B,NOBOX,FAT4,TGFBR2,HNF4G,EPHA3,DSCAM,CNTNAP2,THSD7A,PCGF5,ADAMTS5,NTRK2,FIGN,NAV3,FUT9</TD></TR>
<TR><TD>1.114e-03</TD><TD>-6.80</TD><TD>positive regulation of cell projection organization</TD><TD>biological process</TD><TD>GO:0031346</TD><TD>361</TD><TD>12</TD><TD>18905</TD><TD>220</TD>
<TD>PTPRD,CNTN1,DSCAM,NTRK2,FUT9,ROBO2,SHTN1,SLIT2,EPHA4,EPHA3,EFNA5,EPS8</TD></TR>
<TR><TD>1.123e-03</TD><TD>-6.79</TD><TD>mesenchymal cell differentiation</TD><TD>biological process</TD><TD>GO:0048762</TD><TD>177</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2,NRG1,AMELX,FGFR2,SLC39A10,SEMA3C,TWIST1,PAX6</TD></TR>
<TR><TD>1.125e-03</TD><TD>-6.79</TD><TD>FA58C_2</TD><TD>prosite domains</TD><TD>PS01286</TD><TD>16</TD><TD>3</TD><TD>12232</TD><TD>162</TD>
<TD>CPXM2,EDIL3,CNTNAP2</TD></TR>
<TR><TD>1.136e-03</TD><TD>-6.78</TD><TD>arm</TD><TD>COSMIC cancer mutations</TD><TD>arm</TD><TD>1332</TD><TD>28</TD><TD>16984</TD><TD>193</TD>
<TD>PWWP2A,ADAMTS3,AKAP9,ZNF518B,WRN,SYT1,CHRM3,NOVA1,PTPRD,BACH2,FAT4,SHISA3,TCF20,UCHL1,SPATA16,RUNX1T1,FGFR2,RGS6,ZPLD1,CDH5,ADAM28,SLC39A10,SLIT2,MAP2,MEGF10,EPYC,TRPS1,SPHKAP</TD></TR>
<TR><TD>1.143e-03</TD><TD>-6.77</TD><TD>WNT_subtype</TD><TD>COSMIC cancer mutations</TD><TD>WNT_subtype</TD><TD>182</TD><TD>8</TD><TD>16984</TD><TD>193</TD>
<TD>VAV3,BACH2,EPS8,CNTNAP2,NCKAP5,NBEA,THSD7A,BANK1</TD></TR>
<TR><TD>1.144e-03</TD><TD>-6.77</TD><TD>Peptidase_M12B</TD><TD>interpro domains</TD><TD>IPR001590</TD><TD>40</TD><TD>4</TD><TD>18605</TD><TD>215</TD>
<TD>ADAMTS12,ADAM28,ADAMTS3,ADAMTS5</TD></TR>
<TR><TD>1.149e-03</TD><TD>-6.77</TD><TD>skin-extremity-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-extremity-malignant_melanoma</TD><TD>1878</TD><TD>36</TD><TD>16984</TD><TD>193</TD>
<TD>FBN2,OR2AG1,NAALADL2,RYR2,SPHKAP,FAT4,RBM20,THSD7B,TCF20,SPATA16,FGFR2,PTPRZ1,MUC7,FANCB,SYT1,DAAM1,OR52K2,SEZ6L,CNTNAP2,PTPRD,EPHA3,ZFPM2,KIF6,PARP8,UNC5C,FUT9,COQ2,LRRC3B,FGF5,AKAP9,PCDH9,NAV3,NAT2,ROBO2,NTRK2,ACVR2A</TD></TR>
<TR><TD>1.160e-03</TD><TD>-6.76</TD><TD>extremity</TD><TD>COSMIC cancer mutations</TD><TD>extremity</TD><TD>1879</TD><TD>36</TD><TD>16984</TD><TD>193</TD>
<TD>MUC7,PTPRZ1,FGFR2,SPATA16,TCF20,THSD7B,RBM20,FAT4,SPHKAP,RYR2,NAALADL2,OR2AG1,FBN2,ACVR2A,NTRK2,ROBO2,NAT2,NAV3,AKAP9,PCDH9,LRRC3B,FGF5,COQ2,FUT9,ZFPM2,UNC5C,PARP8,KIF6,EPHA3,PTPRD,CNTNAP2,SEZ6L,OR52K2,SYT1,DAAM1,FANCB</TD></TR>
<TR><TD>1.162e-03</TD><TD>-6.76</TD><TD>tissue morphogenesis</TD><TD>biological process</TD><TD>GO:0048729</TD><TD>574</TD><TD>16</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,SLIT2,IRX1,EPHA4,NRG1,ROBO2,RYR2,TWIST1,ZFPM2,GCNT1,PBX1,ADAMTS5,TGFBR2,FZD6,TMEFF2,SEMA3C</TD></TR>
<TR><TD>1.166e-03</TD><TD>-6.75</TD><TD>human chr5q22.1</TD><TD>chromosome location</TD><TD>human chr5q22.1</TD><TD>24</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>SLC25A46,EPB41L4A-AS1</TD></TR>
<TR><TD>1.167e-03</TD><TD>-6.75</TD><TD>transmembrane receptor protein serine/threonine kinase activity</TD><TD>molecular function</TD><TD>GO:0004675</TD><TD>19</TD><TD>3</TD><TD>18530</TD><TD>207</TD>
<TD>TGFBR2,ACVR1C,ACVR2A</TD></TR>
<TR><TD>1.170e-03</TD><TD>-6.75</TD><TD>cell communication</TD><TD>biological process</TD><TD>GO:0007154</TD><TD>5154</TD><TD>81</TD><TD>18905</TD><TD>220</TD>
<TD>OR2AG1,ZFAND5,SYT1,SS18,PPP1R17,MAST4,VAV3,GAP43,EFEMP1,SEPTIN5,HNF4G,PAX6,PECAM1,LHCGR,SHTN1,SLIT2,SKAP2,SERGEF,DNER,PARP8,GAREM1,ACVR1C,EPHA4,CD226,WWOX,IPO8,PRLHR,NRCAM,CXCL13,ADGRL3,SGCD,EFNA5,FGF14,ATG10,UCHL1,NTRK2,DSCAM,UTRN,FZD6,CYTL1,GPR83,FGF5,AKAP9,FGF20,GMDS,UNC5C,FAT4,IL1RAPL2,CHRM3,FNIP2,DCDC2C,PRKCE,NRG1,RYR2,PTPRK,BANK1,TEC,SPAG9,LRRN2,EPS8,RPH3A,EPHA3,PHLPP1,CNTN1,TGFBR2,PTPRD,FBN2,RGS6,SEMA3C,OR52K2,CDH5,RASGEF1B,FGFR2,ACVR2A,RGS5,AMELX,DEPTOR,DAAM1,CNTNAP2,IQGAP2,PLEK</TD></TR>
<TR><TD>1.173e-03</TD><TD>-6.75</TD><TD>regulation of developmental growth</TD><TD>biological process</TD><TD>GO:0048638</TD><TD>314</TD><TD>11</TD><TD>18905</TD><TD>220</TD>
<TD>SHTN1,FGFR2,SPAG9,FGF20,ZFPM2,NRCAM,MAP2,EFNA5,SYT1,DSCAM,ARX</TD></TR>
<TR><TD>1.211e-03</TD><TD>-6.72</TD><TD>urinary_tract</TD><TD>COSMIC cancer mutations</TD><TD>urinary_tract</TD><TD>14159</TD><TD>176</TD><TD>16984</TD><TD>193</TD>
<TD>CELF2,XPO4,MUC7,TWIST1,TMEFF2,UHMK1,EFR3A,ARX,TCF20,CPXM2,PRLHR,MRPL3,PRKCE,ADAMTS5,FGF5,PBX1,EPHA3,KIF6,EFNA5,PCGF5,OR52K2,CHRM3,DSCAM,DEPTOR,LRFN5,PHF14,KLF12,KCNK9,RPH3A,AMELX,MAP2,MEGF10,PAX6,NRCAM,RAI2,OR2AG1,SKAP2,AOAH,EDIL3,COX7B2,CXCL13,CALN1,LRRC3B,NRSN1,AGA,WWOX,CTSO,BCHE,NOL4,FERD3L,LMX1A,PXDNL,TRPS1,IPO8,ZPLD1,SLC39A10,PI15,SEMA3C,ACVR2A,COQ2,PWWP2A,PCDH9,RGS5,NAV3,PTPRD,NUP35,ZFAND5,JMJD1C,FGFR2,ZNF521,SERGEF,SPHKAP,FMNL2,CDH5,MPEG1,CASK,SLC7A14,FGD3,NTRK2,DNAJC12,STXBP6,TSN,NCKAP5,SS18,ADAMTS3,NBEA,FIGN,SPANXN1,FANCB,EPS8,SEZ6L,PTPRZ1,RGS6,SERINC5,FAT4,SHISA3,FZD6,BANK1,RYR2,LHCGR,CD96,GMDS,CD226,TGFBR2,ZFPM2,ERCC6L2,SYT1,DNER,ACVR1C,RUNX1T1,SPATA16,GCNT1,CNTN1,FBN2,EFEMP1,DAOA,LRRN2,ROBO2,PRSS12,RASGEF1B,PHLPP1,ACP6,UNC5C,VAV3,THSD7A,ZNF133,LRIG3,BACH2,NOBOX,INSM1,IGFL4,NAALADL2,ADAMTS12,REG1B,GAP43,GPR83,NRG1,DAAM1,UTRN,CETN3,SPAG9,FGF20,PLEK,CYTL1,IL1RAPL2,THSD7B,LGI1,AFM,UCHL1,GHITM,IQGAP2,LMBRD1,ARL14,B3GAT2,PTPRK,SLC7A8,UBR4,CRTC3,FGF14,ADAM28,KAZN,PSKH2,EPHA4,IRX1,FUT9,SLC25A46,MRPL13,AKAP9,ZNF518B,SLC10A2,NOVA1,HNF4G,PARP8,WRN,CNTNAP2,ASPN</TD></TR>
<TR><TD>1.211e-03</TD><TD>-6.72</TD><TD>bladder</TD><TD>COSMIC cancer mutations</TD><TD>bladder</TD><TD>14159</TD><TD>176</TD><TD>16984</TD><TD>193</TD>
<TD>SPHKAP,FMNL2,SLC7A14,CASK,FGD3,MPEG1,CDH5,SERGEF,FGFR2,ZNF521,SEZ6L,FANCB,EPS8,NCKAP5,TSN,STXBP6,NTRK2,DNAJC12,FIGN,SPANXN1,NBEA,SS18,ADAMTS3,IPO8,TRPS1,PXDNL,SLC39A10,PI15,ZPLD1,NOL4,LMX1A,FERD3L,NUP35,ZFAND5,PTPRD,JMJD1C,ACVR2A,SEMA3C,RGS5,NAV3,PCDH9,PWWP2A,COQ2,PAX6,NRCAM,MAP2,MEGF10,OR2AG1,RAI2,PHF14,LRFN5,DEPTOR,AMELX,RPH3A,KCNK9,KLF12,BCHE,CTSO,WWOX,AGA,COX7B2,CXCL13,EDIL3,AOAH,SKAP2,NRSN1,LRRC3B,CALN1,PRKCE,MRPL3,TMEFF2,MUC7,TWIST1,XPO4,CELF2,CPXM2,PRLHR,TCF20,EFR3A,UHMK1,ARX,KIF6,EPHA3,DSCAM,CHRM3,OR52K2,PCGF5,EFNA5,ADAMTS5,PBX1,FGF5,SLC7A8,UBR4,PTPRK,ARL14,B3GAT2,LMBRD1,ADAM28,CRTC3,FGF14,FGF20,UCHL1,IQGAP2,GHITM,AFM,LGI1,THSD7B,IL1RAPL2,PLEK,CYTL1,PARP8,HNF4G,NOVA1,CNTNAP2,ASPN,WRN,EPHA4,IRX1,PSKH2,KAZN,SLC10A2,AKAP9,ZNF518B,MRPL13,FUT9,SLC25A46,IGFL4,INSM1,ADAMTS12,NAALADL2,LRIG3,NOBOX,BACH2,GPR83,SPAG9,CETN3,UTRN,DAAM1,NRG1,GAP43,REG1B,CNTN1,GCNT1,DAOA,LRRN2,EFEMP1,FBN2,ACVR1C,RUNX1T1,SPATA16,DNER,UNC5C,ACP6,ZNF133,THSD7A,VAV3,PRSS12,ROBO2,RASGEF1B,PHLPP1,LHCGR,RYR2,CD96,PTPRZ1,RGS6,BANK1,FZD6,FAT4,SERINC5,SHISA3,ZFPM2,TGFBR2,ERCC6L2,SYT1,GMDS,CD226</TD></TR>
<TR><TD>1.223e-03</TD><TD>-6.71</TD><TD>human chr4q26</TD><TD>chromosome location</TD><TD>human chr4q26</TD><TD>99</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>MIR577,MIR1973,PRSS12</TD></TR>
<TR><TD>1.223e-03</TD><TD>-6.71</TD><TD>human chr5q14.3</TD><TD>chromosome location</TD><TD>human chr5q14.3</TD><TD>99</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>EDIL3,CETN3,MIR9-2HG</TD></TR>
<TR><TD>1.228e-03</TD><TD>-6.70</TD><TD>autonomic_ganglia-neuroblastoma</TD><TD>COSMIC cancer mutations</TD><TD>autonomic_ganglia-neuroblastoma</TD><TD>3974</TD><TD>64</TD><TD>16984</TD><TD>193</TD>
<TD>EPHA3,DAAM1,UTRN,SPAG9,OR52K2,ADAMTS5,GMDS,NAV3,RGS5,NAT2,PCDH9,TRPS1,SGCG,PXDNL,RYR2,ADAMTS12,NAALADL2,SLC39A10,LRIG3,PTPRZ1,DEFB115,RBM20,FZD6,FAT4,CPXM2,TCF20,AGA,VAV3,FANCB,ZNF133,CNTNAP2,THSD7A,NTRK2,PRSS12,NCKAP5,TSN,CXCL13,AOAH,SS18,CALN1,FUT9,AKAP9,MAP2,SLIT2,SLC7A8,SPHKAP,PAX6,PTPRK,OR2AG1,FBN2,CDH5,ADAM28,SERGEF,DEPTOR,ZNF521,FGFR2,LGI1,PLEK,IQGAP2,SPATA16,AMELX,ACVR1C,RPH3A,AFM</TD></TR>
<TR><TD>1.237e-03</TD><TD>-6.70</TD><TD>neuroblastoma</TD><TD>COSMIC cancer mutations</TD><TD>neuroblastoma</TD><TD>3975</TD><TD>64</TD><TD>16984</TD><TD>193</TD>
<TD>AOAH,PRSS12,TSN,NCKAP5,CXCL13,NTRK2,AKAP9,FUT9,CALN1,SS18,AGA,THSD7A,CNTNAP2,ZNF133,FANCB,VAV3,FGFR2,ZNF521,DEPTOR,SERGEF,AFM,RPH3A,ACVR1C,AMELX,SPATA16,IQGAP2,PLEK,LGI1,PTPRK,PAX6,SPHKAP,SLC7A8,SLIT2,MAP2,ADAM28,CDH5,FBN2,OR2AG1,GMDS,ADAMTS5,PCDH9,RGS5,NAT2,NAV3,EPHA3,OR52K2,SPAG9,DAAM1,UTRN,DEFB115,PTPRZ1,LRIG3,TCF20,CPXM2,FAT4,FZD6,RBM20,RYR2,PXDNL,SGCG,TRPS1,SLC39A10,NAALADL2,ADAMTS12</TD></TR>
<TR><TD>1.263e-03</TD><TD>-6.67</TD><TD>central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I</TD><TD>105</TD><TD>6</TD><TD>16984</TD><TD>193</TD>
<TD>NAALADL2,NOL4,SPATA16,ZFPM2,NRG1,FGF14</TD></TR>
<TR><TD>1.274e-03</TD><TD>-6.67</TD><TD>LRRNT</TD><TD>smart domains</TD><TD>SM00013</TD><TD>54</TD><TD>5</TD><TD>9743</TD><TD>147</TD>
<TD>NTRK2,LRRC3B,EPYC,ASPN,SLIT2</TD></TR>
<TR><TD>1.286e-03</TD><TD>-6.66</TD><TD>ADAMTS_CR_2</TD><TD>interpro domains</TD><TD>IPR041645</TD><TD>19</TD><TD>3</TD><TD>18605</TD><TD>215</TD>
<TD>ADAMTS5,ADAMTS3,ADAMTS12</TD></TR>
<TR><TD>1.290e-03</TD><TD>-6.65</TD><TD>endocardial cushion morphogenesis</TD><TD>biological process</TD><TD>GO:0003203</TD><TD>41</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2,ROBO2,ADAMTS5,TWIST1</TD></TR>
<TR><TD>1.295e-03</TD><TD>-6.65</TD><TD>ADAMTS_CR_2</TD><TD>pfam domains</TD><TD>PF17771</TD><TD>19</TD><TD>3</TD><TD>17869</TD><TD>207</TD>
<TD>ADAMTS12,ADAMTS5,ADAMTS3</TD></TR>
<TR><TD>1.304e-03</TD><TD>-6.64</TD><TD>somatodendritic compartment</TD><TD>cellular component</TD><TD>GO:0036477</TD><TD>844</TD><TD>20</TD><TD>19868</TD><TD>222</TD>
<TD>SEZ6L,BRINP3,RPH3A,NTRK2,UNC5C,DNER,UCHL1,MAP2,NRSN1,AKAP9,EPHA4,CNTNAP2,UHMK1,PRSS12,DSCAM,CHRM3,GAP43,EPHA3,SHTN1,LGI1</TD></TR>
<TR><TD>1.313e-03</TD><TD>-6.64</TD><TD>pulmonary valve morphogenesis</TD><TD>biological process</TD><TD>GO:0003184</TD><TD>19</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,ADAMTS5,SLIT2</TD></TR>
<TR><TD>1.317e-03</TD><TD>-6.63</TD><TD>mesenchymal cell proliferation involved in lung development</TD><TD>biological process</TD><TD>GO:0060916</TD><TD>5</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,PHF14</TD></TR>
<TR><TD>1.319e-03</TD><TD>-6.63</TD><TD>response to growth factor</TD><TD>biological process</TD><TD>GO:0070848</TD><TD>526</TD><TD>15</TD><TD>18905</TD><TD>220</TD>
<TD>FGF20,WWOX,CXCL13,TWIST1,CDH5,ACVR1C,GAREM1,FGFR2,FGF5,ACVR2A,PTPRK,NTRK2,PAX6,TGFBR2,ADAMTS12</TD></TR>
<TR><TD>1.320e-03</TD><TD>-6.63</TD><TD>hepatocellular_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>hepatocellular_carcinoma</TD><TD>14860</TD><TD>182</TD><TD>16984</TD><TD>193</TD>
<TD>MRPL3,PRKCE,EFR3B,XPO4,CELF2,TMEFF2,MUC7,TWIST1,EFR3A,UHMK1,ARX,RBM20,CPXM2,PRLHR,TCF20,KIF6,EPHA3,EFNA5,DSCAM,OR52K2,CHRM3,ADAMTS5,FGF5,MEGF10,MAP2,SLIT2,PAX6,NRCAM,ATG10,OR2AG1,LRRC70,RAI2,DEPTOR,PHF14,LRFN5,KLF12,RPH3A,KCNK9,CTSO,BCHE,SKAP2,COX7B2,AOAH,EDIL3,LRRC3B,CALN1,NRSN1,TRPS1,PXDNL,IPO8,FNIP2,ZPLD1,SLC39A10,PI15,NOL4,FERD3L,SGCD,LMX1A,PTPRD,ZFAND5,NUP35,JMJD1C,SEMA3C,ACVR2A,COQ2,PWWP2A,NAT2,RGS5,NAV3,PCDH9,SPHKAP,FMNL2,MPEG1,CDH5,CASK,SLC7A14,FGD3,LINC00583,SERGEF,FGFR2,ZNF521,FANCB,EPS8,SEZ6L,STXBP6,NTRK2,DNAJC12,FABP7,TSN,NCKAP5,SS18,ADAMTS3,FIGN,SPANXN1,NBEA,SGCG,LHCGR,RYR2,CD96,PTPRZ1,RGS6,DEFB115,FZD6,SERINC5,FAT4,SHISA3,BANK1,TGFBR2,ZFPM2,SYT1,CD226,GMDS,DCDC2C,GCNT1,CNTN1,PAQR3,EFEMP1,FBN2,DAOA,LRRN2,ACVR1C,RUNX1T1,SPATA16,DNER,UNC5C,VAV3,ZNF133,THSD7A,ROBO2,PRSS12,RASGEF1B,PHLPP1,EPYC,INSM1,IGFL4,ADAMTS12,NAALADL2,LRIG3,NOBOX,BACH2,GPR83,DAAM1,UTRN,NRG1,SPAG9,REG1B,GAP43,ARL14,B3GAT2,LMBRD1,SLC7A8,UBR4,PTPRK,CRTC3,FGF14,ADAM28,FGF20,IL1RAPL2,THSD7B,LGI1,PLEK,CYTL1,UCHL1,GHITM,IQGAP2,AFM,NOVA1,PARP8,HNF4G,WRN,CNTNAP2,ASPN,PSKH2,KAZN,EPHA4,IRX1,MRPL13,FUT9,SLC25A46,SLC10A2,AKAP9,ZNF518B</TD></TR>
<TR><TD>1.320e-03</TD><TD>-6.63</TD><TD>liver-carcinoma-hepatocellular_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>liver-carcinoma-hepatocellular_carcinoma</TD><TD>14860</TD><TD>182</TD><TD>16984</TD><TD>193</TD>
<TD>LINC00583,CASK,SLC7A14,FGD3,CDH5,MPEG1,SPHKAP,FMNL2,FGFR2,ZNF521,SERGEF,SEZ6L,FANCB,EPS8,NBEA,FIGN,SPANXN1,SS18,ADAMTS3,FABP7,TSN,NCKAP5,NTRK2,DNAJC12,STXBP6,SLC39A10,PI15,ZPLD1,FNIP2,IPO8,PXDNL,TRPS1,LMX1A,SGCD,FERD3L,NOL4,JMJD1C,ZFAND5,NUP35,PTPRD,PCDH9,RGS5,NAT2,NAV3,COQ2,PWWP2A,ACVR2A,SEMA3C,RAI2,LRRC70,OR2AG1,ATG10,PAX6,NRCAM,SLIT2,MEGF10,MAP2,KCNK9,RPH3A,KLF12,LRFN5,PHF14,DEPTOR,BCHE,CTSO,NRSN1,CALN1,LRRC3B,AOAH,EDIL3,COX7B2,SKAP2,EFR3B,PRKCE,MRPL3,TCF20,PRLHR,CPXM2,UHMK1,EFR3A,ARX,RBM20,MUC7,TWIST1,TMEFF2,CELF2,XPO4,CHRM3,OR52K2,DSCAM,EFNA5,EPHA3,KIF6,FGF5,ADAMTS5,ADAM28,CRTC3,FGF14,PTPRK,SLC7A8,UBR4,LMBRD1,B3GAT2,ARL14,AFM,UCHL1,IQGAP2,GHITM,PLEK,CYTL1,LGI1,IL1RAPL2,THSD7B,FGF20,CNTNAP2,ASPN,WRN,HNF4G,PARP8,NOVA1,AKAP9,ZNF518B,SLC10A2,FUT9,SLC25A46,MRPL13,EPHA4,IRX1,KAZN,PSKH2,NAALADL2,ADAMTS12,IGFL4,INSM1,EPYC,BACH2,NOBOX,LRIG3,SPAG9,NRG1,DAAM1,UTRN,GPR83,GAP43,REG1B,DAOA,LRRN2,FBN2,PAQR3,EFEMP1,CNTN1,GCNT1,DNER,ACVR1C,RUNX1T1,SPATA16,THSD7A,ZNF133,VAV3,UNC5C,RASGEF1B,PHLPP1,PRSS12,ROBO2,CD96,RYR2,LHCGR,SGCG,BANK1,FAT4,SERINC5,SHISA3,FZD6,DEFB115,PTPRZ1,RGS6,SYT1,TGFBR2,ZFPM2,DCDC2C,GMDS,CD226</TD></TR>
<TR><TD>1.330e-03</TD><TD>-6.62</TD><TD>neoplasm</TD><TD>COSMIC cancer mutations</TD><TD>neoplasm</TD><TD>14861</TD><TD>182</TD><TD>16984</TD><TD>193</TD>
<TD>TRPS1,PXDNL,IPO8,ZPLD1,FNIP2,PI15,SLC39A10,LINC01387,NOL4,FERD3L,SGCD,LMX1A,PTPRD,NUP35,ZFAND5,JMJD1C,SEMA3C,ACVR2A,PWWP2A,COQ2,NAV3,RGS5,NAT2,PCDH9,FMNL2,SPHKAP,MPEG1,CDH5,FGD3,CASK,SLC7A14,LINC00583,SERGEF,ZNF521,FGFR2,EPS8,FANCB,SEZ6L,STXBP6,DNAJC12,NTRK2,TSN,NCKAP5,FABP7,ADAMTS3,SS18,FIGN,SPANXN1,NBEA,MRPL3,PRKCE,EFR3B,XPO4,CELF2,TMEFF2,TWIST1,MUC7,RBM20,ARX,EFR3A,CPXM2,TCF20,KIF6,EPHA3,PCGF5,EFNA5,DSCAM,CHRM3,ADAMTS5,FGF5,PBX1,MEGF10,MAP2,SLIT2,NRCAM,PAX6,ATG10,OR2AG1,LRRC70,RAI2,DEPTOR,PHF14,LRFN5,KLF12,RPH3A,AMELX,KCNK9,CTSO,AGA,BCHE,SKAP2,CXCL13,AOAH,EDIL3,LRRC3B,NRSN1,EPYC,INSM1,IGFL4,ADAMTS12,NAALADL2,LRIG3,NOBOX,BACH2,GPR83,UTRN,DAAM1,NRG1,SPAG9,CETN3,REG1B,GAP43,B3GAT2,LMBRD1,UBR4,SLC7A8,PTPRK,FGF14,CRTC3,ADAM28,FGF20,IL1RAPL2,THSD7B,LGI1,CYTL1,PLEK,IQGAP2,GHITM,UCHL1,AFM,REXO2,NOVA1,PARP8,HNF4G,WRN,ASPN,CNTNAP2,PSKH2,KAZN,IRX1,EPHA4,MRPL13,SLC25A46,FUT9,SLC10A2,AKAP9,SGCG,LHCGR,RYR2,CD96,PTPRZ1,DEFB115,FZD6,SHISA3,FAT4,BANK1,TGFBR2,ZFPM2,SYT1,CD226,GMDS,DCDC2C,GCNT1,CNTN1,PAQR3,EFEMP1,FBN2,LRRN2,DAOA,RUNX1T1,SPATA16,ACVR1C,DNER,ACP6,UNC5C,VAV3,ZNF133,THSD7A,ROBO2,PRSS12,PHLPP1,RASGEF1B</TD></TR>
<TR><TD>1.330e-03</TD><TD>-6.62</TD><TD>kidney epithelium development</TD><TD>biological process</TD><TD>GO:0072073</TD><TD>141</TD><TD>7</TD><TD>18905</TD><TD>220</TD>
<TD>PBX1,IRX1,EPHA4,SLIT2,FGFR2,ROBO2,PECAM1</TD></TR>
<TR><TD>1.360e-03</TD><TD>-6.60</TD><TD>circulatory system development</TD><TD>biological process</TD><TD>GO:0072359</TD><TD>934</TD><TD>22</TD><TD>18905</TD><TD>220</TD>
<TD>NTRK2,SEMA3C,TGFBR2,ADAMTS5,ZFPM2,CDH5,DAW1,FGFR2,RBM20,PAX6,PECAM1,ZFAND5,VAV3,NRCAM,TWIST1,THSD7A,SGCD,NRG1,ROBO2,RYR2,SLIT2,SGCG</TD></TR>
<TR><TD>1.369e-03</TD><TD>-6.59</TD><TD>human chr9p24.2</TD><TD>chromosome location</TD><TD>human chr9p24.2</TD><TD>26</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>GLIS3-AS1,PUM3</TD></TR>
<TR><TD>1.369e-03</TD><TD>-6.59</TD><TD>human chr13q22.1</TD><TD>chromosome location</TD><TD>human chr13q22.1</TD><TD>26</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LINC00392,KLF12</TD></TR>
<TR><TD>1.373e-03</TD><TD>-6.59</TD><TD>regulation of phosphorylation</TD><TD>biological process</TD><TD>GO:0042325</TD><TD>996</TD><TD>23</TD><TD>18905</TD><TD>220</TD>
<TD>SPAG9,EFNA5,PRKCE,NRG1,EPHA4,SLIT2,BANK1,FNIP2,PECAM1,PAX6,FGF20,DEPTOR,CDH5,AKAP9,ACVR2A,FGF5,FGFR2,UCHL1,DSCAM,PAQR3,NTRK2,TGFBR2,INSM1</TD></TR>
<TR><TD>1.386e-03</TD><TD>-6.58</TD><TD>neuron migration</TD><TD>biological process</TD><TD>GO:0001764</TD><TD>142</TD><TD>7</TD><TD>18905</TD><TD>220</TD>
<TD>DNER,ADGRL3,ARX,TWIST1,PAX6,NRCAM,NTRK2</TD></TR>
<TR><TD>1.392e-03</TD><TD>-6.58</TD><TD>regulation of protein-containing complex assembly</TD><TD>biological process</TD><TD>GO:0043254</TD><TD>422</TD><TD>13</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,STXBP6,AKAP9,PRKCE,CDH5,NRG1,MAP2,CXCL13,PLEK,EPS8,INSM1,NAV3,FNIP2</TD></TR>
<TR><TD>1.395e-03</TD><TD>-6.57</TD><TD>positive regulation of phosphate metabolic process</TD><TD>biological process</TD><TD>GO:0045937</TD><TD>698</TD><TD>18</TD><TD>18905</TD><TD>220</TD>
<TD>FGF20,PLEK,EFNA5,NRG1,CDH5,BANK1,FGF5,ACVR2A,FGFR2,EPHA4,AKAP9,NTRK2,DSCAM,UCHL1,LHCGR,PECAM1,FNIP2,TGFBR2</TD></TR>
<TR><TD>1.395e-03</TD><TD>-6.57</TD><TD>positive regulation of phosphorus metabolic process</TD><TD>biological process</TD><TD>GO:0010562</TD><TD>698</TD><TD>18</TD><TD>18905</TD><TD>220</TD>
<TD>EPHA4,AKAP9,BANK1,ACVR2A,FGF5,FGFR2,CDH5,NRG1,EFNA5,PLEK,FGF20,TGFBR2,LHCGR,PECAM1,FNIP2,NTRK2,DSCAM,UCHL1</TD></TR>
<TR><TD>1.460e-03</TD><TD>-6.53</TD><TD>EPH-ephrin mediated repulsion of cells</TD><TD>REACTOME pathways</TD><TD>R-HSA-3928665</TD><TD>48</TD><TD>4</TD><TD>10391</TD><TD>107</TD>
<TD>EPHA4,EFNA5,EPHA3,VAV3</TD></TR>
<TR><TD>1.461e-03</TD><TD>-6.53</TD><TD>EPHA forward signaling</TD><TD>Pathway Interaction DB</TD><TD>epha_fwdpathway</TD><TD>31</TD><TD>4</TD><TD>2232</TD><TD>37</TD>
<TD>VAV3,EPHA3,EFNA5,EPHA4</TD></TR>
<TR><TD>1.529e-03</TD><TD>-6.48</TD><TD>human chr1q43</TD><TD>chromosome location</TD><TD>human chr1q43</TD><TD>107</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>CHRM3,LINC01139,RYR2</TD></TR>
<TR><TD>1.531e-03</TD><TD>-6.48</TD><TD>neuron projection fasciculation</TD><TD>biological process</TD><TD>GO:0106030</TD><TD>20</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>NRCAM,EPHA4,EPHA3</TD></TR>
<TR><TD>1.531e-03</TD><TD>-6.48</TD><TD>axonal fasciculation</TD><TD>biological process</TD><TD>GO:0007413</TD><TD>20</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>NRCAM,EPHA3,EPHA4</TD></TR>
<TR><TD>1.532e-03</TD><TD>-6.48</TD><TD>upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma</TD><TD>1426</TD><TD>29</TD><TD>16984</TD><TD>193</TD>
<TD>MPEG1,CRTC3,PRKCE,UBR4,FMNL2,SPHKAP,RYR2,B3GAT2,MAP2,LMBRD1,TCF20,TMEFF2,ZNF521,FGFR2,DSCAM,THSD7A,UNC5C,ZFPM2,BCHE,AKAP9,NBEA,ADAMTS3,FGF5,CALN1,REG1B,NCKAP5,ADAMTS5,STXBP6,NTRK2</TD></TR>
<TR><TD>1.532e-03</TD><TD>-6.48</TD><TD>nasopharyngeal_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>nasopharyngeal_carcinoma</TD><TD>1426</TD><TD>29</TD><TD>16984</TD><TD>193</TD>
<TD>CRTC3,MPEG1,B3GAT2,MAP2,LMBRD1,UBR4,FMNL2,PRKCE,SPHKAP,RYR2,TCF20,ZNF521,FGFR2,TMEFF2,DSCAM,THSD7A,UNC5C,ZFPM2,BCHE,ADAMTS3,FGF5,CALN1,REG1B,NBEA,AKAP9,STXBP6,NTRK2,NCKAP5,ADAMTS5</TD></TR>
<TR><TD>1.541e-03</TD><TD>-6.48</TD><TD>negative regulation of cellular process</TD><TD>biological process</TD><TD>GO:0048523</TD><TD>5358</TD><TD>83</TD><TD>18905</TD><TD>220</TD>
<TD>MIR1260B,INSM1,MIR577,UBR4,ARX,FZD6,NTRK2,DSCAM,PAQR3,UCHL1,KLF12,ASPN,BCHE,ZFPM2,LRFN5,MRPL13,FGF20,PCGF5,NAV3,FERD3L,RUNX1T1,SS18,PAX6,FABP7,C8orf88,EFEMP1,EPHA4,IRX1,ACVR1C,SERGEF,MIR9-2HG,SLIT2,SKAP2,FANCB,PTPRZ1,SHISA3,EFNA5,CXCL13,MIR548AA2,GHITM,WWOX,LMX1A,FBN2,MIR147A,ADAMTS12,PTPRD,PHF14,CD96,BRINP3,RGS6,MIR548A3,STXBP6,RGS5,FGFR2,RBM20,MIR551B,CDH5,MAP2,PLEK,ZNF133,DEPTOR,MIR569,MIR891A,PBX1,SLC39A10,FNIP2,TMEFF2,TSN,CASK,BACH2,TRPS1,BANK1,PTPRK,RYR2,ROBO2,NRG1,PRKCE,EPHA3,PHLPP1,EPS8,TWIST1,CRTC3,SPAG9</TD></TR>
<TR><TD>1.551e-03</TD><TD>-6.47</TD><TD>SGSM3 (small G protein signaling modulator 3)</TD><TD>protein interactions</TD><TD>27352</TD><TD>21</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>CHRM3,DSCAM,CD226</TD></TR>
<TR><TD>1.551e-03</TD><TD>-6.47</TD><TD>SHC4 (SHC adaptor protein 4)</TD><TD>protein interactions</TD><TD>399694</TD><TD>21</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>NTRK2,GAREM1,NBEA</TD></TR>
<TR><TD>1.558e-03</TD><TD>-6.46</TD><TD>plasma membrane bounded cell projection</TD><TD>cellular component</TD><TD>GO:0120025</TD><TD>2293</TD><TD>41</TD><TD>19868</TD><TD>222</TD>
<TD>SYT1,NTRK2,DNER,UCHL1,NRSN1,MAP2,IQGAP2,GPR83,RPH3A,RGS6,NRCAM,FGD3,GAP43,CHRM3,LGI1,CETN3,CNTNAP2,CASK,AKAP9,EPHA4,CNTN1,PCDH9,UNC5C,DAAM1,WWOX,PLEK,UTRN,DAW1,ROBO2,SLC7A8,EPS8,PRLHR,BRINP3,EPHA3,DSCAM,SHTN1,DCDC2C,SLC10A2,PRSS12,UHMK1,ADGRL3</TD></TR>
<TR><TD>1.572e-03</TD><TD>-6.46</TD><TD>Bile Acid Indirect Signalling Pathway</TD><TD>SMPDB pathways</TD><TD>SMP0086851</TD><TD>8</TD><TD>2</TD><TD>1382</TD><TD>11</TD>
<TD>SLC10A2,FGFR2</TD></TR>
<TR><TD>1.578e-03</TD><TD>-6.45</TD><TD>axon initial segment</TD><TD>cellular component</TD><TD>GO:0043194</TD><TD>21</TD><TD>3</TD><TD>19868</TD><TD>222</TD>
<TD>NRCAM,MAP2,LGI1</TD></TR>
<TR><TD>1.588e-03</TD><TD>-6.45</TD><TD>human chr5p14.1</TD><TD>chromosome location</TD><TD>human chr5p14.1</TD><TD>28</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>PURPL,LINC02103</TD></TR>
<TR><TD>1.608e-03</TD><TD>-6.43</TD><TD>regulation of neurogenesis</TD><TD>biological process</TD><TD>GO:0050767</TD><TD>377</TD><TD>12</TD><TD>18905</TD><TD>220</TD>
<TD>DSCAM,NTRK2,PAX6,MAP2,EFNA5,PTPRZ1,PTPRD,ROBO2,SHTN1,SLIT2,EPHA4,FERD3L</TD></TR>
<TR><TD>1.608e-03</TD><TD>-6.43</TD><TD>FA58C_1</TD><TD>prosite domains</TD><TD>PS01285</TD><TD>18</TD><TD>3</TD><TD>12232</TD><TD>162</TD>
<TD>EDIL3,CNTNAP2,CPXM2</TD></TR>
<TR><TD>1.612e-03</TD><TD>-6.43</TD><TD>heart valve development</TD><TD>biological process</TD><TD>GO:0003170</TD><TD>73</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,TGFBR2,TWIST1,SLIT2,ADAMTS5</TD></TR>
<TR><TD>1.618e-03</TD><TD>-6.43</TD><TD>SHC-mediated cascade:FGFR2</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654699</TD><TD>23</TD><TD>3</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,FGF20,FGFR2</TD></TR>
<TR><TD>1.618e-03</TD><TD>-6.43</TD><TD>PI-3K cascade:FGFR2</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654695</TD><TD>23</TD><TD>3</TD><TD>10391</TD><TD>107</TD>
<TD>FGFR2,FGF20,FGF5</TD></TR>
<TR><TD>1.654e-03</TD><TD>-6.40</TD><TD>cell surface receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0007166</TD><TD>2070</TD><TD>39</TD><TD>18905</TD><TD>220</TD>
<TD>CDH5,FGFR2,ACVR2A,FGF5,DAAM1,GMDS,FGF20,UNC5C,PLEK,PTPRD,CNTN1,TGFBR2,NTRK2,DSCAM,SEMA3C,FZD6,NRG1,PRKCE,SHTN1,DNER,BANK1,PTPRK,SLIT2,EPHA4,TEC,GAREM1,ACVR1C,WWOX,CXCL13,EFNA5,EPHA3,ADGRL3,SS18,ZFAND5,VAV3,IL1RAPL2,EFEMP1,PAX6,PECAM1</TD></TR>
<TR><TD>1.656e-03</TD><TD>-6.40</TD><TD>cardiac septum development</TD><TD>biological process</TD><TD>GO:0003279</TD><TD>108</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C,ZFPM2,ROBO2,TGFBR2,FGFR2,SLIT2</TD></TR>
<TR><TD>1.657e-03</TD><TD>-6.40</TD><TD>PRKAR2A (protein kinase cAMP-dependent type II regulatory subunit alpha)</TD><TD>protein interactions</TD><TD>5576</TD><TD>197</TD><TD>8</TD><TD>20077</TD><TD>223</TD>
<TD>NBEA,MAP2,RUNX1T1,SPAG9,DEPTOR,RYR2,SLC25A46,AKAP9</TD></TR>
<TR><TD>1.660e-03</TD><TD>-6.40</TD><TD>Galactose-bd-like_sf</TD><TD>interpro domains</TD><TD>IPR008979</TD><TD>74</TD><TD>5</TD><TD>18605</TD><TD>215</TD>
<TD>CPXM2,EPHA4,EDIL3,CNTNAP2,EPHA3</TD></TR>
<TR><TD>1.698e-03</TD><TD>-6.38</TD><TD>human chr4q13.3</TD><TD>chromosome location</TD><TD>human chr4q13.3</TD><TD>111</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>AFM,MUC7,ADAMTS3</TD></TR>
<TR><TD>1.703e-03</TD><TD>-6.38</TD><TD>human chr7q21.2</TD><TD>chromosome location</TD><TD>human chr7q21.2</TD><TD>29</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>AKAP9,MTERF1</TD></TR>
<TR><TD>1.708e-03</TD><TD>-6.37</TD><TD>EGF_CA</TD><TD>prosite domains</TD><TD>PS01187</TD><TD>96</TD><TD>6</TD><TD>12232</TD><TD>162</TD>
<TD>FBN2,FAT4,EFEMP1,EDIL3,SLIT2,DNER</TD></TR>
<TR><TD>1.712e-03</TD><TD>-6.37</TD><TD>ventricular septum development</TD><TD>biological process</TD><TD>GO:0003281</TD><TD>74</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>ZFPM2,TGFBR2,ROBO2,SLIT2,FGFR2</TD></TR>
<TR><TD>1.723e-03</TD><TD>-6.36</TD><TD>dendrite</TD><TD>cellular component</TD><TD>GO:0030425</TD><TD>621</TD><TD>16</TD><TD>19868</TD><TD>222</TD>
<TD>AKAP9,EPHA4,CNTNAP2,UHMK1,PRSS12,DSCAM,GAP43,CHRM3,EPHA3,LGI1,BRINP3,RPH3A,NTRK2,UNC5C,DNER,MAP2</TD></TR>
<TR><TD>1.734e-03</TD><TD>-6.36</TD><TD>HBGFFGF</TD><TD>prints domains</TD><TD>PR00263</TD><TD>18</TD><TD>3</TD><TD>5258</TD><TD>72</TD>
<TD>FGF20,FGF5,FGF14</TD></TR>
<TR><TD>1.747e-03</TD><TD>-6.35</TD><TD>DEP</TD><TD>pfam domains</TD><TD>PF00610</TD><TD>21</TD><TD>3</TD><TD>17869</TD><TD>207</TD>
<TD>PLEK,RGS6,DEPTOR</TD></TR>
<TR><TD>1.780e-03</TD><TD>-6.33</TD><TD>dendritic tree</TD><TD>cellular component</TD><TD>GO:0097447</TD><TD>623</TD><TD>16</TD><TD>19868</TD><TD>222</TD>
<TD>BRINP3,RPH3A,NTRK2,UNC5C,MAP2,DNER,AKAP9,EPHA4,CNTNAP2,UHMK1,PRSS12,DSCAM,EPHA3,CHRM3,GAP43,LGI1</TD></TR>
<TR><TD>1.787e-03</TD><TD>-6.33</TD><TD>human chr8p12</TD><TD>chromosome location</TD><TD>human chr8p12</TD><TD>113</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>WRN,SMIM18,NRG1</TD></TR>
<TR><TD>1.809e-03</TD><TD>-6.32</TD><TD>splicing factor binding</TD><TD>molecular function</TD><TD>GO:1990935</TD><TD>6</TD><TD>2</TD><TD>18530</TD><TD>207</TD>
<TD>UHMK1,RBM20</TD></TR>
<TR><TD>1.809e-03</TD><TD>-6.32</TD><TD>GPI-linked ephrin receptor activity</TD><TD>molecular function</TD><TD>GO:0005004</TD><TD>6</TD><TD>2</TD><TD>18530</TD><TD>207</TD>
<TD>EPHA4,EPHA3</TD></TR>
<TR><TD>1.810e-03</TD><TD>-6.31</TD><TD>activin receptor complex</TD><TD>cellular component</TD><TD>GO:0048179</TD><TD>6</TD><TD>2</TD><TD>19868</TD><TD>222</TD>
<TD>ACVR2A,ACVR1C</TD></TR>
<TR><TD>1.810e-03</TD><TD>-6.31</TD><TD>sarcoglycan complex</TD><TD>cellular component</TD><TD>GO:0016012</TD><TD>6</TD><TD>2</TD><TD>19868</TD><TD>222</TD>
<TD>SGCD,SGCG</TD></TR>
<TR><TD>1.831e-03</TD><TD>-6.30</TD><TD>endometrium-carcinoma-serous_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>endometrium-carcinoma-serous_carcinoma</TD><TD>1443</TD><TD>29</TD><TD>16984</TD><TD>193</TD>
<TD>B3GAT2,TRPS1,LMBRD1,CNTN1,SPHKAP,LHCGR,RYR2,ADAMTS12,FGFR2,FAT4,PLEK,ACVR1C,WWOX,PARP8,NUP35,EPHA3,UTRN,CNTNAP2,SEZ6L,JMJD1C,DNAJC12,ACVR2A,NCKAP5,EPHA4,IRX1,ADAMTS3,RASGEF1B,GAP43,AKAP9</TD></TR>
<TR><TD>1.849e-03</TD><TD>-6.29</TD><TD>EGF</TD><TD>smart domains</TD><TD>SM00181</TD><TD>184</TD><TD>9</TD><TD>9743</TD><TD>147</TD>
<TD>EDIL3,MEGF10,CNTNAP2,DNER,FAT4,FBN2,NRG1,EFEMP1,SLIT2</TD></TR>
<TR><TD>1.869e-03</TD><TD>-6.28</TD><TD>ADAM_MEPRO</TD><TD>prosite domains</TD><TD>PS50215</TD><TD>40</TD><TD>4</TD><TD>12232</TD><TD>162</TD>
<TD>ADAMTS12,ADAMTS5,ADAM28,ADAMTS3</TD></TR>
<TR><TD>1.869e-03</TD><TD>-6.28</TD><TD>synapse organization</TD><TD>biological process</TD><TD>GO:0050808</TD><TD>333</TD><TD>11</TD><TD>18905</TD><TD>220</TD>
<TD>EPHA4,DNER,SEZ6L,EFNA5,ADGRL3,NRCAM,LRFN5,LMX1A,PTPRD,SLC25A46,DSCAM</TD></TR>
<TR><TD>1.879e-03</TD><TD>-6.28</TD><TD>human chr8q22.3</TD><TD>chromosome location</TD><TD>human chr8q22.3</TD><TD>115</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>LOC105375690,MIR548A3,FZD6</TD></TR>
<TR><TD>1.880e-03</TD><TD>-6.28</TD><TD>regulation of neuron differentiation</TD><TD>biological process</TD><TD>GO:0045664</TD><TD>192</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>LMX1A,PBX1,FERD3L,SPAG9,FGF20,BRINP3,PAX6,NRCAM</TD></TR>
<TR><TD>1.885e-03</TD><TD>-6.27</TD><TD>synaptic membrane</TD><TD>cellular component</TD><TD>GO:0097060</TD><TD>400</TD><TD>12</TD><TD>19868</TD><TD>222</TD>
<TD>CASK,UTRN,CNTNAP2,CNTN1,AKAP9,EPHA4,RPH3A,NRCAM,LRFN5,CHRM3,SYT1,PTPRD</TD></TR>
<TR><TD>1.889e-03</TD><TD>-6.27</TD><TD>Laminin</TD><TD>gene3d domains</TD><TD>2.10.25.10</TD><TD>226</TD><TD>9</TD><TD>14531</TD><TD>178</TD>
<TD>NRG1,SLIT2,FAT4,EDIL3,TMEFF2,FBN2,DNER,EFEMP1,CNTNAP2</TD></TR>
<TR><TD>1.914e-03</TD><TD>-6.26</TD><TD>regulation of cellular component biogenesis</TD><TD>biological process</TD><TD>GO:0044087</TD><TD>1022</TD><TD>23</TD><TD>18905</TD><TD>220</TD>
<TD>LRFN5,CNTNAP2,PLEK,MAP2,CDH5,STXBP6,AKAP9,NTRK2,PTPRD,INSM1,CXCL13,EFNA5,EPHA3,EPS8,NRG1,PRKCE,ROBO2,SLIT2,GAP43,TMEFF2,FNIP2,IL1RAPL2,NAV3</TD></TR>
<TR><TD>1.934e-03</TD><TD>-6.25</TD><TD>TSP1_spondin_dom</TD><TD>interpro domains</TD><TD>IPR044004</TD><TD>6</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>THSD7B,THSD7A</TD></TR>
<TR><TD>1.934e-03</TD><TD>-6.25</TD><TD>LRR_5</TD><TD>interpro domains</TD><TD>IPR026906</TD><TD>6</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>LRRC70,LHCGR</TD></TR>
<TR><TD>1.943e-03</TD><TD>-6.24</TD><TD>LRR_5</TD><TD>pfam domains</TD><TD>PF13306</TD><TD>6</TD><TD>2</TD><TD>17869</TD><TD>207</TD>
<TD>LRRC70,LHCGR</TD></TR>
<TR><TD>1.943e-03</TD><TD>-6.24</TD><TD>TSP1_spondin</TD><TD>pfam domains</TD><TD>PF19028</TD><TD>6</TD><TD>2</TD><TD>17869</TD><TD>207</TD>
<TD>THSD7A,THSD7B</TD></TR>
<TR><TD>1.951e-03</TD><TD>-6.24</TD><TD>LRR_1</TD><TD>pfam domains</TD><TD>PF00560</TD><TD>46</TD><TD>4</TD><TD>17869</TD><TD>207</TD>
<TD>LRRC3B,LRIG3,SLIT2,EPYC</TD></TR>
<TR><TD>1.953e-03</TD><TD>-6.24</TD><TD>regulation of growth</TD><TD>biological process</TD><TD>GO:0040008</TD><TD>604</TD><TD>16</TD><TD>18905</TD><TD>220</TD>
<TD>EFNA5,MAP2,NRCAM,ZFPM2,SPAG9,FGF20,SLIT2,FGFR2,WRN,SHTN1,LGI1,ARX,GAP43,DSCAM,LMX1A,SYT1</TD></TR>
<TR><TD>1.961e-03</TD><TD>-6.23</TD><TD>cerebral cortex tangential migration</TD><TD>biological process</TD><TD>GO:0021800</TD><TD>6</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,ARX</TD></TR>
<TR><TD>1.961e-03</TD><TD>-6.23</TD><TD>luteolysis</TD><TD>biological process</TD><TD>GO:0001554</TD><TD>6</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,ROBO2</TD></TR>
<TR><TD>1.977e-03</TD><TD>-6.23</TD><TD>CEACAM21 (CEA cell adhesion molecule 21)</TD><TD>protein interactions</TD><TD>90273</TD><TD>80</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>EPHA3,CNTN1,PCDH9,FAT4,EPHA4</TD></TR>
<TR><TD>1.977e-03</TD><TD>-6.23</TD><TD>LTBP1 (latent transforming growth factor beta binding protein 1)</TD><TD>protein interactions</TD><TD>4052</TD><TD>80</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>NRSN1,CDH5,FBN2,BCHE,EFEMP1</TD></TR>
<TR><TD>1.993e-03</TD><TD>-6.22</TD><TD>DEP_dom</TD><TD>interpro domains</TD><TD>IPR000591</TD><TD>22</TD><TD>3</TD><TD>18605</TD><TD>215</TD>
<TD>RGS6,PLEK,DEPTOR</TD></TR>
<TR><TD>1.993e-03</TD><TD>-6.22</TD><TD>Fibroblast_GF_fam</TD><TD>interpro domains</TD><TD>IPR002209</TD><TD>22</TD><TD>3</TD><TD>18605</TD><TD>215</TD>
<TD>FGF5,FGF20,FGF14</TD></TR>
<TR><TD>1.993e-03</TD><TD>-6.22</TD><TD>FA58C</TD><TD>interpro domains</TD><TD>IPR000421</TD><TD>22</TD><TD>3</TD><TD>18605</TD><TD>215</TD>
<TD>CPXM2,EDIL3,CNTNAP2</TD></TR>
<TR><TD>2.006e-03</TD><TD>-6.21</TD><TD>F5_F8_type_C</TD><TD>pfam domains</TD><TD>PF00754</TD><TD>22</TD><TD>3</TD><TD>17869</TD><TD>207</TD>
<TD>CNTNAP2,CPXM2,EDIL3</TD></TR>
<TR><TD>2.006e-03</TD><TD>-6.21</TD><TD>FGF</TD><TD>pfam domains</TD><TD>PF00167</TD><TD>22</TD><TD>3</TD><TD>17869</TD><TD>207</TD>
<TD>FGF20,FGF5,FGF14</TD></TR>
<TR><TD>2.011e-03</TD><TD>-6.21</TD><TD>head development</TD><TD>biological process</TD><TD>GO:0060322</TD><TD>781</TD><TD>19</TD><TD>18905</TD><TD>220</TD>
<TD>PBX1,LMX1A,TGFBR2,CNTN1,SLC25A46,ZFAND5,ARX,FZD6,PCDH9,PAX6,NTRK2,FGFR2,SLIT2,AFG2A,ROBO2,NRCAM,CNTNAP2,UNC5C,FAT4</TD></TR>
<TR><TD>2.022e-03</TD><TD>-6.20</TD><TD>human chr8q21.13</TD><TD>chromosome location</TD><TD>human chr8q21.13</TD><TD>118</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>PI15,HNF4G,LOC101927141</TD></TR>
<TR><TD>2.023e-03</TD><TD>-6.20</TD><TD>other</TD><TD>COSMIC cancer mutations</TD><TD>other</TD><TD>14918</TD><TD>182</TD><TD>16984</TD><TD>193</TD>
<TD>VAV3,THSD7A,ZNF133,ACP6,UNC5C,PHLPP1,RASGEF1B,ROBO2,PRSS12,FBN2,PAQR3,EFEMP1,LRRN2,DAOA,GCNT1,CNTN1,DNER,SPATA16,RUNX1T1,ACVR1C,SYT1,ZFPM2,TGFBR2,DCDC2C,CD226,GMDS,CD96,SGCG,RYR2,LHCGR,SHISA3,FAT4,FZD6,BANK1,PTPRZ1,DEFB115,WRN,ASPN,CNTNAP2,REXO2,NOVA1,HNF4G,PARP8,SLC25A46,FUT9,MRPL13,AKAP9,SLC10A2,KAZN,PSKH2,IRX1,EPHA4,FGF14,CRTC3,ADAM28,LMBRD1,B3GAT2,PTPRK,UBR4,SLC7A8,CYTL1,PLEK,THSD7B,IL1RAPL2,LGI1,AFM,IQGAP2,GHITM,UCHL1,FGF20,NRG1,UTRN,DAAM1,CETN3,SPAG9,GPR83,REG1B,GAP43,NAALADL2,ADAMTS12,INSM1,EPYC,IGFL4,BACH2,NOBOX,LRIG3,AGA,CTSO,BCHE,LRRC3B,NRSN1,SKAP2,AOAH,EDIL3,CXCL13,RAI2,LRRC70,OR2AG1,SLIT2,MEGF10,MAP2,ATG10,NRCAM,PAX6,KLF12,KCNK9,RPH3A,AMELX,DEPTOR,LRFN5,PHF14,EFNA5,PCGF5,CHRM3,DSCAM,EPHA3,KIF6,FGF5,PBX1,ADAMTS5,MRPL3,EFR3B,PRKCE,RBM20,ARX,EFR3A,TCF20,CPXM2,CELF2,XPO4,TWIST1,MUC7,TMEFF2,EPS8,FANCB,SEZ6L,ADAMTS3,SS18,NBEA,FIGN,SPANXN1,DNAJC12,NTRK2,STXBP6,TSN,NCKAP5,FABP7,CDH5,MPEG1,LINC00583,FGD3,SLC7A14,CASK,FMNL2,SPHKAP,ZNF521,FGFR2,SERGEF,JMJD1C,PTPRD,ZFAND5,NUP35,COQ2,PWWP2A,PCDH9,NAV3,RGS5,NAT2,SEMA3C,ACVR2A,FNIP2,ZPLD1,PI15,SLC39A10,PXDNL,TRPS1,IPO8,FERD3L,LMX1A,SGCD,LINC01387,NOL4</TD></TR>
<TR><TD>2.035e-03</TD><TD>-6.20</TD><TD>vasculature development</TD><TD>biological process</TD><TD>GO:0001944</TD><TD>550</TD><TD>15</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2,ROBO2,ZFAND5,CDH5,SLIT2,FGFR2,VAV3,ZFPM2,SEMA3C,NTRK2,SGCD,PECAM1,THSD7A,PAX6,NRCAM</TD></TR>
<TR><TD>2.062e-03</TD><TD>-6.18</TD><TD>CASK (calcium/calmodulin dependent serine protein kinase)</TD><TD>protein interactions</TD><TD>8573</TD><TD>204</TD><TD>8</TD><TD>20077</TD><TD>223</TD>
<TD>UTRN,EPHA4,ARL14,AKAP9,RPH3A,CASK,EPS8,CNTNAP2</TD></TR>
<TR><TD>2.064e-03</TD><TD>-6.18</TD><TD>tube development</TD><TD>biological process</TD><TD>GO:0035295</TD><TD>904</TD><TD>21</TD><TD>18905</TD><TD>220</TD>
<TD>EPHA4,IRX1,FGFR2,SLIT2,ROBO2,RYR2,SGCD,NRCAM,TWIST1,THSD7A,ZFPM2,FERD3L,PBX1,VAV3,TGFBR2,PHF14,LHCGR,PAX6,FZD6,SEMA3C,NTRK2</TD></TR>
<TR><TD>2.066e-03</TD><TD>-6.18</TD><TD>glycoprotein complex</TD><TD>cellular component</TD><TD>GO:0090665</TD><TD>23</TD><TD>3</TD><TD>19868</TD><TD>222</TD>
<TD>UTRN,SGCG,SGCD</TD></TR>
<TR><TD>2.071e-03</TD><TD>-6.18</TD><TD>FRS-mediated FGFR2 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654700</TD><TD>25</TD><TD>3</TD><TD>10391</TD><TD>107</TD>
<TD>FGF20,FGF5,FGFR2</TD></TR>
<TR><TD>2.071e-03</TD><TD>-6.18</TD><TD>human chr18q11.2</TD><TD>chromosome location</TD><TD>human chr18q11.2</TD><TD>119</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>LINC01894,ZNF521,SS18</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr7p21.1-p15.3</TD><TD>chromosome location</TD><TD>human chr7p21.1-p15.3</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>LINC01162</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr7q35-q36.1</TD><TD>chromosome location</TD><TD>human chr7q35-q36.1</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr9p24.1-p23</TD><TD>chromosome location</TD><TD>human chr9p24.1-p23</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>PTPRD</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr4p12-p11</TD><TD>chromosome location</TD><TD>human chr4p12-p11</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>TEC</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr2q22.3-q23.1</TD><TD>chromosome location</TD><TD>human chr2q22.3-q23.1</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>ACVR2A</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr22q13.2|22q13.3</TD><TD>chromosome location</TD><TD>human chr22q13.2|22q13.3</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>TCF20</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr8q11.22-q11.23</TD><TD>chromosome location</TD><TD>human chr8q11.22-q11.23</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>PXDNL</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr16q23.1-q23.2</TD><TD>chromosome location</TD><TD>human chr16q23.1-q23.2</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>WWOX</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr5q14.1-q14.2</TD><TD>chromosome location</TD><TD>human chr5q14.1-q14.2</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>ATG10</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr3q13.13-q13.2</TD><TD>chromosome location</TD><TD>human chr3q13.13-q13.2</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>CD96</TD></TR>
<TR><TD>2.089e-03</TD><TD>-6.17</TD><TD>human chr1q21.1-q21.2</TD><TD>chromosome location</TD><TD>human chr1q21.1-q21.2</TD><TD>1</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>LINC00624</TD></TR>
<TR><TD>2.104e-03</TD><TD>-6.16</TD><TD>ASX_HYDROXYL</TD><TD>prosite domains</TD><TD>PS00010</TD><TD>100</TD><TD>6</TD><TD>12232</TD><TD>162</TD>
<TD>SLIT2,EDIL3,DNER,FAT4,FBN2,EFEMP1</TD></TR>
<TR><TD>2.111e-03</TD><TD>-6.16</TD><TD>functioning</TD><TD>COSMIC cancer mutations</TD><TD>functioning</TD><TD>1803</TD><TD>34</TD><TD>16984</TD><TD>193</TD>
<TD>RYR2,IPO8,CNTN1,NRCAM,UBR4,MEGF10,RAI2,EFEMP1,MPEG1,PTPRZ1,SERGEF,KCNK9,UCHL1,RUNX1T1,IL1RAPL2,RBM20,BCHE,HNF4G,UNC5C,TGFBR2,PTPRD,CHRM3,WRN,UTRN,EPHA4,ADAMTS5,NCKAP5,NTRK2,SEMA3C,NBEA,PCDH9,FIGN,RASGEF1B,SS18</TD></TR>
<TR><TD>2.111e-03</TD><TD>-6.16</TD><TD>adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning</TD><TD>COSMIC cancer mutations</TD><TD>adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning</TD><TD>1803</TD><TD>34</TD><TD>16984</TD><TD>193</TD>
<TD>UTRN,WRN,CHRM3,PTPRD,UNC5C,TGFBR2,BCHE,HNF4G,SS18,RASGEF1B,FIGN,PCDH9,NBEA,SEMA3C,NTRK2,ADAMTS5,NCKAP5,EPHA4,EFEMP1,MPEG1,RAI2,MEGF10,CNTN1,NRCAM,UBR4,IPO8,RYR2,IL1RAPL2,RBM20,UCHL1,RUNX1T1,KCNK9,PTPRZ1,SERGEF</TD></TR>
<TR><TD>2.133e-03</TD><TD>-6.15</TD><TD>Neurofascin interactions</TD><TD>REACTOME pathways</TD><TD>R-HSA-447043</TD><TD>7</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>CNTN1,NRCAM</TD></TR>
<TR><TD>2.133e-03</TD><TD>-6.15</TD><TD>regulation of plasma membrane bounded cell projection organization</TD><TD>biological process</TD><TD>GO:0120035</TD><TD>667</TD><TD>17</TD><TD>18905</TD><TD>220</TD>
<TD>PTPRD,CNTN1,PAX6,FUT9,PAQR3,DSCAM,NTRK2,GAP43,EPHA4,SLIT2,ROBO2,SHTN1,EFNA5,EPHA3,EPS8,NRCAM,MAP2</TD></TR>
<TR><TD>2.147e-03</TD><TD>-6.14</TD><TD>positive regulation of cell differentiation</TD><TD>biological process</TD><TD>GO:0045597</TD><TD>907</TD><TD>21</TD><TD>18905</TD><TD>220</TD>
<TD>EFNA5,TWIST1,NRCAM,SPAG9,FGF20,EPHA4,ACVR2A,SLIT2,ROBO2,PTPRZ1,SHTN1,CDH5,NRG1,PAX6,BRINP3,DSCAM,NTRK2,FBN2,INSM1,PTPRD,TGFBR2</TD></TR>
<TR><TD>2.151e-03</TD><TD>-6.14</TD><TD>ventricular cardiac muscle tissue morphogenesis</TD><TD>biological process</TD><TD>GO:0055010</TD><TD>47</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,ZFPM2,RYR2,NRG1</TD></TR>
<TR><TD>2.161e-03</TD><TD>-6.14</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm</TD><TD>248</TD><TD>9</TD><TD>16984</TD><TD>193</TD>
<TD>SYT1,IL1RAPL2,DSCAM,CNTNAP2,DNER,PCDH9,KAZN,PARP8,NOL4</TD></TR>
<TR><TD>2.161e-03</TD><TD>-6.14</TD><TD>mast_cell_neoplasm</TD><TD>COSMIC cancer mutations</TD><TD>mast_cell_neoplasm</TD><TD>248</TD><TD>9</TD><TD>16984</TD><TD>193</TD>
<TD>KAZN,NOL4,PARP8,IL1RAPL2,SYT1,PCDH9,DNER,DSCAM,CNTNAP2</TD></TR>
<TR><TD>2.202e-03</TD><TD>-6.12</TD><TD>EGF_1</TD><TD>prosite domains</TD><TD>PS00022</TD><TD>174</TD><TD>8</TD><TD>12232</TD><TD>162</TD>
<TD>DNER,TMEFF2,SLIT2,EDIL3,MEGF10,NRG1,FAT4,FBN2</TD></TR>
<TR><TD>2.203e-03</TD><TD>-6.12</TD><TD>HBGF_FGF</TD><TD>prosite domains</TD><TD>PS00247</TD><TD>20</TD><TD>3</TD><TD>12232</TD><TD>162</TD>
<TD>FGF5,FGF14,FGF20</TD></TR>
<TR><TD>2.203e-03</TD><TD>-6.12</TD><TD>FA58C_3</TD><TD>prosite domains</TD><TD>PS50022</TD><TD>20</TD><TD>3</TD><TD>12232</TD><TD>162</TD>
<TD>EDIL3,CNTNAP2,CPXM2</TD></TR>
<TR><TD>2.207e-03</TD><TD>-6.12</TD><TD>locomotory behavior</TD><TD>biological process</TD><TD>GO:0007626</TD><TD>197</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>EPS8,DSCAM,UCHL1,EPHA4,LMX1A,SLC25A46,CNTN1,PRKCE</TD></TR>
<TR><TD>2.310e-03</TD><TD>-6.07</TD><TD>brain development</TD><TD>biological process</TD><TD>GO:0007420</TD><TD>731</TD><TD>18</TD><TD>18905</TD><TD>220</TD>
<TD>SLC25A46,CNTN1,TGFBR2,PBX1,LMX1A,NTRK2,PAX6,PCDH9,FZD6,ARX,ROBO2,AFG2A,SLIT2,FGFR2,FAT4,UNC5C,CNTNAP2,NRCAM</TD></TR>
<TR><TD>2.318e-03</TD><TD>-6.07</TD><TD>pulmonary valve development</TD><TD>biological process</TD><TD>GO:0003177</TD><TD>23</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>ADAMTS5,SLIT2,ROBO2</TD></TR>
<TR><TD>2.337e-03</TD><TD>-6.06</TD><TD>human chr5q21.3</TD><TD>chromosome location</TD><TD>human chr5q21.3</TD><TD>34</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LINC01950,EFNA5</TD></TR>
<TR><TD>2.342e-03</TD><TD>-6.06</TD><TD>MTA3 (metastasis associated 1 family member 3)</TD><TD>protein interactions</TD><TD>57504</TD><TD>163</TD><TD>7</TD><TD>20077</TD><TD>223</TD>
<TD>FGFR2,TCF20,DSCAM,TRPS1,ZFPM2,KLF12,PWWP2A</TD></TR>
<TR><TD>2.343e-03</TD><TD>-6.06</TD><TD>Tyr_kinase_cat_dom</TD><TD>interpro domains</TD><TD>IPR020635</TD><TD>80</TD><TD>5</TD><TD>18605</TD><TD>215</TD>
<TD>EPHA4,NTRK2,EPHA3,TEC,FGFR2</TD></TR>
<TR><TD>2.350e-03</TD><TD>-6.05</TD><TD>positive regulation of protein-containing complex assembly</TD><TD>biological process</TD><TD>GO:0031334</TD><TD>199</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>CXCL13,PLEK,FNIP2,CDH5,NRG1,PRKCE,NAV3,AKAP9</TD></TR>
<TR><TD>2.396e-03</TD><TD>-6.03</TD><TD>RYK (receptor like tyrosine kinase)</TD><TD>protein interactions</TD><TD>6259</TD><TD>209</TD><TD>8</TD><TD>20077</TD><TD>223</TD>
<TD>PCDH9,PTPRD,PTPRK,CNTN1,CDH5,FAT4,FGFR2,EPHA4</TD></TR>
<TR><TD>2.424e-03</TD><TD>-6.02</TD><TD>lung-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma-adenocarcinoma</TD><TD>15181</TD><TD>184</TD><TD>16984</TD><TD>193</TD>
<TD>INSM1,EPYC,IGFL4,NAALADL2,ADAMTS12,LRIG3,BACH2,NOBOX,GPR83,NRG1,DAAM1,UTRN,CETN3,SPAG9,REG1B,GAP43,LMBRD1,ARL14,B3GAT2,PTPRK,SLC7A8,UBR4,CRTC3,FGF14,ADAM28,FGF20,PLEK,IL1RAPL2,THSD7B,LGI1,AFM,UCHL1,GHITM,IQGAP2,NOVA1,HNF4G,PARP8,WRN,CNTNAP2,ASPN,KAZN,PSKH2,EPHA4,IRX1,FUT9,SLC25A46,MRPL13,AKAP9,ZNF518B,SLC10A2,SGCG,RYR2,LHCGR,CD96,PTPRZ1,RGS6,DEFB115,FAT4,SERINC5,FZD6,BANK1,ZFPM2,TGFBR2,SYT1,CD226,GMDS,GCNT1,CNTN1,FBN2,EFEMP1,PAQR3,DAOA,LRRN2,DNER,ACVR1C,SPATA16,RUNX1T1,ACP6,UNC5C,VAV3,THSD7A,ZNF133,ROBO2,PRSS12,RASGEF1B,PHLPP1,PXDNL,TRPS1,IPO8,ZPLD1,FNIP2,SLC39A10,PI15,NOL4,FERD3L,LMX1A,SGCD,PTPRD,NUP35,ZFAND5,JMJD1C,SEMA3C,ACVR2A,COQ2,PWWP2A,PCDH9,RGS5,NAT2,NAV3,SPHKAP,FMNL2,CDH5,MPEG1,CASK,SLC7A14,FGD3,FGFR2,ZNF521,SERGEF,FANCB,EPS8,SEZ6L,NTRK2,DNAJC12,STXBP6,NCKAP5,TSN,SS18,ADAMTS3,NBEA,SPANXN1,FIGN,MRPL3,PRKCE,CELF2,XPO4,MUC7,TWIST1,TMEFF2,EFR3A,ARX,UHMK1,RBM20,TCF20,PRLHR,CPXM2,EPHA3,KIF6,EFNA5,PCGF5,OR52K2,CHRM3,DSCAM,ADAMTS5,FGF5,PBX1,SLIT2,MAP2,MEGF10,ATG10,PAX6,NRCAM,RAI2,LRRC70,OR2AG1,DEPTOR,LRFN5,PHF14,KLF12,KCNK9,RPH3A,AMELX,WWOX,AGA,CTSO,BCHE,SKAP2,AOAH,EDIL3,COX7B2,CXCL13,CALN1,LRRC3B,NRSN1</TD></TR>
<TR><TD>2.461e-03</TD><TD>-6.01</TD><TD>NRP2 (neuropilin 2)</TD><TD>protein interactions</TD><TD>8828</TD><TD>51</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>NRSN1,BRINP3,TGFBR2,SEMA3C</TD></TR>
<TR><TD>2.483e-03</TD><TD>-6.00</TD><TD>kidney-carcinoma-renal_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>kidney-carcinoma-renal_cell_carcinoma</TD><TD>4562</TD><TD>70</TD><TD>16984</TD><TD>193</TD>
<TD>PHF14,FGFR2,ZNF521,SERGEF,DEPTOR,ACVR1C,AMELX,RUNX1T1,IL1RAPL2,PTPRK,CNTN1,PAX6,SPHKAP,UBR4,ADAM28,CASK,FGD3,RAI2,EPHA4,EDIL3,IRX1,COX7B2,CXCL13,TSN,NTRK2,DNAJC12,PSKH2,AKAP9,SPANXN1,RASGEF1B,SS18,MRPL13,ADAMTS3,NOVA1,CNTNAP2,FANCB,WRN,VAV3,TWIST1,PTPRZ1,RGS6,LRIG3,XPO4,FAT4,BACH2,ARX,UHMK1,FZD6,IPO8,PRKCE,SGCG,TRPS1,ADAMTS12,ACVR2A,ADAMTS5,PCDH9,RGS5,NAV3,PBX1,EPHA3,TGFBR2,KIF6,NUP35,PTPRD,JMJD1C,CHRM3,SPAG9,PCGF5,SYT1,DAAM1</TD></TR>
<TR><TD>2.483e-03</TD><TD>-6.00</TD><TD>renal_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>renal_cell_carcinoma</TD><TD>4562</TD><TD>70</TD><TD>16984</TD><TD>193</TD>
<TD>PCDH9,RGS5,NAV3,PBX1,ACVR2A,ADAMTS5,JMJD1C,CHRM3,SPAG9,PCGF5,SYT1,DAAM1,EPHA3,TGFBR2,KIF6,NUP35,PTPRD,FAT4,BACH2,UHMK1,FZD6,ARX,TWIST1,PTPRZ1,XPO4,LRIG3,RGS6,ADAMTS12,IPO8,PRKCE,SGCG,TRPS1,AKAP9,SPANXN1,RASGEF1B,MRPL13,SS18,ADAMTS3,EDIL3,EPHA4,IRX1,COX7B2,CXCL13,TSN,NTRK2,DNAJC12,PSKH2,CNTNAP2,FANCB,WRN,VAV3,NOVA1,AMELX,ACVR1C,RUNX1T1,IL1RAPL2,PHF14,FGFR2,ZNF521,SERGEF,DEPTOR,ADAM28,CASK,FGD3,RAI2,PTPRK,PAX6,CNTN1,SPHKAP,UBR4</TD></TR>
<TR><TD>2.484e-03</TD><TD>-6.00</TD><TD>regulation of synapse assembly</TD><TD>biological process</TD><TD>GO:0051963</TD><TD>117</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>EFNA5,IL1RAPL2,NTRK2,LRFN5,ROBO2,PTPRD</TD></TR>
<TR><TD>2.486e-03</TD><TD>-6.00</TD><TD>LRRN1 (leucine rich repeat neuronal 1)</TD><TD>protein interactions</TD><TD>57633</TD><TD>7</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>GHITM,PTPRD</TD></TR>
<TR><TD>2.509e-03</TD><TD>-5.99</TD><TD>skin-face-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-face-carcinoma-squamous_cell_carcinoma</TD><TD>2036</TD><TD>37</TD><TD>16984</TD><TD>193</TD>
<TD>KIF6,HNF4G,EPHA3,CNTNAP2,DSCAM,SEZ6L,JMJD1C,ADAMTS5,CALN1,GAP43,NAV3,AKAP9,PCDH9,ZNF518B,SGCG,EPYC,MEGF10,TRPS1,SLIT2,PTPRK,OR2AG1,FBN2,ADAMTS12,SLC39A10,ADAM28,PTPRZ1,DEPTOR,CELF2,FGFR2,ZNF521,LRFN5,KLF12,FAT4,BACH2,SPATA16,IQGAP2,LMX1A</TD></TR>
<TR><TD>2.510e-03</TD><TD>-5.99</TD><TD>ephrin receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0048013</TD><TD>49</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>SS18,EPHA3,EPHA4,EFNA5</TD></TR>
<TR><TD>2.510e-03</TD><TD>-5.99</TD><TD>regulation of protein phosphorylation</TD><TD>biological process</TD><TD>GO:0001932</TD><TD>919</TD><TD>21</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2,INSM1,NTRK2,PAQR3,UCHL1,PAX6,PECAM1,FNIP2,CDH5,NRG1,PRKCE,BANK1,ACVR2A,SLIT2,FGF5,EPHA4,AKAP9,DEPTOR,FGF20,SPAG9,EFNA5</TD></TR>
<TR><TD>2.515e-03</TD><TD>-5.99</TD><TD>dystroglycan complex</TD><TD>cellular component</TD><TD>GO:0016011</TD><TD>7</TD><TD>2</TD><TD>19868</TD><TD>222</TD>
<TD>SGCG,SGCD</TD></TR>
<TR><TD>2.534e-03</TD><TD>-5.98</TD><TD>positive regulation of nervous system development</TD><TD>biological process</TD><TD>GO:0051962</TD><TD>296</TD><TD>10</TD><TD>18905</TD><TD>220</TD>
<TD>EFNA5,PAX6,NTRK2,DSCAM,EPHA4,SLIT2,ROBO2,PTPRD,PTPRZ1,SHTN1</TD></TR>
<TR><TD>2.545e-03</TD><TD>-5.97</TD><TD>DEP</TD><TD>prosite domains</TD><TD>PS50186</TD><TD>21</TD><TD>3</TD><TD>12232</TD><TD>162</TD>
<TD>PLEK,RGS6,DEPTOR</TD></TR>
<TR><TD>2.546e-03</TD><TD>-5.97</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-peripheral_T_cell_lymphoma_unspecified</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-peripheral_T_cell_lymphoma_unspecified</TD><TD>162</TD><TD>7</TD><TD>16984</TD><TD>193</TD>
<TD>IQGAP2,NRSN1,ADAMTS12,EPS8,FMNL2,NCKAP5,NOL4</TD></TR>
<TR><TD>2.575e-03</TD><TD>-5.96</TD><TD>ADAMTS/ADAMTS-like</TD><TD>interpro domains</TD><TD>IPR013273</TD><TD>24</TD><TD>3</TD><TD>18605</TD><TD>215</TD>
<TD>ADAMTS12,ADAMTS5,ADAMTS3</TD></TR>
<TR><TD>2.592e-03</TD><TD>-5.96</TD><TD>synapse assembly</TD><TD>biological process</TD><TD>GO:0007416</TD><TD>118</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>ADGRL3,NRCAM,DSCAM,DNER,SLC25A46,PTPRD</TD></TR>
<TR><TD>2.617e-03</TD><TD>-5.95</TD><TD>human chr13q33.1</TD><TD>chromosome location</TD><TD>human chr13q33.1</TD><TD>36</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>FGF14,SLC10A2</TD></TR>
<TR><TD>2.627e-03</TD><TD>-5.94</TD><TD>synaptic membrane adhesion</TD><TD>biological process</TD><TD>GO:0099560</TD><TD>24</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>LRFN5,PTPRD,EFNA5</TD></TR>
<TR><TD>2.627e-03</TD><TD>-5.94</TD><TD>negative regulation of keratinocyte proliferation</TD><TD>biological process</TD><TD>GO:0010839</TD><TD>24</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>CASK,PTPRK,FGFR2</TD></TR>
<TR><TD>2.677e-03</TD><TD>-5.92</TD><TD>ACTIVIN2R</TD><TD>prints domains</TD><TD>PR00653</TD><TD>6</TD><TD>2</TD><TD>5258</TD><TD>72</TD>
<TD>TGFBR2,ACVR2A</TD></TR>
<TR><TD>2.693e-03</TD><TD>-5.92</TD><TD>cell-cell adhesion mediator activity</TD><TD>molecular function</TD><TD>GO:0098632</TD><TD>52</TD><TD>4</TD><TD>18530</TD><TD>207</TD>
<TD>NRCAM,DSCAM,CNTN1,STXBP6</TD></TR>
<TR><TD>2.699e-03</TD><TD>-5.91</TD><TD>negative regulation of biological process</TD><TD>biological process</TD><TD>GO:0048519</TD><TD>5777</TD><TD>87</TD><TD>18905</TD><TD>220</TD>
<TD>SLC39A10,PBX1,BACH2,FNIP2,NRG1,ROBO2,RYR2,BANK1,PTPRK,CRTC3,TWIST1,PHLPP1,EPS8,PTPRD,ADAMTS12,LMX1A,MIR548A3,RGS6,CD96,FGFR2,STXBP6,DEPTOR,MIR569,CNTNAP2,PAX6,FABP7,PTPRZ1,SLIT2,SKAP2,EPHA4,IRX1,ACVR1C,CXCL13,MIR548AA2,MIR577,INSM1,MIR1260B,ADAMTS5,PAQR3,DSCAM,NTRK2,UCHL1,FZD6,BCHE,ASPN,LRFN5,MRPL13,NOVA1,MIR891A,TRPS1,TSN,TMEFF2,CASK,PRKCE,SPAG9,EPHA3,PHF14,MIR147A,FBN2,BRINP3,MIR551B,CDH5,RGS5,RBM20,AOAH,PLEK,MAP2,ZNF133,SS18,RUNX1T1,FERD3L,NAV3,C8orf88,EFEMP1,SHISA3,FANCB,SERGEF,MIR9-2HG,WWOX,GHITM,EFNA5,UBR4,ARX,KLF12,PCGF5,FGF20,ZFPM2</TD></TR>
<TR><TD>2.724e-03</TD><TD>-5.91</TD><TD>lung lobe development</TD><TD>biological process</TD><TD>GO:0060462</TD><TD>7</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,TGFBR2</TD></TR>
<TR><TD>2.724e-03</TD><TD>-5.91</TD><TD>axon choice point recognition</TD><TD>biological process</TD><TD>GO:0016198</TD><TD>7</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,GAP43</TD></TR>
<TR><TD>2.724e-03</TD><TD>-5.91</TD><TD>lung lobe morphogenesis</TD><TD>biological process</TD><TD>GO:0060463</TD><TD>7</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2,FGFR2</TD></TR>
<TR><TD>2.724e-03</TD><TD>-5.91</TD><TD>lacrimal gland development</TD><TD>biological process</TD><TD>GO:0032808</TD><TD>7</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,PAX6</TD></TR>
<TR><TD>2.724e-03</TD><TD>-5.91</TD><TD>spontaneous neurotransmitter secretion</TD><TD>biological process</TD><TD>GO:0061669</TD><TD>7</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>RPH3A,SYT1</TD></TR>
<TR><TD>2.765e-03</TD><TD>-5.89</TD><TD>regulation of cell projection organization</TD><TD>biological process</TD><TD>GO:0031344</TD><TD>684</TD><TD>17</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,SHTN1,EPHA4,SLIT2,EPHA3,EFNA5,EPS8,MAP2,NRCAM,PTPRD,CNTN1,PAQR3,NTRK2,DSCAM,GAP43,PAX6,FUT9</TD></TR>
<TR><TD>2.800e-03</TD><TD>-5.88</TD><TD>Negative regulation of the PI3K/AKT network</TD><TD>REACTOME pathways</TD><TD>R-HSA-199418</TD><TD>94</TD><TD>5</TD><TD>10391</TD><TD>107</TD>
<TD>NRG1,FGFR2,FGF5,PHLPP1,FGF20</TD></TR>
<TR><TD>2.821e-03</TD><TD>-5.87</TD><TD>Regulation of actin cytoskeleton</TD><TD>KEGG pathways</TD><TD>ko04810</TD><TD>212</TD><TD>8</TD><TD>7246</TD><TD>83</TD>
<TD>FGF14,CHRM3,IQGAP2,VAV3,FGF20,FGD3,FGFR2,FGF5</TD></TR>
<TR><TD>2.821e-03</TD><TD>-5.87</TD><TD>Regulation of actin cytoskeleton</TD><TD>KEGG pathways</TD><TD>hsa04810</TD><TD>212</TD><TD>8</TD><TD>7246</TD><TD>83</TD>
<TD>FGF5,VAV3,FGD3,FGFR2,FGF20,CHRM3,IQGAP2,FGF14</TD></TR>
<TR><TD>2.828e-03</TD><TD>-5.87</TD><TD>-</TD><TD>gene3d domains</TD><TD>2.80.10.50</TD><TD>79</TD><TD>5</TD><TD>14531</TD><TD>178</TD>
<TD>RYR2,FGF20,FGF14,GALNT15,FGF5</TD></TR>
<TR><TD>2.836e-03</TD><TD>-5.87</TD><TD>EGF-like_Ca-bd_dom</TD><TD>interpro domains</TD><TD>IPR001881</TD><TD>121</TD><TD>6</TD><TD>18605</TD><TD>215</TD>
<TD>FAT4,DNER,SLIT2,FBN2,EFEMP1,EDIL3</TD></TR>
<TR><TD>2.901e-03</TD><TD>-5.84</TD><TD>ADAMTS_CR_3</TD><TD>interpro domains</TD><TD>IPR045371</TD><TD>25</TD><TD>3</TD><TD>18605</TD><TD>215</TD>
<TD>ADAMTS5,ADAMTS3,ADAMTS12</TD></TR>
<TR><TD>2.901e-03</TD><TD>-5.84</TD><TD>ADAMTS_spacer1</TD><TD>interpro domains</TD><TD>IPR010294</TD><TD>25</TD><TD>3</TD><TD>18605</TD><TD>215</TD>
<TD>ADAMTS12,ADAMTS5,ADAMTS3</TD></TR>
<TR><TD>2.907e-03</TD><TD>-5.84</TD><TD>endocardial cushion development</TD><TD>biological process</TD><TD>GO:0003197</TD><TD>51</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,TGFBR2,ADAMTS5,TWIST1</TD></TR>
<TR><TD>2.911e-03</TD><TD>-5.84</TD><TD>LYVE1 (lymphatic vessel endothelial hyaluronan receptor 1)</TD><TD>protein interactions</TD><TD>10894</TD><TD>26</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>THSD7A,NRSN1,THSD7B</TD></TR>
<TR><TD>2.912e-03</TD><TD>-5.84</TD><TD>human chr1q31.1</TD><TD>chromosome location</TD><TD>human chr1q31.1</TD><TD>38</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LINC01037,BRINP3</TD></TR>
<TR><TD>2.920e-03</TD><TD>-5.84</TD><TD>ADAMTS_spacer1</TD><TD>pfam domains</TD><TD>PF05986</TD><TD>25</TD><TD>3</TD><TD>17869</TD><TD>207</TD>
<TD>ADAMTS3,ADAMTS12,ADAMTS5</TD></TR>
<TR><TD>2.920e-03</TD><TD>-5.84</TD><TD>ADAMTS_CR_3</TD><TD>pfam domains</TD><TD>PF19236</TD><TD>25</TD><TD>3</TD><TD>17869</TD><TD>207</TD>
<TD>ADAMTS3,ADAMTS5,ADAMTS12</TD></TR>
<TR><TD>2.933e-03</TD><TD>-5.83</TD><TD>regulation of cellular component size</TD><TD>biological process</TD><TD>GO:0032535</TD><TD>353</TD><TD>11</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,PRKCE,SHTN1,PLEK,NRCAM,MAP2,EPS8,EFNA5,DEPTOR,VAV3,DSCAM</TD></TR>
<TR><TD>2.946e-03</TD><TD>-5.83</TD><TD>pseudomyxoma_peritonei</TD><TD>COSMIC cancer mutations</TD><TD>pseudomyxoma_peritonei</TD><TD>587</TD><TD>15</TD><TD>16984</TD><TD>193</TD>
<TD>AKAP9,DNER,FAT4,IRX1,EDIL3,NCKAP5,ROBO2,FGFR2,CNTNAP2,WRN,ZPLD1,NRG1,TGFBR2,TRPS1,MAP2</TD></TR>
<TR><TD>2.946e-03</TD><TD>-5.83</TD><TD>peritoneum-appendix-other-pseudomyxoma_peritonei</TD><TD>COSMIC cancer mutations</TD><TD>peritoneum-appendix-other-pseudomyxoma_peritonei</TD><TD>587</TD><TD>15</TD><TD>16984</TD><TD>193</TD>
<TD>FAT4,AKAP9,DNER,ROBO2,FGFR2,IRX1,EDIL3,NCKAP5,NRG1,WRN,ZPLD1,CNTNAP2,TRPS1,MAP2,TGFBR2</TD></TR>
<TR><TD>2.993e-03</TD><TD>-5.81</TD><TD>appendix</TD><TD>COSMIC cancer mutations</TD><TD>appendix</TD><TD>588</TD><TD>15</TD><TD>16984</TD><TD>193</TD>
<TD>DNER,AKAP9,FAT4,IRX1,EDIL3,NCKAP5,ROBO2,FGFR2,CNTNAP2,ZPLD1,NRG1,WRN,TGFBR2,TRPS1,MAP2</TD></TR>
<TR><TD>3.000e-03</TD><TD>-5.81</TD><TD>PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta)</TD><TD>protein interactions</TD><TD>5291</TD><TD>88</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>CHRM3,PRKCE,TGFBR2,NTRK2,CDH5</TD></TR>
<TR><TD>3.000e-03</TD><TD>-5.81</TD><TD>ROBO1 (roundabout guidance receptor 1)</TD><TD>protein interactions</TD><TD>6091</TD><TD>88</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>DSCAM,PHLPP1,ARL14,SLIT2,ROBO2</TD></TR>
<TR><TD>3.017e-03</TD><TD>-5.80</TD><TD>peripheral_T_cell_lymphoma_unspecified</TD><TD>COSMIC cancer mutations</TD><TD>peripheral_T_cell_lymphoma_unspecified</TD><TD>167</TD><TD>7</TD><TD>16984</TD><TD>193</TD>
<TD>EPS8,ADAMTS12,NRSN1,IQGAP2,FMNL2,NCKAP5,NOL4</TD></TR>
<TR><TD>3.041e-03</TD><TD>-5.80</TD><TD>peritoneum</TD><TD>COSMIC cancer mutations</TD><TD>peritoneum</TD><TD>589</TD><TD>15</TD><TD>16984</TD><TD>193</TD>
<TD>TGFBR2,TRPS1,MAP2,CNTNAP2,NRG1,ZPLD1,WRN,IRX1,EDIL3,NCKAP5,ROBO2,FGFR2,DNER,AKAP9,FAT4</TD></TR>
<TR><TD>3.094e-03</TD><TD>-5.78</TD><TD>kidney-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>kidney-carcinoma</TD><TD>3724</TD><TD>59</TD><TD>16984</TD><TD>193</TD>
<TD>TWIST1,XPO4,RGS6,LRIG3,PTPRZ1,BACH2,FZD6,UHMK1,IPO8,PRKCE,TRPS1,ADAMTS12,ADAMTS5,ACVR2A,PBX1,NAV3,RGS5,EPHA3,NUP35,TGFBR2,KIF6,PTPRD,JMJD1C,SPAG9,PCGF5,DAAM1,SYT1,PHF14,ZNF521,FGFR2,DEPTOR,SERGEF,RUNX1T1,ACVR1C,PTPRK,UBR4,PAX6,SPHKAP,CNTN1,ADAM28,FGD3,CASK,IRX1,EPHA4,TSN,CXCL13,COX7B2,DNAJC12,NTRK2,PSKH2,AKAP9,RASGEF1B,ADAMTS3,SS18,MRPL13,HNF4G,NOVA1,WRN,VAV3</TD></TR>
<TR><TD>3.094e-03</TD><TD>-5.78</TD><TD>PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta)</TD><TD>protein interactions</TD><TD>5577</TD><TD>128</TD><TD>6</TD><TD>20077</TD><TD>223</TD>
<TD>MAP2,NBEA,MATCAP2,SLC25A46,AKAP9,RYR2</TD></TR>
<TR><TD>3.098e-03</TD><TD>-5.78</TD><TD>positive regulation of developmental process</TD><TD>biological process</TD><TD>GO:0051094</TD><TD>1388</TD><TD>28</TD><TD>18905</TD><TD>220</TD>
<TD>NRG1,ROBO2,PTPRZ1,SHTN1,SLIT2,EPHA4,SPAG9,NRCAM,TWIST1,EFNA5,SS18,SYT1,PAX6,CDH5,FGFR2,ACVR2A,AMELX,FGF20,ZFPM2,UNC5C,PTPRD,TGFBR2,INSM1,FBN2,NTRK2,DSCAM,BRINP3,ARX</TD></TR>
<TR><TD>3.178e-03</TD><TD>-5.75</TD><TD>FA58C</TD><TD>smart domains</TD><TD>SM00231</TD><TD>20</TD><TD>3</TD><TD>9743</TD><TD>147</TD>
<TD>CPXM2,EDIL3,CNTNAP2</TD></TR>
<TR><TD>3.295e-03</TD><TD>-5.72</TD><TD>signal transduction</TD><TD>biological process</TD><TD>GO:0007165</TD><TD>4780</TD><TD>74</TD><TD>18905</TD><TD>220</TD>
<TD>CHRM3,IL1RAPL2,FNIP2,DCDC2C,RYR2,PRKCE,NRG1,TEC,PTPRK,BANK1,SPAG9,LRRN2,EPS8,EPHA3,PHLPP1,TGFBR2,CNTN1,PTPRD,FBN2,RGS6,OR52K2,SEMA3C,RASGEF1B,CDH5,AMELX,ACVR2A,FGFR2,RGS5,IQGAP2,DAAM1,DEPTOR,PLEK,PPP1R17,MAST4,ZFAND5,OR2AG1,SS18,VAV3,GAP43,EFEMP1,PECAM1,LHCGR,HNF4G,PAX6,SHTN1,ACVR1C,PARP8,GAREM1,CD226,EPHA4,SKAP2,SLIT2,DNER,SERGEF,IPO8,WWOX,ADGRL3,SGCD,EFNA5,PRLHR,CXCL13,ATG10,FGF14,NTRK2,DSCAM,FZD6,CYTL1,GPR83,AKAP9,FGF5,UNC5C,FAT4,FGF20,GMDS</TD></TR>
<TR><TD>3.383e-03</TD><TD>-5.69</TD><TD>human chr8q24.12</TD><TD>chromosome location</TD><TD>human chr8q24.12</TD><TD>41</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>DEPTOR,MRPL13</TD></TR>
<TR><TD>3.383e-03</TD><TD>-5.69</TD><TD>human chr7p14.2</TD><TD>chromosome location</TD><TD>human chr7p14.2</TD><TD>41</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>AOAH,MATCAP2</TD></TR>
<TR><TD>3.438e-03</TD><TD>-5.67</TD><TD>pleura-mesothelioma</TD><TD>COSMIC cancer mutations</TD><TD>pleura-mesothelioma</TD><TD>4216</TD><TD>65</TD><TD>16984</TD><TD>193</TD>
<TD>FANCB,WRN,VAV3,NOVA1,AKAP9,SPANXN1,RASGEF1B,SS18,MRPL13,ADAMTS3,EPHA4,EDIL3,IRX1,COX7B2,TSN,CXCL13,NTRK2,DNAJC12,PSKH2,ADAM28,CASK,FGD3,RAI2,PTPRK,PAX6,SPHKAP,CNTN1,UBR4,AMELX,ACVR1C,RUNX1T1,IL1RAPL2,PHF14,FGFR2,ZNF521,SERGEF,DEPTOR,JMJD1C,SPAG9,PCGF5,DAAM1,SYT1,EPHA3,TGFBR2,KIF6,NUP35,PTPRD,RGS5,PBX1,NAV3,ACVR2A,ADAMTS5,ADAMTS12,IPO8,PRKCE,TRPS1,BACH2,FZD6,UHMK1,ARX,TWIST1,PTPRZ1,RGS6,XPO4,LRIG3</TD></TR>
<TR><TD>3.439e-03</TD><TD>-5.67</TD><TD>synovial</TD><TD>COSMIC cancer mutations</TD><TD>synovial</TD><TD>8</TD><TD>2</TD><TD>16984</TD><TD>193</TD>
<TD>CNTN1,RYR2</TD></TR>
<TR><TD>3.439e-03</TD><TD>-5.67</TD><TD>bone-knee-chondrosarcoma-synovial</TD><TD>COSMIC cancer mutations</TD><TD>bone-knee-chondrosarcoma-synovial</TD><TD>8</TD><TD>2</TD><TD>16984</TD><TD>193</TD>
<TD>CNTN1,RYR2</TD></TR>
<TR><TD>3.464e-03</TD><TD>-5.67</TD><TD>HTR6 (5-hydroxytryptamine receptor 6)</TD><TD>protein interactions</TD><TD>3362</TD><TD>56</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>PARP8,IPO8,XPO4,NOVA1</TD></TR>
<TR><TD>3.469e-03</TD><TD>-5.66</TD><TD>sensory organ development</TD><TD>biological process</TD><TD>GO:0007423</TD><TD>582</TD><TD>15</TD><TD>18905</TD><TD>220</TD>
<TD>EFEMP1,NTRK2,DSCAM,FZD6,CYTL1,PAX6,TGFBR2,FBN2,PBX1,FGF20,PLAAT1,LRIG3,TWIST1,FGFR2,EPHA4</TD></TR>
<TR><TD>3.478e-03</TD><TD>-5.66</TD><TD>cellular response to fibroblast growth factor stimulus</TD><TD>biological process</TD><TD>GO:0044344</TD><TD>87</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>FGF20,CXCL13,PAX6,FGF5,FGFR2</TD></TR>
<TR><TD>3.521e-03</TD><TD>-5.65</TD><TD>Downstream signaling of activated FGFR2</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654696</TD><TD>30</TD><TD>3</TD><TD>10391</TD><TD>107</TD>
<TD>FGF20,FGF5,FGFR2</TD></TR>
<TR><TD>3.555e-03</TD><TD>-5.64</TD><TD>LRAT_dom</TD><TD>interpro domains</TD><TD>IPR007053</TD><TD>8</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>PLAAT1,LRATD1</TD></TR>
<TR><TD>3.555e-03</TD><TD>-5.64</TD><TD>DAD_dom</TD><TD>interpro domains</TD><TD>IPR014767</TD><TD>8</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>FMNL2,DAAM1</TD></TR>
<TR><TD>3.572e-03</TD><TD>-5.63</TD><TD>LRAT</TD><TD>pfam domains</TD><TD>PF04970</TD><TD>8</TD><TD>2</TD><TD>17869</TD><TD>207</TD>
<TD>LRATD1,PLAAT1</TD></TR>
<TR><TD>3.576e-03</TD><TD>-5.63</TD><TD>positive regulation of developmental growth</TD><TD>biological process</TD><TD>GO:0048639</TD><TD>168</TD><TD>7</TD><TD>18905</TD><TD>220</TD>
<TD>DSCAM,ZFPM2,EFNA5,ARX,SYT1,SHTN1,FGFR2</TD></TR>
<TR><TD>3.582e-03</TD><TD>-5.63</TD><TD>IL1HBGF</TD><TD>prints domains</TD><TD>PR00262</TD><TD>23</TD><TD>3</TD><TD>5258</TD><TD>72</TD>
<TD>FGF14,FGF5,FGF20</TD></TR>
<TR><TD>3.590e-03</TD><TD>-5.63</TD><TD>oesophagus-lower_third-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus-lower_third-carcinoma-squamous_cell_carcinoma</TD><TD>3513</TD><TD>56</TD><TD>16984</TD><TD>193</TD>
<TD>CDH5,FBN2,MPEG1,ADAM28,CASK,SLIT2,MAP2,GCNT1,B3GAT2,ARL14,CNTN1,UBR4,THSD7B,DNER,RPH3A,IQGAP2,RUNX1T1,ZNF521,DEPTOR,LRFN5,WRN,SEZ6L,THSD7A,CNTNAP2,ACP6,NOVA1,UNC5C,PARP8,RASGEF1B,SLC25A46,PHLPP1,SS18,ADAMTS3,NBEA,KAZN,NCKAP5,NAALADL2,ADAMTS12,PXDNL,RYR2,EFR3B,PRKCE,FAT4,TCF20,PTPRZ1,XPO4,NRG1,UTRN,CHRM3,JMJD1C,DSCAM,PTPRD,EPHA3,TGFBR2,PCDH9,NAV3</TD></TR>
<TR><TD>3.594e-03</TD><TD>-5.63</TD><TD>DNA-binding transcription repressor activity</TD><TD>molecular function</TD><TD>GO:0001217</TD><TD>272</TD><TD>9</TD><TD>18530</TD><TD>207</TD>
<TD>BACH2,FERD3L,INSM1,IRX1,PAX6,TWIST1,ARX,KLF12,TRPS1</TD></TR>
<TR><TD>3.604e-03</TD><TD>-5.63</TD><TD>membranous septum morphogenesis</TD><TD>biological process</TD><TD>GO:0003149</TD><TD>8</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2,FGFR2</TD></TR>
<TR><TD>3.604e-03</TD><TD>-5.63</TD><TD>corticospinal tract morphogenesis</TD><TD>biological process</TD><TD>GO:0021957</TD><TD>8</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,EPHA4</TD></TR>
<TR><TD>3.604e-03</TD><TD>-5.63</TD><TD>tangential migration from the subventricular zone to the olfactory bulb</TD><TD>biological process</TD><TD>GO:0022028</TD><TD>8</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,ARX</TD></TR>
<TR><TD>3.608e-03</TD><TD>-5.62</TD><TD>KCNK18 (potassium two pore domain channel subfamily K member 18)</TD><TD>protein interactions</TD><TD>338567</TD><TD>28</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>PTPRD,TGFBR2,ACVR2A</TD></TR>
<TR><TD>3.611e-03</TD><TD>-5.62</TD><TD>signaling</TD><TD>biological process</TD><TD>GO:0023052</TD><TD>5112</TD><TD>78</TD><TD>18905</TD><TD>220</TD>
<TD>DCDC2C,FNIP2,CHRM3,IL1RAPL2,LRRN2,SPAG9,EPHA3,PHLPP1,EPS8,RPH3A,RYR2,NRG1,PRKCE,TEC,BANK1,PTPRK,SEMA3C,OR52K2,RGS6,PTPRD,TGFBR2,CNTN1,FBN2,IQGAP2,DAAM1,DEPTOR,PLEK,RASGEF1B,CDH5,AMELX,RGS5,FGFR2,ACVR2A,SEPTIN5,EFEMP1,GAP43,LHCGR,PECAM1,PAX6,HNF4G,MAST4,PPP1R17,SS18,SYT1,ZFAND5,OR2AG1,VAV3,IPO8,WWOX,EFNA5,SGCD,ADGRL3,CXCL13,PRLHR,SHTN1,EPHA4,CD226,PARP8,GAREM1,ACVR1C,SERGEF,DNER,SLIT2,SKAP2,UTRN,DSCAM,NTRK2,FZD6,CYTL1,ATG10,FGF14,FAT4,UNC5C,FGF20,GMDS,GPR83,AKAP9,FGF5</TD></TR>
<TR><TD>3.648e-03</TD><TD>-5.61</TD><TD>neuronal cell body</TD><TD>cellular component</TD><TD>GO:0043025</TD><TD>491</TD><TD>13</TD><TD>19868</TD><TD>222</TD>
<TD>SHTN1,DSCAM,GAP43,AKAP9,EPHA4,CNTNAP2,NRSN1,MAP2,UCHL1,DNER,UNC5C,BRINP3,SEZ6L</TD></TR>
<TR><TD>3.664e-03</TD><TD>-5.61</TD><TD>chemorepellent activity</TD><TD>molecular function</TD><TD>GO:0045499</TD><TD>28</TD><TD>3</TD><TD>18530</TD><TD>207</TD>
<TD>SEMA3C,EFNA5,NRG1</TD></TR>
<TR><TD>3.667e-03</TD><TD>-5.61</TD><TD>DEP</TD><TD>smart domains</TD><TD>SM00049</TD><TD>21</TD><TD>3</TD><TD>9743</TD><TD>147</TD>
<TD>PLEK,DEPTOR,RGS6</TD></TR>
<TR><TD>3.700e-03</TD><TD>-5.60</TD><TD>cell proliferation in forebrain</TD><TD>biological process</TD><TD>GO:0021846</TD><TD>27</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,PAX6,ARX</TD></TR>
<TR><TD>3.715e-03</TD><TD>-5.60</TD><TD>human chr8q23.1</TD><TD>chromosome location</TD><TD>human chr8q23.1</TD><TD>43</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>EMC2,ZFPM2</TD></TR>
<TR><TD>3.718e-03</TD><TD>-5.59</TD><TD>OCLN (occludin)</TD><TD>protein interactions</TD><TD>100506658</TD><TD>495</TD><TD>13</TD><TD>20077</TD><TD>223</TD>
<TD>ARL14,EFR3A,EFEMP1,EPHA4,TGFBR2,IQGAP2,NBEA,EFR3B,UTRN,CASK,NTRK2,ROBO2,SLC39A10</TD></TR>
<TR><TD>3.732e-03</TD><TD>-5.59</TD><TD>cerebral cortex development</TD><TD>biological process</TD><TD>GO:0021987</TD><TD>127</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,PAX6,ARX,NTRK2,CNTNAP2,FAT4</TD></TR>
<TR><TD>3.733e-03</TD><TD>-5.59</TD><TD>skin-arm-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-arm-malignant_melanoma</TD><TD>1309</TD><TD>26</TD><TD>16984</TD><TD>193</TD>
<TD>RUNX1T1,SPATA16,UCHL1,TCF20,SHISA3,FAT4,BACH2,RGS6,SLC39A10,ADAM28,CDH5,ZPLD1,SPHKAP,TRPS1,EPYC,MAP2,MEGF10,SLIT2,ZNF518B,AKAP9,ADAMTS3,CHRM3,SYT1,WRN,NOVA1,PTPRD</TD></TR>
<TR><TD>3.770e-03</TD><TD>-5.58</TD><TD>cell development</TD><TD>biological process</TD><TD>GO:0048468</TD><TD>2240</TD><TD>40</TD><TD>18905</TD><TD>220</TD>
<TD>INSM1,LMX1A,ACP6,PHF14,TGFBR2,CNTN1,ARX,UCHL1,NTRK2,DSCAM,SEMA3C,UHMK1,FGFR2,LGI1,MAP2,PLEK,SPATA16,CNTNAP2,UNC5C,NOBOX,FERD3L,PBX1,SLC25A46,PAX6,PECAM1,GAP43,SLIT2,DNER,IRX1,EPHA4,NRG1,SHTN1,ROBO2,PTPRZ1,NRCAM,TWIST1,SGCD,EFNA5,EPHA3,MEGF10</TD></TR>
<TR><TD>3.770e-03</TD><TD>-5.58</TD><TD>Axon guidance</TD><TD>KEGG pathways</TD><TD>ko04360</TD><TD>175</TD><TD>7</TD><TD>7246</TD><TD>83</TD>
<TD>UNC5C,EPHA3,EFNA5,SLIT2,SEMA3C,EPHA4,ROBO2</TD></TR>
<TR><TD>3.770e-03</TD><TD>-5.58</TD><TD>Axon guidance</TD><TD>KEGG pathways</TD><TD>hsa04360</TD><TD>175</TD><TD>7</TD><TD>7246</TD><TD>83</TD>
<TD>SLIT2,SEMA3C,EPHA4,ROBO2,UNC5C,EPHA3,EFNA5</TD></TR>
<TR><TD>3.783e-03</TD><TD>-5.58</TD><TD>blood vessel development</TD><TD>biological process</TD><TD>GO:0001568</TD><TD>530</TD><TD>14</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,TGFBR2,CDH5,VAV3,FGFR2,SLIT2,SEMA3C,ZFPM2,NTRK2,PECAM1,SGCD,NRCAM,PAX6,THSD7A</TD></TR>
<TR><TD>3.784e-03</TD><TD>-5.58</TD><TD>lower_leg</TD><TD>COSMIC cancer mutations</TD><TD>lower_leg</TD><TD>174</TD><TD>7</TD><TD>16984</TD><TD>193</TD>
<TD>PTPRD,PXDNL,FGFR2,CHRM3,ADAM28,PWWP2A,ADAMTS3</TD></TR>
<TR><TD>3.819e-03</TD><TD>-5.57</TD><TD>-</TD><TD>gene3d domains</TD><TD>2.60.120.830</TD><TD>26</TD><TD>3</TD><TD>14531</TD><TD>178</TD>
<TD>ADAMTS3,ADAMTS5,ADAMTS12</TD></TR>
<TR><TD>3.886e-03</TD><TD>-5.55</TD><TD>human chr4q34.3</TD><TD>chromosome location</TD><TD>human chr4q34.3</TD><TD>44</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>AGA,LINC01098</TD></TR>
<TR><TD>3.886e-03</TD><TD>-5.55</TD><TD>human chr11q23.2</TD><TD>chromosome location</TD><TD>human chr11q23.2</TD><TD>44</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LOC101928847,REXO2</TD></TR>
<TR><TD>3.891e-03</TD><TD>-5.55</TD><TD>Growth_fac_rcpt_cys_sf</TD><TD>interpro domains</TD><TD>IPR009030</TD><TD>129</TD><TD>6</TD><TD>18605</TD><TD>215</TD>
<TD>FAT4,DNER,EFEMP1,FBN2,EPHA3,BRINP3</TD></TR>
<TR><TD>3.910e-03</TD><TD>-5.54</TD><TD>cell junction organization</TD><TD>biological process</TD><TD>GO:0034330</TD><TD>532</TD><TD>14</TD><TD>18905</TD><TD>220</TD>
<TD>DNER,SEZ6L,PTPRK,EPHA4,CDH5,NRCAM,EFNA5,ADGRL3,LRFN5,LMX1A,SLC25A46,PTPRD,PECAM1,DSCAM</TD></TR>
<TR><TD>3.952e-03</TD><TD>-5.53</TD><TD>plasma membrane</TD><TD>cellular component</TD><TD>GO:0005886</TD><TD>5920</TD><TD>85</TD><TD>19868</TD><TD>222</TD>
<TD>UTRN,ACVR1C,IL1RAPL2,PLEK,RASGEF1B,KAZN,CALN1,RGS5,PXDNL,KCNK9,TGFBR2,SLC10A2,EPHA3,THSD7B,MUC7,GPR83,PECAM1,CD226,SKAP2,SERINC5,NTRK2,PHLPP1,IQGAP2,UCHL1,EFNA5,ACVR2A,CASK,OR2AG1,CNTNAP2,AKAP9,PTPRZ1,UBR4,THSD7A,LRFN5,MEGF10,NUP35,SGCG,OR52K2,ROBO2,SLC7A14,ADAM28,PRLHR,SGCD,EPS8,FAT4,SLC7A8,RYR2,LRIG3,UNC5C,WWOX,DAAM1,EFR3A,TEC,PRSS12,LMBRD1,ADGRL3,DSCAM,NBEA,SEPTIN5,EFR3B,CDH5,PTPRD,VAV3,PRKCE,RGS6,RPH3A,NRCAM,GAREM1,CD96,SYT1,NRG1,SLC39A10,DNER,LHCGR,CNTN1,EPHA4,BCHE,PCDH9,SEMA3C,PTPRK,FGFR2,GAP43,CHRM3,LRRC70,FZD6</TD></TR>
<TR><TD>3.980e-03</TD><TD>-5.53</TD><TD>endopeptidase domain like (from Nostoc punctiforme)</TD><TD>gene3d domains</TD><TD>3.90.1720.10</TD><TD>8</TD><TD>2</TD><TD>14531</TD><TD>178</TD>
<TD>PLAAT1,LRATD1</TD></TR>
<TR><TD>3.985e-03</TD><TD>-5.53</TD><TD>regulation of cell junction assembly</TD><TD>biological process</TD><TD>GO:1901888</TD><TD>217</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>PTPRD,ROBO2,IL1RAPL2,LRFN5,CNTNAP2,NTRK2,EPHA3,EFNA5</TD></TR>
<TR><TD>4.014e-03</TD><TD>-5.52</TD><TD>regulation of anatomical structure morphogenesis</TD><TD>biological process</TD><TD>GO:0022603</TD><TD>894</TD><TD>20</TD><TD>18905</TD><TD>220</TD>
<TD>SYT1,PTPRD,ADAMTS12,TGFBR2,NTRK2,DSCAM,FMNL2,CDH5,ROBO2,SHTN1,FGFR2,SLIT2,EPHA4,SPAG9,CXCL13,TWIST1,MAP2,FGD3,EFNA5,EPS8</TD></TR>
<TR><TD>4.031e-03</TD><TD>-5.51</TD><TD>muscle organ development</TD><TD>biological process</TD><TD>GO:0007517</TD><TD>316</TD><TD>10</TD><TD>18905</TD><TD>220</TD>
<TD>UTRN,ZFPM2,MEGF10,TWIST1,SGCD,NRG1,RYR2,SGCG,FGFR2,DNER</TD></TR>
<TR><TD>4.045e-03</TD><TD>-5.51</TD><TD>Prot_kinase_dom</TD><TD>interpro domains</TD><TD>IPR000719</TD><TD>481</TD><TD>13</TD><TD>18605</TD><TD>215</TD>
<TD>PRKCE,EPHA3,NTRK2,ACVR2A,ACVR1C,TGFBR2,EPHA4,PSKH2,FGFR2,MAST4,TEC,UHMK1,CASK</TD></TR>
<TR><TD>4.054e-03</TD><TD>-5.51</TD><TD>ADAMTSFAMILY</TD><TD>prints domains</TD><TD>PR01857</TD><TD>24</TD><TD>3</TD><TD>5258</TD><TD>72</TD>
<TD>ADAMTS12,ADAMTS5,ADAMTS3</TD></TR>
<TR><TD>4.061e-03</TD><TD>-5.51</TD><TD>human chr5p12</TD><TD>chromosome location</TD><TD>human chr5p12</TD><TD>45</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>FGF10-AS1,NNT-AS1</TD></TR>
<TR><TD>4.061e-03</TD><TD>-5.51</TD><TD>human chr6q16.1</TD><TD>chromosome location</TD><TD>human chr6q16.1</TD><TD>45</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>FUT9,TSG1</TD></TR>
<TR><TD>4.084e-03</TD><TD>-5.50</TD><TD>mesenchyme morphogenesis</TD><TD>biological process</TD><TD>GO:0072132</TD><TD>56</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2,ROBO2,TWIST1,ADAMTS5</TD></TR>
<TR><TD>4.168e-03</TD><TD>-5.48</TD><TD>GRIN1 (glutamate ionotropic receptor NMDA type subunit 1)</TD><TD>protein interactions</TD><TD>2902</TD><TD>95</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>PRKCE,NTRK2,PTPRK,AKAP9,MAP2</TD></TR>
<TR><TD>4.174e-03</TD><TD>-5.48</TD><TD>human chr5q33.2-q33.3</TD><TD>chromosome location</TD><TD>human chr5q33.2-q33.3</TD><TD>2</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>SGCD</TD></TR>
<TR><TD>4.174e-03</TD><TD>-5.48</TD><TD>human chr13q33.2|13q34</TD><TD>chromosome location</TD><TD>human chr13q33.2|13q34</TD><TD>2</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>DAOA</TD></TR>
<TR><TD>4.174e-03</TD><TD>-5.48</TD><TD>human chr5p13.3-p13.2</TD><TD>chromosome location</TD><TD>human chr5p13.3-p13.2</TD><TD>2</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>ADAMTS12</TD></TR>
<TR><TD>4.199e-03</TD><TD>-5.47</TD><TD>FGF</TD><TD>smart domains</TD><TD>SM00442</TD><TD>22</TD><TD>3</TD><TD>9743</TD><TD>147</TD>
<TD>FGF20,FGF14,FGF5</TD></TR>
<TR><TD>4.210e-03</TD><TD>-5.47</TD><TD>glial cell differentiation</TD><TD>biological process</TD><TD>GO:0010001</TD><TD>219</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>GAP43,NTRK2,PAX6,CNTN1,PTPRZ1,SLC25A46,FGF5,DNER</TD></TR>
<TR><TD>4.212e-03</TD><TD>-5.47</TD><TD>pelvis</TD><TD>COSMIC cancer mutations</TD><TD>pelvis</TD><TD>987</TD><TD>21</TD><TD>16984</TD><TD>193</TD>
<TD>THSD7B,NOBOX,SPATA16,IQGAP2,NAV3,SGCD,FIGN,TCF20,BANK1,SERGEF,ACVR2A,DAAM1,UTRN,FGD3,TRPS1,PTPRD,MEGF10,ZFPM2,BCHE,EPHA3,RYR2</TD></TR>
<TR><TD>4.220e-03</TD><TD>-5.47</TD><TD>striated_muscle</TD><TD>COSMIC cancer mutations</TD><TD>striated_muscle</TD><TD>4251</TD><TD>65</TD><TD>16984</TD><TD>193</TD>
<TD>PXDNL,INSM1,MRPL3,TRPS1,RYR2,LHCGR,SLC39A10,PTPRZ1,RGS6,FAT4,SHISA3,UHMK1,NOBOX,FZD6,ARX,RBM20,TCF20,KIF6,ZFPM2,NRG1,JMJD1C,DSCAM,SPAG9,CD226,ADAMTS5,COQ2,GAP43,MAP2,GCNT1,UBR4,FMNL2,FBN2,MPEG1,FGD3,FGFR2,SERGEF,THSD7B,DNER,KCNK9,AFM,UCHL1,RPH3A,ACVR1C,IQGAP2,BCHE,FANCB,WRN,VAV3,SEZ6L,THSD7A,CNTNAP2,ASPN,ROBO2,AOAH,IRX1,NCKAP5,PRSS12,RASGEF1B,PHLPP1,SS18,ADAMTS3,NBEA,AKAP9,ZNF518B,SLC10A2</TD></TR>
<TR><TD>4.268e-03</TD><TD>-5.46</TD><TD>regulation of developmental process</TD><TD>biological process</TD><TD>GO:0050793</TD><TD>2545</TD><TD>44</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6,FMNL2,EFEMP1,FERD3L,SS18,RUNX1T1,SYT1,NRCAM,CXCL13,EFNA5,SLIT2,EPHA4,PTPRZ1,SHTN1,ARX,NTRK2,DSCAM,INSM1,FGD3,FGF20,UNC5C,ZFPM2,ASPN,TRPS1,PBX1,TWIST1,EPHA3,EPS8,SPAG9,MEGF10,NRG1,ROBO2,BRINP3,FBN2,LMX1A,PHF14,PTPRD,ADAMTS12,TGFBR2,MAP2,FGFR2,ACVR2A,AMELX,CDH5</TD></TR>
<TR><TD>4.269e-03</TD><TD>-5.46</TD><TD>rhabdomyosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>rhabdomyosarcoma</TD><TD>4173</TD><TD>64</TD><TD>16984</TD><TD>193</TD>
<TD>AOAH,PRSS12,NCKAP5,ROBO2,ZNF518B,AKAP9,NBEA,SLC10A2,PHLPP1,RASGEF1B,ADAMTS3,SS18,BCHE,THSD7A,SEZ6L,ASPN,CNTNAP2,WRN,FANCB,VAV3,FGFR2,SERGEF,AFM,DNER,KCNK9,IQGAP2,UCHL1,RPH3A,ACVR1C,THSD7B,UBR4,FMNL2,MAP2,GCNT1,FGD3,FBN2,MPEG1,ADAMTS5,CD226,GAP43,COQ2,ZFPM2,KIF6,JMJD1C,SPAG9,DSCAM,NRG1,RGS6,PTPRZ1,TCF20,SHISA3,FAT4,RBM20,FZD6,UHMK1,NOBOX,ARX,RYR2,LHCGR,PXDNL,INSM1,TRPS1,MRPL3,SLC39A10</TD></TR>
<TR><TD>4.272e-03</TD><TD>-5.46</TD><TD>growth factor binding</TD><TD>molecular function</TD><TD>GO:0019838</TD><TD>136</TD><TD>6</TD><TD>18530</TD><TD>207</TD>
<TD>TGFBR2,ACVR1C,CXCL13,FGFR2,NTRK2,ACVR2A</TD></TR>
<TR><TD>4.322e-03</TD><TD>-5.44</TD><TD>cell adhesion molecule binding</TD><TD>molecular function</TD><TD>GO:0050839</TD><TD>561</TD><TD>14</TD><TD>18530</TD><TD>207</TD>
<TD>ADAMTS5,NRG1,DSCAM,FMNL2,CNTN1,NRCAM,CD226,UTRN,EDIL3,PTPRD,CDH5,PTPRZ1,STXBP6,SHTN1</TD></TR>
<TR><TD>4.423e-03</TD><TD>-5.42</TD><TD>human chr3p24.1</TD><TD>chromosome location</TD><TD>human chr3p24.1</TD><TD>47</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LRRC3B,TGFBR2</TD></TR>
<TR><TD>4.443e-03</TD><TD>-5.42</TD><TD>EOGT (EGF domain specific O-linked N-acetylglucosamine transferase)</TD><TD>protein interactions</TD><TD>285203</TD><TD>60</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>SLC7A14,PTPRK,LGI1,PI15</TD></TR>
<TR><TD>4.445e-03</TD><TD>-5.42</TD><TD>Constitutive Signaling by Aberrant PI3K in Cancer</TD><TD>REACTOME pathways</TD><TD>R-HSA-2219530</TD><TD>65</TD><TD>4</TD><TD>10391</TD><TD>107</TD>
<TD>FGFR2,NRG1,FGF20,FGF5</TD></TR>
<TR><TD>4.502e-03</TD><TD>-5.40</TD><TD>cell surface receptor protein tyrosine kinase signaling pathway</TD><TD>biological process</TD><TD>GO:0007169</TD><TD>428</TD><TD>12</TD><TD>18905</TD><TD>220</TD>
<TD>GAREM1,EPHA4,FGF5,FGFR2,NRG1,EPHA3,EFNA5,FGF20,ZFAND5,SS18,EFEMP1,NTRK2</TD></TR>
<TR><TD>4.536e-03</TD><TD>-5.40</TD><TD>GTPase-bd</TD><TD>interpro domains</TD><TD>IPR010473</TD><TD>9</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>FMNL2,DAAM1</TD></TR>
<TR><TD>4.536e-03</TD><TD>-5.40</TD><TD>FH3_dom</TD><TD>interpro domains</TD><TD>IPR010472</TD><TD>9</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>DAAM1,FMNL2</TD></TR>
<TR><TD>4.536e-03</TD><TD>-5.40</TD><TD>Activin_recp</TD><TD>interpro domains</TD><TD>IPR000472</TD><TD>9</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>ACVR1C,ACVR2A</TD></TR>
<TR><TD>4.544e-03</TD><TD>-5.39</TD><TD>salivary gland morphogenesis</TD><TD>biological process</TD><TD>GO:0007435</TD><TD>29</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6,FGFR2,SEMA3C</TD></TR>
<TR><TD>4.551e-03</TD><TD>-5.39</TD><TD>adenoid_cystic_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>adenoid_cystic_carcinoma</TD><TD>1126</TD><TD>23</TD><TD>16984</TD><TD>193</TD>
<TD>AKAP9,DNAJC12,NTRK2,CD226,ACVR2A,UTRN,THSD7A,SEZ6L,JMJD1C,TGFBR2,PARP8,RBM20,UHMK1,FAT4,IQGAP2,FGFR2,CRTC3,FBN2,CASK,MAP2,NRCAM,PTPRK,RYR2</TD></TR>
<TR><TD>4.555e-03</TD><TD>-5.39</TD><TD>PCK2 (phosphoenolpyruvate carboxykinase 2, mitochondrial)</TD><TD>protein interactions</TD><TD>5106</TD><TD>97</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>EMC2,NUP35,COQ2,PRKCE,GAP43</TD></TR>
<TR><TD>4.557e-03</TD><TD>-5.39</TD><TD>Activin_recp</TD><TD>pfam domains</TD><TD>PF01064</TD><TD>9</TD><TD>2</TD><TD>17869</TD><TD>207</TD>
<TD>ACVR2A,ACVR1C</TD></TR>
<TR><TD>4.557e-03</TD><TD>-5.39</TD><TD>Drf_GBD</TD><TD>pfam domains</TD><TD>PF06371</TD><TD>9</TD><TD>2</TD><TD>17869</TD><TD>207</TD>
<TD>FMNL2,DAAM1</TD></TR>
<TR><TD>4.557e-03</TD><TD>-5.39</TD><TD>Drf_FH3</TD><TD>pfam domains</TD><TD>PF06367</TD><TD>9</TD><TD>2</TD><TD>17869</TD><TD>207</TD>
<TD>FMNL2,DAAM1</TD></TR>
<TR><TD>4.599e-03</TD><TD>-5.38</TD><TD>limb bud formation</TD><TD>biological process</TD><TD>GO:0060174</TD><TD>9</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,SEMA3C</TD></TR>
<TR><TD>4.599e-03</TD><TD>-5.38</TD><TD>spontaneous synaptic transmission</TD><TD>biological process</TD><TD>GO:0098814</TD><TD>9</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>SYT1,RPH3A</TD></TR>
<TR><TD>4.599e-03</TD><TD>-5.38</TD><TD>positive regulation of cardiac epithelial to mesenchymal transition</TD><TD>biological process</TD><TD>GO:0062043</TD><TD>9</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2,TWIST1</TD></TR>
<TR><TD>4.626e-03</TD><TD>-5.38</TD><TD>regulation of extent of cell growth</TD><TD>biological process</TD><TD>GO:0061387</TD><TD>93</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>SHTN1,DSCAM,EFNA5,NRCAM,MAP2</TD></TR>
<TR><TD>4.627e-03</TD><TD>-5.38</TD><TD>Regulation of beta-cell development</TD><TD>REACTOME pathways</TD><TD>R-HSA-186712</TD><TD>33</TD><TD>3</TD><TD>10391</TD><TD>107</TD>
<TD>INSM1,HNF4G,PAX6</TD></TR>
<TR><TD>4.627e-03</TD><TD>-5.38</TD><TD>FGFR2 mutant receptor activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-1839126</TD><TD>33</TD><TD>3</TD><TD>10391</TD><TD>107</TD>
<TD>FGF20,FGF5,FGFR2</TD></TR>
<TR><TD>4.632e-03</TD><TD>-5.37</TD><TD>LRAT</TD><TD>prosite domains</TD><TD>PS51934</TD><TD>8</TD><TD>2</TD><TD>12232</TD><TD>162</TD>
<TD>LRATD1,PLAAT1</TD></TR>
<TR><TD>4.632e-03</TD><TD>-5.37</TD><TD>DAD</TD><TD>prosite domains</TD><TD>PS51231</TD><TD>8</TD><TD>2</TD><TD>12232</TD><TD>162</TD>
<TD>FMNL2,DAAM1</TD></TR>
<TR><TD>4.679e-03</TD><TD>-5.36</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_T_cell_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_T_cell_leukaemia</TD><TD>740</TD><TD>17</TD><TD>16984</TD><TD>193</TD>
<TD>DSCAM,ADAMTS12,NRG1,CRTC3,RYR2,TGFBR2,PXDNL,PTPRD,TRPS1,NBEA,RPH3A,NOBOX,NOL4,PHF14,FGFR2,ROBO2,DNAJC12</TD></TR>
<TR><TD>4.679e-03</TD><TD>-5.36</TD><TD>acute_lymphoblastic_T_cell_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>acute_lymphoblastic_T_cell_leukaemia</TD><TD>740</TD><TD>17</TD><TD>16984</TD><TD>193</TD>
<TD>CRTC3,NRG1,DSCAM,ADAMTS12,PTPRD,TRPS1,PXDNL,TGFBR2,RYR2,NOBOX,RPH3A,NBEA,FGFR2,ROBO2,DNAJC12,PHF14,NOL4</TD></TR>
<TR><TD>4.836e-03</TD><TD>-5.33</TD><TD>regulation of locomotion</TD><TD>biological process</TD><TD>GO:0040012</TD><TD>1167</TD><TD>24</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2,NAV3,INSM1,SEMA3C,DSCAM,PECAM1,FUT9,TMEFF2,PAX6,SHTN1,ROBO2,PRKCE,CDH5,ACVR1C,EPHA4,FGF5,PTPRK,SLIT2,UNC5C,GCNT1,SPAG9,FGF20,CXCL13,TWIST1</TD></TR>
<TR><TD>4.841e-03</TD><TD>-5.33</TD><TD>positive regulation of neuron differentiation</TD><TD>biological process</TD><TD>GO:0045666</TD><TD>94</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>FGF20,SPAG9,NRCAM,PAX6,BRINP3</TD></TR>
<TR><TD>4.914e-03</TD><TD>-5.32</TD><TD>Tyr_kinase_AS</TD><TD>interpro domains</TD><TD>IPR008266</TD><TD>95</TD><TD>5</TD><TD>18605</TD><TD>215</TD>
<TD>EPHA3,EPHA4,NTRK2,FGFR2,TEC</TD></TR>
<TR><TD>4.920e-03</TD><TD>-5.31</TD><TD>GJA1 (gap junction protein alpha 1)</TD><TD>protein interactions</TD><TD>2697</TD><TD>572</TD><TD>14</TD><TD>20077</TD><TD>223</TD>
<TD>ROBO2,SLC39A10,PRKCE,LRIG3,CASK,PCDH9,EPHA4,NBEA,UNC5C,EFR3B,UTRN,WWOX,EPHA3,EFR3A</TD></TR>
<TR><TD>4.920e-03</TD><TD>-5.31</TD><TD>fibula</TD><TD>COSMIC cancer mutations</TD><TD>fibula</TD><TD>388</TD><TD>11</TD><TD>16984</TD><TD>193</TD>
<TD>SS18,SPATA16,BANK1,SERGEF,SKAP2,PHF14,NCKAP5,MPEG1,FBN2,DSCAM,ZFPM2</TD></TR>
<TR><TD>4.991e-03</TD><TD>-5.30</TD><TD>human chr2q32.3</TD><TD>chromosome location</TD><TD>human chr2q32.3</TD><TD>50</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>SLC39A10,TMEFF2</TD></TR>
<TR><TD>4.996e-03</TD><TD>-5.30</TD><TD>CETN1 (centrin 1)</TD><TD>protein interactions</TD><TD>1068</TD><TD>62</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>TWIST1,CALN1,ZFAND5,CETN3</TD></TR>
<TR><TD>5.035e-03</TD><TD>-5.29</TD><TD>Signaling pathways regulating pluripotency of stem cells</TD><TD>KEGG pathways</TD><TD>hsa04550</TD><TD>139</TD><TD>6</TD><TD>7246</TD><TD>83</TD>
<TD>FZD6,PCGF5,FGFR2,ACVR1C,ACVR2A,PAX6</TD></TR>
<TR><TD>5.035e-03</TD><TD>-5.29</TD><TD>Signaling pathways regulating pluripotency of stem cells</TD><TD>KEGG pathways</TD><TD>ko04550</TD><TD>139</TD><TD>6</TD><TD>7246</TD><TD>83</TD>
<TD>FGFR2,PCGF5,FZD6,PAX6,ACVR2A,ACVR1C</TD></TR>
<TR><TD>5.038e-03</TD><TD>-5.29</TD><TD>Negative regulation of FGFR2 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654727</TD><TD>34</TD><TD>3</TD><TD>10391</TD><TD>107</TD>
<TD>FGFR2,FGF20,FGF5</TD></TR>
<TR><TD>5.038e-03</TD><TD>-5.29</TD><TD>EPHA-mediated growth cone collapse</TD><TD>REACTOME pathways</TD><TD>R-HSA-3928663</TD><TD>34</TD><TD>3</TD><TD>10391</TD><TD>107</TD>
<TD>EPHA3,EFNA5,EPHA4</TD></TR>
<TR><TD>5.040e-03</TD><TD>-5.29</TD><TD>lung-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma</TD><TD>4282</TD><TD>65</TD><TD>16984</TD><TD>193</TD>
<TD>ADAM28,FGD3,CASK,RAI2,PTPRK,UBR4,SPHKAP,PAX6,CNTN1,RUNX1T1,ACVR1C,AMELX,IL1RAPL2,PHF14,ZNF521,FGFR2,DEPTOR,SERGEF,WRN,FANCB,VAV3,NOVA1,AKAP9,SPANXN1,RASGEF1B,ADAMTS3,MRPL13,SS18,IRX1,EDIL3,EPHA4,TSN,CXCL13,COX7B2,DNAJC12,NTRK2,PSKH2,ADAMTS12,IPO8,PRKCE,TRPS1,BACH2,FZD6,ARX,UHMK1,TWIST1,LRIG3,XPO4,RGS6,PTPRZ1,JMJD1C,SPAG9,PCGF5,DAAM1,SYT1,EPHA3,NUP35,TGFBR2,KIF6,PTPRD,PBX1,NAV3,RGS5,ADAMTS5,ACVR2A</TD></TR>
<TR><TD>5.042e-03</TD><TD>-5.29</TD><TD>gliogenesis</TD><TD>biological process</TD><TD>GO:0042063</TD><TD>275</TD><TD>9</TD><TD>18905</TD><TD>220</TD>
<TD>GAP43,NTRK2,PAX6,CNTN1,PTPRZ1,SLC25A46,EPHA4,FGF5,DNER</TD></TR>
<TR><TD>5.062e-03</TD><TD>-5.29</TD><TD>response to fibroblast growth factor</TD><TD>biological process</TD><TD>GO:0071774</TD><TD>95</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>FGF20,FGFR2,FGF5,PAX6,CXCL13</TD></TR>
<TR><TD>5.138e-03</TD><TD>-5.27</TD><TD>GOLM1 (golgi membrane protein 1)</TD><TD>protein interactions</TD><TD>51280</TD><TD>142</TD><TD>6</TD><TD>20077</TD><TD>223</TD>
<TD>GALNT15,THSD7A,SLC7A14,NRSN1,SYT1,FUT9</TD></TR>
<TR><TD>5.153e-03</TD><TD>-5.27</TD><TD>FGFR4 (fibroblast growth factor receptor 4)</TD><TD>protein interactions</TD><TD>2264</TD><TD>456</TD><TD>12</TD><TD>20077</TD><TD>223</TD>
<TD>SEPTIN5,UBR4,SLC39A10,PI15,ADAMTS12,FGF5,NRSN1,UTRN,EFR3B,EPHA4,TGFBR2,NBEA</TD></TR>
<TR><TD>5.161e-03</TD><TD>-5.27</TD><TD>sensory organ morphogenesis</TD><TD>biological process</TD><TD>GO:0090596</TD><TD>276</TD><TD>9</TD><TD>18905</TD><TD>220</TD>
<TD>FZD6,TWIST1,PAX6,EFEMP1,DSCAM,NTRK2,LRIG3,FGFR2,FBN2</TD></TR>
<TR><TD>5.211e-03</TD><TD>-5.26</TD><TD>soft_tissue-striated_muscle-rhabdomyosarcoma-alveolar</TD><TD>COSMIC cancer mutations</TD><TD>soft_tissue-striated_muscle-rhabdomyosarcoma-alveolar</TD><TD>2423</TD><TD>41</TD><TD>16984</TD><TD>193</TD>
<TD>MPEG1,FBN2,FMNL2,LHCGR,RYR2,TRPS1,MAP2,INSM1,IQGAP2,ACVR1C,UCHL1,KCNK9,DNER,RBM20,THSD7B,ARX,NOBOX,FZD6,SHISA3,SERGEF,FGFR2,SPAG9,CNTNAP2,THSD7A,JMJD1C,SEZ6L,VAV3,WRN,FANCB,KIF6,ZFPM2,BCHE,SLC10A2,ZNF518B,AKAP9,PHLPP1,NCKAP5,PRSS12,CD226,AOAH,ROBO2</TD></TR>
<TR><TD>5.211e-03</TD><TD>-5.26</TD><TD>alveolar</TD><TD>COSMIC cancer mutations</TD><TD>alveolar</TD><TD>2423</TD><TD>41</TD><TD>16984</TD><TD>193</TD>
<TD>FANCB,WRN,VAV3,JMJD1C,SEZ6L,THSD7A,CNTNAP2,SPAG9,BCHE,ZFPM2,KIF6,PHLPP1,AKAP9,ZNF518B,SLC10A2,ROBO2,AOAH,CD226,PRSS12,NCKAP5,FBN2,MPEG1,INSM1,MAP2,TRPS1,RYR2,LHCGR,FMNL2,SHISA3,THSD7B,FZD6,NOBOX,ARX,RBM20,DNER,KCNK9,ACVR1C,UCHL1,IQGAP2,FGFR2,SERGEF</TD></TR>
<TR><TD>5.265e-03</TD><TD>-5.25</TD><TD>protein tyrosine kinase activity</TD><TD>molecular function</TD><TD>GO:0004713</TD><TD>142</TD><TD>6</TD><TD>18530</TD><TD>207</TD>
<TD>TEC,FGFR2,NTRK2,EFEMP1,EPHA3,EPHA4</TD></TR>
<TR><TD>5.275e-03</TD><TD>-5.24</TD><TD>metallopeptidase activity</TD><TD>molecular function</TD><TD>GO:0008237</TD><TD>188</TD><TD>7</TD><TD>18530</TD><TD>207</TD>
<TD>CPQ,CPXM2,ADAMTS12,ADAM28,MATCAP2,ADAMTS3,ADAMTS5</TD></TR>
<TR><TD>5.307e-03</TD><TD>-5.24</TD><TD>stomach-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>stomach-carcinoma-adenocarcinoma</TD><TD>15170</TD><TD>183</TD><TD>16984</TD><TD>193</TD>
<TD>CD226,GMDS,SYT1,ERCC6L2,ZFPM2,TGFBR2,BANK1,SHISA3,FAT4,SERINC5,FZD6,RGS6,PTPRZ1,CD96,RYR2,LHCGR,SGCG,PHLPP1,RASGEF1B,PRSS12,ROBO2,THSD7A,ZNF133,VAV3,UNC5C,ACP6,DNER,RUNX1T1,SPATA16,ACVR1C,LRRN2,DAOA,FBN2,EFEMP1,PAQR3,CNTN1,GCNT1,GAP43,REG1B,CETN3,SPAG9,NRG1,DAAM1,UTRN,GPR83,BACH2,NOBOX,LRIG3,NAALADL2,ADAMTS12,IGFL4,INSM1,EPYC,ZNF518B,AKAP9,SLC10A2,SLC25A46,FUT9,MRPL13,IRX1,EPHA4,KAZN,PSKH2,ASPN,CNTNAP2,WRN,HNF4G,PARP8,REXO2,NOVA1,AFM,IQGAP2,GHITM,UCHL1,CYTL1,PLEK,IL1RAPL2,THSD7B,LGI1,FGF20,ADAM28,FGF14,CRTC3,PTPRK,UBR4,SLC7A8,LMBRD1,B3GAT2,FGF5,ADAMTS5,CHRM3,OR52K2,DSCAM,PCGF5,EFNA5,EPHA3,KIF6,TCF20,CPXM2,PRLHR,UHMK1,ARX,EFR3A,TWIST1,MUC7,TMEFF2,CELF2,XPO4,PRKCE,MRPL3,NRSN1,CALN1,LRRC3B,EDIL3,AOAH,COX7B2,SKAP2,BCHE,AGA,WWOX,CTSO,KCNK9,AMELX,RPH3A,KLF12,LRFN5,PHF14,DEPTOR,RAI2,OR2AG1,ATG10,NRCAM,PAX6,SLIT2,MAP2,MEGF10,PCDH9,NAV3,NAT2,RGS5,PWWP2A,COQ2,ACVR2A,SEMA3C,JMJD1C,NUP35,ZFAND5,PTPRD,LMX1A,SGCD,FERD3L,NOL4,PI15,SLC39A10,ZPLD1,FNIP2,IPO8,PXDNL,TRPS1,NBEA,FIGN,SPANXN1,ADAMTS3,SS18,NCKAP5,TSN,FABP7,DNAJC12,NTRK2,STXBP6,SEZ6L,EPS8,FANCB,ZNF521,FGFR2,SERGEF,FGD3,SLC7A14,CASK,CDH5,MPEG1,FMNL2,SPHKAP</TD></TR>
<TR><TD>5.388e-03</TD><TD>-5.22</TD><TD>salivary_gland</TD><TD>COSMIC cancer mutations</TD><TD>salivary_gland</TD><TD>1142</TD><TD>23</TD><TD>16984</TD><TD>193</TD>
<TD>TGFBR2,PARP8,JMJD1C,SEZ6L,THSD7A,UTRN,CD226,ACVR2A,NTRK2,DNAJC12,AKAP9,RYR2,PTPRK,NRCAM,MAP2,CASK,FBN2,CRTC3,FGFR2,IQGAP2,FAT4,UHMK1,RBM20</TD></TR>
<TR><TD>5.403e-03</TD><TD>-5.22</TD><TD>FAM171A2 (family with sequence similarity 171 member A2)</TD><TD>protein interactions</TD><TD>284069</TD><TD>101</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>EPHA4,TGFBR2,NTRK2,NRSN1,EPHA3</TD></TR>
<TR><TD>5.438e-03</TD><TD>-5.21</TD><TD>Signaling by activated point mutants of FGFR1</TD><TD>REACTOME pathways</TD><TD>R-HSA-1839122</TD><TD>11</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>5.496e-03</TD><TD>-5.20</TD><TD>activin receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0032924</TD><TD>31</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>ACVR1C,ACVR2A,TGFBR2</TD></TR>
<TR><TD>5.547e-03</TD><TD>-5.19</TD><TD>cardiac muscle tissue morphogenesis</TD><TD>biological process</TD><TD>GO:0055008</TD><TD>61</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>NRG1,ZFPM2,RYR2,FGFR2</TD></TR>
<TR><TD>5.547e-03</TD><TD>-5.19</TD><TD>regulation of microtubule polymerization</TD><TD>biological process</TD><TD>GO:0031113</TD><TD>61</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>CDH5,MAP2,AKAP9,NAV3</TD></TR>
<TR><TD>5.591e-03</TD><TD>-5.19</TD><TD>human chr14q21.1</TD><TD>chromosome location</TD><TD>human chr14q21.1</TD><TD>53</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LINC02315,LRFN5</TD></TR>
<TR><TD>5.594e-03</TD><TD>-5.19</TD><TD>CD83 (CD83 molecule)</TD><TD>protein interactions</TD><TD>9308</TD><TD>64</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>SPAG9,PTPRD,FGFR2,ACVR2A</TD></TR>
<TR><TD>5.594e-03</TD><TD>-5.19</TD><TD>RELT (RELT TNF receptor)</TD><TD>protein interactions</TD><TD>84957</TD><TD>64</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>NRSN1,ACVR2A,PTPRD,TGFBR2</TD></TR>
<TR><TD>5.594e-03</TD><TD>-5.19</TD><TD>protein kinase activity</TD><TD>molecular function</TD><TD>GO:0004672</TD><TD>578</TD><TD>14</TD><TD>18530</TD><TD>207</TD>
<TD>TGFBR2,TEC,CASK,NTRK2,FGFR2,ACVR1C,EPHA3,UHMK1,ACVR2A,PRKCE,EFEMP1,MAST4,PSKH2,EPHA4</TD></TR>
<TR><TD>5.606e-03</TD><TD>-5.18</TD><TD>head_neck</TD><TD>COSMIC cancer mutations</TD><TD>head_neck</TD><TD>15414</TD><TD>185</TD><TD>16984</TD><TD>193</TD>
<TD>EPYC,IGFL4,ADAMTS12,NAALADL2,LRIG3,NOBOX,BACH2,GPR83,DAAM1,UTRN,NRG1,SPAG9,CETN3,REG1B,GAP43,ARL14,B3GAT2,LMBRD1,UBR4,SLC7A8,PTPRK,FGF14,CRTC3,ADAM28,FGF20,LGI1,THSD7B,IL1RAPL2,CYTL1,PLEK,IQGAP2,UCHL1,AFM,NOVA1,PARP8,HNF4G,WRN,ASPN,CNTNAP2,PSKH2,KAZN,IRX1,EPHA4,MRPL13,SLC25A46,FUT9,SLC10A2,ZNF518B,AKAP9,SGCG,LHCGR,RYR2,CD96,RGS6,PTPRZ1,DEFB115,FZD6,SHISA3,SERINC5,FAT4,BANK1,ERCC6L2,ZFPM2,TGFBR2,SYT1,GMDS,CD226,GCNT1,CNTN1,PAQR3,EFEMP1,FBN2,LRRN2,DAOA,SPATA16,RUNX1T1,ACVR1C,DNER,ACP6,UNC5C,VAV3,ZNF133,THSD7A,ROBO2,PRSS12,PHLPP1,RASGEF1B,TRPS1,PXDNL,IPO8,FNIP2,ZPLD1,PI15,SLC39A10,NOL4,FERD3L,SGCD,LMX1A,PTPRD,NUP35,JMJD1C,SEMA3C,ACVR2A,PWWP2A,COQ2,NAV3,NAT2,RGS5,PCDH9,FMNL2,SPHKAP,MPEG1,CDH5,FGD3,SLC7A14,CASK,SERGEF,ZNF521,FGFR2,EPS8,FANCB,SEZ6L,STXBP6,DNAJC12,NTRK2,NCKAP5,TSN,ADAMTS3,SS18,SPANXN1,FIGN,NBEA,MRPL3,PRKCE,EFR3B,XPO4,CELF2,TMEFF2,TWIST1,MUC7,RBM20,EFR3A,UHMK1,ARX,CPXM2,PRLHR,TCF20,KIF6,EPHA3,PCGF5,EFNA5,DSCAM,OR52K2,CHRM3,ADAMTS5,FGF5,PBX1,MEGF10,MAP2,SLIT2,NRCAM,PAX6,ATG10,OR2AG1,LRRC70,RAI2,DEPTOR,PHF14,LRFN5,KLF12,RPH3A,AMELX,KCNK9,CTSO,WWOX,AGA,BCHE,SKAP2,CXCL13,COX7B2,EDIL3,AOAH,LRRC3B,CALN1,NRSN1</TD></TR>
<TR><TD>5.705e-03</TD><TD>-5.17</TD><TD>substrate-independent telencephalic tangential interneuron migration</TD><TD>biological process</TD><TD>GO:0021843</TD><TD>10</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>ARX,SLIT2</TD></TR>
<TR><TD>5.705e-03</TD><TD>-5.17</TD><TD>action potential propagation</TD><TD>biological process</TD><TD>GO:0098870</TD><TD>10</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>NTRK2,NRCAM</TD></TR>
<TR><TD>5.705e-03</TD><TD>-5.17</TD><TD>neuronal action potential propagation</TD><TD>biological process</TD><TD>GO:0019227</TD><TD>10</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>NTRK2,NRCAM</TD></TR>
<TR><TD>5.705e-03</TD><TD>-5.17</TD><TD>thrombin-activated receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0070493</TD><TD>10</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>IQGAP2,PLEK</TD></TR>
<TR><TD>5.705e-03</TD><TD>-5.17</TD><TD>substrate-independent telencephalic tangential migration</TD><TD>biological process</TD><TD>GO:0021826</TD><TD>10</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>ARX,SLIT2</TD></TR>
<TR><TD>5.705e-03</TD><TD>-5.17</TD><TD>learned vocalization behavior or vocal learning</TD><TD>biological process</TD><TD>GO:0098598</TD><TD>10</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>CNTNAP2,PAX6</TD></TR>
<TR><TD>5.705e-03</TD><TD>-5.17</TD><TD>pancreatic A cell differentiation</TD><TD>biological process</TD><TD>GO:0003310</TD><TD>10</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>INSM1,PAX6</TD></TR>
<TR><TD>5.705e-03</TD><TD>-5.17</TD><TD>regulation of dopaminergic neuron differentiation</TD><TD>biological process</TD><TD>GO:1904338</TD><TD>10</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>FGF20,FERD3L</TD></TR>
<TR><TD>5.770e-03</TD><TD>-5.16</TD><TD>HS6ST1 (heparan sulfate 6-O-sulfotransferase 1)</TD><TD>protein interactions</TD><TD>9394</TD><TD>33</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>CPQ,NRSN1,NRG1</TD></TR>
<TR><TD>5.790e-03</TD><TD>-5.15</TD><TD>FBXO2 (F-box protein 2)</TD><TD>protein interactions</TD><TD>26232</TD><TD>405</TD><TD>11</TD><TD>20077</TD><TD>223</TD>
<TD>PTPRK,EDIL3,CNTN1,FGFR2,SLIT2,PCDH9,AGA,LRIG3,SEMA3C,BCHE,FBN2</TD></TR>
<TR><TD>5.798e-03</TD><TD>-5.15</TD><TD>human chr4p15.1</TD><TD>chromosome location</TD><TD>human chr4p15.1</TD><TD>54</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LINC02484,LINC02497</TD></TR>
<TR><TD>5.972e-03</TD><TD>-5.12</TD><TD>Cell adhesion molecules (CAMs)</TD><TD>KEGG pathways</TD><TD>ko04514</TD><TD>144</TD><TD>6</TD><TD>7246</TD><TD>83</TD>
<TD>CNTNAP2,CDH5,PECAM1,CNTN1,CD226,NRCAM</TD></TR>
<TR><TD>5.972e-03</TD><TD>-5.12</TD><TD>Cell adhesion molecules (CAMs)</TD><TD>KEGG pathways</TD><TD>hsa04514</TD><TD>144</TD><TD>6</TD><TD>7246</TD><TD>83</TD>
<TD>CNTN1,PECAM1,CDH5,CNTNAP2,NRCAM,CD226</TD></TR>
<TR><TD>6.005e-03</TD><TD>-5.12</TD><TD>skeletal system development</TD><TD>biological process</TD><TD>GO:0001501</TD><TD>501</TD><TD>13</TD><TD>18905</TD><TD>220</TD>
<TD>AMELX,FGFR2,ACVR2A,TWIST1,WWOX,EPYC,FBN2,PBX1,ADAMTS12,TGFBR2,ZFAND5,CYTL1,TRPS1</TD></TR>
<TR><TD>6.013e-03</TD><TD>-5.11</TD><TD>salivary gland development</TD><TD>biological process</TD><TD>GO:0007431</TD><TD>32</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C,PAX6,FGFR2</TD></TR>
<TR><TD>6.219e-03</TD><TD>-5.08</TD><TD>ventricular cardiac muscle tissue development</TD><TD>biological process</TD><TD>GO:0003229</TD><TD>63</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,ZFPM2,RYR2,NRG1</TD></TR>
<TR><TD>6.223e-03</TD><TD>-5.08</TD><TD>human chr3p12.3</TD><TD>chromosome location</TD><TD>human chr3p12.3</TD><TD>56</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>ROBO2,LINC02077</TD></TR>
<TR><TD>6.254e-03</TD><TD>-5.07</TD><TD>glycosaminoglycan binding</TD><TD>molecular function</TD><TD>GO:0005539</TD><TD>244</TD><TD>8</TD><TD>18530</TD><TD>207</TD>
<TD>TGFBR2,EPYC,ADAMTS5,REG1B,FGFR2,ADAMTS3,SLIT2,CXCL13</TD></TR>
<TR><TD>6.254e-03</TD><TD>-5.07</TD><TD>human chr6q22.2</TD><TD>chromosome location</TD><TD>human chr6q22.2</TD><TD>3</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>LOC105377967</TD></TR>
<TR><TD>6.254e-03</TD><TD>-5.07</TD><TD>human chr9q11</TD><TD>chromosome location</TD><TD>human chr9q11</TD><TD>3</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>LOC102724904</TD></TR>
<TR><TD>6.302e-03</TD><TD>-5.07</TD><TD>protein phosphorylation</TD><TD>biological process</TD><TD>GO:0006468</TD><TD>504</TD><TD>13</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2,MAST4,FNIP2,UHMK1,EFEMP1,NTRK2,ACVR1C,TEC,EPHA4,FGFR2,ACVR2A,PRKCE,EPHA3</TD></TR>
<TR><TD>6.323e-03</TD><TD>-5.06</TD><TD>SCN3A (sodium voltage-gated channel alpha subunit 3)</TD><TD>protein interactions</TD><TD>6328</TD><TD>11</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>CNTN1,UCHL1</TD></TR>
<TR><TD>6.323e-03</TD><TD>-5.06</TD><TD>Caskin1 (CASK interacting protein 1)</TD><TD>protein interactions</TD><TD>140722</TD><TD>11</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>CASK,SYT1</TD></TR>
<TR><TD>6.323e-03</TD><TD>-5.06</TD><TD>CACNA1D (calcium voltage-gated channel subunit alpha1 D)</TD><TD>protein interactions</TD><TD>776</TD><TD>11</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>RYR2,FGFR2</TD></TR>
<TR><TD>6.330e-03</TD><TD>-5.06</TD><TD>cell junction assembly</TD><TD>biological process</TD><TD>GO:0034329</TD><TD>285</TD><TD>9</TD><TD>18905</TD><TD>220</TD>
<TD>DNER,PTPRK,PTPRD,SLC25A46,CDH5,PECAM1,ADGRL3,NRCAM,DSCAM</TD></TR>
<TR><TD>6.379e-03</TD><TD>-5.05</TD><TD>genital_tract-extragonadal-germ_cell_tumour-seminoma</TD><TD>COSMIC cancer mutations</TD><TD>genital_tract-extragonadal-germ_cell_tumour-seminoma</TD><TD>65</TD><TD>4</TD><TD>16984</TD><TD>193</TD>
<TD>FAT4,IPO8,CNTN1,ERCC6L2</TD></TR>
<TR><TD>6.392e-03</TD><TD>-5.05</TD><TD>neuropeptide Y receptor activity</TD><TD>molecular function</TD><TD>GO:0004983</TD><TD>11</TD><TD>2</TD><TD>18530</TD><TD>207</TD>
<TD>GPR83,PRLHR</TD></TR>
<TR><TD>6.392e-03</TD><TD>-5.05</TD><TD>activin binding</TD><TD>molecular function</TD><TD>GO:0048185</TD><TD>11</TD><TD>2</TD><TD>18530</TD><TD>207</TD>
<TD>ACVR2A,TGFBR2</TD></TR>
<TR><TD>6.397e-03</TD><TD>-5.05</TD><TD>nuclear envelope lumen</TD><TD>cellular component</TD><TD>GO:0005641</TD><TD>11</TD><TD>2</TD><TD>19868</TD><TD>222</TD>
<TD>BCHE,PLAAT1</TD></TR>
<TR><TD>6.428e-03</TD><TD>-5.05</TD><TD>regulation of cell migration</TD><TD>biological process</TD><TD>GO:0030334</TD><TD>1063</TD><TD>22</TD><TD>18905</TD><TD>220</TD>
<TD>CXCL13,TWIST1,GCNT1,UNC5C,SPAG9,FGF20,EPHA4,ACVR1C,PTPRK,SLIT2,FGF5,SHTN1,CDH5,PRKCE,PECAM1,TMEFF2,PAX6,FUT9,SEMA3C,NAV3,INSM1,TGFBR2</TD></TR>
<TR><TD>6.432e-03</TD><TD>-5.05</TD><TD>IL1/FGF</TD><TD>interpro domains</TD><TD>IPR008996</TD><TD>33</TD><TD>3</TD><TD>18605</TD><TD>215</TD>
<TD>FGF20,FGF5,FGF14</TD></TR>
<TR><TD>6.440e-03</TD><TD>-5.05</TD><TD>human chr21q22.2</TD><TD>chromosome location</TD><TD>human chr21q22.2</TD><TD>57</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>DSCAM-AS1,DSCAM</TD></TR>
<TR><TD>6.482e-03</TD><TD>-5.04</TD><TD>FGFR1c ligand binding and activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-190373</TD><TD>12</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF20,FGF5</TD></TR>
<TR><TD>6.482e-03</TD><TD>-5.04</TD><TD>FGFR3 mutant receptor activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-2033514</TD><TD>12</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF20,FGF5</TD></TR>
<TR><TD>6.482e-03</TD><TD>-5.04</TD><TD>Regulation of signaling by NODAL</TD><TD>REACTOME pathways</TD><TD>R-HSA-1433617</TD><TD>12</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>ACVR2A,ACVR1C</TD></TR>
<TR><TD>6.482e-03</TD><TD>-5.04</TD><TD>Signaling by activated point mutants of FGFR3</TD><TD>REACTOME pathways</TD><TD>R-HSA-1839130</TD><TD>12</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>6.558e-03</TD><TD>-5.03</TD><TD>regulation of mesenchymal cell proliferation</TD><TD>biological process</TD><TD>GO:0010464</TD><TD>33</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>PHF14,TGFBR2,FGFR2</TD></TR>
<TR><TD>6.577e-03</TD><TD>-5.02</TD><TD>EVA1B (eva-1 homolog B)</TD><TD>protein interactions</TD><TD>55194</TD><TD>67</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>PTPRK,GHITM,ACVR2A,NUP35</TD></TR>
<TR><TD>6.612e-03</TD><TD>-5.02</TD><TD>USP6NL (USP6 N-terminal like)</TD><TD>protein interactions</TD><TD>9712</TD><TD>106</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>EPS8,WWOX,EPHA4,FGFR2,NTRK2</TD></TR>
<TR><TD>6.699e-03</TD><TD>-5.01</TD><TD>cell adhesion mediator activity</TD><TD>molecular function</TD><TD>GO:0098631</TD><TD>67</TD><TD>4</TD><TD>18530</TD><TD>207</TD>
<TD>NRCAM,STXBP6,CNTN1,DSCAM</TD></TR>
<TR><TD>6.715e-03</TD><TD>-5.00</TD><TD>chest</TD><TD>COSMIC cancer mutations</TD><TD>chest</TD><TD>147</TD><TD>6</TD><TD>16984</TD><TD>193</TD>
<TD>PWWP2A,ADAMTS3,PTPRD,FGFR2,ACVR2A,CHRM3</TD></TR>
<TR><TD>6.725e-03</TD><TD>-5.00</TD><TD>skin-abdomen-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-abdomen-malignant_melanoma</TD><TD>405</TD><TD>11</TD><TD>16984</TD><TD>193</TD>
<TD>MPEG1,REG1B,FUT9,CALN1,ADAMTS12,RPH3A,NAV3,CHRM3,PTPRD,ROBO2,ADAMTS5</TD></TR>
<TR><TD>6.726e-03</TD><TD>-5.00</TD><TD>lung-middle_lobe-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-middle_lobe-carcinoma-adenocarcinoma</TD><TD>1370</TD><TD>26</TD><TD>16984</TD><TD>193</TD>
<TD>PCDH9,ADAMTS3,REG1B,NCKAP5,IRX1,STXBP6,CNTNAP2,SEZ6L,WRN,TGFBR2,ZFPM2,BCHE,PTPRD,ACVR1C,FAT4,NOL4,DEPTOR,FGFR2,ZNF521,SLC7A14,ADAMTS12,RAI2,FBN2,PAX6,RYR2,SLIT2</TD></TR>
<TR><TD>6.784e-03</TD><TD>-4.99</TD><TD>Galactose-binding domain-like</TD><TD>gene3d domains</TD><TD>2.60.120.260</TD><TD>97</TD><TD>5</TD><TD>14531</TD><TD>178</TD>
<TD>EPHA4,CNTNAP2,EDIL3,EPHA3,CPXM2</TD></TR>
<TR><TD>6.810e-03</TD><TD>-4.99</TD><TD>NRXN1 (neurexin 1)</TD><TD>protein interactions</TD><TD>9378</TD><TD>35</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>RPH3A,CASK,SYT1</TD></TR>
<TR><TD>6.826e-03</TD><TD>-4.99</TD><TD>Peptidase_M28</TD><TD>interpro domains</TD><TD>IPR007484</TD><TD>11</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>CPQ,NAALADL2</TD></TR>
<TR><TD>6.826e-03</TD><TD>-4.99</TD><TD>GBD/FH3_dom</TD><TD>interpro domains</TD><TD>IPR014768</TD><TD>11</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>DAAM1,FMNL2</TD></TR>
<TR><TD>6.857e-03</TD><TD>-4.98</TD><TD>MACPF</TD><TD>pfam domains</TD><TD>PF01823</TD><TD>11</TD><TD>2</TD><TD>17869</TD><TD>207</TD>
<TD>MPEG1,BRINP3</TD></TR>
<TR><TD>6.857e-03</TD><TD>-4.98</TD><TD>Peptidase_M28</TD><TD>pfam domains</TD><TD>PF04389</TD><TD>11</TD><TD>2</TD><TD>17869</TD><TD>207</TD>
<TD>NAALADL2,CPQ</TD></TR>
<TR><TD>6.857e-03</TD><TD>-4.98</TD><TD>RINGv</TD><TD>pfam domains</TD><TD>PF12906</TD><TD>11</TD><TD>2</TD><TD>17869</TD><TD>207</TD>
<TD>MARCHF3,MARCHF11</TD></TR>
<TR><TD>6.875e-03</TD><TD>-4.98</TD><TD>BMPR2 (bone morphogenetic protein receptor type 2)</TD><TD>protein interactions</TD><TD>659</TD><TD>107</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>NRSN1,CDH5,LMX1A,ACVR2A,NBEA</TD></TR>
<TR><TD>6.915e-03</TD><TD>-4.97</TD><TD>pancreas-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>pancreas-carcinoma</TD><TD>14868</TD><TD>180</TD><TD>16984</TD><TD>193</TD>
<TD>KAZN,PSKH2,IRX1,EPHA4,SLC25A46,MRPL13,ZNF518B,AKAP9,SLC10A2,REXO2,NOVA1,PARP8,WRN,ASPN,CNTNAP2,FGF20,CYTL1,PLEK,THSD7B,IL1RAPL2,LGI1,AFM,IQGAP2,GHITM,UCHL1,LMBRD1,B3GAT2,PTPRK,UBR4,SLC7A8,FGF14,CRTC3,ADAM28,REG1B,GAP43,GPR83,NRG1,DAAM1,UTRN,CETN3,SPAG9,LRIG3,BACH2,NOBOX,INSM1,EPYC,NAALADL2,ADAMTS12,ROBO2,PRSS12,PHLPP1,RASGEF1B,ACP6,UNC5C,VAV3,THSD7A,ZNF133,DNER,RUNX1T1,SPATA16,ACVR1C,GCNT1,CNTN1,FBN2,PAQR3,EFEMP1,LRRN2,DAOA,GMDS,CD226,DCDC2C,ERCC6L2,TGFBR2,ZFPM2,SYT1,RGS6,PTPRZ1,DEFB115,SHISA3,FAT4,FZD6,BANK1,SGCG,RYR2,LHCGR,CD96,DNAJC12,NTRK2,STXBP6,NCKAP5,TSN,FABP7,ADAMTS3,SS18,NBEA,FIGN,SPANXN1,EPS8,FANCB,SEZ6L,ZNF521,FGFR2,SERGEF,FMNL2,SPHKAP,CDH5,MPEG1,LINC00583,FGD3,SLC7A14,CASK,SEMA3C,ACVR2A,PWWP2A,COQ2,PCDH9,NAV3,RGS5,PTPRD,NUP35,JMJD1C,LINC01387,NOL4,LMX1A,SGCD,PXDNL,TRPS1,IPO8,ZPLD1,PI15,SLC39A10,SKAP2,AOAH,EDIL3,CXCL13,COX7B2,LRRC3B,NRSN1,AGA,CTSO,BCHE,DEPTOR,LRFN5,PHF14,KLF12,KCNK9,RPH3A,SLIT2,MAP2,MEGF10,ATG10,NRCAM,PAX6,RAI2,LRRC70,OR2AG1,ADAMTS5,FGF5,PBX1,EPHA3,KIF6,EFNA5,PCGF5,OR52K2,CHRM3,DSCAM,CELF2,XPO4,TWIST1,MUC7,TMEFF2,RBM20,EFR3A,ARX,TCF20,CPXM2,PRLHR,MRPL3,EFR3B,PRKCE</TD></TR>
<TR><TD>6.919e-03</TD><TD>-4.97</TD><TD>positive regulation of integrin activation</TD><TD>biological process</TD><TD>GO:0033625</TD><TD>11</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>CXCL13,PLEK</TD></TR>
<TR><TD>6.935e-03</TD><TD>-4.97</TD><TD>foot</TD><TD>COSMIC cancer mutations</TD><TD>foot</TD><TD>148</TD><TD>6</TD><TD>16984</TD><TD>193</TD>
<TD>PTPRD,ADAMTS3,PWWP2A,FAT4,ADAM28,CHRM3</TD></TR>
<TR><TD>6.937e-03</TD><TD>-4.97</TD><TD>mucin core 1 and core 2 O-glycosylation</TD><TD>BIOCYC pathways</TD><TD>HUMAN_PWY-7433</TD><TD>25</TD><TD>2</TD><TD>907</TD><TD>5</TD>
<TD>GCNT1,GALNT15</TD></TR>
<TR><TD>6.946e-03</TD><TD>-4.97</TD><TD>large_intestine-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>large_intestine-carcinoma-adenocarcinoma</TD><TD>16221</TD><TD>191</TD><TD>16984</TD><TD>193</TD>
<TD>FMNL2,SPHKAP,FGD3,CASK,SLC7A14,CDH5,MPEG1,ZNF521,FGFR2,SERGEF,SEZ6L,EPS8,FANCB,NCKAP5,TSN,FABP7,DNAJC12,NTRK2,STXBP6,NBEA,FIGN,SPANXN1,ADAMTS3,SS18,IPO8,PXDNL,TRPS1,PI15,SLC39A10,FNIP2,ZPLD1,NOL4,LMX1A,SGCD,FERD3L,ZFAND5,NUP35,PTPRD,JMJD1C,ACVR2A,SEMA3C,PCDH9,NAV3,RGS5,NAT2,COQ2,PWWP2A,ATG10,NRCAM,PAX6,SLIT2,MAP2,MEGF10,RAI2,LRRC70,OR2AG1,LRFN5,PHF14,DEPTOR,KCNK9,AMELX,RPH3A,KLF12,BCHE,WWOX,AGA,CTSO,EDIL3,AOAH,CXCL13,COX7B2,SKAP2,NRSN1,CALN1,LRRC3B,EFR3B,PRKCE,MRPL3,TWIST1,MUC7,TMEFF2,CELF2,XPO4,TCF20,PRLHR,CPXM2,RBM20,EFR3A,UHMK1,ARX,EPHA3,KIF6,CHRM3,OR52K2,DSCAM,EFNA5,PCGF5,ADAMTS5,PBX1,FGF5,PTPRK,UBR4,SLC7A8,LMBRD1,ARL14,B3GAT2,ADAM28,FGF14,CRTC3,FGF20,AFM,IQGAP2,GHITM,UCHL1,CYTL1,PLEK,IL1RAPL2,LGI1,THSD7B,HNF4G,PARP8,REXO2,NOVA1,ASPN,CNTNAP2,WRN,IRX1,EPHA4,KAZN,PSKH2,ZNF518B,AKAP9,SLC10A2,SLC25A46,FUT9,MRPL13,IGFL4,INSM1,EPYC,NAALADL2,ADAMTS12,LRIG3,BACH2,NOBOX,GPR83,CETN3,SPAG9,NRG1,UTRN,DAAM1,GAP43,REG1B,CNTN1,GCNT1,LRRN2,DAOA,FBN2,EFEMP1,PAQR3,DNER,RUNX1T1,SPATA16,ACVR1C,UNC5C,ACP6,THSD7A,ZNF133,VAV3,PRSS12,ROBO2,PHLPP1,RASGEF1B,RYR2,LHCGR,SGCG,CD96,DEFB115,RGS6,PTPRZ1,BANK1,SHISA3,FAT4,SERINC5,FZD6,ERCC6L2,TGFBR2,ZFPM2,SYT1,CD226,GMDS,DCDC2C</TD></TR>
<TR><TD>6.962e-03</TD><TD>-4.97</TD><TD>molecular transducer activity</TD><TD>molecular function</TD><TD>GO:0060089</TD><TD>1537</TD><TD>28</TD><TD>18530</TD><TD>207</TD>
<TD>LHCGR,EPHA4,OR52K2,CHRM3,ROBO2,LRRN2,PAQR3,ACVR1C,NTRK2,TGFBR2,REG1B,PTPRZ1,EFEMP1,GPR83,ADGRL3,ACVR2A,PECAM1,FZD6,EPHA3,DNER,IL1RAPL2,PRLHR,OR2AG1,UNC5C,PTPRD,FGFR2,PTPRK,HNF4G</TD></TR>
<TR><TD>6.962e-03</TD><TD>-4.97</TD><TD>signaling receptor activity</TD><TD>molecular function</TD><TD>GO:0038023</TD><TD>1537</TD><TD>28</TD><TD>18530</TD><TD>207</TD>
<TD>EPHA3,FZD6,ACVR2A,PECAM1,UNC5C,PTPRD,OR2AG1,IL1RAPL2,DNER,PRLHR,PTPRK,FGFR2,HNF4G,PTPRZ1,REG1B,ADGRL3,EFEMP1,GPR83,PAQR3,ACVR1C,ROBO2,LRRN2,NTRK2,TGFBR2,LHCGR,OR52K2,EPHA4,CHRM3</TD></TR>
<TR><TD>6.995e-03</TD><TD>-4.96</TD><TD>Peptidase_M12B_N</TD><TD>interpro domains</TD><TD>IPR002870</TD><TD>34</TD><TD>3</TD><TD>18605</TD><TD>215</TD>
<TD>ADAMTS3,ADAM28,ADAMTS12</TD></TR>
<TR><TD>7.006e-03</TD><TD>-4.96</TD><TD>cellular response to endogenous stimulus</TD><TD>biological process</TD><TD>GO:0071495</TD><TD>1137</TD><TD>23</TD><TD>18905</TD><TD>220</TD>
<TD>FGF20,WWOX,TWIST1,CXCL13,EFNA5,CDH5,PRKCE,ROBO2,RYR2,FGF5,ACVR2A,FGFR2,PTPRK,SLIT2,EPHA4,ACVR1C,GAREM1,AKAP9,NTRK2,PAX6,LHCGR,ADAMTS12,TGFBR2</TD></TR>
<TR><TD>7.027e-03</TD><TD>-4.96</TD><TD>response to endogenous stimulus</TD><TD>biological process</TD><TD>GO:0009719</TD><TD>1406</TD><TD>27</TD><TD>18905</TD><TD>220</TD>
<TD>NTRK2,ADAMTS12,TGFBR2,FGF20,GCNT1,GPR83,CDH5,BCHE,ACVR2A,FGF5,FGFR2,AKAP9,PAX6,LHCGR,WWOX,TWIST1,CXCL13,EFNA5,PRKCE,RYR2,ROBO2,REG1B,SLIT2,PTPRK,EPHA4,GAREM1,ACVR1C</TD></TR>
<TR><TD>7.039e-03</TD><TD>-4.96</TD><TD>Pep_M12B_propep</TD><TD>pfam domains</TD><TD>PF01562</TD><TD>34</TD><TD>3</TD><TD>17869</TD><TD>207</TD>
<TD>ADAMTS3,ADAM28,ADAMTS12</TD></TR>
<TR><TD>7.091e-03</TD><TD>-4.95</TD><TD>TyrKc</TD><TD>smart domains</TD><TD>SM00219</TD><TD>80</TD><TD>5</TD><TD>9743</TD><TD>147</TD>
<TD>TEC,EPHA4,FGFR2,EPHA3,NTRK2</TD></TR>
<TR><TD>7.101e-03</TD><TD>-4.95</TD><TD>regulation of biomineral tissue development</TD><TD>biological process</TD><TD>GO:0070167</TD><TD>103</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>TWIST1,ACVR2A,ASPN,FBN2,AMELX</TD></TR>
<TR><TD>7.282e-03</TD><TD>-4.92</TD><TD>leg</TD><TD>COSMIC cancer mutations</TD><TD>leg</TD><TD>970</TD><TD>20</TD><TD>16984</TD><TD>193</TD>
<TD>MEGF10,PTPRD,HNF4G,CNTN1,TGFBR2,CDH5,CHRM3,OR52K2,CNTNAP2,FGFR2,PTPRZ1,NOL4,FGF20,FAT4,ADAMTS3,PWWP2A,DNER,RUNX1T1,RPH3A,ACVR1C</TD></TR>
<TR><TD>7.284e-03</TD><TD>-4.92</TD><TD>heart development</TD><TD>biological process</TD><TD>GO:0007507</TD><TD>572</TD><TD>14</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,SGCG,RBM20,SLIT2,ROBO2,RYR2,DAW1,NRG1,SGCD,TWIST1,ZFPM2,ADAMTS5,TGFBR2,SEMA3C</TD></TR>
<TR><TD>7.292e-03</TD><TD>-4.92</TD><TD>TIGD5 (tigger transposable element derived 5)</TD><TD>protein interactions</TD><TD>84948</TD><TD>69</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>GAP43,CDH5,EFR3B,EFR3A</TD></TR>
<TR><TD>7.325e-03</TD><TD>-4.92</TD><TD>peptidyl-tyrosine phosphorylation</TD><TD>biological process</TD><TD>GO:0018108</TD><TD>66</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>EPHA3,EPHA4,FGFR2,EFEMP1</TD></TR>
<TR><TD>7.328e-03</TD><TD>-4.92</TD><TD>EFNB1 (ephrin B1)</TD><TD>protein interactions</TD><TD>1947</TD><TD>252</TD><TD>8</TD><TD>20077</TD><TD>223</TD>
<TD>EPHA3,ARL14,NRSN1,GHITM,ACVR2A,IPO8,XPO4,PHLPP1</TD></TR>
<TR><TD>7.338e-03</TD><TD>-4.91</TD><TD>pallium development</TD><TD>biological process</TD><TD>GO:0021543</TD><TD>192</TD><TD>7</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,PAX6,LMX1A,ARX,NTRK2,CNTNAP2,FAT4</TD></TR>
<TR><TD>7.339e-03</TD><TD>-4.91</TD><TD>regulation of nervous system development</TD><TD>biological process</TD><TD>GO:0051960</TD><TD>456</TD><TD>12</TD><TD>18905</TD><TD>220</TD>
<TD>PTPRD,FERD3L,DSCAM,NTRK2,PAX6,PTPRZ1,ROBO2,SHTN1,SLIT2,EPHA4,MAP2,EFNA5</TD></TR>
<TR><TD>7.344e-03</TD><TD>-4.91</TD><TD>human chr12q21.2</TD><TD>chromosome location</TD><TD>human chr12q21.2</TD><TD>61</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>SYT1,NAV3</TD></TR>
<TR><TD>7.369e-03</TD><TD>-4.91</TD><TD>PTPRB (protein tyrosine phosphatase receptor type B)</TD><TD>protein interactions</TD><TD>5787</TD><TD>36</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>CDH5,CNTN1,NRCAM</TD></TR>
<TR><TD>7.369e-03</TD><TD>-4.91</TD><TD>ARSG (arylsulfatase G)</TD><TD>protein interactions</TD><TD>22901</TD><TD>36</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>B3GAT2,ADAMTS12,PTPRK</TD></TR>
<TR><TD>7.416e-03</TD><TD>-4.90</TD><TD>human chr2q35</TD><TD>chromosome location</TD><TD>human chr2q35</TD><TD>188</TD><TD>3</TD><TD>193383</TD><TD>404</TD>
<TD>LINC00607,LINC01614,MIR4268</TD></TR>
<TR><TD>7.434e-03</TD><TD>-4.90</TD><TD>testis-germ_cell_tumour-seminoma</TD><TD>COSMIC cancer mutations</TD><TD>testis-germ_cell_tumour-seminoma</TD><TD>650</TD><TD>15</TD><TD>16984</TD><TD>193</TD>
<TD>PSKH2,RGS6,FGFR2,NTRK2,ACVR2A,EPHA4,UHMK1,ACVR1C,TRPS1,LMBRD1,TGFBR2,KIF6,PRKCE,EPHA3,CASK</TD></TR>
<TR><TD>7.486e-03</TD><TD>-4.89</TD><TD>Transferase(Phosphotransferase) domain 1</TD><TD>gene3d domains</TD><TD>1.10.510.10</TD><TD>491</TD><TD>13</TD><TD>14531</TD><TD>178</TD>
<TD>PRKCE,FGFR2,CASK,UHMK1,PSKH2,MAST4,TEC,EPHA3,ACVR2A,EPHA4,NTRK2,TGFBR2,ACVR1C</TD></TR>
<TR><TD>7.493e-03</TD><TD>-4.89</TD><TD>positive regulation of cellular component biogenesis</TD><TD>biological process</TD><TD>GO:0044089</TD><TD>515</TD><TD>13</TD><TD>18905</TD><TD>220</TD>
<TD>FNIP2,NTRK2,NAV3,PTPRD,EFNA5,EPS8,PLEK,CXCL13,CNTNAP2,AKAP9,NRG1,CDH5,PRKCE</TD></TR>
<TR><TD>7.506e-03</TD><TD>-4.89</TD><TD>kidney</TD><TD>COSMIC cancer mutations</TD><TD>kidney</TD><TD>15454</TD><TD>185</TD><TD>16984</TD><TD>193</TD>
<TD>ROBO2,PRSS12,PHLPP1,RASGEF1B,ACP6,UNC5C,VAV3,ZNF133,THSD7A,SPATA16,RUNX1T1,ACVR1C,DNER,GCNT1,CNTN1,PAQR3,EFEMP1,FBN2,LRRN2,DAOA,GMDS,CD226,DCDC2C,ERCC6L2,ZFPM2,TGFBR2,SYT1,RGS6,PTPRZ1,DEFB115,FZD6,FAT4,SERINC5,BANK1,SGCG,LHCGR,RYR2,CD96,PSKH2,KAZN,IRX1,EPHA4,MRPL13,SLC25A46,FUT9,SLC10A2,ZNF518B,AKAP9,REXO2,NOVA1,PARP8,HNF4G,WRN,ASPN,CNTNAP2,FGF20,LGI1,THSD7B,IL1RAPL2,PLEK,IQGAP2,GHITM,UCHL1,AFM,B3GAT2,LMBRD1,UBR4,SLC7A8,PTPRK,FGF14,CRTC3,ADAM28,REG1B,GAP43,GPR83,UTRN,DAAM1,NRG1,SPAG9,CETN3,LRIG3,NOBOX,BACH2,EPYC,IGFL4,ADAMTS12,NAALADL2,SKAP2,CXCL13,COX7B2,AOAH,EDIL3,LRRC3B,CALN1,NRSN1,CTSO,AGA,BCHE,DEPTOR,PHF14,LRFN5,KLF12,AMELX,RPH3A,KCNK9,MEGF10,MAP2,SLIT2,NRCAM,PAX6,ATG10,OR2AG1,LRRC70,RAI2,ADAMTS5,FGF5,PBX1,KIF6,EPHA3,EFNA5,PCGF5,DSCAM,OR52K2,CHRM3,XPO4,CELF2,TMEFF2,TWIST1,MUC7,RBM20,UHMK1,EFR3A,ARX,PRLHR,CPXM2,TCF20,MRPL3,PRKCE,EFR3B,STXBP6,DNAJC12,NTRK2,NCKAP5,TSN,ADAMTS3,SS18,FIGN,SPANXN1,NBEA,EPS8,FANCB,SEZ6L,SERGEF,ZNF521,FGFR2,FMNL2,SPHKAP,MPEG1,CDH5,FGD3,SLC7A14,CASK,SEMA3C,ACVR2A,COQ2,PWWP2A,NAV3,NAT2,RGS5,PCDH9,PTPRD,NUP35,ZFAND5,JMJD1C,LINC01387,NOL4,SGCD,LMX1A,TRPS1,PXDNL,IPO8,FNIP2,ZPLD1,PI15,SLC39A10</TD></TR>
<TR><TD>7.529e-03</TD><TD>-4.89</TD><TD>CD59</TD><TD>gene3d domains</TD><TD>2.10.60.10</TD><TD>33</TD><TD>3</TD><TD>14531</TD><TD>178</TD>
<TD>TGFBR2,ACVR2A,ACVR1C</TD></TR>
<TR><TD>7.533e-03</TD><TD>-4.89</TD><TD>ORF17.5 (ORF17.5)</TD><TD>protein interactions</TD><TD>4961482</TD><TD>12</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>GMDS,WWOX</TD></TR>
<TR><TD>7.579e-03</TD><TD>-4.88</TD><TD>human chrXq27.3</TD><TD>chromosome location</TD><TD>human chrXq27.3</TD><TD>62</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>MIR891A,SPANXN1</TD></TR>
<TR><TD>7.579e-03</TD><TD>-4.88</TD><TD>human chr7p21.1</TD><TD>chromosome location</TD><TD>human chr7p21.1</TD><TD>62</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>TWIST1,FERD3L</TD></TR>
<TR><TD>7.581e-03</TD><TD>-4.88</TD><TD>adrenal_gland</TD><TD>COSMIC cancer mutations</TD><TD>adrenal_gland</TD><TD>2628</TD><TD>43</TD><TD>16984</TD><TD>193</TD>
<TD>SERGEF,FGFR2,LRFN5,THSD7B,IL1RAPL2,UCHL1,RUNX1T1,KCNK9,MEGF10,CNTN1,UBR4,NRCAM,PTPRK,MPEG1,EFEMP1,RAI2,FBN2,NTRK2,NCKAP5,EPHA4,SS18,RASGEF1B,FIGN,NBEA,UNC5C,HNF4G,BCHE,WRN,PTPRZ1,RBM20,FAT4,BANK1,LHCGR,IPO8,RYR2,SEMA3C,CD226,ADAMTS5,PCDH9,PTPRD,TGFBR2,UTRN,CHRM3</TD></TR>
<TR><TD>7.586e-03</TD><TD>-4.88</TD><TD>positive regulation of cell development</TD><TD>biological process</TD><TD>GO:0010720</TD><TD>458</TD><TD>12</TD><TD>18905</TD><TD>220</TD>
<TD>EFNA5,SHTN1,ROBO2,PTPRZ1,CDH5,EPHA4,SLIT2,DSCAM,NTRK2,PAX6,TGFBR2,PTPRD</TD></TR>
<TR><TD>7.593e-03</TD><TD>-4.88</TD><TD>Drf_GBD</TD><TD>smart domains</TD><TD>SM01140</TD><TD>9</TD><TD>2</TD><TD>9743</TD><TD>147</TD>
<TD>DAAM1,FMNL2</TD></TR>
<TR><TD>7.593e-03</TD><TD>-4.88</TD><TD>Drf_FH3</TD><TD>smart domains</TD><TD>SM01139</TD><TD>9</TD><TD>2</TD><TD>9743</TD><TD>147</TD>
<TD>FMNL2,DAAM1</TD></TR>
<TR><TD>7.609e-03</TD><TD>-4.88</TD><TD>FGFR3 ligand binding and activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-190239</TD><TD>13</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>7.609e-03</TD><TD>-4.88</TD><TD>Signaling by Activin</TD><TD>REACTOME pathways</TD><TD>R-HSA-1502540</TD><TD>13</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>ACVR1C,ACVR2A</TD></TR>
<TR><TD>7.609e-03</TD><TD>-4.88</TD><TD>FGFR3c ligand binding and activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-190372</TD><TD>13</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF20,FGF5</TD></TR>
<TR><TD>7.609e-03</TD><TD>-4.88</TD><TD>Phospholipase C-mediated cascade; FGFR3</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654227</TD><TD>13</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>7.614e-03</TD><TD>-4.88</TD><TD>GTPase inhibitor activity</TD><TD>molecular function</TD><TD>GO:0005095</TD><TD>12</TD><TD>2</TD><TD>18530</TD><TD>207</TD>
<TD>IQGAP2,SLIT2</TD></TR>
<TR><TD>7.616e-03</TD><TD>-4.88</TD><TD>stomach</TD><TD>COSMIC cancer mutations</TD><TD>stomach</TD><TD>15576</TD><TD>186</TD><TD>16984</TD><TD>193</TD>
<TD>MRPL3,PRKCE,EFR3B,XPO4,CELF2,TMEFF2,TWIST1,MUC7,RBM20,EFR3A,UHMK1,ARX,PRLHR,CPXM2,TCF20,KIF6,EPHA3,EFNA5,PCGF5,DSCAM,CHRM3,OR52K2,ADAMTS5,FGF5,MAP2,MEGF10,SLIT2,NRCAM,PAX6,ATG10,OR2AG1,RAI2,DEPTOR,PHF14,LRFN5,KLF12,AMELX,RPH3A,KCNK9,CTSO,WWOX,AGA,BCHE,SKAP2,COX7B2,EDIL3,AOAH,LRRC3B,CALN1,NRSN1,TRPS1,PXDNL,IPO8,FNIP2,ZPLD1,PI15,SLC39A10,NOL4,FERD3L,SGCD,LMX1A,PTPRD,ZFAND5,NUP35,JMJD1C,SEMA3C,ACVR2A,PWWP2A,COQ2,NAV3,NAT2,RGS5,PCDH9,FMNL2,SPHKAP,MPEG1,CDH5,FGD3,CASK,SLC7A14,SERGEF,ZNF521,FGFR2,EPS8,FANCB,SEZ6L,STXBP6,DNAJC12,NTRK2,NCKAP5,TSN,FABP7,ADAMTS3,SS18,FIGN,SPANXN1,NBEA,SGCG,LHCGR,RYR2,CD96,RGS6,PTPRZ1,DEFB115,FZD6,SHISA3,FAT4,SERINC5,BANK1,ERCC6L2,TGFBR2,ZFPM2,SYT1,GMDS,CD226,GCNT1,CNTN1,EFEMP1,PAQR3,FBN2,LRRN2,DAOA,SPATA16,RUNX1T1,ACVR1C,DNER,ACP6,UNC5C,VAV3,ZNF133,THSD7A,ROBO2,PRSS12,PHLPP1,RASGEF1B,EPYC,INSM1,IGFL4,ADAMTS12,NAALADL2,LRIG3,NOBOX,BACH2,GPR83,UTRN,DAAM1,NRG1,SPAG9,CETN3,REG1B,GAP43,B3GAT2,LMBRD1,UBR4,SLC7A8,PTPRK,FGF14,CRTC3,ADAM28,FGF20,LGI1,IL1RAPL2,THSD7B,CYTL1,PLEK,GHITM,IQGAP2,UCHL1,AFM,REXO2,NOVA1,PARP8,HNF4G,WRN,ASPN,CNTNAP2,PSKH2,KAZN,IRX1,EPHA4,MRPL13,SLC25A46,FUT9,SLC10A2,ZNF518B,AKAP9</TD></TR>
<TR><TD>7.620e-03</TD><TD>-4.88</TD><TD>nuclear pore nuclear basket</TD><TD>cellular component</TD><TD>GO:0044615</TD><TD>12</TD><TD>2</TD><TD>19868</TD><TD>222</TD>
<TD>NUP35,CETN3</TD></TR>
<TR><TD>7.640e-03</TD><TD>-4.87</TD><TD>middle_lobe</TD><TD>COSMIC cancer mutations</TD><TD>middle_lobe</TD><TD>1384</TD><TD>26</TD><TD>16984</TD><TD>193</TD>
<TD>NOL4,DEPTOR,FGFR2,ZNF521,ACVR1C,FAT4,PAX6,RYR2,SLIT2,ADAMTS12,SLC7A14,RAI2,FBN2,NCKAP5,IRX1,STXBP6,PCDH9,ADAMTS3,REG1B,TGFBR2,ZFPM2,BCHE,PTPRD,CNTNAP2,SEZ6L,WRN</TD></TR>
<TR><TD>7.679e-03</TD><TD>-4.87</TD><TD>synapse</TD><TD>cellular component</TD><TD>GO:0045202</TD><TD>1474</TD><TD>27</TD><TD>19868</TD><TD>222</TD>
<TD>PRSS12,KCNK9,ADGRL3,SEPTIN5,PTPRD,DSCAM,EPS8,UTRN,IL1RAPL2,UNC5C,PTPRZ1,FGFR2,CNTNAP2,CASK,AKAP9,EPHA4,CNTN1,LGI1,CHRM3,GAP43,LRFN5,RPH3A,NRCAM,PRKCE,EFNA5,SYT1,NTRK2</TD></TR>
<TR><TD>7.685e-03</TD><TD>-4.87</TD><TD>LRR_SD22</TD><TD>smart domains</TD><TD>SM00365</TD><TD>52</TD><TD>4</TD><TD>9743</TD><TD>147</TD>
<TD>LRRC70,LRIG3,LRRN2,SLIT2</TD></TR>
<TR><TD>7.708e-03</TD><TD>-4.87</TD><TD>HOXB5 (homeobox B5)</TD><TD>protein interactions</TD><TD>3215</TD><TD>110</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>NUP35,EFR3B,PBX1,EFR3A,CNTN1</TD></TR>
<TR><TD>7.734e-03</TD><TD>-4.86</TD><TD>apoptotic process involved in development</TD><TD>biological process</TD><TD>GO:1902742</TD><TD>35</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,MEGF10,SLIT2</TD></TR>
<TR><TD>7.816e-03</TD><TD>-4.85</TD><TD>human chr3q26.31</TD><TD>chromosome location</TD><TD>human chr3q26.31</TD><TD>63</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>NAALADL2,SPATA16</TD></TR>
<TR><TD>7.857e-03</TD><TD>-4.85</TD><TD>embryonic organ morphogenesis</TD><TD>biological process</TD><TD>GO:0048562</TD><TD>295</TD><TD>9</TD><TD>18905</TD><TD>220</TD>
<TD>LRIG3,EFEMP1,PAX6,TWIST1,FZD6,RYR2,TGFBR2,FBN2,FGFR2</TD></TR>
<TR><TD>7.865e-03</TD><TD>-4.85</TD><TD>skin-ankle-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-ankle-malignant_melanoma</TD><TD>69</TD><TD>4</TD><TD>16984</TD><TD>193</TD>
<TD>ADAMTS3,PTPRD,CHRM3,ADAM28</TD></TR>
<TR><TD>7.955e-03</TD><TD>-4.83</TD><TD>HCRTR2 (hypocretin receptor 2)</TD><TD>protein interactions</TD><TD>3062</TD><TD>37</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>SLC25A46,ACTR3C,PTPRD</TD></TR>
<TR><TD>8.000e-03</TD><TD>-4.83</TD><TD>P2RY2 (purinergic receptor P2Y2)</TD><TD>protein interactions</TD><TD>5029</TD><TD>111</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>XPO4,CDH5,GHITM,SLC39A10,IPO8</TD></TR>
<TR><TD>8.056e-03</TD><TD>-4.82</TD><TD>FTSJ1 (FtsJ RNA 2'-O-methyltransferase 1)</TD><TD>protein interactions</TD><TD>24140</TD><TD>71</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>NTRK2,EPHA3,EPHA4,CHRM3</TD></TR>
<TR><TD>8.115e-03</TD><TD>-4.81</TD><TD>Kinase-like_dom_sf</TD><TD>interpro domains</TD><TD>IPR011009</TD><TD>524</TD><TD>13</TD><TD>18605</TD><TD>215</TD>
<TD>TGFBR2,PSKH2,EPHA4,ACVR2A,ACVR1C,PRKCE,EPHA3,NTRK2,UHMK1,CASK,FGFR2,MAST4,TEC</TD></TR>
<TR><TD>8.126e-03</TD><TD>-4.81</TD><TD>ST14 (ST14 transmembrane serine protease matriptase)</TD><TD>protein interactions</TD><TD>6768</TD><TD>205</TD><TD>7</TD><TD>20077</TD><TD>223</TD>
<TD>BCHE,EFNA5,FBN2,SEMA3C,SLIT2,GCNT1,AGA</TD></TR>
<TR><TD>8.129e-03</TD><TD>-4.81</TD><TD>MACPF</TD><TD>interpro domains</TD><TD>IPR020864</TD><TD>12</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>MPEG1,BRINP3</TD></TR>
<TR><TD>8.129e-03</TD><TD>-4.81</TD><TD>peptidyl-tyrosine modification</TD><TD>biological process</TD><TD>GO:0018212</TD><TD>68</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>EPHA4,EPHA3,FGFR2,EFEMP1</TD></TR>
<TR><TD>8.160e-03</TD><TD>-4.81</TD><TD>thyroid-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>thyroid-carcinoma</TD><TD>4128</TD><TD>62</TD><TD>16984</TD><TD>193</TD>
<TD>FBN2,SLIT2,MAP2,PTPRK,UBR4,PLEK,LGI1,THSD7B,AFM,RUNX1T1,ZNF521,FGFR2,FGF20,WRN,VAV3,SEZ6L,AGA,PARP8,RASGEF1B,FUT9,ADAMTS3,AKAP9,SPANXN1,ROBO2,KAZN,SKAP2,EPHA4,CXCL13,PRSS12,NAALADL2,TRPS1,IGFL4,RYR2,ARX,EFR3A,LMX1A,TCF20,CELF2,RGS6,XPO4,PTPRZ1,TWIST1,MUC7,NOL4,SYT1,DAAM1,UTRN,CHRM3,JMJD1C,SPAG9,DSCAM,GPR83,PTPRD,ZFAND5,ZFPM2,TGFBR2,PWWP2A,FGF5,PCDH9,NAV3,ACVR2A,GMDS</TD></TR>
<TR><TD>8.164e-03</TD><TD>-4.81</TD><TD>PROTEIN_KINASE_TYR</TD><TD>prosite domains</TD><TD>PS00109</TD><TD>94</TD><TD>5</TD><TD>12232</TD><TD>162</TD>
<TD>TEC,FGFR2,NTRK2,EPHA4,EPHA3</TD></TR>
<TR><TD>8.240e-03</TD><TD>-4.80</TD><TD>neuronal ion channel clustering</TD><TD>biological process</TD><TD>GO:0045161</TD><TD>12</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>NRCAM,CNTNAP2</TD></TR>
<TR><TD>8.241e-03</TD><TD>-4.80</TD><TD>large_intestine-caecum-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>large_intestine-caecum-carcinoma-adenocarcinoma</TD><TD>14247</TD><TD>174</TD><TD>16984</TD><TD>193</TD>
<TD>SLC39A10,PI15,ZPLD1,IPO8,PXDNL,TRPS1,LMX1A,FERD3L,NOL4,JMJD1C,NUP35,PTPRD,PCDH9,RGS5,NAT2,NAV3,PWWP2A,ACVR2A,SEMA3C,CASK,SLC7A14,FGD3,CDH5,MPEG1,SPHKAP,FMNL2,FGFR2,ZNF521,SERGEF,SEZ6L,FANCB,EPS8,NBEA,FIGN,SS18,ADAMTS3,TSN,NCKAP5,NTRK2,DNAJC12,STXBP6,PRKCE,MRPL3,TCF20,PRLHR,CPXM2,EFR3A,ARX,UHMK1,RBM20,MUC7,TWIST1,TMEFF2,CELF2,XPO4,OR52K2,CHRM3,DSCAM,EPHA3,KIF6,FGF5,ADAMTS5,RAI2,LRRC70,OR2AG1,ATG10,PAX6,NRCAM,SLIT2,MAP2,MEGF10,KCNK9,RPH3A,AMELX,KLF12,LRFN5,PHF14,BCHE,AGA,WWOX,CTSO,NRSN1,LRRC3B,EDIL3,AOAH,CXCL13,SKAP2,NAALADL2,ADAMTS12,INSM1,EPYC,BACH2,NOBOX,LRIG3,CETN3,SPAG9,NRG1,DAAM1,UTRN,GPR83,GAP43,REG1B,ADAM28,CRTC3,FGF14,PTPRK,SLC7A8,UBR4,LMBRD1,B3GAT2,AFM,UCHL1,IQGAP2,GHITM,PLEK,CYTL1,IL1RAPL2,LGI1,THSD7B,FGF20,CNTNAP2,ASPN,WRN,HNF4G,PARP8,NOVA1,REXO2,AKAP9,ZNF518B,SLC10A2,FUT9,SLC25A46,MRPL13,EPHA4,IRX1,KAZN,PSKH2,CD96,RYR2,LHCGR,SGCG,BANK1,SERINC5,FAT4,SHISA3,FZD6,DEFB115,PTPRZ1,RGS6,SYT1,TGFBR2,ZFPM2,ERCC6L2,GMDS,CD226,LRRN2,FBN2,EFEMP1,PAQR3,CNTN1,GCNT1,DNER,ACVR1C,SPATA16,RUNX1T1,THSD7A,ZNF133,VAV3,UNC5C,ACP6,RASGEF1B,PHLPP1,PRSS12,ROBO2</TD></TR>
<TR><TD>8.278e-03</TD><TD>-4.79</TD><TD>soft_tissue-striated_muscle-rhabdomyosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>soft_tissue-striated_muscle-rhabdomyosarcoma</TD><TD>596</TD><TD>14</TD><TD>16984</TD><TD>193</TD>
<TD>ZFPM2,RYR2,TRPS1,SPAG9,ASPN,SLC39A10,NRG1,IQGAP2,NBEA,SS18,COQ2,ADAMTS3,FAT4,RASGEF1B</TD></TR>
<TR><TD>8.293e-03</TD><TD>-4.79</TD><TD>appendage morphogenesis</TD><TD>biological process</TD><TD>GO:0035107</TD><TD>150</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C,TWIST1,FZD6,FGFR2,PBX1,FBN2</TD></TR>
<TR><TD>8.293e-03</TD><TD>-4.79</TD><TD>limb morphogenesis</TD><TD>biological process</TD><TD>GO:0035108</TD><TD>150</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>PBX1,FBN2,FGFR2,SEMA3C,TWIST1,FZD6</TD></TR>
<TR><TD>8.300e-03</TD><TD>-4.79</TD><TD>SIGLECL1 (SIGLEC family like 1)</TD><TD>protein interactions</TD><TD>284369</TD><TD>112</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>XPO4,FGFR2,CNTN1,SLC39A10,IPO8</TD></TR>
<TR><TD>8.313e-03</TD><TD>-4.79</TD><TD>regulation of cell morphogenesis</TD><TD>biological process</TD><TD>GO:0022604</TD><TD>246</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>PTPRD,SYT1,EPHA4,SPAG9,FMNL2,EFNA5,EPS8,FGD3</TD></TR>
<TR><TD>8.313e-03</TD><TD>-4.79</TD><TD>regulation of synapse organization</TD><TD>biological process</TD><TD>GO:0050807</TD><TD>246</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>IL1RAPL2,EPHA4,PTPRD,ROBO2,NRCAM,EFNA5,NTRK2,LRFN5</TD></TR>
<TR><TD>8.388e-03</TD><TD>-4.78</TD><TD>Glypican 1 network</TD><TD>Pathway Interaction DB</TD><TD>glypican_1pathway</TD><TD>26</TD><TD>3</TD><TD>2232</TD><TD>37</TD>
<TD>TGFBR2,NRG1,SLIT2</TD></TR>
<TR><TD>8.466e-03</TD><TD>-4.77</TD><TD>muscle structure development</TD><TD>biological process</TD><TD>GO:0061061</TD><TD>523</TD><TD>13</TD><TD>18905</TD><TD>220</TD>
<TD>TWIST1,SGCD,SPAG9,MEGF10,ZFPM2,DNER,FGFR2,SGCG,NRG1,RYR2,UCHL1,UTRN,ADAMTS5</TD></TR>
<TR><TD>8.507e-03</TD><TD>-4.77</TD><TD>pancreas</TD><TD>COSMIC cancer mutations</TD><TD>pancreas</TD><TD>16572</TD><TD>193</TD><TD>16984</TD><TD>193</TD>
<TD>PCDH9,NAV3,NAT2,RGS5,PWWP2A,COQ2,ACVR2A,SEMA3C,JMJD1C,ZFAND5,NUP35,PTPRD,LMX1A,SGCD,FERD3L,NOL4,LINC01387,PI15,SLC39A10,FNIP2,ZPLD1,IPO8,PXDNL,TRPS1,NBEA,FIGN,SPANXN1,ADAMTS3,SS18,TSN,NCKAP5,FABP7,DNAJC12,NTRK2,STXBP6,SEZ6L,EPS8,FANCB,ZNF521,FGFR2,SERGEF,LINC00583,FGD3,SLC7A14,CASK,CDH5,MPEG1,FMNL2,SPHKAP,PBX1,FGF5,ADAMTS5,OR52K2,CHRM3,DSCAM,EFNA5,PCGF5,EPHA3,KIF6,TCF20,CPXM2,PRLHR,RBM20,UHMK1,EFR3A,ARX,TWIST1,MUC7,TMEFF2,CELF2,XPO4,EFR3B,PRKCE,MRPL3,NRSN1,CALN1,LRRC3B,EDIL3,AOAH,CXCL13,COX7B2,SKAP2,BCHE,WWOX,AGA,CTSO,KCNK9,AMELX,RPH3A,KLF12,LRFN5,PHF14,DEPTOR,RAI2,OR2AG1,LRRC70,ATG10,NRCAM,PAX6,SLIT2,MAP2,MEGF10,GAP43,REG1B,CETN3,SPAG9,NRG1,UTRN,DAAM1,GPR83,BACH2,NOBOX,LRIG3,NAALADL2,ADAMTS12,IGFL4,INSM1,EPYC,ZNF518B,AKAP9,SLC10A2,SLC25A46,FUT9,MRPL13,IRX1,EPHA4,KAZN,PSKH2,ASPN,CNTNAP2,WRN,HNF4G,PARP8,REXO2,NOVA1,AFM,GHITM,IQGAP2,UCHL1,CYTL1,PLEK,IL1RAPL2,LGI1,THSD7B,FGF20,ADAM28,FGF14,CRTC3,PTPRK,UBR4,SLC7A8,LMBRD1,ARL14,B3GAT2,DCDC2C,CD226,GMDS,SYT1,ERCC6L2,TGFBR2,ZFPM2,BANK1,SHISA3,SERINC5,FAT4,FZD6,DEFB115,RGS6,PTPRZ1,CD96,RYR2,LHCGR,SGCG,PHLPP1,RASGEF1B,PRSS12,ROBO2,THSD7A,ZNF133,VAV3,UNC5C,ACP6,DNER,SPATA16,RUNX1T1,ACVR1C,LRRN2,DAOA,FBN2,PAQR3,EFEMP1,CNTN1,GCNT1</TD></TR>
<TR><TD>8.555e-03</TD><TD>-4.76</TD><TD>calmodulin binding</TD><TD>molecular function</TD><TD>GO:0005516</TD><TD>206</TD><TD>7</TD><TD>18530</TD><TD>207</TD>
<TD>MAP2,RYR2,IQGAP2,SYT1,UBR4,CASK,GAP43</TD></TR>
<TR><TD>8.567e-03</TD><TD>-4.76</TD><TD>LRRIQ1 (leucine rich repeats and IQ motif containing 1)</TD><TD>protein interactions</TD><TD>84125</TD><TD>38</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>FGFR2,ACVR2A,EPHA3</TD></TR>
<TR><TD>8.573e-03</TD><TD>-4.76</TD><TD>muscle tissue development</TD><TD>biological process</TD><TD>GO:0060537</TD><TD>353</TD><TD>10</TD><TD>18905</TD><TD>220</TD>
<TD>SGCD,MEGF10,ZFPM2,SEMA3C,FGFR2,SGCG,DNER,RYR2,ZFAND5,NRG1</TD></TR>
<TR><TD>8.732e-03</TD><TD>-4.74</TD><TD>integrin binding</TD><TD>molecular function</TD><TD>GO:0005178</TD><TD>158</TD><TD>6</TD><TD>18530</TD><TD>207</TD>
<TD>NRG1,UTRN,EDIL3,PTPRZ1,CD226,ADAMTS5</TD></TR>
<TR><TD>8.829e-03</TD><TD>-4.73</TD><TD>caecum</TD><TD>COSMIC cancer mutations</TD><TD>caecum</TD><TD>14259</TD><TD>174</TD><TD>16984</TD><TD>193</TD>
<TD>PARP8,HNF4G,REXO2,NOVA1,ASPN,CNTNAP2,WRN,IRX1,EPHA4,PSKH2,KAZN,SLC10A2,ZNF518B,AKAP9,MRPL13,SLC25A46,FUT9,UBR4,SLC7A8,PTPRK,B3GAT2,LMBRD1,ADAM28,FGF14,CRTC3,FGF20,IQGAP2,GHITM,UCHL1,AFM,IL1RAPL2,THSD7B,LGI1,CYTL1,PLEK,GPR83,SPAG9,CETN3,DAAM1,UTRN,NRG1,GAP43,REG1B,EPYC,INSM1,ADAMTS12,NAALADL2,LRIG3,NOBOX,BACH2,UNC5C,ACP6,ZNF133,THSD7A,VAV3,PRSS12,ROBO2,PHLPP1,RASGEF1B,CNTN1,GCNT1,LRRN2,PAQR3,EFEMP1,FBN2,RUNX1T1,SPATA16,ACVR1C,DNER,ERCC6L2,TGFBR2,ZFPM2,SYT1,GMDS,CD226,LHCGR,RYR2,SGCG,CD96,DEFB115,RGS6,PTPRZ1,BANK1,FZD6,SHISA3,FAT4,SERINC5,SEZ6L,EPS8,FANCB,TSN,NCKAP5,STXBP6,DNAJC12,NTRK2,FIGN,NBEA,ADAMTS3,SS18,FMNL2,SPHKAP,FGD3,CASK,SLC7A14,MPEG1,CDH5,SERGEF,ZNF521,FGFR2,NUP35,PTPRD,JMJD1C,ACVR2A,SEMA3C,NAV3,RGS5,NAT2,PCDH9,PWWP2A,IPO8,TRPS1,PXDNL,PI15,SLC39A10,ZPLD1,NOL4,LMX1A,FERD3L,BCHE,CTSO,AGA,WWOX,CXCL13,EDIL3,AOAH,SKAP2,NRSN1,LRRC3B,NRCAM,PAX6,ATG10,MAP2,MEGF10,SLIT2,LRRC70,OR2AG1,RAI2,PHF14,LRFN5,RPH3A,AMELX,KCNK9,KLF12,KIF6,EPHA3,DSCAM,OR52K2,CHRM3,ADAMTS5,FGF5,PRKCE,MRPL3,TMEFF2,TWIST1,MUC7,XPO4,CELF2,PRLHR,CPXM2,TCF20,RBM20,UHMK1,EFR3A,ARX</TD></TR>
<TR><TD>8.847e-03</TD><TD>-4.73</TD><TD>ameboidal-type cell migration</TD><TD>biological process</TD><TD>GO:0001667</TD><TD>199</TD><TD>7</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,CDH5,ZFAND5,CXCL13,TWIST1,PAX6,SEMA3C</TD></TR>
<TR><TD>8.864e-03</TD><TD>-4.73</TD><TD>ZF_RING_CH</TD><TD>prosite domains</TD><TD>PS51292</TD><TD>11</TD><TD>2</TD><TD>12232</TD><TD>162</TD>
<TD>MARCHF3,MARCHF11</TD></TR>
<TR><TD>8.864e-03</TD><TD>-4.73</TD><TD>GBD_FH3</TD><TD>prosite domains</TD><TD>PS51232</TD><TD>11</TD><TD>2</TD><TD>12232</TD><TD>162</TD>
<TD>FMNL2,DAAM1</TD></TR>
<TR><TD>8.871e-03</TD><TD>-4.72</TD><TD>PCDHGB1 (protocadherin gamma subfamily B, 1)</TD><TD>protein interactions</TD><TD>56104</TD><TD>73</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>FAT4,PTPRK,PCDH9,CNTN1</TD></TR>
<TR><TD>8.911e-03</TD><TD>-4.72</TD><TD>SAM_2</TD><TD>pfam domains</TD><TD>PF07647</TD><TD>37</TD><TD>3</TD><TD>17869</TD><TD>207</TD>
<TD>EPHA3,EPHA4,KAZN</TD></TR>
<TR><TD>8.945e-03</TD><TD>-4.72</TD><TD>protein binding</TD><TD>molecular function</TD><TD>GO:0005515</TD><TD>14097</TD><TD>172</TD><TD>18530</TD><TD>207</TD>
<TD>DAW1,CNTN1,MEGF10,PECAM1,ZFAND5,LGI1,PTPRD,DNER,PAX6,NAT2,SPHKAP,FHIP1A,WWOX,TEC,NRG1,IPO8,CTSO,EDIL3,LRFN5,INSM1,NOVA1,SHISA3,PTPRK,FGFR2,FUT9,ADAMTS12,RGS5,UNC5C,FGF14,JMJD1C,SS18,PLEK,SLC39A10,KAZN,RBM20,FNIP2,SEPTIN5,AKAP9,ACTR3C,PARP8,RPH3A,SLC25A46,TSN,SKAP2,FIGN,PLAAT1,EFR3B,KIF6,AGA,LMBRD1,UBR4,CRTC3,DEFB115,ERCC6L2,AOAH,SHTN1,ZFPM2,LRIG3,NUP35,NTRK2,ADAMTS5,FMNL2,TGFBR2,IQGAP2,CD226,NAALADL2,DAAM1,VAV3,EFNA5,GAP43,STXBP6,LRRC3B,CALN1,CXCL13,FERD3L,CNTNAP2,UTRN,MAP2,OR2AG1,XPO4,C8orf88,GALNT15,EFEMP1,AMELX,AFG2A,FGF5,TRPS1,SLC7A8,RUNX1T1,FAT4,MUC7,TMEFF2,DAOA,PCGF5,PUM3,RYR2,ACVR2A,TWIST1,BANK1,SERGEF,PBX1,PSKH2,ADAM28,FGD3,FGF20,RAI2,PHLPP1,ZNF133,EMC2,MTERF1,ROBO2,CHRM3,LRATD1,GMDS,SGCG,NBEA,LHCGR,ZNF521,BACH2,ARL14,DSCAM,EPHA3,PHF14,PRLHR,AFM,GHITM,ADGRL3,SLC7A14,CPQ,TCF20,FANCB,CASK,CDH5,EPS8,PWWP2A,CYTL1,SYT1,PRKCE,IGFL4,NRSN1,WRN,PTPRZ1,LMX1A,SEMA3C,GAREM1,DNAJC12,ADAMTS3,GCNT1,NRCAM,PAQR3,ARX,SLIT2,MRPL13,SLC10A2,UCHL1,BCHE,FBN2,EPHA4,FABP7,DEPTOR,FZD6,MARCHF3,RGS6,KLF12,THSD7A,NAV3,UHMK1,ACVR1C,CETN3,SPAG9,ATG10,THSD7B</TD></TR>
<TR><TD>9.055e-03</TD><TD>-4.70</TD><TD>human chr22q12.1</TD><TD>chromosome location</TD><TD>human chr22q12.1</TD><TD>68</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>SEZ6L,MIR5739</TD></TR>
<TR><TD>9.055e-03</TD><TD>-4.70</TD><TD>human chr3q13.33</TD><TD>chromosome location</TD><TD>human chr3q13.33</TD><TD>68</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>ARHGAP31-AS1,LINC02049</TD></TR>
<TR><TD>9.111e-03</TD><TD>-4.70</TD><TD>collagen-containing extracellular matrix</TD><TD>cellular component</TD><TD>GO:0062023</TD><TD>429</TD><TD>11</TD><TD>19868</TD><TD>222</TD>
<TD>EDIL3,EFNA5,ASPN,FBN2,ADAMTS5,PTPRZ1,ADAMTS3,FGFR2,EFEMP1,CASK,AMELX</TD></TR>
<TR><TD>9.143e-03</TD><TD>-4.69</TD><TD>back</TD><TD>COSMIC cancer mutations</TD><TD>back</TD><TD>310</TD><TD>9</TD><TD>16984</TD><TD>193</TD>
<TD>LRIG3,PTPRD,FGFR2,GHITM,CHRM3,ADAM28,ADAMTS3,PWWP2A,LGI1</TD></TR>
<TR><TD>9.215e-03</TD><TD>-4.69</TD><TD>LGALS1 (galectin 1)</TD><TD>protein interactions</TD><TD>3956</TD><TD>317</TD><TD>9</TD><TD>20077</TD><TD>223</TD>
<TD>PTPRK,SLC39A10,PECAM1,FAT4,PCDH9,NRCAM,PTPRD,PTPRZ1,ADGRL3</TD></TR>
<TR><TD>9.312e-03</TD><TD>-4.68</TD><TD>human chr7p21.3</TD><TD>chromosome location</TD><TD>human chr7p21.3</TD><TD>69</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>PHF14,THSD7A</TD></TR>
<TR><TD>9.316e-03</TD><TD>-4.68</TD><TD>PIP3 activates AKT signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-1257604</TD><TD>125</TD><TD>5</TD><TD>10391</TD><TD>107</TD>
<TD>FGF20,PHLPP1,FGF5,FGFR2,NRG1</TD></TR>
<TR><TD>9.534e-03</TD><TD>-4.65</TD><TD>AA/rel_permease1</TD><TD>interpro domains</TD><TD>IPR002293</TD><TD>13</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>SLC7A14,SLC7A8</TD></TR>
<TR><TD>9.534e-03</TD><TD>-4.65</TD><TD>regulation of synapse structure or activity</TD><TD>biological process</TD><TD>GO:0050803</TD><TD>252</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>NRCAM,EFNA5,NTRK2,LRFN5,EPHA4,IL1RAPL2,ROBO2,PTPRD</TD></TR>
<TR><TD>9.577e-03</TD><TD>-4.65</TD><TD>AA_permease_2</TD><TD>pfam domains</TD><TD>PF13520</TD><TD>13</TD><TD>2</TD><TD>17869</TD><TD>207</TD>
<TD>SLC7A14,SLC7A8</TD></TR>
<TR><TD>9.620e-03</TD><TD>-4.64</TD><TD>DNA-binding transcription repressor activity, RNA polymerase II-specific</TD><TD>molecular function</TD><TD>GO:0001227</TD><TD>263</TD><TD>8</TD><TD>18530</TD><TD>207</TD>
<TD>ARX,KLF12,TRPS1,IRX1,PAX6,INSM1,FERD3L,BACH2</TD></TR>
<TR><TD>9.622e-03</TD><TD>-4.64</TD><TD>central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-medullomyoblastoma</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-medullomyoblastoma</TD><TD>485</TD><TD>12</TD><TD>16984</TD><TD>193</TD>
<TD>RYR2,LHCGR,CNTN1,SPHKAP,NOVA1,AKAP9,PCDH9,BACH2,IL1RAPL2,PAQR3,UTRN,FGF14</TD></TR>
<TR><TD>9.622e-03</TD><TD>-4.64</TD><TD>medullomyoblastoma</TD><TD>COSMIC cancer mutations</TD><TD>medullomyoblastoma</TD><TD>485</TD><TD>12</TD><TD>16984</TD><TD>193</TD>
<TD>NOVA1,RYR2,SPHKAP,CNTN1,LHCGR,PAQR3,UTRN,FGF14,BACH2,IL1RAPL2,PCDH9,AKAP9</TD></TR>
<TR><TD>9.663e-03</TD><TD>-4.64</TD><TD>regulation of T cell tolerance induction</TD><TD>biological process</TD><TD>GO:0002664</TD><TD>13</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>PHLPP1,TGFBR2</TD></TR>
<TR><TD>9.663e-03</TD><TD>-4.64</TD><TD>negative regulation of microtubule polymerization</TD><TD>biological process</TD><TD>GO:0031115</TD><TD>13</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>MAP2,CDH5</TD></TR>
<TR><TD>9.663e-03</TD><TD>-4.64</TD><TD>regulation of tooth mineralization</TD><TD>biological process</TD><TD>GO:0070170</TD><TD>13</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>ASPN,AMELX</TD></TR>
<TR><TD>9.663e-03</TD><TD>-4.64</TD><TD>detection of calcium ion</TD><TD>biological process</TD><TD>GO:0005513</TD><TD>13</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>RYR2,SYT1</TD></TR>
<TR><TD>9.718e-03</TD><TD>-4.63</TD><TD>Signaling by FGFR2 in disease</TD><TD>REACTOME pathways</TD><TD>R-HSA-5655253</TD><TD>43</TD><TD>3</TD><TD>10391</TD><TD>107</TD>
<TD>FGF20,FGF5,FGFR2</TD></TR>
<TR><TD>9.806e-03</TD><TD>-4.62</TD><TD>regulation of protein polymerization</TD><TD>biological process</TD><TD>GO:0032271</TD><TD>203</TD><TD>7</TD><TD>18905</TD><TD>220</TD>
<TD>NAV3,AKAP9,SLIT2,PRKCE,CDH5,EPS8,MAP2</TD></TR>
<TR><TD>9.807e-03</TD><TD>-4.62</TD><TD>growth factor activity</TD><TD>molecular function</TD><TD>GO:0008083</TD><TD>162</TD><TD>6</TD><TD>18530</TD><TD>207</TD>
<TD>FGF20,FGF5,AMELX,NRG1,FGF14,EFEMP1</TD></TR>
<TR><TD>9.824e-03</TD><TD>-4.62</TD><TD>testis</TD><TD>COSMIC cancer mutations</TD><TD>testis</TD><TD>735</TD><TD>16</TD><TD>16984</TD><TD>193</TD>
<TD>LMBRD1,TRPS1,EPHA3,PRKCE,TGFBR2,KIF6,NAALADL2,CASK,NTRK2,FGFR2,PSKH2,RGS6,EPHA4,ACVR2A,UHMK1,ACVR1C</TD></TR>
<TR><TD>9.872e-03</TD><TD>-4.62</TD><TD>CPNE5 (copine 5)</TD><TD>protein interactions</TD><TD>57699</TD><TD>40</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>UTRN,DSCAM,UBR4</TD></TR>
<TR><TD>9.890e-03</TD><TD>-4.62</TD><TD>bone-pelvis-chondrosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>bone-pelvis-chondrosarcoma</TD><TD>314</TD><TD>9</TD><TD>16984</TD><TD>193</TD>
<TD>MEGF10,RYR2,DAAM1,NOBOX,SPATA16,NAV3,FGD3,SGCD,FIGN</TD></TR>
<TR><TD>9.900e-03</TD><TD>-4.62</TD><TD>EGF_CA</TD><TD>smart domains</TD><TD>SM00179</TD><TD>121</TD><TD>6</TD><TD>9743</TD><TD>147</TD>
<TD>DNER,FAT4,EDIL3,SLIT2,EFEMP1,FBN2</TD></TR>
<TR><TD>9.908e-03</TD><TD>-4.61</TD><TD>negative regulation of neuron differentiation</TD><TD>biological process</TD><TD>GO:0045665</TD><TD>72</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>SPAG9,PAX6,LMX1A,PBX1</TD></TR>
<TR><TD>9.918e-03</TD><TD>-4.61</TD><TD>ARL14 (ADP ribosylation factor like GTPase 14)</TD><TD>protein interactions</TD><TD>80117</TD><TD>117</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>PCDH9,SLC39A10,CASK,NBEA,FAT4</TD></TR>
<TR><TD>1.000e-02</TD><TD>-4.60</TD><TD>anatomical structure formation involved in morphogenesis</TD><TD>biological process</TD><TD>GO:0048646</TD><TD>974</TD><TD>20</TD><TD>18905</TD><TD>220</TD>
<TD>FBN2,ADAMTS5,VAV3,SLC25A46,TGFBR2,CNTN1,PAX6,FZD6,SEMA3C,DSCAM,IRX1,AMELX,SLIT2,RBM20,FGFR2,ROBO2,NRCAM,TWIST1,CXCL13,THSD7A</TD></TR>
<TR><TD>1.003e-02</TD><TD>-4.60</TD><TD>Signalling by NGF</TD><TD>REACTOME pathways</TD><TD>R-HSA-166520</TD><TD>478</TD><TD>11</TD><TD>10391</TD><TD>107</TD>
<TD>PAQR3,FGF20,PRKCE,NTRK2,VAV3,NRG1,FGF5,AKAP9,FGD3,PHLPP1,FGFR2</TD></TR>
<TR><TD>1.011e-02</TD><TD>-4.59</TD><TD>enzyme binding</TD><TD>molecular function</TD><TD>GO:0019899</TD><TD>2100</TD><TD>35</TD><TD>18530</TD><TD>207</TD>
<TD>RPH3A,CD226,IQGAP2,UHMK1,NTRK2,FMNL2,IPO8,PARP8,NRG1,BCHE,UCHL1,LHCGR,EPHA4,CDH5,EPS8,DAAM1,INSM1,NBEA,SPAG9,UTRN,FZD6,RYR2,PRKCE,XPO4,UNC5C,BANK1,TWIST1,PTPRK,CNTNAP2,DSCAM,PLEK,WWOX,PAX6,ERCC6L2,FGD3</TD></TR>
<TR><TD>1.024e-02</TD><TD>-4.58</TD><TD>SYNPR (synaptoporin)</TD><TD>protein interactions</TD><TD>132204</TD><TD>14</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>SPAG9,GALNT15</TD></TR>
<TR><TD>1.024e-02</TD><TD>-4.58</TD><TD>Snake_toxin-like_sf</TD><TD>interpro domains</TD><TD>IPR045860</TD><TD>39</TD><TD>3</TD><TD>18605</TD><TD>215</TD>
<TD>ACVR1C,ACVR2A,TGFBR2</TD></TR>
<TR><TD>1.025e-02</TD><TD>-4.58</TD><TD>cell body</TD><TD>cellular component</TD><TD>GO:0044297</TD><TD>558</TD><TD>13</TD><TD>19868</TD><TD>222</TD>
<TD>SEZ6L,BRINP3,UNC5C,UCHL1,DNER,MAP2,NRSN1,CNTNAP2,EPHA4,AKAP9,GAP43,DSCAM,SHTN1</TD></TR>
<TR><TD>1.026e-02</TD><TD>-4.58</TD><TD>GAB1 signalosome</TD><TD>REACTOME pathways</TD><TD>R-HSA-180292</TD><TD>128</TD><TD>5</TD><TD>10391</TD><TD>107</TD>
<TD>FGFR2,NRG1,FGF20,PHLPP1,FGF5</TD></TR>
<TR><TD>1.026e-02</TD><TD>-4.58</TD><TD>PI3K/AKT activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-198203</TD><TD>128</TD><TD>5</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,PHLPP1,FGF20,NRG1,FGFR2</TD></TR>
<TR><TD>1.027e-02</TD><TD>-4.58</TD><TD>SHTN1 (shootin 1)</TD><TD>protein interactions</TD><TD>57698</TD><TD>118</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>BCHE,SHTN1,PHLPP1,MEGF10,DSCAM</TD></TR>
<TR><TD>1.030e-02</TD><TD>-4.58</TD><TD>Mitochondrial transcription termination</TD><TD>REACTOME pathways</TD><TD>R-HSA-163316</TD><TD>1</TD><TD>1</TD><TD>10391</TD><TD>107</TD>
<TD>MTERF1</TD></TR>
<TR><TD>1.030e-02</TD><TD>-4.58</TD><TD>Signaling by FGFR2 fusions</TD><TD>REACTOME pathways</TD><TD>R-HSA-8853333</TD><TD>1</TD><TD>1</TD><TD>10391</TD><TD>107</TD>
<TD>FGFR2</TD></TR>
<TR><TD>1.030e-02</TD><TD>-4.58</TD><TD>Signaling by FGFR2 amplification mutants</TD><TD>REACTOME pathways</TD><TD>R-HSA-2023837</TD><TD>1</TD><TD>1</TD><TD>10391</TD><TD>107</TD>
<TD>FGFR2</TD></TR>
<TR><TD>1.031e-02</TD><TD>-4.57</TD><TD>striated muscle tissue development</TD><TD>biological process</TD><TD>GO:0014706</TD><TD>205</TD><TD>7</TD><TD>18905</TD><TD>220</TD>
<TD>RYR2,NRG1,SGCG,FGFR2,SEMA3C,ZFPM2,SGCD</TD></TR>
<TR><TD>1.037e-02</TD><TD>-4.57</TD><TD>human chr9q21.13</TD><TD>chromosome location</TD><TD>human chr9q21.13</TD><TD>73</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>ZFAND5,GCNT1</TD></TR>
<TR><TD>1.044e-02</TD><TD>-4.56</TD><TD>animal organ formation</TD><TD>biological process</TD><TD>GO:0048645</TD><TD>39</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>RBM20,FGFR2,TGFBR2</TD></TR>
<TR><TD>1.044e-02</TD><TD>-4.56</TD><TD>negative regulation of microtubule polymerization or depolymerization</TD><TD>biological process</TD><TD>GO:0031111</TD><TD>39</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>CDH5,MAP2,NAV3</TD></TR>
<TR><TD>1.045e-02</TD><TD>-4.56</TD><TD>chromophobe_renal_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>chromophobe_renal_cell_carcinoma</TD><TD>431</TD><TD>11</TD><TD>16984</TD><TD>193</TD>
<TD>ACVR2A,EPHA4,PSKH2,NTRK2,FGFR2,ACVR1C,UHMK1,TGFBR2,PRKCE,EPHA3,CASK</TD></TR>
<TR><TD>1.045e-02</TD><TD>-4.56</TD><TD>kidney-carcinoma-chromophobe_renal_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>kidney-carcinoma-chromophobe_renal_cell_carcinoma</TD><TD>431</TD><TD>11</TD><TD>16984</TD><TD>193</TD>
<TD>CASK,TGFBR2,PRKCE,EPHA3,UHMK1,ACVR1C,PSKH2,FGFR2,NTRK2,ACVR2A,EPHA4</TD></TR>
<TR><TD>1.061e-02</TD><TD>-4.55</TD><TD>TYRKINASE</TD><TD>prints domains</TD><TD>PR00109</TD><TD>98</TD><TD>5</TD><TD>5258</TD><TD>72</TD>
<TD>EPHA3,TEC,NTRK2,EPHA4,FGFR2</TD></TR>
<TR><TD>1.065e-02</TD><TD>-4.54</TD><TD>positive regulation of growth</TD><TD>biological process</TD><TD>GO:0045927</TD><TD>257</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>SYT1,LGI1,SHTN1,FGFR2,DSCAM,ZFPM2,EFNA5,ARX</TD></TR>
<TR><TD>1.086e-02</TD><TD>-4.52</TD><TD>negative regulation of cytoskeleton organization</TD><TD>biological process</TD><TD>GO:0051494</TD><TD>159</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,NAV3,CDH5,MAP2,TMEFF2,EPS8</TD></TR>
<TR><TD>1.087e-02</TD><TD>-4.52</TD><TD>FNTYPEIII</TD><TD>prints domains</TD><TD>PR00014</TD><TD>34</TD><TD>3</TD><TD>5258</TD><TD>72</TD>
<TD>EPHA3,PTPRD,EPHA4</TD></TR>
<TR><TD>1.088e-02</TD><TD>-4.52</TD><TD>negative regulation of protein polymerization</TD><TD>biological process</TD><TD>GO:0032272</TD><TD>74</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>EPS8,MAP2,SLIT2,CDH5</TD></TR>
<TR><TD>1.092e-02</TD><TD>-4.52</TD><TD>human chr13q31.1</TD><TD>chromosome location</TD><TD>human chr13q31.1</TD><TD>75</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LINC00430,LINC00377</TD></TR>
<TR><TD>1.092e-02</TD><TD>-4.52</TD><TD>human chr18q12.1</TD><TD>chromosome location</TD><TD>human chr18q12.1</TD><TD>75</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>GAREM1,NOL4</TD></TR>
<TR><TD>1.092e-02</TD><TD>-4.52</TD><TD>human chr21q21.3</TD><TD>chromosome location</TD><TD>human chr21q21.3</TD><TD>75</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LINC01697,ADAMTS5</TD></TR>
<TR><TD>1.094e-02</TD><TD>-4.52</TD><TD>LAM_G_DOMAIN</TD><TD>prosite domains</TD><TD>PS50025</TD><TD>35</TD><TD>3</TD><TD>12232</TD><TD>162</TD>
<TD>CNTNAP2,SLIT2,FAT4</TD></TR>
<TR><TD>1.099e-02</TD><TD>-4.51</TD><TD>calcium ion binding</TD><TD>molecular function</TD><TD>GO:0005509</TD><TD>691</TD><TD>15</TD><TD>18530</TD><TD>207</TD>
<TD>SLIT2,DNER,CETN3,RYR2,RPH3A,ASPN,SYT1,EDIL3,AOAH,EFEMP1,PCDH9,ADGRL3,FAT4,CALN1,FBN2</TD></TR>
<TR><TD>1.104e-02</TD><TD>-4.51</TD><TD>Tyr-kin_ephrin_A/B_rcpt-like</TD><TD>interpro domains</TD><TD>IPR011641</TD><TD>14</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.104e-02</TD><TD>-4.51</TD><TD>Ephrin_rcpt_lig-bd_dom</TD><TD>interpro domains</TD><TD>IPR001090</TD><TD>14</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>EPHA4,EPHA3</TD></TR>
<TR><TD>1.104e-02</TD><TD>-4.51</TD><TD>Tyr_kinase_rcpt_V_CS</TD><TD>interpro domains</TD><TD>IPR001426</TD><TD>14</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>EPHA4,EPHA3</TD></TR>
<TR><TD>1.104e-02</TD><TD>-4.51</TD><TD>Eph_TM</TD><TD>interpro domains</TD><TD>IPR027936</TD><TD>14</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>EPHA4,EPHA3</TD></TR>
<TR><TD>1.104e-02</TD><TD>-4.51</TD><TD>Tyr_kinase_ephrin_rcpt</TD><TD>interpro domains</TD><TD>IPR016257</TD><TD>14</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.104e-02</TD><TD>-4.51</TD><TD>DAP12 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-2424491</TD><TD>356</TD><TD>9</TD><TD>10391</TD><TD>107</TD>
<TD>PHLPP1,FGF5,AKAP9,FGF20,PRKCE,FGFR2,VAV3,NRG1,PAQR3</TD></TR>
<TR><TD>1.108e-02</TD><TD>-4.50</TD><TD>catalytic activity, acting on a protein</TD><TD>molecular function</TD><TD>GO:0140096</TD><TD>2341</TD><TD>38</TD><TD>18530</TD><TD>207</TD>
<TD>CPQ,PRSS12,MARCHF11,PSKH2,JMJD1C,MAST4,PTPRZ1,EFEMP1,ADAM28,GALNT15,PRKCE,ACVR2A,MARCHF3,EPHA3,UBR4,PTPRD,FGFR2,PCGF5,PTPRK,CPXM2,ADAMTS12,ATG10,UCHL1,EPHA4,MATCAP2,FIGN,UHMK1,CTSO,PHLPP1,ACVR1C,ADAMTS3,NTRK2,GCNT1,ADAMTS5,CASK,TEC,PARP8,TGFBR2</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>Ephrin_lbd</TD><TD>pfam domains</TD><TD>PF01404</TD><TD>14</TD><TD>2</TD><TD>17869</TD><TD>207</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>EphA2_TM</TD><TD>pfam domains</TD><TD>PF14575</TD><TD>14</TD><TD>2</TD><TD>17869</TD><TD>207</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.109e-02</TD><TD>-4.50</TD><TD>Ephrin_rec_like</TD><TD>pfam domains</TD><TD>PF07699</TD><TD>14</TD><TD>2</TD><TD>17869</TD><TD>207</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.111e-02</TD><TD>-4.50</TD><TD>Apob (apolipoprotein B)</TD><TD>protein interactions</TD><TD>54225</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>CELF2</TD></TR>
<TR><TD>1.111e-02</TD><TD>-4.50</TD><TD>F11r (F11 receptor)</TD><TD>protein interactions</TD><TD>16456</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>CASK</TD></TR>
<TR><TD>1.111e-02</TD><TD>-4.50</TD><TD>RPS15AP21 (ribosomal protein S15a pseudogene 21)</TD><TD>protein interactions</TD><TD>100271357</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>WWOX</TD></TR>
<TR><TD>1.111e-02</TD><TD>-4.50</TD><TD>AMELX (amelogenin X-linked)</TD><TD>protein interactions</TD><TD>265</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>AMELX</TD></TR>
<TR><TD>1.111e-02</TD><TD>-4.50</TD><TD>USP17L24 (ubiquitin specific peptidase 17 like family member 24)</TD><TD>protein interactions</TD><TD>728369</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>UCHL1</TD></TR>
<TR><TD>1.111e-02</TD><TD>-4.50</TD><TD>CSNK1E (casein kinase 1 epsilon)</TD><TD>protein interactions</TD><TD>700565</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>AKAP9</TD></TR>
<TR><TD>1.111e-02</TD><TD>-4.50</TD><TD>Cntnap2 (contactin associated protein-like 2)</TD><TD>protein interactions</TD><TD>66797</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>CNTN1</TD></TR>
<TR><TD>1.111e-02</TD><TD>-4.50</TD><TD>Robo1 (roundabout guidance receptor 1)</TD><TD>protein interactions</TD><TD>58946</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>SLIT2</TD></TR>
<TR><TD>1.111e-02</TD><TD>-4.50</TD><TD>GIS1 (histone demethylase GIS1)</TD><TD>protein interactions</TD><TD>851670</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>WRN</TD></TR>
<TR><TD>1.111e-02</TD><TD>-4.50</TD><TD>PRLH (prolactin releasing hormone)</TD><TD>protein interactions</TD><TD>51052</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>PRLHR</TD></TR>
<TR><TD>1.111e-02</TD><TD>-4.50</TD><TD>Bdnf (brain derived neurotrophic factor)</TD><TD>protein interactions</TD><TD>12064</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>NTRK2</TD></TR>
<TR><TD>1.111e-02</TD><TD>-4.50</TD><TD>DAO (D-amino acid oxidase)</TD><TD>protein interactions</TD><TD>397134</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>DAOA</TD></TR>
<TR><TD>1.111e-02</TD><TD>-4.50</TD><TD>Erbb4 (erb-b2 receptor tyrosine kinase 4)</TD><TD>protein interactions</TD><TD>13869</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>NRG1</TD></TR>
<TR><TD>1.111e-02</TD><TD>-4.50</TD><TD>SMARCA2 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2)</TD><TD>protein interactions</TD><TD>396040</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>SS18</TD></TR>
<TR><TD>1.111e-02</TD><TD>-4.50</TD><TD>Csnk1e (casein kinase 1, epsilon)</TD><TD>protein interactions</TD><TD>58822</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>AKAP9</TD></TR>
<TR><TD>1.111e-02</TD><TD>-4.50</TD><TD>Dynlt1 (dynein light chain Tctex-type 1)</TD><TD>protein interactions</TD><TD>83462</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>NTRK2</TD></TR>
<TR><TD>1.111e-02</TD><TD>-4.50</TD><TD>PRKAR2B (protein kinase cAMP-dependent type II regulatory subunit beta)</TD><TD>protein interactions</TD><TD>282463</TD><TD>1</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>MAP2</TD></TR>
<TR><TD>1.117e-02</TD><TD>-4.49</TD><TD>3'-flap-structured DNA binding</TD><TD>molecular function</TD><TD>GO:0070337</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>WRN</TD></TR>
<TR><TD>1.117e-02</TD><TD>-4.49</TD><TD>CXCR5 chemokine receptor binding</TD><TD>molecular function</TD><TD>GO:0031724</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>CXCL13</TD></TR>
<TR><TD>1.117e-02</TD><TD>-4.49</TD><TD>GDP-mannose 4,6-dehydratase activity</TD><TD>molecular function</TD><TD>GO:0008446</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>GMDS</TD></TR>
<TR><TD>1.117e-02</TD><TD>-4.49</TD><TD>4-hydroxybenzoate octaprenyltransferase activity</TD><TD>molecular function</TD><TD>GO:0008412</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>COQ2</TD></TR>
<TR><TD>1.117e-02</TD><TD>-4.49</TD><TD>luteinizing hormone receptor activity</TD><TD>molecular function</TD><TD>GO:0004964</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>LHCGR</TD></TR>
<TR><TD>1.117e-02</TD><TD>-4.49</TD><TD>choriogonadotropin hormone receptor activity</TD><TD>molecular function</TD><TD>GO:0035472</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>LHCGR</TD></TR>
<TR><TD>1.117e-02</TD><TD>-4.49</TD><TD>4-hydroxybenzoate nonaprenyltransferase activity</TD><TD>molecular function</TD><TD>GO:0047293</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>COQ2</TD></TR>
<TR><TD>1.117e-02</TD><TD>-4.49</TD><TD>neurotrophin TRKB receptor binding</TD><TD>molecular function</TD><TD>GO:0005169</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>EFNA5</TD></TR>
<TR><TD>1.117e-02</TD><TD>-4.49</TD><TD>Atg12 conjugating enzyme activity</TD><TD>molecular function</TD><TD>GO:0061651</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>ATG10</TD></TR>
<TR><TD>1.117e-02</TD><TD>-4.49</TD><TD>choriogonadotropin hormone binding</TD><TD>molecular function</TD><TD>GO:0038106</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>LHCGR</TD></TR>
<TR><TD>1.117e-02</TD><TD>-4.49</TD><TD>neurotrophin TRKC receptor binding</TD><TD>molecular function</TD><TD>GO:0005170</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>EFNA5</TD></TR>
<TR><TD>1.117e-02</TD><TD>-4.49</TD><TD>netrin receptor activity involved in chemorepulsion</TD><TD>molecular function</TD><TD>GO:0005043</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>UNC5C</TD></TR>
<TR><TD>1.117e-02</TD><TD>-4.49</TD><TD>brain-derived neurotrophic factor receptor activity</TD><TD>molecular function</TD><TD>GO:0060175</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>NTRK2</TD></TR>
<TR><TD>1.117e-02</TD><TD>-4.49</TD><TD>acyloxyacyl hydrolase activity</TD><TD>molecular function</TD><TD>GO:0050528</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>AOAH</TD></TR>
<TR><TD>1.117e-02</TD><TD>-4.49</TD><TD>DH domain binding</TD><TD>molecular function</TD><TD>GO:0097161</TD><TD>1</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>EPHA4</TD></TR>
<TR><TD>1.117e-02</TD><TD>-4.49</TD><TD>apical distal dendrite</TD><TD>cellular component</TD><TD>GO:0150014</TD><TD>1</TD><TD>1</TD><TD>19868</TD><TD>222</TD>
<TD>MAP2</TD></TR>
<TR><TD>1.117e-02</TD><TD>-4.49</TD><TD>extrinsic component of endoplasmic reticulum membrane</TD><TD>cellular component</TD><TD>GO:0042406</TD><TD>1</TD><TD>1</TD><TD>19868</TD><TD>222</TD>
<TD>EMC2</TD></TR>
<TR><TD>1.119e-02</TD><TD>-4.49</TD><TD>regulation of cardiac epithelial to mesenchymal transition</TD><TD>biological process</TD><TD>GO:0062042</TD><TD>14</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2,TWIST1</TD></TR>
<TR><TD>1.120e-02</TD><TD>-4.49</TD><TD>human chr10q26.13</TD><TD>chromosome location</TD><TD>human chr10q26.13</TD><TD>76</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>FGFR2,CPXM2</TD></TR>
<TR><TD>1.129e-02</TD><TD>-4.48</TD><TD>LOC254896 (uncharacterized LOC254896)</TD><TD>protein interactions</TD><TD>254896</TD><TD>42</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>FAT4,NBEA,BCHE</TD></TR>
<TR><TD>1.130e-02</TD><TD>-4.48</TD><TD>epithelial tube morphogenesis</TD><TD>biological process</TD><TD>GO:0060562</TD><TD>313</TD><TD>9</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,FGFR2,IRX1,EPHA4,PBX1,RYR2,TGFBR2,TWIST1,FZD6</TD></TR>
<TR><TD>1.131e-02</TD><TD>-4.48</TD><TD>typical</TD><TD>COSMIC cancer mutations</TD><TD>typical</TD><TD>321</TD><TD>9</TD><TD>16984</TD><TD>193</TD>
<TD>FGFR2,TRPS1,PTPRZ1,FMNL2,WRN,FAT4,JMJD1C,PRLHR,CNTNAP2</TD></TR>
<TR><TD>1.131e-02</TD><TD>-4.48</TD><TD>lung-carcinoid-endocrine_tumour-typical</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoid-endocrine_tumour-typical</TD><TD>321</TD><TD>9</TD><TD>16984</TD><TD>193</TD>
<TD>FGFR2,PTPRZ1,TRPS1,FMNL2,WRN,FAT4,JMJD1C,CNTNAP2,PRLHR</TD></TR>
<TR><TD>1.138e-02</TD><TD>-4.48</TD><TD>bone-fibula-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour</TD><TD>COSMIC cancer mutations</TD><TD>bone-fibula-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour</TD><TD>378</TD><TD>10</TD><TD>16984</TD><TD>193</TD>
<TD>PHF14,NCKAP5,ZFPM2,SKAP2,SERGEF,BANK1,SPATA16,DSCAM,FBN2,MPEG1</TD></TR>
<TR><TD>1.140e-02</TD><TD>-4.47</TD><TD>muscle tissue morphogenesis</TD><TD>biological process</TD><TD>GO:0060415</TD><TD>75</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>NRG1,ZFPM2,RYR2,FGFR2</TD></TR>
<TR><TD>1.147e-02</TD><TD>-4.47</TD><TD>FGFR1 ligand binding and activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-190242</TD><TD>16</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>1.147e-02</TD><TD>-4.47</TD><TD>Phospholipase C-mediated cascade: FGFR1</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654219</TD><TD>16</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF20,FGF5</TD></TR>
<TR><TD>1.150e-02</TD><TD>-4.47</TD><TD>extragonadal</TD><TD>COSMIC cancer mutations</TD><TD>extragonadal</TD><TD>165</TD><TD>6</TD><TD>16984</TD><TD>193</TD>
<TD>CNTN1,ERCC6L2,IPO8,JMJD1C,LRFN5,FAT4</TD></TR>
<TR><TD>1.151e-02</TD><TD>-4.46</TD><TD>eye morphogenesis</TD><TD>biological process</TD><TD>GO:0048592</TD><TD>161</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>TWIST1,PAX6,NTRK2,DSCAM,EFEMP1,FBN2</TD></TR>
<TR><TD>1.151e-02</TD><TD>-4.46</TD><TD>regulation of microtubule cytoskeleton organization</TD><TD>biological process</TD><TD>GO:0070507</TD><TD>161</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>AKAP9,NAV3,CDH5,EPHA3,EFNA5,MAP2</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>EMC2-like</TD><TD>interpro domains</TD><TD>IPR039856</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>EMC2</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>MPEG1</TD><TD>interpro domains</TD><TD>IPR039707</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MPEG1</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Contactin-1_Ig1</TD><TD>interpro domains</TD><TD>IPR036992</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>CNTN1</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>STXBP6_SNARE</TD><TD>interpro domains</TD><TD>IPR037822</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>STXBP6</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Kazrin_SAM_rpt_1</TD><TD>interpro domains</TD><TD>IPR037613</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>KAZN</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>PUM3</TD><TD>interpro domains</TD><TD>IPR040059</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>PUM3</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Neuromodulin_palmitoyl_site</TD><TD>interpro domains</TD><TD>IPR018243</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Contactin-1_Ig3</TD><TD>interpro domains</TD><TD>IPR047100</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>CNTN1</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>TCF-20_ePHD</TD><TD>interpro domains</TD><TD>IPR041972</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>TCF20</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Contactin-1_Ig6</TD><TD>interpro domains</TD><TD>IPR047101</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>CNTN1</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>HB_polyprenyltransferase-like</TD><TD>interpro domains</TD><TD>IPR006370</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>COQ2</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>CASK_SH3</TD><TD>interpro domains</TD><TD>IPR035473</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>CASK</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>ELK_dom</TD><TD>interpro domains</TD><TD>IPR005539</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>AKAP9</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>NOBOX</TD><TD>interpro domains</TD><TD>IPR042988</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NOBOX</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Neuromodulin_P_site</TD><TD>interpro domains</TD><TD>IPR033137</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Oligoribonuclease</TD><TD>interpro domains</TD><TD>IPR022894</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>REXO2</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>RGS_RGS5</TD><TD>interpro domains</TD><TD>IPR034956</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RGS5</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>DAOA</TD><TD>interpro domains</TD><TD>IPR027929</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>DAOA</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Lmx1a_LIM1</TD><TD>interpro domains</TD><TD>IPR042688</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>LMX1A</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>RRM_NUP35_dom</TD><TD>interpro domains</TD><TD>IPR007846</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NUP35</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>nPKC_epsilon</TD><TD>interpro domains</TD><TD>IPR034669</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>PRKCE</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Death_UNC5C</TD><TD>interpro domains</TD><TD>IPR042154</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>UNC5C</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>FZD6_7TM</TD><TD>interpro domains</TD><TD>IPR026543</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>FZD6</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Transforming_GF_b_rcpt_2_ecto</TD><TD>interpro domains</TD><TD>IPR015013</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>KCNK9</TD><TD>interpro domains</TD><TD>IPR005407</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>KCNK9</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>DNER_C</TD><TD>interpro domains</TD><TD>IPR045769</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>DNER</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>EphA3_rcpt_lig-bd</TD><TD>interpro domains</TD><TD>IPR034266</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>EPHA3</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>DEPTOR_DEP_1</TD><TD>interpro domains</TD><TD>IPR037335</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>DEPTOR</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>GDP_Man_deHydtase</TD><TD>interpro domains</TD><TD>IPR006368</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>GMDS</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Helicase_HTH</TD><TD>interpro domains</TD><TD>IPR029491</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>WRN</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>CBFA2T1</TD><TD>interpro domains</TD><TD>IPR013290</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RUNX1T1</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>DEPTOR_DEP_2</TD><TD>interpro domains</TD><TD>IPR037336</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>DEPTOR</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>FYVE_RPH3A</TD><TD>interpro domains</TD><TD>IPR028698</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RPH3A</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Neuromodulin</TD><TD>interpro domains</TD><TD>IPR001422</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>SPATA16</TD><TD>interpro domains</TD><TD>IPR029161</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>SPATA16</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>CYTL1</TD><TD>interpro domains</TD><TD>IPR029253</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>CYTL1</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>EphA4_SAM</TD><TD>interpro domains</TD><TD>IPR030602</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>EPHA4</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Prenyltransferase</TD><TD>interpro domains</TD><TD>IPR039653</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>COQ2</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>UBR4-like_UBR-box</TD><TD>interpro domains</TD><TD>IPR047509</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>UBR4</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>R-PTP-delta_cat</TD><TD>interpro domains</TD><TD>IPR045905</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>PTPRD</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>UBR4-like</TD><TD>interpro domains</TD><TD>IPR045189</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>UBR4</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Ribosomal_uL3_bac/org-type</TD><TD>interpro domains</TD><TD>IPR019927</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MRPL3</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>PI15_CAP</TD><TD>interpro domains</TD><TD>IPR047832</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>PI15</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Transform_growth_fac-b_typ-2</TD><TD>interpro domains</TD><TD>IPR017194</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Translin</TD><TD>interpro domains</TD><TD>IPR033956</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>TSN</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>EphA4_rcpt_lig-bd</TD><TD>interpro domains</TD><TD>IPR034270</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>EPHA4</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Neuromodulin_gap-junction_N</TD><TD>interpro domains</TD><TD>IPR018947</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>E3_Ub_ligase_UBR4_C</TD><TD>interpro domains</TD><TD>IPR025704</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>UBR4</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>UHMK1</TD><TD>interpro domains</TD><TD>IPR034372</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>UHMK1</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>STXBP6_PH</TD><TD>interpro domains</TD><TD>IPR037821</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>STXBP6</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>MUC7</TD><TD>interpro domains</TD><TD>IPR033529</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MUC7</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Musac_Ach_M3_rcpt</TD><TD>interpro domains</TD><TD>IPR001183</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>CHRM3</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>RBM20_RRM</TD><TD>interpro domains</TD><TD>IPR034790</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RBM20</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Kazrin</TD><TD>interpro domains</TD><TD>IPR037614</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>KAZN</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>NRG1</TD><TD>interpro domains</TD><TD>IPR018250</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NRG1</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Neuromodulin_C</TD><TD>interpro domains</TD><TD>IPR017454</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>SLC25A46</TD><TD>interpro domains</TD><TD>IPR039158</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>SLC25A46</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>E3_UBR4_N</TD><TD>interpro domains</TD><TD>IPR045841</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>UBR4</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>CPL_dom</TD><TD>interpro domains</TD><TD>IPR012959</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>PUM3</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>AOAH_Saposin_N</TD><TD>interpro domains</TD><TD>IPR048593</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>AOAH</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Tec_SH3</TD><TD>interpro domains</TD><TD>IPR035572</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>TEC</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>LSH_rcpt</TD><TD>interpro domains</TD><TD>IPR002273</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>LHCGR</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Heliccase-ass-bd</TD><TD>interpro domains</TD><TD>IPR029256</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>ERCC6L2</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Ribosomal_uL13_bac-type</TD><TD>interpro domains</TD><TD>IPR005823</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MRPL13</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>PKC_epsilon</TD><TD>interpro domains</TD><TD>IPR027274</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>PRKCE</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>VAV3_SH3_2</TD><TD>interpro domains</TD><TD>IPR035734</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>VAV3</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>MARCHF11_RING_CH-C4HC3</TD><TD>interpro domains</TD><TD>IPR047906</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MARCHF11</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Kazrin_SAM_rpt_2</TD><TD>interpro domains</TD><TD>IPR037615</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>KAZN</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>PLEK_DEP</TD><TD>interpro domains</TD><TD>IPR037371</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>PLEK</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Shootin-1</TD><TD>interpro domains</TD><TD>IPR024849</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>SHTN1</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Kazrin_SAM_rpt_3</TD><TD>interpro domains</TD><TD>IPR037616</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>KAZN</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>FZ6_CRD</TD><TD>interpro domains</TD><TD>IPR041770</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>FZD6</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Pept_M12B_ADAM-TS5</TD><TD>interpro domains</TD><TD>IPR013276</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>ADAMTS5</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>AOAH</TD><TD>interpro domains</TD><TD>IPR039676</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>AOAH</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>CPQ</TD><TD>interpro domains</TD><TD>IPR039866</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>CPQ</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>CD226</TD><TD>interpro domains</TD><TD>IPR042842</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>CD226</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Prolrel_pep_rcpt</TD><TD>interpro domains</TD><TD>IPR001402</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>PRLHR</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>TRPS1</TD><TD>interpro domains</TD><TD>IPR028440</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>TRPS1</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>GHITM</TD><TD>interpro domains</TD><TD>IPR035871</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>GHITM</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>FANCB</TD><TD>interpro domains</TD><TD>IPR033333</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>FANCB</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>Nucleoporin_NUP53</TD><TD>interpro domains</TD><TD>IPR017389</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NUP35</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>VAV3_SH3_1</TD><TD>interpro domains</TD><TD>IPR047015</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>VAV3</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>WWOX_SDR_c-like</TD><TD>interpro domains</TD><TD>IPR042732</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>WWOX</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>MAP2_projctn</TD><TD>interpro domains</TD><TD>IPR013588</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MAP2</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>VAV3_SH2</TD><TD>interpro domains</TD><TD>IPR035881</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>VAV3</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>NTRK2</TD><TD>interpro domains</TD><TD>IPR020455</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NTRK2</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>PPP1R17</TD><TD>interpro domains</TD><TD>IPR033242</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>PPP1R17</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>JDP1-like</TD><TD>interpro domains</TD><TD>IPR029827</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>DNAJC12</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>RGS6_RGS</TD><TD>interpro domains</TD><TD>IPR037956</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RGS6</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>TWIST1_bHLH</TD><TD>interpro domains</TD><TD>IPR047093</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>TWIST1</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>CD96</TD><TD>interpro domains</TD><TD>IPR042381</TD><TD>1</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>CD96</TD></TR>
<TR><TD>1.156e-02</TD><TD>-4.46</TD><TD>PROTEIN_KINASE_DOM</TD><TD>prosite domains</TD><TD>PS50011</TD><TD>481</TD><TD>13</TD><TD>12232</TD><TD>162</TD>
<TD>TGFBR2,MAST4,PSKH2,ACVR1C,PRKCE,NTRK2,EPHA4,CASK,ACVR2A,FGFR2,EPHA3,UHMK1,TEC</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>CYTL1</TD><TD>pfam domains</TD><TD>PF15153</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>CYTL1</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>DNER_C</TD><TD>pfam domains</TD><TD>PF19330</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>DNER</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>E3_UBR4_N</TD><TD>pfam domains</TD><TD>PF19423</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>UBR4</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>CPL</TD><TD>pfam domains</TD><TD>PF08144</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>PUM3</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>ecTbetaR2</TD><TD>pfam domains</TD><TD>PF08917</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>E3_UbLigase_R4</TD><TD>pfam domains</TD><TD>PF13764</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>UBR4</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>NYD-SP12_N</TD><TD>pfam domains</TD><TD>PF15015</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>SPATA16</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>VIGSSK</TD><TD>pfam domains</TD><TD>PF14773</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>ERCC6L2</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>MAP2_projctn</TD><TD>pfam domains</TD><TD>PF08377</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>MAP2</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>Nup35_RRM</TD><TD>pfam domains</TD><TD>PF05172</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>NUP35</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>HTH_40</TD><TD>pfam domains</TD><TD>PF14493</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>WRN</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>Neuromodulin</TD><TD>pfam domains</TD><TD>PF06614</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>DAOA</TD><TD>pfam domains</TD><TD>PF15199</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>DAOA</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>Saposin</TD><TD>pfam domains</TD><TD>PF20825</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>AOAH</TD></TR>
<TR><TD>1.158e-02</TD><TD>-4.46</TD><TD>Neuromodulin_N</TD><TD>pfam domains</TD><TD>PF10580</TD><TD>1</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.162e-02</TD><TD>-4.46</TD><TD>transmembrane signaling receptor activity</TD><TD>molecular function</TD><TD>GO:0004888</TD><TD>1311</TD><TD>24</TD><TD>18530</TD><TD>207</TD>
<TD>CHRM3,LHCGR,OR52K2,EPHA4,NTRK2,TGFBR2,ROBO2,ACVR1C,PTPRZ1,EFEMP1,GPR83,ADGRL3,FGFR2,PTPRK,ACVR2A,PECAM1,EPHA3,FZD6,DNER,IL1RAPL2,PRLHR,PTPRD,OR2AG1,UNC5C</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>positive regulation of Rho guanyl-nucleotide exchange factor activity</TD><TD>biological process</TD><TD>GO:2001108</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>EPHA4</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>negative regulation of TORC2 signaling</TD><TD>biological process</TD><TD>GO:1903940</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>DEPTOR</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>regulation of endocardial cushion to mesenchymal transition</TD><TD>biological process</TD><TD>GO:0140049</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TWIST1</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>trans-synaptic signaling by neuropeptide</TD><TD>biological process</TD><TD>GO:0099540</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>NTRK2</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>protein secretion by platelet</TD><TD>biological process</TD><TD>GO:0070560</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PLEK</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>regulation of tolerance induction to self antigen</TD><TD>biological process</TD><TD>GO:0002649</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell</TD><TD>biological process</TD><TD>GO:0035602</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>lymphocyte chemotaxis across high endothelial venule</TD><TD>biological process</TD><TD>GO:0002518</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>CXCL13</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>fast, calcium ion-dependent exocytosis of neurotransmitter</TD><TD>biological process</TD><TD>GO:0098746</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SYT1</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>fibroblast growth factor receptor signaling pathway involved in hemopoiesis</TD><TD>biological process</TD><TD>GO:0035603</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>protein transport within extracellular region</TD><TD>biological process</TD><TD>GO:0071693</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>AFM</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>positive regulation of glutamatergic neuron differentiation</TD><TD>biological process</TD><TD>GO:0120008</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>primary adaptive immune response involving T cells and B cells</TD><TD>biological process</TD><TD>GO:0090721</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>BACH2</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>Lewis x epitope biosynthetic process</TD><TD>biological process</TD><TD>GO:0106402</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FUT9</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>inferior endocardial cushion morphogenesis</TD><TD>biological process</TD><TD>GO:1905317</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>sensory neuron migration</TD><TD>biological process</TD><TD>GO:1904937</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>positive regulation of strand invasion</TD><TD>biological process</TD><TD>GO:0098530</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>WRN</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>actin filament bundle retrograde transport</TD><TD>biological process</TD><TD>GO:0061573</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SHTN1</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>positive regulation of calcium ion-dependent exocytosis of neurotransmitter</TD><TD>biological process</TD><TD>GO:1903235</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SYT1</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>regulation of cellular response to hepatocyte growth factor stimulus</TD><TD>biological process</TD><TD>GO:2001112</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>ADAMTS12</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>cell proliferation involved in heart valve development</TD><TD>biological process</TD><TD>GO:2000793</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TWIST1</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>tropane alkaloid metabolic process</TD><TD>biological process</TD><TD>GO:0046448</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>BCHE</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>regulation of inositol-polyphosphate 5-phosphatase activity</TD><TD>biological process</TD><TD>GO:0010924</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PLEK</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>lipopolysaccharide catabolic process</TD><TD>biological process</TD><TD>GO:0009104</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>AOAH</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>regulation of strand invasion</TD><TD>biological process</TD><TD>GO:0060542</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>WRN</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>positive regulation of protein localization to cell-cell junction</TD><TD>biological process</TD><TD>GO:0150107</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PECAM1</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>O-glycan processing, core 2</TD><TD>biological process</TD><TD>GO:0016268</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>GCNT1</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>regulation of endocardial cushion to mesenchymal transition involved in heart valve formation</TD><TD>biological process</TD><TD>GO:2000800</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TWIST1</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>corticospinal neuron axon guidance through spinal cord</TD><TD>biological process</TD><TD>GO:0021972</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>negative regulation of hepatocyte growth factor receptor signaling pathway</TD><TD>biological process</TD><TD>GO:1902203</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>ADAMTS12</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>regulation of cellular glucuronidation</TD><TD>biological process</TD><TD>GO:2001029</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PRKCE</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>positive regulation of guanyl-nucleotide exchange factor activity</TD><TD>biological process</TD><TD>GO:1905099</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>EPHA4</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>negative regulation of cellular response to hepatocyte growth factor stimulus</TD><TD>biological process</TD><TD>GO:2001113</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>ADAMTS12</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>lipopolysaccharide metabolic process</TD><TD>biological process</TD><TD>GO:0008653</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>AOAH</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>cell proliferation involved in endocardial cushion morphogenesis</TD><TD>biological process</TD><TD>GO:1905315</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>superior endocardial cushion morphogenesis</TD><TD>biological process</TD><TD>GO:1905316</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>endothelial cell chemotaxis to fibroblast growth factor</TD><TD>biological process</TD><TD>GO:0035768</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>CXCL13</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>induction of negative chemotaxis</TD><TD>biological process</TD><TD>GO:0050929</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>regulation of transcriptional start site selection at RNA polymerase II promoter</TD><TD>biological process</TD><TD>GO:0001178</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PWWP2A</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>cocaine metabolic process</TD><TD>biological process</TD><TD>GO:0050783</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>BCHE</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>primary adaptive immune response</TD><TD>biological process</TD><TD>GO:0090720</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>BACH2</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>positive regulation of inositol-polyphosphate 5-phosphatase activity</TD><TD>biological process</TD><TD>GO:0010925</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PLEK</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>phospholipase C-inhibiting G protein-coupled receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0030845</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PLEK</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>positive regulation of negative chemotaxis</TD><TD>biological process</TD><TD>GO:0050924</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>actin filament bundle distribution</TD><TD>biological process</TD><TD>GO:0070650</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SHTN1</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>trans-synaptic signaling by neuropeptide, modulating synaptic transmission</TD><TD>biological process</TD><TD>GO:0099551</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>NTRK2</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>fibroblast growth factor receptor signaling pathway involved in mammary gland specification</TD><TD>biological process</TD><TD>GO:0060595</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation</TD><TD>biological process</TD><TD>GO:2000802</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TWIST1</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>forebrain-midbrain boundary formation</TD><TD>biological process</TD><TD>GO:0021905</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow</TD><TD>biological process</TD><TD>GO:0035604</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>synchronous neurotransmitter secretion</TD><TD>biological process</TD><TD>GO:0071911</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SYT1</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>regulation of cell diameter</TD><TD>biological process</TD><TD>GO:0060305</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PLEK</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>cell chemotaxis to fibroblast growth factor</TD><TD>biological process</TD><TD>GO:0035766</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>CXCL13</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>endoplasmic reticulum polarization</TD><TD>biological process</TD><TD>GO:0061163</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SHTN1</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>positive regulation of tolerance induction to self antigen</TD><TD>biological process</TD><TD>GO:0002651</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>positive regulation of cellular glucuronidation</TD><TD>biological process</TD><TD>GO:2001031</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PRKCE</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>pancreatic A cell development</TD><TD>biological process</TD><TD>GO:0003322</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>positive regulation of endocardial cushion to mesenchymal transition</TD><TD>biological process</TD><TD>GO:0140051</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TWIST1</TD></TR>
<TR><TD>1.164e-02</TD><TD>-4.45</TD><TD>cardiac endothelial to mesenchymal transition</TD><TD>biological process</TD><TD>GO:0140074</TD><TD>1</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C</TD></TR>
<TR><TD>1.172e-02</TD><TD>-4.45</TD><TD>EFCAB11 (EF-hand calcium binding domain 11)</TD><TD>protein interactions</TD><TD>90141</TD><TD>15</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>CASK,CETN3</TD></TR>
<TR><TD>1.172e-02</TD><TD>-4.45</TD><TD>CCDC127 (coiled-coil domain containing 127)</TD><TD>protein interactions</TD><TD>133957</TD><TD>15</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>CETN3,GHITM</TD></TR>
<TR><TD>1.172e-02</TD><TD>-4.45</TD><TD>PIANP (PILR alpha associated neural protein)</TD><TD>protein interactions</TD><TD>196500</TD><TD>15</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>PTPRD,GHITM</TD></TR>
<TR><TD>1.172e-02</TD><TD>-4.45</TD><TD>INHBB (inhibin subunit beta B)</TD><TD>protein interactions</TD><TD>3625</TD><TD>15</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>ACVR2A,ACVR1C</TD></TR>
<TR><TD>1.172e-02</TD><TD>-4.45</TD><TD>FGF9 (fibroblast growth factor 9)</TD><TD>protein interactions</TD><TD>2254</TD><TD>15</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>FGFR2,FGF20</TD></TR>
<TR><TD>1.172e-02</TD><TD>-4.45</TD><TD>ACOT12 (acyl-CoA thioesterase 12)</TD><TD>protein interactions</TD><TD>134526</TD><TD>15</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>SPAG9,PAX6</TD></TR>
<TR><TD>1.175e-02</TD><TD>-4.44</TD><TD>Laminin_G</TD><TD>interpro domains</TD><TD>IPR001791</TD><TD>41</TD><TD>3</TD><TD>18605</TD><TD>215</TD>
<TD>SLIT2,CNTNAP2,FAT4</TD></TR>
<TR><TD>1.177e-02</TD><TD>-4.44</TD><TD>positive regulation of cellular component organization</TD><TD>biological process</TD><TD>GO:0051130</TD><TD>1123</TD><TD>22</TD><TD>18905</TD><TD>220</TD>
<TD>EPS8,EPHA3,EFNA5,PLEK,CXCL13,CNTNAP2,AKAP9,EPHA4,SLIT2,SHTN1,ROBO2,PRKCE,NRG1,CDH5,FNIP2,FUT9,DSCAM,NTRK2,NAV3,CNTN1,PTPRD,SYT1</TD></TR>
<TR><TD>1.185e-02</TD><TD>-4.44</TD><TD>transmembrane-ephrin receptor activity</TD><TD>molecular function</TD><TD>GO:0005005</TD><TD>15</TD><TD>2</TD><TD>18530</TD><TD>207</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.186e-02</TD><TD>-4.43</TD><TD>axolemma</TD><TD>cellular component</TD><TD>GO:0030673</TD><TD>15</TD><TD>2</TD><TD>19868</TD><TD>222</TD>
<TD>CNTNAP2,ROBO2</TD></TR>
<TR><TD>1.192e-02</TD><TD>-4.43</TD><TD>regulation of axon extension</TD><TD>biological process</TD><TD>GO:0030516</TD><TD>76</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>MAP2,NRCAM,DSCAM,SHTN1</TD></TR>
<TR><TD>1.197e-02</TD><TD>-4.43</TD><TD>cortical actin cytoskeleton organization</TD><TD>biological process</TD><TD>GO:0030866</TD><TD>41</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>FMNL2,PLEK,IQGAP2</TD></TR>
<TR><TD>1.199e-02</TD><TD>-4.42</TD><TD>regulation of cell motility</TD><TD>biological process</TD><TD>GO:2000145</TD><TD>1125</TD><TD>22</TD><TD>18905</TD><TD>220</TD>
<TD>CXCL13,TWIST1,GCNT1,UNC5C,FGF20,SPAG9,EPHA4,ACVR1C,SLIT2,PTPRK,FGF5,SHTN1,CDH5,PRKCE,PECAM1,TMEFF2,PAX6,FUT9,SEMA3C,NAV3,INSM1,TGFBR2</TD></TR>
<TR><TD>1.205e-02</TD><TD>-4.42</TD><TD>stomach-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>stomach-carcinoma</TD><TD>440</TD><TD>11</TD><TD>16984</TD><TD>193</TD>
<TD>CASK,EPHA3,TGFBR2,PRKCE,ACVR1C,UHMK1,EPHA4,ACVR2A,FGFR2,NTRK2,PSKH2</TD></TR>
<TR><TD>1.213e-02</TD><TD>-4.41</TD><TD>AVPR2 (arginine vasopressin receptor 2)</TD><TD>protein interactions</TD><TD>554</TD><TD>123</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>XPO4,PAQR3,IPO8,SLC25A46,SLC39A10</TD></TR>
<TR><TD>1.217e-02</TD><TD>-4.41</TD><TD>negative regulation of supramolecular fiber organization</TD><TD>biological process</TD><TD>GO:1902904</TD><TD>163</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>MAP2,TMEFF2,EPS8,CDH5,SLIT2,NAV3</TD></TR>
<TR><TD>1.225e-02</TD><TD>-4.40</TD><TD>ppGaNTase-T1 linker domain-like</TD><TD>gene3d domains</TD><TD>1.10.8.460</TD><TD>1</TD><TD>1</TD><TD>14531</TD><TD>178</TD>
<TD>GALNT15</TD></TR>
<TR><TD>1.231e-02</TD><TD>-4.40</TD><TD>PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-6811558</TD><TD>87</TD><TD>4</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,FGF20,NRG1,FGFR2</TD></TR>
<TR><TD>1.233e-02</TD><TD>-4.40</TD><TD>ephrin a2 ectodomain</TD><TD>gene3d domains</TD><TD>2.60.40.1770</TD><TD>14</TD><TD>2</TD><TD>14531</TD><TD>178</TD>
<TD>EPHA4,EPHA3</TD></TR>
<TR><TD>1.234e-02</TD><TD>-4.40</TD><TD>Cell-Cell communication</TD><TD>REACTOME pathways</TD><TD>R-HSA-1500931</TD><TD>134</TD><TD>5</TD><TD>10391</TD><TD>107</TD>
<TD>CDH5,SKAP2,CASK,SLC7A14-AS1,DSCAM</TD></TR>
<TR><TD>1.249e-02</TD><TD>-4.38</TD><TD>genital_tract</TD><TD>COSMIC cancer mutations</TD><TD>genital_tract</TD><TD>168</TD><TD>6</TD><TD>16984</TD><TD>193</TD>
<TD>FAT4,ERCC6L2,CNTN1,LRFN5,IPO8,JMJD1C</TD></TR>
<TR><TD>1.255e-02</TD><TD>-4.38</TD><TD>PTP_cat</TD><TD>interpro domains</TD><TD>IPR000242</TD><TD>42</TD><TD>3</TD><TD>18605</TD><TD>215</TD>
<TD>PTPRD,PTPRK,PTPRZ1</TD></TR>
<TR><TD>1.257e-02</TD><TD>-4.38</TD><TD>lung-carcinoid-endocrine_tumour</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoid-endocrine_tumour</TD><TD>503</TD><TD>12</TD><TD>16984</TD><TD>193</TD>
<TD>ACVR1C,UHMK1,EPHA4,ACVR2A,FGFR2,NTRK2,PSKH2,CASK,EPHA3,PRKCE,TGFBR2,SPHKAP</TD></TR>
<TR><TD>1.262e-02</TD><TD>-4.37</TD><TD>Y_phosphatase</TD><TD>pfam domains</TD><TD>PF00102</TD><TD>42</TD><TD>3</TD><TD>17869</TD><TD>207</TD>
<TD>PTPRK,PTPRD,PTPRZ1</TD></TR>
<TR><TD>1.264e-02</TD><TD>-4.37</TD><TD>Signaling by EGFR</TD><TD>REACTOME pathways</TD><TD>R-HSA-177929</TD><TD>364</TD><TD>9</TD><TD>10391</TD><TD>107</TD>
<TD>FGF20,FGF5,AKAP9,PHLPP1,FGFR2,PRKCE,PTPRK,PAQR3,NRG1</TD></TR>
<TR><TD>1.264e-02</TD><TD>-4.37</TD><TD>FH2_Formin_sf</TD><TD>interpro domains</TD><TD>IPR042201</TD><TD>15</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>DAAM1,FMNL2</TD></TR>
<TR><TD>1.264e-02</TD><TD>-4.37</TD><TD>FH2_Formin</TD><TD>interpro domains</TD><TD>IPR015425</TD><TD>15</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>FMNL2,DAAM1</TD></TR>
<TR><TD>1.270e-02</TD><TD>-4.37</TD><TD>FH2</TD><TD>pfam domains</TD><TD>PF02181</TD><TD>15</TD><TD>2</TD><TD>17869</TD><TD>207</TD>
<TD>DAAM1,FMNL2</TD></TR>
<TR><TD>1.274e-02</TD><TD>-4.36</TD><TD>TYR_PHOSPHATASE_PTP</TD><TD>prosite domains</TD><TD>PS50055</TD><TD>37</TD><TD>3</TD><TD>12232</TD><TD>162</TD>
<TD>PTPRZ1,PTPRK,PTPRD</TD></TR>
<TR><TD>1.281e-02</TD><TD>-4.36</TD><TD>peripheral nervous system neuron differentiation</TD><TD>biological process</TD><TD>GO:0048934</TD><TD>15</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>NTRK2,SLC25A46</TD></TR>
<TR><TD>1.281e-02</TD><TD>-4.36</TD><TD>regulation of inositol phosphate biosynthetic process</TD><TD>biological process</TD><TD>GO:0010919</TD><TD>15</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>LHCGR,PLEK</TD></TR>
<TR><TD>1.281e-02</TD><TD>-4.36</TD><TD>peripheral nervous system neuron development</TD><TD>biological process</TD><TD>GO:0048935</TD><TD>15</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>SLC25A46,NTRK2</TD></TR>
<TR><TD>1.284e-02</TD><TD>-4.36</TD><TD>SAM/pointed_sf</TD><TD>interpro domains</TD><TD>IPR013761</TD><TD>120</TD><TD>5</TD><TD>18605</TD><TD>215</TD>
<TD>KAZN,EPHA3,EPHA4,GAREM1,EPS8</TD></TR>
<TR><TD>1.287e-02</TD><TD>-4.35</TD><TD>homophilic cell adhesion via plasma membrane adhesion molecules</TD><TD>biological process</TD><TD>GO:0007156</TD><TD>165</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>PECAM1,PCDH9,FAT4,DSCAM,ROBO2,CDH5</TD></TR>
<TR><TD>1.294e-02</TD><TD>-4.35</TD><TD>LSR (lipolysis stimulated lipoprotein receptor)</TD><TD>protein interactions</TD><TD>51599</TD><TD>173</TD><TD>6</TD><TD>20077</TD><TD>223</TD>
<TD>EPHA4,TGFBR2,NRG1,MARCHF3,ARL14,NTRK2</TD></TR>
<TR><TD>1.295e-02</TD><TD>-4.35</TD><TD>human chr8p22</TD><TD>chromosome location</TD><TD>human chr8p22</TD><TD>82</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>NAT2,FGF20</TD></TR>
<TR><TD>1.302e-02</TD><TD>-4.34</TD><TD>neural crest cell development</TD><TD>biological process</TD><TD>GO:0014032</TD><TD>78</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6,TWIST1,NRG1,SEMA3C</TD></TR>
<TR><TD>1.305e-02</TD><TD>-4.34</TD><TD>adrenal_cortical_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>adrenal_cortical_carcinoma</TD><TD>2256</TD><TD>37</TD><TD>16984</TD><TD>193</TD>
<TD>SERGEF,PTPRZ1,IL1RAPL2,RBM20,KCNK9,BANK1,UCHL1,RUNX1T1,MEGF10,RYR2,IPO8,LHCGR,CNTN1,UBR4,NRCAM,FBN2,RAI2,EFEMP1,MPEG1,NTRK2,SEMA3C,EPHA4,NCKAP5,ADAMTS5,RASGEF1B,SS18,PCDH9,NBEA,FIGN,PTPRD,HNF4G,BCHE,TGFBR2,UNC5C,WRN,UTRN,CHRM3</TD></TR>
<TR><TD>1.310e-02</TD><TD>-4.34</TD><TD>primitive_neuroectodermal_tumour-medulloblastoma</TD><TD>COSMIC cancer mutations</TD><TD>primitive_neuroectodermal_tumour-medulloblastoma</TD><TD>15417</TD><TD>184</TD><TD>16984</TD><TD>193</TD>
<TD>CALN1,LRRC3B,NRSN1,SKAP2,AOAH,EDIL3,CXCL13,AGA,WWOX,CTSO,BCHE,KLF12,KCNK9,RPH3A,AMELX,DEPTOR,LRFN5,PHF14,RAI2,SLIT2,MAP2,MEGF10,ATG10,NRCAM,PAX6,FGF5,PBX1,ADAMTS5,EFNA5,PCGF5,CHRM3,DSCAM,EPHA3,KIF6,RBM20,UHMK1,ARX,EFR3A,TCF20,PRLHR,CPXM2,CELF2,XPO4,TWIST1,MUC7,TMEFF2,MRPL3,EFR3B,PRKCE,ADAMTS3,SS18,NBEA,FIGN,SPANXN1,DNAJC12,NTRK2,STXBP6,TSN,NCKAP5,FABP7,EPS8,FANCB,SEZ6L,ZNF521,FGFR2,SERGEF,CDH5,MPEG1,FGD3,CASK,SLC7A14,FMNL2,SPHKAP,PWWP2A,COQ2,PCDH9,NAV3,NAT2,RGS5,SEMA3C,ACVR2A,JMJD1C,PTPRD,ZFAND5,FERD3L,LMX1A,SGCD,NOL4,ZPLD1,FNIP2,PI15,SLC39A10,PXDNL,TRPS1,IPO8,PHLPP1,RASGEF1B,ROBO2,PRSS12,VAV3,THSD7A,ZNF133,ACP6,UNC5C,DNER,RUNX1T1,SPATA16,ACVR1C,FBN2,EFEMP1,PAQR3,LRRN2,DAOA,GCNT1,CNTN1,DCDC2C,CD226,GMDS,SYT1,TGFBR2,ZFPM2,SHISA3,FAT4,FZD6,BANK1,RGS6,PTPRZ1,DEFB115,CD96,SGCG,RYR2,LHCGR,SLC25A46,FUT9,MRPL13,ZNF518B,AKAP9,SLC10A2,KAZN,PSKH2,IRX1,EPHA4,WRN,ASPN,CNTNAP2,REXO2,NOVA1,HNF4G,PARP8,CYTL1,PLEK,LGI1,IL1RAPL2,THSD7B,AFM,GHITM,IQGAP2,UCHL1,FGF20,FGF14,CRTC3,ADAM28,LMBRD1,ARL14,B3GAT2,PTPRK,UBR4,SLC7A8,REG1B,GAP43,NRG1,DAAM1,UTRN,CETN3,SPAG9,GPR83,BACH2,NOBOX,LRIG3,NAALADL2,ADAMTS12,INSM1,EPYC,IGFL4</TD></TR>
<TR><TD>1.312e-02</TD><TD>-4.33</TD><TD>central_nervous_system-brain-glioma-astrocytoma_Grade_IV</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-brain-glioma-astrocytoma_Grade_IV</TD><TD>15893</TD><TD>188</TD><TD>16984</TD><TD>193</TD>
<TD>PWWP2A,COQ2,PCDH9,NAT2,RGS5,NAV3,SEMA3C,ACVR2A,JMJD1C,PTPRD,ZFAND5,NUP35,FERD3L,LMX1A,SGCD,NOL4,ZPLD1,FNIP2,SLC39A10,PI15,PXDNL,TRPS1,IPO8,SS18,ADAMTS3,NBEA,FIGN,NTRK2,DNAJC12,STXBP6,FABP7,TSN,NCKAP5,FANCB,EPS8,SEZ6L,FGFR2,ZNF521,SERGEF,CDH5,MPEG1,SLC7A14,CASK,FGD3,SPHKAP,FMNL2,FGF5,PBX1,ADAMTS5,EFNA5,PCGF5,CHRM3,OR52K2,DSCAM,EPHA3,KIF6,ARX,UHMK1,EFR3A,RBM20,TCF20,CPXM2,PRLHR,CELF2,XPO4,MUC7,TWIST1,TMEFF2,MRPL3,PRKCE,CALN1,LRRC3B,NRSN1,SKAP2,EDIL3,AOAH,COX7B2,CXCL13,WWOX,AGA,CTSO,BCHE,KLF12,KCNK9,AMELX,RPH3A,DEPTOR,LRFN5,PHF14,RAI2,LRRC70,OR2AG1,SLIT2,MAP2,MEGF10,ATG10,PAX6,NRCAM,REG1B,GAP43,NRG1,UTRN,DAAM1,CETN3,SPAG9,GPR83,BACH2,NOBOX,LRIG3,NAALADL2,ADAMTS12,INSM1,EPYC,IGFL4,FUT9,SLC25A46,MRPL13,AKAP9,ZNF518B,SLC10A2,KAZN,PSKH2,EPHA4,IRX1,WRN,CNTNAP2,ASPN,NOVA1,REXO2,HNF4G,PARP8,PLEK,CYTL1,LGI1,IL1RAPL2,THSD7B,AFM,UCHL1,GHITM,IQGAP2,FGF20,CRTC3,FGF14,ADAM28,LMBRD1,B3GAT2,ARL14,PTPRK,SLC7A8,UBR4,DCDC2C,CD226,GMDS,SYT1,TGFBR2,ZFPM2,SERINC5,FAT4,SHISA3,FZD6,BANK1,PTPRZ1,RGS6,DEFB115,CD96,SGCG,RYR2,LHCGR,RASGEF1B,PHLPP1,ROBO2,PRSS12,VAV3,THSD7A,ZNF133,ACP6,UNC5C,DNER,ACVR1C,RUNX1T1,SPATA16,FBN2,PAQR3,EFEMP1,DAOA,LRRN2,GCNT1,CNTN1</TD></TR>
<TR><TD>1.320e-02</TD><TD>-4.33</TD><TD>HYAL2 (hyaluronidase 2)</TD><TD>protein interactions</TD><TD>8692</TD><TD>82</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>ADAMTS12,PTPRK,WWOX,LGI1</TD></TR>
<TR><TD>1.321e-02</TD><TD>-4.33</TD><TD>protein tyrosine kinase binding</TD><TD>molecular function</TD><TD>GO:1990782</TD><TD>125</TD><TD>5</TD><TD>18530</TD><TD>207</TD>
<TD>CDH5,EPHA4,NRG1,BANK1,DSCAM</TD></TR>
<TR><TD>1.324e-02</TD><TD>-4.32</TD><TD>NEUROMODULIN_2</TD><TD>prosite domains</TD><TD>PS00413</TD><TD>1</TD><TD>1</TD><TD>12232</TD><TD>162</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.324e-02</TD><TD>-4.32</TD><TD>NEUROMODULIN_1</TD><TD>prosite domains</TD><TD>PS00412</TD><TD>1</TD><TD>1</TD><TD>12232</TD><TD>162</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.324e-02</TD><TD>-4.32</TD><TD>RRM_NUP35</TD><TD>prosite domains</TD><TD>PS51472</TD><TD>1</TD><TD>1</TD><TD>12232</TD><TD>162</TD>
<TD>NUP35</TD></TR>
<TR><TD>1.330e-02</TD><TD>-4.32</TD><TD>TWIST2 (twist family bHLH transcription factor 2)</TD><TD>protein interactions</TD><TD>117581</TD><TD>16</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>TWIST1,FERD3L</TD></TR>
<TR><TD>1.330e-02</TD><TD>-4.32</TD><TD>RBM18 (RNA binding motif protein 18)</TD><TD>protein interactions</TD><TD>92400</TD><TD>16</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>SYT1,EPHA3</TD></TR>
<TR><TD>1.333e-02</TD><TD>-4.32</TD><TD>large_intestine-rectum</TD><TD>COSMIC cancer mutations</TD><TD>large_intestine-rectum</TD><TD>569</TD><TD>13</TD><TD>16984</TD><TD>193</TD>
<TD>PTPRD,TRPS1,CNTN1,RYR2,EPS8,ZNF133,ASPN,FGFR2,FAT4,IQGAP2,RUNX1T1,GAP43,AKAP9</TD></TR>
<TR><TD>1.348e-02</TD><TD>-4.31</TD><TD>Role of LAT2/NTAL/LAB on calcium mobilization</TD><TD>REACTOME pathways</TD><TD>R-HSA-2730905</TD><TD>137</TD><TD>5</TD><TD>10391</TD><TD>107</TD>
<TD>NRG1,FGFR2,PHLPP1,FGF5,FGF20</TD></TR>
<TR><TD>1.351e-02</TD><TD>-4.30</TD><TD>MACPF</TD><TD>smart domains</TD><TD>SM00457</TD><TD>12</TD><TD>2</TD><TD>9743</TD><TD>147</TD>
<TD>MPEG1,BRINP3</TD></TR>
<TR><TD>1.357e-02</TD><TD>-4.30</TD><TD>Transcription Factor, Ets-1</TD><TD>gene3d domains</TD><TD>1.10.150.50</TD><TD>115</TD><TD>5</TD><TD>14531</TD><TD>178</TD>
<TD>GAREM1,EPHA3,EPHA4,EPS8,KAZN</TD></TR>
<TR><TD>1.360e-02</TD><TD>-4.30</TD><TD>bone-vertebrae-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour</TD><TD>COSMIC cancer mutations</TD><TD>bone-vertebrae-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour</TD><TD>44</TD><TD>3</TD><TD>16984</TD><TD>193</TD>
<TD>ADAMTS5,FBN2,THSD7B</TD></TR>
<TR><TD>1.369e-02</TD><TD>-4.29</TD><TD>NTKRECEPTOR2</TD><TD>prints domains</TD><TD>PR01941</TD><TD>1</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>NTRK2</TD></TR>
<TR><TD>1.369e-02</TD><TD>-4.29</TD><TD>TASK3CHANNEL</TD><TD>prints domains</TD><TD>PR01585</TD><TD>1</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>KCNK9</TD></TR>
<TR><TD>1.369e-02</TD><TD>-4.29</TD><TD>NEUROMODULIN</TD><TD>prints domains</TD><TD>PR00215</TD><TD>1</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>GAP43</TD></TR>
<TR><TD>1.369e-02</TD><TD>-4.29</TD><TD>MTG8PROTEIN</TD><TD>prints domains</TD><TD>PR01876</TD><TD>1</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>RUNX1T1</TD></TR>
<TR><TD>1.369e-02</TD><TD>-4.29</TD><TD>PRPRECEPTOR</TD><TD>prints domains</TD><TD>PR01018</TD><TD>1</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>PRLHR</TD></TR>
<TR><TD>1.369e-02</TD><TD>-4.29</TD><TD>LSHRECEPTOR</TD><TD>prints domains</TD><TD>PR01144</TD><TD>1</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>LHCGR</TD></TR>
<TR><TD>1.369e-02</TD><TD>-4.29</TD><TD>MUSCRINICM3R</TD><TD>prints domains</TD><TD>PR00540</TD><TD>1</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>CHRM3</TD></TR>
<TR><TD>1.369e-02</TD><TD>-4.29</TD><TD>ADAMTS5</TD><TD>prints domains</TD><TD>PR01860</TD><TD>1</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>ADAMTS5</TD></TR>
<TR><TD>1.369e-02</TD><TD>-4.29</TD><TD>NEUREGULIN</TD><TD>prints domains</TD><TD>PR01089</TD><TD>1</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>NRG1</TD></TR>
<TR><TD>1.371e-02</TD><TD>-4.29</TD><TD>postsynaptic membrane</TD><TD>cellular component</TD><TD>GO:0045211</TD><TD>280</TD><TD>8</TD><TD>19868</TD><TD>222</TD>
<TD>LRFN5,CHRM3,UTRN,CNTN1,AKAP9,EPHA4,RPH3A,NRCAM</TD></TR>
<TR><TD>1.371e-02</TD><TD>-4.29</TD><TD>PRTYPHPHTASE</TD><TD>prints domains</TD><TD>PR00700</TD><TD>37</TD><TD>3</TD><TD>5258</TD><TD>72</TD>
<TD>PTPRK,PTPRZ1,PTPRD</TD></TR>
<TR><TD>1.371e-02</TD><TD>-4.29</TD><TD>cell surface</TD><TD>cellular component</TD><TD>GO:0009986</TD><TD>909</TD><TD>18</TD><TD>19868</TD><TD>222</TD>
<TD>ROBO2,NRCAM,CD226,PECAM1,UNC5C,EFNA5,IQGAP2,ZPLD1,EPHA4,AMELX,CNTNAP2,ACVR2A,FGFR2,PTPRK,TGFBR2,LRFN5,CDH5,FZD6</TD></TR>
<TR><TD>1.378e-02</TD><TD>-4.28</TD><TD>PAX9 (paired box 9)</TD><TD>protein interactions</TD><TD>5083</TD><TD>127</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>FIGN,PCGF5,TCF20,TRPS1,WWOX</TD></TR>
<TR><TD>1.380e-02</TD><TD>-4.28</TD><TD>breast-carcinoma-lobular_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>breast-carcinoma-lobular_carcinoma</TD><TD>764</TD><TD>16</TD><TD>16984</TD><TD>193</TD>
<TD>CDH5,CASK,ADAMTS12,PTPRD,TGFBR2,LHCGR,PRKCE,EPHA3,UHMK1,ACVR1C,PSKH2,FGFR2,NTRK2,ACVR2A,EPHA4,IRX1</TD></TR>
<TR><TD>1.380e-02</TD><TD>-4.28</TD><TD>lobular_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lobular_carcinoma</TD><TD>764</TD><TD>16</TD><TD>16984</TD><TD>193</TD>
<TD>PRKCE,TGFBR2,LHCGR,EPHA3,PTPRD,CASK,ADAMTS12,CDH5,ACVR2A,IRX1,EPHA4,PSKH2,FGFR2,NTRK2,ACVR1C,UHMK1</TD></TR>
<TR><TD>1.380e-02</TD><TD>-4.28</TD><TD>PI3K/AKT Signaling in Cancer</TD><TD>REACTOME pathways</TD><TD>R-HSA-2219528</TD><TD>90</TD><TD>4</TD><TD>10391</TD><TD>107</TD>
<TD>NRG1,FGFR2,FGF5,FGF20</TD></TR>
<TR><TD>1.385e-02</TD><TD>-4.28</TD><TD>positive regulation of phosphorylation</TD><TD>biological process</TD><TD>GO:0042327</TD><TD>619</TD><TD>14</TD><TD>18905</TD><TD>220</TD>
<TD>EFNA5,FGF20,BANK1,FGF5,FGFR2,ACVR2A,EPHA4,AKAP9,NRG1,PECAM1,FNIP2,DSCAM,NTRK2,TGFBR2</TD></TR>
<TR><TD>1.386e-02</TD><TD>-4.28</TD><TD>human chr11q21</TD><TD>chromosome location</TD><TD>human chr11q21</TD><TD>85</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>MIR1260B,GPR83</TD></TR>
<TR><TD>1.394e-02</TD><TD>-4.27</TD><TD>protein kinase binding</TD><TD>molecular function</TD><TD>GO:0019901</TD><TD>711</TD><TD>15</TD><TD>18530</TD><TD>207</TD>
<TD>CD226,RYR2,UTRN,BANK1,UNC5C,PTPRK,DSCAM,NRG1,PLEK,EPHA4,PAX6,ERCC6L2,CDH5,SPAG9,NBEA</TD></TR>
<TR><TD>1.406e-02</TD><TD>-4.26</TD><TD>LYN (LYN proto-oncogene, Src family tyrosine kinase)</TD><TD>protein interactions</TD><TD>4067</TD><TD>715</TD><TD>15</TD><TD>20077</TD><TD>223</TD>
<TD>CASK,FGFR2,FMNL2,PECAM1,ROBO2,SLC39A10,BANK1,TEC,EPHA3,SKAP2,EFR3A,IQGAP2,EPHA4,EFR3B,UTRN</TD></TR>
<TR><TD>1.411e-02</TD><TD>-4.26</TD><TD>Formin, FH2 domain</TD><TD>gene3d domains</TD><TD>1.20.58.2220</TD><TD>15</TD><TD>2</TD><TD>14531</TD><TD>178</TD>
<TD>FMNL2,DAAM1</TD></TR>
<TR><TD>1.417e-02</TD><TD>-4.26</TD><TD>DAP12 interactions</TD><TD>REACTOME pathways</TD><TD>R-HSA-2172127</TD><TD>371</TD><TD>9</TD><TD>10391</TD><TD>107</TD>
<TD>VAV3,PAQR3,NRG1,FGF20,PHLPP1,AKAP9,FGF5,FGFR2,PRKCE</TD></TR>
<TR><TD>1.421e-02</TD><TD>-4.25</TD><TD>EPB41L4A (erythrocyte membrane protein band 4.1 like 4A)</TD><TD>protein interactions</TD><TD>64097</TD><TD>128</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>EFR3B,UTRN,SLC39A10,EFR3A,CASK</TD></TR>
<TR><TD>1.429e-02</TD><TD>-4.25</TD><TD>RECEPTOR_TYR_KIN_V_1</TD><TD>prosite domains</TD><TD>PS00790</TD><TD>14</TD><TD>2</TD><TD>12232</TD><TD>162</TD>
<TD>EPHA4,EPHA3</TD></TR>
<TR><TD>1.429e-02</TD><TD>-4.25</TD><TD>EPH_LBD</TD><TD>prosite domains</TD><TD>PS51550</TD><TD>14</TD><TD>2</TD><TD>12232</TD><TD>162</TD>
<TD>EPHA4,EPHA3</TD></TR>
<TR><TD>1.429e-02</TD><TD>-4.25</TD><TD>RECEPTOR_TYR_KIN_V_2</TD><TD>prosite domains</TD><TD>PS00791</TD><TD>14</TD><TD>2</TD><TD>12232</TD><TD>162</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.432e-02</TD><TD>-4.25</TD><TD>TMEM185A (transmembrane protein 185A)</TD><TD>protein interactions</TD><TD>84548</TD><TD>84</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>EFR3B,DAAM1,EFR3A,GAP43</TD></TR>
<TR><TD>1.432e-02</TD><TD>-4.25</TD><TD>P3H3 (prolyl 3-hydroxylase 3)</TD><TD>protein interactions</TD><TD>10536</TD><TD>84</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>PI15,LGI1,ADAMTS12,PTPRK</TD></TR>
<TR><TD>1.443e-02</TD><TD>-4.24</TD><TD>PI-3K cascade:FGFR3</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654710</TD><TD>18</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF20,FGF5</TD></TR>
<TR><TD>1.443e-02</TD><TD>-4.24</TD><TD>SHC-mediated cascade:FGFR3</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654704</TD><TD>18</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>1.444e-02</TD><TD>-4.24</TD><TD>CH_dom</TD><TD>interpro domains</TD><TD>IPR001715</TD><TD>81</TD><TD>4</TD><TD>18605</TD><TD>215</TD>
<TD>NAV3,VAV3,UTRN,IQGAP2</TD></TR>
<TR><TD>1.449e-02</TD><TD>-4.23</TD><TD>human chr10q21.3</TD><TD>chromosome location</TD><TD>human chr10q21.3</TD><TD>87</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>JMJD1C,DNAJC12</TD></TR>
<TR><TD>1.449e-02</TD><TD>-4.23</TD><TD>human chr4q32.1</TD><TD>chromosome location</TD><TD>human chr4q32.1</TD><TD>87</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>CTSO,FNIP2</TD></TR>
<TR><TD>1.450e-02</TD><TD>-4.23</TD><TD>regulation of synaptic vesicle exocytosis</TD><TD>biological process</TD><TD>GO:2000300</TD><TD>44</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>SEPTIN5,SYT1,CASK</TD></TR>
<TR><TD>1.450e-02</TD><TD>-4.23</TD><TD>exocrine system development</TD><TD>biological process</TD><TD>GO:0035272</TD><TD>44</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C,PAX6,FGFR2</TD></TR>
<TR><TD>1.453e-02</TD><TD>-4.23</TD><TD>regulation of postsynaptic specialization assembly</TD><TD>biological process</TD><TD>GO:0099150</TD><TD>16</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>GAP43,PTPRD</TD></TR>
<TR><TD>1.453e-02</TD><TD>-4.23</TD><TD>branching involved in salivary gland morphogenesis</TD><TD>biological process</TD><TD>GO:0060445</TD><TD>16</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,SEMA3C</TD></TR>
<TR><TD>1.453e-02</TD><TD>-4.23</TD><TD>cellular response to prostaglandin E stimulus</TD><TD>biological process</TD><TD>GO:0071380</TD><TD>16</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6,PRKCE</TD></TR>
<TR><TD>1.453e-02</TD><TD>-4.23</TD><TD>cardiac left ventricle morphogenesis</TD><TD>biological process</TD><TD>GO:0003214</TD><TD>16</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>RYR2,TGFBR2</TD></TR>
<TR><TD>1.455e-02</TD><TD>-4.23</TD><TD>neuron projection terminus</TD><TD>cellular component</TD><TD>GO:0044306</TD><TD>128</TD><TD>5</TD><TD>19868</TD><TD>222</TD>
<TD>UCHL1,PRSS12,NTRK2,EPHA4,SYT1</TD></TR>
<TR><TD>1.460e-02</TD><TD>-4.23</TD><TD>essential_thrombocythaemia</TD><TD>COSMIC cancer mutations</TD><TD>essential_thrombocythaemia</TD><TD>393</TD><TD>10</TD><TD>16984</TD><TD>193</TD>
<TD>PXDNL,LRIG3,EPYC,PHF14,NCKAP5,FAT4,COQ2,THSD7B,CASK,UCHL1</TD></TR>
<TR><TD>1.460e-02</TD><TD>-4.23</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-essential_thrombocythaemia</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-essential_thrombocythaemia</TD><TD>393</TD><TD>10</TD><TD>16984</TD><TD>193</TD>
<TD>PXDNL,LRIG3,EPYC,PHF14,NCKAP5,FAT4,COQ2,THSD7B,CASK,UCHL1</TD></TR>
<TR><TD>1.463e-02</TD><TD>-4.22</TD><TD>tube morphogenesis</TD><TD>biological process</TD><TD>GO:0035239</TD><TD>686</TD><TD>15</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,SLIT2,EPHA4,IRX1,RYR2,THSD7A,NRCAM,TWIST1,SGCD,ZFPM2,VAV3,PBX1,TGFBR2,FZD6,NTRK2</TD></TR>
<TR><TD>1.471e-02</TD><TD>-4.22</TD><TD>ERBB4 (erb-b2 receptor tyrosine kinase 4)</TD><TD>protein interactions</TD><TD>2066</TD><TD>178</TD><TD>6</TD><TD>20077</TD><TD>223</TD>
<TD>NTRK2,NRG1,WWOX,TEC,LRIG3,VAV3</TD></TR>
<TR><TD>1.474e-02</TD><TD>-4.22</TD><TD>small GTPase binding</TD><TD>molecular function</TD><TD>GO:0031267</TD><TD>284</TD><TD>8</TD><TD>18530</TD><TD>207</TD>
<TD>IQGAP2,RPH3A,XPO4,EPS8,DAAM1,IPO8,FGD3,FMNL2</TD></TR>
<TR><TD>1.490e-02</TD><TD>-4.21</TD><TD>CFAP298 (cilia and flagella associated protein 298)</TD><TD>protein interactions</TD><TD>56683</TD><TD>85</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>PAX6,RPH3A,ZNF521,TRPS1</TD></TR>
<TR><TD>1.497e-02</TD><TD>-4.20</TD><TD>Tnks (tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase)</TD><TD>protein interactions</TD><TD>21951</TD><TD>17</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>GMDS,SLC39A10</TD></TR>
<TR><TD>1.497e-02</TD><TD>-4.20</TD><TD>GRIN2C (glutamate ionotropic receptor NMDA type subunit 2C)</TD><TD>protein interactions</TD><TD>2905</TD><TD>17</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>PTPRK,BCHE</TD></TR>
<TR><TD>1.505e-02</TD><TD>-4.20</TD><TD>CH_dom_sf</TD><TD>interpro domains</TD><TD>IPR036872</TD><TD>82</TD><TD>4</TD><TD>18605</TD><TD>215</TD>
<TD>IQGAP2,UTRN,NAV3,VAV3</TD></TR>
<TR><TD>1.509e-02</TD><TD>-4.19</TD><TD>ELK</TD><TD>smart domains</TD><TD>SM01188</TD><TD>1</TD><TD>1</TD><TD>9743</TD><TD>147</TD>
<TD>AKAP9</TD></TR>
<TR><TD>1.512e-02</TD><TD>-4.19</TD><TD>human chr6q13</TD><TD>chromosome location</TD><TD>human chr6q13</TD><TD>89</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LMBRD1,B3GAT2</TD></TR>
<TR><TD>1.513e-02</TD><TD>-4.19</TD><TD>ephrin receptor activity</TD><TD>molecular function</TD><TD>GO:0005003</TD><TD>17</TD><TD>2</TD><TD>18530</TD><TD>207</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.531e-02</TD><TD>-4.18</TD><TD>LRIG3 (leucine rich repeats and immunoglobulin like domains 3)</TD><TD>protein interactions</TD><TD>121227</TD><TD>47</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>LRRN2,PTPRK,NRSN1</TD></TR>
<TR><TD>1.540e-02</TD><TD>-4.17</TD><TD>parotid</TD><TD>COSMIC cancer mutations</TD><TD>parotid</TD><TD>580</TD><TD>13</TD><TD>16984</TD><TD>193</TD>
<TD>UHMK1,IQGAP2,AKAP9,NTRK2,FGFR2,ACVR2A,CRTC3,CASK,THSD7A,SEZ6L,NRCAM,PARP8,TGFBR2</TD></TR>
<TR><TD>1.540e-02</TD><TD>-4.17</TD><TD>skin-foot-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-foot-malignant_melanoma</TD><TD>84</TD><TD>4</TD><TD>16984</TD><TD>193</TD>
<TD>ADAM28,CHRM3,ADAMTS3,PTPRD</TD></TR>
<TR><TD>1.540e-02</TD><TD>-4.17</TD><TD>muscle organ morphogenesis</TD><TD>biological process</TD><TD>GO:0048644</TD><TD>82</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,ZFPM2,RYR2,NRG1</TD></TR>
<TR><TD>1.541e-02</TD><TD>-4.17</TD><TD>embryonic cranial skeleton morphogenesis</TD><TD>biological process</TD><TD>GO:0048701</TD><TD>45</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2,FGFR2,TWIST1</TD></TR>
<TR><TD>1.542e-02</TD><TD>-4.17</TD><TD>ear development</TD><TD>biological process</TD><TD>GO:0043583</TD><TD>222</TD><TD>7</TD><TD>18905</TD><TD>220</TD>
<TD>LRIG3,FGF20,EPHA4,TWIST1,CYTL1,FZD6,FGFR2</TD></TR>
<TR><TD>1.549e-02</TD><TD>-4.17</TD><TD>FAM171A1 (family with sequence similarity 171 member A1)</TD><TD>protein interactions</TD><TD>221061</TD><TD>86</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>EPHA3,NTRK2,NRSN1,EPHA4</TD></TR>
<TR><TD>1.553e-02</TD><TD>-4.16</TD><TD>regulation of actin filament-based process</TD><TD>biological process</TD><TD>GO:0032970</TD><TD>387</TD><TD>10</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,AKAP9,PRKCE,RYR2,TMEFF2,PLEK,EPS8,EPHA3,EFNA5,IQGAP2</TD></TR>
<TR><TD>1.553e-02</TD><TD>-4.16</TD><TD>carboxypeptidase activity</TD><TD>molecular function</TD><TD>GO:0004180</TD><TD>47</TD><TD>3</TD><TD>18530</TD><TD>207</TD>
<TD>CPQ,MATCAP2,CPXM2</TD></TR>
<TR><TD>1.558e-02</TD><TD>-4.16</TD><TD>ovary-carcinoma-mucinous_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>ovary-carcinoma-mucinous_carcinoma</TD><TD>457</TD><TD>11</TD><TD>16984</TD><TD>193</TD>
<TD>ACVR1C,CASK,UHMK1,EPHA3,EPHA4,PRKCE,TGFBR2,ACVR2A,NTRK2,FGFR2,PSKH2</TD></TR>
<TR><TD>1.567e-02</TD><TD>-4.16</TD><TD>MetalloPept_cat_dom_sf</TD><TD>interpro domains</TD><TD>IPR024079</TD><TD>83</TD><TD>4</TD><TD>18605</TD><TD>215</TD>
<TD>ADAMTS3,ADAMTS5,ADAMTS12,ADAM28</TD></TR>
<TR><TD>1.583e-02</TD><TD>-4.15</TD><TD>Fc epsilon receptor (FCERI) signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-2454202</TD><TD>378</TD><TD>9</TD><TD>10391</TD><TD>107</TD>
<TD>TEC,VAV3,NRG1,PAQR3,FGF20,PHLPP1,FGF5,AKAP9,FGFR2</TD></TR>
<TR><TD>1.591e-02</TD><TD>-4.14</TD><TD>large_intestine-caecum-adenoma</TD><TD>COSMIC cancer mutations</TD><TD>large_intestine-caecum-adenoma</TD><TD>229</TD><TD>7</TD><TD>16984</TD><TD>193</TD>
<TD>FGD3,RPH3A,UBR4,LHCGR,UNC5C,EDIL3,SLIT2</TD></TR>
<TR><TD>1.604e-02</TD><TD>-4.13</TD><TD>biliary_tract-gallbladder-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>biliary_tract-gallbladder-carcinoma-adenocarcinoma</TD><TD>2826</TD><TD>44</TD><TD>16984</TD><TD>193</TD>
<TD>AKAP9,PCDH9,NBEA,ADAMTS3,AOAH,CD226,COX7B2,ACVR2A,ROBO2,THSD7A,CNTNAP2,DSCAM,WRN,NRG1,FANCB,NUP35,TGFBR2,UNC5C,GPR83,NOVA1,AFM,KCNK9,PRLHR,SPATA16,FAT4,ZNF521,FGFR2,LRIG3,PTPRZ1,SLC39A10,CD96,ADAMTS12,FBN2,ZPLD1,FGF14,EFR3B,IPO8,NRCAM,SPHKAP,INSM1,SLIT2,TRPS1,MEGF10,GCNT1</TD></TR>
<TR><TD>1.604e-02</TD><TD>-4.13</TD><TD>gallbladder</TD><TD>COSMIC cancer mutations</TD><TD>gallbladder</TD><TD>2826</TD><TD>44</TD><TD>16984</TD><TD>193</TD>
<TD>PCDH9,ACVR2A,CD226,NRG1,DSCAM,GPR83,TGFBR2,NUP35,FAT4,PRLHR,PTPRZ1,LRIG3,ZPLD1,ADAMTS12,CD96,SLC39A10,TRPS1,INSM1,IPO8,EFR3B,ADAMTS3,AKAP9,NBEA,ROBO2,COX7B2,AOAH,WRN,FANCB,CNTNAP2,THSD7A,NOVA1,UNC5C,SPATA16,KCNK9,AFM,FGFR2,ZNF521,FGF14,FBN2,GCNT1,MEGF10,SLIT2,SPHKAP,NRCAM</TD></TR>
<TR><TD>1.604e-02</TD><TD>-4.13</TD><TD>kinase binding</TD><TD>molecular function</TD><TD>GO:0019900</TD><TD>790</TD><TD>16</TD><TD>18530</TD><TD>207</TD>
<TD>PLEK,EPHA4,PAX6,CDH5,ERCC6L2,SPAG9,NBEA,CD226,RYR2,UTRN,BANK1,UNC5C,PTPRK,DSCAM,NRG1,PARP8</TD></TR>
<TR><TD>1.605e-02</TD><TD>-4.13</TD><TD>mucinous_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>mucinous_carcinoma</TD><TD>459</TD><TD>11</TD><TD>16984</TD><TD>193</TD>
<TD>UHMK1,ACVR1C,PSKH2,FGFR2,NTRK2,ACVR2A,EPHA4,CASK,TGFBR2,PRKCE,EPHA3</TD></TR>
<TR><TD>1.605e-02</TD><TD>-4.13</TD><TD>Calponin-like domain</TD><TD>gene3d domains</TD><TD>1.10.418.10</TD><TD>79</TD><TD>4</TD><TD>14531</TD><TD>178</TD>
<TD>VAV3,IQGAP2,NAV3,UTRN</TD></TR>
<TR><TD>1.613e-02</TD><TD>-4.13</TD><TD>Znf_RING-CH</TD><TD>interpro domains</TD><TD>IPR011016</TD><TD>17</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>MARCHF3,MARCHF11</TD></TR>
<TR><TD>1.613e-02</TD><TD>-4.13</TD><TD>Synaptotagmin</TD><TD>interpro domains</TD><TD>IPR001565</TD><TD>17</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>SYT1,RPH3A</TD></TR>
<TR><TD>1.613e-02</TD><TD>-4.13</TD><TD>HDAC1 (histone deacetylase 1)</TD><TD>protein interactions</TD><TD>3065</TD><TD>1070</TD><TD>20</TD><TD>20077</TD><TD>223</TD>
<TD>ZFPM2,PHF14,JMJD1C,AKAP9,PWWP2A,SS18,WWOX,ZNF521,TCF20,UTRN,RBM20,SHTN1,RUNX1T1,INSM1,PHLPP1,UBR4,SPAG9,TRPS1,PBX1,WRN</TD></TR>
<TR><TD>1.620e-02</TD><TD>-4.12</TD><TD>IL3RA (interleukin 3 receptor subunit alpha)</TD><TD>protein interactions</TD><TD>3563</TD><TD>48</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>MARCHF3,PTPRD,FGFR2</TD></TR>
<TR><TD>1.623e-02</TD><TD>-4.12</TD><TD>pleura-pulmonary_blastoma</TD><TD>COSMIC cancer mutations</TD><TD>pleura-pulmonary_blastoma</TD><TD>648</TD><TD>14</TD><TD>16984</TD><TD>193</TD>
<TD>TRPS1,MAP2,PTPRD,TGFBR2,SPHKAP,BCHE,CASK,CNTNAP2,XPO4,PRSS12,NCKAP5,CALN1,FAT4,RUNX1T1</TD></TR>
<TR><TD>1.623e-02</TD><TD>-4.12</TD><TD>pulmonary_blastoma</TD><TD>COSMIC cancer mutations</TD><TD>pulmonary_blastoma</TD><TD>648</TD><TD>14</TD><TD>16984</TD><TD>193</TD>
<TD>CALN1,FAT4,RUNX1T1,XPO4,PRSS12,NCKAP5,CNTNAP2,CASK,TRPS1,PTPRD,MAP2,SPHKAP,TGFBR2,BCHE</TD></TR>
<TR><TD>1.634e-02</TD><TD>-4.11</TD><TD>regulation of integrin activation</TD><TD>biological process</TD><TD>GO:0033623</TD><TD>17</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>PLEK,CXCL13</TD></TR>
<TR><TD>1.634e-02</TD><TD>-4.11</TD><TD>ganglion development</TD><TD>biological process</TD><TD>GO:0061548</TD><TD>17</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>UNC5C,INSM1</TD></TR>
<TR><TD>1.635e-02</TD><TD>-4.11</TD><TD>FH2</TD><TD>prosite domains</TD><TD>PS51444</TD><TD>15</TD><TD>2</TD><TD>12232</TD><TD>162</TD>
<TD>DAAM1,FMNL2</TD></TR>
<TR><TD>1.641e-02</TD><TD>-4.11</TD><TD>telencephalon development</TD><TD>biological process</TD><TD>GO:0021537</TD><TD>278</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>ARX,PAX6,CNTNAP2,FAT4,NTRK2,LMX1A,SLIT2,ROBO2</TD></TR>
<TR><TD>1.647e-02</TD><TD>-4.11</TD><TD>L-asparagine degradation III (mammalian)</TD><TD>BIOCYC pathways</TD><TD>META_ASPARAGINE-DEG1-PWY-1</TD><TD>3</TD><TD>1</TD><TD>907</TD><TD>5</TD>
<TD>AGA</TD></TR>
<TR><TD>1.647e-02</TD><TD>-4.11</TD><TD>bronchioloalveolar_adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>bronchioloalveolar_adenocarcinoma</TD><TD>780</TD><TD>16</TD><TD>16984</TD><TD>193</TD>
<TD>TGFBR2,PRKCE,EPHA3,BCHE,SYT1,CASK,ADAMTS12,LRIG3,PSKH2,FGFR2,NTRK2,ACVR2A,EPHA4,UHMK1,ACVR1C,CPXM2</TD></TR>
<TR><TD>1.647e-02</TD><TD>-4.11</TD><TD>lung-carcinoma-bronchioloalveolar_adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma-bronchioloalveolar_adenocarcinoma</TD><TD>780</TD><TD>16</TD><TD>16984</TD><TD>193</TD>
<TD>LRIG3,PSKH2,NTRK2,FGFR2,ACVR2A,EPHA4,UHMK1,ACVR1C,CPXM2,TGFBR2,PRKCE,BCHE,EPHA3,SYT1,ADAMTS12,CASK</TD></TR>
<TR><TD>1.654e-02</TD><TD>-4.10</TD><TD>EPH-Ephrin signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-2682334</TD><TD>95</TD><TD>4</TD><TD>10391</TD><TD>107</TD>
<TD>VAV3,EFNA5,EPHA3,EPHA4</TD></TR>
<TR><TD>1.658e-02</TD><TD>-4.10</TD><TD>-</TD><TD>gene3d domains</TD><TD>2.60.120.200</TD><TD>121</TD><TD>5</TD><TD>14531</TD><TD>178</TD>
<TD>NBEA,FAT4,PTPRK,CNTNAP2,SLIT2</TD></TR>
<TR><TD>1.669e-02</TD><TD>-4.09</TD><TD>stem cell development</TD><TD>biological process</TD><TD>GO:0048864</TD><TD>84</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C,NRG1,TWIST1,PAX6</TD></TR>
<TR><TD>1.673e-02</TD><TD>-4.09</TD><TD>regulation of GTPase activity</TD><TD>biological process</TD><TD>GO:0043087</TD><TD>279</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>EPHA4,VAV3,EFNA5,EPHA3,FGD3,CXCL13,RGS6,NTRK2</TD></TR>
<TR><TD>1.682e-02</TD><TD>-4.08</TD><TD>WW_DOMAIN_1</TD><TD>prosite domains</TD><TD>PS01159</TD><TD>41</TD><TD>3</TD><TD>12232</TD><TD>162</TD>
<TD>IQGAP2,WWOX,UTRN</TD></TR>
<TR><TD>1.689e-02</TD><TD>-4.08</TD><TD>transmembrane receptor protein tyrosine kinase activator activity</TD><TD>molecular function</TD><TD>GO:0030297</TD><TD>18</TD><TD>2</TD><TD>18530</TD><TD>207</TD>
<TD>EFNA5,NRG1</TD></TR>
<TR><TD>1.690e-02</TD><TD>-4.08</TD><TD>filopodium membrane</TD><TD>cellular component</TD><TD>GO:0031527</TD><TD>18</TD><TD>2</TD><TD>19868</TD><TD>222</TD>
<TD>GAP43,UTRN</TD></TR>
<TR><TD>1.701e-02</TD><TD>-4.07</TD><TD>ARL4C (ADP ribosylation factor like GTPase 4C)</TD><TD>protein interactions</TD><TD>10123</TD><TD>134</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>DNAJC12,PTPRK,SLC39A10,PCDH9,UNC5C</TD></TR>
<TR><TD>1.703e-02</TD><TD>-4.07</TD><TD>embryonic skeletal system development</TD><TD>biological process</TD><TD>GO:0048706</TD><TD>128</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>PBX1,TWIST1,FGFR2,ACVR2A,TGFBR2</TD></TR>
<TR><TD>1.707e-02</TD><TD>-4.07</TD><TD>ARM-type_fold</TD><TD>interpro domains</TD><TD>IPR016024</TD><TD>338</TD><TD>9</TD><TD>18605</TD><TD>215</TD>
<TD>FMNL2,DAAM1,XPO4,EFR3A,UBR4,PUM3,IPO8,NBEA,EFR3B</TD></TR>
<TR><TD>1.710e-02</TD><TD>-4.07</TD><TD>AAA</TD><TD>pfam domains</TD><TD>PF00004</TD><TD>47</TD><TD>3</TD><TD>17869</TD><TD>207</TD>
<TD>AFG2A,FIGN,NAV3</TD></TR>
<TR><TD>1.712e-02</TD><TD>-4.07</TD><TD>positive regulation of locomotion</TD><TD>biological process</TD><TD>GO:0040017</TD><TD>636</TD><TD>14</TD><TD>18905</TD><TD>220</TD>
<TD>EPHA4,SLIT2,SHTN1,PRKCE,CDH5,TWIST1,CXCL13,SPAG9,INSM1,TGFBR2,PECAM1,PAX6,SEMA3C,DSCAM</TD></TR>
<TR><TD>1.718e-02</TD><TD>-4.06</TD><TD>epithelium development</TD><TD>biological process</TD><TD>GO:0060429</TD><TD>1096</TD><TD>21</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C,ARX,PECAM1,FZD6,PAX6,TMEFF2,TGFBR2,PBX1,FERD3L,INSM1,KAZN,FGF20,PLAAT1,TWIST1,RYR2,ROBO2,NRG1,IRX1,EPHA4,SLIT2,FGFR2</TD></TR>
<TR><TD>1.731e-02</TD><TD>-4.06</TD><TD>regulation of neuron migration</TD><TD>biological process</TD><TD>GO:2001222</TD><TD>47</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>UNC5C,SHTN1,PAX6</TD></TR>
<TR><TD>1.731e-02</TD><TD>-4.06</TD><TD>ovulation cycle process</TD><TD>biological process</TD><TD>GO:0022602</TD><TD>47</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,LHCGR,SLIT2</TD></TR>
<TR><TD>1.736e-02</TD><TD>-4.05</TD><TD>oligodendrocyte differentiation</TD><TD>biological process</TD><TD>GO:0048709</TD><TD>85</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6,NTRK2,CNTN1,PTPRZ1</TD></TR>
<TR><TD>1.736e-02</TD><TD>-4.05</TD><TD>chondrocyte differentiation</TD><TD>biological process</TD><TD>GO:0002062</TD><TD>85</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>ADAMTS12,TGFBR2,CYTL1,AMELX</TD></TR>
<TR><TD>1.736e-02</TD><TD>-4.05</TD><TD>regulation of sodium ion transport</TD><TD>biological process</TD><TD>GO:0002028</TD><TD>85</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>PRKCE,FGF14,UTRN,CNTN1</TD></TR>
<TR><TD>1.741e-02</TD><TD>-4.05</TD><TD>CH</TD><TD>smart domains</TD><TD>SM00033</TD><TD>66</TD><TD>4</TD><TD>9743</TD><TD>147</TD>
<TD>VAV3,IQGAP2,NAV3,UTRN</TD></TR>
<TR><TD>1.749e-02</TD><TD>-4.05</TD><TD>ovary-carcinoma-endometrioid_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>ovary-carcinoma-endometrioid_carcinoma</TD><TD>465</TD><TD>11</TD><TD>16984</TD><TD>193</TD>
<TD>UHMK1,ACVR1C,PSKH2,FGFR2,NTRK2,ACVR2A,EPHA4,CASK,TGFBR2,PRKCE,EPHA3</TD></TR>
<TR><TD>1.764e-02</TD><TD>-4.04</TD><TD>embryonic organ development</TD><TD>biological process</TD><TD>GO:0048568</TD><TD>454</TD><TD>11</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6,TWIST1,FZD6,LRIG3,ZFPM2,EFEMP1,PBX1,FBN2,FGFR2,RYR2,TGFBR2</TD></TR>
<TR><TD>1.769e-02</TD><TD>-4.03</TD><TD>FRS-mediated FGFR3 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654706</TD><TD>20</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>1.785e-02</TD><TD>-4.03</TD><TD>glutamatergic synapse</TD><TD>cellular component</TD><TD>GO:0098978</TD><TD>412</TD><TD>10</TD><TD>19868</TD><TD>222</TD>
<TD>LRFN5,SYT1,LGI1,PTPRD,IL1RAPL2,AKAP9,EPHA4,EPS8,ADGRL3,NRCAM</TD></TR>
<TR><TD>1.798e-02</TD><TD>-4.02</TD><TD>PTPc</TD><TD>smart domains</TD><TD>SM00194</TD><TD>37</TD><TD>3</TD><TD>9743</TD><TD>147</TD>
<TD>PTPRZ1,PTPRK,PTPRD</TD></TR>
<TR><TD>1.799e-02</TD><TD>-4.02</TD><TD>skin-head_neck-malignant_melanoma-superficial_spreading</TD><TD>COSMIC cancer mutations</TD><TD>skin-head_neck-malignant_melanoma-superficial_spreading</TD><TD>923</TD><TD>18</TD><TD>16984</TD><TD>193</TD>
<TD>ASPN,CNTNAP2,ADAMTS12,FBN2,SYT1,UTRN,HNF4G,EPHA3,PTPRK,SPHKAP,SLIT2,NOVA1,RUNX1T1,SLC25A46,RASGEF1B,FUT9,FAT4,EFR3A</TD></TR>
<TR><TD>1.801e-02</TD><TD>-4.02</TD><TD>PLAC</TD><TD>interpro domains</TD><TD>IPR010909</TD><TD>18</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>ADAMTS3,ADAMTS12</TD></TR>
<TR><TD>1.804e-02</TD><TD>-4.02</TD><TD>ACBD3 (acyl-CoA binding domain containing 3)</TD><TD>protein interactions</TD><TD>64746</TD><TD>240</TD><TD>7</TD><TD>20077</TD><TD>223</TD>
<TD>EPHA4,FGFR2,NUP35,SPAG9,NTRK2,EPHA3,SLC25A46</TD></TR>
<TR><TD>1.807e-02</TD><TD>-4.01</TD><TD>TGFBR3 (transforming growth factor beta receptor 3)</TD><TD>protein interactions</TD><TD>7049</TD><TD>50</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>ACVR2A,TGFBR2,SHISA3</TD></TR>
<TR><TD>1.807e-02</TD><TD>-4.01</TD><TD>ZNF516 (zinc finger protein 516)</TD><TD>protein interactions</TD><TD>9658</TD><TD>50</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>PAX6,NOL4,KLF12</TD></TR>
<TR><TD>1.818e-02</TD><TD>-4.01</TD><TD>NGF signalling via TRKA from the plasma membrane</TD><TD>REACTOME pathways</TD><TD>R-HSA-187037</TD><TD>387</TD><TD>9</TD><TD>10391</TD><TD>107</TD>
<TD>PRKCE,FGFR2,NTRK2,AKAP9,FGF5,PHLPP1,FGF20,PAQR3,NRG1</TD></TR>
<TR><TD>1.825e-02</TD><TD>-4.00</TD><TD>cellular response to gonadotropin stimulus</TD><TD>biological process</TD><TD>GO:0071371</TD><TD>18</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>LHCGR,EFNA5</TD></TR>
<TR><TD>1.825e-02</TD><TD>-4.00</TD><TD>regulation of leukocyte tethering or rolling</TD><TD>biological process</TD><TD>GO:1903236</TD><TD>18</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>GCNT1,FUT9</TD></TR>
<TR><TD>1.825e-02</TD><TD>-4.00</TD><TD>positive regulation of neuron migration</TD><TD>biological process</TD><TD>GO:2001224</TD><TD>18</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>SHTN1,PAX6</TD></TR>
<TR><TD>1.827e-02</TD><TD>-4.00</TD><TD>EPH_lbd</TD><TD>smart domains</TD><TD>SM00615</TD><TD>14</TD><TD>2</TD><TD>9743</TD><TD>147</TD>
<TD>EPHA3,EPHA4</TD></TR>
<TR><TD>1.831e-02</TD><TD>-4.00</TD><TD>regulation of cardiac muscle cell proliferation</TD><TD>biological process</TD><TD>GO:0060043</TD><TD>48</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,ZFPM2,FGF20</TD></TR>
<TR><TD>1.831e-02</TD><TD>-4.00</TD><TD>regulation of keratinocyte proliferation</TD><TD>biological process</TD><TD>GO:0010837</TD><TD>48</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>PTPRK,CASK,FGFR2</TD></TR>
<TR><TD>1.841e-02</TD><TD>-3.99</TD><TD>ERBIN (erbb2 interacting protein)</TD><TD>protein interactions</TD><TD>55914</TD><TD>241</TD><TD>7</TD><TD>20077</TD><TD>223</TD>
<TD>EPHA3,ARL14,NTRK2,ACVR2A,CASK,FGFR2,EPHA4</TD></TR>
<TR><TD>1.847e-02</TD><TD>-3.99</TD><TD>spleen</TD><TD>COSMIC cancer mutations</TD><TD>spleen</TD><TD>408</TD><TD>10</TD><TD>16984</TD><TD>193</TD>
<TD>FBN2,FAT4,LRRC3B,UTRN,NAT2,ROBO2,PTPRZ1,PTPRD,PTPRK,EDIL3</TD></TR>
<TR><TD>1.848e-02</TD><TD>-3.99</TD><TD>human chr17p12</TD><TD>chromosome location</TD><TD>human chr17p12</TD><TD>99</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LOC101928475,LINC00670</TD></TR>
<TR><TD>1.854e-02</TD><TD>-3.99</TD><TD>GNA13 (G protein subunit alpha 13)</TD><TD>protein interactions</TD><TD>10672</TD><TD>137</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>TEC,EPHA4,PRKCE,EFNA5,UTRN</TD></TR>
<TR><TD>1.855e-02</TD><TD>-3.99</TD><TD>TNR (tenascin R)</TD><TD>protein interactions</TD><TD>7143</TD><TD>19</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>PTPRZ1,CNTN1</TD></TR>
<TR><TD>1.855e-02</TD><TD>-3.99</TD><TD>DEFB125 (defensin beta 125)</TD><TD>protein interactions</TD><TD>245938</TD><TD>19</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>FBN2,UBR4</TD></TR>
<TR><TD>1.855e-02</TD><TD>-3.99</TD><TD>CCL19 (C-C motif chemokine ligand 19)</TD><TD>protein interactions</TD><TD>6363</TD><TD>19</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>FAT4,CXCL13</TD></TR>
<TR><TD>1.855e-02</TD><TD>-3.99</TD><TD>DYNLT4 (dynein light chain Tctex-type 4)</TD><TD>protein interactions</TD><TD>343521</TD><TD>19</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>ACVR2A,TGFBR2</TD></TR>
<TR><TD>1.855e-02</TD><TD>-3.99</TD><TD>HTR4 (5-hydroxytryptamine receptor 4)</TD><TD>protein interactions</TD><TD>3360</TD><TD>19</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>GHITM,TMEFF2</TD></TR>
<TR><TD>1.869e-02</TD><TD>-3.98</TD><TD>ACVR1B (activin A receptor type 1B)</TD><TD>protein interactions</TD><TD>91</TD><TD>91</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>ACVR2A,GPR83,ACVR1C,TGFBR2</TD></TR>
<TR><TD>1.869e-02</TD><TD>-3.98</TD><TD>IPO13 (importin 13)</TD><TD>protein interactions</TD><TD>9670</TD><TD>91</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>CHRM3,ARX,PAX6,XPO4</TD></TR>
<TR><TD>1.869e-02</TD><TD>-3.98</TD><TD>DGUOK (deoxyguanosine kinase)</TD><TD>protein interactions</TD><TD>1716</TD><TD>91</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>MAP2,EDIL3,CNTN1,SYT1</TD></TR>
<TR><TD>1.891e-02</TD><TD>-3.97</TD><TD>Collagenase (Catalytic Domain)</TD><TD>gene3d domains</TD><TD>3.40.390.10</TD><TD>83</TD><TD>4</TD><TD>14531</TD><TD>178</TD>
<TD>ADAMTS3,ADAMTS12,ADAMTS5,ADAM28</TD></TR>
<TR><TD>1.899e-02</TD><TD>-3.96</TD><TD>ATPase_AAA_core</TD><TD>interpro domains</TD><TD>IPR003959</TD><TD>49</TD><TD>3</TD><TD>18605</TD><TD>215</TD>
<TD>FIGN,NAV3,AFG2A</TD></TR>
<TR><TD>1.904e-02</TD><TD>-3.96</TD><TD>CHST10 (carbohydrate sulfotransferase 10)</TD><TD>protein interactions</TD><TD>9486</TD><TD>51</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>PTPRK,NRG1,CDH5</TD></TR>
<TR><TD>1.924e-02</TD><TD>-3.95</TD><TD>morphogenesis of an epithelium</TD><TD>biological process</TD><TD>GO:0002009</TD><TD>460</TD><TD>11</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C,TMEFF2,TWIST1,FZD6,RYR2,TGFBR2,IRX1,EPHA4,PBX1,FGFR2,SLIT2</TD></TR>
<TR><TD>1.934e-02</TD><TD>-3.95</TD><TD>regulation of sodium ion transmembrane transporter activity</TD><TD>biological process</TD><TD>GO:2000649</TD><TD>49</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>UTRN,FGF14,PRKCE</TD></TR>
<TR><TD>1.942e-02</TD><TD>-3.94</TD><TD>Regulation of gene expression in beta cells</TD><TD>REACTOME pathways</TD><TD>R-HSA-210745</TD><TD>21</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>HNF4G,PAX6</TD></TR>
<TR><TD>1.942e-02</TD><TD>-3.94</TD><TD>SHC-mediated cascade:FGFR1</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654688</TD><TD>21</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>1.942e-02</TD><TD>-3.94</TD><TD>Signaling by NODAL</TD><TD>REACTOME pathways</TD><TD>R-HSA-1181150</TD><TD>21</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>ACVR2A,ACVR1C</TD></TR>
<TR><TD>1.942e-02</TD><TD>-3.94</TD><TD>PI-3K cascade:FGFR1</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654689</TD><TD>21</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>1.946e-02</TD><TD>-3.94</TD><TD>growth factor receptor binding</TD><TD>molecular function</TD><TD>GO:0070851</TD><TD>138</TD><TD>5</TD><TD>18530</TD><TD>207</TD>
<TD>CDH5,FGF20,FGF5,VAV3,EFEMP1</TD></TR>
<TR><TD>1.947e-02</TD><TD>-3.94</TD><TD>ureteric bud development</TD><TD>biological process</TD><TD>GO:0001657</TD><TD>88</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>PBX1,SLIT2,FGFR2,ROBO2</TD></TR>
<TR><TD>1.967e-02</TD><TD>-3.93</TD><TD>regulation of cell growth</TD><TD>biological process</TD><TD>GO:0001558</TD><TD>402</TD><TD>10</TD><TD>18905</TD><TD>220</TD>
<TD>SPAG9,DSCAM,EFNA5,NRCAM,MAP2,SHTN1,LGI1,SYT1,LMX1A,SLIT2</TD></TR>
<TR><TD>1.976e-02</TD><TD>-3.92</TD><TD>Zn peptidases</TD><TD>gene3d domains</TD><TD>3.40.630.10</TD><TD>47</TD><TD>3</TD><TD>14531</TD><TD>178</TD>
<TD>NAALADL2,CPQ,CPXM2</TD></TR>
<TR><TD>2.005e-02</TD><TD>-3.91</TD><TD>FBXO34 (F-box protein 34)</TD><TD>protein interactions</TD><TD>55030</TD><TD>52</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>FGF14,TGFBR2,GAP43</TD></TR>
<TR><TD>2.005e-02</TD><TD>-3.91</TD><TD>ovary-carcinoma-clear_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>ovary-carcinoma-clear_cell_carcinoma</TD><TD>666</TD><TD>14</TD><TD>16984</TD><TD>193</TD>
<TD>UHMK1,FAT4,ACVR1C,PSKH2,NTRK2,FGFR2,ACVR2A,EPHA4,UTRN,RAI2,CASK,PRKCE,TGFBR2,EPHA3</TD></TR>
<TR><TD>2.007e-02</TD><TD>-3.91</TD><TD>MYADM (myeloid associated differentiation marker)</TD><TD>protein interactions</TD><TD>91663</TD><TD>93</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>NRSN1,TGFBR2,SEZ6L,SHISA3</TD></TR>
<TR><TD>2.016e-02</TD><TD>-3.90</TD><TD>EFNB2 (ephrin B2)</TD><TD>protein interactions</TD><TD>1948</TD><TD>140</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>PECAM1,PHLPP1,EPHA4,ARL14,EPHA3</TD></TR>
<TR><TD>2.021e-02</TD><TD>-3.90</TD><TD>mesonephric epithelium development</TD><TD>biological process</TD><TD>GO:0072163</TD><TD>89</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,SLIT2,FGFR2,PBX1</TD></TR>
<TR><TD>2.021e-02</TD><TD>-3.90</TD><TD>mesonephric tubule development</TD><TD>biological process</TD><TD>GO:0072164</TD><TD>89</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,SLIT2,PBX1,ROBO2</TD></TR>
<TR><TD>2.023e-02</TD><TD>-3.90</TD><TD>embryo development</TD><TD>biological process</TD><TD>GO:0009790</TD><TD>1046</TD><TD>20</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2,ZFAND5,PBX1,FERD3L,FBN2,SEMA3C,RAI2,EFEMP1,FZD6,PAX6,LMBRD1,RYR2,ADAMTS3,ACVR1C,IRX1,ACVR2A,FGFR2,ZFPM2,LRIG3,TWIST1</TD></TR>
<TR><TD>2.034e-02</TD><TD>-3.90</TD><TD>regulation of cytoskeleton organization</TD><TD>biological process</TD><TD>GO:0051493</TD><TD>525</TD><TD>12</TD><TD>18905</TD><TD>220</TD>
<TD>IQGAP2,EPS8,EPHA3,EFNA5,PLEK,MAP2,PRKCE,CDH5,AKAP9,SLIT2,TMEFF2,NAV3</TD></TR>
<TR><TD>2.040e-02</TD><TD>-3.89</TD><TD>cortical cytoskeleton organization</TD><TD>biological process</TD><TD>GO:0030865</TD><TD>50</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>PLEK,FMNL2,IQGAP2</TD></TR>
<TR><TD>2.040e-02</TD><TD>-3.89</TD><TD>eye photoreceptor cell differentiation</TD><TD>biological process</TD><TD>GO:0001754</TD><TD>50</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>DSCAM,NTRK2,PAX6</TD></TR>
<TR><TD>2.042e-02</TD><TD>-3.89</TD><TD>VEGFA-VEGFR2 Pathway</TD><TD>REACTOME pathways</TD><TD>R-HSA-4420097</TD><TD>330</TD><TD>8</TD><TD>10391</TD><TD>107</TD>
<TD>PAQR3,NRG1,VAV3,CDH5,FGFR2,FGF5,AKAP9,FGF20</TD></TR>
<TR><TD>2.045e-02</TD><TD>-3.89</TD><TD>pituitary-craniopharyngeal_duct-craniopharyngioma-adamantinomatous</TD><TD>COSMIC cancer mutations</TD><TD>pituitary-craniopharyngeal_duct-craniopharyngioma-adamantinomatous</TD><TD>355</TD><TD>9</TD><TD>16984</TD><TD>193</TD>
<TD>ADAM28,VAV3,UTRN,CRTC3,NRCAM,UBR4,PXDNL,EPYC,PTPRZ1</TD></TR>
<TR><TD>2.045e-02</TD><TD>-3.89</TD><TD>adamantinomatous</TD><TD>COSMIC cancer mutations</TD><TD>adamantinomatous</TD><TD>355</TD><TD>9</TD><TD>16984</TD><TD>193</TD>
<TD>UBR4,NRCAM,EPYC,PTPRZ1,PXDNL,ADAM28,VAV3,UTRN,CRTC3</TD></TR>
<TR><TD>2.046e-02</TD><TD>-3.89</TD><TD>DOK5 (docking protein 5)</TD><TD>protein interactions</TD><TD>55816</TD><TD>20</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>NTRK2,RAI2</TD></TR>
<TR><TD>2.046e-02</TD><TD>-3.89</TD><TD>CCDC197 (coiled-coil domain containing 197)</TD><TD>protein interactions</TD><TD>256369</TD><TD>20</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>FMNL2,RUNX1T1</TD></TR>
<TR><TD>2.046e-02</TD><TD>-3.89</TD><TD>CPQ (carboxypeptidase Q)</TD><TD>protein interactions</TD><TD>10404</TD><TD>20</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>DAAM1,SLC25A46</TD></TR>
<TR><TD>2.046e-02</TD><TD>-3.89</TD><TD>ADRA2C (adrenoceptor alpha 2C)</TD><TD>protein interactions</TD><TD>152</TD><TD>20</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>WWOX,UCHL1</TD></TR>
<TR><TD>2.046e-02</TD><TD>-3.89</TD><TD>TTC38 (tetratricopeptide repeat domain 38)</TD><TD>protein interactions</TD><TD>55020</TD><TD>20</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>SEMA3C,GMDS</TD></TR>
<TR><TD>2.046e-02</TD><TD>-3.89</TD><TD>C1orf87 (chromosome 1 open reading frame 87)</TD><TD>protein interactions</TD><TD>127795</TD><TD>20</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>AKAP9,UBR4</TD></TR>
<TR><TD>2.049e-02</TD><TD>-3.89</TD><TD>TGFBR2 MSI Frameshift Mutants in Cancer</TD><TD>REACTOME pathways</TD><TD>R-HSA-3642279</TD><TD>2</TD><TD>1</TD><TD>10391</TD><TD>107</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>2.049e-02</TD><TD>-3.89</TD><TD>Acetylation</TD><TD>REACTOME pathways</TD><TD>R-HSA-156582</TD><TD>2</TD><TD>1</TD><TD>10391</TD><TD>107</TD>
<TD>NAT2</TD></TR>
<TR><TD>2.049e-02</TD><TD>-3.89</TD><TD>TWIK-releated acid-sensitive K+ channel (TASK)</TD><TD>REACTOME pathways</TD><TD>R-HSA-1299316</TD><TD>2</TD><TD>1</TD><TD>10391</TD><TD>107</TD>
<TD>KCNK9</TD></TR>
<TR><TD>2.059e-02</TD><TD>-3.88</TD><TD>astrocytoma_Grade_IV</TD><TD>COSMIC cancer mutations</TD><TD>astrocytoma_Grade_IV</TD><TD>15952</TD><TD>188</TD><TD>16984</TD><TD>193</TD>
<TD>IPO8,PXDNL,TRPS1,PI15,SLC39A10,FNIP2,ZPLD1,NOL4,LMX1A,SGCD,FERD3L,ZFAND5,NUP35,PTPRD,JMJD1C,ACVR2A,SEMA3C,PCDH9,NAV3,RGS5,NAT2,PWWP2A,COQ2,FMNL2,SPHKAP,FGD3,SLC7A14,CASK,CDH5,MPEG1,ZNF521,FGFR2,SERGEF,SEZ6L,EPS8,FANCB,NCKAP5,TSN,FABP7,DNAJC12,NTRK2,STXBP6,NBEA,FIGN,ADAMTS3,SS18,PRKCE,MRPL3,TWIST1,MUC7,TMEFF2,CELF2,XPO4,TCF20,PRLHR,CPXM2,RBM20,UHMK1,ARX,EFR3A,EPHA3,KIF6,CHRM3,OR52K2,DSCAM,PCGF5,EFNA5,ADAMTS5,PBX1,FGF5,ATG10,NRCAM,PAX6,SLIT2,MEGF10,MAP2,RAI2,LRRC70,OR2AG1,LRFN5,PHF14,DEPTOR,KCNK9,RPH3A,AMELX,KLF12,BCHE,WWOX,AGA,CTSO,AOAH,EDIL3,CXCL13,COX7B2,SKAP2,NRSN1,CALN1,LRRC3B,IGFL4,INSM1,EPYC,NAALADL2,ADAMTS12,LRIG3,BACH2,NOBOX,GPR83,CETN3,SPAG9,NRG1,UTRN,DAAM1,GAP43,REG1B,PTPRK,UBR4,SLC7A8,LMBRD1,B3GAT2,ARL14,ADAM28,FGF14,CRTC3,FGF20,AFM,IQGAP2,GHITM,UCHL1,CYTL1,PLEK,THSD7B,IL1RAPL2,LGI1,HNF4G,PARP8,REXO2,NOVA1,ASPN,CNTNAP2,WRN,IRX1,EPHA4,KAZN,PSKH2,ZNF518B,AKAP9,SLC10A2,SLC25A46,FUT9,MRPL13,RYR2,LHCGR,SGCG,CD96,DEFB115,RGS6,PTPRZ1,BANK1,SHISA3,FAT4,SERINC5,FZD6,ZFPM2,TGFBR2,SYT1,CD226,GMDS,DCDC2C,CNTN1,GCNT1,LRRN2,DAOA,FBN2,EFEMP1,PAQR3,DNER,RUNX1T1,SPATA16,ACVR1C,UNC5C,ACP6,THSD7A,ZNF133,VAV3,PRSS12,ROBO2,PHLPP1,RASGEF1B</TD></TR>
<TR><TD>2.070e-02</TD><TD>-3.88</TD><TD>human chr5q21.2</TD><TD>chromosome location</TD><TD>human chr5q21.2</TD><TD>10</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>LINC02115</TD></TR>
<TR><TD>2.075e-02</TD><TD>-3.87</TD><TD>abdomen</TD><TD>COSMIC cancer mutations</TD><TD>abdomen</TD><TD>604</TD><TD>13</TD><TD>16984</TD><TD>193</TD>
<TD>PTPRD,MPEG1,ADAMTS12,CHRM3,FGFR2,ROBO2,ADAMTS5,FUT9,REG1B,FAT4,CALN1,RPH3A,NAV3</TD></TR>
<TR><TD>2.078e-02</TD><TD>-3.87</TD><TD>EIF1AD (eukaryotic translation initiation factor 1A domain containing)</TD><TD>protein interactions</TD><TD>84285</TD><TD>94</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>MTERF1,ZNF521,PAX6,CASK</TD></TR>
<TR><TD>2.079e-02</TD><TD>-3.87</TD><TD>embryonic morphogenesis</TD><TD>biological process</TD><TD>GO:0048598</TD><TD>589</TD><TD>13</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6,FZD6,EFEMP1,PBX1,FBN2,TGFBR2,TWIST1,LRIG3,IRX1,ACVR2A,FGFR2,RYR2,LMBRD1</TD></TR>
<TR><TD>2.087e-02</TD><TD>-3.87</TD><TD>FH2</TD><TD>smart domains</TD><TD>SM00498</TD><TD>15</TD><TD>2</TD><TD>9743</TD><TD>147</TD>
<TD>FMNL2,DAAM1</TD></TR>
<TR><TD>2.091e-02</TD><TD>-3.87</TD><TD>L1CAM interactions</TD><TD>REACTOME pathways</TD><TD>R-HSA-373760</TD><TD>102</TD><TD>4</TD><TD>10391</TD><TD>107</TD>
<TD>NRCAM,SHTN1,CNTN1,GAP43</TD></TR>
<TR><TD>2.096e-02</TD><TD>-3.87</TD><TD>epithelial to mesenchymal transition</TD><TD>biological process</TD><TD>GO:0001837</TD><TD>90</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2,SLC39A10,FGFR2,AMELX</TD></TR>
<TR><TD>2.099e-02</TD><TD>-3.86</TD><TD>clear_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>clear_cell_carcinoma</TD><TD>670</TD><TD>14</TD><TD>16984</TD><TD>193</TD>
<TD>ACVR2A,EPHA4,PSKH2,NTRK2,FGFR2,ACVR1C,UHMK1,FAT4,PRKCE,TGFBR2,EPHA3,CASK,UTRN,RAI2</TD></TR>
<TR><TD>2.110e-02</TD><TD>-3.86</TD><TD>WW_dom</TD><TD>interpro domains</TD><TD>IPR001202</TD><TD>51</TD><TD>3</TD><TD>18605</TD><TD>215</TD>
<TD>IQGAP2,UTRN,WWOX</TD></TR>
<TR><TD>2.122e-02</TD><TD>-3.85</TD><TD>SHC1 events in ERBB2 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-1250196</TD><TD>22</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>PRKCE,NRG1</TD></TR>
<TR><TD>2.122e-02</TD><TD>-3.85</TD><TD>Signaling by FGFR3 point mutants in cancer</TD><TD>REACTOME pathways</TD><TD>R-HSA-8853338</TD><TD>22</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>2.122e-02</TD><TD>-3.85</TD><TD>Signaling by FGFR3 in disease</TD><TD>REACTOME pathways</TD><TD>R-HSA-5655332</TD><TD>22</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>2.128e-02</TD><TD>-3.85</TD><TD>skin-trunk-malignant_melanoma-nodular</TD><TD>COSMIC cancer mutations</TD><TD>skin-trunk-malignant_melanoma-nodular</TD><TD>1292</TD><TD>23</TD><TD>16984</TD><TD>193</TD>
<TD>FBN2,LHCGR,SPHKAP,PTPRK,PLEK,FAT4,IQGAP2,CPXM2,AFM,LMX1A,KCNK9,RGS6,PTPRZ1,FGFR2,LRFN5,UTRN,CHRM3,SEZ6L,KIF6,PARP8,EPHA3,FGF5,NTRK2</TD></TR>
<TR><TD>2.132e-02</TD><TD>-3.85</TD><TD>skin-lower_leg-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-lower_leg-malignant_melanoma</TD><TD>139</TD><TD>5</TD><TD>16984</TD><TD>193</TD>
<TD>ADAMTS3,PTPRD,PXDNL,CHRM3,ADAM28</TD></TR>
<TR><TD>2.138e-02</TD><TD>-3.85</TD><TD>protein kinase A binding</TD><TD>molecular function</TD><TD>GO:0051018</TD><TD>53</TD><TD>3</TD><TD>18530</TD><TD>207</TD>
<TD>RYR2,SPHKAP,AKAP9</TD></TR>
<TR><TD>2.150e-02</TD><TD>-3.84</TD><TD>negative regulation of chemotaxis</TD><TD>biological process</TD><TD>GO:0050922</TD><TD>51</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>CXCL13,SLIT2,ROBO2</TD></TR>
<TR><TD>2.151e-02</TD><TD>-3.84</TD><TD>POM121C (POM121 transmembrane nucleoporin C)</TD><TD>protein interactions</TD><TD>100101267</TD><TD>95</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>PI15,SHISA3,CHRM3,NUP35</TD></TR>
<TR><TD>2.171e-02</TD><TD>-3.83</TD><TD>Interleukin-3, 5 and GM-CSF signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-512988</TD><TD>271</TD><TD>7</TD><TD>10391</TD><TD>107</TD>
<TD>FGFR2,FGF20,AKAP9,FGF5,PAQR3,NRG1,TEC</TD></TR>
<TR><TD>2.171e-02</TD><TD>-3.83</TD><TD>FCERI mediated MAPK activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-2871796</TD><TD>271</TD><TD>7</TD><TD>10391</TD><TD>107</TD>
<TD>NRG1,PAQR3,VAV3,FGFR2,AKAP9,FGF5,FGF20</TD></TR>
<TR><TD>2.171e-02</TD><TD>-3.83</TD><TD>pancreatic_intraepithelial_neoplasia_(PanIN)</TD><TD>COSMIC cancer mutations</TD><TD>pancreatic_intraepithelial_neoplasia_(PanIN)</TD><TD>673</TD><TD>14</TD><TD>16984</TD><TD>193</TD>
<TD>ZNF521,KAZN,XPO4,LRFN5,REG1B,NAV3,NRSN1,RYR2,UBR4,EPS8,RAI2,FANCB,VAV3,ASPN</TD></TR>
<TR><TD>2.171e-02</TD><TD>-3.83</TD><TD>pancreas-pancreatic_intraepithelial_neoplasia_(PanIN)</TD><TD>COSMIC cancer mutations</TD><TD>pancreas-pancreatic_intraepithelial_neoplasia_(PanIN)</TD><TD>673</TD><TD>14</TD><TD>16984</TD><TD>193</TD>
<TD>UBR4,RYR2,VAV3,FANCB,RAI2,EPS8,ASPN,XPO4,KAZN,ZNF521,LRFN5,REG1B,NAV3,NRSN1</TD></TR>
<TR><TD>2.173e-02</TD><TD>-3.83</TD><TD>neural crest cell differentiation</TD><TD>biological process</TD><TD>GO:0014033</TD><TD>91</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>NRG1,SEMA3C,TWIST1,PAX6</TD></TR>
<TR><TD>2.173e-02</TD><TD>-3.83</TD><TD>feeding behavior</TD><TD>biological process</TD><TD>GO:0007631</TD><TD>91</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>PRLHR,UCHL1,GPR83,NTRK2</TD></TR>
<TR><TD>2.185e-02</TD><TD>-3.82</TD><TD>biliary_tract</TD><TD>COSMIC cancer mutations</TD><TD>biliary_tract</TD><TD>15383</TD><TD>183</TD><TD>16984</TD><TD>193</TD>
<TD>NRCAM,PAX6,ATG10,MAP2,MEGF10,SLIT2,OR2AG1,RAI2,PHF14,LRFN5,DEPTOR,AMELX,RPH3A,KCNK9,KLF12,BCHE,CTSO,WWOX,AGA,CXCL13,COX7B2,AOAH,EDIL3,SKAP2,NRSN1,LRRC3B,CALN1,PRKCE,EFR3B,MRPL3,TMEFF2,TWIST1,MUC7,XPO4,CELF2,PRLHR,CPXM2,TCF20,UHMK1,EFR3A,ARX,KIF6,EPHA3,DSCAM,CHRM3,OR52K2,PCGF5,EFNA5,ADAMTS5,PBX1,FGF5,FMNL2,SPHKAP,FGD3,CASK,SLC7A14,MPEG1,CDH5,SERGEF,ZNF521,FGFR2,SEZ6L,EPS8,FANCB,TSN,FABP7,STXBP6,DNAJC12,NTRK2,FIGN,NBEA,ADAMTS3,SS18,IPO8,TRPS1,PXDNL,PI15,SLC39A10,ZPLD1,FNIP2,NOL4,LMX1A,FERD3L,NUP35,ZFAND5,PTPRD,JMJD1C,ACVR2A,SEMA3C,NAV3,RGS5,NAT2,PCDH9,COQ2,PWWP2A,CNTN1,GCNT1,LRRN2,DAOA,EFEMP1,PAQR3,FBN2,SPATA16,RUNX1T1,ACVR1C,DNER,UNC5C,ACP6,ZNF133,THSD7A,VAV3,PRSS12,ROBO2,PHLPP1,RASGEF1B,LHCGR,RYR2,SGCG,CD96,DEFB115,RGS6,PTPRZ1,BANK1,FZD6,SHISA3,FAT4,TGFBR2,ZFPM2,SYT1,GMDS,CD226,UBR4,SLC7A8,PTPRK,B3GAT2,ARL14,LMBRD1,ADAM28,FGF14,CRTC3,FGF20,GHITM,IQGAP2,UCHL1,AFM,LGI1,IL1RAPL2,THSD7B,CYTL1,PLEK,PARP8,HNF4G,REXO2,NOVA1,ASPN,CNTNAP2,WRN,IRX1,EPHA4,PSKH2,KAZN,SLC10A2,ZNF518B,AKAP9,MRPL13,SLC25A46,FUT9,IGFL4,EPYC,INSM1,ADAMTS12,NAALADL2,LRIG3,NOBOX,BACH2,GPR83,SPAG9,CETN3,UTRN,DAAM1,NRG1,GAP43,REG1B</TD></TR>
<TR><TD>2.186e-02</TD><TD>-3.82</TD><TD>GPM6A (glycoprotein M6A)</TD><TD>protein interactions</TD><TD>2823</TD><TD>143</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>EDIL3,CNTN1,SYT1,MAP2,SEPTIN5</TD></TR>
<TR><TD>2.189e-02</TD><TD>-3.82</TD><TD>appendage development</TD><TD>biological process</TD><TD>GO:0048736</TD><TD>186</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C,TWIST1,FZD6,FGFR2,PBX1,FBN2</TD></TR>
<TR><TD>2.189e-02</TD><TD>-3.82</TD><TD>limb development</TD><TD>biological process</TD><TD>GO:0060173</TD><TD>186</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,PBX1,FBN2,SEMA3C,TWIST1,FZD6</TD></TR>
<TR><TD>2.191e-02</TD><TD>-3.82</TD><TD>terminal O-glycans residues modification</TD><TD>BIOCYC pathways</TD><TD>META_PWY-7434</TD><TD>4</TD><TD>1</TD><TD>907</TD><TD>5</TD>
<TD>FUT9</TD></TR>
<TR><TD>2.191e-02</TD><TD>-3.82</TD><TD>asparagine degradation</TD><TD>BIOCYC pathways</TD><TD>HUMAN_ASPARAGINE-DEG1-PWY-1</TD><TD>4</TD><TD>1</TD><TD>907</TD><TD>5</TD>
<TD>AGA</TD></TR>
<TR><TD>2.193e-02</TD><TD>-3.82</TD><TD>PH</TD><TD>pfam domains</TD><TD>PF00169</TD><TD>187</TD><TD>6</TD><TD>17869</TD><TD>207</TD>
<TD>PHLPP1,FGD3,VAV3,TEC,SKAP2,PLEK</TD></TR>
<TR><TD>2.195e-02</TD><TD>-3.82</TD><TD>neuron to neuron synapse</TD><TD>cellular component</TD><TD>GO:0098984</TD><TD>365</TD><TD>9</TD><TD>19868</TD><TD>222</TD>
<TD>NRCAM,EPS8,EPHA4,AKAP9,PTPRD,NTRK2,SYT1,GAP43,LRFN5</TD></TR>
<TR><TD>2.202e-02</TD><TD>-3.82</TD><TD>SYNAPTOTAGMN</TD><TD>prints domains</TD><TD>PR00399</TD><TD>17</TD><TD>2</TD><TD>5258</TD><TD>72</TD>
<TD>SYT1,RPH3A</TD></TR>
<TR><TD>2.209e-02</TD><TD>-3.81</TD><TD>Diaph1 (diaphanous related formin 1)</TD><TD>protein interactions</TD><TD>13367</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>PAX6</TD></TR>
<TR><TD>2.209e-02</TD><TD>-3.81</TD><TD>Cacnb3 (calcium voltage-gated channel auxiliary subunit beta 3)</TD><TD>protein interactions</TD><TD>25297</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>PAX6</TD></TR>
<TR><TD>2.209e-02</TD><TD>-3.81</TD><TD>Cdon (cell adhesion associated, oncogene regulated)</TD><TD>protein interactions</TD><TD>50938</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>SPAG9</TD></TR>
<TR><TD>2.209e-02</TD><TD>-3.81</TD><TD>Flcn (folliculin)</TD><TD>protein interactions</TD><TD>303185</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.209e-02</TD><TD>-3.81</TD><TD>FCRL6 (Fc receptor like 6)</TD><TD>protein interactions</TD><TD>343413</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>GALNT15</TD></TR>
<TR><TD>2.209e-02</TD><TD>-3.81</TD><TD>TEX30 (testis expressed 30)</TD><TD>protein interactions</TD><TD>93081</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>SHTN1</TD></TR>
<TR><TD>2.209e-02</TD><TD>-3.81</TD><TD>SLC3A1 (solute carrier family 3 member 1)</TD><TD>protein interactions</TD><TD>6519</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>SLC7A8</TD></TR>
<TR><TD>2.209e-02</TD><TD>-3.81</TD><TD>Prkcz (protein kinase C, zeta)</TD><TD>protein interactions</TD><TD>25522</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>PRKCE</TD></TR>
<TR><TD>2.209e-02</TD><TD>-3.81</TD><TD>MDH1B (malate dehydrogenase 1B)</TD><TD>protein interactions</TD><TD>130752</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>EPHA3</TD></TR>
<TR><TD>2.209e-02</TD><TD>-3.81</TD><TD>EXO1 (Rad2 family nuclease EXO1)</TD><TD>protein interactions</TD><TD>854198</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>WRN</TD></TR>
<TR><TD>2.209e-02</TD><TD>-3.81</TD><TD>RAX (retina and anterior neural fold homeobox)</TD><TD>protein interactions</TD><TD>30062</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>PAX6</TD></TR>
<TR><TD>2.209e-02</TD><TD>-3.81</TD><TD>OR4E2 (olfactory receptor family 4 subfamily E member 2)</TD><TD>protein interactions</TD><TD>26686</TD><TD>2</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>SHTN1</TD></TR>
<TR><TD>2.212e-02</TD><TD>-3.81</TD><TD>human chr13q14.11</TD><TD>chromosome location</TD><TD>human chr13q14.11</TD><TD>109</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LINC00332,MIR4305</TD></TR>
<TR><TD>2.213e-02</TD><TD>-3.81</TD><TD>LamG</TD><TD>smart domains</TD><TD>SM00282</TD><TD>40</TD><TD>3</TD><TD>9743</TD><TD>147</TD>
<TD>FAT4,CNTNAP2,SLIT2</TD></TR>
<TR><TD>2.214e-02</TD><TD>-3.81</TD><TD>GALNT10 (polypeptide N-acetylgalactosaminyltransferase 10)</TD><TD>protein interactions</TD><TD>55568</TD><TD>54</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>MUC7,GCNT1,PI15</TD></TR>
<TR><TD>2.214e-02</TD><TD>-3.81</TD><TD>PKLR (pyruvate kinase L/R)</TD><TD>protein interactions</TD><TD>5313</TD><TD>54</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>PI15,WWOX,LRRC3B</TD></TR>
<TR><TD>2.219e-02</TD><TD>-3.81</TD><TD>forebrain development</TD><TD>biological process</TD><TD>GO:0030900</TD><TD>410</TD><TD>10</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,LMX1A,FGFR2,SLIT2,FAT4,CNTNAP2,NTRK2,ARX,PAX6,PCDH9</TD></TR>
<TR><TD>2.222e-02</TD><TD>-3.81</TD><TD>N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity</TD><TD>molecular function</TD><TD>GO:0003948</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>AGA</TD></TR>
<TR><TD>2.222e-02</TD><TD>-3.81</TD><TD>transforming growth factor beta receptor activity, type II</TD><TD>molecular function</TD><TD>GO:0005026</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>2.222e-02</TD><TD>-3.81</TD><TD>forked DNA-dependent helicase activity</TD><TD>molecular function</TD><TD>GO:0061749</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>WRN</TD></TR>
<TR><TD>2.222e-02</TD><TD>-3.81</TD><TD>syntaxin-3 binding</TD><TD>molecular function</TD><TD>GO:0030348</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>SYT1</TD></TR>
<TR><TD>2.222e-02</TD><TD>-3.81</TD><TD>interleukin-1, type II, blocking receptor activity</TD><TD>molecular function</TD><TD>GO:0004910</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>IL1RAPL2</TD></TR>
<TR><TD>2.222e-02</TD><TD>-3.81</TD><TD>acetylcholinesterase activity</TD><TD>molecular function</TD><TD>GO:0003990</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>BCHE</TD></TR>
<TR><TD>2.222e-02</TD><TD>-3.81</TD><TD>netrin receptor binding</TD><TD>molecular function</TD><TD>GO:1990890</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>DSCAM</TD></TR>
<TR><TD>2.222e-02</TD><TD>-3.81</TD><TD>calcium:proton antiporter activity</TD><TD>molecular function</TD><TD>GO:0015369</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>GHITM</TD></TR>
<TR><TD>2.222e-02</TD><TD>-3.81</TD><TD>suramin binding</TD><TD>molecular function</TD><TD>GO:0043924</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>RYR2</TD></TR>
<TR><TD>2.222e-02</TD><TD>-3.81</TD><TD>ethanol binding</TD><TD>molecular function</TD><TD>GO:0035276</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>PRKCE</TD></TR>
<TR><TD>2.222e-02</TD><TD>-3.81</TD><TD>flap-structured DNA binding</TD><TD>molecular function</TD><TD>GO:0070336</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>WRN</TD></TR>
<TR><TD>2.222e-02</TD><TD>-3.81</TD><TD>4-hydroxybenzoate decaprenyltransferase activity</TD><TD>molecular function</TD><TD>GO:0002083</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>COQ2</TD></TR>
<TR><TD>2.222e-02</TD><TD>-3.81</TD><TD>Atg12 transferase activity</TD><TD>molecular function</TD><TD>GO:0019777</TD><TD>2</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>ATG10</TD></TR>
<TR><TD>2.222e-02</TD><TD>-3.81</TD><TD>primary dendrite</TD><TD>cellular component</TD><TD>GO:0150001</TD><TD>2</TD><TD>1</TD><TD>19868</TD><TD>222</TD>
<TD>MAP2</TD></TR>
<TR><TD>2.222e-02</TD><TD>-3.81</TD><TD>distal dendrite</TD><TD>cellular component</TD><TD>GO:0150002</TD><TD>2</TD><TD>1</TD><TD>19868</TD><TD>222</TD>
<TD>MAP2</TD></TR>
<TR><TD>2.230e-02</TD><TD>-3.80</TD><TD>biliary_tract-bile_duct-carcinoma-adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>biliary_tract-bile_duct-carcinoma-adenocarcinoma</TD><TD>15167</TD><TD>181</TD><TD>16984</TD><TD>193</TD>
<TD>PWWP2A,COQ2,NAV3,NAT2,RGS5,PCDH9,SEMA3C,ACVR2A,JMJD1C,PTPRD,ZFAND5,NUP35,FERD3L,LMX1A,NOL4,FNIP2,ZPLD1,PI15,SLC39A10,TRPS1,PXDNL,IPO8,ADAMTS3,SS18,FIGN,NBEA,STXBP6,DNAJC12,NTRK2,TSN,FABP7,EPS8,FANCB,SEZ6L,SERGEF,ZNF521,FGFR2,MPEG1,CDH5,FGD3,SLC7A14,CASK,FMNL2,FGF5,PBX1,ADAMTS5,PCGF5,EFNA5,DSCAM,OR52K2,CHRM3,KIF6,EPHA3,ARX,UHMK1,EFR3A,PRLHR,CPXM2,TCF20,XPO4,CELF2,TMEFF2,TWIST1,MUC7,MRPL3,PRKCE,LRRC3B,CALN1,NRSN1,SKAP2,CXCL13,COX7B2,AOAH,EDIL3,CTSO,WWOX,AGA,BCHE,KLF12,RPH3A,AMELX,KCNK9,DEPTOR,PHF14,LRFN5,OR2AG1,RAI2,MEGF10,MAP2,SLIT2,NRCAM,PAX6,ATG10,REG1B,GAP43,DAAM1,UTRN,NRG1,SPAG9,CETN3,GPR83,NOBOX,BACH2,LRIG3,ADAMTS12,NAALADL2,EPYC,INSM1,IGFL4,MRPL13,SLC25A46,FUT9,SLC10A2,ZNF518B,AKAP9,PSKH2,KAZN,IRX1,EPHA4,WRN,ASPN,CNTNAP2,REXO2,NOVA1,PARP8,HNF4G,IL1RAPL2,LGI1,THSD7B,CYTL1,PLEK,GHITM,IQGAP2,UCHL1,AFM,FGF20,FGF14,CRTC3,ADAM28,ARL14,B3GAT2,LMBRD1,UBR4,SLC7A8,PTPRK,GMDS,CD226,SYT1,TGFBR2,ZFPM2,FZD6,SHISA3,FAT4,BANK1,RGS6,PTPRZ1,DEFB115,CD96,SGCG,LHCGR,RYR2,PHLPP1,RASGEF1B,ROBO2,PRSS12,VAV3,ZNF133,THSD7A,ACP6,UNC5C,SPATA16,RUNX1T1,ACVR1C,DNER,EFEMP1,PAQR3,FBN2,LRRN2,DAOA,GCNT1,CNTN1</TD></TR>
<TR><TD>2.230e-02</TD><TD>-3.80</TD><TD>bile_duct</TD><TD>COSMIC cancer mutations</TD><TD>bile_duct</TD><TD>15167</TD><TD>181</TD><TD>16984</TD><TD>193</TD>
<TD>SYT1,ZFPM2,TGFBR2,GMDS,CD226,CD96,SGCG,LHCGR,RYR2,FZD6,FAT4,SHISA3,BANK1,PTPRZ1,RGS6,DEFB115,VAV3,ZNF133,THSD7A,ACP6,UNC5C,RASGEF1B,PHLPP1,ROBO2,PRSS12,EFEMP1,PAQR3,FBN2,DAOA,LRRN2,GCNT1,CNTN1,ACVR1C,RUNX1T1,SPATA16,DNER,UTRN,DAAM1,NRG1,SPAG9,CETN3,GPR83,REG1B,GAP43,ADAMTS12,NAALADL2,EPYC,INSM1,IGFL4,NOBOX,BACH2,LRIG3,WRN,CNTNAP2,ASPN,NOVA1,REXO2,PARP8,HNF4G,MRPL13,FUT9,SLC25A46,SLC10A2,AKAP9,ZNF518B,PSKH2,KAZN,EPHA4,IRX1,CRTC3,FGF14,ADAM28,B3GAT2,ARL14,LMBRD1,SLC7A8,UBR4,PTPRK,LGI1,IL1RAPL2,THSD7B,PLEK,CYTL1,UCHL1,GHITM,IQGAP2,AFM,FGF20,EFNA5,PCGF5,DSCAM,OR52K2,CHRM3,KIF6,EPHA3,FGF5,PBX1,ADAMTS5,MRPL3,PRKCE,EFR3A,ARX,UHMK1,CPXM2,PRLHR,TCF20,XPO4,CELF2,TMEFF2,MUC7,TWIST1,CTSO,AGA,WWOX,BCHE,LRRC3B,CALN1,NRSN1,SKAP2,COX7B2,CXCL13,AOAH,EDIL3,OR2AG1,RAI2,MAP2,MEGF10,SLIT2,PAX6,NRCAM,ATG10,KLF12,RPH3A,AMELX,KCNK9,DEPTOR,PHF14,LRFN5,JMJD1C,PTPRD,NUP35,ZFAND5,PWWP2A,COQ2,NAT2,RGS5,NAV3,PCDH9,SEMA3C,ACVR2A,FNIP2,ZPLD1,SLC39A10,PI15,TRPS1,PXDNL,IPO8,FERD3L,LMX1A,NOL4,FANCB,EPS8,SEZ6L,SS18,ADAMTS3,FIGN,NBEA,STXBP6,NTRK2,DNAJC12,FABP7,TSN,MPEG1,CDH5,CASK,SLC7A14,FGD3,FMNL2,SERGEF,FGFR2,ZNF521</TD></TR>
<TR><TD>2.232e-02</TD><TD>-3.80</TD><TD>positive regulation of transcription regulatory region DNA binding</TD><TD>biological process</TD><TD>GO:2000679</TD><TD>20</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>TWIST1,PAX6</TD></TR>
<TR><TD>2.232e-02</TD><TD>-3.80</TD><TD>regulation of tolerance induction</TD><TD>biological process</TD><TD>GO:0002643</TD><TD>20</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>PHLPP1,TGFBR2</TD></TR>
<TR><TD>2.232e-02</TD><TD>-3.80</TD><TD>immune response-regulating cell surface receptor signaling pathway involved in phagocytosis</TD><TD>biological process</TD><TD>GO:0002433</TD><TD>20</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>PRKCE,VAV3</TD></TR>
<TR><TD>2.232e-02</TD><TD>-3.80</TD><TD>Fc-gamma receptor signaling pathway involved in phagocytosis</TD><TD>biological process</TD><TD>GO:0038096</TD><TD>20</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>PRKCE,VAV3</TD></TR>
<TR><TD>2.233e-02</TD><TD>-3.80</TD><TD>mycosis_fungoides-Sezary_syndrome</TD><TD>COSMIC cancer mutations</TD><TD>mycosis_fungoides-Sezary_syndrome</TD><TD>53</TD><TD>3</TD><TD>16984</TD><TD>193</TD>
<TD>FGFR2,PTPRD,NBEA</TD></TR>
<TR><TD>2.233e-02</TD><TD>-3.80</TD><TD>haematopoietic_and_lymphoid_tissue-skin-lymphoid_neoplasm-mycosis_fungoides-Sezary_syndrome</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-skin-lymphoid_neoplasm-mycosis_fungoides-Sezary_syndrome</TD><TD>53</TD><TD>3</TD><TD>16984</TD><TD>193</TD>
<TD>NBEA,PTPRD,FGFR2</TD></TR>
<TR><TD>2.238e-02</TD><TD>-3.80</TD><TD>kidney-Wilms_tumour</TD><TD>COSMIC cancer mutations</TD><TD>kidney-Wilms_tumour</TD><TD>546</TD><TD>12</TD><TD>16984</TD><TD>193</TD>
<TD>CASK,TGFBR2,PRKCE,EPHA3,UHMK1,SS18,ACVR1C,PSKH2,FGFR2,NTRK2,ACVR2A,EPHA4</TD></TR>
<TR><TD>2.241e-02</TD><TD>-3.80</TD><TD>regulation of cellular process</TD><TD>biological process</TD><TD>GO:0050794</TD><TD>11710</TD><TD>151</TD><TD>18905</TD><TD>220</TD>
<TD>GAP43,EFEMP1,C8orf88,SEPTIN5,EDIL3,RUNX1T1,SYT1,SS18,MAST4,NOBOX,FERD3L,NAV3,WWOX,IPO8,XPO4,GHITM,NRCAM,SGCD,ADGRL3,EFNA5,ADAMTS3,SHISA3,SHTN1,FANCB,MIR9-2HG,SERGEF,DNER,GAREM1,CD226,PUM3,UTRN,ARX,UBR4,FGF14,ATG10,PCGF5,GMDS,FGF20,ZFPM2,ZNF518B,FAT4,GPR83,KLF12,TRPS1,CASK,TSN,TMEFF2,CELF2,MIR891A,IL1RAPL2,SPAG9,MEGF10,RPH3A,EPHA3,PRKCE,SEMA3C,BRINP3,PHF14,TGFBR2,CNTN1,MIR147A,FBN2,GCNT1,ZNF133,PLEK,MAP2,CDH5,MIR551B,LGI1,RASGEF1B,ACVR2A,RBM20,RGS5,JMJD1C,HNF4G,FABP7,PAX6,LHCGR,PECAM1,ZFAND5,OR2AG1,PPP1R17,VAV3,PWWP2A,MIR548AA2,PRLHR,CXCL13,REG1B,PTPRZ1,SKAP2,SLIT2,SEZ6L,ACVR1C,PARP8,EPHA4,IRX1,UCHL1,DSCAM,NTRK2,PAQR3,CYTL1,FUT9,FZD6,ZNF521,MIR577,INSM1,MIR1260B,UNC5C,LRFN5,MRPL13,NOVA1,FGD3,BCHE,MTERF1,FGF5,AKAP9,ASPN,BACH2,FNIP2,DCDC2C,SLC39A10,PBX1,CHRM3,LRRN2,CRTC3,TWIST1,EPS8,PHLPP1,NRG1,RYR2,ROBO2,PTPRK,BANK1,TEC,MIR548A3,RGS6,UHMK1,OR52K2,CD96,TCF20,PTPRD,ADAMTS12,LMX1A,MIR569,DAAM1,DEPTOR,CNTNAP2,IQGAP2,FGFR2,STXBP6,AMELX</TD></TR>
<TR><TD>2.244e-02</TD><TD>-3.80</TD><TD>CH</TD><TD>prosite domains</TD><TD>PS50021</TD><TD>81</TD><TD>4</TD><TD>12232</TD><TD>162</TD>
<TD>VAV3,UTRN,IQGAP2,NAV3</TD></TR>
<TR><TD>2.245e-02</TD><TD>-3.80</TD><TD>PDX1 (pancreatic and duodenal homeobox 1)</TD><TD>protein interactions</TD><TD>3651</TD><TD>21</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>NAV3,PBX1</TD></TR>
<TR><TD>2.245e-02</TD><TD>-3.80</TD><TD>LINC01588 (long intergenic non-protein coding RNA 1588)</TD><TD>protein interactions</TD><TD>283551</TD><TD>21</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>SKAP2,FAT4</TD></TR>
<TR><TD>2.247e-02</TD><TD>-3.80</TD><TD>phosphotransferase activity, alcohol group as acceptor</TD><TD>molecular function</TD><TD>GO:0016773</TD><TD>687</TD><TD>14</TD><TD>18530</TD><TD>207</TD>
<TD>EPHA3,ACVR2A,UHMK1,PRKCE,ACVR1C,TEC,CASK,NTRK2,FGFR2,TGFBR2,EPHA4,MAST4,PSKH2,EFEMP1</TD></TR>
<TR><TD>2.256e-02</TD><TD>-3.79</TD><TD>nodular</TD><TD>COSMIC cancer mutations</TD><TD>nodular</TD><TD>1517</TD><TD>26</TD><TD>16984</TD><TD>193</TD>
<TD>NTRK2,FGF5,EPHA3,PARP8,KIF6,UTRN,CHRM3,SEZ6L,FGFR2,RGS6,PTPRZ1,LRFN5,FGF20,PLEK,FAT4,AFM,LMX1A,KCNK9,IQGAP2,CPXM2,RPH3A,PTPRK,LHCGR,SPHKAP,CNTN1,FBN2</TD></TR>
<TR><TD>2.266e-02</TD><TD>-3.79</TD><TD>Wilms_tumour</TD><TD>COSMIC cancer mutations</TD><TD>Wilms_tumour</TD><TD>547</TD><TD>12</TD><TD>16984</TD><TD>193</TD>
<TD>ACVR1C,UHMK1,SS18,ACVR2A,EPHA4,PSKH2,NTRK2,FGFR2,CASK,PRKCE,TGFBR2,EPHA3</TD></TR>
<TR><TD>2.274e-02</TD><TD>-3.78</TD><TD>negative regulation of response to stimulus</TD><TD>biological process</TD><TD>GO:0048585</TD><TD>1766</TD><TD>30</TD><TD>18905</TD><TD>220</TD>
<TD>CRTC3,WWOX,PHLPP1,CXCL13,TWIST1,GHITM,ROBO2,FANCB,SHISA3,EPHA4,BANK1,SLIT2,CASK,CNTNAP2,LRFN5,DEPTOR,PLEK,CDH5,AOAH,ASPN,RGS5,RGS6,PAQR3,UCHL1,CD96,FZD6,ADAMTS12,PTPRD,PHF14,FBN2</TD></TR>
<TR><TD>2.282e-02</TD><TD>-3.78</TD><TD>Signaling by SCF-KIT</TD><TD>REACTOME pathways</TD><TD>R-HSA-1433557</TD><TD>337</TD><TD>8</TD><TD>10391</TD><TD>107</TD>
<TD>FGF20,AKAP9,FGF5,PHLPP1,FGFR2,TEC,NRG1,PAQR3</TD></TR>
<TR><TD>2.291e-02</TD><TD>-3.78</TD><TD>C11orf52 (chromosome 11 open reading frame 52)</TD><TD>protein interactions</TD><TD>91894</TD><TD>310</TD><TD>8</TD><TD>20077</TD><TD>223</TD>
<TD>EFR3B,UTRN,SLC39A10,EFR3A,EPHA3,EPS8,CASK,IQGAP2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Translin_sf</TD><TD>interpro domains</TD><TD>IPR036081</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>TSN</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>HNF4-like_DBD</TD><TD>interpro domains</TD><TD>IPR049636</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>HNF4G</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>AChE_tetra</TD><TD>interpro domains</TD><TD>IPR014788</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>BCHE</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>HNF4_LBD</TD><TD>interpro domains</TD><TD>IPR049635</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>HNF4G</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>FNIP_mid_dom</TD><TD>interpro domains</TD><TD>IPR028085</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>KH-I_NOVA_rpt1</TD><TD>interpro domains</TD><TD>IPR047275</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NOVA1</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>PACT_domain</TD><TD>interpro domains</TD><TD>IPR019528</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>AKAP9</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>FNIP_C_dom</TD><TD>interpro domains</TD><TD>IPR028086</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>KH-I_NOVA_rpt2</TD><TD>interpro domains</TD><TD>IPR047276</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NOVA1</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Dystrophin/utrophin</TD><TD>interpro domains</TD><TD>IPR035436</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>UTRN</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>UbiA_prenylTrfase_CS</TD><TD>interpro domains</TD><TD>IPR030470</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>COQ2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>JIP_LZII</TD><TD>interpro domains</TD><TD>IPR032486</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>SPAG9</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>bZIP_BACH</TD><TD>interpro domains</TD><TD>IPR043321</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>BACH2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Neuregulin_C</TD><TD>interpro domains</TD><TD>IPR002154</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NRG1</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Sec3-PIP2_bind</TD><TD>interpro domains</TD><TD>IPR028258</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>STXBP6</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>FNIP_N_dom</TD><TD>interpro domains</TD><TD>IPR028084</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>KH-I_NOVA_rpt3</TD><TD>interpro domains</TD><TD>IPR047274</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NOVA1</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>INSM1/2</TD><TD>interpro domains</TD><TD>IPR042972</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>INSM1</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Ribosomal_uL13_CS</TD><TD>interpro domains</TD><TD>IPR023563</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MRPL13</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Fidgetin_ATPase</TD><TD>interpro domains</TD><TD>IPR047828</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>FIGN</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>LRATD1_LRATD2</TD><TD>interpro domains</TD><TD>IPR043299</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>LRATD1</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>NOL4/NOL4L</TD><TD>interpro domains</TD><TD>IPR039788</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NOL4</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Nckap5l</TD><TD>interpro domains</TD><TD>IPR026163</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NCKAP5</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>AKAP9/Pericentrin</TD><TD>interpro domains</TD><TD>IPR028745</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>AKAP9</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Cyt_c_oxidase_suVIIB_dom_sf</TD><TD>interpro domains</TD><TD>IPR023272</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>COX7B2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Cyt_c_oxidase_suVIIB</TD><TD>interpro domains</TD><TD>IPR008433</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>COX7B2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>CELF1/2_RRM1</TD><TD>interpro domains</TD><TD>IPR034196</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>CELF2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Peroxidasin_peroxidase</TD><TD>interpro domains</TD><TD>IPR034824</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>PXDNL</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>ZFPM1/2_PR</TD><TD>interpro domains</TD><TD>IPR049361</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>ZFPM2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>FNIP_fam</TD><TD>interpro domains</TD><TD>IPR026156</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Translin_C</TD><TD>interpro domains</TD><TD>IPR016069</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>TSN</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Neurensin</TD><TD>interpro domains</TD><TD>IPR024883</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NRSN1</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Arylamine_N-AcTrfase</TD><TD>interpro domains</TD><TD>IPR001447</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NAT2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>ZF_CCHC_FOG</TD><TD>interpro domains</TD><TD>IPR034731</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>ZFPM2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>IL-1_rcpt_II-typ</TD><TD>interpro domains</TD><TD>IPR004077</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>IL1RAPL2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Contactin-1_2_Ig1</TD><TD>interpro domains</TD><TD>IPR047102</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>CNTN1</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Ribosomal_uL13</TD><TD>interpro domains</TD><TD>IPR005822</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MRPL13</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>SKAP_fam</TD><TD>interpro domains</TD><TD>IPR037781</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>SKAP2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Cholinesterase</TD><TD>interpro domains</TD><TD>IPR000997</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>BCHE</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>CELF1/2_RRM3</TD><TD>interpro domains</TD><TD>IPR034199</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>CELF2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>NCKAP5_C</TD><TD>interpro domains</TD><TD>IPR032769</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NCKAP5</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>RAI2/SOBP</TD><TD>interpro domains</TD><TD>IPR026092</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RAI2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>FOG</TD><TD>interpro domains</TD><TD>IPR039746</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>ZFPM2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>DENN_FNIP1/2</TD><TD>interpro domains</TD><TD>IPR037545</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Translin_fam</TD><TD>interpro domains</TD><TD>IPR002848</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>TSN</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Translin_N</TD><TD>interpro domains</TD><TD>IPR016068</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>TSN</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>MATCAP</TD><TD>interpro domains</TD><TD>IPR012548</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MATCAP2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Pleckstrin</TD><TD>interpro domains</TD><TD>IPR037370</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>PLEK</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>RQC_domain</TD><TD>interpro domains</TD><TD>IPR018982</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>WRN</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Alpha_CARP_receptor-type</TD><TD>interpro domains</TD><TD>IPR041887</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>PTPRZ1</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Atg3/Atg10</TD><TD>interpro domains</TD><TD>IPR007135</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>ATG10</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>NBEA-like_DUF1088</TD><TD>interpro domains</TD><TD>IPR010508</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NBEA</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>CELF1/2_RRM2</TD><TD>interpro domains</TD><TD>IPR034198</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>CELF2</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>DBB_domain</TD><TD>interpro domains</TD><TD>IPR017893</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>BANK1</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Ribosomal_uL13_sf</TD><TD>interpro domains</TD><TD>IPR036899</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MRPL13</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>XPO1_C_dom</TD><TD>interpro domains</TD><TD>IPR014877</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>XPO4</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>JIP3/JIP4</TD><TD>interpro domains</TD><TD>IPR039911</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>SPAG9</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>PIK3AP1_TIR</TD><TD>interpro domains</TD><TD>IPR041340</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>BANK1</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>SS18</TD><TD>interpro domains</TD><TD>IPR044779</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>SS18</TD></TR>
<TR><TD>2.298e-02</TD><TD>-3.77</TD><TD>Amelogenin</TD><TD>interpro domains</TD><TD>IPR004116</TD><TD>2</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>AMELX</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>Translin</TD><TD>pfam domains</TD><TD>PF01997</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>TSN</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>NCKAP5</TD><TD>pfam domains</TD><TD>PF15246</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>NCKAP5</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>PACT_coil_coil</TD><TD>pfam domains</TD><TD>PF10495</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>AKAP9</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>FNIP_C</TD><TD>pfam domains</TD><TD>PF14638</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>CRM1_C</TD><TD>pfam domains</TD><TD>PF08767</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>XPO4</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>COX7B</TD><TD>pfam domains</TD><TD>PF05392</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>COX7B2</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>JIP_LZII</TD><TD>pfam domains</TD><TD>PF16471</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>SPAG9</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>Amelogenin</TD><TD>pfam domains</TD><TD>PF02948</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>AMELX</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>Neuregulin</TD><TD>pfam domains</TD><TD>PF02158</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>NRG1</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>AChE_tetra</TD><TD>pfam domains</TD><TD>PF08674</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>BCHE</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>FOG1-like_PR</TD><TD>pfam domains</TD><TD>PF21182</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>ZFPM2</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>RQC</TD><TD>pfam domains</TD><TD>PF09382</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>WRN</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>TIR_3</TD><TD>pfam domains</TD><TD>PF18567</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>BANK1</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>MATCAP</TD><TD>pfam domains</TD><TD>PF08014</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>MATCAP2</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>Autophagy_act_C</TD><TD>pfam domains</TD><TD>PF03987</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>ATG10</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>Acetyltransf_2</TD><TD>pfam domains</TD><TD>PF00797</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>NAT2</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>FNIP_M</TD><TD>pfam domains</TD><TD>PF14637</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>SOBP</TD><TD>pfam domains</TD><TD>PF15279</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>RAI2</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>DUF1088</TD><TD>pfam domains</TD><TD>PF06469</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>NBEA</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>FNIP_N</TD><TD>pfam domains</TD><TD>PF14636</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>Ribosomal_L13</TD><TD>pfam domains</TD><TD>PF00572</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>MRPL13</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>DBB</TD><TD>pfam domains</TD><TD>PF14545</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>BANK1</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>Sec3-PIP2_bind</TD><TD>pfam domains</TD><TD>PF15277</TD><TD>2</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>STXBP6</TD></TR>
<TR><TD>2.304e-02</TD><TD>-3.77</TD><TD>cell population proliferation</TD><TD>biological process</TD><TD>GO:0008283</TD><TD>726</TD><TD>15</TD><TD>18905</TD><TD>220</TD>
<TD>TWIST1,CNTNAP2,MEGF10,ACVR2A,FGFR2,ACVR1C,FABP7,FZD6,PAX6,ARX,UCHL1,INSM1,PBX1,PHF14,TGFBR2</TD></TR>
<TR><TD>2.309e-02</TD><TD>-3.77</TD><TD>FRS-mediated FGFR1 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654693</TD><TD>23</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF20,FGF5</TD></TR>
<TR><TD>2.309e-02</TD><TD>-3.77</TD><TD>Dopamine Neurotransmitter Release Cycle</TD><TD>REACTOME pathways</TD><TD>R-HSA-212676</TD><TD>23</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>CASK,SYT1</TD></TR>
<TR><TD>2.309e-02</TD><TD>-3.77</TD><TD>endometrium-carcinoma-endometrioid_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>endometrium-carcinoma-endometrioid_carcinoma</TD><TD>15731</TD><TD>186</TD><TD>16984</TD><TD>193</TD>
<TD>ADAMTS5,FGF5,KIF6,EPHA3,EFNA5,PCGF5,DSCAM,OR52K2,CHRM3,XPO4,CELF2,TMEFF2,MUC7,TWIST1,ARX,UHMK1,EFR3A,RBM20,PRLHR,CPXM2,TCF20,MRPL3,PRKCE,EFR3B,SKAP2,COX7B2,CXCL13,AOAH,EDIL3,LRRC3B,CALN1,NRSN1,CTSO,WWOX,AGA,BCHE,DEPTOR,PHF14,LRFN5,KLF12,RPH3A,AMELX,KCNK9,MAP2,MEGF10,SLIT2,PAX6,NRCAM,ATG10,LRRC70,OR2AG1,RAI2,SEMA3C,ACVR2A,COQ2,PWWP2A,RGS5,NAT2,NAV3,PCDH9,PTPRD,ZFAND5,NUP35,JMJD1C,NOL4,FERD3L,SGCD,LMX1A,TRPS1,PXDNL,IPO8,FNIP2,ZPLD1,SLC39A10,PI15,STXBP6,NTRK2,DNAJC12,FABP7,TSN,NCKAP5,SS18,ADAMTS3,SPANXN1,FIGN,NBEA,FANCB,EPS8,SEZ6L,SERGEF,FGFR2,ZNF521,SPHKAP,FMNL2,MPEG1,CDH5,CASK,SLC7A14,FGD3,GMDS,CD226,ZFPM2,TGFBR2,SYT1,PTPRZ1,RGS6,DEFB115,FZD6,FAT4,SERINC5,SHISA3,BANK1,SGCG,LHCGR,RYR2,CD96,ROBO2,PRSS12,RASGEF1B,PHLPP1,ACP6,UNC5C,VAV3,ZNF133,THSD7A,ACVR1C,SPATA16,RUNX1T1,DNER,GCNT1,CNTN1,EFEMP1,PAQR3,FBN2,DAOA,LRRN2,REG1B,GAP43,GPR83,UTRN,DAAM1,NRG1,SPAG9,CETN3,LRIG3,NOBOX,BACH2,EPYC,IGFL4,ADAMTS12,NAALADL2,PSKH2,KAZN,EPHA4,IRX1,MRPL13,FUT9,SLC25A46,SLC10A2,AKAP9,ZNF518B,NOVA1,REXO2,PARP8,HNF4G,WRN,CNTNAP2,ASPN,THSD7B,LGI1,IL1RAPL2,PLEK,CYTL1,UCHL1,IQGAP2,GHITM,AFM,B3GAT2,ARL14,LMBRD1,SLC7A8,UBR4,PTPRK,CRTC3,FGF14,ADAM28</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>branch elongation involved in salivary gland morphogenesis</TD><TD>biological process</TD><TD>GO:0060667</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>'de novo' GDP-L-fucose biosynthetic process</TD><TD>biological process</TD><TD>GO:0042351</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>GMDS</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>mitochondrial membrane fission</TD><TD>biological process</TD><TD>GO:0090149</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SLC25A46</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>luteinizing hormone signaling pathway</TD><TD>biological process</TD><TD>GO:0042700</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>LHCGR</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>positive regulation of GTP binding</TD><TD>biological process</TD><TD>GO:1904426</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>EPHA4</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>penile erection</TD><TD>biological process</TD><TD>GO:0043084</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>ACVR2A</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>bronchus morphogenesis</TD><TD>biological process</TD><TD>GO:0060434</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>negative regulation of integrin biosynthetic process</TD><TD>biological process</TD><TD>GO:0045720</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TMEFF2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>negative regulation of negative chemotaxis</TD><TD>biological process</TD><TD>GO:0050925</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>negative regulation of inositol phosphate biosynthetic process</TD><TD>biological process</TD><TD>GO:0010920</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PLEK</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>negative regulation of tooth mineralization</TD><TD>biological process</TD><TD>GO:0070171</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>ASPN</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>mammary gland specification</TD><TD>biological process</TD><TD>GO:0060594</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>negative regulation of mesenchymal cell proliferation involved in lung development</TD><TD>biological process</TD><TD>GO:2000791</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PHF14</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>squamous basal epithelial stem cell differentiation involved in prostate gland acinus development</TD><TD>biological process</TD><TD>GO:0060529</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>regulation of anterograde synaptic vesicle transport</TD><TD>biological process</TD><TD>GO:1903742</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>MAP2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>proximal/distal pattern formation involved in metanephric nephron development</TD><TD>biological process</TD><TD>GO:0072272</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>IRX1</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>regulation of glutamatergic neuron differentiation</TD><TD>biological process</TD><TD>GO:0120006</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>postnatal olfactory bulb interneuron migration</TD><TD>biological process</TD><TD>GO:0021827</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>negative regulation of axon guidance</TD><TD>biological process</TD><TD>GO:1902668</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>adrenal chromaffin cell differentiation</TD><TD>biological process</TD><TD>GO:0061104</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>INSM1</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>neuronal stem cell division</TD><TD>biological process</TD><TD>GO:0036445</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FUT9</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>positive regulation of anterograde synaptic vesicle transport</TD><TD>biological process</TD><TD>GO:1903744</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>MAP2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>chemorepulsion involved in postnatal olfactory bulb interneuron migration</TD><TD>biological process</TD><TD>GO:0021836</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>negative regulation of platelet-derived growth factor receptor-alpha signaling pathway</TD><TD>biological process</TD><TD>GO:2000584</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PHF14</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>mammary gland bud formation</TD><TD>biological process</TD><TD>GO:0060615</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>cerebral cortex tangential migration using cell-cell interactions</TD><TD>biological process</TD><TD>GO:0021823</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>substrate-dependent cerebral cortex tangential migration</TD><TD>biological process</TD><TD>GO:0021825</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>pulmonary myocardium development</TD><TD>biological process</TD><TD>GO:0003350</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>corticospinal neuron axon guidance</TD><TD>biological process</TD><TD>GO:0021966</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>negative regulation of chorionic trophoblast cell proliferation</TD><TD>biological process</TD><TD>GO:1901383</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>ACVR1C</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>termination of mitochondrial transcription</TD><TD>biological process</TD><TD>GO:0006393</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>MTERF1</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>lysobisphosphatidic acid metabolic process</TD><TD>biological process</TD><TD>GO:2001311</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>ACP6</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>superior temporal gyrus development</TD><TD>biological process</TD><TD>GO:0071109</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity</TD><TD>biological process</TD><TD>GO:1904217</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SERINC5</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>regulation of mesenchymal cell proliferation involved in lung development</TD><TD>biological process</TD><TD>GO:2000790</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PHF14</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>positive regulation of synaptic vesicle transport</TD><TD>biological process</TD><TD>GO:1902805</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>MAP2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity</TD><TD>biological process</TD><TD>GO:1904219</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SERINC5</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>positive regulation of serine C-palmitoyltransferase activity</TD><TD>biological process</TD><TD>GO:1904222</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SERINC5</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>negative regulation of natural killer cell cytokine production</TD><TD>biological process</TD><TD>GO:0002728</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>CD96</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>post-embryonic retina morphogenesis in camera-type eye</TD><TD>biological process</TD><TD>GO:0060060</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>DSCAM</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>negative regulation of microtubule binding</TD><TD>biological process</TD><TD>GO:1904527</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>MAP2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>regulation of B cell tolerance induction</TD><TD>biological process</TD><TD>GO:0002661</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>negative regulation of retinal ganglion cell axon guidance</TD><TD>biological process</TD><TD>GO:0090260</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development</TD><TD>biological process</TD><TD>GO:0035607</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>mesenchymal cell differentiation involved in lung development</TD><TD>biological process</TD><TD>GO:0060915</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>positive regulation of B cell tolerance induction</TD><TD>biological process</TD><TD>GO:0002663</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>2.314e-02</TD><TD>-3.77</TD><TD>development of secondary male sexual characteristics</TD><TD>biological process</TD><TD>GO:0046544</TD><TD>2</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>LHCGR</TD></TR>
<TR><TD>2.318e-02</TD><TD>-3.76</TD><TD>Signaling by VEGF</TD><TD>REACTOME pathways</TD><TD>R-HSA-194138</TD><TD>338</TD><TD>8</TD><TD>10391</TD><TD>107</TD>
<TD>VAV3,NRG1,PAQR3,FGF20,AKAP9,FGF5,FGFR2,CDH5</TD></TR>
<TR><TD>2.321e-02</TD><TD>-3.76</TD><TD>PLAC</TD><TD>prosite domains</TD><TD>PS50900</TD><TD>18</TD><TD>2</TD><TD>12232</TD><TD>162</TD>
<TD>ADAMTS3,ADAMTS12</TD></TR>
<TR><TD>2.323e-02</TD><TD>-3.76</TD><TD>skin-leg-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-leg-malignant_melanoma</TD><TD>549</TD><TD>12</TD><TD>16984</TD><TD>193</TD>
<TD>ADAMTS3,FAT4,ACVR1C,DNER,PTPRZ1,NOL4,CDH5,OR52K2,CHRM3,PTPRD,MEGF10,HNF4G</TD></TR>
<TR><TD>2.323e-02</TD><TD>-3.76</TD><TD>SCAF8 (SR-related CTD associated factor 8)</TD><TD>protein interactions</TD><TD>22828</TD><TD>55</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>NUP35,EMC2,WWOX</TD></TR>
<TR><TD>2.329e-02</TD><TD>-3.76</TD><TD>regulation of multicellular organismal process</TD><TD>biological process</TD><TD>GO:0051239</TD><TD>3120</TD><TD>48</TD><TD>18905</TD><TD>220</TD>
<TD>ADAMTS5,ARX,NTRK2,DSCAM,AKAP9,ASPN,NOVA1,LRFN5,ZFPM2,FGF20,FERD3L,NAV3,VAV3,SS18,PAX6,EFEMP1,ACVR1C,CD226,EPHA4,SLIT2,SHTN1,PTPRZ1,EFNA5,CXCL13,FBN2,MIR147A,TGFBR2,PTPRD,ADAMTS12,PHF14,CD96,AMELX,ACVR2A,FGFR2,CDH5,MAP2,PLEK,PBX1,CHRM3,SLC39A10,CELF2,TRPS1,TEC,BANK1,RYR2,ROBO2,PRKCE,TWIST1</TD></TR>
<TR><TD>2.332e-02</TD><TD>-3.76</TD><TD>mesonephros development</TD><TD>biological process</TD><TD>GO:0001823</TD><TD>93</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,FGFR2,SLIT2,PBX1</TD></TR>
<TR><TD>2.337e-02</TD><TD>-3.76</TD><TD>bone-femur-chondrosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>bone-femur-chondrosarcoma</TD><TD>424</TD><TD>10</TD><TD>16984</TD><TD>193</TD>
<TD>THSD7B,PHLPP1,IQGAP2,PI15,LRIG3,UNC5C,SPHKAP,CXCL13,UBR4,FMNL2</TD></TR>
<TR><TD>2.358e-02</TD><TD>-3.75</TD><TD>eye-uveal_tract-malignant_melanoma-spindle</TD><TD>COSMIC cancer mutations</TD><TD>eye-uveal_tract-malignant_melanoma-spindle</TD><TD>364</TD><TD>9</TD><TD>16984</TD><TD>193</TD>
<TD>CASK,SLC7A14,SLC10A2,SPATA16,SPAG9,NRSN1,PCDH9,THSD7B,FAT4</TD></TR>
<TR><TD>2.371e-02</TD><TD>-3.74</TD><TD>Bile Acid Direct Signalling Pathway (2) </TD><TD>SMPDB pathways</TD><TD>SMP0089751</TD><TD>3</TD><TD>1</TD><TD>1382</TD><TD>11</TD>
<TD>SLC10A2</TD></TR>
<TR><TD>2.373e-02</TD><TD>-3.74</TD><TD>RHOB (ras homolog family member B)</TD><TD>protein interactions</TD><TD>388</TD><TD>832</TD><TD>16</TD><TD>20077</TD><TD>223</TD>
<TD>UNC5C,DAAM1,UTRN,EFR3B,IQGAP2,FZD6,NBEA,EFR3A,EMC2,EPS8,PTPRK,SLC39A10,ROBO2,FMNL2,FAT4,CASK</TD></TR>
<TR><TD>2.378e-02</TD><TD>-3.74</TD><TD>positive regulation of organ growth</TD><TD>biological process</TD><TD>GO:0046622</TD><TD>53</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>ZFPM2,ARX,FGFR2</TD></TR>
<TR><TD>2.378e-02</TD><TD>-3.74</TD><TD>regulation of chondrocyte differentiation</TD><TD>biological process</TD><TD>GO:0032330</TD><TD>53</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>EFEMP1,TRPS1,ADAMTS12</TD></TR>
<TR><TD>2.380e-02</TD><TD>-3.74</TD><TD>FBRS (fibrosin)</TD><TD>protein interactions</TD><TD>64319</TD><TD>98</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>PCGF5,WWOX,NUP35,PAX6</TD></TR>
<TR><TD>2.389e-02</TD><TD>-3.73</TD><TD>regulation of multicellular organismal development</TD><TD>biological process</TD><TD>GO:2000026</TD><TD>1485</TD><TD>26</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,FGFR2,ACVR2A,EPHA4,ASPN,AMELX,CDH5,ROBO2,PTPRZ1,SHTN1,MAP2,TWIST1,CXCL13,EFNA5,FGF20,ZFPM2,FERD3L,FBN2,PTPRD,ADAMTS12,TGFBR2,PAX6,NTRK2,DSCAM,EFEMP1,TRPS1</TD></TR>
<TR><TD>2.396e-02</TD><TD>-3.73</TD><TD>testis-germ_cell_tumour-non_seminoma</TD><TD>COSMIC cancer mutations</TD><TD>testis-germ_cell_tumour-non_seminoma</TD><TD>488</TD><TD>11</TD><TD>16984</TD><TD>193</TD>
<TD>UHMK1,ACVR1C,NTRK2,FGFR2,PSKH2,EPHA4,ACVR2A,CASK,EPHA3,TGFBR2,PRKCE</TD></TR>
<TR><TD>2.425e-02</TD><TD>-3.72</TD><TD>primary_central_nervous_system_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>primary_central_nervous_system_lymphoma</TD><TD>683</TD><TD>14</TD><TD>16984</TD><TD>193</TD>
<TD>MPEG1,CNTNAP2,MAP2,PRKCE,UBR4,EPHA3,RYR2,FZD6,LGI1,PRLHR,XPO4,LRIG3,ADAMTS5,ACVR2A</TD></TR>
<TR><TD>2.425e-02</TD><TD>-3.72</TD><TD>haematopoietic_and_lymphoid_tissue-central_nervous_system-lymphoid_neoplasm-primary_central_nervous_system_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-central_nervous_system-lymphoid_neoplasm-primary_central_nervous_system_lymphoma</TD><TD>683</TD><TD>14</TD><TD>16984</TD><TD>193</TD>
<TD>ADAMTS5,ACVR2A,LRIG3,XPO4,PRLHR,LGI1,FZD6,EPHA3,RYR2,PRKCE,UBR4,MAP2,CNTNAP2,MPEG1</TD></TR>
<TR><TD>2.435e-02</TD><TD>-3.72</TD><TD>ECI1 (enoyl-CoA delta isomerase 1)</TD><TD>protein interactions</TD><TD>1632</TD><TD>56</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>REXO2,ACP6,AGA</TD></TR>
<TR><TD>2.435e-02</TD><TD>-3.72</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.30.2140.20</TD><TD>2</TD><TD>1</TD><TD>14531</TD><TD>178</TD>
<TD>NAT2</TD></TR>
<TR><TD>2.435e-02</TD><TD>-3.72</TD><TD>Cytochrome C Oxidase, chain K</TD><TD>gene3d domains</TD><TD>4.10.51.10</TD><TD>2</TD><TD>1</TD><TD>14531</TD><TD>178</TD>
<TD>COX7B2</TD></TR>
<TR><TD>2.435e-02</TD><TD>-3.72</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.30.1460.50</TD><TD>2</TD><TD>1</TD><TD>14531</TD><TD>178</TD>
<TD>ATG10</TD></TR>
<TR><TD>2.435e-02</TD><TD>-3.72</TD><TD>-</TD><TD>gene3d domains</TD><TD>2.30.29.90</TD><TD>2</TD><TD>1</TD><TD>14531</TD><TD>178</TD>
<TD>STXBP6</TD></TR>
<TR><TD>2.435e-02</TD><TD>-3.72</TD><TD>Ribosomal protein L13</TD><TD>gene3d domains</TD><TD>3.90.1180.10</TD><TD>2</TD><TD>1</TD><TD>14531</TD><TD>178</TD>
<TD>MRPL13</TD></TR>
<TR><TD>2.435e-02</TD><TD>-3.72</TD><TD>-</TD><TD>gene3d domains</TD><TD>6.10.250.220</TD><TD>2</TD><TD>1</TD><TD>14531</TD><TD>178</TD>
<TD>SKAP2</TD></TR>
<TR><TD>2.435e-02</TD><TD>-3.72</TD><TD>arf6 gtpase in complex with a specific effector, jip4</TD><TD>gene3d domains</TD><TD>1.20.5.1000</TD><TD>2</TD><TD>1</TD><TD>14531</TD><TD>178</TD>
<TD>SPAG9</TD></TR>
<TR><TD>2.444e-02</TD><TD>-3.71</TD><TD>human chr1p13.3</TD><TD>chromosome location</TD><TD>human chr1p13.3</TD><TD>115</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LINC01661,VAV3</TD></TR>
<TR><TD>2.448e-02</TD><TD>-3.71</TD><TD>cardiac right ventricle morphogenesis</TD><TD>biological process</TD><TD>GO:0003215</TD><TD>21</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C,ZFPM2</TD></TR>
<TR><TD>2.448e-02</TD><TD>-3.71</TD><TD>cellular response to prostaglandin stimulus</TD><TD>biological process</TD><TD>GO:0071379</TD><TD>21</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6,PRKCE</TD></TR>
<TR><TD>2.452e-02</TD><TD>-3.71</TD><TD>RFXAP (regulatory factor X associated protein)</TD><TD>protein interactions</TD><TD>5994</TD><TD>22</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>PAX6,EPS8</TD></TR>
<TR><TD>2.452e-02</TD><TD>-3.71</TD><TD>TTC7B (tetratricopeptide repeat domain 7B)</TD><TD>protein interactions</TD><TD>145567</TD><TD>22</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>DSCAM,CD226</TD></TR>
<TR><TD>2.452e-02</TD><TD>-3.71</TD><TD>ENC1 (ectodermal-neural cortex 1)</TD><TD>protein interactions</TD><TD>8507</TD><TD>22</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>DSCAM,BACH2</TD></TR>
<TR><TD>2.452e-02</TD><TD>-3.71</TD><TD>TRHR (thyrotropin releasing hormone receptor)</TD><TD>protein interactions</TD><TD>7201</TD><TD>22</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>EFNA5,TMEFF2</TD></TR>
<TR><TD>2.457e-02</TD><TD>-3.71</TD><TD>phosphorylation</TD><TD>biological process</TD><TD>GO:0016310</TD><TD>732</TD><TD>15</TD><TD>18905</TD><TD>220</TD>
<TD>FNIP2,CASK,UHMK1,NTRK2,EFEMP1,MAST4,TGFBR2,EPHA3,PSKH2,EPHA4,TEC,ACVR1C,ACVR2A,FGFR2,PRKCE</TD></TR>
<TR><TD>2.459e-02</TD><TD>-3.71</TD><TD>PRKACG (protein kinase cAMP-activated catalytic subunit gamma)</TD><TD>protein interactions</TD><TD>5568</TD><TD>99</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>AKAP9,MAP2,SPAG9,RYR2</TD></TR>
<TR><TD>2.469e-02</TD><TD>-3.70</TD><TD>protein localization to extracellular region</TD><TD>biological process</TD><TD>GO:0071692</TD><TD>141</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>AFM,FBN2,ACVR1C,PLEK,PRKCE</TD></TR>
<TR><TD>2.471e-02</TD><TD>-3.70</TD><TD>skin-knee-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-knee-malignant_melanoma</TD><TD>97</TD><TD>4</TD><TD>16984</TD><TD>193</TD>
<TD>PTPRD,ADAMTS3,CHRM3,ADAM28</TD></TR>
<TR><TD>2.472e-02</TD><TD>-3.70</TD><TD>endometrioid_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>endometrioid_carcinoma</TD><TD>15741</TD><TD>186</TD><TD>16984</TD><TD>193</TD>
<TD>PRSS12,ROBO2,RASGEF1B,PHLPP1,UNC5C,ACP6,ZNF133,THSD7A,VAV3,ACVR1C,RUNX1T1,SPATA16,DNER,CNTN1,GCNT1,DAOA,LRRN2,EFEMP1,PAQR3,FBN2,CD226,GMDS,TGFBR2,ZFPM2,SYT1,DEFB115,PTPRZ1,RGS6,BANK1,FZD6,FAT4,SERINC5,SHISA3,LHCGR,RYR2,SGCG,CD96,EPHA4,IRX1,PSKH2,KAZN,SLC10A2,AKAP9,ZNF518B,MRPL13,FUT9,SLC25A46,PARP8,HNF4G,NOVA1,REXO2,CNTNAP2,ASPN,WRN,UCHL1,IQGAP2,GHITM,AFM,THSD7B,LGI1,IL1RAPL2,PLEK,CYTL1,SLC7A8,UBR4,PTPRK,B3GAT2,ARL14,LMBRD1,ADAM28,CRTC3,FGF14,GAP43,REG1B,GPR83,SPAG9,CETN3,DAAM1,UTRN,NRG1,LRIG3,NOBOX,BACH2,IGFL4,EPYC,ADAMTS12,NAALADL2,COX7B2,CXCL13,EDIL3,AOAH,SKAP2,NRSN1,LRRC3B,CALN1,BCHE,CTSO,AGA,WWOX,PHF14,LRFN5,DEPTOR,AMELX,RPH3A,KCNK9,KLF12,PAX6,NRCAM,ATG10,MEGF10,MAP2,SLIT2,LRRC70,OR2AG1,RAI2,ADAMTS5,FGF5,KIF6,EPHA3,DSCAM,OR52K2,CHRM3,EFNA5,PCGF5,TMEFF2,MUC7,TWIST1,XPO4,CELF2,CPXM2,PRLHR,TCF20,UHMK1,EFR3A,ARX,RBM20,PRKCE,EFR3B,MRPL3,FABP7,TSN,NCKAP5,STXBP6,NTRK2,DNAJC12,SPANXN1,FIGN,NBEA,SS18,ADAMTS3,SEZ6L,FANCB,EPS8,SERGEF,FGFR2,ZNF521,SPHKAP,FMNL2,CASK,SLC7A14,FGD3,MPEG1,CDH5,ACVR2A,SEMA3C,NAT2,RGS5,NAV3,PCDH9,PWWP2A,COQ2,ZFAND5,NUP35,PTPRD,JMJD1C,NOL4,SGCD,LMX1A,FERD3L,IPO8,TRPS1,PXDNL,SLC39A10,PI15,ZPLD1,FNIP2</TD></TR>
<TR><TD>2.477e-02</TD><TD>-3.70</TD><TD>extracellular matrix structural constituent conferring compression resistance</TD><TD>molecular function</TD><TD>GO:0030021</TD><TD>22</TD><TD>2</TD><TD>18530</TD><TD>207</TD>
<TD>ASPN,AMELX</TD></TR>
<TR><TD>2.478e-02</TD><TD>-3.70</TD><TD>human chr5q11.1</TD><TD>chromosome location</TD><TD>human chr5q11.1</TD><TD>12</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>PARP8</TD></TR>
<TR><TD>2.478e-02</TD><TD>-3.70</TD><TD>human chr4q21.3</TD><TD>chromosome location</TD><TD>human chr4q21.3</TD><TD>12</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>MAPK10-AS1</TD></TR>
<TR><TD>2.479e-02</TD><TD>-3.70</TD><TD>synaptic cleft</TD><TD>cellular component</TD><TD>GO:0043083</TD><TD>22</TD><TD>2</TD><TD>19868</TD><TD>222</TD>
<TD>LGI1,PRSS12</TD></TR>
<TR><TD>2.483e-02</TD><TD>-3.70</TD><TD>human chrXp22.2</TD><TD>chromosome location</TD><TD>human chrXp22.2</TD><TD>116</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>AMELX,FANCB</TD></TR>
<TR><TD>2.496e-02</TD><TD>-3.69</TD><TD>positive regulation of biomineral tissue development</TD><TD>biological process</TD><TD>GO:0070169</TD><TD>54</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>ACVR2A,FBN2,AMELX</TD></TR>
<TR><TD>2.506e-02</TD><TD>-3.69</TD><TD>endometrium</TD><TD>COSMIC cancer mutations</TD><TD>endometrium</TD><TD>15743</TD><TD>186</TD><TD>16984</TD><TD>193</TD>
<TD>CNTN1,GCNT1,LRRN2,DAOA,EFEMP1,PAQR3,FBN2,RUNX1T1,SPATA16,ACVR1C,DNER,UNC5C,ACP6,ZNF133,THSD7A,VAV3,PRSS12,ROBO2,PHLPP1,RASGEF1B,LHCGR,RYR2,SGCG,CD96,DEFB115,RGS6,PTPRZ1,BANK1,FZD6,SHISA3,SERINC5,FAT4,TGFBR2,ZFPM2,SYT1,GMDS,CD226,UBR4,SLC7A8,PTPRK,ARL14,B3GAT2,LMBRD1,ADAM28,FGF14,CRTC3,IQGAP2,GHITM,UCHL1,AFM,IL1RAPL2,THSD7B,LGI1,CYTL1,PLEK,PARP8,HNF4G,REXO2,NOVA1,ASPN,CNTNAP2,WRN,IRX1,EPHA4,PSKH2,KAZN,SLC10A2,ZNF518B,AKAP9,MRPL13,SLC25A46,FUT9,IGFL4,EPYC,ADAMTS12,NAALADL2,LRIG3,NOBOX,BACH2,GPR83,SPAG9,CETN3,UTRN,DAAM1,NRG1,GAP43,REG1B,NRCAM,PAX6,ATG10,MEGF10,MAP2,SLIT2,LRRC70,OR2AG1,RAI2,PHF14,LRFN5,DEPTOR,AMELX,RPH3A,KCNK9,KLF12,BCHE,CTSO,AGA,WWOX,CXCL13,COX7B2,EDIL3,AOAH,SKAP2,NRSN1,LRRC3B,CALN1,PRKCE,EFR3B,MRPL3,TMEFF2,TWIST1,MUC7,XPO4,CELF2,CPXM2,PRLHR,TCF20,RBM20,UHMK1,EFR3A,ARX,KIF6,EPHA3,DSCAM,OR52K2,CHRM3,PCGF5,EFNA5,ADAMTS5,FGF5,FMNL2,SPHKAP,FGD3,CASK,SLC7A14,MPEG1,CDH5,SERGEF,ZNF521,FGFR2,SEZ6L,EPS8,FANCB,NCKAP5,TSN,FABP7,STXBP6,DNAJC12,NTRK2,SPANXN1,FIGN,NBEA,ADAMTS3,SS18,IPO8,TRPS1,PXDNL,PI15,SLC39A10,FNIP2,ZPLD1,NOL4,SGCD,LMX1A,FERD3L,NUP35,ZFAND5,PTPRD,JMJD1C,ACVR2A,SEMA3C,NAV3,NAT2,RGS5,PCDH9,PWWP2A,COQ2</TD></TR>
<TR><TD>2.506e-02</TD><TD>-3.69</TD><TD>microvillus</TD><TD>cellular component</TD><TD>GO:0005902</TD><TD>99</TD><TD>4</TD><TD>19868</TD><TD>222</TD>
<TD>WWOX,SLC7A8,SLC10A2,IQGAP2</TD></TR>
<TR><TD>2.540e-02</TD><TD>-3.67</TD><TD>FATE1 (fetal and adult testis expressed 1)</TD><TD>protein interactions</TD><TD>89885</TD><TD>100</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>CALN1,SLC7A14,MARCHF3,NRSN1</TD></TR>
<TR><TD>2.540e-02</TD><TD>-3.67</TD><TD>NDFIP1 (Nedd4 family interacting protein 1)</TD><TD>protein interactions</TD><TD>80762</TD><TD>100</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>NTRK2,NRSN1,LRRN2,TGFBR2</TD></TR>
<TR><TD>2.555e-02</TD><TD>-3.67</TD><TD>PLCG1 (phospholipase C gamma 1)</TD><TD>protein interactions</TD><TD>5335</TD><TD>258</TD><TD>7</TD><TD>20077</TD><TD>223</TD>
<TD>GAREM1,VAV3,FGFR2,PECAM1,NTRK2,TEC,PRKCE</TD></TR>
<TR><TD>2.557e-02</TD><TD>-3.67</TD><TD>non_seminoma</TD><TD>COSMIC cancer mutations</TD><TD>non_seminoma</TD><TD>493</TD><TD>11</TD><TD>16984</TD><TD>193</TD>
<TD>ACVR2A,EPHA4,PSKH2,FGFR2,NTRK2,ACVR1C,UHMK1,TGFBR2,PRKCE,EPHA3,CASK</TD></TR>
<TR><TD>2.583e-02</TD><TD>-3.66</TD><TD>regulation of microtubule polymerization or depolymerization</TD><TD>biological process</TD><TD>GO:0031110</TD><TD>96</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>MAP2,NAV3,AKAP9,CDH5</TD></TR>
<TR><TD>2.585e-02</TD><TD>-3.66</TD><TD>soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal</TD><TD>COSMIC cancer mutations</TD><TD>soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal</TD><TD>2677</TD><TD>41</TD><TD>16984</TD><TD>193</TD>
<TD>RYR2,LHCGR,FMNL2,UBR4,PXDNL,MRPL3,GCNT1,SLC39A10,FGD3,FBN2,FGFR2,PTPRZ1,RGS6,TCF20,AFM,ACVR1C,RPH3A,IQGAP2,FAT4,UHMK1,NOBOX,THSD7B,KIF6,ZFPM2,SEZ6L,THSD7A,DSCAM,CNTNAP2,ASPN,SPAG9,WRN,NRG1,VAV3,CD226,PRSS12,ADAMTS5,ROBO2,GAP43,SLC10A2,RASGEF1B,ADAMTS3</TD></TR>
<TR><TD>2.585e-02</TD><TD>-3.66</TD><TD>embryonal</TD><TD>COSMIC cancer mutations</TD><TD>embryonal</TD><TD>2677</TD><TD>41</TD><TD>16984</TD><TD>193</TD>
<TD>FBN2,SLC39A10,FGD3,PXDNL,GCNT1,MRPL3,RYR2,LHCGR,UBR4,FMNL2,FAT4,THSD7B,NOBOX,UHMK1,AFM,TCF20,ACVR1C,RPH3A,IQGAP2,FGFR2,PTPRZ1,RGS6,WRN,NRG1,VAV3,SEZ6L,THSD7A,CNTNAP2,DSCAM,ASPN,SPAG9,ZFPM2,KIF6,RASGEF1B,ADAMTS3,SLC10A2,GAP43,ROBO2,CD226,ADAMTS5,PRSS12</TD></TR>
<TR><TD>2.586e-02</TD><TD>-3.66</TD><TD>clathrin binding</TD><TD>molecular function</TD><TD>GO:0030276</TD><TD>57</TD><TD>3</TD><TD>18530</TD><TD>207</TD>
<TD>DNER,LMBRD1,SYT1</TD></TR>
<TR><TD>2.599e-02</TD><TD>-3.65</TD><TD>GTPase binding</TD><TD>molecular function</TD><TD>GO:0051020</TD><TD>316</TD><TD>8</TD><TD>18530</TD><TD>207</TD>
<TD>IQGAP2,RPH3A,XPO4,DAAM1,EPS8,IPO8,FGD3,FMNL2</TD></TR>
<TR><TD>2.603e-02</TD><TD>-3.65</TD><TD>human chr16q21</TD><TD>chromosome location</TD><TD>human chr16q21</TD><TD>119</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>CDH5,APOOP5</TD></TR>
<TR><TD>2.618e-02</TD><TD>-3.64</TD><TD>neural crest cell migration</TD><TD>biological process</TD><TD>GO:0001755</TD><TD>55</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6,TWIST1,SEMA3C</TD></TR>
<TR><TD>2.618e-02</TD><TD>-3.64</TD><TD>regulation of alternative mRNA splicing, via spliceosome</TD><TD>biological process</TD><TD>GO:0000381</TD><TD>55</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>CELF2,NOVA1,RBM20</TD></TR>
<TR><TD>2.623e-02</TD><TD>-3.64</TD><TD>LRP5 (LDL receptor related protein 5)</TD><TD>protein interactions</TD><TD>4041</TD><TD>101</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>NRSN1,BRINP3,LGI1,PI15</TD></TR>
<TR><TD>2.623e-02</TD><TD>-3.64</TD><TD>LDB1 (LIM domain binding 1)</TD><TD>protein interactions</TD><TD>8861</TD><TD>101</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>LMX1A,ATG10,DSCAM,PAX6</TD></TR>
<TR><TD>2.623e-02</TD><TD>-3.64</TD><TD>EFNA1 (ephrin A1)</TD><TD>protein interactions</TD><TD>1942</TD><TD>101</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>EPHA4,EPHA3,KAZN,GAREM1</TD></TR>
<TR><TD>2.625e-02</TD><TD>-3.64</TD><TD>embryo development ending in birth or egg hatching</TD><TD>biological process</TD><TD>GO:0009792</TD><TD>673</TD><TD>14</TD><TD>18905</TD><TD>220</TD>
<TD>RAI2,SEMA3C,FZD6,PAX6,ZFAND5,TGFBR2,FERD3L,PBX1,ZFPM2,TWIST1,ADAMTS3,ACVR2A,FGFR2,ACVR1C</TD></TR>
<TR><TD>2.631e-02</TD><TD>-3.64</TD><TD>DBB</TD><TD>prosite domains</TD><TD>PS51376</TD><TD>2</TD><TD>1</TD><TD>12232</TD><TD>162</TD>
<TD>BANK1</TD></TR>
<TR><TD>2.631e-02</TD><TD>-3.64</TD><TD>UBIA</TD><TD>prosite domains</TD><TD>PS00943</TD><TD>2</TD><TD>1</TD><TD>12232</TD><TD>162</TD>
<TD>COQ2</TD></TR>
<TR><TD>2.631e-02</TD><TD>-3.64</TD><TD>RIBOSOMAL_L13</TD><TD>prosite domains</TD><TD>PS00783</TD><TD>2</TD><TD>1</TD><TD>12232</TD><TD>162</TD>
<TD>MRPL13</TD></TR>
<TR><TD>2.631e-02</TD><TD>-3.64</TD><TD>UCH_1</TD><TD>prosite domains</TD><TD>PS00140</TD><TD>2</TD><TD>1</TD><TD>12232</TD><TD>162</TD>
<TD>UCHL1</TD></TR>
<TR><TD>2.631e-02</TD><TD>-3.64</TD><TD>ZF_CCHC_FOG</TD><TD>prosite domains</TD><TD>PS51810</TD><TD>2</TD><TD>1</TD><TD>12232</TD><TD>162</TD>
<TD>ZFPM2</TD></TR>
<TR><TD>2.631e-02</TD><TD>-3.64</TD><TD>DENN_FNIP12</TD><TD>prosite domains</TD><TD>PS51836</TD><TD>2</TD><TD>1</TD><TD>12232</TD><TD>162</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.638e-02</TD><TD>-3.64</TD><TD>EPHD</TD><TD>interpro domains</TD><TD>IPR034732</TD><TD>22</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>PHF14,TCF20</TD></TR>
<TR><TD>2.639e-02</TD><TD>-3.63</TD><TD>large_intestine-rectum-adenoma</TD><TD>COSMIC cancer mutations</TD><TD>large_intestine-rectum-adenoma</TD><TD>99</TD><TD>4</TD><TD>16984</TD><TD>193</TD>
<TD>FAT4,NTRK2,UCHL1,PTPRK</TD></TR>
<TR><TD>2.639e-02</TD><TD>-3.63</TD><TD>bone-tibia-other-chondroblastoma</TD><TD>COSMIC cancer mutations</TD><TD>bone-tibia-other-chondroblastoma</TD><TD>99</TD><TD>4</TD><TD>16984</TD><TD>193</TD>
<TD>NAALADL2,NOL4,NCKAP5,VAV3</TD></TR>
<TR><TD>2.650e-02</TD><TD>-3.63</TD><TD>ear</TD><TD>COSMIC cancer mutations</TD><TD>ear</TD><TD>625</TD><TD>13</TD><TD>16984</TD><TD>193</TD>
<TD>PTPRK,SLC7A8,UBR4,AGA,PTPRD,CHRM3,LRRN2,CNTNAP2,UTRN,EDIL3,FGFR2,SPATA16,FAT4</TD></TR>
<TR><TD>2.651e-02</TD><TD>-3.63</TD><TD>RINGv</TD><TD>smart domains</TD><TD>SM00744</TD><TD>17</TD><TD>2</TD><TD>9743</TD><TD>147</TD>
<TD>MARCHF11,MARCHF3</TD></TR>
<TR><TD>2.666e-02</TD><TD>-3.62</TD><TD>TGFB2 (transforming growth factor beta 2)</TD><TD>protein interactions</TD><TD>7042</TD><TD>23</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>EFEMP1,TGFBR2</TD></TR>
<TR><TD>2.666e-02</TD><TD>-3.62</TD><TD>LRRN2 (leucine rich repeat neuronal 2)</TD><TD>protein interactions</TD><TD>10446</TD><TD>23</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>LRIG3,PTPRD</TD></TR>
<TR><TD>2.667e-02</TD><TD>-3.62</TD><TD>SNAP25 (synaptosome associated protein 25)</TD><TD>protein interactions</TD><TD>6616</TD><TD>58</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>RPH3A,STXBP6,SYT1</TD></TR>
<TR><TD>2.672e-02</TD><TD>-3.62</TD><TD>negative regulation of translational initiation</TD><TD>biological process</TD><TD>GO:0045947</TD><TD>22</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>BANK1,C8orf88</TD></TR>
<TR><TD>2.672e-02</TD><TD>-3.62</TD><TD>Fc receptor mediated stimulatory signaling pathway</TD><TD>biological process</TD><TD>GO:0002431</TD><TD>22</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>PRKCE,VAV3</TD></TR>
<TR><TD>2.672e-02</TD><TD>-3.62</TD><TD>type B pancreatic cell differentiation</TD><TD>biological process</TD><TD>GO:0003309</TD><TD>22</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>INSM1,PAX6</TD></TR>
<TR><TD>2.673e-02</TD><TD>-3.62</TD><TD>postsynaptic density membrane</TD><TD>cellular component</TD><TD>GO:0098839</TD><TD>101</TD><TD>4</TD><TD>19868</TD><TD>222</TD>
<TD>NRCAM,LRFN5,EPHA4,AKAP9</TD></TR>
<TR><TD>2.681e-02</TD><TD>-3.62</TD><TD>inner ear development</TD><TD>biological process</TD><TD>GO:0048839</TD><TD>195</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>FZD6,CYTL1,FGF20,LRIG3,FGFR2,EPHA4</TD></TR>
<TR><TD>2.682e-02</TD><TD>-3.62</TD><TD>human chr8q23.2</TD><TD>chromosome location</TD><TD>human chr8q23.2</TD><TD>13</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>LINC01608</TD></TR>
<TR><TD>2.694e-02</TD><TD>-3.61</TD><TD>fibroblast growth factor binding</TD><TD>molecular function</TD><TD>GO:0017134</TD><TD>23</TD><TD>2</TD><TD>18530</TD><TD>207</TD>
<TD>CXCL13,FGFR2</TD></TR>
<TR><TD>2.699e-02</TD><TD>-3.61</TD><TD>Signaling by FGFR in disease</TD><TD>REACTOME pathways</TD><TD>R-HSA-1226099</TD><TD>63</TD><TD>3</TD><TD>10391</TD><TD>107</TD>
<TD>FGFR2,FGF20,FGF5</TD></TR>
<TR><TD>2.701e-02</TD><TD>-3.61</TD><TD>Downstream signaling of activated FGFR3</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654708</TD><TD>25</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>2.701e-02</TD><TD>-3.61</TD><TD>Nuclear signaling by ERBB4</TD><TD>REACTOME pathways</TD><TD>R-HSA-1251985</TD><TD>25</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>WWOX,NRG1</TD></TR>
<TR><TD>2.707e-02</TD><TD>-3.61</TD><TD>CLEC4A (C-type lectin domain family 4 member A)</TD><TD>protein interactions</TD><TD>50856</TD><TD>102</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>PTPRK,FGFR2,LRRN2,LRIG3</TD></TR>
<TR><TD>2.720e-02</TD><TD>-3.60</TD><TD>AMELOGENIN</TD><TD>prints domains</TD><TD>PR01757</TD><TD>2</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>AMELX</TD></TR>
<TR><TD>2.720e-02</TD><TD>-3.60</TD><TD>WILMSTUMOUR</TD><TD>prints domains</TD><TD>PR00049</TD><TD>2</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>FMNL2</TD></TR>
<TR><TD>2.720e-02</TD><TD>-3.60</TD><TD>INTRLEUKN1R2</TD><TD>prints domains</TD><TD>PR01539</TD><TD>2</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>IL1RAPL2</TD></TR>
<TR><TD>2.720e-02</TD><TD>-3.60</TD><TD>AFETOPROTEIN</TD><TD>prints domains</TD><TD>PR00803</TD><TD>2</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>AFM</TD></TR>
<TR><TD>2.720e-02</TD><TD>-3.60</TD><TD>FOLLICULNIP1</TD><TD>prints domains</TD><TD>PR02073</TD><TD>2</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>FNIP2</TD></TR>
<TR><TD>2.720e-02</TD><TD>-3.60</TD><TD>CHOLNESTRASE</TD><TD>prints domains</TD><TD>PR00878</TD><TD>2</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>BCHE</TD></TR>
<TR><TD>2.720e-02</TD><TD>-3.60</TD><TD>ANATRNSFRASE</TD><TD>prints domains</TD><TD>PR01543</TD><TD>2</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>NAT2</TD></TR>
<TR><TD>2.721e-02</TD><TD>-3.60</TD><TD>EGFBLOOD</TD><TD>prints domains</TD><TD>PR00010</TD><TD>19</TD><TD>2</TD><TD>5258</TD><TD>72</TD>
<TD>DNER,FBN2</TD></TR>
<TR><TD>2.722e-02</TD><TD>-3.60</TD><TD>kidney development</TD><TD>biological process</TD><TD>GO:0001822</TD><TD>306</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,SLIT2,FGFR2,EPHA4,IRX1,PBX1,GCNT1,PECAM1</TD></TR>
<TR><TD>2.732e-02</TD><TD>-3.60</TD><TD>mucin core 1 and core 2 O-glycosylation</TD><TD>BIOCYC pathways</TD><TD>META_PWY-7433</TD><TD>5</TD><TD>1</TD><TD>907</TD><TD>5</TD>
<TD>GCNT1</TD></TR>
<TR><TD>2.752e-02</TD><TD>-3.59</TD><TD>salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>salivary_gland-parotid-carcinoma-adenoid_cystic_carcinoma</TD><TD>563</TD><TD>12</TD><TD>16984</TD><TD>193</TD>
<TD>UHMK1,IQGAP2,AKAP9,NTRK2,FGFR2,ACVR2A,CASK,SEZ6L,THSD7A,PARP8,TGFBR2,NRCAM</TD></TR>
<TR><TD>2.753e-02</TD><TD>-3.59</TD><TD>TRIP11 (thyroid hormone receptor interactor 11)</TD><TD>protein interactions</TD><TD>9321</TD><TD>152</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>NTRK2,SLC25A46,FGFR2,DSCAM,NUP35</TD></TR>
<TR><TD>2.758e-02</TD><TD>-3.59</TD><TD>biological regulation</TD><TD>biological process</TD><TD>GO:0065007</TD><TD>12754</TD><TD>162</TD><TD>18905</TD><TD>220</TD>
<TD>MIR569,DEPTOR,DAAM1,CNTNAP2,IQGAP2,LRRC70,FGFR2,AMELX,STXBP6,MIR548A3,RGS6,UHMK1,OR52K2,CD96,DAOA,TCF20,ADAMTS12,PTPRD,LMX1A,CRTC3,LRRN2,TWIST1,EPS8,PHLPP1,NRG1,ROBO2,RYR2,PTPRK,BANK1,TEC,BACH2,FNIP2,DCDC2C,CPQ,SLC39A10,PBX1,CHRM3,MRPL13,LRFN5,UNC5C,FGD3,NOVA1,BCHE,MTERF1,FGF5,AKAP9,ASPN,UCHL1,DSCAM,NTRK2,PAQR3,FZD6,CYTL1,FUT9,ZNF521,MIR577,INSM1,ADAMTS5,MIR1260B,PWWP2A,MIR548AA2,CXCL13,PRLHR,AFM,PTPRZ1,REG1B,SLIT2,SKAP2,SEZ6L,WRN,PARP8,ACVR1C,IRX1,EPHA4,KCNK9,JMJD1C,FABP7,HNF4G,PAX6,LHCGR,PECAM1,FMNL2,ZFAND5,OR2AG1,PPP1R17,VAV3,SLC7A8,GCNT1,ZNF133,MAP2,PLEK,CDH5,MIR551B,RASGEF1B,LGI1,ACVR2A,RBM20,RGS5,AOAH,SEMA3C,BRINP3,PHF14,CNTN1,TGFBR2,MIR147A,FBN2,SPAG9,MEGF10,RPH3A,EPHA3,SERINC5,PRKCE,TRPS1,CASK,TSN,TMEFF2,CELF2,MIR891A,IL1RAPL2,GMDS,FGF20,PCGF5,ZFPM2,FAT4,ZNF518B,GPR83,KLF12,PUM3,UTRN,ARX,FGF14,UBR4,ATG10,IPO8,WWOX,XPO4,GHITM,NRCAM,SGCD,ADGRL3,EFNA5,ADAMTS3,SHISA3,SHTN1,FANCB,MIR9-2HG,SERGEF,DNER,GAREM1,CD226,EFEMP1,GAP43,C8orf88,SEPTIN5,EDIL3,RUNX1T1,SS18,SYT1,MAST4,NOBOX,FERD3L,NAV3</TD></TR>
<TR><TD>2.760e-02</TD><TD>-3.59</TD><TD>positive regulation of cell division</TD><TD>biological process</TD><TD>GO:0051781</TD><TD>98</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>PRKCE,FGFR2,FGF5,GAREM1</TD></TR>
<TR><TD>2.763e-02</TD><TD>-3.59</TD><TD>superficial_spreading</TD><TD>COSMIC cancer mutations</TD><TD>superficial_spreading</TD><TD>1110</TD><TD>20</TD><TD>16984</TD><TD>193</TD>
<TD>FGFR2,RUNX1T1,EFR3A,FUT9,FAT4,RASGEF1B,SLC25A46,SPHKAP,TGFBR2,PTPRK,EPHA3,HNF4G,NOVA1,SLIT2,ADAMTS12,CNTNAP2,ASPN,UTRN,SYT1,FBN2</TD></TR>
<TR><TD>2.792e-02</TD><TD>-3.58</TD><TD>ZFYVE9 (zinc finger FYVE-type containing 9)</TD><TD>protein interactions</TD><TD>9372</TD><TD>103</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>FGFR2,EPHA4,TGFBR2,NTRK2</TD></TR>
<TR><TD>2.802e-02</TD><TD>-3.57</TD><TD>upper_third</TD><TD>COSMIC cancer mutations</TD><TD>upper_third</TD><TD>630</TD><TD>13</TD><TD>16984</TD><TD>193</TD>
<TD>FUT9,EPHA4,NOL4,ROBO2,EFEMP1,UTRN,SLC7A8,PAX6,IGFL4,RYR2,EPHA3,SGCG,PXDNL</TD></TR>
<TR><TD>2.802e-02</TD><TD>-3.57</TD><TD>oesophagus-upper_third-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>oesophagus-upper_third-carcinoma-squamous_cell_carcinoma</TD><TD>630</TD><TD>13</TD><TD>16984</TD><TD>193</TD>
<TD>FUT9,ROBO2,EPHA4,NOL4,UTRN,EFEMP1,PXDNL,SGCG,EPHA3,RYR2,IGFL4,PAX6,SLC7A8</TD></TR>
<TR><TD>2.805e-02</TD><TD>-3.57</TD><TD>breast-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>breast-carcinoma</TD><TD>15099</TD><TD>180</TD><TD>16984</TD><TD>193</TD>
<TD>FMNL2,SPHKAP,FGD3,CASK,SLC7A14,MPEG1,CDH5,SERGEF,ZNF521,FGFR2,SEZ6L,EPS8,FANCB,NCKAP5,TSN,FABP7,STXBP6,DNAJC12,NTRK2,FIGN,NBEA,ADAMTS3,SS18,IPO8,TRPS1,PXDNL,PI15,SLC39A10,FNIP2,ZPLD1,NOL4,SGCD,LMX1A,FERD3L,NUP35,ZFAND5,PTPRD,JMJD1C,ACVR2A,SEMA3C,NAV3,RGS5,PCDH9,PWWP2A,NRCAM,PAX6,ATG10,MEGF10,MAP2,SLIT2,LRRC70,OR2AG1,RAI2,PHF14,LRFN5,DEPTOR,RPH3A,AMELX,KCNK9,KLF12,BCHE,CTSO,WWOX,AGA,COX7B2,EDIL3,AOAH,SKAP2,NRSN1,LRRC3B,CALN1,PRKCE,EFR3B,MRPL3,TMEFF2,TWIST1,MUC7,XPO4,CELF2,PRLHR,CPXM2,TCF20,RBM20,UHMK1,EFR3A,ARX,KIF6,EPHA3,DSCAM,OR52K2,CHRM3,PCGF5,EFNA5,ADAMTS5,FGF5,UBR4,SLC7A8,PTPRK,B3GAT2,LMBRD1,ADAM28,FGF14,CRTC3,FGF20,GHITM,IQGAP2,UCHL1,AFM,IL1RAPL2,LGI1,THSD7B,PLEK,PARP8,HNF4G,REXO2,NOVA1,ASPN,CNTNAP2,WRN,EPHA4,PSKH2,KAZN,SLC10A2,ZNF518B,AKAP9,MRPL13,SLC25A46,FUT9,IGFL4,EPYC,ADAMTS12,NAALADL2,LRIG3,NOBOX,BACH2,GPR83,SPAG9,DAAM1,UTRN,NRG1,GAP43,REG1B,CNTN1,GCNT1,LRRN2,DAOA,PAQR3,EFEMP1,FBN2,RUNX1T1,SPATA16,ACVR1C,DNER,UNC5C,ACP6,ZNF133,THSD7A,VAV3,PRSS12,ROBO2,PHLPP1,RASGEF1B,LHCGR,RYR2,SGCG,CD96,DEFB115,RGS6,PTPRZ1,BANK1,FZD6,SHISA3,SERINC5,FAT4,ZFPM2,TGFBR2,SYT1,CD226,GMDS,DCDC2C</TD></TR>
<TR><TD>2.807e-02</TD><TD>-3.57</TD><TD>Mannose type O-glycan biosynthesis</TD><TD>KEGG pathways</TD><TD>hsa00515</TD><TD>23</TD><TD>2</TD><TD>7246</TD><TD>83</TD>
<TD>B3GAT2,FUT9</TD></TR>
<TR><TD>2.807e-02</TD><TD>-3.57</TD><TD>Mannose type O-glycan biosynthesis</TD><TD>KEGG pathways</TD><TD>ko00515</TD><TD>23</TD><TD>2</TD><TD>7246</TD><TD>83</TD>
<TD>FUT9,B3GAT2</TD></TR>
<TR><TD>2.814e-02</TD><TD>-3.57</TD><TD>adult behavior</TD><TD>biological process</TD><TD>GO:0030534</TD><TD>146</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>SEPTIN5,CNTNAP2,UCHL1,EPHA4,EPS8</TD></TR>
<TR><TD>2.839e-02</TD><TD>-3.56</TD><TD>WW_DOMAIN_2</TD><TD>prosite domains</TD><TD>PS50020</TD><TD>50</TD><TD>3</TD><TD>12232</TD><TD>162</TD>
<TD>WWOX,IQGAP2,UTRN</TD></TR>
<TR><TD>2.842e-02</TD><TD>-3.56</TD><TD>HGS (hepatocyte growth factor-regulated tyrosine kinase substrate)</TD><TD>protein interactions</TD><TD>9146</TD><TD>512</TD><TD>11</TD><TD>20077</TD><TD>223</TD>
<TD>PAX6,FIGN,EPHA3,BRINP3,EPHA4,SERGEF,NRSN1,CASK,NTRK2,FGFR2,PLAAT1</TD></TR>
<TR><TD>2.863e-02</TD><TD>-3.55</TD><TD>Downstream signal transduction</TD><TD>REACTOME pathways</TD><TD>R-HSA-186763</TD><TD>352</TD><TD>8</TD><TD>10391</TD><TD>107</TD>
<TD>NRG1,PAQR3,FGFR2,PRKCE,FGF20,AKAP9,FGF5,PHLPP1</TD></TR>
<TR><TD>2.868e-02</TD><TD>-3.55</TD><TD>Homeobox_KN_domain</TD><TD>interpro domains</TD><TD>IPR008422</TD><TD>23</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>IRX1,PBX1</TD></TR>
<TR><TD>2.869e-02</TD><TD>-3.55</TD><TD>extracellular region</TD><TD>cellular component</TD><TD>GO:0005576</TD><TD>4518</TD><TD>63</TD><TD>19868</TD><TD>222</TD>
<TD>TGFBR2,PXDNL,MUC7,EPHA3,CTSO,BRINP3,AGA,UTRN,GHITM,FGF5,EDDM13,PLEK,FGF20,SPAG9,THSD7A,PTPRZ1,PI15,LRRC3B,TMEFF2,GMDS,LRRN2,PECAM1,DEFB115,IQGAP2,MIR1973,ZPLD1,SERINC5,PRSS12,ACTR3C,REG1B,PTPRD,IGFL4,EDIL3,DSCAM,GCNT1,FAT4,EPS8,ADAMTS3,ADAM28,DAW1,ROBO2,FBN2,ADAMTS12,LRIG3,FGFR2,BCHE,SEMA3C,CYTL1,MPEG1,SLIT2,AOAH,AMELX,CNTN1,LHCGR,LGI1,NRCAM,AFM,EFEMP1,ASPN,CXCL13,CPQ,NRG1,ADAMTS5</TD></TR>
<TR><TD>2.870e-02</TD><TD>-3.55</TD><TD>negative regulation of response to external stimulus</TD><TD>biological process</TD><TD>GO:0032102</TD><TD>428</TD><TD>10</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,CDH5,EPHA4,AOAH,SLIT2,CNTNAP2,LRFN5,CD96,CXCL13,CASK</TD></TR>
<TR><TD>2.872e-02</TD><TD>-3.55</TD><TD>fibroblast growth factor receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0008543</TD><TD>57</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>FGF20,FGFR2,FGF5</TD></TR>
<TR><TD>2.872e-02</TD><TD>-3.55</TD><TD>mesenchymal cell migration</TD><TD>biological process</TD><TD>GO:0090497</TD><TD>57</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C,PAX6,TWIST1</TD></TR>
<TR><TD>2.876e-02</TD><TD>-3.55</TD><TD>lung</TD><TD>COSMIC cancer mutations</TD><TD>lung</TD><TD>16375</TD><TD>191</TD><TD>16984</TD><TD>193</TD>
<TD>REG1B,GAP43,GPR83,DAAM1,UTRN,NRG1,SPAG9,CETN3,LRIG3,NOBOX,BACH2,EPYC,INSM1,IGFL4,ADAMTS12,NAALADL2,PSKH2,KAZN,IRX1,EPHA4,MRPL13,SLC25A46,FUT9,SLC10A2,ZNF518B,AKAP9,REXO2,NOVA1,PARP8,HNF4G,WRN,ASPN,CNTNAP2,FGF20,IL1RAPL2,THSD7B,LGI1,CYTL1,PLEK,IQGAP2,GHITM,UCHL1,AFM,ARL14,B3GAT2,LMBRD1,UBR4,SLC7A8,PTPRK,FGF14,CRTC3,ADAM28,CD226,GMDS,DCDC2C,ERCC6L2,TGFBR2,ZFPM2,SYT1,RGS6,PTPRZ1,DEFB115,FZD6,SHISA3,FAT4,SERINC5,BANK1,SGCG,LHCGR,RYR2,CD96,ROBO2,PRSS12,PHLPP1,RASGEF1B,ACP6,UNC5C,VAV3,ZNF133,THSD7A,RUNX1T1,SPATA16,ACVR1C,DNER,GCNT1,CNTN1,EFEMP1,PAQR3,FBN2,LRRN2,DAOA,SEMA3C,ACVR2A,PWWP2A,COQ2,NAV3,NAT2,RGS5,PCDH9,PTPRD,NUP35,ZFAND5,JMJD1C,NOL4,FERD3L,SGCD,LMX1A,TRPS1,PXDNL,IPO8,FNIP2,ZPLD1,PI15,SLC39A10,STXBP6,DNAJC12,NTRK2,NCKAP5,TSN,FABP7,ADAMTS3,SS18,FIGN,SPANXN1,NBEA,EPS8,FANCB,SEZ6L,SERGEF,ZNF521,FGFR2,FMNL2,SPHKAP,MPEG1,CDH5,FGD3,SLC7A14,CASK,ADAMTS5,FGF5,PBX1,KIF6,EPHA3,PCGF5,EFNA5,DSCAM,OR52K2,CHRM3,XPO4,CELF2,TMEFF2,TWIST1,MUC7,RBM20,EFR3A,ARX,UHMK1,PRLHR,CPXM2,TCF20,MRPL3,PRKCE,EFR3B,SKAP2,CXCL13,COX7B2,AOAH,EDIL3,LRRC3B,CALN1,NRSN1,CTSO,AGA,WWOX,BCHE,DEPTOR,PHF14,LRFN5,KLF12,AMELX,RPH3A,KCNK9,MEGF10,MAP2,SLIT2,NRCAM,PAX6,ATG10,OR2AG1,LRRC70,RAI2</TD></TR>
<TR><TD>2.879e-02</TD><TD>-3.55</TD><TD>locomotion</TD><TD>biological process</TD><TD>GO:0040011</TD><TD>368</TD><TD>9</TD><TD>18905</TD><TD>220</TD>
<TD>VAV3,SLIT2,ROBO2,SLC25A46,NRG1,EFNA5,CXCL13,SEMA3C,UNC5C</TD></TR>
<TR><TD>2.880e-02</TD><TD>-3.55</TD><TD>Homeobox_KN</TD><TD>pfam domains</TD><TD>PF05920</TD><TD>23</TD><TD>2</TD><TD>17869</TD><TD>207</TD>
<TD>IRX1,PBX1</TD></TR>
<TR><TD>2.883e-02</TD><TD>-3.55</TD><TD>liver-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>liver-carcinoma</TD><TD>15428</TD><TD>183</TD><TD>16984</TD><TD>193</TD>
<TD>PSKH2,KAZN,EPHA4,IRX1,MRPL13,FUT9,SLC25A46,SLC10A2,AKAP9,ZNF518B,NOVA1,REXO2,PARP8,HNF4G,WRN,CNTNAP2,ASPN,FGF20,IL1RAPL2,THSD7B,LGI1,PLEK,CYTL1,UCHL1,IQGAP2,GHITM,AFM,B3GAT2,LMBRD1,SLC7A8,UBR4,PTPRK,CRTC3,FGF14,ADAM28,REG1B,GAP43,GPR83,DAAM1,UTRN,NRG1,SPAG9,CETN3,LRIG3,BACH2,EPYC,INSM1,IGFL4,ADAMTS12,NAALADL2,ROBO2,PRSS12,RASGEF1B,PHLPP1,ACP6,UNC5C,VAV3,ZNF133,THSD7A,ACVR1C,SPATA16,RUNX1T1,DNER,GCNT1,CNTN1,EFEMP1,PAQR3,FBN2,DAOA,LRRN2,CD226,GMDS,DCDC2C,ZFPM2,SYT1,PTPRZ1,RGS6,DEFB115,FZD6,SERINC5,FAT4,SHISA3,BANK1,SGCG,LHCGR,RYR2,CD96,STXBP6,NTRK2,DNAJC12,FABP7,TSN,NCKAP5,SS18,ADAMTS3,SPANXN1,FIGN,NBEA,FANCB,EPS8,SEZ6L,SERGEF,FGFR2,ZNF521,SPHKAP,FMNL2,MPEG1,CDH5,CASK,SLC7A14,FGD3,LINC00583,SEMA3C,ACVR2A,COQ2,PWWP2A,RGS5,NAV3,PCDH9,PTPRD,ZFAND5,NUP35,JMJD1C,LINC01387,NOL4,FERD3L,SGCD,LMX1A,TRPS1,PXDNL,IPO8,ZPLD1,FNIP2,SLC39A10,PI15,SKAP2,COX7B2,CXCL13,AOAH,EDIL3,CALN1,NRSN1,CTSO,AGA,BCHE,DEPTOR,PHF14,LRFN5,KLF12,RPH3A,KCNK9,MEGF10,MAP2,SLIT2,PAX6,NRCAM,ATG10,OR2AG1,LRRC70,RAI2,ADAMTS5,FGF5,KIF6,EPHA3,EFNA5,PCGF5,DSCAM,OR52K2,CHRM3,XPO4,CELF2,TMEFF2,MUC7,EFR3A,ARX,UHMK1,RBM20,CPXM2,PRLHR,TCF20,MRPL3,PRKCE,EFR3B</TD></TR>
<TR><TD>2.885e-02</TD><TD>-3.55</TD><TD>human chr6q16.2</TD><TD>chromosome location</TD><TD>human chr6q16.2</TD><TD>14</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>MIR548AI</TD></TR>
<TR><TD>2.887e-02</TD><TD>-3.54</TD><TD>ADAM22 (ADAM metallopeptidase domain 22)</TD><TD>protein interactions</TD><TD>53616</TD><TD>24</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>EPS8,LGI1</TD></TR>
<TR><TD>2.887e-02</TD><TD>-3.54</TD><TD>CYS1 (cystin 1)</TD><TD>protein interactions</TD><TD>192668</TD><TD>24</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>UCHL1,SPAG9</TD></TR>
<TR><TD>2.887e-02</TD><TD>-3.54</TD><TD>SLC37A3 (solute carrier family 37 member 3)</TD><TD>protein interactions</TD><TD>84255</TD><TD>24</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>SLC25A46,DAAM1</TD></TR>
<TR><TD>2.887e-02</TD><TD>-3.54</TD><TD>RNF133 (ring finger protein 133)</TD><TD>protein interactions</TD><TD>168433</TD><TD>24</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>PTPRD,NUP35</TD></TR>
<TR><TD>2.897e-02</TD><TD>-3.54</TD><TD>OPALIN (oligodendrocytic myelin paranodal and inner loop protein)</TD><TD>protein interactions</TD><TD>93377</TD><TD>208</TD><TD>6</TD><TD>20077</TD><TD>223</TD>
<TD>PTPRD,XPO4,IPO8,ACVR2A,EFR3A,GHITM</TD></TR>
<TR><TD>2.905e-02</TD><TD>-3.54</TD><TD>substrate-dependent cell migration</TD><TD>biological process</TD><TD>GO:0006929</TD><TD>23</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,SHTN1</TD></TR>
<TR><TD>2.905e-02</TD><TD>-3.54</TD><TD>regulation of establishment of cell polarity</TD><TD>biological process</TD><TD>GO:2000114</TD><TD>23</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>SHTN1,CDH5</TD></TR>
<TR><TD>2.905e-02</TD><TD>-3.54</TD><TD>signal transduction involved in regulation of gene expression</TD><TD>biological process</TD><TD>GO:0023019</TD><TD>23</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6,FGF5</TD></TR>
<TR><TD>2.905e-02</TD><TD>-3.54</TD><TD>embryonic hemopoiesis</TD><TD>biological process</TD><TD>GO:0035162</TD><TD>23</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>PBX1,TGFBR2</TD></TR>
<TR><TD>2.911e-02</TD><TD>-3.54</TD><TD>PTPRE (protein tyrosine phosphatase receptor type E)</TD><TD>protein interactions</TD><TD>5791</TD><TD>60</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>PTPRD,XPO4,EFR3A</TD></TR>
<TR><TD>2.911e-02</TD><TD>-3.54</TD><TD>CRLF2 (cytokine receptor like factor 2)</TD><TD>protein interactions</TD><TD>64109</TD><TD>60</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>SLC25A46,ACVR2A,FGFR2</TD></TR>
<TR><TD>2.911e-02</TD><TD>-3.54</TD><TD>GALNT18 (polypeptide N-acetylgalactosaminyltransferase 18)</TD><TD>protein interactions</TD><TD>374378</TD><TD>60</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>PI15,PTPRK,ADAMTS12</TD></TR>
<TR><TD>2.921e-02</TD><TD>-3.53</TD><TD>cardiac muscle tissue development</TD><TD>biological process</TD><TD>GO:0048738</TD><TD>199</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>ZFPM2,SGCD,NRG1,RYR2,FGFR2,SGCG</TD></TR>
<TR><TD>2.931e-02</TD><TD>-3.53</TD><TD>plasma membrane region</TD><TD>cellular component</TD><TD>GO:0098590</TD><TD>1279</TD><TD>22</TD><TD>19868</TD><TD>222</TD>
<TD>PLEK,EPS8,SLC7A8,UTRN,ROBO2,PTPRD,SLC10A2,TGFBR2,SLC39A10,EFNA5,SYT1,RPH3A,NRCAM,FZD6,LRFN5,GAP43,CHRM3,CASK,CNTNAP2,CNTN1,EPHA4,AKAP9</TD></TR>
<TR><TD>2.961e-02</TD><TD>-3.52</TD><TD>Disease</TD><TD>REACTOME pathways</TD><TD>R-HSA-1643685</TD><TD>859</TD><TD>15</TD><TD>10391</TD><TD>107</TD>
<TD>ADAMTS5,FZD6,NUP35,TGFBR2,THSD7A,FGF20,THSD7B,NRG1,SYT1,ADAMTS3,ADAMTS12,FGFR2,AKAP9,FGF5,MUC7</TD></TR>
<TR><TD>2.967e-02</TD><TD>-3.52</TD><TD>signaling receptor activator activity</TD><TD>molecular function</TD><TD>GO:0030546</TD><TD>513</TD><TD>11</TD><TD>18530</TD><TD>207</TD>
<TD>FGF20,EFNA5,NRG1,EFEMP1,FGF5,FBN2,PRKCE,SEMA3C,CXCL13,AMELX,FGF14</TD></TR>
<TR><TD>2.967e-02</TD><TD>-3.52</TD><TD>skin-upper_back-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-upper_back-malignant_melanoma</TD><TD>319</TD><TD>8</TD><TD>16984</TD><TD>193</TD>
<TD>MUC7,SPHKAP,CNTN1,PTPRD,CHRM3,FBN2,FAT4,FUT9</TD></TR>
<TR><TD>2.995e-02</TD><TD>-3.51</TD><TD>Amelogenin</TD><TD>smart domains</TD><TD>SM00818</TD><TD>2</TD><TD>1</TD><TD>9743</TD><TD>147</TD>
<TD>AMELX</TD></TR>
<TR><TD>2.995e-02</TD><TD>-3.51</TD><TD>RQC</TD><TD>smart domains</TD><TD>SM00956</TD><TD>2</TD><TD>1</TD><TD>9743</TD><TD>147</TD>
<TD>WRN</TD></TR>
<TR><TD>2.995e-02</TD><TD>-3.51</TD><TD>DBB</TD><TD>smart domains</TD><TD>SM01282</TD><TD>2</TD><TD>1</TD><TD>9743</TD><TD>147</TD>
<TD>BANK1</TD></TR>
<TR><TD>2.995e-02</TD><TD>-3.51</TD><TD>Sec3-PIP2_bind</TD><TD>smart domains</TD><TD>SM01313</TD><TD>2</TD><TD>1</TD><TD>9743</TD><TD>147</TD>
<TD>STXBP6</TD></TR>
<TR><TD>2.995e-02</TD><TD>-3.51</TD><TD>DUF1704</TD><TD>smart domains</TD><TD>SM01154</TD><TD>2</TD><TD>1</TD><TD>9743</TD><TD>147</TD>
<TD>MATCAP2</TD></TR>
<TR><TD>2.999e-02</TD><TD>-3.51</TD><TD>regulation of biological process</TD><TD>biological process</TD><TD>GO:0050789</TD><TD>12325</TD><TD>157</TD><TD>18905</TD><TD>220</TD>
<TD>LRFN5,UNC5C,MRPL13,FGD3,NOVA1,BCHE,MTERF1,FGF5,ASPN,AKAP9,DSCAM,PAQR3,NTRK2,UCHL1,CYTL1,FZD6,FUT9,MIR577,ZNF521,INSM1,MIR1260B,ADAMTS5,PWWP2A,PRLHR,CXCL13,MIR548AA2,PTPRZ1,REG1B,SEZ6L,WRN,SLIT2,SKAP2,IRX1,EPHA4,ACVR1C,PARP8,JMJD1C,PAX6,HNF4G,FABP7,LHCGR,FMNL2,PECAM1,OR2AG1,ZFAND5,PPP1R17,VAV3,DEPTOR,DAAM1,MIR569,IQGAP2,CNTNAP2,LRRC70,FGFR2,STXBP6,AMELX,MIR548A3,UHMK1,OR52K2,RGS6,CD96,TCF20,DAOA,ADAMTS12,PTPRD,LMX1A,LRRN2,CRTC3,TWIST1,PHLPP1,EPS8,NRG1,ROBO2,RYR2,BANK1,PTPRK,TEC,BACH2,DCDC2C,FNIP2,SLC39A10,CHRM3,PBX1,PCGF5,GMDS,FGF20,ZNF518B,FAT4,ZFPM2,GPR83,KLF12,PUM3,UTRN,ARX,UBR4,FGF14,ATG10,XPO4,WWOX,IPO8,NRCAM,GHITM,EFNA5,SGCD,ADGRL3,SHISA3,ADAMTS3,FANCB,SHTN1,DNER,SERGEF,MIR9-2HG,CD226,GAREM1,C8orf88,GAP43,EFEMP1,SEPTIN5,EDIL3,SYT1,RUNX1T1,SS18,MAST4,NOBOX,FERD3L,NAV3,GCNT1,MAP2,PLEK,ZNF133,CDH5,MIR551B,RASGEF1B,LGI1,RGS5,RBM20,ACVR2A,AOAH,SEMA3C,BRINP3,PHF14,TGFBR2,CNTN1,MIR147A,FBN2,SPAG9,MEGF10,EPHA3,RPH3A,PRKCE,TRPS1,TSN,TMEFF2,CASK,CELF2,IL1RAPL2,MIR891A</TD></TR>
<TR><TD>3.003e-02</TD><TD>-3.51</TD><TD>B cell receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0050853</TD><TD>58</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>BANK1,VAV3,TEC</TD></TR>
<TR><TD>3.009e-02</TD><TD>-3.50</TD><TD>endometrial_stromal_sarcoma</TD><TD>COSMIC cancer mutations</TD><TD>endometrial_stromal_sarcoma</TD><TD>24</TD><TD>2</TD><TD>16984</TD><TD>193</TD>
<TD>FGFR2,SS18</TD></TR>
<TR><TD>3.009e-02</TD><TD>-3.50</TD><TD>soft_tissue-fibrous_tissue_and_uncertain_origin-endometrial_stromal_sarcoma</TD><TD>COSMIC cancer mutations</TD><TD>soft_tissue-fibrous_tissue_and_uncertain_origin-endometrial_stromal_sarcoma</TD><TD>24</TD><TD>2</TD><TD>16984</TD><TD>193</TD>
<TD>SS18,FGFR2</TD></TR>
<TR><TD>3.009e-02</TD><TD>-3.50</TD><TD>mouth_roof</TD><TD>COSMIC cancer mutations</TD><TD>mouth_roof</TD><TD>24</TD><TD>2</TD><TD>16984</TD><TD>193</TD>
<TD>CRTC3,MAP2</TD></TR>
<TR><TD>3.012e-02</TD><TD>-3.50</TD><TD>pancreas-carcinoma-ductal_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>pancreas-carcinoma-ductal_carcinoma</TD><TD>15657</TD><TD>185</TD><TD>16984</TD><TD>193</TD>
<TD>PRKCE,EFR3B,MRPL3,PRLHR,CPXM2,TCF20,UHMK1,EFR3A,ARX,TMEFF2,MUC7,TWIST1,XPO4,CELF2,DSCAM,CHRM3,OR52K2,PCGF5,EFNA5,KIF6,EPHA3,PBX1,FGF5,ADAMTS5,OR2AG1,RAI2,PAX6,NRCAM,ATG10,MAP2,MEGF10,SLIT2,AMELX,RPH3A,KCNK9,KLF12,PHF14,LRFN5,DEPTOR,BCHE,CTSO,WWOX,AGA,NRSN1,LRRC3B,CALN1,COX7B2,CXCL13,AOAH,EDIL3,SKAP2,SLC39A10,PI15,FNIP2,ZPLD1,IPO8,TRPS1,PXDNL,SGCD,LMX1A,FERD3L,NOL4,JMJD1C,ZFAND5,NUP35,PTPRD,NAT2,RGS5,NAV3,PCDH9,COQ2,PWWP2A,ACVR2A,SEMA3C,SLC7A14,CASK,FGD3,MPEG1,CDH5,SPHKAP,FMNL2,SERGEF,FGFR2,ZNF521,SEZ6L,FANCB,EPS8,SPANXN1,FIGN,NBEA,SS18,ADAMTS3,FABP7,NCKAP5,TSN,STXBP6,NTRK2,DNAJC12,CD96,LHCGR,RYR2,SGCG,BANK1,FZD6,FAT4,SHISA3,DEFB115,PTPRZ1,RGS6,SYT1,TGFBR2,ZFPM2,GMDS,CD226,DAOA,LRRN2,EFEMP1,PAQR3,FBN2,CNTN1,GCNT1,ACVR1C,RUNX1T1,SPATA16,DNER,ZNF133,THSD7A,VAV3,UNC5C,ACP6,RASGEF1B,PRSS12,ROBO2,ADAMTS12,NAALADL2,IGFL4,EPYC,INSM1,NOBOX,BACH2,LRIG3,SPAG9,CETN3,UTRN,DAAM1,NRG1,GPR83,GAP43,REG1B,ADAM28,CRTC3,FGF14,SLC7A8,UBR4,PTPRK,B3GAT2,ARL14,LMBRD1,UCHL1,GHITM,IQGAP2,AFM,LGI1,IL1RAPL2,THSD7B,PLEK,CYTL1,FGF20,CNTNAP2,ASPN,WRN,PARP8,HNF4G,NOVA1,REXO2,SLC10A2,AKAP9,ZNF518B,MRPL13,FUT9,SLC25A46,EPHA4,IRX1,PSKH2,KAZN</TD></TR>
<TR><TD>3.018e-02</TD><TD>-3.50</TD><TD>large_cell</TD><TD>COSMIC cancer mutations</TD><TD>large_cell</TD><TD>14901</TD><TD>178</TD><TD>16984</TD><TD>193</TD>
<TD>VAV3,ZNF133,THSD7A,ACP6,UNC5C,RASGEF1B,ROBO2,PRSS12,EFEMP1,FBN2,DAOA,LRRN2,GCNT1,CNTN1,ACVR1C,RUNX1T1,SPATA16,DNER,SYT1,TGFBR2,ZFPM2,GMDS,CD226,CD96,SGCG,LHCGR,RYR2,FZD6,FAT4,SHISA3,BANK1,PTPRZ1,RGS6,DEFB115,WRN,CNTNAP2,ASPN,NOVA1,REXO2,PARP8,HNF4G,MRPL13,FUT9,SLC25A46,SLC10A2,AKAP9,ZNF518B,PSKH2,KAZN,EPHA4,IRX1,CRTC3,FGF14,ADAM28,ARL14,B3GAT2,LMBRD1,SLC7A8,UBR4,PTPRK,IL1RAPL2,LGI1,THSD7B,PLEK,CYTL1,UCHL1,IQGAP2,GHITM,AFM,FGF20,DAAM1,UTRN,NRG1,SPAG9,CETN3,GPR83,REG1B,GAP43,ADAMTS12,NAALADL2,EPYC,INSM1,IGFL4,NOBOX,BACH2,LRIG3,CTSO,WWOX,AGA,BCHE,LRRC3B,CALN1,NRSN1,SKAP2,CXCL13,EDIL3,AOAH,RAI2,MEGF10,MAP2,SLIT2,PAX6,NRCAM,ATG10,KLF12,RPH3A,AMELX,KCNK9,DEPTOR,PHF14,LRFN5,PCGF5,EFNA5,DSCAM,CHRM3,KIF6,EPHA3,FGF5,PBX1,ADAMTS5,MRPL3,PRKCE,ARX,UHMK1,EFR3A,RBM20,PRLHR,CPXM2,TCF20,XPO4,CELF2,TMEFF2,MUC7,TWIST1,FANCB,EPS8,SEZ6L,SS18,ADAMTS3,FIGN,SPANXN1,NBEA,STXBP6,NTRK2,DNAJC12,FABP7,TSN,NCKAP5,MPEG1,CDH5,CASK,SLC7A14,FGD3,SPHKAP,FMNL2,SERGEF,FGFR2,ZNF521,JMJD1C,PTPRD,ZFAND5,COQ2,PWWP2A,NAT2,RGS5,NAV3,PCDH9,SEMA3C,ACVR2A,FNIP2,ZPLD1,SLC39A10,PI15,TRPS1,IPO8,FERD3L,LMX1A,NOL4</TD></TR>
<TR><TD>3.031e-02</TD><TD>-3.50</TD><TD>response to xenobiotic stimulus</TD><TD>biological process</TD><TD>GO:0009410</TD><TD>432</TD><TD>10</TD><TD>18905</TD><TD>220</TD>
<TD>LHCGR,PAX6,NAT2,SEMA3C,UCHL1,AMELX,VAV3,TGFBR2,SS18,BCHE</TD></TR>
<TR><TD>3.037e-02</TD><TD>-3.49</TD><TD>MAPK8IP3 (mitogen-activated protein kinase 8 interacting protein 3)</TD><TD>protein interactions</TD><TD>23162</TD><TD>61</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>SHTN1,FGF14,SPAG9</TD></TR>
<TR><TD>3.050e-02</TD><TD>-3.49</TD><TD>ERBB2 (erb-b2 receptor tyrosine kinase 2)</TD><TD>protein interactions</TD><TD>2064</TD><TD>584</TD><TD>12</TD><TD>20077</TD><TD>223</TD>
<TD>TGFBR2,VAV3,EPHA4,NAALADL2,NAT2,DEPTOR,TEC,EPHA3,NRG1,FGFR2,LRIG3,NTRK2</TD></TR>
<TR><TD>3.058e-02</TD><TD>-3.49</TD><TD>cell-cell junction</TD><TD>cellular component</TD><TD>GO:0005911</TD><TD>515</TD><TD>11</TD><TD>19868</TD><TD>222</TD>
<TD>STXBP6,CDH5,EFNA5,KAZN,CNTNAP2,CASK,EPHA4,PCDH9,PECAM1,ADGRL3,PTPRK</TD></TR>
<TR><TD>3.058e-02</TD><TD>-3.49</TD><TD>Toxicity of botulinum toxin type B (BoNT/B)</TD><TD>REACTOME pathways</TD><TD>R-HSA-5250958</TD><TD>3</TD><TD>1</TD><TD>10391</TD><TD>107</TD>
<TD>SYT1</TD></TR>
<TR><TD>3.058e-02</TD><TD>-3.49</TD><TD>Toxicity of botulinum toxin type G (BoNT/G)</TD><TD>REACTOME pathways</TD><TD>R-HSA-5250989</TD><TD>3</TD><TD>1</TD><TD>10391</TD><TD>107</TD>
<TD>SYT1</TD></TR>
<TR><TD>3.088e-02</TD><TD>-3.48</TD><TD>human chr20p11.1</TD><TD>chromosome location</TD><TD>human chr20p11.1</TD><TD>15</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>MIR663AHG</TD></TR>
<TR><TD>3.113e-02</TD><TD>-3.47</TD><TD>Globo Sphingolipid Metabolism</TD><TD>WikiPathways</TD><TD>WP1424</TD><TD>22</TD><TD>2</TD><TD>5358</TD><TD>68</TD>
<TD>GCNT1,FUT9</TD></TR>
<TR><TD>3.116e-02</TD><TD>-3.47</TD><TD>TIGIT (T cell immunoreceptor with Ig and ITIM domains)</TD><TD>protein interactions</TD><TD>201633</TD><TD>25</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>PTPRD,ACVR2A</TD></TR>
<TR><TD>3.116e-02</TD><TD>-3.47</TD><TD>LCTL (lactase like)</TD><TD>protein interactions</TD><TD>197021</TD><TD>25</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>GHITM,SLC25A46</TD></TR>
<TR><TD>3.116e-02</TD><TD>-3.47</TD><TD>PAQR3 (progestin and adipoQ receptor family member 3)</TD><TD>protein interactions</TD><TD>152559</TD><TD>25</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>TWIST1,NRSN1</TD></TR>
<TR><TD>3.126e-02</TD><TD>-3.47</TD><TD>lung-carcinoid-endocrine_tumour-atypical</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoid-endocrine_tumour-atypical</TD><TD>509</TD><TD>11</TD><TD>16984</TD><TD>193</TD>
<TD>ACVR2A,EPHA4,PSKH2,FGFR2,NTRK2,ACVR1C,UHMK1,PRKCE,TGFBR2,EPHA3,CASK</TD></TR>
<TR><TD>3.134e-02</TD><TD>-3.46</TD><TD>regulation of organ growth</TD><TD>biological process</TD><TD>GO:0046620</TD><TD>102</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>ZFPM2,FGF20,ARX,FGFR2</TD></TR>
<TR><TD>3.138e-02</TD><TD>-3.46</TD><TD>regulation of sodium ion transmembrane transport</TD><TD>biological process</TD><TD>GO:1902305</TD><TD>59</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>UTRN,PRKCE,FGF14</TD></TR>
<TR><TD>3.145e-02</TD><TD>-3.46</TD><TD>chondroitin sulfate proteoglycan biosynthetic process</TD><TD>biological process</TD><TD>GO:0050650</TD><TD>24</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>CYTL1,B3GAT2</TD></TR>
<TR><TD>3.145e-02</TD><TD>-3.46</TD><TD>regulation of dopamine secretion</TD><TD>biological process</TD><TD>GO:0014059</TD><TD>24</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>FGF20,SYT1</TD></TR>
<TR><TD>3.148e-02</TD><TD>-3.46</TD><TD>fibroblast growth factor receptor binding</TD><TD>molecular function</TD><TD>GO:0005104</TD><TD>25</TD><TD>2</TD><TD>18530</TD><TD>207</TD>
<TD>FGF20,FGF5</TD></TR>
<TR><TD>3.148e-02</TD><TD>-3.46</TD><TD>protein kinase A regulatory subunit binding</TD><TD>molecular function</TD><TD>GO:0034237</TD><TD>25</TD><TD>2</TD><TD>18530</TD><TD>207</TD>
<TD>RYR2,AKAP9</TD></TR>
<TR><TD>3.149e-02</TD><TD>-3.46</TD><TD>Heroin Metabolism Pathway</TD><TD>SMPDB pathways</TD><TD>SMP0000623</TD><TD>4</TD><TD>1</TD><TD>1382</TD><TD>11</TD>
<TD>BCHE</TD></TR>
<TR><TD>3.150e-02</TD><TD>-3.46</TD><TD>extrinsic component of organelle membrane</TD><TD>cellular component</TD><TD>GO:0031312</TD><TD>25</TD><TD>2</TD><TD>19868</TD><TD>222</TD>
<TD>RPH3A,EMC2</TD></TR>
<TR><TD>3.160e-02</TD><TD>-3.45</TD><TD>haematopoietic_and_lymphoid_tissue-spleen-lymphoid_neoplasm-marginal_zone_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-spleen-lymphoid_neoplasm-marginal_zone_lymphoma</TD><TD>323</TD><TD>8</TD><TD>16984</TD><TD>193</TD>
<TD>FAT4,LRRC3B,NAT2,ROBO2,PTPRD,PTPRZ1,EDIL3,PTPRK</TD></TR>
<TR><TD>3.162e-02</TD><TD>-3.45</TD><TD>O-linked glycosylation of mucins</TD><TD>REACTOME pathways</TD><TD>R-HSA-913709</TD><TD>67</TD><TD>3</TD><TD>10391</TD><TD>107</TD>
<TD>GALNT15,GCNT1,MUC7</TD></TR>
<TR><TD>3.166e-02</TD><TD>-3.45</TD><TD>MYH4 (myosin heavy chain 4)</TD><TD>protein interactions</TD><TD>4622</TD><TD>62</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>CNTN1,GAP43,WWOX</TD></TR>
<TR><TD>3.173e-02</TD><TD>-3.45</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-follicular_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-follicular_lymphoma</TD><TD>208</TD><TD>6</TD><TD>16984</TD><TD>193</TD>
<TD>ZNF521,FBN2,KIF6,CNTNAP2,AMELX,PCDH9</TD></TR>
<TR><TD>3.176e-02</TD><TD>-3.45</TD><TD>cell-cell signaling</TD><TD>biological process</TD><TD>GO:0007267</TD><TD>824</TD><TD>16</TD><TD>18905</TD><TD>220</TD>
<TD>UTRN,SEPTIN5,NTRK2,CHRM3,PTPRD,SYT1,FGF14,RPH3A,CXCL13,FGF20,ACVR1C,AKAP9,FGFR2,FGF5,RYR2,PRKCE</TD></TR>
<TR><TD>3.206e-02</TD><TD>-3.44</TD><TD>renal system development</TD><TD>biological process</TD><TD>GO:0072001</TD><TD>316</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,FGFR2,PBX1,EPHA4,IRX1,ROBO2,PECAM1,GCNT1</TD></TR>
<TR><TD>3.206e-02</TD><TD>-3.44</TD><TD>Protein_kinase_ATP_BS</TD><TD>interpro domains</TD><TD>IPR017441</TD><TD>378</TD><TD>9</TD><TD>18605</TD><TD>215</TD>
<TD>NTRK2,EPHA3,PRKCE,EPHA4,PSKH2,TGFBR2,ACVR1C,TEC,FGFR2</TD></TR>
<TR><TD>3.245e-02</TD><TD>-3.43</TD><TD>POGLUT1 (protein O-glucosyltransferase 1)</TD><TD>protein interactions</TD><TD>56983</TD><TD>108</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>PI15,UBR4,LGI1,PTPRK</TD></TR>
<TR><TD>3.248e-02</TD><TD>-3.43</TD><TD>PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1)</TD><TD>protein interactions</TD><TD>5295</TD><TD>394</TD><TD>9</TD><TD>20077</TD><TD>223</TD>
<TD>NTRK2,EPHA3,TEC,PTPRK,FGFR2,VAV3,EPHA4,TGFBR2,PECAM1</TD></TR>
<TR><TD>3.263e-02</TD><TD>-3.42</TD><TD>DLG1 (discs large MAGUK scaffold protein 1)</TD><TD>protein interactions</TD><TD>1739</TD><TD>214</TD><TD>6</TD><TD>20077</TD><TD>223</TD>
<TD>ARL14,DSCAM,PAX6,PHLPP1,CASK,EPHA4</TD></TR>
<TR><TD>3.269e-02</TD><TD>-3.42</TD><TD>regulation of anatomical structure size</TD><TD>biological process</TD><TD>GO:0090066</TD><TD>500</TD><TD>11</TD><TD>18905</TD><TD>220</TD>
<TD>PLEK,NRCAM,MAP2,EFNA5,EPS8,DSCAM,DEPTOR,VAV3,SLIT2,PRKCE,SHTN1</TD></TR>
<TR><TD>3.271e-02</TD><TD>-3.42</TD><TD>glycoaminoglycan-protein linkage region biosynthesis</TD><TD>BIOCYC pathways</TD><TD>META_PWY-6557</TD><TD>6</TD><TD>1</TD><TD>907</TD><TD>5</TD>
<TD>B3GAT2</TD></TR>
<TR><TD>3.271e-02</TD><TD>-3.42</TD><TD>glycoaminoglycan-protein linkage region biosynthesis</TD><TD>BIOCYC pathways</TD><TD>HUMAN_PWY-6557</TD><TD>6</TD><TD>1</TD><TD>907</TD><TD>5</TD>
<TD>B3GAT2</TD></TR>
<TR><TD>3.275e-02</TD><TD>-3.42</TD><TD>transmission of nerve impulse</TD><TD>biological process</TD><TD>GO:0019226</TD><TD>60</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>CNTNAP2,NTRK2,NRCAM</TD></TR>
<TR><TD>3.287e-02</TD><TD>-3.42</TD><TD>brain</TD><TD>COSMIC cancer mutations</TD><TD>brain</TD><TD>16260</TD><TD>190</TD><TD>16984</TD><TD>193</TD>
<TD>EPYC,INSM1,IGFL4,ADAMTS12,NAALADL2,LRIG3,NOBOX,BACH2,GPR83,DAAM1,UTRN,NRG1,SPAG9,CETN3,REG1B,GAP43,ARL14,B3GAT2,LMBRD1,SLC7A8,UBR4,PTPRK,CRTC3,FGF14,ADAM28,FGF20,LGI1,IL1RAPL2,THSD7B,PLEK,CYTL1,UCHL1,GHITM,IQGAP2,AFM,NOVA1,REXO2,PARP8,HNF4G,WRN,CNTNAP2,ASPN,PSKH2,KAZN,EPHA4,IRX1,MRPL13,FUT9,SLC25A46,SLC10A2,AKAP9,ZNF518B,SGCG,LHCGR,RYR2,CD96,PTPRZ1,RGS6,DEFB115,FZD6,FAT4,SERINC5,SHISA3,BANK1,ZFPM2,TGFBR2,SYT1,CD226,GMDS,DCDC2C,GCNT1,CNTN1,EFEMP1,PAQR3,FBN2,DAOA,LRRN2,ACVR1C,RUNX1T1,SPATA16,DNER,ACP6,UNC5C,VAV3,ZNF133,THSD7A,ROBO2,PRSS12,RASGEF1B,PHLPP1,TRPS1,PXDNL,IPO8,ZPLD1,FNIP2,SLC39A10,PI15,NOL4,FERD3L,SGCD,LMX1A,PTPRD,ZFAND5,NUP35,JMJD1C,SEMA3C,ACVR2A,PWWP2A,COQ2,NAT2,RGS5,NAV3,PCDH9,SPHKAP,FMNL2,MPEG1,CDH5,SLC7A14,CASK,FGD3,SERGEF,FGFR2,ZNF521,FANCB,EPS8,SEZ6L,STXBP6,NTRK2,DNAJC12,FABP7,TSN,NCKAP5,SS18,ADAMTS3,FIGN,SPANXN1,NBEA,MRPL3,PRKCE,EFR3B,XPO4,CELF2,TMEFF2,MUC7,TWIST1,EFR3A,UHMK1,ARX,RBM20,CPXM2,PRLHR,TCF20,KIF6,EPHA3,EFNA5,PCGF5,DSCAM,CHRM3,OR52K2,ADAMTS5,FGF5,PBX1,MEGF10,MAP2,SLIT2,PAX6,NRCAM,ATG10,LRRC70,OR2AG1,RAI2,DEPTOR,PHF14,LRFN5,KLF12,AMELX,RPH3A,KCNK9,CTSO,WWOX,AGA,BCHE,SKAP2,COX7B2,CXCL13,AOAH,EDIL3,LRRC3B,CALN1,NRSN1</TD></TR>
<TR><TD>3.295e-02</TD><TD>-3.41</TD><TD>CYP7B1 (cytochrome P450 family 7 subfamily B member 1)</TD><TD>protein interactions</TD><TD>9420</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>GHITM</TD></TR>
<TR><TD>3.295e-02</TD><TD>-3.41</TD><TD>NRN1L (neuritin 1 like)</TD><TD>protein interactions</TD><TD>123904</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>SLC39A10</TD></TR>
<TR><TD>3.295e-02</TD><TD>-3.41</TD><TD>PRDM12 (PR/SET domain 12)</TD><TD>protein interactions</TD><TD>59335</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>RUNX1T1</TD></TR>
<TR><TD>3.295e-02</TD><TD>-3.41</TD><TD>LRRC74A (leucine rich repeat containing 74A)</TD><TD>protein interactions</TD><TD>145497</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>EPHA4</TD></TR>
<TR><TD>3.295e-02</TD><TD>-3.41</TD><TD>Cdk5 (cyclin-dependent kinase 5)</TD><TD>protein interactions</TD><TD>140908</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>SEPTIN5</TD></TR>
<TR><TD>3.295e-02</TD><TD>-3.41</TD><TD>Daxx (Fas death domain-associated protein)</TD><TD>protein interactions</TD><TD>13163</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>3.295e-02</TD><TD>-3.41</TD><TD>KLHL4 (kelch like family member 4)</TD><TD>protein interactions</TD><TD>56062</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>DSCAM</TD></TR>
<TR><TD>3.295e-02</TD><TD>-3.41</TD><TD>SSPN (sarcospan)</TD><TD>protein interactions</TD><TD>8082</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>SGCG</TD></TR>
<TR><TD>3.295e-02</TD><TD>-3.41</TD><TD>TPH2 (tryptophan hydroxylase 2)</TD><TD>protein interactions</TD><TD>121278</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>DNAJC12</TD></TR>
<TR><TD>3.295e-02</TD><TD>-3.41</TD><TD>Hsp90aa1 (heat shock protein 90 alpha family class A member 1)</TD><TD>protein interactions</TD><TD>299331</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>3.295e-02</TD><TD>-3.41</TD><TD>PRRT3 (proline rich transmembrane protein 3)</TD><TD>protein interactions</TD><TD>285368</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>PTPRD</TD></TR>
<TR><TD>3.295e-02</TD><TD>-3.41</TD><TD>LYSET (lysosomal enzyme trafficking factor)</TD><TD>protein interactions</TD><TD>26175</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>ATG10</TD></TR>
<TR><TD>3.295e-02</TD><TD>-3.41</TD><TD>IL34 (interleukin 34)</TD><TD>protein interactions</TD><TD>146433</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>PTPRZ1</TD></TR>
<TR><TD>3.295e-02</TD><TD>-3.41</TD><TD>FRMD7 (FERM domain containing 7)</TD><TD>protein interactions</TD><TD>90167</TD><TD>3</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>CASK</TD></TR>
<TR><TD>3.298e-02</TD><TD>-3.41</TD><TD>PTX3 (pentraxin 3)</TD><TD>protein interactions</TD><TD>5806</TD><TD>63</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>FGF20,FGF5,UBR4</TD></TR>
<TR><TD>3.298e-02</TD><TD>-3.41</TD><TD>PPP1R16B (protein phosphatase 1 regulatory subunit 16B)</TD><TD>protein interactions</TD><TD>26051</TD><TD>63</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>DSCAM,TGFBR2,PXDNL</TD></TR>
<TR><TD>3.298e-02</TD><TD>-3.41</TD><TD>BCHE (butyrylcholinesterase)</TD><TD>protein interactions</TD><TD>590</TD><TD>63</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>BCHE,PTPRK,SHTN1</TD></TR>
<TR><TD>3.298e-02</TD><TD>-3.41</TD><TD>GP5 (glycoprotein V platelet)</TD><TD>protein interactions</TD><TD>2814</TD><TD>63</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>ADGRL3,SLC39A10,GHITM</TD></TR>
<TR><TD>3.309e-02</TD><TD>-3.41</TD><TD>spindle</TD><TD>COSMIC cancer mutations</TD><TD>spindle</TD><TD>387</TD><TD>9</TD><TD>16984</TD><TD>193</TD>
<TD>PCDH9,SPAG9,SPATA16,SLC10A2,NRSN1,SLC7A14,CASK,FAT4,THSD7B</TD></TR>
<TR><TD>3.314e-02</TD><TD>-3.41</TD><TD>NuRD complex binding</TD><TD>molecular function</TD><TD>GO:0120325</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>PWWP2A</TD></TR>
<TR><TD>3.314e-02</TD><TD>-3.41</TD><TD>telomeric G-quadruplex DNA binding</TD><TD>molecular function</TD><TD>GO:0061849</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>WRN</TD></TR>
<TR><TD>3.314e-02</TD><TD>-3.41</TD><TD>polyprenyltransferase activity</TD><TD>molecular function</TD><TD>GO:0002094</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>COQ2</TD></TR>
<TR><TD>3.314e-02</TD><TD>-3.41</TD><TD>epidermal growth factor receptor activity</TD><TD>molecular function</TD><TD>GO:0005006</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>EFEMP1</TD></TR>
<TR><TD>3.314e-02</TD><TD>-3.41</TD><TD>beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity</TD><TD>molecular function</TD><TD>GO:0003829</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>GCNT1</TD></TR>
<TR><TD>3.314e-02</TD><TD>-3.41</TD><TD>diacylglycerol-dependent, calcium-independent serine/threonine kinase activity</TD><TD>molecular function</TD><TD>GO:0004699</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>PRKCE</TD></TR>
<TR><TD>3.314e-02</TD><TD>-3.41</TD><TD>arylamine N-acetyltransferase activity</TD><TD>molecular function</TD><TD>GO:0004060</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>NAT2</TD></TR>
<TR><TD>3.314e-02</TD><TD>-3.41</TD><TD>NADP+ binding</TD><TD>molecular function</TD><TD>GO:0070401</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>GMDS</TD></TR>
<TR><TD>3.314e-02</TD><TD>-3.41</TD><TD>galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity</TD><TD>molecular function</TD><TD>GO:0015018</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>B3GAT2</TD></TR>
<TR><TD>3.314e-02</TD><TD>-3.41</TD><TD>CCR10 chemokine receptor binding</TD><TD>molecular function</TD><TD>GO:0031735</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>CXCL13</TD></TR>
<TR><TD>3.314e-02</TD><TD>-3.41</TD><TD>8-hydroxy-2'-deoxyguanosine DNA binding</TD><TD>molecular function</TD><TD>GO:1905773</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>WRN</TD></TR>
<TR><TD>3.314e-02</TD><TD>-3.41</TD><TD>cholinesterase activity</TD><TD>molecular function</TD><TD>GO:0004104</TD><TD>3</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>BCHE</TD></TR>
<TR><TD>3.315e-02</TD><TD>-3.41</TD><TD>transforming growth factor beta ligand-receptor complex</TD><TD>cellular component</TD><TD>GO:0070021</TD><TD>3</TD><TD>1</TD><TD>19868</TD><TD>222</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>3.315e-02</TD><TD>-3.41</TD><TD>inhibin-betaglycan-ActRII complex</TD><TD>cellular component</TD><TD>GO:0034673</TD><TD>3</TD><TD>1</TD><TD>19868</TD><TD>222</TD>
<TD>ACVR2A</TD></TR>
<TR><TD>3.315e-02</TD><TD>-3.41</TD><TD>clathrin-sculpted acetylcholine transport vesicle</TD><TD>cellular component</TD><TD>GO:0060200</TD><TD>3</TD><TD>1</TD><TD>19868</TD><TD>222</TD>
<TD>SYT1</TD></TR>
<TR><TD>3.315e-02</TD><TD>-3.41</TD><TD>phagolysosome membrane</TD><TD>cellular component</TD><TD>GO:0061474</TD><TD>3</TD><TD>1</TD><TD>19868</TD><TD>222</TD>
<TD>MPEG1</TD></TR>
<TR><TD>3.315e-02</TD><TD>-3.41</TD><TD>dendritic filopodium</TD><TD>cellular component</TD><TD>GO:1902737</TD><TD>3</TD><TD>1</TD><TD>19868</TD><TD>222</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.315e-02</TD><TD>-3.41</TD><TD>clathrin-sculpted acetylcholine transport vesicle membrane</TD><TD>cellular component</TD><TD>GO:0060201</TD><TD>3</TD><TD>1</TD><TD>19868</TD><TD>222</TD>
<TD>SYT1</TD></TR>
<TR><TD>3.340e-02</TD><TD>-3.40</TD><TD>XPR1 (xenotropic and polytropic retrovirus receptor 1)</TD><TD>protein interactions</TD><TD>9213</TD><TD>109</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>FGFR2,UTRN,CD226,NTRK2</TD></TR>
<TR><TD>3.349e-02</TD><TD>-3.40</TD><TD>Extracellular matrix organization</TD><TD>REACTOME pathways</TD><TD>R-HSA-1474244</TD><TD>297</TD><TD>7</TD><TD>10391</TD><TD>107</TD>
<TD>FBN2,ADAMTS3,ASPN,EFEMP1,ADAMTS5,PECAM1,CASK</TD></TR>
<TR><TD>3.349e-02</TD><TD>-3.40</TD><TD>sulfur compound binding</TD><TD>molecular function</TD><TD>GO:1901681</TD><TD>272</TD><TD>7</TD><TD>18530</TD><TD>207</TD>
<TD>FGFR2,ADAMTS3,ADAMTS5,FGF20,RYR2,SLIT2,CXCL13</TD></TR>
<TR><TD>3.351e-02</TD><TD>-3.40</TD><TD>Fbxo21 (F-box protein 21)</TD><TD>protein interactions</TD><TD>231670</TD><TD>26</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>TCF20,PHF14</TD></TR>
<TR><TD>3.351e-02</TD><TD>-3.40</TD><TD>Csk (c-src tyrosine kinase)</TD><TD>protein interactions</TD><TD>12988</TD><TD>26</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>PCGF5,CELF2</TD></TR>
<TR><TD>3.351e-02</TD><TD>-3.40</TD><TD>CRTAC1 (cartilage acidic protein 1)</TD><TD>protein interactions</TD><TD>55118</TD><TD>26</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>EFEMP1,DSCAM</TD></TR>
<TR><TD>3.356e-02</TD><TD>-3.39</TD><TD>Tyr_Pase_cat</TD><TD>interpro domains</TD><TD>IPR003595</TD><TD>61</TD><TD>3</TD><TD>18605</TD><TD>215</TD>
<TD>PTPRD,PTPRK,PTPRZ1</TD></TR>
<TR><TD>3.357e-02</TD><TD>-3.39</TD><TD>CALM3 (calmodulin 3)</TD><TD>protein interactions</TD><TD>808</TD><TD>334</TD><TD>8</TD><TD>20077</TD><TD>223</TD>
<TD>AKAP9,CETN3,NTRK2,EPHA3,UBR4,CHRM3,FGFR2,EPHA4</TD></TR>
<TR><TD>3.371e-02</TD><TD>-3.39</TD><TD>salivary_gland-mouth_roof-carcinoma-mucoepidermoid_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>salivary_gland-mouth_roof-carcinoma-mucoepidermoid_carcinoma</TD><TD>3</TD><TD>1</TD><TD>16984</TD><TD>193</TD>
<TD>CRTC3</TD></TR>
<TR><TD>3.371e-02</TD><TD>-3.39</TD><TD>soft_tissue-nerve_sheath-malignant_peripheral_nerve_sheath_tumour-with_rhabdomyosarcomatous_differentiation</TD><TD>COSMIC cancer mutations</TD><TD>soft_tissue-nerve_sheath-malignant_peripheral_nerve_sheath_tumour-with_rhabdomyosarcomatous_differentiation</TD><TD>3</TD><TD>1</TD><TD>16984</TD><TD>193</TD>
<TD>SS18</TD></TR>
<TR><TD>3.371e-02</TD><TD>-3.39</TD><TD>salivary_gland-mouth_floor-carcinoma-mucoepidermoid_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>salivary_gland-mouth_floor-carcinoma-mucoepidermoid_carcinoma</TD><TD>3</TD><TD>1</TD><TD>16984</TD><TD>193</TD>
<TD>CRTC3</TD></TR>
<TR><TD>3.371e-02</TD><TD>-3.39</TD><TD>with_rhabdomyosarcomatous_differentiation</TD><TD>COSMIC cancer mutations</TD><TD>with_rhabdomyosarcomatous_differentiation</TD><TD>3</TD><TD>1</TD><TD>16984</TD><TD>193</TD>
<TD>SS18</TD></TR>
<TR><TD>3.383e-02</TD><TD>-3.39</TD><TD>regulation of protein modification process</TD><TD>biological process</TD><TD>GO:0031399</TD><TD>1247</TD><TD>22</TD><TD>18905</TD><TD>220</TD>
<TD>NTRK2,PAQR3,UCHL1,TGFBR2,ATG10,INSM1,DEPTOR,FGF20,CDH5,FGF5,ACVR2A,AKAP9,PAX6,PECAM1,FNIP2,SPAG9,EFNA5,NRG1,PRKCE,BANK1,SLIT2,EPHA4</TD></TR>
<TR><TD>3.386e-02</TD><TD>-3.39</TD><TD>Notch binding</TD><TD>molecular function</TD><TD>GO:0005112</TD><TD>26</TD><TD>2</TD><TD>18530</TD><TD>207</TD>
<TD>DNER,MEGF10</TD></TR>
<TR><TD>3.386e-02</TD><TD>-3.39</TD><TD>EPHD</TD><TD>prosite domains</TD><TD>PS51805</TD><TD>22</TD><TD>2</TD><TD>12232</TD><TD>162</TD>
<TD>PHF14,TCF20</TD></TR>
<TR><TD>3.393e-02</TD><TD>-3.38</TD><TD>response to prostaglandin E</TD><TD>biological process</TD><TD>GO:0034695</TD><TD>25</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>PRKCE,PAX6</TD></TR>
<TR><TD>3.393e-02</TD><TD>-3.38</TD><TD>negative regulation of chondrocyte differentiation</TD><TD>biological process</TD><TD>GO:0032331</TD><TD>25</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>EFEMP1,ADAMTS12</TD></TR>
<TR><TD>3.401e-02</TD><TD>-3.38</TD><TD>atypical</TD><TD>COSMIC cancer mutations</TD><TD>atypical</TD><TD>516</TD><TD>11</TD><TD>16984</TD><TD>193</TD>
<TD>CASK,EPHA3,TGFBR2,PRKCE,ACVR1C,UHMK1,EPHA4,ACVR2A,FGFR2,NTRK2,PSKH2</TD></TR>
<TR><TD>3.414e-02</TD><TD>-3.38</TD><TD>upper_back</TD><TD>COSMIC cancer mutations</TD><TD>upper_back</TD><TD>328</TD><TD>8</TD><TD>16984</TD><TD>193</TD>
<TD>MUC7,SPHKAP,CNTN1,PTPRD,CHRM3,FUT9,FAT4,FBN2</TD></TR>
<TR><TD>3.416e-02</TD><TD>-3.38</TD><TD>exocytic process</TD><TD>biological process</TD><TD>GO:0140029</TD><TD>61</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>SEPTIN5,RPH3A,PLEK</TD></TR>
<TR><TD>3.416e-02</TD><TD>-3.38</TD><TD>negative regulation of G protein-coupled receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0045744</TD><TD>61</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>CRTC3,PLEK,SLIT2</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>PUM-HD</TD><TD>interpro domains</TD><TD>IPR033133</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>PUM3</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>CBFA2T1/2/3</TD><TD>interpro domains</TD><TD>IPR013289</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RUNX1T1</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>GDSL</TD><TD>interpro domains</TD><TD>IPR001087</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>AOAH</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>TORC_N</TD><TD>interpro domains</TD><TD>IPR024783</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>CRTC3</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>Glyco_trans_43</TD><TD>interpro domains</TD><TD>IPR005027</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>B3GAT2</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>SS18_N</TD><TD>interpro domains</TD><TD>IPR007726</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>SS18</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>GPCR_2_latrophilin_rcpt_C</TD><TD>interpro domains</TD><TD>IPR003334</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>ADGRL3</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>Serum_albumin/AFP/Afamin</TD><TD>interpro domains</TD><TD>IPR021177</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>AFM</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>FBN_EGF_N</TD><TD>interpro domains</TD><TD>IPR049388</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>FBN2</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>UbiA_sf</TD><TD>interpro domains</TD><TD>IPR044878</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>COQ2</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>SLRP_I_decor/aspor/byglycan</TD><TD>interpro domains</TD><TD>IPR016352</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>ASPN</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>Peptidase_T2</TD><TD>interpro domains</TD><TD>IPR000246</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>AGA</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>NTRK_LRRCT</TD><TD>interpro domains</TD><TD>IPR031635</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NTRK2</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>BRINP</TD><TD>interpro domains</TD><TD>IPR033237</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>BRINP3</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>GPCR_2_latrophilin</TD><TD>interpro domains</TD><TD>IPR003924</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>ADGRL3</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>SPRY3_RyR</TD><TD>interpro domains</TD><TD>IPR035762</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>PH_Vav</TD><TD>interpro domains</TD><TD>IPR037832</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>VAV3</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>Neurobeachin_a-sol</TD><TD>interpro domains</TD><TD>IPR046852</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NBEA</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>MARCHF4/9/11</TD><TD>interpro domains</TD><TD>IPR046356</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MARCHF11</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>Mimecan/Epiphycan/Opticin</TD><TD>interpro domains</TD><TD>IPR043547</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>EPYC</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>XPO4/7-like</TD><TD>interpro domains</TD><TD>IPR044189</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>XPO4</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>Ryan_recept</TD><TD>interpro domains</TD><TD>IPR013333</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>Neuregulin</TD><TD>interpro domains</TD><TD>IPR040180</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NRG1</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>NTRK</TD><TD>interpro domains</TD><TD>IPR020777</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NTRK2</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>Rabphilin_Doc2_C2A</TD><TD>interpro domains</TD><TD>IPR047022</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RPH3A</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>Ribosomal_uL3_CS</TD><TD>interpro domains</TD><TD>IPR019926</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MRPL3</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>IL-40-like_Ig</TD><TD>interpro domains</TD><TD>IPR040878</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>PECAM1</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>AKAP_110_C</TD><TD>interpro domains</TD><TD>IPR018292</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>SPHKAP</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>MAP2/MAP4/Tau</TD><TD>interpro domains</TD><TD>IPR027324</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>TORC_M</TD><TD>interpro domains</TD><TD>IPR024784</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>CRTC3</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>RasGAP_C</TD><TD>interpro domains</TD><TD>IPR000593</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>IQGAP2</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>L_AA_transporter</TD><TD>interpro domains</TD><TD>IPR004760</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>SLC7A8</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>Ryanrecept_TM4-6</TD><TD>interpro domains</TD><TD>IPR009460</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>Ribosomal_uL3</TD><TD>interpro domains</TD><TD>IPR000597</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MRPL3</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>MAP_tubulin-bd_rpt</TD><TD>interpro domains</TD><TD>IPR001084</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>HRDC_dom_sf</TD><TD>interpro domains</TD><TD>IPR044876</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>WRN</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>UbiA_prenyltransferase</TD><TD>interpro domains</TD><TD>IPR000537</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>COQ2</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>FMNL_animal</TD><TD>interpro domains</TD><TD>IPR043592</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>FMNL2</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>Ryanodine_rcpt</TD><TD>interpro domains</TD><TD>IPR003032</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>HRDC_dom</TD><TD>interpro domains</TD><TD>IPR002121</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>WRN</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>TORC</TD><TD>interpro domains</TD><TD>IPR024786</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>CRTC3</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>SPRY1_RyR</TD><TD>interpro domains</TD><TD>IPR035761</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>SMIM5/18/22</TD><TD>interpro domains</TD><TD>IPR031671</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>SMIM18</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>XPO2_central</TD><TD>interpro domains</TD><TD>IPR013713</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>IPO8</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>TORC_C</TD><TD>interpro domains</TD><TD>IPR024785</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>CRTC3</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>RYDR_Jsol</TD><TD>interpro domains</TD><TD>IPR048581</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>Nav/unc-53</TD><TD>interpro domains</TD><TD>IPR039041</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NAV3</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>CDC4_N-term_subdom</TD><TD>interpro domains</TD><TD>IPR003338</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>AFG2A</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>SPRY2_RyR</TD><TD>interpro domains</TD><TD>IPR035764</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>NHR2</TD><TD>interpro domains</TD><TD>IPR014896</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RUNX1T1</TD></TR>
<TR><TD>3.427e-02</TD><TD>-3.37</TD><TD>Fibrillin_U_N</TD><TD>interpro domains</TD><TD>IPR040872</TD><TD>3</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>FBN2</TD></TR>
<TR><TD>3.433e-02</TD><TD>-3.37</TD><TD>neural precursor cell proliferation</TD><TD>biological process</TD><TD>GO:0061351</TD><TD>105</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6,FGFR2,FZD6,ARX</TD></TR>
<TR><TD>3.433e-02</TD><TD>-3.37</TD><TD>gland morphogenesis</TD><TD>biological process</TD><TD>GO:0022612</TD><TD>105</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,PAX6,TGFBR2,SEMA3C</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>UbiA</TD><TD>pfam domains</TD><TD>PF01040</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>COQ2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>HRDC</TD><TD>pfam domains</TD><TD>PF00570</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>WRN</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>NHR2</TD><TD>pfam domains</TD><TD>PF08788</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>RUNX1T1</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>Ig_C17orf99</TD><TD>pfam domains</TD><TD>PF17736</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>PECAM1</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>TORC_N</TD><TD>pfam domains</TD><TD>PF12884</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>CRTC3</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>LRRCT_2</TD><TD>pfam domains</TD><TD>PF16920</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>NTRK2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>RasGAP_C</TD><TD>pfam domains</TD><TD>PF03836</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>IQGAP2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>BRINP</TD><TD>pfam domains</TD><TD>PF19052</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>BRINP3</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>Neurensin</TD><TD>pfam domains</TD><TD>PF14927</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>NRSN1</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>Neurobeachin</TD><TD>pfam domains</TD><TD>PF20425</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>NBEA</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>SMIM5_18_22</TD><TD>pfam domains</TD><TD>PF15831</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>SMIM18</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>Ribosomal_L3</TD><TD>pfam domains</TD><TD>PF00297</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>MRPL3</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>Lipase_GDSL</TD><TD>pfam domains</TD><TD>PF00657</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>AOAH</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>Cse1</TD><TD>pfam domains</TD><TD>PF08506</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>IPO8</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>Tubulin-binding</TD><TD>pfam domains</TD><TD>PF00418</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>Glyco_transf_43</TD><TD>pfam domains</TD><TD>PF03360</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>B3GAT2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>FBN_EGF_st1</TD><TD>pfam domains</TD><TD>PF21364</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>FBN2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>Asparaginase_2</TD><TD>pfam domains</TD><TD>PF01112</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>AGA</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>TORC_M</TD><TD>pfam domains</TD><TD>PF12885</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>CRTC3</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>Fibrillin_U_N</TD><TD>pfam domains</TD><TD>PF18193</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>FBN2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>RYDR_Jsol</TD><TD>pfam domains</TD><TD>PF21119</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>AKAP_110</TD><TD>pfam domains</TD><TD>PF05716</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>SPHKAP</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>Latrophilin</TD><TD>pfam domains</TD><TD>PF02354</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>ADGRL3</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>TORC_C</TD><TD>pfam domains</TD><TD>PF12886</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>CRTC3</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>RyR</TD><TD>pfam domains</TD><TD>PF02026</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>SSXT</TD><TD>pfam domains</TD><TD>PF05030</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>SS18</TD></TR>
<TR><TD>3.435e-02</TD><TD>-3.37</TD><TD>RR_TM4-6</TD><TD>pfam domains</TD><TD>PF06459</TD><TD>3</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.437e-02</TD><TD>-3.37</TD><TD>UBIAD1 (UbiA prenyltransferase domain containing 1)</TD><TD>protein interactions</TD><TD>29914</TD><TD>110</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>SYT1,NTRK2,TMEFF2,SLC7A14</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>positive regulation of ATPase-coupled calcium transmembrane transporter activity</TD><TD>biological process</TD><TD>GO:1901896</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>trans-synaptic signaling by BDNF, modulating synaptic transmission</TD><TD>biological process</TD><TD>GO:0099183</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>NTRK2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>trophectodermal cell proliferation</TD><TD>biological process</TD><TD>GO:0001834</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>ACVR1C</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>TRAM-dependent toll-like receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0035668</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PRKCE</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>regulation of SA node cell action potential</TD><TD>biological process</TD><TD>GO:0098907</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>positive regulation of anterograde dense core granule transport</TD><TD>biological process</TD><TD>GO:1901953</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>export from the mitochondrion</TD><TD>biological process</TD><TD>GO:0170037</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>GHITM</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>mitotic actomyosin contractile ring assembly actin filament organization</TD><TD>biological process</TD><TD>GO:1903479</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>IQGAP2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>establishment of body hair or bristle planar orientation</TD><TD>biological process</TD><TD>GO:0048104</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FZD6</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>habenula development</TD><TD>biological process</TD><TD>GO:0021986</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>regulation of anterograde dense core granule transport</TD><TD>biological process</TD><TD>GO:1901951</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>positive regulation of synaptic vesicle exocytosis</TD><TD>biological process</TD><TD>GO:2000302</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SYT1</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>assembly of actomyosin apparatus involved in mitotic cytokinesis</TD><TD>biological process</TD><TD>GO:1902407</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>IQGAP2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>L-leucine import across plasma membrane</TD><TD>biological process</TD><TD>GO:1903801</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SLC7A8</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>germ cell proliferation</TD><TD>biological process</TD><TD>GO:0036093</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>UCHL1</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>insulin receptor internalization</TD><TD>biological process</TD><TD>GO:0038016</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>LMBRD1</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>regulation of dense core granule transport</TD><TD>biological process</TD><TD>GO:1904809</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration</TD><TD>biological process</TD><TD>GO:0021834</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>regulation of serine C-palmitoyltransferase activity</TD><TD>biological process</TD><TD>GO:1904220</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SERINC5</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>acetylcholine catabolic process</TD><TD>biological process</TD><TD>GO:0006581</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>BCHE</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>type B pancreatic cell apoptotic process</TD><TD>biological process</TD><TD>GO:0097050</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>calcium export from the mitochondrion</TD><TD>biological process</TD><TD>GO:0099093</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>GHITM</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>negative regulation of female gonad development</TD><TD>biological process</TD><TD>GO:2000195</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>ZFPM2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>GDP-L-fucose biosynthetic process</TD><TD>biological process</TD><TD>GO:0042350</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>GMDS</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>epithalamus development</TD><TD>biological process</TD><TD>GO:0021538</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>male germ cell proliferation</TD><TD>biological process</TD><TD>GO:0002176</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>UCHL1</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>positive regulation of dopaminergic neuron differentiation</TD><TD>biological process</TD><TD>GO:1904340</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FGF20</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>mitotic actomyosin contractile ring assembly</TD><TD>biological process</TD><TD>GO:1903475</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>IQGAP2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>right ventricular cardiac muscle tissue morphogenesis</TD><TD>biological process</TD><TD>GO:0003221</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>ZFPM2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>regulation of protein localization to cell-cell junction</TD><TD>biological process</TD><TD>GO:0150106</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PECAM1</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis</TD><TD>biological process</TD><TD>GO:1905312</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>axon target recognition</TD><TD>biological process</TD><TD>GO:0007412</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>UCHL1</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>cytoplasmic actin-based contraction involved in cell motility</TD><TD>biological process</TD><TD>GO:0060327</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SHTN1</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>cell adhesion molecule production</TD><TD>biological process</TD><TD>GO:0060352</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>GCNT1</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>establishment of body hair planar orientation</TD><TD>biological process</TD><TD>GO:0048105</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FZD6</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>growth plate cartilage chondrocyte growth</TD><TD>biological process</TD><TD>GO:0003430</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>ventricular zone neuroblast division</TD><TD>biological process</TD><TD>GO:0021847</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>midbrain morphogenesis</TD><TD>biological process</TD><TD>GO:1904693</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FZD6</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>positive regulation of cell fate specification</TD><TD>biological process</TD><TD>GO:0042660</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>positive regulation of dense core granule transport</TD><TD>biological process</TD><TD>GO:1904811</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>cell proliferation involved in heart morphogenesis</TD><TD>biological process</TD><TD>GO:0061323</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>miRNA transport</TD><TD>biological process</TD><TD>GO:1990428</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>rhombomere morphogenesis</TD><TD>biological process</TD><TD>GO:0021593</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>orbitofrontal cortex development</TD><TD>biological process</TD><TD>GO:0021769</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>olfactory bulb mitral cell layer development</TD><TD>biological process</TD><TD>GO:0061034</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>prostate epithelial cord elongation</TD><TD>biological process</TD><TD>GO:0060523</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>TRAM-dependent toll-like receptor 4 signaling pathway</TD><TD>biological process</TD><TD>GO:0035669</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PRKCE</TD></TR>
<TR><TD>3.451e-02</TD><TD>-3.37</TD><TD>mammary gland bud morphogenesis</TD><TD>biological process</TD><TD>GO:0060648</TD><TD>3</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2</TD></TR>
<TR><TD>3.452e-02</TD><TD>-3.37</TD><TD>Amino acid/polyamine transporter I</TD><TD>gene3d domains</TD><TD>1.20.1740.10</TD><TD>24</TD><TD>2</TD><TD>14531</TD><TD>178</TD>
<TD>SLC7A8,SLC7A14</TD></TR>
<TR><TD>3.452e-02</TD><TD>-3.37</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.50.30.30</TD><TD>24</TD><TD>2</TD><TD>14531</TD><TD>178</TD>
<TD>NAALADL2,CPQ</TD></TR>
<TR><TD>3.462e-02</TD><TD>-3.36</TD><TD>upper_arm</TD><TD>COSMIC cancer mutations</TD><TD>upper_arm</TD><TD>583</TD><TD>12</TD><TD>16984</TD><TD>193</TD>
<TD>AOAH,FGFR2,ROBO2,FIGN,SLC10A2,PBX1,ADAMTS3,PWWP2A,FUT9,SPHKAP,PTPRD,ADAM28</TD></TR>
<TR><TD>3.492e-02</TD><TD>-3.35</TD><TD>lung-carcinoma-acinar_adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>lung-carcinoma-acinar_adenocarcinoma</TD><TD>26</TD><TD>2</TD><TD>16984</TD><TD>193</TD>
<TD>LRIG3,FGFR2</TD></TR>
<TR><TD>3.501e-02</TD><TD>-3.35</TD><TD>skin-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-malignant_melanoma</TD><TD>15793</TD><TD>186</TD><TD>16984</TD><TD>193</TD>
<TD>CD226,GMDS,SYT1,ERCC6L2,TGFBR2,ZFPM2,BANK1,SHISA3,SERINC5,FAT4,FZD6,DEFB115,RGS6,PTPRZ1,CD96,RYR2,LHCGR,SGCG,PHLPP1,RASGEF1B,PRSS12,ROBO2,THSD7A,ZNF133,VAV3,UNC5C,ACP6,DNER,SPATA16,RUNX1T1,ACVR1C,LRRN2,DAOA,FBN2,PAQR3,EFEMP1,CNTN1,GCNT1,GAP43,REG1B,CETN3,SPAG9,NRG1,DAAM1,UTRN,GPR83,BACH2,NOBOX,LRIG3,NAALADL2,ADAMTS12,IGFL4,INSM1,EPYC,ZNF518B,AKAP9,SLC10A2,SLC25A46,FUT9,MRPL13,IRX1,EPHA4,KAZN,PSKH2,ASPN,CNTNAP2,WRN,HNF4G,PARP8,NOVA1,AFM,GHITM,IQGAP2,UCHL1,CYTL1,PLEK,IL1RAPL2,THSD7B,LGI1,FGF20,ADAM28,FGF14,CRTC3,PTPRK,UBR4,SLC7A8,LMBRD1,ARL14,B3GAT2,PBX1,FGF5,ADAMTS5,OR52K2,CHRM3,DSCAM,PCGF5,EFNA5,EPHA3,KIF6,TCF20,PRLHR,CPXM2,RBM20,UHMK1,ARX,EFR3A,TWIST1,MUC7,TMEFF2,CELF2,XPO4,PRKCE,MRPL3,NRSN1,CALN1,LRRC3B,AOAH,EDIL3,CXCL13,COX7B2,SKAP2,BCHE,AGA,CTSO,KCNK9,RPH3A,AMELX,KLF12,LRFN5,PHF14,DEPTOR,RAI2,OR2AG1,ATG10,NRCAM,PAX6,SLIT2,MAP2,MEGF10,PCDH9,NAV3,RGS5,NAT2,PWWP2A,COQ2,ACVR2A,SEMA3C,JMJD1C,ZFAND5,NUP35,PTPRD,LMX1A,SGCD,FERD3L,NOL4,PI15,SLC39A10,ZPLD1,FNIP2,IPO8,PXDNL,TRPS1,NBEA,FIGN,SPANXN1,ADAMTS3,SS18,NCKAP5,TSN,FABP7,DNAJC12,NTRK2,STXBP6,SEZ6L,EPS8,FANCB,ZNF521,FGFR2,SERGEF,FGD3,CASK,SLC7A14,CDH5,MPEG1,FMNL2,SPHKAP</TD></TR>
<TR><TD>3.510e-02</TD><TD>-3.35</TD><TD>regulation of G protein-coupled receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0008277</TD><TD>155</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,PLEK,RGS5,RGS6,CRTC3</TD></TR>
<TR><TD>3.526e-02</TD><TD>-3.34</TD><TD>response to alcohol</TD><TD>biological process</TD><TD>GO:0097305</TD><TD>264</TD><TD>7</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6,SLIT2,FGFR2,EFNA5,EPS8,PRKCE,TGFBR2</TD></TR>
<TR><TD>3.527e-02</TD><TD>-3.34</TD><TD>Maturity onset diabetes of the young</TD><TD>KEGG pathways</TD><TD>ko04950</TD><TD>26</TD><TD>2</TD><TD>7246</TD><TD>83</TD>
<TD>PAX6,HNF4G</TD></TR>
<TR><TD>3.527e-02</TD><TD>-3.34</TD><TD>Maturity onset diabetes of the young</TD><TD>KEGG pathways</TD><TD>hsa04950</TD><TD>26</TD><TD>2</TD><TD>7246</TD><TD>83</TD>
<TD>HNF4G,PAX6</TD></TR>
<TR><TD>3.528e-02</TD><TD>-3.34</TD><TD>eye development</TD><TD>biological process</TD><TD>GO:0001654</TD><TD>382</TD><TD>9</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2,PBX1,FBN2,PLAAT1,EFEMP1,NTRK2,DSCAM,PAX6,TWIST1</TD></TR>
<TR><TD>3.535e-02</TD><TD>-3.34</TD><TD>CTNNA3 (catenin alpha 3)</TD><TD>protein interactions</TD><TD>29119</TD><TD>111</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>EPS8,PAX6,AKAP9,FERD3L</TD></TR>
<TR><TD>3.535e-02</TD><TD>-3.34</TD><TD>DLG3 (discs large MAGUK scaffold protein 3)</TD><TD>protein interactions</TD><TD>1741</TD><TD>111</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>NBEA,CASK,AOAH,ARL14</TD></TR>
<TR><TD>3.536e-02</TD><TD>-3.34</TD><TD>cerebellum development</TD><TD>biological process</TD><TD>GO:0021549</TD><TD>106</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>SLC25A46,CNTN1,LMX1A,PAX6</TD></TR>
<TR><TD>3.560e-02</TD><TD>-3.34</TD><TD>VEGFR2 mediated vascular permeability</TD><TD>REACTOME pathways</TD><TD>R-HSA-5218920</TD><TD>29</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>VAV3,CDH5</TD></TR>
<TR><TD>3.560e-02</TD><TD>-3.34</TD><TD>Negative regulation of FGFR3 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654732</TD><TD>29</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>3.562e-02</TD><TD>-3.33</TD><TD>PHF21A (PHD finger protein 21A)</TD><TD>protein interactions</TD><TD>51317</TD><TD>338</TD><TD>8</TD><TD>20077</TD><TD>223</TD>
<TD>JMJD1C,UBR4,PAX6,TRPS1,WWOX,RBM20,UTRN,NOL4</TD></TR>
<TR><TD>3.573e-02</TD><TD>-3.33</TD><TD>marginal_zone_lymphoma</TD><TD>COSMIC cancer mutations</TD><TD>marginal_zone_lymphoma</TD><TD>331</TD><TD>8</TD><TD>16984</TD><TD>193</TD>
<TD>FAT4,LRRC3B,NAT2,ROBO2,PTPRD,PTPRZ1,EDIL3,PTPRK</TD></TR>
<TR><TD>3.580e-02</TD><TD>-3.33</TD><TD>RGSPROTEIN</TD><TD>prints domains</TD><TD>PR01301</TD><TD>22</TD><TD>2</TD><TD>5258</TD><TD>72</TD>
<TD>RGS5,RGS6</TD></TR>
<TR><TD>3.593e-02</TD><TD>-3.33</TD><TD>NPPB (natriuretic peptide B)</TD><TD>protein interactions</TD><TD>4879</TD><TD>27</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>FAT4,CASK</TD></TR>
<TR><TD>3.593e-02</TD><TD>-3.33</TD><TD>ZNF354C (zinc finger protein 354C)</TD><TD>protein interactions</TD><TD>30832</TD><TD>27</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>LINC00624,IPO8</TD></TR>
<TR><TD>3.595e-02</TD><TD>-3.33</TD><TD>metalloendopeptidase activity</TD><TD>molecular function</TD><TD>GO:0004222</TD><TD>111</TD><TD>4</TD><TD>18530</TD><TD>207</TD>
<TD>ADAMTS5,ADAMTS3,ADAMTS12,ADAM28</TD></TR>
<TR><TD>3.596e-02</TD><TD>-3.33</TD><TD>MCAM (melanoma cell adhesion molecule)</TD><TD>protein interactions</TD><TD>4162</TD><TD>466</TD><TD>10</TD><TD>20077</TD><TD>223</TD>
<TD>EFR3A,EPHA3,ARL14,PHLPP1,CASK,SLC39A10,PTPRK,UTRN,EFR3B,CNTN1</TD></TR>
<TR><TD>3.602e-02</TD><TD>-3.32</TD><TD>TIR_dom</TD><TD>interpro domains</TD><TD>IPR000157</TD><TD>26</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>IL1RAPL2,BANK1</TD></TR>
<TR><TD>3.630e-02</TD><TD>-3.32</TD><TD>ephrin receptor binding</TD><TD>molecular function</TD><TD>GO:0046875</TD><TD>27</TD><TD>2</TD><TD>18530</TD><TD>207</TD>
<TD>EFNA5,EPHA4</TD></TR>
<TR><TD>3.630e-02</TD><TD>-3.32</TD><TD>(Glycosyl)asparaginase</TD><TD>gene3d domains</TD><TD>3.60.20.30</TD><TD>3</TD><TD>1</TD><TD>14531</TD><TD>178</TD>
<TD>AGA</TD></TR>
<TR><TD>3.630e-02</TD><TD>-3.32</TD><TD>-</TD><TD>gene3d domains</TD><TD>2.30.30.1150</TD><TD>3</TD><TD>1</TD><TD>14531</TD><TD>178</TD>
<TD>PHF14</TD></TR>
<TR><TD>3.630e-02</TD><TD>-3.32</TD><TD>UbiA prenyltransferase</TD><TD>gene3d domains</TD><TD>1.10.357.140</TD><TD>3</TD><TD>1</TD><TD>14531</TD><TD>178</TD>
<TD>COQ2</TD></TR>
<TR><TD>3.630e-02</TD><TD>-3.32</TD><TD>-</TD><TD>gene3d domains</TD><TD>1.10.490.160</TD><TD>3</TD><TD>1</TD><TD>14531</TD><TD>178</TD>
<TD>RYR2</TD></TR>
<TR><TD>3.630e-02</TD><TD>-3.32</TD><TD>HRDC domain</TD><TD>gene3d domains</TD><TD>1.10.150.80</TD><TD>3</TD><TD>1</TD><TD>14531</TD><TD>178</TD>
<TD>WRN</TD></TR>
<TR><TD>3.632e-02</TD><TD>-3.32</TD><TD>dendrite cytoplasm</TD><TD>cellular component</TD><TD>GO:0032839</TD><TD>27</TD><TD>2</TD><TD>19868</TD><TD>222</TD>
<TD>MAP2,UHMK1</TD></TR>
<TR><TD>3.632e-02</TD><TD>-3.32</TD><TD>axonal growth cone</TD><TD>cellular component</TD><TD>GO:0044295</TD><TD>27</TD><TD>2</TD><TD>19868</TD><TD>222</TD>
<TD>EPHA4,SHTN1</TD></TR>
<TR><TD>3.636e-02</TD><TD>-3.31</TD><TD>PTPRU (protein tyrosine phosphatase receptor type U)</TD><TD>protein interactions</TD><TD>10076</TD><TD>112</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>PI15,PTPRK,NRSN1,CDH5</TD></TR>
<TR><TD>3.643e-02</TD><TD>-3.31</TD><TD>DLG4 (discs large MAGUK scaffold protein 4)</TD><TD>protein interactions</TD><TD>1742</TD><TD>164</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>NRG1,CNTNAP2,LGI1,CASK,DSCAM</TD></TR>
<TR><TD>3.644e-02</TD><TD>-3.31</TD><TD>human chr14q12</TD><TD>chromosome location</TD><TD>human chr14q12</TD><TD>143</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>STXBP6,NOVA1</TD></TR>
<TR><TD>3.648e-02</TD><TD>-3.31</TD><TD>embryonic camera-type eye morphogenesis</TD><TD>biological process</TD><TD>GO:0048596</TD><TD>26</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6,TWIST1</TD></TR>
<TR><TD>3.648e-02</TD><TD>-3.31</TD><TD>positive regulation of mesenchymal cell proliferation</TD><TD>biological process</TD><TD>GO:0002053</TD><TD>26</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,TGFBR2</TD></TR>
<TR><TD>3.648e-02</TD><TD>-3.31</TD><TD>atrioventricular valve morphogenesis</TD><TD>biological process</TD><TD>GO:0003181</TD><TD>26</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>TWIST1,TGFBR2</TD></TR>
<TR><TD>3.648e-02</TD><TD>-3.31</TD><TD>motor neuron axon guidance</TD><TD>biological process</TD><TD>GO:0008045</TD><TD>26</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>EPHA4,SLIT2</TD></TR>
<TR><TD>3.648e-02</TD><TD>-3.31</TD><TD>regulation of skeletal muscle tissue development</TD><TD>biological process</TD><TD>GO:0048641</TD><TD>26</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>TWIST1,MEGF10</TD></TR>
<TR><TD>3.648e-02</TD><TD>-3.31</TD><TD>regulation of establishment or maintenance of cell polarity</TD><TD>biological process</TD><TD>GO:0032878</TD><TD>26</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>SHTN1,CDH5</TD></TR>
<TR><TD>3.658e-02</TD><TD>-3.31</TD><TD>ERG (ETS transcription factor ERG)</TD><TD>protein interactions</TD><TD>2078</TD><TD>220</TD><TD>6</TD><TD>20077</TD><TD>223</TD>
<TD>PTPRD,TRPS1,ZNF521,SS18,UBR4,TCF20</TD></TR>
<TR><TD>3.678e-02</TD><TD>-3.30</TD><TD>neural tube development</TD><TD>biological process</TD><TD>GO:0021915</TD><TD>157</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>FZD6,PAX6,TWIST1,FERD3L,SEMA3C</TD></TR>
<TR><TD>3.682e-02</TD><TD>-3.30</TD><TD>positive regulation of protein phosphorylation</TD><TD>biological process</TD><TD>GO:0001934</TD><TD>574</TD><TD>12</TD><TD>18905</TD><TD>220</TD>
<TD>AKAP9,EPHA4,FGF5,ACVR2A,BANK1,TGFBR2,NRG1,FNIP2,PECAM1,EFNA5,FGF20,NTRK2</TD></TR>
<TR><TD>3.685e-02</TD><TD>-3.30</TD><TD>cell junction</TD><TD>cellular component</TD><TD>GO:0030054</TD><TD>2227</TD><TD>34</TD><TD>19868</TD><TD>222</TD>
<TD>FGFR2,PTPRK,PCDH9,PTPRZ1,EPHA4,AKAP9,CNTN1,CNTNAP2,CASK,LGI1,CHRM3,GAP43,LRFN5,NRCAM,RPH3A,PECAM1,PRKCE,EFNA5,NTRK2,SYT1,ADGRL3,PRSS12,KCNK9,REXO2,PTPRD,CDH5,SEPTIN5,DSCAM,EPS8,IL1RAPL2,UTRN,KAZN,STXBP6,UNC5C</TD></TR>
<TR><TD>3.707e-02</TD><TD>-3.30</TD><TD>synaptic vesicle exocytosis</TD><TD>biological process</TD><TD>GO:0016079</TD><TD>63</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>RPH3A,SEPTIN5,SYT1</TD></TR>
<TR><TD>3.711e-02</TD><TD>-3.29</TD><TD>CLSTN3 (calsyntenin 3)</TD><TD>protein interactions</TD><TD>9746</TD><TD>66</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>B3GAT2,ADAMTS12,NRSN1</TD></TR>
<TR><TD>3.727e-02</TD><TD>-3.29</TD><TD>SCGB2A2 (secretoglobin family 2A member 2)</TD><TD>protein interactions</TD><TD>4250</TD><TD>221</TD><TD>6</TD><TD>20077</TD><TD>223</TD>
<TD>GCNT1,BRINP3,SLIT2,PRSS12,SEMA3C,BCHE</TD></TR>
<TR><TD>3.731e-02</TD><TD>-3.29</TD><TD>visual system development</TD><TD>biological process</TD><TD>GO:0150063</TD><TD>386</TD><TD>9</TD><TD>18905</TD><TD>220</TD>
<TD>PBX1,FBN2,TGFBR2,TWIST1,PAX6,NTRK2,DSCAM,PLAAT1,EFEMP1</TD></TR>
<TR><TD>3.737e-02</TD><TD>-3.29</TD><TD>CEP170P1 (centrosomal protein 170 pseudogene 1)</TD><TD>protein interactions</TD><TD>645455</TD><TD>113</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>TRPS1,RUNX1T1,AKAP9,PHF14</TD></TR>
<TR><TD>3.744e-02</TD><TD>-3.29</TD><TD>acinar_adenocarcinoma</TD><TD>COSMIC cancer mutations</TD><TD>acinar_adenocarcinoma</TD><TD>27</TD><TD>2</TD><TD>16984</TD><TD>193</TD>
<TD>LRIG3,FGFR2</TD></TR>
<TR><TD>3.754e-02</TD><TD>-3.28</TD><TD>ovary-carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>ovary-carcinoma</TD><TD>934</TD><TD>17</TD><TD>16984</TD><TD>193</TD>
<TD>UHMK1,FAT4,ACVR1C,PSKH2,FGFR2,NTRK2,ZNF521,ACVR2A,EPHA4,EDIL3,SYT1,CASK,LHCGR,PAX6,TGFBR2,PRKCE,EPHA3</TD></TR>
<TR><TD>3.776e-02</TD><TD>-3.28</TD><TD>vertebrae</TD><TD>COSMIC cancer mutations</TD><TD>vertebrae</TD><TD>65</TD><TD>3</TD><TD>16984</TD><TD>193</TD>
<TD>FBN2,THSD7B,ADAMTS5</TD></TR>
<TR><TD>3.781e-02</TD><TD>-3.28</TD><TD>O-glycan biosynthesis, mucin type core</TD><TD>KEGG pathways</TD><TD>M00056</TD><TD>27</TD><TD>2</TD><TD>7246</TD><TD>83</TD>
<TD>GCNT1,GALNT15</TD></TR>
<TR><TD>3.781e-02</TD><TD>-3.28</TD><TD>O-glycan biosynthesis, mucin type core</TD><TD>KEGG pathways</TD><TD>hsa_M00056</TD><TD>27</TD><TD>2</TD><TD>7246</TD><TD>83</TD>
<TD>GCNT1,GALNT15</TD></TR>
<TR><TD>3.795e-02</TD><TD>-3.27</TD><TD>Protein-protein interactions at synapses</TD><TD>REACTOME pathways</TD><TD>R-HSA-6794362</TD><TD>72</TD><TD>3</TD><TD>10391</TD><TD>107</TD>
<TD>SYT1,PTPRD,CASK</TD></TR>
<TR><TD>3.823e-02</TD><TD>-3.26</TD><TD>SPPL3 (signal peptide peptidase like 3)</TD><TD>protein interactions</TD><TD>121665</TD><TD>884</TD><TD>16</TD><TD>20077</TD><TD>223</TD>
<TD>RASGEF1B,IL1RAPL2,ADAM28,ADGRL3,SPAG9,LRRC3B,PXDNL,UHMK1,EDIL3,KIF6,SLC7A14,EPHA3,BCHE,PRLHR,RBM20,NBEA</TD></TR>
<TR><TD>3.830e-02</TD><TD>-3.26</TD><TD>human chr4p16.1</TD><TD>chromosome location</TD><TD>human chr4p16.1</TD><TD>147</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>MIR548I2,ZNF518B</TD></TR>
<TR><TD>3.841e-02</TD><TD>-3.26</TD><TD>ORF3b (ORF3b protein)</TD><TD>protein interactions</TD><TD>1489670</TD><TD>114</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>TGFBR2,NOVA1,NRG1,PCDH9</TD></TR>
<TR><TD>3.841e-02</TD><TD>-3.26</TD><TD>ACVR1 (activin A receptor type 1)</TD><TD>protein interactions</TD><TD>90</TD><TD>114</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>TGFBR2,PLEK,NRSN1,ACVR2A</TD></TR>
<TR><TD>3.842e-02</TD><TD>-3.26</TD><TD>B3GALNT2 (beta-1,3-N-acetylgalactosaminyltransferase 2)</TD><TD>protein interactions</TD><TD>148789</TD><TD>28</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>NRG1,KLF12</TD></TR>
<TR><TD>3.842e-02</TD><TD>-3.26</TD><TD>EGF (epidermal growth factor)</TD><TD>protein interactions</TD><TD>1950</TD><TD>28</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>FGF5,NRG1</TD></TR>
<TR><TD>3.842e-02</TD><TD>-3.26</TD><TD>KCNC3 (potassium voltage-gated channel subfamily C member 3)</TD><TD>protein interactions</TD><TD>3748</TD><TD>28</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>PAX6,PTPRD</TD></TR>
<TR><TD>3.842e-02</TD><TD>-3.26</TD><TD>IZUMO1 (izumo sperm-oocyte fusion 1)</TD><TD>protein interactions</TD><TD>284359</TD><TD>28</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>GHITM,PTPRD</TD></TR>
<TR><TD>3.848e-02</TD><TD>-3.26</TD><TD>ankle</TD><TD>COSMIC cancer mutations</TD><TD>ankle</TD><TD>398</TD><TD>9</TD><TD>16984</TD><TD>193</TD>
<TD>PTPRD,MAP2,GPR83,ADAMTS3,CNTNAP2,SPATA16,AKAP9,CHRM3,ADAM28</TD></TR>
<TR><TD>3.854e-02</TD><TD>-3.26</TD><TD>EFNA5 (ephrin A5)</TD><TD>protein interactions</TD><TD>1946</TD><TD>67</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>SLC10A2,EPHA4,EPHA3</TD></TR>
<TR><TD>3.854e-02</TD><TD>-3.26</TD><TD>ZNF696 (zinc finger protein 696)</TD><TD>protein interactions</TD><TD>79943</TD><TD>67</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>SHISA3,EFEMP1,IPO8</TD></TR>
<TR><TD>3.854e-02</TD><TD>-3.26</TD><TD>CRIPTO (cripto, EGF-CFC family member)</TD><TD>protein interactions</TD><TD>6997</TD><TD>67</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>ACVR1C,TGFBR2,ACVR2A</TD></TR>
<TR><TD>3.857e-02</TD><TD>-3.26</TD><TD>photoreceptor cell differentiation</TD><TD>biological process</TD><TD>GO:0046530</TD><TD>64</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6,NTRK2,DSCAM</TD></TR>
<TR><TD>3.857e-02</TD><TD>-3.26</TD><TD>glandular epithelial cell differentiation</TD><TD>biological process</TD><TD>GO:0002067</TD><TD>64</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,INSM1,PAX6</TD></TR>
<TR><TD>3.861e-02</TD><TD>-3.25</TD><TD>ADAM_Cys-rich</TD><TD>interpro domains</TD><TD>IPR006586</TD><TD>27</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>ADAM28,ADAMTS5</TD></TR>
<TR><TD>3.861e-02</TD><TD>-3.25</TD><TD>ATPase_AAA_CS</TD><TD>interpro domains</TD><TD>IPR003960</TD><TD>27</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>FIGN,AFG2A</TD></TR>
<TR><TD>3.861e-02</TD><TD>-3.25</TD><TD>Toll_tir_struct_dom_sf</TD><TD>interpro domains</TD><TD>IPR035897</TD><TD>27</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>IL1RAPL2,BANK1</TD></TR>
<TR><TD>3.881e-02</TD><TD>-3.25</TD><TD>extracellular matrix structural constituent</TD><TD>molecular function</TD><TD>GO:0005201</TD><TD>166</TD><TD>5</TD><TD>18530</TD><TD>207</TD>
<TD>ASPN,EDIL3,FBN2,EFEMP1,AMELX</TD></TR>
<TR><TD>3.887e-02</TD><TD>-3.25</TD><TD>C2DOMAIN</TD><TD>prints domains</TD><TD>PR00360</TD><TD>23</TD><TD>2</TD><TD>5258</TD><TD>72</TD>
<TD>RPH3A,SYT1</TD></TR>
<TR><TD>3.890e-02</TD><TD>-3.25</TD><TD>ATP13A1 (ATPase 13A1)</TD><TD>protein interactions</TD><TD>57130</TD><TD>167</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>SLC7A14,CD226,CDH5,EMC2,NUP35</TD></TR>
<TR><TD>3.892e-02</TD><TD>-3.25</TD><TD>glioma</TD><TD>COSMIC cancer mutations</TD><TD>glioma</TD><TD>16158</TD><TD>189</TD><TD>16984</TD><TD>193</TD>
<TD>SYT1,TGFBR2,ZFPM2,DCDC2C,GMDS,CD226,CD96,RYR2,LHCGR,SGCG,BANK1,SERINC5,FAT4,SHISA3,FZD6,DEFB115,PTPRZ1,RGS6,THSD7A,ZNF133,VAV3,UNC5C,ACP6,RASGEF1B,PHLPP1,PRSS12,ROBO2,DAOA,LRRN2,FBN2,EFEMP1,PAQR3,CNTN1,GCNT1,DNER,ACVR1C,RUNX1T1,SPATA16,CETN3,SPAG9,NRG1,UTRN,DAAM1,GPR83,GAP43,REG1B,NAALADL2,ADAMTS12,IGFL4,INSM1,EPYC,BACH2,NOBOX,LRIG3,CNTNAP2,ASPN,WRN,HNF4G,PARP8,NOVA1,REXO2,AKAP9,ZNF518B,SLC10A2,FUT9,SLC25A46,MRPL13,EPHA4,IRX1,KAZN,PSKH2,ADAM28,CRTC3,FGF14,PTPRK,SLC7A8,UBR4,LMBRD1,B3GAT2,ARL14,AFM,UCHL1,IQGAP2,GHITM,PLEK,CYTL1,IL1RAPL2,LGI1,THSD7B,FGF20,CHRM3,OR52K2,DSCAM,PCGF5,EFNA5,EPHA3,KIF6,PBX1,FGF5,ADAMTS5,PRKCE,MRPL3,TCF20,CPXM2,PRLHR,UHMK1,EFR3A,ARX,RBM20,MUC7,TWIST1,TMEFF2,CELF2,XPO4,BCHE,AGA,WWOX,CTSO,NRSN1,CALN1,LRRC3B,EDIL3,AOAH,COX7B2,CXCL13,SKAP2,RAI2,OR2AG1,LRRC70,ATG10,PAX6,NRCAM,SLIT2,MAP2,MEGF10,KCNK9,AMELX,RPH3A,KLF12,LRFN5,PHF14,DEPTOR,JMJD1C,ZFAND5,NUP35,PTPRD,PCDH9,NAT2,RGS5,NAV3,PWWP2A,COQ2,ACVR2A,SEMA3C,SLC39A10,PI15,FNIP2,ZPLD1,IPO8,PXDNL,TRPS1,LMX1A,SGCD,FERD3L,NOL4,SEZ6L,FANCB,EPS8,NBEA,SPANXN1,FIGN,SS18,ADAMTS3,FABP7,NCKAP5,TSN,NTRK2,DNAJC12,STXBP6,CASK,SLC7A14,FGD3,CDH5,MPEG1,SPHKAP,FMNL2,FGFR2,ZNF521,SERGEF</TD></TR>
<TR><TD>3.896e-02</TD><TD>-3.25</TD><TD>human chr8q24.23</TD><TD>chromosome location</TD><TD>human chr8q24.23</TD><TD>19</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>LINC02055</TD></TR>
<TR><TD>3.904e-02</TD><TD>-3.24</TD><TD>Integrins in angiogenesis</TD><TD>Pathway Interaction DB</TD><TD>avb3_integrin_pathway</TD><TD>46</TD><TD>3</TD><TD>2232</TD><TD>37</TD>
<TD>TGFBR2,EDIL3,VAV3</TD></TR>
<TR><TD>3.910e-02</TD><TD>-3.24</TD><TD>positive regulation of lipid catabolic process</TD><TD>biological process</TD><TD>GO:0050996</TD><TD>27</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>TWIST1,PRKCE</TD></TR>
<TR><TD>3.910e-02</TD><TD>-3.24</TD><TD>cytokine production</TD><TD>biological process</TD><TD>GO:0001816</TD><TD>27</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>ADAMTS3,CD226</TD></TR>
<TR><TD>3.910e-02</TD><TD>-3.24</TD><TD>regulation of dendrite extension</TD><TD>biological process</TD><TD>GO:1903859</TD><TD>27</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>SPAG9,SYT1</TD></TR>
<TR><TD>3.910e-02</TD><TD>-3.24</TD><TD>adrenal gland development</TD><TD>biological process</TD><TD>GO:0030325</TD><TD>27</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>PBX1,INSM1</TD></TR>
<TR><TD>3.910e-02</TD><TD>-3.24</TD><TD>mesenchymal cell proliferation</TD><TD>biological process</TD><TD>GO:0010463</TD><TD>27</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2,PHF14</TD></TR>
<TR><TD>3.921e-02</TD><TD>-3.24</TD><TD>PUM_HD</TD><TD>prosite domains</TD><TD>PS50303</TD><TD>3</TD><TD>1</TD><TD>12232</TD><TD>162</TD>
<TD>PUM3</TD></TR>
<TR><TD>3.921e-02</TD><TD>-3.24</TD><TD>HRDC</TD><TD>prosite domains</TD><TD>PS50967</TD><TD>3</TD><TD>1</TD><TD>12232</TD><TD>162</TD>
<TD>WRN</TD></TR>
<TR><TD>3.921e-02</TD><TD>-3.24</TD><TD>TAU_MAP_1</TD><TD>prosite domains</TD><TD>PS00229</TD><TD>3</TD><TD>1</TD><TD>12232</TD><TD>162</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.921e-02</TD><TD>-3.24</TD><TD>TAU_MAP_2</TD><TD>prosite domains</TD><TD>PS51491</TD><TD>3</TD><TD>1</TD><TD>12232</TD><TD>162</TD>
<TD>MAP2</TD></TR>
<TR><TD>3.921e-02</TD><TD>-3.24</TD><TD>PUM</TD><TD>prosite domains</TD><TD>PS50302</TD><TD>3</TD><TD>1</TD><TD>12232</TD><TD>162</TD>
<TD>PUM3</TD></TR>
<TR><TD>3.921e-02</TD><TD>-3.24</TD><TD>RIBOSOMAL_L3</TD><TD>prosite domains</TD><TD>PS00474</TD><TD>3</TD><TD>1</TD><TD>12232</TD><TD>162</TD>
<TD>MRPL3</TD></TR>
<TR><TD>3.922e-02</TD><TD>-3.24</TD><TD>Bile Acid Direct Signalling Pathway (1)</TD><TD>SMPDB pathways</TD><TD>SMP0086608</TD><TD>5</TD><TD>1</TD><TD>1382</TD><TD>11</TD>
<TD>SLC10A2</TD></TR>
<TR><TD>3.922e-02</TD><TD>-3.24</TD><TD>Ubiquinone Biosynthesis</TD><TD>SMPDB pathways</TD><TD>SMP0000065</TD><TD>5</TD><TD>1</TD><TD>1382</TD><TD>11</TD>
<TD>COQ2</TD></TR>
<TR><TD>3.930e-02</TD><TD>-3.24</TD><TD>kinase activity</TD><TD>molecular function</TD><TD>GO:0016301</TD><TD>742</TD><TD>14</TD><TD>18530</TD><TD>207</TD>
<TD>EFEMP1,PSKH2,MAST4,EPHA4,TGFBR2,NTRK2,FGFR2,CASK,TEC,ACVR1C,PRKCE,ACVR2A,UHMK1,EPHA3</TD></TR>
<TR><TD>3.946e-02</TD><TD>-3.23</TD><TD>YIPF6 (Yip1 domain family member 6)</TD><TD>protein interactions</TD><TD>286451</TD><TD>115</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>SLC7A14,EFNA5,SLC7A8,LRRC3B</TD></TR>
<TR><TD>3.947e-02</TD><TD>-3.23</TD><TD>Hypothesized Pathways in Pathogenesis of Cardiovascular Disease</TD><TD>WikiPathways</TD><TD>WP3668</TD><TD>25</TD><TD>2</TD><TD>5358</TD><TD>68</TD>
<TD>FBN2,TGFBR2</TD></TR>
<TR><TD>3.963e-02</TD><TD>-3.23</TD><TD>central_nervous_system-brainstem-glioma</TD><TD>COSMIC cancer mutations</TD><TD>central_nervous_system-brainstem-glioma</TD><TD>338</TD><TD>8</TD><TD>16984</TD><TD>193</TD>
<TD>IL1RAPL2,RPH3A,CNTNAP2,THSD7A,NAALADL2,PTPRD,GMDS,IGFL4</TD></TR>
<TR><TD>3.967e-02</TD><TD>-3.23</TD><TD>positive regulation of cell junction assembly</TD><TD>biological process</TD><TD>GO:1901890</TD><TD>110</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>EFNA5,NTRK2,CNTNAP2,PTPRD</TD></TR>
<TR><TD>3.994e-02</TD><TD>-3.22</TD><TD>Signaling by PDGF</TD><TD>REACTOME pathways</TD><TD>R-HSA-186797</TD><TD>376</TD><TD>8</TD><TD>10391</TD><TD>107</TD>
<TD>PAQR3,NRG1,FGFR2,PRKCE,FGF20,AKAP9,FGF5,PHLPP1</TD></TR>
<TR><TD>3.995e-02</TD><TD>-3.22</TD><TD>regulation of supramolecular fiber organization</TD><TD>biological process</TD><TD>GO:1902903</TD><TD>391</TD><TD>9</TD><TD>18905</TD><TD>220</TD>
<TD>PRKCE,CDH5,NAV3,AKAP9,SLIT2,EPS8,TMEFF2,MAP2,PLEK</TD></TR>
<TR><TD>4.000e-02</TD><TD>-3.22</TD><TD>C1QTNF7 (C1q and TNF related 7)</TD><TD>protein interactions</TD><TD>114905</TD><TD>68</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>SLIT2,BCHE,SEMA3C</TD></TR>
<TR><TD>4.001e-02</TD><TD>-3.22</TD><TD>Toll/interleukin-1 receptor homology (TIR) domain</TD><TD>gene3d domains</TD><TD>3.40.50.10140</TD><TD>26</TD><TD>2</TD><TD>14531</TD><TD>178</TD>
<TD>IL1RAPL2,BANK1</TD></TR>
<TR><TD>4.002e-02</TD><TD>-3.22</TD><TD>lip</TD><TD>COSMIC cancer mutations</TD><TD>lip</TD><TD>28</TD><TD>2</TD><TD>16984</TD><TD>193</TD>
<TD>FGFR2,CRTC3</TD></TR>
<TR><TD>4.004e-02</TD><TD>-3.22</TD><TD>craniopharyngeal_duct</TD><TD>COSMIC cancer mutations</TD><TD>craniopharyngeal_duct</TD><TD>401</TD><TD>9</TD><TD>16984</TD><TD>193</TD>
<TD>VAV3,CRTC3,UTRN,ADAM28,EPYC,PTPRZ1,PXDNL,UBR4,NRCAM</TD></TR>
<TR><TD>4.004e-02</TD><TD>-3.22</TD><TD>craniopharyngioma</TD><TD>COSMIC cancer mutations</TD><TD>craniopharyngioma</TD><TD>401</TD><TD>9</TD><TD>16984</TD><TD>193</TD>
<TD>NRCAM,UBR4,PXDNL,PTPRZ1,EPYC,ADAM28,VAV3,CRTC3,UTRN</TD></TR>
<TR><TD>4.010e-02</TD><TD>-3.22</TD><TD>positive regulation of synapse assembly</TD><TD>biological process</TD><TD>GO:0051965</TD><TD>65</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>PTPRD,NTRK2,EFNA5</TD></TR>
<TR><TD>4.010e-02</TD><TD>-3.22</TD><TD>KLF3 (KLF transcription factor 3)</TD><TD>protein interactions</TD><TD>51274</TD><TD>225</TD><TD>6</TD><TD>20077</TD><TD>223</TD>
<TD>JMJD1C,PCGF5,UCHL1,TRPS1,NOL4,SS18</TD></TR>
<TR><TD>4.024e-02</TD><TD>-3.21</TD><TD>Activated NOTCH1 Transmits Signal to the Nucleus</TD><TD>REACTOME pathways</TD><TD>R-HSA-2122948</TD><TD>31</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>CNTN1,DNER</TD></TR>
<TR><TD>4.024e-02</TD><TD>-3.21</TD><TD>Downstream signaling of activated FGFR1</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654687</TD><TD>31</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>4.024e-02</TD><TD>-3.21</TD><TD>FGFR1 mutant receptor activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-1839124</TD><TD>31</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>4.049e-02</TD><TD>-3.21</TD><TD>sensory system development</TD><TD>biological process</TD><TD>GO:0048880</TD><TD>392</TD><TD>9</TD><TD>18905</TD><TD>220</TD>
<TD>NTRK2,DSCAM,EFEMP1,PLAAT1,PAX6,TWIST1,TGFBR2,PBX1,FBN2</TD></TR>
<TR><TD>4.053e-02</TD><TD>-3.21</TD><TD>CDK2AP1 (cyclin dependent kinase 2 associated protein 1)</TD><TD>protein interactions</TD><TD>8099</TD><TD>116</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>TCF20,PHF14,PWWP2A,TRPS1</TD></TR>
<TR><TD>4.053e-02</TD><TD>-3.21</TD><TD>ETOFAMILY</TD><TD>prints domains</TD><TD>PR01875</TD><TD>3</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>RUNX1T1</TD></TR>
<TR><TD>4.053e-02</TD><TD>-3.21</TD><TD>NTKRECEPTOR</TD><TD>prints domains</TD><TD>PR01939</TD><TD>3</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>NTRK2</TD></TR>
<TR><TD>4.053e-02</TD><TD>-3.21</TD><TD>RYANODINER</TD><TD>prints domains</TD><TD>PR00795</TD><TD>3</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>RYR2</TD></TR>
<TR><TD>4.053e-02</TD><TD>-3.21</TD><TD>LATROPHILIN</TD><TD>prints domains</TD><TD>PR01444</TD><TD>3</TD><TD>1</TD><TD>5258</TD><TD>72</TD>
<TD>ADGRL3</TD></TR>
<TR><TD>4.056e-02</TD><TD>-3.20</TD><TD>Transcription from mitochondrial promoters</TD><TD>REACTOME pathways</TD><TD>R-HSA-75944</TD><TD>4</TD><TD>1</TD><TD>10391</TD><TD>107</TD>
<TD>MTERF1</TD></TR>
<TR><TD>4.060e-02</TD><TD>-3.20</TD><TD>presynaptic membrane</TD><TD>cellular component</TD><TD>GO:0042734</TD><TD>168</TD><TD>5</TD><TD>19868</TD><TD>222</TD>
<TD>PTPRD,SYT1,CASK,EPHA4,CNTN1</TD></TR>
<TR><TD>4.065e-02</TD><TD>-3.20</TD><TD>Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour</TD><TD>COSMIC cancer mutations</TD><TD>Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour</TD><TD>7438</TD><TD>97</TD><TD>16984</TD><TD>193</TD>
<TD>GAP43,NAV3,RGS5,COQ2,ACVR2A,JMJD1C,SPAG9,NRG1,UTRN,GPR83,PTPRD,LMX1A,FERD3L,BACH2,NOL4,NAALADL2,SLC39A10,ADAMTS12,ZPLD1,IPO8,PXDNL,TRPS1,EPYC,AKAP9,SS18,EPHA4,NCKAP5,NTRK2,PSKH2,SEZ6L,WRN,FANCB,HNF4G,PARP8,AFM,IQGAP2,THSD7B,FGF20,ZNF521,FGFR2,SERGEF,ADAM28,FGD3,CDH5,FGF14,MPEG1,UBR4,FMNL2,SPHKAP,LMBRD1,B3GAT2,FGF5,ADAMTS5,OR52K2,DSCAM,EPHA3,KIF6,ZFPM2,TCF20,BANK1,CPXM2,PRLHR,FAT4,RBM20,TMEFF2,CELF2,RGS6,PTPRZ1,RYR2,PRKCE,LHCGR,PHLPP1,RASGEF1B,AOAH,EDIL3,PRSS12,SKAP2,THSD7A,ZNF133,VAV3,BCHE,UNC5C,KCNK9,DNER,SPATA16,RUNX1T1,ACVR1C,KLF12,LRFN5,PHF14,RAI2,FBN2,OR2AG1,NRCAM,CNTN1,PAX6,MAP2</TD></TR>
<TR><TD>4.065e-02</TD><TD>-3.20</TD><TD>pancreas-carcinoma-acinar_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>pancreas-carcinoma-acinar_carcinoma</TD><TD>1983</TD><TD>31</TD><TD>16984</TD><TD>193</TD>
<TD>RUNX1T1,SPATA16,FERD3L,FAT4,SERINC5,EFR3A,FGFR2,XPO4,PTPRZ1,CD96,ZPLD1,CDH5,UBR4,FMNL2,ARL14,NBEA,NAV3,PHLPP1,FUT9,FGF5,ACVR2A,SEMA3C,THSD7A,DSCAM,CNTNAP2,UTRN,BCHE,ZFPM2,REXO2,PTPRD,NOVA1</TD></TR>
<TR><TD>4.065e-02</TD><TD>-3.20</TD><TD>acinar_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>acinar_carcinoma</TD><TD>1983</TD><TD>31</TD><TD>16984</TD><TD>193</TD>
<TD>CDH5,ZPLD1,CD96,ARL14,FMNL2,UBR4,FAT4,FERD3L,SERINC5,EFR3A,RUNX1T1,SPATA16,FGFR2,XPO4,PTPRZ1,UTRN,THSD7A,DSCAM,CNTNAP2,REXO2,NOVA1,PTPRD,BCHE,ZFPM2,PHLPP1,FUT9,FGF5,NBEA,NAV3,SEMA3C,ACVR2A</TD></TR>
<TR><TD>4.070e-02</TD><TD>-3.20</TD><TD>SOS-mediated signalling</TD><TD>REACTOME pathways</TD><TD>R-HSA-112412</TD><TD>245</TD><TD>6</TD><TD>10391</TD><TD>107</TD>
<TD>FGFR2,FGF20,AKAP9,FGF5,NRG1,PAQR3</TD></TR>
<TR><TD>4.070e-02</TD><TD>-3.20</TD><TD>SHC1 events in EGFR signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-180336</TD><TD>245</TD><TD>6</TD><TD>10391</TD><TD>107</TD>
<TD>FGF20,AKAP9,FGF5,FGFR2,NRG1,PAQR3</TD></TR>
<TR><TD>4.070e-02</TD><TD>-3.20</TD><TD>GRB2 events in EGFR signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-179812</TD><TD>245</TD><TD>6</TD><TD>10391</TD><TD>107</TD>
<TD>NRG1,PAQR3,FGF20,FGF5,AKAP9,FGFR2</TD></TR>
<TR><TD>4.070e-02</TD><TD>-3.20</TD><TD>RAF/MAP kinase cascade</TD><TD>REACTOME pathways</TD><TD>R-HSA-5673001</TD><TD>245</TD><TD>6</TD><TD>10391</TD><TD>107</TD>
<TD>FGFR2,AKAP9,FGF5,FGF20,PAQR3,NRG1</TD></TR>
<TR><TD>4.083e-02</TD><TD>-3.20</TD><TD>PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2)</TD><TD>protein interactions</TD><TD>5296</TD><TD>226</TD><TD>6</TD><TD>20077</TD><TD>223</TD>
<TD>NTRK2,EPHA3,TGFBR2,FGFR2,EPHA4,TEC</TD></TR>
<TR><TD>4.097e-02</TD><TD>-3.20</TD><TD>human chr5q14.2</TD><TD>chromosome location</TD><TD>human chr5q14.2</TD><TD>20</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>MIR3977</TD></TR>
<TR><TD>4.097e-02</TD><TD>-3.19</TD><TD>CAPN15 (calpain 15)</TD><TD>protein interactions</TD><TD>6650</TD><TD>29</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>NRSN1,CDH5</TD></TR>
<TR><TD>4.100e-02</TD><TD>-3.19</TD><TD>regulation of monoatomic ion transmembrane transporter activity</TD><TD>biological process</TD><TD>GO:0032412</TD><TD>216</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>CHRM3,AKAP9,FGF14,PRKCE,RYR2,UTRN</TD></TR>
<TR><TD>4.111e-02</TD><TD>-3.19</TD><TD>skin-chest-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-chest-malignant_melanoma</TD><TD>114</TD><TD>4</TD><TD>16984</TD><TD>193</TD>
<TD>CHRM3,ACVR2A,ADAMTS3,PTPRD</TD></TR>
<TR><TD>4.117e-02</TD><TD>-3.19</TD><TD>human chr1q41</TD><TD>chromosome location</TD><TD>human chr1q41</TD><TD>153</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LINC02817,LYPLAL1-AS1</TD></TR>
<TR><TD>4.118e-02</TD><TD>-3.19</TD><TD>skin-back-malignant_melanoma</TD><TD>COSMIC cancer mutations</TD><TD>skin-back-malignant_melanoma</TD><TD>280</TD><TD>7</TD><TD>16984</TD><TD>193</TD>
<TD>GHITM,CHRM3,ADAM28,ADAMTS3,LGI1,LRIG3,PTPRD</TD></TR>
<TR><TD>4.118e-02</TD><TD>-3.19</TD><TD>positive regulation of cell growth</TD><TD>biological process</TD><TD>GO:0030307</TD><TD>162</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>SYT1,DSCAM,LGI1,SHTN1,EFNA5</TD></TR>
<TR><TD>4.157e-02</TD><TD>-3.18</TD><TD>BCL6 (BCL6 transcription repressor)</TD><TD>protein interactions</TD><TD>604</TD><TD>227</TD><TD>6</TD><TD>20077</TD><TD>223</TD>
<TD>UCHL1,PRKCE,TWIST1,BACH2,RUNX1T1,PCDH9</TD></TR>
<TR><TD>4.161e-02</TD><TD>-3.18</TD><TD>PTGER3 (prostaglandin E receptor 3)</TD><TD>protein interactions</TD><TD>5733</TD><TD>117</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>IPO8,ACVR2A,LRIG3,XPO4</TD></TR>
<TR><TD>4.166e-02</TD><TD>-3.18</TD><TD>ERBB signaling pathway</TD><TD>biological process</TD><TD>GO:0038127</TD><TD>66</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>GAREM1,EFEMP1,NRG1</TD></TR>
<TR><TD>4.166e-02</TD><TD>-3.18</TD><TD>regulation of lipid catabolic process</TD><TD>biological process</TD><TD>GO:0050994</TD><TD>66</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>TWIST1,CRTC3,PRKCE</TD></TR>
<TR><TD>4.166e-02</TD><TD>-3.18</TD><TD>FGFR1 (fibroblast growth factor receptor 1)</TD><TD>protein interactions</TD><TD>2260</TD><TD>613</TD><TD>12</TD><TD>20077</TD><TD>223</TD>
<TD>CASK,SEPTIN5,LRRN2,FGFR2,EFR3A,FGF5,EPHA4,TGFBR2,NBEA,NRSN1,UTRN,EFR3B</TD></TR>
<TR><TD>4.173e-02</TD><TD>-3.18</TD><TD>HSPA1B (heat shock protein family A (Hsp70) member 1B)</TD><TD>protein interactions</TD><TD>3304</TD><TD>287</TD><TD>7</TD><TD>20077</TD><TD>223</TD>
<TD>EPHA3,NTRK2,FNIP2,SGCG,GMDS,EPHA4,FGFR2</TD></TR>
<TR><TD>4.179e-02</TD><TD>-3.18</TD><TD>response to gonadotropin</TD><TD>biological process</TD><TD>GO:0034698</TD><TD>28</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>LHCGR,EFNA5</TD></TR>
<TR><TD>4.179e-02</TD><TD>-3.18</TD><TD>regulation of calcium ion-dependent exocytosis</TD><TD>biological process</TD><TD>GO:0017158</TD><TD>28</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>SYT1,RPH3A</TD></TR>
<TR><TD>4.179e-02</TD><TD>-3.18</TD><TD>positive regulation of antigen receptor-mediated signaling pathway</TD><TD>biological process</TD><TD>GO:0050857</TD><TD>28</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>SLC39A10,CD226</TD></TR>
<TR><TD>4.179e-02</TD><TD>-3.18</TD><TD>endochondral bone growth</TD><TD>biological process</TD><TD>GO:0003416</TD><TD>28</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2,FGFR2</TD></TR>
<TR><TD>4.189e-02</TD><TD>-3.17</TD><TD>Calcium Regulation in the Cardiac Cell</TD><TD>WikiPathways</TD><TD>WP536</TD><TD>151</TD><TD>5</TD><TD>5358</TD><TD>68</TD>
<TD>RYR2,CHRM3,RGS5,PRKCE,RGS6</TD></TR>
<TR><TD>4.204e-02</TD><TD>-3.17</TD><TD>Signaling by FGFR2</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654738</TD><TD>75</TD><TD>3</TD><TD>10391</TD><TD>107</TD>
<TD>FGFR2,FGF20,FGF5</TD></TR>
<TR><TD>4.204e-02</TD><TD>-3.17</TD><TD>chordate embryonic development</TD><TD>biological process</TD><TD>GO:0043009</TD><TD>652</TD><TD>13</TD><TD>18905</TD><TD>220</TD>
<TD>TWIST1,ZFPM2,FGFR2,ACVR2A,ACVR1C,ADAMTS3,PAX6,FZD6,SEMA3C,FERD3L,PBX1,ZFAND5,TGFBR2</TD></TR>
<TR><TD>4.213e-02</TD><TD>-3.17</TD><TD>ConA-like_dom_sf</TD><TD>interpro domains</TD><TD>IPR013320</TD><TD>219</TD><TD>6</TD><TD>18605</TD><TD>215</TD>
<TD>PTPRK,FAT4,SLIT2,RYR2,NBEA,CNTNAP2</TD></TR>
<TR><TD>4.230e-02</TD><TD>-3.16</TD><TD>EPHA2 (EPH receptor A2)</TD><TD>protein interactions</TD><TD>1969</TD><TD>350</TD><TD>8</TD><TD>20077</TD><TD>223</TD>
<TD>PHLPP1,NTRK2,EPHA3,EPHA4,FGFR2,EFR3B,EFNA5,CDH5</TD></TR>
<TR><TD>4.239e-02</TD><TD>-3.16</TD><TD>regulation of cell communication</TD><TD>biological process</TD><TD>GO:0010646</TD><TD>3556</TD><TD>52</TD><TD>18905</TD><TD>220</TD>
<TD>WWOX,EFNA5,GHITM,ADAMTS3,SHISA3,GAREM1,ACVR1C,CD226,EPHA4,SLIT2,SEZ6L,SEPTIN5,LHCGR,SYT1,VAV3,FGF20,FGD3,BCHE,ASPN,FGF5,UCHL1,PAQR3,NTRK2,FZD6,MIR1260B,SPAG9,CRTC3,EPS8,PHLPP1,TWIST1,ROBO2,RYR2,PRKCE,NRG1,BANK1,FNIP2,CASK,CHRM3,SLC39A10,DEPTOR,PLEK,LGI1,CDH5,FGFR2,ACVR2A,RGS5,RGS6,TGFBR2,PTPRD,ADAMTS12,PHF14,FBN2</TD></TR>
<TR><TD>4.253e-02</TD><TD>-3.16</TD><TD>RAC3 (Rac family small GTPase 3)</TD><TD>protein interactions</TD><TD>5881</TD><TD>615</TD><TD>12</TD><TD>20077</TD><TD>223</TD>
<TD>PTPRK,SLC39A10,FAT4,SHTN1,DAAM1,UTRN,FZD6,IQGAP2,EPHA3,EFR3A,EMC2,EPS8</TD></TR>
<TR><TD>4.267e-02</TD><TD>-3.15</TD><TD>positive regulation of cell population proliferation</TD><TD>biological process</TD><TD>GO:0008284</TD><TD>995</TD><TD>18</TD><TD>18905</TD><TD>220</TD>
<TD>FGF5,FGFR2,GAREM1,EPHA4,NRG1,REG1B,TWIST1,FGF20,MEGF10,ZFPM2,SLC39A10,INSM1,VAV3,PBX1,SS18,TGFBR2,PAX6,NTRK2</TD></TR>
<TR><TD>4.271e-02</TD><TD>-3.15</TD><TD>ALDH7A1 (aldehyde dehydrogenase 7 family member A1)</TD><TD>protein interactions</TD><TD>501</TD><TD>118</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>NUP35,EMC2,WWOX,EPS8</TD></TR>
<TR><TD>4.271e-02</TD><TD>-3.15</TD><TD>DDR1 (discoidin domain receptor tyrosine kinase 1)</TD><TD>protein interactions</TD><TD>780</TD><TD>118</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>TGFBR2,WWOX,SHISA3,GPR83</TD></TR>
<TR><TD>4.275e-02</TD><TD>-3.15</TD><TD>CH</TD><TD>pfam domains</TD><TD>PF00307</TD><TD>67</TD><TD>3</TD><TD>17869</TD><TD>207</TD>
<TD>NAV3,IQGAP2,UTRN</TD></TR>
<TR><TD>4.290e-02</TD><TD>-3.15</TD><TD>Regulation of Actin Cytoskeleton</TD><TD>WikiPathways</TD><TD>WP51</TD><TD>152</TD><TD>5</TD><TD>5358</TD><TD>68</TD>
<TD>FGF20,FGF14,CHRM3,FGFR2,FGF5</TD></TR>
<TR><TD>4.300e-02</TD><TD>-3.15</TD><TD>NCAM1 (neural cell adhesion molecule 1)</TD><TD>protein interactions</TD><TD>4684</TD><TD>70</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>ARL14,EPHA3,UCHL1</TD></TR>
<TR><TD>4.300e-02</TD><TD>-3.15</TD><TD>DUSP10 (dual specificity phosphatase 10)</TD><TD>protein interactions</TD><TD>11221</TD><TD>70</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>UTRN,FBN2,CASK</TD></TR>
<TR><TD>4.300e-02</TD><TD>-3.15</TD><TD>ITGB3 (integrin subunit beta 3)</TD><TD>protein interactions</TD><TD>3690</TD><TD>70</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>EPS8,PTPRZ1,PECAM1</TD></TR>
<TR><TD>4.307e-02</TD><TD>-3.14</TD><TD>VANGL1 (VANGL planar cell polarity protein 1)</TD><TD>protein interactions</TD><TD>81839</TD><TD>229</TD><TD>6</TD><TD>20077</TD><TD>223</TD>
<TD>PHLPP1,FGFR2,EPHA4,SLC25A46,EPHA3,NTRK2</TD></TR>
<TR><TD>4.325e-02</TD><TD>-3.14</TD><TD>neutrophil migration</TD><TD>biological process</TD><TD>GO:1990266</TD><TD>67</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>PECAM1,CXCL13,VAV3</TD></TR>
<TR><TD>4.325e-02</TD><TD>-3.14</TD><TD>regulation of cardiac muscle tissue growth</TD><TD>biological process</TD><TD>GO:0055021</TD><TD>67</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>FGF20,ZFPM2,FGFR2</TD></TR>
<TR><TD>4.332e-02</TD><TD>-3.14</TD><TD>regulation of molecular function</TD><TD>biological process</TD><TD>GO:0065009</TD><TD>2017</TD><TD>32</TD><TD>18905</TD><TD>220</TD>
<TD>PPP1R17,VAV3,CHRM3,PAX6,LHCGR,NRG1,PRKCE,RYR2,WRN,EPHA4,ACVR1C,CRTC3,CXCL13,TWIST1,SERINC5,EPHA3,EFNA5,FGF14,TGFBR2,PAQR3,NTRK2,UCHL1,PUM3,UTRN,RGS6,FZD6,FGFR2,AKAP9,DEPTOR,PLEK,MAP2,FGD3</TD></TR>
<TR><TD>4.342e-02</TD><TD>-3.14</TD><TD>terminal O-glycans residues modification</TD><TD>BIOCYC pathways</TD><TD>HUMAN_PWY-7434</TD><TD>8</TD><TD>1</TD><TD>907</TD><TD>5</TD>
<TD>FUT9</TD></TR>
<TR><TD>4.344e-02</TD><TD>-3.14</TD><TD>camera-type eye development</TD><TD>biological process</TD><TD>GO:0043010</TD><TD>336</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>PLAAT1,EFEMP1,NTRK2,DSCAM,PAX6,TWIST1,TGFBR2,FBN2</TD></TR>
<TR><TD>4.346e-02</TD><TD>-3.14</TD><TD>Signalling to p38 via RIT and RIN</TD><TD>REACTOME pathways</TD><TD>R-HSA-187706</TD><TD>249</TD><TD>6</TD><TD>10391</TD><TD>107</TD>
<TD>FGFR2,AKAP9,FGF5,FGF20,NRG1,PAQR3</TD></TR>
<TR><TD>4.346e-02</TD><TD>-3.14</TD><TD>ARMS-mediated activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-170984</TD><TD>249</TD><TD>6</TD><TD>10391</TD><TD>107</TD>
<TD>FGFR2,AKAP9,FGF5,FGF20,PAQR3,NRG1</TD></TR>
<TR><TD>4.349e-02</TD><TD>-3.14</TD><TD>SHC1 (SHC adaptor protein 1)</TD><TD>protein interactions</TD><TD>6464</TD><TD>352</TD><TD>8</TD><TD>20077</TD><TD>223</TD>
<TD>VAV3,FGFR2,EPHA4,TEC,EPS8,NTRK2,CDH5,GAREM1</TD></TR>
<TR><TD>4.358e-02</TD><TD>-3.13</TD><TD>ACVRL1 (activin A receptor like type 1)</TD><TD>protein interactions</TD><TD>94</TD><TD>30</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>ACVR2A,TGFBR2</TD></TR>
<TR><TD>4.358e-02</TD><TD>-3.13</TD><TD>PARD6G (par-6 family cell polarity regulator gamma)</TD><TD>protein interactions</TD><TD>84552</TD><TD>30</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>CASK,AKAP9</TD></TR>
<TR><TD>4.358e-02</TD><TD>-3.13</TD><TD>PECAM1 (platelet and endothelial cell adhesion molecule 1)</TD><TD>protein interactions</TD><TD>5175</TD><TD>30</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>PRKCE,PECAM1</TD></TR>
<TR><TD>4.362e-02</TD><TD>-3.13</TD><TD>human chr6p22.3</TD><TD>chromosome location</TD><TD>human chr6p22.3</TD><TD>158</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>NRSN1,CASC15</TD></TR>
<TR><TD>4.362e-02</TD><TD>-3.13</TD><TD>regulation of cell population proliferation</TD><TD>biological process</TD><TD>GO:0042127</TD><TD>1794</TD><TD>29</TD><TD>18905</TD><TD>220</TD>
<TD>CDH5,BCHE,AMELX,FGF5,FGFR2,ZFPM2,FGF20,TGFBR2,PHF14,INSM1,NTRK2,ARX,REG1B,PTPRZ1,NRG1,GAREM1,ACVR1C,EPHA4,SKAP2,PTPRK,MEGF10,TWIST1,SS18,PBX1,SLC39A10,VAV3,FABP7,CASK,PAX6</TD></TR>
<TR><TD>4.370e-02</TD><TD>-3.13</TD><TD>GJA10 (gap junction protein alpha 10)</TD><TD>protein interactions</TD><TD>84694</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>PCAT1</TD></TR>
<TR><TD>4.370e-02</TD><TD>-3.13</TD><TD>RAD50 (MRX complex DNA-binding subunit)</TD><TD>protein interactions</TD><TD>855471</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>WRN</TD></TR>
<TR><TD>4.370e-02</TD><TD>-3.13</TD><TD>ORF52 (ORF52)</TD><TD>protein interactions</TD><TD>4961496</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>PUM3</TD></TR>
<TR><TD>4.370e-02</TD><TD>-3.13</TD><TD>Pax6 (paired box 6)</TD><TD>protein interactions</TD><TD>18508</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>PAX6</TD></TR>
<TR><TD>4.370e-02</TD><TD>-3.13</TD><TD>CASD1 (CAS1 domain containing 1)</TD><TD>protein interactions</TD><TD>64921</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>PCAT1</TD></TR>
<TR><TD>4.370e-02</TD><TD>-3.13</TD><TD>ERI2 (ERI1 exoribonuclease family member 2)</TD><TD>protein interactions</TD><TD>112479</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>DNAJC12</TD></TR>
<TR><TD>4.370e-02</TD><TD>-3.13</TD><TD>Adar (adenosine deaminase, RNA-specific)</TD><TD>protein interactions</TD><TD>56417</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>LINC00624</TD></TR>
<TR><TD>4.370e-02</TD><TD>-3.13</TD><TD>OR52N5 (olfactory receptor family 52 subfamily N member 5)</TD><TD>protein interactions</TD><TD>390075</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>CD226</TD></TR>
<TR><TD>4.370e-02</TD><TD>-3.13</TD><TD>mug82 (putative translation release factor)</TD><TD>protein interactions</TD><TD>2541472</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>MRPL3</TD></TR>
<TR><TD>4.370e-02</TD><TD>-3.13</TD><TD>CALY (calcyon neuron specific vesicular protein)</TD><TD>protein interactions</TD><TD>50632</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>NRG1</TD></TR>
<TR><TD>4.370e-02</TD><TD>-3.13</TD><TD>IGL (immunoglobulin lambda locus)</TD><TD>protein interactions</TD><TD>3535</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>SHTN1</TD></TR>
<TR><TD>4.370e-02</TD><TD>-3.13</TD><TD>MYH16 (myosin heavy chain 16 (pseudogene))</TD><TD>protein interactions</TD><TD>84176</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>WWOX</TD></TR>
<TR><TD>4.370e-02</TD><TD>-3.13</TD><TD>SPATA31G1 (SPATA31 subfamily G member 1)</TD><TD>protein interactions</TD><TD>138724</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>UCHL1</TD></TR>
<TR><TD>4.370e-02</TD><TD>-3.13</TD><TD>MAMLD1 (mastermind like domain containing 1)</TD><TD>protein interactions</TD><TD>10046</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>NUP35</TD></TR>
<TR><TD>4.370e-02</TD><TD>-3.13</TD><TD>CALHM2 (calcium homeostasis modulator family member 2)</TD><TD>protein interactions</TD><TD>51063</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>4.370e-02</TD><TD>-3.13</TD><TD>DAOA (D-amino acid oxidase activator)</TD><TD>protein interactions</TD><TD>267012</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>DAOA</TD></TR>
<TR><TD>4.370e-02</TD><TD>-3.13</TD><TD>Fancc (Fanconi anemia, complementation group C)</TD><TD>protein interactions</TD><TD>14088</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>FANCB</TD></TR>
<TR><TD>4.370e-02</TD><TD>-3.13</TD><TD>IFNL2 (interferon lambda 2)</TD><TD>protein interactions</TD><TD>282616</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>ATG10</TD></TR>
<TR><TD>4.370e-02</TD><TD>-3.13</TD><TD>CPT1B (carnitine palmitoyltransferase 1B)</TD><TD>protein interactions</TD><TD>1375</TD><TD>4</TD><TD>1</TD><TD>20077</TD><TD>223</TD>
<TD>UCHL1</TD></TR>
<TR><TD>4.394e-02</TD><TD>-3.12</TD><TD>calcium ion sensor activity</TD><TD>molecular function</TD><TD>GO:0061891</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>SYT1</TD></TR>
<TR><TD>4.394e-02</TD><TD>-3.12</TD><TD>lactoperoxidase activity</TD><TD>molecular function</TD><TD>GO:0140825</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>PXDNL</TD></TR>
<TR><TD>4.394e-02</TD><TD>-3.12</TD><TD>receptor-receptor interaction</TD><TD>molecular function</TD><TD>GO:0090722</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>FGF20</TD></TR>
<TR><TD>4.394e-02</TD><TD>-3.12</TD><TD>hydroxyapatite binding</TD><TD>molecular function</TD><TD>GO:0046848</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>AMELX</TD></TR>
<TR><TD>4.394e-02</TD><TD>-3.12</TD><TD>telomeric D-loop binding</TD><TD>molecular function</TD><TD>GO:0061821</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>WRN</TD></TR>
<TR><TD>4.394e-02</TD><TD>-3.12</TD><TD>inhibin binding</TD><TD>molecular function</TD><TD>GO:0034711</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>ACVR2A</TD></TR>
<TR><TD>4.394e-02</TD><TD>-3.12</TD><TD>choline binding</TD><TD>molecular function</TD><TD>GO:0033265</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>BCHE</TD></TR>
<TR><TD>4.394e-02</TD><TD>-3.12</TD><TD>ryanodine-sensitive calcium-release channel activity</TD><TD>molecular function</TD><TD>GO:0005219</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>RYR2</TD></TR>
<TR><TD>4.394e-02</TD><TD>-3.12</TD><TD>vitamin E binding</TD><TD>molecular function</TD><TD>GO:0008431</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>AFM</TD></TR>
<TR><TD>4.394e-02</TD><TD>-3.12</TD><TD>Y-form DNA binding</TD><TD>molecular function</TD><TD>GO:0000403</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>WRN</TD></TR>
<TR><TD>4.394e-02</TD><TD>-3.12</TD><TD>brain-derived neurotrophic factor binding</TD><TD>molecular function</TD><TD>GO:0048403</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>NTRK2</TD></TR>
<TR><TD>4.394e-02</TD><TD>-3.12</TD><TD>histone H2AK119 ubiquitin ligase activity</TD><TD>molecular function</TD><TD>GO:0140862</TD><TD>4</TD><TD>1</TD><TD>18530</TD><TD>207</TD>
<TD>PCGF5</TD></TR>
<TR><TD>4.395e-02</TD><TD>-3.12</TD><TD>clathrin-sculpted glutamate transport vesicle</TD><TD>cellular component</TD><TD>GO:0060199</TD><TD>4</TD><TD>1</TD><TD>19868</TD><TD>222</TD>
<TD>SYT1</TD></TR>
<TR><TD>4.395e-02</TD><TD>-3.12</TD><TD>proximal neuron projection</TD><TD>cellular component</TD><TD>GO:1990769</TD><TD>4</TD><TD>1</TD><TD>19868</TD><TD>222</TD>
<TD>MAP2</TD></TR>
<TR><TD>4.395e-02</TD><TD>-3.12</TD><TD>clathrin-sculpted glutamate transport vesicle membrane</TD><TD>cellular component</TD><TD>GO:0060203</TD><TD>4</TD><TD>1</TD><TD>19868</TD><TD>222</TD>
<TD>SYT1</TD></TR>
<TR><TD>4.397e-02</TD><TD>-3.12</TD><TD>cellular response to transforming growth factor beta stimulus</TD><TD>biological process</TD><TD>GO:0071560</TD><TD>165</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>WWOX,CDH5,TGFBR2,PTPRK,FGFR2</TD></TR>
<TR><TD>4.417e-02</TD><TD>-3.12</TD><TD>Frs2-mediated activation</TD><TD>REACTOME pathways</TD><TD>R-HSA-170968</TD><TD>250</TD><TD>6</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,AKAP9,FGF20,NRG1,PAQR3,FGFR2</TD></TR>
<TR><TD>4.424e-02</TD><TD>-3.12</TD><TD>Melanoma</TD><TD>KEGG pathways</TD><TD>ko05218</TD><TD>69</TD><TD>3</TD><TD>7246</TD><TD>83</TD>
<TD>FGF5,FGF20,FGF14</TD></TR>
<TR><TD>4.424e-02</TD><TD>-3.12</TD><TD>Melanoma</TD><TD>KEGG pathways</TD><TD>hsa05218</TD><TD>69</TD><TD>3</TD><TD>7246</TD><TD>83</TD>
<TD>FGF14,FGF20,FGF5</TD></TR>
<TR><TD>4.427e-02</TD><TD>-3.12</TD><TD>regulation of regulated secretory pathway</TD><TD>biological process</TD><TD>GO:1903305</TD><TD>114</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>CASK,RPH3A,SYT1,SEPTIN5</TD></TR>
<TR><TD>4.450e-02</TD><TD>-3.11</TD><TD>positive regulation of cellular process</TD><TD>biological process</TD><TD>GO:0048522</TD><TD>5745</TD><TD>79</TD><TD>18905</TD><TD>220</TD>
<TD>PTPRD,CNTN1,TGFBR2,LMX1A,FBN2,SEMA3C,UHMK1,BRINP3,TCF20,CDH5,LGI1,ACVR2A,FGFR2,RBM20,DEPTOR,GCNT1,CNTNAP2,MAP2,PLEK,SLC39A10,CHRM3,PBX1,CASK,FNIP2,NRG1,PRKCE,ROBO2,RYR2,BANK1,CRTC3,SPAG9,MEGF10,TWIST1,EPHA3,EPS8,ZNF521,INSM1,MIR1260B,DSCAM,NTRK2,UCHL1,UTRN,CYTL1,FUT9,ARX,FGF5,KLF12,AKAP9,FGF20,PCGF5,ZFPM2,UNC5C,SYT1,SS18,VAV3,NAV3,PAX6,HNF4G,EDIL3,LHCGR,PECAM1,ADAMTS3,PTPRZ1,FANCB,REG1B,SHTN1,SLIT2,EPHA4,IRX1,CD226,GAREM1,ACVR1C,PWWP2A,XPO4,WWOX,NRCAM,CXCL13,GHITM,EFNA5</TD></TR>
<TR><TD>4.455e-02</TD><TD>-3.11</TD><TD>atrioventricular valve development</TD><TD>biological process</TD><TD>GO:0003171</TD><TD>29</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>TWIST1,TGFBR2</TD></TR>
<TR><TD>4.455e-02</TD><TD>-3.11</TD><TD>peripheral nervous system axon ensheathment</TD><TD>biological process</TD><TD>GO:0032292</TD><TD>29</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>NTRK2,SLC25A46</TD></TR>
<TR><TD>4.455e-02</TD><TD>-3.11</TD><TD>glandular epithelial cell development</TD><TD>biological process</TD><TD>GO:0002068</TD><TD>29</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>INSM1,PAX6</TD></TR>
<TR><TD>4.455e-02</TD><TD>-3.11</TD><TD>myelination in peripheral nervous system</TD><TD>biological process</TD><TD>GO:0022011</TD><TD>29</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>NTRK2,SLC25A46</TD></TR>
<TR><TD>4.455e-02</TD><TD>-3.11</TD><TD>enteroendocrine cell differentiation</TD><TD>biological process</TD><TD>GO:0035883</TD><TD>29</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6,INSM1</TD></TR>
<TR><TD>4.455e-02</TD><TD>-3.11</TD><TD>central nervous system projection neuron axonogenesis</TD><TD>biological process</TD><TD>GO:0021952</TD><TD>29</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2,EPHA4</TD></TR>
<TR><TD>4.455e-02</TD><TD>-3.11</TD><TD>regulation of cardiac muscle cell action potential</TD><TD>biological process</TD><TD>GO:0098901</TD><TD>29</TD><TD>2</TD><TD>18905</TD><TD>220</TD>
<TD>AKAP9,RYR2</TD></TR>
<TR><TD>4.459e-02</TD><TD>-3.11</TD><TD>HRDC</TD><TD>smart domains</TD><TD>SM00341</TD><TD>3</TD><TD>1</TD><TD>9743</TD><TD>147</TD>
<TD>WRN</TD></TR>
<TR><TD>4.459e-02</TD><TD>-3.11</TD><TD>CDC48_N</TD><TD>smart domains</TD><TD>SM01073</TD><TD>3</TD><TD>1</TD><TD>9743</TD><TD>147</TD>
<TD>AFG2A</TD></TR>
<TR><TD>4.469e-02</TD><TD>-3.11</TD><TD>bone-fibula-osteosarcoma</TD><TD>COSMIC cancer mutations</TD><TD>bone-fibula-osteosarcoma</TD><TD>4</TD><TD>1</TD><TD>16984</TD><TD>193</TD>
<TD>SS18</TD></TR>
<TR><TD>4.469e-02</TD><TD>-3.11</TD><TD>bone-frontal-other-ameloblastoma</TD><TD>COSMIC cancer mutations</TD><TD>bone-frontal-other-ameloblastoma</TD><TD>4</TD><TD>1</TD><TD>16984</TD><TD>193</TD>
<TD>FGFR2</TD></TR>
<TR><TD>4.469e-02</TD><TD>-3.11</TD><TD>soft_tissue-fibrous_tissue_and_uncertain_origin-synovial_sarcoma-poorly_differentiated</TD><TD>COSMIC cancer mutations</TD><TD>soft_tissue-fibrous_tissue_and_uncertain_origin-synovial_sarcoma-poorly_differentiated</TD><TD>4</TD><TD>1</TD><TD>16984</TD><TD>193</TD>
<TD>SS18</TD></TR>
<TR><TD>4.469e-02</TD><TD>-3.11</TD><TD>poorly_differentiated</TD><TD>COSMIC cancer mutations</TD><TD>poorly_differentiated</TD><TD>4</TD><TD>1</TD><TD>16984</TD><TD>193</TD>
<TD>SS18</TD></TR>
<TR><TD>4.487e-02</TD><TD>-3.10</TD><TD>cellular response to retinoic acid</TD><TD>biological process</TD><TD>GO:0071300</TD><TD>68</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>EPHA3,BRINP3,FGFR2</TD></TR>
<TR><TD>4.489e-02</TD><TD>-3.10</TD><TD>MAPK1/MAPK3 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-5684996</TD><TD>251</TD><TD>6</TD><TD>10391</TD><TD>107</TD>
<TD>NRG1,PAQR3,FGF20,FGF5,AKAP9,FGFR2</TD></TR>
<TR><TD>4.493e-02</TD><TD>-3.10</TD><TD>morphogenesis of a branching epithelium</TD><TD>biological process</TD><TD>GO:0061138</TD><TD>166</TD><TD>5</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C,TGFBR2,PBX1,FGFR2,SLIT2</TD></TR>
<TR><TD>4.496e-02</TD><TD>-3.10</TD><TD>regulation of cell-substrate adhesion</TD><TD>biological process</TD><TD>GO:0010810</TD><TD>221</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>PRKCE,UTRN,EFNA5,EPHA3,EDIL3,CASK</TD></TR>
<TR><TD>4.509e-02</TD><TD>-3.10</TD><TD>Negative regulation of FGFR1 signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-5654726</TD><TD>33</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>FGF5,FGF20</TD></TR>
<TR><TD>4.509e-02</TD><TD>-3.10</TD><TD>Signaling by Robo receptor</TD><TD>REACTOME pathways</TD><TD>R-HSA-376176</TD><TD>33</TD><TD>2</TD><TD>10391</TD><TD>107</TD>
<TD>ROBO2,SLIT2</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>Peptidase_C12_UCH</TD><TD>interpro domains</TD><TD>IPR001578</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>UCHL1</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>RGS6/7/9/11_DHEX_sf</TD><TD>interpro domains</TD><TD>IPR047017</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RGS6</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>SPHK1-interactor_AKAP_110</TD><TD>interpro domains</TD><TD>IPR008382</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>SPHKAP</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>FHIP_KELAA_motif</TD><TD>interpro domains</TD><TD>IPR045668</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>FHIP1A</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>RGS_DHEX</TD><TD>interpro domains</TD><TD>IPR040759</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RGS6</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>MTERF</TD><TD>interpro domains</TD><TD>IPR003690</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MTERF1</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>FHIP</TD><TD>interpro domains</TD><TD>IPR019384</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>FHIP1A</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>Pumilio_RNA-bd_rpt</TD><TD>interpro domains</TD><TD>IPR001313</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>PUM3</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>MAST_pre-PK_dom_sf</TD><TD>interpro domains</TD><TD>IPR023142</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MAST4</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>Serum_albumin_N</TD><TD>interpro domains</TD><TD>IPR014760</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>AFM</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>Serum_albumin_CS</TD><TD>interpro domains</TD><TD>IPR020857</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>AFM</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>FHIP_C</TD><TD>interpro domains</TD><TD>IPR045669</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>FHIP1A</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>Neurofascin/L1/NrCAM_C</TD><TD>interpro domains</TD><TD>IPR026966</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NRCAM</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>JNK/Rab-associated_protein-1_N</TD><TD>interpro domains</TD><TD>IPR019143</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>SPAG9</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>RecQ_Zn-bd</TD><TD>interpro domains</TD><TD>IPR032284</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>WRN</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>JHDM2-like</TD><TD>interpro domains</TD><TD>IPR045109</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>JMJD1C</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>Rabphilin/DOC2/Noc2</TD><TD>interpro domains</TD><TD>IPR043566</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RPH3A</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>FGD1-4_PH2</TD><TD>interpro domains</TD><TD>IPR035941</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>FGD3</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>LMBR1-like_membr_prot</TD><TD>interpro domains</TD><TD>IPR006876</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>LMBRD1</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>MAST</TD><TD>interpro domains</TD><TD>IPR037711</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MAST4</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>PBX_PBC_dom</TD><TD>interpro domains</TD><TD>IPR005542</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>PBX1</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>Eps8_SH3</TD><TD>interpro domains</TD><TD>IPR035462</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>EPS8</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>Peptidase_C12_UCH_sf</TD><TD>interpro domains</TD><TD>IPR036959</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>UCHL1</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>NBEA/BDCP_DUF4704</TD><TD>interpro domains</TD><TD>IPR031570</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NBEA</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>EPS8_PTB</TD><TD>interpro domains</TD><TD>IPR033928</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>EPS8</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>CABIT_dom</TD><TD>interpro domains</TD><TD>IPR025946</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>GAREM1</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>Asp_de-COase-like_dom_sf</TD><TD>interpro domains</TD><TD>IPR009010</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>AFG2A</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>MTERF_sf</TD><TD>interpro domains</TD><TD>IPR038538</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MTERF1</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>IGFL</TD><TD>interpro domains</TD><TD>IPR032744</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>IGFL4</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>NBCH_WD40</TD><TD>interpro domains</TD><TD>IPR046851</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>NBEA</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>RGS6/7/9/11</TD><TD>interpro domains</TD><TD>IPR047016</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>RGS6</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>ALB/AFP/VDB</TD><TD>interpro domains</TD><TD>IPR000264</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>AFM</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>Prot_kin_PKC_delta</TD><TD>interpro domains</TD><TD>IPR014376</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>PRKCE</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>FGF_rcpt_fam</TD><TD>interpro domains</TD><TD>IPR016248</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>FGFR2</TD></TR>
<TR><TD>4.543e-02</TD><TD>-3.09</TD><TD>MAST_pre-PK_dom</TD><TD>interpro domains</TD><TD>IPR015022</TD><TD>4</TD><TD>1</TD><TD>18605</TD><TD>215</TD>
<TD>MAST4</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>CABIT</TD><TD>pfam domains</TD><TD>PF12736</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>GAREM1</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>PBC</TD><TD>pfam domains</TD><TD>PF03792</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>PBX1</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>DUF4704</TD><TD>pfam domains</TD><TD>PF15787</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>NBEA</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>NBCH_WD40</TD><TD>pfam domains</TD><TD>PF20426</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>NBEA</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>Serum_albumin</TD><TD>pfam domains</TD><TD>PF00273</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>AFM</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>DUF1908</TD><TD>pfam domains</TD><TD>PF08926</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>MAST4</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>RAI16-like</TD><TD>pfam domains</TD><TD>PF10257</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>FHIP1A</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>IGFL</TD><TD>pfam domains</TD><TD>PF14653</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>IGFL4</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>Peptidase_C12</TD><TD>pfam domains</TD><TD>PF01088</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>UCHL1</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>GDP_Man_Dehyd</TD><TD>pfam domains</TD><TD>PF16363</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>GMDS</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>Bravo_FIGEY</TD><TD>pfam domains</TD><TD>PF13882</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>NRCAM</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>mTERF</TD><TD>pfam domains</TD><TD>PF02536</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>MTERF1</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>KELAA</TD><TD>pfam domains</TD><TD>PF19311</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>FHIP1A</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>LMBR1</TD><TD>pfam domains</TD><TD>PF04791</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>LMBRD1</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>RGS_DHEX</TD><TD>pfam domains</TD><TD>PF18148</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>RGS6</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>Jnk-SapK_ap_N</TD><TD>pfam domains</TD><TD>PF09744</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>SPAG9</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>RecQ_Zn_bind</TD><TD>pfam domains</TD><TD>PF16124</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>WRN</TD></TR>
<TR><TD>4.554e-02</TD><TD>-3.09</TD><TD>DUF5917</TD><TD>pfam domains</TD><TD>PF19314</TD><TD>4</TD><TD>1</TD><TD>17869</TD><TD>207</TD>
<TD>FHIP1A</TD></TR>
<TR><TD>4.562e-02</TD><TD>-3.09</TD><TD>Prolonged ERK activation events</TD><TD>REACTOME pathways</TD><TD>R-HSA-169893</TD><TD>252</TD><TD>6</TD><TD>10391</TD><TD>107</TD>
<TD>FGF20,FGF5,AKAP9,FGFR2,NRG1,PAQR3</TD></TR>
<TR><TD>4.572e-02</TD><TD>-3.09</TD><TD>positive regulation of cell migration</TD><TD>biological process</TD><TD>GO:0030335</TD><TD>594</TD><TD>12</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C,PAX6,PECAM1,TGFBR2,INSM1,SPAG9,CXCL13,TWIST1,PRKCE,CDH5,SHTN1,EPHA4</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>sequestering of TGFbeta in extracellular matrix</TD><TD>biological process</TD><TD>GO:0035583</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FBN2</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>regulation of AV node cell action potential</TD><TD>biological process</TD><TD>GO:0098904</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>RYR2</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>vestibular reflex</TD><TD>biological process</TD><TD>GO:0060005</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>ZPLD1</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>D-amino acid metabolic process</TD><TD>biological process</TD><TD>GO:0046416</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>DAOA</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>myoblast development</TD><TD>biological process</TD><TD>GO:0048627</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>MEGF10</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>positive regulation of core promoter binding</TD><TD>biological process</TD><TD>GO:1904798</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>positive regulation of NK T cell differentiation</TD><TD>biological process</TD><TD>GO:0051138</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>left ventricular cardiac muscle tissue morphogenesis</TD><TD>biological process</TD><TD>GO:0003220</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>RYR2</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis</TD><TD>biological process</TD><TD>GO:1905310</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>oligodendrocyte cell fate commitment</TD><TD>biological process</TD><TD>GO:0021779</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>actomyosin contractile ring assembly actin filament organization</TD><TD>biological process</TD><TD>GO:2000689</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>IQGAP2</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>negative regulation of gonad development</TD><TD>biological process</TD><TD>GO:1905940</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>ZFPM2</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>negative regulation of smooth muscle cell chemotaxis</TD><TD>biological process</TD><TD>GO:0071672</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>regulation of inositol trisphosphate biosynthetic process</TD><TD>biological process</TD><TD>GO:0032960</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>LHCGR</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>negative regulation of apoptotic process in bone marrow cell</TD><TD>biological process</TD><TD>GO:0071866</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>negative regulation of skeletal muscle tissue development</TD><TD>biological process</TD><TD>GO:0048642</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TWIST1</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>regulation of calcium ion-dependent exocytosis of neurotransmitter</TD><TD>biological process</TD><TD>GO:1903233</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SYT1</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>regulation of hepatocyte growth factor receptor signaling pathway</TD><TD>biological process</TD><TD>GO:1902202</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>ADAMTS12</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>positive regulation of synaptic vesicle membrane organization</TD><TD>biological process</TD><TD>GO:1901634</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SYT1</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>trans-synaptic signaling by BDNF</TD><TD>biological process</TD><TD>GO:0099191</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>NTRK2</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>prostate gland morphogenetic growth</TD><TD>biological process</TD><TD>GO:0060737</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FGFR2</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>positive regulation of synaptic vesicle fusion to presynaptic active zone membrane</TD><TD>biological process</TD><TD>GO:0031632</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SYT1</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>regulation of atrial cardiac muscle cell action potential</TD><TD>biological process</TD><TD>GO:0098910</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>RYR2</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>cartilage homeostasis</TD><TD>biological process</TD><TD>GO:1990079</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>CYTL1</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>positive regulation of mitochondrial ATP synthesis coupled electron transport</TD><TD>biological process</TD><TD>GO:1905448</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>GHITM</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>clustering of voltage-gated potassium channels</TD><TD>biological process</TD><TD>GO:0045163</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>N-glycan fucosylation</TD><TD>biological process</TD><TD>GO:0036071</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FUT9</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>positive regulation of inositol trisphosphate biosynthetic process</TD><TD>biological process</TD><TD>GO:0032962</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>LHCGR</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>valine transport</TD><TD>biological process</TD><TD>GO:0015829</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SLC7A8</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>monocyte extravasation</TD><TD>biological process</TD><TD>GO:0035696</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PECAM1</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>calcium-dependent activation of synaptic vesicle fusion</TD><TD>biological process</TD><TD>GO:0099502</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SYT1</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>protein localization to juxtaparanode region of axon</TD><TD>biological process</TD><TD>GO:0071205</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>CNTNAP2</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>mitochondrial potassium ion transmembrane transport</TD><TD>biological process</TD><TD>GO:0140141</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>GHITM</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>response to fluoride</TD><TD>biological process</TD><TD>GO:1902617</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>ASPN</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>peripheral nervous system neuron axonogenesis</TD><TD>biological process</TD><TD>GO:0048936</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SLC25A46</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>specification of loop of Henle identity</TD><TD>biological process</TD><TD>GO:0072086</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>IRX1</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>negative regulation of peroxisome proliferator activated receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0035359</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TWIST1</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>GDP-L-fucose metabolic process</TD><TD>biological process</TD><TD>GO:0046368</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>GMDS</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation</TD><TD>biological process</TD><TD>GO:1905007</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>negative regulation of endothelial cell chemotaxis to fibroblast growth factor</TD><TD>biological process</TD><TD>GO:2000545</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>CXCL13</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>synaptic vesicle targeting</TD><TD>biological process</TD><TD>GO:0016080</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SEPTIN5</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>negative regulation of dendrite extension</TD><TD>biological process</TD><TD>GO:1903860</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SPAG9</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>cellular response to heparin</TD><TD>biological process</TD><TD>GO:0071504</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>lens fiber cell apoptotic process</TD><TD>biological process</TD><TD>GO:1990086</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>oligodendrocyte cell fate specification</TD><TD>biological process</TD><TD>GO:0021778</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>PAX6</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>Langerhans cell differentiation</TD><TD>biological process</TD><TD>GO:0061520</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>TGFBR2</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>brain-derived neurotrophic factor receptor signaling pathway</TD><TD>biological process</TD><TD>GO:0031547</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>NTRK2</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>dichotomous subdivision of terminal units involved in salivary gland branching</TD><TD>biological process</TD><TD>GO:0060666</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SEMA3C</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>regulation of retinal ganglion cell axon guidance</TD><TD>biological process</TD><TD>GO:0090259</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SLIT2</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>L-alanine import across plasma membrane</TD><TD>biological process</TD><TD>GO:1904273</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>SLC7A8</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>pattern specification involved in metanephros development</TD><TD>biological process</TD><TD>GO:0072268</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>IRX1</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>globus pallidus development</TD><TD>biological process</TD><TD>GO:0021759</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>ARX</TD></TR>
<TR><TD>4.575e-02</TD><TD>-3.08</TD><TD>embryonic nail plate morphogenesis</TD><TD>biological process</TD><TD>GO:0035880</TD><TD>4</TD><TD>1</TD><TD>18905</TD><TD>220</TD>
<TD>FZD6</TD></TR>
<TR><TD>4.592e-02</TD><TD>-3.08</TD><TD>heparin binding</TD><TD>molecular function</TD><TD>GO:0008201</TD><TD>174</TD><TD>5</TD><TD>18530</TD><TD>207</TD>
<TD>ADAMTS5,ADAMTS3,FGFR2,CXCL13,SLIT2</TD></TR>
<TR><TD>4.598e-02</TD><TD>-3.08</TD><TD>EGF_CA</TD><TD>pfam domains</TD><TD>PF07645</TD><TD>69</TD><TD>3</TD><TD>17869</TD><TD>207</TD>
<TD>FAT4,EFEMP1,FBN2</TD></TR>
<TR><TD>4.599e-02</TD><TD>-3.08</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia</TD><TD>2082</TD><TD>32</TD><TD>16984</TD><TD>193</TD>
<TD>HNF4G,EPHA3,TGFBR2,KIF6,ZNF133,DAAM1,SYT1,EPHA4,ACVR2A,NTRK2,PSKH2,PTPRK,PRKCE,UBR4,SLC7A8,TRPS1,MAP2,FGD3,ADAMTS12,CASK,FBN2,MPEG1,FGFR2,RGS6,PTPRZ1,TCF20,SPATA16,PRLHR,RUNX1T1,ACVR1C,FAT4,UHMK1</TD></TR>
<TR><TD>4.603e-02</TD><TD>-3.08</TD><TD>TIR</TD><TD>prosite domains</TD><TD>PS50104</TD><TD>26</TD><TD>2</TD><TD>12232</TD><TD>162</TD>
<TD>IL1RAPL2,BANK1</TD></TR>
<TR><TD>4.625e-02</TD><TD>-3.07</TD><TD>DSE (dermatan sulfate epimerase)</TD><TD>protein interactions</TD><TD>29940</TD><TD>31</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>SLC7A14,NRG1</TD></TR>
<TR><TD>4.625e-02</TD><TD>-3.07</TD><TD>MMP15 (matrix metallopeptidase 15)</TD><TD>protein interactions</TD><TD>4324</TD><TD>31</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>PI15,EMC2</TD></TR>
<TR><TD>4.625e-02</TD><TD>-3.07</TD><TD>GNPTG (N-acetylglucosamine-1-phosphate transferase subunit gamma)</TD><TD>protein interactions</TD><TD>84572</TD><TD>31</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>PTPRK,ZPLD1</TD></TR>
<TR><TD>4.635e-02</TD><TD>-3.07</TD><TD>Signaling by Leptin</TD><TD>REACTOME pathways</TD><TD>R-HSA-2586552</TD><TD>253</TD><TD>6</TD><TD>10391</TD><TD>107</TD>
<TD>FGF20,AKAP9,FGF5,FGFR2,NRG1,PAQR3</TD></TR>
<TR><TD>4.640e-02</TD><TD>-3.07</TD><TD>microtubule cytoskeleton</TD><TD>cellular component</TD><TD>GO:0015630</TD><TD>1419</TD><TD>23</TD><TD>19868</TD><TD>222</TD>
<TD>HNF4G,SPAG9,KIF6,DAAM1,DAW1,WRN,SEPTIN5,SHTN1,DCDC2C,AFG2A,NAV3,PCGF5,MAP2,SERINC5,SS18,FIGN,FNIP2,ERCC6L2,CETN3,UBR4,LHCGR,NCKAP5,AKAP9</TD></TR>
<TR><TD>4.663e-02</TD><TD>-3.07</TD><TD>RCOR1 (REST corepressor 1)</TD><TD>protein interactions</TD><TD>23186</TD><TD>488</TD><TD>10</TD><TD>20077</TD><TD>223</TD>
<TD>SPAG9,UBR4,TRPS1,WWOX,JMJD1C,KLF12,NOL4,RBM20,UTRN,SHTN1</TD></TR>
<TR><TD>4.667e-02</TD><TD>-3.06</TD><TD>metencephalon development</TD><TD>biological process</TD><TD>GO:0022037</TD><TD>116</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>CNTN1,SLC25A46,PAX6,LMX1A</TD></TR>
<TR><TD>4.667e-02</TD><TD>-3.06</TD><TD>Notch signaling pathway</TD><TD>biological process</TD><TD>GO:0007219</TD><TD>116</TD><TD>4</TD><TD>18905</TD><TD>220</TD>
<TD>GMDS,CNTN1,TGFBR2,DNER</TD></TR>
<TR><TD>4.679e-02</TD><TD>-3.06</TD><TD>cEGF</TD><TD>interpro domains</TD><TD>IPR026823</TD><TD>30</TD><TD>2</TD><TD>18605</TD><TD>215</TD>
<TD>FBN2,EFEMP1</TD></TR>
<TR><TD>4.696e-02</TD><TD>-3.06</TD><TD>human chr18q22.2</TD><TD>chromosome location</TD><TD>human chr18q22.2</TD><TD>23</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>CD226</TD></TR>
<TR><TD>4.696e-02</TD><TD>-3.06</TD><TD>human chr3p11.1</TD><TD>chromosome location</TD><TD>human chr3p11.1</TD><TD>23</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>EPHA3</TD></TR>
<TR><TD>4.696e-02</TD><TD>-3.06</TD><TD>human chr4p16.2</TD><TD>chromosome location</TD><TD>human chr4p16.2</TD><TD>23</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>CYTL1</TD></TR>
<TR><TD>4.696e-02</TD><TD>-3.06</TD><TD>human chr13q22.2</TD><TD>chromosome location</TD><TD>human chr13q22.2</TD><TD>23</TD><TD>1</TD><TD>193383</TD><TD>404</TD>
<TD>LINC00561</TD></TR>
<TR><TD>4.699e-02</TD><TD>-3.06</TD><TD>cEGF</TD><TD>pfam domains</TD><TD>PF12662</TD><TD>30</TD><TD>2</TD><TD>17869</TD><TD>207</TD>
<TD>EFEMP1,FBN2</TD></TR>
<TR><TD>4.705e-02</TD><TD>-3.06</TD><TD>upper_aerodigestive_tract-sinonasal_and_nasal_cavity-carcinoma-squamous_cell_carcinoma</TD><TD>COSMIC cancer mutations</TD><TD>upper_aerodigestive_tract-sinonasal_and_nasal_cavity-carcinoma-squamous_cell_carcinoma</TD><TD>71</TD><TD>3</TD><TD>16984</TD><TD>193</TD>
<TD>UNC5C,THSD7B,MPEG1</TD></TR>
<TR><TD>4.710e-02</TD><TD>-3.06</TD><TD>Mesodermal Commitment Pathway</TD><TD>WikiPathways</TD><TD>WP2857</TD><TD>156</TD><TD>5</TD><TD>5358</TD><TD>68</TD>
<TD>PBX1,PAX6,ACVR2A,PARP8,VAV3</TD></TR>
<TR><TD>4.714e-02</TD><TD>-3.05</TD><TD>human chr7q36.1</TD><TD>chromosome location</TD><TD>human chr7q36.1</TD><TD>165</TD><TD>2</TD><TD>193383</TD><TD>404</TD>
<TD>LOC100134040,ACTR3C</TD></TR>
<TR><TD>4.725e-02</TD><TD>-3.05</TD><TD>cell projection membrane</TD><TD>cellular component</TD><TD>GO:0031253</TD><TD>356</TD><TD>8</TD><TD>19868</TD><TD>222</TD>
<TD>ROBO2,CASK,CNTNAP2,UTRN,EPS8,SLC7A8,GAP43,PLEK</TD></TR>
<TR><TD>4.745e-02</TD><TD>-3.05</TD><TD>regulation of transmembrane transporter activity</TD><TD>biological process</TD><TD>GO:0022898</TD><TD>224</TD><TD>6</TD><TD>18905</TD><TD>220</TD>
<TD>AKAP9,CHRM3,PRKCE,FGF14,UTRN,RYR2</TD></TR>
<TR><TD>4.749e-02</TD><TD>-3.05</TD><TD>small molecule binding</TD><TD>molecular function</TD><TD>GO:0036094</TD><TD>6276</TD><TD>82</TD><TD>18530</TD><TD>207</TD>
<TD>LMX1A,AOAH,FGD3,ADAM28,MAST4,ERCC6L2,PSKH2,ZFPM2,CPXM2,PCGF5,UBR4,DNER,WRN,SYT1,LMBRD1,ACVR2A,ZFAND5,REXO2,RYR2,PRKCE,GAP43,VAV3,CHRM3,INSM1,GMDS,EPHA4,ZNF521,FABP7,PXDNL,FBN2,BCHE,CALN1,TGFBR2,TEC,ADAMTS5,ADAMTS3,NTRK2,SLIT2,B3GAT2,EDIL3,PHLPP1,ASPN,ZNF133,IQGAP2,ADGRL3,GALNT15,EFEMP1,AFM,JMJD1C,AMELX,MARCHF11,NAV3,KLF12,ZNF518B,CPQ,RBM20,PLEK,DEPTOR,HNF4G,ADAMTS12,ARL14,FGFR2,EPHA3,UTRN,MARCHF3,PHF14,FIGN,PCDH9,MATCAP2,FAT4,RUNX1T1,KIF6,AFG2A,ACTR3C,TCF20,CASK,SEPTIN5,CETN3,ACVR1C,TRPS1,UHMK1,RPH3A</TD></TR>
<TR><TD>4.770e-02</TD><TD>-3.04</TD><TD>PKNOX1 (PBX/knotted 1 homeobox 1)</TD><TD>protein interactions</TD><TD>5316</TD><TD>73</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>PBX1,PAX6,FMNL2</TD></TR>
<TR><TD>4.770e-02</TD><TD>-3.04</TD><TD>TMED4 (transmembrane p24 trafficking protein 4)</TD><TD>protein interactions</TD><TD>222068</TD><TD>73</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>SLC7A14,EMC2,LGI1</TD></TR>
<TR><TD>4.782e-02</TD><TD>-3.04</TD><TD>PI3K Cascade</TD><TD>REACTOME pathways</TD><TD>R-HSA-109704</TD><TD>79</TD><TD>3</TD><TD>10391</TD><TD>107</TD>
<TD>FGFR2,FGF20,FGF5</TD></TR>
<TR><TD>4.783e-02</TD><TD>-3.04</TD><TD>Interleukin receptor SHC signaling</TD><TD>REACTOME pathways</TD><TD>R-HSA-912526</TD><TD>255</TD><TD>6</TD><TD>10391</TD><TD>107</TD>
<TD>FGF20,AKAP9,FGF5,FGFR2,PAQR3,NRG1</TD></TR>
<TR><TD>4.797e-02</TD><TD>-3.04</TD><TD>SRC (SRC proto-oncogene, non-receptor tyrosine kinase)</TD><TD>protein interactions</TD><TD>6714</TD><TD>627</TD><TD>12</TD><TD>20077</TD><TD>223</TD>
<TD>WWOX,PRKCE,EPS8,EPHA3,ARL14,SKAP2,EPHA4,FGFR2,PECAM1,EFNA5,CDH5,MAP2</TD></TR>
<TR><TD>4.811e-02</TD><TD>-3.03</TD><TD>-</TD><TD>gene3d domains</TD><TD>1.10.1240.60</TD><TD>4</TD><TD>1</TD><TD>14531</TD><TD>178</TD>
<TD>RGS6</TD></TR>
<TR><TD>4.811e-02</TD><TD>-3.03</TD><TD>Peptidase C12, ubiquitin carboxyl-terminal hydrolase</TD><TD>gene3d domains</TD><TD>3.40.532.10</TD><TD>4</TD><TD>1</TD><TD>14531</TD><TD>178</TD>
<TD>UCHL1</TD></TR>
<TR><TD>4.811e-02</TD><TD>-3.03</TD><TD>MAST3 pre-PK domain-like</TD><TD>gene3d domains</TD><TD>1.20.1480.20</TD><TD>4</TD><TD>1</TD><TD>14531</TD><TD>178</TD>
<TD>MAST4</TD></TR>
<TR><TD>4.811e-02</TD><TD>-3.03</TD><TD>Transcription termination factor 3, mitochondrial</TD><TD>gene3d domains</TD><TD>1.25.70.10</TD><TD>4</TD><TD>1</TD><TD>14531</TD><TD>178</TD>
<TD>MTERF1</TD></TR>
<TR><TD>4.811e-02</TD><TD>-3.03</TD><TD>-</TD><TD>gene3d domains</TD><TD>6.10.250.230</TD><TD>4</TD><TD>1</TD><TD>14531</TD><TD>178</TD>
<TD>RUNX1T1</TD></TR>
<TR><TD>4.820e-02</TD><TD>-3.03</TD><TD>ovulation cycle</TD><TD>biological process</TD><TD>GO:0042698</TD><TD>70</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>ROBO2,LHCGR,SLIT2</TD></TR>
<TR><TD>4.845e-02</TD><TD>-3.03</TD><TD>EIF2B3 (eukaryotic translation initiation factor 2B subunit gamma)</TD><TD>protein interactions</TD><TD>8891</TD><TD>123</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>FGF14,CD226,SYT1,DEPTOR</TD></TR>
<TR><TD>4.845e-02</TD><TD>-3.03</TD><TD>TPST2 (tyrosylprotein sulfotransferase 2)</TD><TD>protein interactions</TD><TD>8459</TD><TD>123</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>SPAG9,XPO4,IPO8,NRSN1</TD></TR>
<TR><TD>4.852e-02</TD><TD>-3.03</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelofibrosis</TD><TD>COSMIC cancer mutations</TD><TD>haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelofibrosis</TD><TD>416</TD><TD>9</TD><TD>16984</TD><TD>193</TD>
<TD>ADAMTS12,CDH5,FAT4,FUT9,FBN2,SLC7A8,PARP8,PRSS12,ZNF521</TD></TR>
<TR><TD>4.852e-02</TD><TD>-3.03</TD><TD>myelofibrosis</TD><TD>COSMIC cancer mutations</TD><TD>myelofibrosis</TD><TD>416</TD><TD>9</TD><TD>16984</TD><TD>193</TD>
<TD>ZNF521,PRSS12,SLC7A8,PARP8,FBN2,FUT9,CDH5,FAT4,ADAMTS12</TD></TR>
<TR><TD>4.858e-02</TD><TD>-3.02</TD><TD>SP7 (Sp7 transcription factor)</TD><TD>protein interactions</TD><TD>121340</TD><TD>297</TD><TD>7</TD><TD>20077</TD><TD>223</TD>
<TD>PCGF5,TRPS1,SS18,FBN2,RBM20,PBX1,TCF20</TD></TR>
<TR><TD>4.859e-02</TD><TD>-3.02</TD><TD>Signalling to RAS</TD><TD>REACTOME pathways</TD><TD>R-HSA-167044</TD><TD>256</TD><TD>6</TD><TD>10391</TD><TD>107</TD>
<TD>FGFR2,PAQR3,NRG1,FGF20,FGF5,AKAP9</TD></TR>
<TR><TD>4.865e-02</TD><TD>-3.02</TD><TD>Mucin type O-glycan biosynthesis</TD><TD>KEGG pathways</TD><TD>hsa00512</TD><TD>31</TD><TD>2</TD><TD>7246</TD><TD>83</TD>
<TD>GALNT15,GCNT1</TD></TR>
<TR><TD>4.865e-02</TD><TD>-3.02</TD><TD>Mucin type O-glycan biosynthesis</TD><TD>KEGG pathways</TD><TD>ko00512</TD><TD>31</TD><TD>2</TD><TD>7246</TD><TD>83</TD>
<TD>GCNT1,GALNT15</TD></TR>
<TR><TD>4.870e-02</TD><TD>-3.02</TD><TD>adrenal_gland-adrenal_gland-adrenal_cortical_adenoma-cortisol_producing</TD><TD>COSMIC cancer mutations</TD><TD>adrenal_gland-adrenal_gland-adrenal_cortical_adenoma-cortisol_producing</TD><TD>72</TD><TD>3</TD><TD>16984</TD><TD>193</TD>
<TD>RYR2,LRFN5,FAT4</TD></TR>
<TR><TD>4.870e-02</TD><TD>-3.02</TD><TD>cortisol_producing</TD><TD>COSMIC cancer mutations</TD><TD>cortisol_producing</TD><TD>72</TD><TD>3</TD><TD>16984</TD><TD>193</TD>
<TD>FAT4,RYR2,LRFN5</TD></TR>
<TR><TD>4.878e-02</TD><TD>-3.02</TD><TD>HADHA (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha)</TD><TD>protein interactions</TD><TD>3030</TD><TD>492</TD><TD>10</TD><TD>20077</TD><TD>223</TD>
<TD>CETN3,UBR4,CASK,WWOX,PTPRD,EMC2,CDH5,EPHA4,FGFR2,PSKH2</TD></TR>
<TR><TD>4.879e-02</TD><TD>-3.02</TD><TD>bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour</TD><TD>COSMIC cancer mutations</TD><TD>bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour</TD><TD>6026</TD><TD>80</TD><TD>16984</TD><TD>193</TD>
<TD>SS18,PHLPP1,AKAP9,PSKH2,NTRK2,NCKAP5,PRSS12,EDIL3,EPHA4,VAV3,WRN,FANCB,ZNF133,THSD7A,SEZ6L,UNC5C,PARP8,BCHE,KLF12,THSD7B,IQGAP2,RUNX1T1,ACVR1C,AFM,KCNK9,SERGEF,ZNF521,FGFR2,PHF14,LRFN5,FGF14,FBN2,RAI2,CDH5,FGD3,ADAM28,B3GAT2,MAP2,LMBRD1,NRCAM,UBR4,SPHKAP,CNTN1,PAX6,COQ2,FGF5,NAV3,GAP43,RGS5,ADAMTS5,ACVR2A,UTRN,NRG1,SPAG9,DSCAM,OR52K2,JMJD1C,PTPRD,GPR83,ZFPM2,EPHA3,RBM20,FAT4,PRLHR,CPXM2,BANK1,LMX1A,TCF20,RGS6,PTPRZ1,CELF2,TMEFF2,ZPLD1,NAALADL2,SLC39A10,EPYC,PXDNL,PRKCE,IPO8,RYR2</TD></TR>
<TR><TD>4.883e-02</TD><TD>-3.02</TD><TD>CCL3 (C-C motif chemokine ligand 3)</TD><TD>protein interactions</TD><TD>6348</TD><TD>178</TD><TD>5</TD><TD>20077</TD><TD>223</TD>
<TD>BCHE,SLIT2,EDIL3,SEMA3C,PRSS12</TD></TR>
<TR><TD>4.893e-02</TD><TD>-3.02</TD><TD>Ephrin A  reverse signaling</TD><TD>Pathway Interaction DB</TD><TD>ephrinarevpathway</TD><TD>3</TD><TD>1</TD><TD>2232</TD><TD>37</TD>
<TD>EFNA5</TD></TR>
<TR><TD>4.898e-02</TD><TD>-3.02</TD><TD>DSG3 (desmoglein 3)</TD><TD>protein interactions</TD><TD>1830</TD><TD>32</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>NRSN1,WWOX</TD></TR>
<TR><TD>4.898e-02</TD><TD>-3.02</TD><TD>SERINC5 (serine incorporator 5)</TD><TD>protein interactions</TD><TD>256987</TD><TD>32</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>SERINC5,UBR4</TD></TR>
<TR><TD>4.898e-02</TD><TD>-3.02</TD><TD>SLC2A9 (solute carrier family 2 member 9)</TD><TD>protein interactions</TD><TD>56606</TD><TD>32</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>RAI2,SLC25A46</TD></TR>
<TR><TD>4.898e-02</TD><TD>-3.02</TD><TD>MCOLN2 (mucolipin TRP cation channel 2)</TD><TD>protein interactions</TD><TD>255231</TD><TD>32</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>PTPRD,UTRN</TD></TR>
<TR><TD>4.898e-02</TD><TD>-3.02</TD><TD>ELL2 (elongation factor for RNA polymerase II 2)</TD><TD>protein interactions</TD><TD>22936</TD><TD>32</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>EFR3A,CASK</TD></TR>
<TR><TD>4.898e-02</TD><TD>-3.02</TD><TD>RUFY2 (RUN and FYVE domain containing 2)</TD><TD>protein interactions</TD><TD>55680</TD><TD>32</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>DSCAM,EPHA3</TD></TR>
<TR><TD>4.898e-02</TD><TD>-3.02</TD><TD>NXPH2 (neurexophilin 2)</TD><TD>protein interactions</TD><TD>11249</TD><TD>32</TD><TD>2</TD><TD>20077</TD><TD>223</TD>
<TD>FAT4,PCDH9</TD></TR>
<TR><TD>4.916e-02</TD><TD>-3.01</TD><TD>Arrhythmogenic right ventricular cardiomyopathy (ARVC)</TD><TD>KEGG pathways</TD><TD>ko05412</TD><TD>72</TD><TD>3</TD><TD>7246</TD><TD>83</TD>
<TD>RYR2,SGCG,SGCD</TD></TR>
<TR><TD>4.916e-02</TD><TD>-3.01</TD><TD>Arrhythmogenic right ventricular cardiomyopathy (ARVC)</TD><TD>KEGG pathways</TD><TD>hsa05412</TD><TD>72</TD><TD>3</TD><TD>7246</TD><TD>83</TD>
<TD>RYR2,SGCG,SGCD</TD></TR>
<TR><TD>4.929e-02</TD><TD>-3.01</TD><TD>AAA</TD><TD>prosite domains</TD><TD>PS00674</TD><TD>27</TD><TD>2</TD><TD>12232</TD><TD>162</TD>
<TD>AFG2A,FIGN</TD></TR>
<TR><TD>4.933e-02</TD><TD>-3.01</TD><TD>BNIP3L (BCL2 interacting protein 3 like)</TD><TD>protein interactions</TD><TD>665</TD><TD>74</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>ROBO2,SLC25A46,CASK</TD></TR>
<TR><TD>4.933e-02</TD><TD>-3.01</TD><TD>CBARP (CACN subunit beta associated regulatory protein)</TD><TD>protein interactions</TD><TD>255057</TD><TD>74</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>NTRK2,ARL14,PHLPP1</TD></TR>
<TR><TD>4.933e-02</TD><TD>-3.01</TD><TD>FUT11 (fucosyltransferase 11)</TD><TD>protein interactions</TD><TD>170384</TD><TD>74</TD><TD>3</TD><TD>20077</TD><TD>223</TD>
<TD>PI15,LGI1,PTPRK</TD></TR>
<TR><TD>4.933e-02</TD><TD>-3.01</TD><TD>regulation of actin cytoskeleton organization</TD><TD>biological process</TD><TD>GO:0032956</TD><TD>345</TD><TD>8</TD><TD>18905</TD><TD>220</TD>
<TD>IQGAP2,TMEFF2,PLEK,EPS8,EFNA5,EPHA3,PRKCE,SLIT2</TD></TR>
<TR><TD>4.948e-02</TD><TD>-3.01</TD><TD>protein tyrosine kinase activator activity</TD><TD>molecular function</TD><TD>GO:0030296</TD><TD>32</TD><TD>2</TD><TD>18530</TD><TD>207</TD>
<TD>EFNA5,NRG1</TD></TR>
<TR><TD>4.965e-02</TD><TD>-3.00</TD><TD>BRMS1L (BRMS1 like transcriptional repressor)</TD><TD>protein interactions</TD><TD>84312</TD><TD>124</TD><TD>4</TD><TD>20077</TD><TD>223</TD>
<TD>PBX1,KLF12,PWWP2A,PAX6</TD></TR>
<TR><TD>4.974e-02</TD><TD>-3.00</TD><TD>regulation of MAPK cascade</TD><TD>biological process</TD><TD>GO:0043408</TD><TD>669</TD><TD>13</TD><TD>18905</TD><TD>220</TD>
<TD>UCHL1,NTRK2,PAQR3,FGF5,FGFR2,BANK1,GAREM1,EPHA4,PRKCE,NRG1,PHLPP1,SPAG9,FGF20</TD></TR>
<TR><TD>4.982e-02</TD><TD>-3.00</TD><TD>eIF5A regulation in response to inhibition of the nuclear export system</TD><TD>WikiPathways</TD><TD>WP3302</TD><TD>4</TD><TD>1</TD><TD>5358</TD><TD>68</TD>
<TD>XPO4</TD></TR>
<TR><TD>4.982e-02</TD><TD>-3.00</TD><TD>Caffeine and Theobromine metabolism</TD><TD>WikiPathways</TD><TD>WP3633</TD><TD>4</TD><TD>1</TD><TD>5358</TD><TD>68</TD>
<TD>NAT2</TD></TR>
<TR><TD>4.991e-02</TD><TD>-3.00</TD><TD>negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction</TD><TD>biological process</TD><TD>GO:0051898</TD><TD>71</TD><TD>3</TD><TD>18905</TD><TD>220</TD>
<TD>PHLPP1,TWIST1,BANK1</TD></TR>
</TABLE>
</BODY></HTML>
